<SEC-DOCUMENT>0000105770-24-000066.txt : 20240725
<SEC-HEADER>0000105770-24-000066.hdr.sgml : 20240725
<ACCEPTANCE-DATETIME>20240725161057
ACCESSION NUMBER:		0000105770-24-000066
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		98
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240725
DATE AS OF CHANGE:		20240725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		241142173

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>wst-20240630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7,d:8e08f59eae304691ab0e971847e56044-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:wst="http://www.westpharma.com/20240630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>wst-20240630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0000105770</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-26">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-427">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-429">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-431">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="wst-20240630.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:unit id="bbl"><xbrli:measure>utr:bbl</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerBbl"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>wst:bbl</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>wst:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardContractsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardContractsTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2022RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-02</xbrli:startDate><xbrli:endDate>2024-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-07-05</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8e08f59eae304691ab0e971847e56044_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.&#160;&#160;20549</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June&#160;30, 2024</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-8036</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.107%"><tr><td style="width:1.0%"/><td style="width:6.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.975%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.109%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Pennsylvania</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">23-1210010</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">530 Herman O. West Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Exton</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">PA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">19341-1147</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">610</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">594-2900</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:40.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.25 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">WST</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:27.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;       </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="margin-bottom:6pt;text-indent:432pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9745;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;22, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">72,541,593</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:63.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_13">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_16">FINANCIAL STATEMENTS (UNAUDITED)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_19">Condensed Consolidated Statements of Income for the Three and Six Months ended June&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_22">Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months ended June&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_25">Condensed Consolidated Balance Sheets at June&#160;30, 2024 and December 31, 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_25">5</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_28">Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_88">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_88">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_100">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_100">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_103">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_103">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_106">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_109">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_109">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_112">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_112">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_115">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_115">42</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_124">EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_124">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_127">SIGNATURE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_127">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.   FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-30">702.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-31">753.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-32">1,397.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-33">1,470.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-34">472.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-35">462.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-36">937.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-37">907.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-38">230.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-39">291.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-40">460.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-41">562.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-42">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-43">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-44">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-45">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-46">83.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-47">88.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-48">169.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-49">174.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-50">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-51">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-52">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-53">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-54">126.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-55">182.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-56">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-57">337.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-58">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-59">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-60">3.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-61">4.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-62">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-63">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-64">10.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-65">9.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other nonoperating (income) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-67">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-69">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-70">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-71">184.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-72">256.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-73">342.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-74">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-75">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-76">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-77">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net income of affiliated companies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-78">4.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-79">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-80">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-81">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-82">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-83">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-84">226.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-85">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-86">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-87">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-88">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-89">3.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-90">1.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-91">2.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-92">3.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-93">3.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-94">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-95">74.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-96">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-97">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-98">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-99">75.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-100">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-101">75.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-102">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-103">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-104">226.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-105">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="f-106">0.7</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="f-107">1.3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="f-108">1.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" scale="6" id="f-109">1.5</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-110">21.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-111">11.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-112">68.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-113">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and other postretirement plan adjustments, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="f-114">0.1</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="f-115">0.3</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="f-116">0.1</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="f-117">0.5</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-118">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-119">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-120">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-121">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on equity affiliate accumulated other comprehensive income, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OciEquityMethodInvestmentTaxParent" scale="6" id="f-122">0.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OciEquityMethodInvestmentTaxParent" scale="6" id="f-123">0.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OciEquityMethodInvestmentTaxParent" scale="6" id="f-124">0.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OciEquityMethodInvestmentTaxParent" scale="6" id="f-125">0.0</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTaxParent" scale="6" id="f-126">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTaxParent" scale="6" id="f-127">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTaxParent" scale="6" id="f-128">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTaxParent" scale="6" id="f-129">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on derivatives, net of tax of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="f-130">0.3</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="f-131">1.0</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="f-132">0.4</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="f-133">1.1</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="f-134">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="f-135">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="f-136">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" scale="6" id="f-137">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-138">24.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-139">15.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-140">73.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-141">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-142">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-143">140.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-144">153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-145">294.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-146">446.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-147">853.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-148">479.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-149">512.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-150">419.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-151">434.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-152">138.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-153">135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-154">1,483.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-155">1,936.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-156">2,863.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-157">2,738.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-158">1,369.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-159">1,324.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-160">1,493.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-161">1,413.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-162">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-163">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investments in affiliated companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-164">198.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-165">210.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-166">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-167">108.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-168">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-169">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-170">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-171">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-172">50.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-173">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-174">3,489.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-175">3,829.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Notes payable and other current debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="f-176">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="f-177">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-178">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-179">242.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued salaries, wages and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="f-180">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="f-181">105.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-182">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-183">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-184">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-185">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-186">169.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-187">155.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-188">633.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-189">671.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-190">72.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-191">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-192">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-193">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-194">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="f-195">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-196">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-197">84.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="f-198">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="f-199">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-200">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-201">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-202">912.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-203">948.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-204"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-7" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-205"/></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock, <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-206"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-207">3.0</ix:nonFraction></ix:nonFraction>&#160;million shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-208"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-209"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-210"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-211">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-214"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-215">0.25</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-216"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-217">200.0</ix:nonFraction></ix:nonFraction> million shares authorized; shares issued: <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-218">75.3</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-219">75.3</ix:nonFraction> million as of June 30,2024 and December 31, 2023, respectively; shares outstanding: <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-220">72.6</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-221">73.5</ix:nonFraction> million as of June 30, 2024 and December 31, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-222">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-223">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-224">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-225">120.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-226">3,720.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-227">3,523.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-228">216.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-229">143.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-230">2.7</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-231">1.8</ix:nonFraction> million shares)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-232">979.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-233">637.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-234">2,576.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-235">2,881.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-236">3,489.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-237">3,829.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-238">226.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-239">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-240">72.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-241">64.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-242">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="f-243">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-244">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-245">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="6" id="f-246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-247">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-248">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-249">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash items, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-250">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-251">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="f-252">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="f-253">72.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-254">283.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-255">307.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-256">190.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-257">157.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-258">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-259">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-260">191.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-261">164.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-262">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="f-264">36.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="f-265">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal repayments on finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-266">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="6" id="f-267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-268">29.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-269">28.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="f-270">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="f-271">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="6" id="f-272">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="6" id="f-273">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-274">454.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-275">233.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for employee tax withholdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-276">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-277">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-278">489.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-279">247.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-280">9.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-281">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-282">407.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-283">98.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, including cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-284">853.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-285">894.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, including cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-286">446.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-287">796.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-288" continuedAt="f-288-1" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-289" escape="true"><ix:continuation id="f-288-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial reporting and U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and six months ended June&#160;30, 2024, should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as &#8220;West&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577024000015/wst-20231231.htm">2023 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The results of operations for any interim period are not necessarily indicative of results for the full year.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="f-290" continuedAt="f-290-1" escape="true">New Accounting Standards</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-291" continuedAt="f-291-1" escape="true"><ix:continuation id="f-290-1" continuedAt="f-290-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendment enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures. The Company does not expect the adoption to have a material impact on the consolidated financial statements and disclosures.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-291-1"><ix:continuation id="f-290-2">In December 2023, the FASB issued guidance that seeks to enhance income tax disclosures to provide information to better assess how an entity's operations and related tax risks affect its tax rate and prospects for future cash flows. Within the income tax rate reconciliation, the amendment requires disclosure of additional categories and greater detail about individual reconciling items over a specified threshold. It also requires information pertaining to taxes paid to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions over a specified threshold. This guidance is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures, but we do not expect the adoption to have a material impact on the consolidated financial statements other than the expanded footnote disclosure.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_40"></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-292" continuedAt="f-292-1" escape="true">Revenue</ix:nonNumeric></span></div><div style="margin-bottom:1pt"><span><br/></span></div><ix:continuation id="f-292-1" continuedAt="f-292-2"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. </span></div></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-292-2" continuedAt="f-292-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-293" continuedAt="f-293-1" escape="true"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-294">36</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-295">37</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-296">37</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-297">36</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonFraction unitRef="number" contextRef="c-14" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-298">18</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-15" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-299">20</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-16" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-300">18</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-17" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-301">20</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-302">26</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-19" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-303">25</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-304">25</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-21" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-305">26</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-22" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-306">20</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-23" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-307">18</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-24" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-308">20</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-25" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-309">18</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-26" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-310">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-27" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-311">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-28" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-312">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-29" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-313">100</ix:nonFraction> %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-30" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-314">46</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-315">49</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-316">46</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-33" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-317">50</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-34" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-318">11</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-35" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-319">12</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-36" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-320">11</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-37" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-321">10</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-38" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-322">23</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-39" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-323">21</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-40" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-324">23</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-41" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-325">22</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-42" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-326">20</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-43" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-327">18</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-44" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-328">20</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-45" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-329">18</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-46" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-330">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-47" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-331">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-48" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-332">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-49" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-333">100</ix:nonFraction> %</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company's reassessment of product categories, beginning in the second quarter of 2023 certain product types have been moved from High-Value Product Components to High-Value Product Delivery Devices. No adjustments were made to the product categorization prior to the second quarter of 2023. </span></div><div style="margin-bottom:1pt"><span><br/></span></div><ix:continuation id="f-293-1"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-50" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-334">43</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-51" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-335">44</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-52" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-336">43</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-53" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-337">44</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-54" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-338">48</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-55" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-339">46</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-56" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-340">48</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-57" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-341">47</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-58" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-342">9</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-59" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-343">10</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-344">9</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-345">9</ix:nonFraction> %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-62" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-346">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-63" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-347">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-64" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-348">100</ix:nonFraction> %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-65" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-349">100</ix:nonFraction> %</span></div></td></tr></table></div></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:1pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-350" escape="true"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-351">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-352">22.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="f-353">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-354">53.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-355">52.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - decrease (increase)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-356">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-292-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. During the six months ended June&#160;30, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="f-357">24.2</ix:nonFraction>&#160;million of revenue was recognized that was included in deferred income at the beginning of the year. </span></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year are not material as of June&#160;30, 2024.</span></div></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-358" continuedAt="f-358-1" escape="true">Net Income Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-358-1" continuedAt="f-358-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-359" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-360">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-361">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-362">226.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-363">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-364">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-365">74.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-366">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-367">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-368">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-369">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-370">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-371">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-372">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-373">75.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-374">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-375">75.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2024 and 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-376">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-377">0.1</ix:nonFraction> million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-378">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-379">0.1</ix:nonFraction> million antidilutive shares outstanding during the six months ended June&#160;30, 2024 and 2023, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $<ix:nonFraction unitRef="shares" contextRef="c-66" decimals="INF" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="9" id="f-380">1.0</ix:nonFraction>&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2024, we purchased <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-381">509,336</ix:nonFraction> shares of our common stock under the program at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-382">187.1</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-383">367.48</ix:nonFraction> per share. During the six months ended June&#160;30, 2024, we purchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-384">1,239,015</ix:nonFraction> shares of our common stock under the program at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-385">454.1</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-386">366.53</ix:nonFraction> per share. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-358-2">During the three months ended June&#160;30, 2023, we purchased <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-387">492,710</ix:nonFraction> shares of our common stock under the program at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-388">173.4</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-389">351.82</ix:nonFraction> per share. During the six months ended June&#160;30, 2023, we purchased <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-390">676,070</ix:nonFraction> shares of our common stock under the program at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-391">233.5</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-392">345.33</ix:nonFraction> per share.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-393" continuedAt="f-393-1" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-394" escape="true"><ix:continuation id="f-393-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory balances were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.611%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-395">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-396">172.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-397">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-398">87.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-399">164.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-400">175.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-401">419.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-402">434.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-404" continuedAt="f-404-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-403" continuedAt="f-403-1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-404-1" continuedAt="f-404-2"><ix:continuation id="f-403-1" continuedAt="f-403-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. Lease payments included in the measurement of the lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-405" continuedAt="f-405-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-406">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-407">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-408">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-409">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease - amortization of right-of-use (ROU) assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-410">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:fixed-zero" scale="6" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-412">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:fixed-zero" scale="6" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-414">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-415">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-416">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-417">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-418">1.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-419">1.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-420">3.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-421">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-422">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-423">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-424">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-425">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="wst:ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" id="f-426" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.746%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.831%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-427">Other noncurrent assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-428">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (current)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-429">Other current liabilities</span></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-430">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (noncurrent)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-431">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-432">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-404-2" continuedAt="f-404-3"><ix:continuation id="f-403-2" continuedAt="f-403-3"><ix:continuation id="f-405-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-433">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-434">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-435">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-436">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-437">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="6" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-439">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="6" id="f-440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-441">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-442">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-443">34.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-444">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-445">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-447">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average remaining lease term for operating leases was <ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-449">8.6</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-450">9.8</ix:nonNumeric> years, respectively. As of June&#160;30, 2024, the weighted average remaining lease term for finance leases was <ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-451">7.6</ix:nonNumeric> years. As of December&#160;31, 2023, finance leases were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average discount rate for operating leases was <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-452">3.96</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-453">3.55</ix:nonFraction>%, respectively. As of June&#160;30, 2024, the weighted average discount rate for finance leases was <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-454">4.94</ix:nonFraction>%. As of December&#160;31, 2023, finance leases were not material.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-404-3"><ix:continuation id="f-403-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-455" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="f-456">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="f-457">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-458">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-459">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-460">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-461">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-462">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-463">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-464">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-465">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="6" id="f-466">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="6" id="f-467">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-468">119.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-469">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-470">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-471">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-472">104.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-473">102.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-474" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="f-475">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-476">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-477">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-478">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-479">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="wst:FinanceLeaseLiabilityToBePaidAfterYearFour" scale="6" id="f-480">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="f-481">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-482">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-483">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, finance leases were not material.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="f-484" continuedAt="f-484-1" escape="true">Affiliated Companies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-484-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024 and December&#160;31, 2023, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-485">191.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-486">203.2</ix:nonFraction> million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-487">7.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-488">6.8</ix:nonFraction> million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-489">24.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-490">53.5</ix:nonFraction> million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-491">39.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-492">84.1</ix:nonFraction> million, respectively, for the same period in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the payable balance due to affiliates was $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-493">20.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="f-494">25.9</ix:nonFraction> million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. ("Daikyo") that allows us to purchase and re-sell Daikyo products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to affiliates were $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-495">4.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-496">7.2</ix:nonFraction> million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-497">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-498">6.0</ix:nonFraction> million, respectively, for the same periods in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the receivable balance due from affiliates was $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-499">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-500">1.6</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-501" continuedAt="f-501-1" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-501-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-502" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of June&#160;30, 2024.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:69.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (<ix:nonFraction unitRef="number" contextRef="c-77" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-503">8.50</ix:nonFraction>%)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-504">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-505">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (<ix:nonFraction unitRef="number" contextRef="c-79" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-506">3.82</ix:nonFraction>%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-507">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-508">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (<ix:nonFraction unitRef="number" contextRef="c-81" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-509">4.02</ix:nonFraction>%) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-510">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-511">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-512">205.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-513">207.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-514">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-515">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-516">205.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-517">206.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-518">132.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-519">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-520">72.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-521">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024, the borrowing capacity available under our $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-522">500.0</ix:nonFraction>&#160;million multi-currency revolving credit facility (the &#8220;Credit Facility&#8221;), including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:LineOfCredit" scale="6" id="f-523">2.4</ix:nonFraction> million, was $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="f-524">497.6</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024, we had $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-525">79.9</ix:nonFraction> million in borrowings under the Term Loan, of which $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-526">79.9</ix:nonFraction> million was classified as current. Please refer to Note 9, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_58">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At June&#160;30, 2024, we were in compliance with all of our debt covenants.</span></div></ix:continuation><div id="i8e08f59eae304691ab0e971847e56044_58"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-527" continuedAt="f-527-1" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-527-1" continuedAt="f-527-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="f-527-2" continuedAt="f-527-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of both June&#160;30, 2024 and December&#160;31, 2023, the total amount of these forward exchange contracts was Singapore Dollar (&#8220;SGD&#8221;) <ix:nonFraction unitRef="sgd" contextRef="c-85" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-528"><ix:nonFraction unitRef="sgd" contextRef="c-86" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-529">601.5</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-530"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-531">13.4</ix:nonFraction></ix:nonFraction> million. We have also entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany demand notes which were executed at various times throughout 2023 and 2024. As of June&#160;30, 2024, the total amount of these forward exchange contracts was Euro ("EUR") <ix:nonFraction unitRef="eur" contextRef="c-89" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-532">290.2</ix:nonFraction> million, SGD <ix:nonFraction unitRef="sgd" contextRef="c-90" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-533">98.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-534">178.3</ix:nonFraction> million, and EUR <ix:nonFraction unitRef="eur" contextRef="c-92" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-535">23.5</ix:nonFraction> million. As of December&#160;31, 2023, the total amount of these forward exchange contracts was EUR <ix:nonFraction unitRef="eur" contextRef="c-93" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-536">278.6</ix:nonFraction> million and SGD <ix:nonFraction unitRef="sgd" contextRef="c-94" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-537">94.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to <ix:nonNumeric contextRef="c-95" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="f-538">eighteen months</ix:nonNumeric>, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="f-539" continuedAt="f-539-1" escape="true">As of June&#160;30, 2024, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-539-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SGD</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-96" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-540">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-541">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-97" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="c-97" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="c-98" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-544">5,750.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-545">27.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-99" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-546">11.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="c-99" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-547">1.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="c-100" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-548">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-549">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="c-101" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-550">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sgd" contextRef="c-101" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="f-551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we entered into a cross-currency swap for $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-552">90</ix:nonFraction>&#160;million, which we designated as a hedge of our net investment in Daikyo. As of June&#160;30, 2024, the notional amount of the cross-currency swap is &#165;<ix:nonFraction unitRef="jpy" contextRef="c-103" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="f-553">8.7</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-554">79.9</ix:nonFraction>&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded Secured Overnight Financing Rate ("SOFR") plus a margin, in return for paying floating interest rate payments based on Japanese Yen (&#8220;Yen&#8221;) Tokyo Overnight Average Rate ("TONAR") plus a margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we will periodically enter into forward exchange contracts to mitigate our exposure to fluctuating foreign exchange rates on assets and liabilities, other than the intercompany loans and demand notes referenced above, which are denominated in foreign currencies. The Company has elected not to designate these forward contracts in hedging relationships, and any change in the value of the contracts is recognized in income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through June 2024, we purchased several series of call options for a total of <ix:nonFraction unitRef="bbl" contextRef="c-105" decimals="0" name="us-gaap:DerivativeNonmonetaryNotionalAmountVolume" format="ixt:num-dot-decimal" scale="0" id="f-555">1,079,145</ix:nonFraction> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regard to a portion of our forecasted elastomer purchases. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-527-3" continuedAt="f-527-4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024, we had outstanding contracts to purchase <ix:nonFraction unitRef="bbl" contextRef="c-106" decimals="0" name="us-gaap:DerivativeNonmonetaryNotionalAmountVolume" format="ixt:num-dot-decimal" scale="0" id="f-556">201,801</ix:nonFraction> barrels of crude oil from June 2024 to December 2025, at a weighted-average strike price of $<ix:nonFraction unitRef="usdPerBbl" contextRef="c-107" decimals="2" name="us-gaap:DerivativeAveragePriceRiskOptionStrikePrice" scale="0" id="f-557">86.26</ix:nonFraction> per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 10, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_61">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of June&#160;30, 2024 and December&#160;31, 2023.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-558" continuedAt="f-558-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-559">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-560">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-561">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-562">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-563">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-564">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-565">10.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-566">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="f-567">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="f-568">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="f-569">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="6" id="f-570">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="f-571">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="f-572">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="f-573">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="f-574">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components for hedges of intercompany loans on a straight-line basis over the life of the fair value hedge. The value of forward point components for hedges of intercompany demand notes is recognized currently in earnings using a market approach. The expense recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" sign="-" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="f-575">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" sign="-" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="f-576">3.5</ix:nonFraction> million, respectively. The income recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="f-577">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="f-578">1.4</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-558-1" continuedAt="f-558-2"><ix:continuation id="f-527-4" continuedAt="f-527-5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (&#8220;OCI&#8221;) and earnings, net of tax:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:26.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.227%"/><td style="width:0.1%"/></tr><tr style="height:44pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-579">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-580">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-581">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-582">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-583">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-584">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-585">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-586">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-588">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-589">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-590">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-591">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-592">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-593">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-594">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" format="ixt:fixed-zero" scale="6" id="f-597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-598">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-599">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-600">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-601">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-602">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-603">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-604">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-607">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-608">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:26.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.227%"/><td style="width:0.1%"/></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-611">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-612">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-613">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-614">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-615">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-616">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-617">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-618">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-619">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-620">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-621">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-622">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-623">6.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-624">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-625">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-626">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="f-628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-629">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-630">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-631">6.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-632">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-633">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" scale="6" id="f-634">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-635">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-636">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-639">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-640">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-527-5"><ix:continuation id="f-558-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our condensed consolidated statements of income for the three and six months ended June&#160;30, 2024 and June&#160;30, 2023. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-643">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-644">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-645">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-646">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-647">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-648">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-649">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-650">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="6" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-652">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-653">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="f-654">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="f-655" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.473%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-656">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-657">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-658">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-659">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency forwards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-660">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-661">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-662">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-663">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-664">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-665">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-666">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-667">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2024 and 2023, there was no material ineffectiveness related to our hedges.</span></div></ix:continuation><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-668" continuedAt="f-668-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-669" escape="true"><ix:continuation id="f-668-1" continuedAt="f-668-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-668-2" continuedAt="f-668-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-670" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-671">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-672">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="f-675">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="f-677">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-679">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-681">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-683">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-685">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-178" xsi:nil="true" name="us-gaap:DerivativeAssets" id="f-686"/></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-687">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-688">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-689">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-691">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-693">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-694">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="f-695">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="f-696">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="f-697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="f-698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-699">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-701">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-702">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-703">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-704">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-705">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-706">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-707">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-708">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="f-711">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="f-713">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-715">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-717">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-719">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-721">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-723">34.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-724">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-725">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-727">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-730">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="f-731">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" scale="6" id="f-732">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="f-733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-735">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="f-737">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-739">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-740">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-741">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-742">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities as of June 30, 2024, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of the cross-currency swap, included within other current assets, is valued using a market approach. Please refer to Note 9, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_58">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform (the &#8220;SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-668-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of short-term and long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At June&#160;30, 2024, the estimated fair value of short-term and long-term debt was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtInstrumentFairValue" scale="6" id="f-743">203.0</ix:nonFraction> million compared to a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-744">205.8</ix:nonFraction> million. At December&#160;31, 2023, the estimated fair value of short-term and long-term debt was $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtInstrumentFairValue" scale="6" id="f-745">204.4</ix:nonFraction> million and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-746">206.8</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-747" continuedAt="f-747-1" escape="true">Accumulated Other Comprehensive Loss </ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-748" escape="true"><ix:continuation id="f-747-1" continuedAt="f-747-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-750">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-751">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-752">136.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-753">143.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-754">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-755">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-757">68.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-758">74.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-759">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-761">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-763">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-764">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-765">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-766">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-767">68.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-768">73.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-769">4.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-770">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-771">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-772">204.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-773">216.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June 30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-774">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-775">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-776">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-777">175.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-778">183.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-779">6.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-780">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-781">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-782">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="f-783">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-784">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-786">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="f-788">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-789">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-790">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-791">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-792">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-793">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-794">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-795">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-796">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-797">171.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-798">183.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="f-799" escape="true"><ix:continuation id="f-747-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out from accumulated other comprehensive loss is presented in the following table: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.269%"/><td style="width:0.1%"/></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-800">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-801">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-802">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-803">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-804">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-805">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-806">3.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-807">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="f-808">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-809">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="f-810">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-811">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="6" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="6" id="f-813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-814">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-815">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-816">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-817">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-818">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-819">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-820">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-821">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-822">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-823">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-824">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-825">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-826">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-827">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-828">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-829">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-830">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="f-831">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="f-832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="f-833">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" format="ixt:fixed-zero" scale="6" id="f-834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="f-835">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-836">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-837">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-838">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-839">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="f-840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-841">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-842">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-843">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-844">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-845">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-846">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-847">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-848">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-849">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-850">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-851">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This component is included in the computation of net periodic benefit cost.</span></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12: <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-852" continuedAt="f-852-1" escape="true">Shareholders</ix:nonNumeric></span><ix:continuation id="f-852-1" continuedAt="f-852-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="f-853" continuedAt="f-853-1" escape="true"><ix:continuation id="f-852-2" continuedAt="f-852-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.423%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.431%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-238" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-854">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-855">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-856">120.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-857">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-858">637.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-859">3,523.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-860">143.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-861">2,881.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-862">115.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-863">115.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-864">65.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-245" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-865">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-866">79.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-867">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-245" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-868">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-869">267.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-870">267.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-243" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-871">0.20</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-872">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-873">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-874">48.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-875">48.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-247" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-876">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-877">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-878">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-249" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-879">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-880">825.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-881">3,624.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-882">192.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-883">2,680.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-884">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-885">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-886">21.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-255" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-887">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-888">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-889">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-255" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-890">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-891">187.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-892">187.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-893">0.20</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-894">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-895">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-896">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-897">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-257" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-898">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-899">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-900">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-259" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-901">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-902">979.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-903">3,720.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-904">216.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-905">2,576.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-853-1"><ix:continuation id="f-852-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.421%"><tr><td style="width:1.0%"/><td style="width:32.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.768%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.884%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.768%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.884%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.473%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-261" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-906">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-907">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-908">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-263" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-909">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-910">370.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-911">2,987.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-912">183.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-913">2,684.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-914">140.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-915">140.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-916">50.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-268" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-917">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-918">61.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-919">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-268" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-920">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-921">60.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-922">60.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-266" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-923">0.19</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-924">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-925">14.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-926">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-927">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-270" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-928">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-929">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-930">181.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-272" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-931">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-932">369.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-933">3,113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-934">168.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-935">2,776.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-936">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-937">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-938">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-278" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-939">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-940">41.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-941">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-278" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-942">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-943">173.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-944">173.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-945">0.19</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-946">14.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-947">14.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-948">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-949">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-280" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="f-950">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-951">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-952">158.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-953">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-954">501.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-955">3,254.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-956">183.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-957">2,746.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-958" continuedAt="f-958-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-958-1" continuedAt="f-958-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At June&#160;30, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-959">1,339,458</ix:nonFraction> shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-960">85,263</ix:nonFraction> stock options at a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-961">350.28</ix:nonFraction> per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-962">134.93</ix:nonFraction> per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-963">4.3</ix:nonFraction>%; expected life of <ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-964">6.0</ix:nonNumeric> years based on prior experience; stock volatility of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-965">32.0</ix:nonFraction>% based on historical data; and a dividend yield of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-966">0.3</ix:nonFraction>%. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-967">32,876</ix:nonFraction> stock-settled performance share unit (&#8220;PSU&#8221;) awards at a weighted average grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-968">350.28</ix:nonFraction> per share to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from <ix:nonFraction unitRef="number" contextRef="c-285" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="f-969">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-286" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="f-970">200</ix:nonFraction>% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-971">7,019</ix:nonFraction> stock-settled restricted share unit (&#8220;RSU&#8221;) awards at a weighted average grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-972">350.65</ix:nonFraction> per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-958-2">Stock-based compensation expense was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-973">4.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-974">9.3</ix:nonFraction> million for the three and six months ended June&#160;30, 2024, respectively. For the three and six months ended June&#160;30, 2023, stock-based compensation expense was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-975">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-976">16.0</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="f-977" continuedAt="f-977-1" escape="true">Other Expense (Income)</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" id="f-978" escape="true"><ix:continuation id="f-977-1" continuedAt="f-977-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="6" id="f-979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-980">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="6" id="f-981">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-982">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-983">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-984">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-985">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-986">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-987">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-988">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-989">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-990">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-991">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-992">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-993">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-994">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="f-995">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="f-996">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="f-997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="f-998">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="f-999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="f-1000">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="f-1001">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="f-1002">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-1003">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-1004">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-1005">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="f-1006">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="f-977-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Disposal of Plant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company recorded expense of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1007">2.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1008">11.6</ix:nonFraction>&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration. Please refer to Note 10, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_61">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to <ix:nonNumeric contextRef="c-288" name="wst:RestructuringAndRelatedActivitiesPeriodOfImplementation" format="ixt-sec:durwordsen" id="f-1009">twenty-four months</ix:nonNumeric> from the date of approval. The plan is expected to require restructuring and related charges of approximately $<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-1010">22</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-1011">24</ix:nonFraction>&#160;million, with annualized savings in the range of $<ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-6" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="f-1012">22</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-6" name="us-gaap:EffectOnFutureEarningsAmount" format="ixt:num-dot-decimal" scale="6" id="f-1013">24</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-1014" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance<br/>and benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1015">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-1016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1017">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Credits) Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="wst:RestructuringChargesCredits" format="ixt:fixed-zero" scale="6" id="f-1018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="wst:RestructuringChargesCredits" format="ixt:fixed-zero" scale="6" id="f-1019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="wst:RestructuringChargesCredits" format="ixt:fixed-zero" scale="6" id="f-1020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1021">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="f-1022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1023">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1024">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-1025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1026">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1027" continuedAt="f-1027-1" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1027-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1028">21.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1029">34.8</ix:nonFraction> million for the three months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1030">17.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1031">18.8</ix:nonFraction>%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for three months ended June&#160;30, 2024 as compared to the same period in 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1032">38.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1033">58.4</ix:nonFraction> million for the six months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1034">15.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1035">17.0</ix:nonFraction>%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to address the change in tax laws enacted pursuant to the Organization for Economic Cooperation and Development (OECD)&#8217;s 15% global minimum tax initiative (Pillar 2). The 2024 forecasted impact of Pillar 2 is not expected to be material to the Company.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1036" continuedAt="f-1036-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1036-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to commitments and contingencies since December 31, 2023.</span></div></ix:continuation><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1037" continuedAt="f-1037-1" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1037-1" continuedAt="f-1037-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1038">two</ix:nonFraction> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="f-1039" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1040">559.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1041">618.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1042">1,119.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1043">1,201.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1044">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1045">135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1046">278.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1047">269.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1048">702.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1049">753.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1050">1,397.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1051">1,470.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><ix:continuation id="f-1037-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1052" continuedAt="f-1052-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summarized financial information for our segments:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1053">131.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1054">194.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1055">257.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1056">364.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1057">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1058">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1059">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1060">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1061">148.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1062">209.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1063">291.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1064">397.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-1065">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-1066">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-1067">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-1068">16.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1069">17.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1070">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1071">32.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1072">31.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1073">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1074">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1075">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-1076">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="6" id="f-1077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-1078">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="6" id="f-1079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-1080">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-1081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-1082">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="f-1083">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="f-1084">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1085">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1086">26.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1087">42.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1088">59.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1089">126.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1090">182.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1091">249.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1092">337.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net and other nonoperating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1093">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1094">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1095">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1096">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1097">128.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1098">184.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1099">256.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1100">342.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During the three and six months ended June&#160;30, 2024, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1101">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1102">0.4</ix:nonFraction>&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June&#160;30, 2023, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1103">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1104">0.4</ix:nonFraction>&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the three and six months ended June&#160;30, 2023, the Company recorded expense of $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1105">2.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1106">11.6</ix:nonFraction>&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  </span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="f-1052-1" continuedAt="f-1052-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-1107"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-1108">0.1</ix:nonFraction></ix:nonFraction>&#160;million </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2023 represents the net impact of an</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inventory write down of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="f-1109"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="f-1110">0.9</ix:nonFraction></ix:nonFraction>&#160;million within cost of goods and services sold and a $<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1111"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1112">0.8</ix:nonFraction></ix:nonFraction>&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> benefit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within other expense (income) </span></ix:continuation><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1052-2">for revised severance estimates in connection with its 2022 restructuring plan.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_76">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of certain unallocated items referenced above.</span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_1336"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1113" continuedAt="f-1113-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="padding-left:22.5pt"><span><br/></span></div><ix:continuation id="f-1113-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 2, 2024, the Company entered into the Third Amendment to the Credit Facility Agreement, which amended the Existing Credit Facility Agreement. Among other changes to the existing credit agreement, the Third Amendment established an incremental term loan in the stated principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1114">130.0</ix:nonFraction>&#160;million (the &#8220;New Term Loan&#8221;), which was fully drawn at closing and matures on July 2, 2027. The entire stated principal amount of the New Term Loan is due at maturity and there is no scheduled amortization prior to such date. Together with cash on hand, proceeds from the New Term Loan were used to repay an outstanding term loan under the Existing Credit Facility Agreement in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1115">79.9</ix:nonFraction>&#160;million and to repay an aggregate principal amount of  $<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1116">53.0</ix:nonFraction>&#160;million of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="c-331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1117">3.82</ix:nonFraction>% Series B Senior Notes due July 5, 2024 issued under that certain Note Purchase Agreement dated as of July 5, 2012.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is intended to further the reader&#8217;s understanding of the consolidated financial condition and results of operations of our Company. It should be read in conjunction with our condensed consolidated financial statements and accompanying notes elsewhere in this Quarterly Report on Form 10-Q (&#8220;Form 10-Q&#8221;) as well as Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and accompanying notes included in our 2023 Annual Report. Our historical financial statements may not be indicative of our future performance. This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of our 2023 Annual Report and in Part II, Item 1A of this Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this section, references to &#8220;Notes&#8221; refer to the notes to our condensed consolidated financial statements (unaudited) in Part I, Item 1 of this Form 10-Q, unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-U.S. GAAP Financial Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than USD at the applicable foreign exchange rates in effect during the comparable prior-year period. We may also refer to adjusted consolidated operating profit and adjusted consolidated operating profit margin, which exclude the effects of unallocated items. The unallocated items are not representative of ongoing operations, and generally include restructuring and related charges, certain asset impairments, and other specifically-identified income or expense items. The re-measured results excluding effects from currency translation, the impact from acquisitions and/or divestitures, and excluding the effects of unallocated items are not in conformity with U.S. Generally Accepted Accounting Principles ("GAAP") and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are incorporated in our discussion and analysis as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies around the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two global segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery systems, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We also maintain collaborations to share technologies and market products with affiliates in Japan and Mexico.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Macroeconomic Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have operations based in Israel that conduct research and development activities and manufacture certain components for our devices. Our Israel-based facilities continue to substantially operate as they had prior to the conflict in Israel and surrounding area. We continue to monitor the impact of the conflict in Israel and surrounding areas on our operations and those of our suppliers, the possible expansion of such conflict and potential geopolitical consequences, if any, on our business and operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Performance Summary</span></div><div><span><br/></span></div><div><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present a reconciliation from U.S. GAAP to non-U.S. GAAP financial measures for the three and six months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"/><td style="width:42.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June&#160;30, 2024 GAAP</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June&#160;30, 2024 adjusted amounts (non-U.S. GAAP)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"/><td style="width:42.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June&#160;30, 2024 GAAP</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June&#160;30, 2024 adjusted amounts (non-U.S. GAAP)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2024, we recorded a tax benefit of $5.7 million and $16.6 million, respectively, associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present a reconciliation from U.S. GAAP to non-U.S. GAAP financial measures for the three and six months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"/><td style="width:42.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June&#160;30, 2023 GAAP</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June&#160;30, 2023 adjusted amounts (non-U.S. GAAP)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"/><td style="width:42.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June&#160;30, 2023 GAAP</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June&#160;30, 2023 adjusted amounts (non-U.S. GAAP)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.09&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2023, we recorded a tax benefit of $7.7&#160;million and $19.3&#160;million, respectively, associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the three and six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2024 and </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023, the Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.4&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2020. During the three and six months ended June&#160;30, 2024 and </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded $0.5&#160;million and $1.0&#160;million, respectively, of amortization expense </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in association with an acquisition of increased ownership interest in Daikyo.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Restructuring and other charges of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1&#160;million </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2023 represents the net impact of an</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inventory write down of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.9&#160;million within cost of goods and services sold and a $0.8&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> benefit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within other expense (income) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for revised severance estimates in connection with its 2022 restructuring plan. </span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items for which further information can be found above in the reconciliation from U.S. GAAP to non-U.S. GAAP financial measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Percentages in the following tables and throughout the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section may reflect rounding adjustments.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales, consolidated and by reportable segment, for the three months ended June&#160;30, 2024 and 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As-Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales decreased by $51.7 million, or 6.9%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $6.1&#160;million. Excluding foreign currency translation effects and removal of the 2023 sales impact related to one of our plants that was disposed of in the second quarter of 2023 of $1.1&#160;million, consolidated net sales for the three months ended June&#160;30, 2024 decreased by $44.5 million, or 5.9%, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proprietary Products net sales decreased by $58.3 million, or 9.4%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $5.4&#160;million. Excluding foreign currency translation effects and removal of the 2023 sales impact related to one of our plants that was disposed of in the second quarter of 2023 of $1.1&#160;million, net sales for the three months ended June&#160;30, 2024 decreased by $51.8 million, or 8.4%, as compared to the same period in 2023, due to a decline in sales of certain high-value product offerings due to customer inventory management, primarily Westar&#174; components, Daikyo Crystal Zenith&#174; and FluroTec&#174; products. These reductions were partially offset by an increase in sales of self-injection device platforms and Envision&#174; products, as well as increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contract-Manufactured Products net sales increased by $6.6 million, or 4.9%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.7 million. Excluding foreign currency translation effects, net sales for the three months ended June&#160;30, 2024 increased by $7.3 million, or 5.4%, as compared to the same period in 2023, primarily due to an increase in sales of components associated with injection-related devices and sales price increases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales, consolidated and by reportable segment, for the six months ended June&#160;30, 2024 and 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.120%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As-Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales decreased by $72.9 million, or 5.0%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $2.7&#160;million. Excluding foreign currency translation effects and removal of the 2023 sales impact related to one of our plants that was disposed of in the second quarter of 2023 of $4.3&#160;million, consolidated net sales for the six months ended June&#160;30, 2024 decreased by $65.9 million, or 4.5%, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Proprietary Products net sales decreased by $81.9 million, or 6.8%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $2.6&#160;million. Excluding foreign currency translation effects and removal of the 2023 sales impact related to one of our plants that was disposed of in the second quarter of 2023 of $4.3&#160;million, net sales for the six months ended June&#160;30, 2024 decreased by $75.0 million, or 6.3%, as compared to the same period in 2023, due to a decline in sales of certain high-value product offerings due to customer inventory management, primarily Westar&#174; components, FluroTec&#174; products and Daikyo Crystal Zenith&#174;. These reductions were partially offset by an increase in sales of NovaPure&#174; products and self-injection device platforms, as well as increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Contract-Manufactured Products net sales increased by $9.0 million, or 3.3%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.1 million. Excluding foreign currency translation effects, net sales for the six months ended June&#160;30, 2024 increased by $9.1 million, or 3.4%, as compared to the same period in 2023, primarily due to an increase in sales of components associated with injection-related devices and sales price increases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents gross profit and related gross profit margins, consolidated and by reportable segment:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross profit decreased by $61.4 million, or 21.1%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $2.2 million. Consolidated gross profit margin decreased by 5.9 margin points for the three months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated gross profit decreased by $102.5 million, or 18.2% for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.9 million. Consolidated gross profit margin decreased by 5.4 margin points for the six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products gross profit decreased by $64.4 million, or 23.7%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $2.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Proprietary Products gross profit margin decreased by 6.9 margin points for the three months ended June&#160;30, 2024, as compared to the same period in 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to lower plant absorption from reduced customer demand and an unfavorable mix of products sold. These headwinds were partially offset by increased sales prices.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products gross profit decreased by $105.1 million, or 20.2%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.9 million. Proprietary Products gross profit margin decreased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by 6.2 margin points for the six months ended June&#160;30, 2024, as compared to the same period in 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to lower plant absorption from reduced customer demand and an unfavorable mix of products sold. These headwinds were partially offset by increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products gross profit increased by $2.1 million, or 10.0%, for the three months ended June&#160;30, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.1 million. Contract-Manufactured Products gross profit margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by 0.8 margin points for the three months ended June&#160;30, 2024, as compared to the same period in 2023, primarily due to increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products gross profit increased by $1.7 million, or 3.8%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023. Contract-Manufactured Products gross profit marg</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in increased by 0.1 margin points for the six months ended June&#160;30, 2024, as compared to the same period in 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents consolidated R&amp;D costs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated R&amp;D costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated R&amp;D costs increased by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.0 million, or 6.1%, and $1.5 million, or 4.5% for the three and six months ended June&#160;30, 2024, respectively, as compared to the same period in 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to additional research performed to identify new product opportunities. Efforts remain focused on the continued investment in elastomeric packaging components, formulation development, drug containment systems, self-injection systems and drug administration consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the R&amp;D costs incurred the </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2024 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to Proprietary Products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents SG&amp;A costs, consolidated and by reportable segment and corporate and unallocated items:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated SG&amp;A costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">SG&amp;A as a % of net sales</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A costs decreased by $5.4 million, or 6.1%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the three months ended June&#160;30, 2024, as compared to the same period in 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, due primarily to a decrease in expense related to stock-based compensation, lower annual incentive compensation and a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> favorable foreign currency translation impact of $0.4 million, offset by increased compensation costs. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated SG&amp;A costs decreased by $4.7 million,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 2.7%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due primarily to a decrease in expense related to stock-based compensation and a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> favorable foreign currency translation impact of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $0.3 million, offset by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased compensation costs and increased costs related to professional services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products SG&amp;A costs decreased by $2.8 million, or 4.8%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023. Proprietary Products SG&amp;A costs decreased primarily due to lower annual incentive compensation and a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> favorable foreign currency translation impact of $0.4 million, offset by increased compensation costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products SG&amp;A costs increased by $1.4 million, or 1.2%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023. Proprietary Products SG&amp;A costs increased p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rimaril</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y due to increased compensation costs and an increase in costs related to professional services, offset by a favorable foreign currency translation impact of $0.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products SG&amp;A costs increased by $0.1 million, or 1.6% for the three months ended June&#160;30, 2024, as compared to the same period in 2023, and increased by $0.3 million, or 2.5% for the six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate SG&amp;A costs decreased by $2.7 million, or 11.5%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue to a decrease in expense related to stock-based compensation and lower annual incentive compensation, offset by increased compensation costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate SG&amp;A costs decreased by $6.4 million, or 13.6%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ue to a decrease in expense related to stock-based compensation, offset by increased compensation costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense (Income) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents other expense and income items, consolidated and by reportable segment, corporate and unallocated items:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense (Income)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense and income items consist of a loss on disposal of plant, asset impairments, foreign exchange transaction gains and losses, contingent consideration and miscellaneous income and charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated other expense (income) changed by $0.7 million for the three months ended June&#160;30, 2024, as compared to the same period in 2023, and changed by $10.5 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to the factors described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products -</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proprietary Products other expense (income) changed by $0.6 million for the three months ended June&#160;30, 2024, as compared to the same period in 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily due to increased losses on foreign exchange transactions being recorded in the three months ended June&#160;30, 2024, as compared to the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> same period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2023. This was offset by an increase in asset impairments recorded in the three months ended June&#160;30, 2023, as compared to the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> same period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2024.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other expense (income)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> changed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to additional asset impairments being recorded in the six months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023, as compared to the same period in 2024. This was offset by increased losses on foreign exchange transactions and increased contingent consideration expense being recorded in the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2024, as compared to the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> same period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2023.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ctured Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other expense (income)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> changed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> changed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.6 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated items - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and unallocated items changed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to the Company recording expense of $2.2&#160;million as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment, offset by the Company recording a benefit of $0.8&#160;million for revised estimates associated with its restructuring plans in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023 that did not repeat in 2024.</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and unallocated items changed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as compared to the same period in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily due to the Company recording expense of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.6 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment, offset by the Company recording a benefit of $0.8&#160;million for revised estimates associated with its restructuring plans in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the six months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023 that did not repeat in 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Profit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and unallocated items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating profit margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated items</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted consolidated operating profit margin</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating profit decreased by $56.3 million, or 30.8%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $1.9 million for the three months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating profit decreased by $88.8 million, or 26.3%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.6 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products operating profit decreased by $63.2 million, or 32.5%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $1.7 million, due to the factors described above, most notably lower gross profit driven by lower sales volume and an unfavorable mix of products sold.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Products operating profit decreased by $107.6 million, or 29.5%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, including an unfavorable foreign currency translation impact of $0.6 million, due to the factors described above, most notably lower gross profit driven by lower sales volume and an unfavorable mix of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract-Manufactured Products - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products operating profit increased by $2.3 million, or 15.4%, for the three months ended June&#160;30, 2024, as compared to the same period in 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including an unfavorable foreign currency translation impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, due to the factors described abo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ve, most notably the increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract-Manufactured Products operating profit increased by $2.0 million, or 6.2%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to the factors described above, most notably the increased sales prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and unallocated - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the unallocated items, Corporate costs decreased by $2.3 million, or 9.5%, for the three months ended June&#160;30, 2024, as compared </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the same period in 2023, due to the factors described above, most notably the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease in expense related to stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the unallocated items, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate costs decreased by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or 10.8%, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to the factors described above, most notably the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease in expense related to stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For unallocated items, please refer to the Financial Performance Summary section above for details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net and Interest Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest expense, net, and interest income by significant component:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, decreased by $1.2 million, for the three months ended June&#160;30, 2024, as compared to the same period in 2023, and decreased by $1.8 million, for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to an increase in capitalized interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income decreased by $1.0 million for the three months ended June&#160;30, 2024, as compared to the same period in 2023, primarily due to the Company having a lower average cash balance in three months ended June&#160;30, 2024, as compared to the same period in 2023. Interest income increased by $0.4 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due primarily from 2024 investments in liquid low-risk money market funds or bank deposits in the U.S., Europe, and South America yielding higher interest rates compared to 2023.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $21.9 million and $34.8 million for the three months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 17.0% and 18.8%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for the three months ended June&#160;30, 2024 as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $38.3 million and $58.4 million for the six months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 15.0% and 17.0%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for the for the six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity in Net Income of Affiliated Companies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in net income of affiliated companies decreased by $0.5 million for the three months ended June&#160;30, 2024, as compared to the same period in 2023, due to less favorable operating results at Daikyo. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in net income of affiliated companies decreased by $1.9 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to less favorable operating results at Daikyo. </span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flow data for the six months ended June&#160;30:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(489.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Provided by Operating Activities &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by operating activities decreased by $24.1 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, primarily due to a decline in operating results, offset by favorable working capital management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Investing Activities &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities increased by $27.6 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, due to an increase in capital expenditures for additional manufacturing capacity to meet customer demand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Cash Used in Financing Activities &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in financing activities increased by $241.5 million for the six months ended June&#160;30, 2024, as compared to the same period in 2023, primarily due to an increase in purchases under our share repurchase program in 2024, as compared to 2023.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected liquidity and capital measures:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our cash and cash equivalents balance at June&#160;30, 2024 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at June&#160;30, 2024 included $140.9&#160;million of cash held by subsidiaries within the U.S., and $305.3&#160;million of cash held by subsidiaries outside of the U.S. During the six months ended June&#160;30, 2024, we purchased 1,239,015 shares of our common stock under the share repurchase program at a cost of $454.1 million, or an average price of $366.53 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working capital &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Working capital at June&#160;30, 2024 decreased by $415.3 million, or 32.8%, as compared to December&#160;31, 2023, which includes an unfavorable foreign currently translation impact of $23.1 million. Excluding the impact of currency exchange rates, cash and cash equivalents, accounts receivable and total current liabilities decreased by $398.3 million, $22.7 million and $27.7 million, respectively.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in cash and cash equivalents was due to capital expenditures and share repurchases, offset by cash from operations during the six months ended June&#160;30, 2024. The decrease in accounts receivable is primarily due to reduced net sales leading up to the June&#160;30, 2024 balance sheet date as compared to the December&#160;31, 2023 balance sheet date. The decrease in total current liabilities was primarily caused by a decline in accounts payable and the payout of the 2023 annual incentive plan accrual during the six months ended June&#160;30, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and credit facilities &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The $1.0 million decrease in total debt at June&#160;30, 2024, as compared to December&#160;31, 2023, resulted from debt repayments under our Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of liquidity include our Credit Facility. At June&#160;30, 2024, we had no outstanding borrowings under the Credit Facility. At June&#160;30, 2024, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.4 million, was $497.6 million. We do not expect any significant limitations on our ability to access this source of funds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and not to exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At June&#160;30, 2024, we were in compliance with all of our debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contractual Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of future material cash payments resulting from commitments and contractual obligations was provided in our 2023 Annual Report. During the three months ended June&#160;30, 2024, there were no material changes outside of the ordinary course of business to our commitments and contractual obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OFF-BALANCE SHEET ARRANGEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024, we had no off-balance sheet financing arrangements other than unconditional purchase obligations incurred in the ordinary course of business and outstanding letters of credit related to various insurance programs, as noted in our 2023 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the Critical Accounting Policies and Estimates disclosed in Part II, Item 7 of our 2023 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING STANDARDS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no new accounting standards adopted during the three months ended June&#160;30, 2024, see Note 2, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_37">New Accounting Standards</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure and analysis in this Form 10-Q contains some forward-looking statements that are based on management&#8217;s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public, as well as oral forward-looking statements. Such statements provide our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue&#8221; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance, as well as our strategy for growth, product development, market position and expenditures. All statements that address operating performance or events or developments that we expect or anticipate will occur in the future - including statements relating to sales and earnings per share growth, cash flows or uses, and statements expressing views about future operating results - are forward-looking statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on current expectations of future events. The forward-looking statements are, and will be, based on management&#8217;s then-current views and assumptions regarding future events and operating performance, and speak only as of their dates. Investors should realize that, if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements: </span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales demand and our ability to meet that demand;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition from other providers in our businesses, including customers&#8217; in-house operations, and from lower-cost producers in emerging markets, which can impact unit volume, price and profitability;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">customers&#8217; changing inventory requirements and manufacturing plans that alter existing orders or ordering patterns for the products we supply to them;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruptions or weaknesses in our supply chain, including from reasons beyond our control such as extreme weather, longer-term climate changes, natural disasters, pandemic, war, accidental damage, or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unauthorized access to our or our customers&#8217; information and systems, which could cause delivery delays or restrict the availability of raw materials, key purchased components and finished products;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, regulatory approval and commercial success of customer products that incorporate our products and systems;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether customers agree to incorporate our products and delivery systems with their new and existing drug products, the ultimate timing and successful commercialization of those products and systems, which involves substantial evaluations of the functional, operational, clinical and economic viability of our products, and the rate, timing and success of regulatory approval for the drug products that incorporate our components and systems;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timely and adequate availability of filling capacity, which is essential to conducting definitive stability trials and the timing of first commercialization of customers&#8217; products in Crystal Zenith prefilled syringes;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">profitability, or mix, of the products sold in any reporting period, including lower-than-expected sales growth of our high-value proprietary product offerings;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining or improving production efficiencies and overhead absorption;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on third-party suppliers and partners, some of which are single-source suppliers of critical materials and products, including our Japanese partner and affiliate, Daikyo;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of key personnel or highly-skilled employees;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability and cost of skilled employees required to meet increased production, managerial, research and other needs, including professional employees and persons employed under collective bargaining agreements;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successful and timely implementation of price increases necessary to offset rising production costs, including raw material prices, particularly petroleum-based raw materials;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and progress of development, regulatory approval and marketing of new products;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain licenses in any jurisdiction in which we do business;</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the relative strength of USD in relation to other currencies, particularly the Euro, SGD, the Danish Krone, Yen, Colombian Peso, Brazilian Real, and the South Korean Won; and</span></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential adverse effects of global healthcare legislation on customer demand, product pricing and profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This list sets forth many, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all of the factors and should not consider this list to be a complete statement of all potential risks and uncertainties. For further discussion of these and other factors, see the risk factors disclosed in Part I, Item 1A of our 2023 Annual Report as well as Part II, section 1A of this quarterly report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law or regulation, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our exposure to market risk or the information provided in Part II, Item 7A of our 2023 Annual Report.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this quarterly report, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this quarterly report on Form 10-Q. Based on this evaluation, our CEO and CFO have concluded that, as of June&#160;30, 2024, our disclosure controls and procedures are effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June&#160;30, 2024, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;RISK FACTORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes to the risk factors disclosed in Part I, Item 1A of our 2023 Annual Report.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows information with respect to purchases of our common stock made during the three months ended June&#160;30, 2024 by us or any of our &#8220;affiliated purchasers&#8221; as defined in Rule 10b-18(a)(3) under the Exchange Act: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid per share (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate dollar value of shares that may yet be purchased under the plans or programs (1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.48&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,500,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions.</span></div><div><span><br/></span></div><div id="i8e08f59eae304691ab0e971847e56044_118"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;EXHIBITS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31articlesofincorporat.htm">Our Amended and Restated Articles of Incorporation, effective April 24, 2024, attached hereto as Exhibit 3.1.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577023000068/amendedrestatedbylawsoct20.htm">Our Amended and Restated Bylaws, effective October 23, 2023 (incorporated by reference to Exhibit 3.2 to the Company's Form 10-Q report for the quarter ended September 30, 2023, filed October 26, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/0000105770-99-000016-index.html">Form of stock certificate for common stock (incorporated by reference to Exhibit 4 to the Company's 1998 Form 10-K, filed May 6, 1999).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31articlesofincorporat.htm">Articles 5, 7, 8 and 9 of our Amended and Restated Articles of Incorporation, effective April 24, 2024, attached hereto as Exhibit 3.1.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/105770/000010577023000068/amendedrestatedbylawsoct20.htm">Articles I and IV of our Bylaws, as amended through October 23, 2023 (incorporated by reference to Exhibit 3.2 to the Company's Form 10-Q report for the quarter ended September 30, 2023, filed October 26, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries have been omitted.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/105770/000010577024000055/wst-20240702.htm">Third Amendment and Incremental Facility Amendment, dated as of July 2, 2024, among the Company, as borrower's representative, each of the lenders party thereto and Bank of America, N.A., as the administrative agent (incorporated by reference from our Form 8-k, filed July 8, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex311q22024.htm">Certification by the Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312q22024.htm">Certification by the Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex321q22024.htm">Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322q22024.htm">Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Furnished, not filed.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i8e08f59eae304691ab0e971847e56044_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i8e08f59eae304691ab0e971847e56044_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WEST PHARMACEUTICAL SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By: /s/ Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;25, 2024 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex31articlesofincorporat.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex31articlesofincorporat</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex31articlesofincorporat001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">        AMENDED AND RESTATED ARTICLES OF INCORPORATION  OF WEST PHARMACEUTICAL SERVICES, INC.  (Effective as of April 24, 2024)     1.  The name of the Corporation is West Pharmaceutical Services, Inc.     2.  The location and post office address of the Corporation&#8217;s registered office in Pennsylvania is c/o  Corporation Service Company, 2595 Interstate Drive, Suite 103, Harrisburg, PA 17110.     3.  The Corporation is incorporated under the Pennsylvania Business Corporation Law and shall have  unlimited power to engage in and to do any lawful act concerning any or all lawful business, including manufacturing,  processing, research and development, for which corporations may be incorporated under the Pennsylvania  Business Corporation Law.     4.  The term for which the Corporation is to exist is perpetual.     5.  Capital Stock. The aggregate number of shares of capital stock which the Corporation shall have  authority to issue is 203,000,000 shares, consisting of (i) 3,000,000 shares of Preferred Stock, par value $.25 per  share (&#8220;Preferred Stock&#8221;) and (ii) 200,000,000 shares of Common Stock, par value $.25 per share (&#8220;Common Stock&#8221;).      The following is a statement of the designations, preferences qualifications, limitations, restrictions  and the special or relative rights granted to or imposed upon the shares of each such class:    Preferred Stock      (a)  Issue in Series. Preferred Stock may be issued from time to time in one or more series,  each such series to have the terms stated herein and in the resolution of the board of directors providing for its issue.  All shares of any one series of Preferred Stock shall be identical, but shares of different series of Preferred Stock  need not rank equally or be identical except insofar as provided by law or hereunder.      (b)  Creation of Series. The board of directors shall have authority by resolution to cause to be  created one or more series of Preferred Stock, and to determine and fix with respect to each series, prior to the  issuance of any shares of the series to which such resolution relates:       (i)  The distinctive designation of the series and the number of shares which shall  constitute the series, which number may be increased or decreased (but not below the number of shares then  outstanding) from time to time by action of the board of directors;       (ii)  The dividend rate and the times of payment of dividends on the shares of the  series, whether dividends shall be cumulative, and, if so, from what date or dates;       (iii)  The price or prices at which, and the terms and conditions on which, the shares  of the series may be redeemed at the option of the Corporation;       (iv)  Whether or not the shares of the series shall be entitled to the benefit of a  retirement or sinking fund to be applied to the purchase or redemption of such shares and, if so entitled, the annual  amount of such fund and the terms and provisions relative to the operation thereof;       (v)  Whether or not the shares of the series shall be convertible into, or exchangeable  for, shares of any other series of the same or any other class or classes of stock of the Corporation, and if so  convertible or exchangeable, the conversion price or prices, or the rates of exchange, and any adjustments thereof, if  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 2 -    any, at which such conversion or exchange may be made, and any other terms and conditions of such conversion or  exchange;       (vi)  The rights of the shares of the series in the event of voluntary or involuntary  liquidation, dissolution or winding up of the Corporation;       (vii)  Whether or not the shares of the series shall have priority over or parity with or  be junior to the shares of any other series or class in any respect or shall be entitled to the benefit of limitations  restricting the issuance of shares of any other series or class having priority over or being on a parity with the shares  of such series in any respect, or restricting the payment of dividends on, or the making of other distributions in  respect of shares of any other series or class ranking junior to the shares of the series as to dividends or assets, or  restricting the purchase or redemption of the shares of any such junior series or class, and the terms of any such  restrictions;       (viii)  Whether the series shall have voting rights, in addition to the voting rights  provided by law, and, if so, the terms of such voting rights; and       (ix)  Any other preferences qualifications, privileges and other relative or special rights  and limitations of that series.      (c)  Dividends. Holders of Preferred Stock shall be entitled to receive, when and as declared  by the board of directors, out of funds legally available for the payment thereof, dividends at the rates fixed by the  board of directors for the respective series, and no more, before any dividends shall be declared and paid, or set  apart for payment, on Common Stock with respect to the same dividend period.      (d)  Preference on Liquidation. In the event of the voluntary or involuntary liquidation,  dissolution or winding up of the Corporation, holders of each series of Preferred Stock shall be entitled to receive the  amount fixed for such series plus, in the case of any series on which dividends shall have been determined by the  board of directors to be cumulative, an amount equal to all dividends accumulated and unpaid thereon to the date of  final distribution whether or not earned or declared. If the assets of the Corporation are not sufficient to pay such  amounts in full, holders of all shares of Preferred Stock shall participate ratably in the distribution of assets in  proportion to the full amounts to which they are entitled or in such order or priority, if any, as shall have been fixed in  the resolution or resolutions providing for the issuance of the series of Preferred Stock. Neither the merger nor  consolidation of the Corporation into or with any other corporation, nor a sale, transfer or lease of all or part of its  assets, shall be deemed a liquidation of the Corporation within the meaning of this paragraph.      (e)  Redemption. The Corporation at the option of the board of directors may redeem all or  part of the shares of any series of Preferred Stock on the terms and conditions fixed for such series. In case of the  redemption of less than all outstanding shares of any series of Preferred Stock, the shares to be redeemed shall be  selected by lot or in such other manner as the board of directors determines.      (f)  Voting Rights. Except as otherwise required by law or as otherwise provided in any  certificate creating any series of Preferred Stock, the holders of such of the series of Preferred Stock, if any, as shall  have been granted such power pursuant to any certificate creating any series of Preferred Stock shall, together with  the holders of Common Stock, exclusively possess voting power in the election of directors and for all other  purposes, and the holders of the other series of Preferred Stock shall have no voting power and shall not be entitled  to any notice of any meeting of shareholders.    Series A Junior Participating Preferred Stock    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 3 -      (a)  Designation and Amount. There shall be a series of Preferred Stock designated as &#8220;Series  A Junior Participating Preferred Stock&#8221; and the aggregate number of shares constituting such series shall be 50,000.      (b)  Dividends and Distributions.       (i)  Subject to the prior and superior rights of the holders of any shares of any series  of Preferred Stock ranking prior and superior to the shares of Series A Junior Participating Preferred Stock with  respect to dividends, the holders of shares of Series A Junior Participating Preferred Stock shall be entitled to receive,  when, as and if declared by the board of directors out of funds legally available for the purpose, quarterly dividends  payable in cash on March 31, June 30, September 30 and December 31 in each year (each such date being referred  to herein as a &#8220;Quarterly Dividend Payment Date&#8221;), commencing on the first Quarterly Dividend Payment Date after  the first issuance of a share or fraction of a share of Series A Junior Participating Preferred Stock, in an amount per  share (rounded to the nearest cent) equal to the greater of (a) $10 or (b) subject to the provision for adjustment  hereinafter set forth, 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the  aggregate per share amount (payable in kind) of all non-cash dividends or other distributions other than a dividend  payable in shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification  or otherwise), declared on the Common Stock since the immediately preceding Quarterly Dividend Payment Date, or,  with respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share  of Series A Junior Participating Preferred Stock. In the event the Corporation shall at any time after January 16, 1990  (the &#8220;Rights Declaration Date&#8221;) (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii)  subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of  shares, then in each such case the amount to which holders of shares of Series A Junior Participating Preferred  Stock were entitled immediately prior to such event under clause (b) of the preceding sentence shall be adjusted by  multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding  immediately after such event and the denominator of which is the number of shares of Common Stock that were  outstanding immediately prior to such event.       (ii)  The Corporation shall declare a dividend or distribution on the Series A Junior  Participating Preferred Stock as provided in paragraph (I) above immediately after it declares a dividend or  distribution on the Common Stock (other than a dividend payable in shares of Common Stock); provided that, in the  event no dividend or distribution shall have been declared on the Common Stock during the period between any  Quarterly Dividend Payment Date and the next subsequent Quarterly Dividend Payment Date, a dividend of $10 per  share on the Series A Junior Participating Preferred Stock shall nevertheless be payable on such subsequent  Quarterly Dividend Payment Date.       (iii)  Dividends shall begin to accrue and be cumulative on outstanding shares of  Series A Junior Participating Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of  issue of such shares of Series A Junior Participating Preferred Stock, unless the date of issue of such shares is prior  to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin  to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or  is a date after the record date for the determination of holders of shares of Series A Junior Participating Preferred  Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares  shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of  Directors may fix a record date for the determination of holders of shares of Series A Junior participating Preferred  Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be no more  than 30 days prior to the date fixed for the payment thereof.      (c)  Voting Rights. The holders of shares of Series A Junior Participating Preferred Stock shall  have the following voting rights:    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 4 -       (i)  Subject to the provision for adjustment hereinafter set forth, each share of Series  A Junior Participating Preferred Stock shall entitle the holder thereof to 1,000 votes on all matters submitted to a vote  of the shareholders of the Corporation. In the event the Corporation shall at any time after the Rights Declaration  Date (a) declare any dividend on Common Stock payable in shares of Common Stock, (b) subdivide the outstanding  Common Stock, or (c) combine the~ outstanding Common Stock into a smaller number of shares, then in each such  case the number of votes per share to which holders of shares of Series A Junior Participating Preferred Stock were  entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction the numerator of  which is the number of shares of Common Stock outstanding immediately after such event and the denominator of  which is the number of shares of Common Stock that were outstanding immediately prior to such event.       (ii)  Except as otherwise provided herein or by law, the holders of shares of Series A  Junior Participating Preferred Stock and the holders of shares of common Stock shall vote together as one class on  all matters submitted to a vote of shareholders of the Corporation.       (iii) (A)  If at any time dividends on any Series A Junior Participating Preferred  Stock shall be in arrears in an amount equal to six (6) quarterly dividends thereon, the occurrence of such  contingency shall mark the beginning of a period (herein called a &#8220;default period&#8221;) which shall extend until such time  when all accrued and unpaid dividends for all previous quarterly dividend periods and for the current quarterly  dividend period on all shares of Series A Junior Participating Preferred Stock then outstanding shall have been  declared and paid or set apart for payment. During each default period, all holders of Preferred Stock (including  holders of the Series A Junior Participating Preferred Stock) with dividends in arrears in an amount equal to six (6)  quarterly dividends thereon, voting as a class, irrespective of series, shall have the right to elect two (2) directors.        (B)  During any default period, such voting right of the holders of Series A  Junior Participating Preferred Stock may be exercised initially at a special meeting called pursuant to subparagraph  (C) of this paragraph (c)(iii) or at any annual meeting of shareholders, and thereafter at annual meetings of  shareholders, provided that neither such voting right nor the right of the holders of any other series of Preferred  Stock, if any, to increase, in certain cases, the authorized number of directors shall be exercised unless the holders of  ten percent (10)% in number of shares of Preferred Stock outstanding shall be present in person or by proxy. The  absence of a quorum of the holders of Common Stock shall not affect the exercise by the holders of Preferred Stock  of such voting right. At any meeting at which the holders of Preferred Stock shall exercise such voting right initially  during an existing default period, they shall have the right, voting as a class, to elect directors to fill such vacancies, if  any, in the board of directors as may then exist up to two (2) directors or, if such right Is exercised at an annual  meeting, to elect two (2) directors. If the number which may be so elected at any special meeting does not amount to  the required number, the holders of the Preferred Stock shall have the right to make such increase in the number of  directors as shall be necessary to permit the election by them of the required number. After the holders of the  Preferred Stock shall have exercised their right to elect directors in any default period and during the continuance of  such period, the number of directors shall not be increased or decreased except by vote of the holders of Preferred  Stock as herein provided or pursuant to the rights of any equity securities ranking senior to or pari passu with the  Series A Junior Participating Preferred Stock.        (C)  Unless the holders of Preferred Stock shall, during an existing default  period, have previously exercised their right to elect directors, the board of directors may order, or any shareholder or  shareholders owning in the aggregate not less than ten percent (10%) of the total number of shares of Preferred  Stock outstanding, irrespective of series, may request, the calling of a special meeting of the holders of Preferred  Stock, which meeting shall thereupon be called by the President, a Vice-President or the Secretary of the  Corporation. Notice of such meeting and of any annual meeting at which holders of Preferred Stock are entitled to  vote pursuant to this subparagraph (C) shall be given to each holder of record of Preferred Stock by mailing a copy of  such notice to him at his last address as the same appears on the books of the Corporation. Such meeting shall be  called for a time not earlier than 20 days and not later than 60 days after such order or request or in default of the  calling of such meeting within 60 days after such order or request, such meeting may be called on similar notice by  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 5 -    any shareholder or shareholders owning in the aggregate not less than ten percent (10%) of the total number of  shares of Preferred Stock outstanding. Notwithstanding the provisions of this subparagraph (C), no such special  meeting shall be called during the period within 60 days immediately preceding the date fixed for the next annual  meeting of the shareholders.        (D)  In any default period, the holders of Common Stock, and other classes  of stock of the Corporation if applicable, shall continue to be entitled to elect the whole number of directors until the  holders of Preferred Stock shall have exercised their right to elect two (2) directors voting as a class, after the  exercise of which right (x) the directors so elected by the holders of Preferred Stock shall continue in office until their  successors shall have been elected by such holders or until the expiration of the default period, and (y) any vacancy  in the board of directors may (except as provided in subparagraph (B) of this paragraph (c)(iii) be filled by vote of a  majority of the remaining directors theretofore elected by the holders of the class of stock which elected the director  whose office shall have become vacant. References in this subparagraph (D) to directors elected by the holders of a  particular class of stock shall include directors elected by such directors to fill vacancies as provided in clause (y) of  the preceding sentence.        (E)  Immediately upon the expiration of a default period, (x) the right of the  holders of Preferred Stock as a class to elect directors shall cease, (y) the term of any directors elected by the  holders of Preferred Stock as a class shall terminate, and (z) the number of directors shall be such number as may  be provided for in the Articles of Incorporation or Bylaws irrespective of any increase made pursuant to the provisions  of subparagraph (B) of this paragraph (c)(iii) (such number being subject, however, to change thereafter in any  manner provided by law or in the Articles of Incorporation or Bylaws). Any vacancies in the board of directors effected  by the provisions of clauses (y) and (z) in the preceding sentence may be filled by a majority of the remaining  directors.       (iv)  Except as set forth herein, holders of Series A Junior participating Preferred  Stock shall have no special voting rights and their consent shall not be required (except to the extend they are  entitled to vote with holders of Common Stock as set forth herein) for taking any corporate action.      (d)  Certain Restrictions       (i)  Whenever quarterly dividends or other dividends or distributions payable on the  Series A Junior Participating Preferred Stock as provided in paragraph (b) are in arrears, thereafter and until all  accrued and unpaid dividends and distributions, whether or not declared, on shares of Series A Junior Participating  Preferred Stock outstanding shall have been paid in full, the Corporation shall not        (A)  declare or pay dividends on, make any other distributions on, or redeem  or purchase or otherwise acquire for consideration any shares of stock ranking junior (either as to dividends or upon  liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock;        (B)  declare or pay dividends on or make any other distributions on any  shares of stock ranking on a party (either as to dividends or upon liquidation, dissolution or winding up) with the  Series A Junior Participating Preferred Stock, except dividends paid ratably on the Series A Junior Participating  Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total  amounts to which the holders of all such shares are then entitled;        (C)  redeem or purchase or otherwise acquire for consideration shares of  any stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A  Junior Participating Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise  acquire shares of any such parity stock in exchange for shares of any stock of the Corporation ranking junior (either  as to dividends or upon dissolution, liquidation or winding up) to the Series A Junior Participating Preferred Stock; or  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 6 -          (D)  purchase or otherwise acquire for consideration any shares of Series A  Junior Participating Preferred Stock, or any shares of stock ranking on a parity with the Series A Junior Participating  Preferred Stock, except in accordance with a purchase offer made in writing or by publication (as determined by the  board of directors) to all holders of such shares upon such terms as the board of directors, after consideration of the  respective annual dividend rates and other relative rights and preferences of the respective series and classes, shall  determine in good faith will result in fair and equitable treatment among the respective series or classes.       (ii) the Corporation shall not permit any subsidiary of the Corporation to purchase or  otherwise acquire for consideration any shares of stock of the Corporation unless the Corporation could, under  paragraph (d)(i), purchase or otherwise acquire such shares at such time and in such manner.      (e)  Reacquired Shares. Any shares of Series A Junior Participating Preferred Stock  purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and cancelled  promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued  shares of Preferred Stock and may be reissued as part of a new series of Preferred Stock to be created by resolution  or resolutions of the board of directors, subject to the conditions and restrictions on issuance set forth herein.      (f)  Liquidation, Dissolution or Winding Up.       (i)  Upon any liquidation (voluntary or otherwise), dissolution or winding up of the  Corporation, no distribution shall be made to the holders of shares of stock ranking junior (either as to dividends or  upon liquidation, dissolution or winding up) to the Series A Junior Participating Preferred Stock unless, prior thereto,  the holders of shares of Series A Junior Participating Preferred Stock shall have received $10 per share, plus an  amount equal to accrued and unpaid dividends any distribution thereon, whether or not declared, to the date of such  payment (the &#8220;Series A Liquidation Preference&#8221;). Following the payment of the full amount of the Series A Liquidation  Preference, no additional distributions shall be made to the holders of shares of Series A Junior Participating  Preferred Stock unless, prior thereto, the holders of shares of Common Stock shall have received an amount per  share (the &#8220;Common Adjustment&#8221;) equal to the quotient obtained by dividing (a) the Series A Liquidation Preference  by (b) 1,000 (as appropriately adjusted as set forth in paragraph (iii) below to reflect such events as stock splits, stock  dividends and recapitalizations with respect to the Common Stock) (such number in clause (b), the &#8220;Adjustment  Number&#8221;). Following the payment of the full amount of the Series A Liquidation Preference and the Common  Adjustment in respect of all outstanding shares of Series A Junior participating Preferred Stock and common Stock,  respectively, holders of Series A Junior Participating Preferred Stock and holders of shares of Common Stock shall  receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the Adjustment  Number to I with respect to such Preferred Stock and common Stock, on a per share basis, respectively.       (ii) In the event, however, that there are not sufficient assets available to permit  payment in full of the Series A Liquidation Preference and the liquidation preferences of all other series of Preferred  Stock, if any, which rank on a parity with the Series A Junior Participating Preferred Stock, then such remaining  assets shall be distributed ratably to the holders of such parity shares in proportion to their respective liquidation  preferences. In the event, however, that there are not sufficient assets available to permit payment in full of the  Common Adjustment, then such remaining assets shall be distributed ratably to the holders of Common Stock.       (iii)  In the event the Corporation shall at any time after the Rights Declaration Date  (a) declare any dividend on Common Stock payable in shares of Common Stock, (b) subdivide the outstanding  Common Stock, or (c) combine the outstanding common Stock into a smaller number of shares, then in each such  case the Adjustment Number in effect immediately prior to such event shall be adjusted by multiplying such  Adjustment Number by a fraction the numerator of which is the number of shares of Common Stock outstanding  immediately after such event and the denominator of which is the number of shares of Common Stock that were  outstanding immediately prior to such event.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 7 -        (g)  Consolidation, Merger, etc. In case the Corporation shall enter into any consolidation,  merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into  other stock or securities, cash and/or any other property, then in any such case the shares of Series A Junior  Participating Preferred Stock shall at the same time be similarly exchanged or changed in an amount per share  (subject to the provision for adjustment hereinafter set forth) equal to 1,000 times the aggregate amount of stock,  securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share  of Common Stock is changed or exchanged. In the event the Corporation shall at any time after the Rights  Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the  outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in  each such case the amount set forth in the preceding sentence with respect to the exchange or change of shares of  Series A Junior Participating Preferred Stock shall be adjusted by multiplying such amount by a fraction the  numerator of which is the number of shares of Common Stock outstanding immediately after such event and the  denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such  event.      (h)  No Redemption. The shares of Series A Junior Participating Preferred Stock shall not be  redeemable.      (i)  Ranking. The Series A Junior Participating Preferred Stock shall rank junior to all other  series of Preferred Stock as to the payment of dividends and the distribution of assets unless the terms of any such  series shall provide otherwise.      (j)  Amendment. The Articles of Incorporation of the Corporation shall not be further amended  in any manner which would materially alter or change the powers, preferences or special rights of the Series A Junior  Participating Preferred Stock so as to affect them adversely without the affirmative vote of the holders of a majority or  more of the outstanding shares of Series A Junior Participating Preferred Stock, voting separately as a class.      (k)  Fractional Shares. Series A Junior Participating Preferred Stock may be issued in fractions  of a share which shall entitle the holder, in proportion to such holder&#8217;s fractional shares, to exercise voting rights,  receive dividends participate in distributions and to have the benefit of all other rights of holders of Series A Junior  Participating Preferred Stock.    Common Stock      (a)  Dividends. Holders of Common Stock shall be entitled to receive such dividends as may  be declared by the board of directors, except that the Corporation will not declare, pay or set apart for payment any  dividend on shares of Common Stock (other than dividends payable in Common Stock), or directly or indirectly make  any distribution on, redeem, purchase or otherwise acquire any such shares, if at the time of such action the  Corporation is in default with respect to any dividend due and payable on, or any sinking or purchase fund  requirement relating to, any shares of Preferred Stock.      (b)  Distribution of Assets. In the event of voluntary or involuntary liquidation, dissolution or  winding up of the Corporation, holders of Common Stock shall be entitled to receive pro rate all of the remaining  assets of the Corporation available for distribution to its shareholders after all amounts to which the holders of  Preferred Stock are entitled have been paid or set aside in cash for payment.      (c)  Voting Rights. Except as otherwise required by law or provided in any certificate creating  any series of Preferred Stock, the holders of Common Stock shall have the exclusive right to vote in the election of  directors and for all other purposes, each such holder being entitled to one vote for each share thereof held.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 8 -     6.  [OMITTED]     7.  Evaluation of Certain Proposals by the Board of Directors. The board of directors of the  Corporation, when evaluating any proposal from another party to (a) make a tender offer for securities of the  Corporation, (b) merge or consolidate the Corporation with another corporation, (c) purchase or otherwise acquire  substantially all of the properties or assets of the Corporation, or (d) engage in any other transaction having a similar  effect upon the properties, operations or control of the Corporation, shall, in connection with the exercise of its  judgment in determining what is the best interests of the Corporation and its shareholders, give due consideration to  the following:       (i)  the character, integrity, business philosophy and financial status of the other  party or parties to the transaction;       (ii)  the consideration to be received by the Corporation or its shareholders in  connection with such transaction, as compared to: (a) the current market price or value of the Corporation&#8217;s  properties or securities; (b) the estimated future value of the Corporation, its properties or securities; and (c) such  other measures of the value of the Corporation, its properties or securities as the directors may deem appropriate.       (iii) the projected social, legal and economic effects of the proposed action or  transaction upon the Corporation, its employees, suppliers and customers and the communities in which the  Corporation does business;       (iv)  the general desirability of the Corporation&#8217;s continuing as an independent entity;  and       (v)  such other factors as the board of directors may deem relevant.     8.  Directors      (a)  Number, Election and Term. Except as otherwise fixed by or pursuant to the provisions of  Article 5 hereof relating to the rights of the holders of any class or series of stock having a preference over the  Common Stock as to dividends or in the event of and during a default period to elect directors under specified  circumstances, the number of the directors of the Corporation shall be fixed from time to time pursuant to the Bylaws  of the Corporation. At the annual meeting of shareholders held in 2012, and at each succeeding annual meeting of  the shareholders of the Corporation, the directors shall not be classified, and the directors, other than those who may  be elected by the holders of any class or series of stock having a preference over the Common Stock as to dividends  or in the event and during a default period, shall be elected and shall hold office until the next annual meeting of  shareholders and until their respective successors are elected and qualified, or until the earlier of his or her death,  resignation, retirement, disqualification or removal from office. Subject to paragraph (c) of this Article 8, at each  meeting of the stockholders for the election of directors at which a quorum is present, the persons receiving a  majority of the votes cast at such election shall be elected; provided, however, that at any meeting of the stockholders  for which the Secretary of the Corporation determines that the number of nominees for director exceeds the number  of directors to be elected, directors shall be elected by a plurality of the votes of the shares represented in person or  represented by proxy at such meeting and entitled to vote on the election of directors.  For purposes of this paragraph  (a), a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a director must exceed the number of  votes cast &#8220;against&#8221; that director.  Votes cast shall include &#8220;for&#8221; and &#8220;against&#8221; a nominee, but shall exclude  &#8220;abstentions&#8221; and &#8220;broker non-votes&#8221; with respect to that nominee&#8217;s election. If a director is not elected, the director  shall tender his or her resignation to the Board of Directors.  The Board of Directors will publicly disclose its decision  with respect to whether to accept or reject the resignation, or whether other action should be taken and the rationale  behind it within ninety (90) days from the date of the certification of the election results.  The Board of Directors shall  have the authority to adopt and amend appropriate Bylaws to implement this paragraph (a).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 9 -        (b)  Vacancies. Vacancies in the board of directors, including vacancies resulting from an  increase in the number of directors, shall be filled only by a majority of the directors then in office, though less than a  quorum, and each person so elected shall be a director to serve for the balance of the unexpired term and until his  successor is duly elected and qualified.      (c)  Cumulative Voting in Certain Circumstances       (i)  Except as and to the extent otherwise provided in this paragraph (c)  shareholders of the Corporation shall not be entitled to cumulative voting rights in any election of directors of the  Corporation.       (ii)  There shall be cumulative voting in any election of directors of the Corporation on  or after the occurrence of both of the following events:        (A)  the public announcement (which, for purposes of this definition, shall  include, without limitation, a report filed pursuant to Section 13(d) under the Securities Exchange Act of 1934, as  amended (the &#8220;Exchange Act&#8221;), by the Corporation or a 40% Shareholder that a 40% Shareholder has become such.    and        (B)  such 40% Shareholder makes, or in any way participates in, directly or  indirectly, any &#8220;solicitation&#8221; of &#8220;proxies&#8221; (as such terms are defined or used in Regulation 14A under the Exchange  Act) or becomes a &#8220;participant&#8221; in any &#8220;election contest&#8221; (as such terms are defined or used in Rule 14a-11 of the  Exchange Act) with respect to the Corporation; seeks to advise or influence any person (within the meaning of  Section 13(d)(3) of the Exchange Act) with respect to the voting of any securities of the Corporation: or executes any  written consent in lieu of a meeting of holders of the Voting Stock.      &#8220;40% Shareholder&#8221; shall mean any Person who or which, together with all Affiliates and Associate  of such Person, shall be the Beneficial Owner of 40% or more of the Voting Stock but shall not include (i) the  Corporation, (ii) any wholly owned Subsidiary, (iii) any employee benefit plan of the Corporation or of any Subsidiary,  or (iv) any Person holding securities of the Corporation for or pursuant to the terms of any such plan.    Notwithstanding the foregoing, no Person shall become a &#8220;40% Shareholder&#8221; as the result of an acquisition of  Common Stock by the Corporation which, by reducing the number of shares outstanding, increases the proportionate  number of shares beneficially owned by such Person to 40% or more of the Voting Stock; provided, however, that if a  Person who would otherwise be a 40% Shareholder but for the provisions of this sentence shall, after such share  purchases by the Corporation, become the Beneficial Owner of any additional Voting Stock then such Person shall be  deemed to be a &#8220;40% Shareholder.&#8221;       (iii)  Certain Definitions. For purposes of this Article 8:      &#8220;Affiliate&#8221; and &#8220;Associate&#8221; shall have the respective meanings ascribed to such terms in rule 12b-2  of the General Rules and Regulations under the Exchange Act as in effect on May 3, 1990.      A Person shall be deemed the &#8220;Beneficial Owner&#8221; of and shall be deemed to &#8220;beneficially own&#8221; any  securities:        (A)  which such Person or any such Person&#8217;s affiliates or Associates  beneficially owns, directly or indirectly:    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex31articlesofincorporat010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex31articlesofincorporat010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      - 10 -        (B)  which such Person or any of such Person&#8217;s Affiliates or Associates has  (A) the right to acquire (whether such right is exercisable immediately or only after the passage of time) pursuant to  any agreement, arrangement or understanding (whether or not in writing), or upon the exercise of conversion rights,  exchange rights, rights (other than the Rights granted pursuant to the Flip-In Rights Agreement and Flip-Over-Rights  Agreement between the Corporation and American Stock Transfer &amp; Trust Company, dated as of January 16, 1990),  warrants or options, or otherwise or (B) the right to vote pursuant to any agreement, arrangement or understanding;  provided, however, that a Person shall not be deemed the Beneficial Owner of, or to beneficially own, securities  tendered pursuant to a tender or exchange offer made by or on behalf of such Person or any of such Person&#8217;s  Affiliates or Associates until such tendered securities are accepted for purchase or exchange; or        (C)  which are beneficially owned, directly or indirectly, by any other Person  with which such Person or any of such Person&#8217;s Affiliates or Associates has any agreement, arrangement or  understanding for the purpose of acquiring, holding, voting or disposing of any securities of the Corporation.      &#8220;Person&#8221; shall mean any individual, firm, corporation or other entity, and shall include any  successor (by merger or otherwise) of such entity.      &#8220;Subsidiary&#8221; shall mean any corporation or other entity of which a majority of the voting power of  the voting equity securities or equity interest is owned, directly or indirectly, by the Corporation.      &#8220;Voting Stock&#8221; means Common Stock and any other securities of the Corporation entitled to vote  generally for the election of directors or any security convertible into or exchangeable for or exercisable for the  purchase of Common Stock or other securities of the Corporation entitled to vote generally for the election of  directors.     9. Uncertificated Shares. Any and all classes or series of shares of capital stock of the Corporation, or  any part thereof, may be represented by uncertificated shares to the extent determined by the board of directors,  except as required by applicable law, including that shares represented by a certificate that is issued and outstanding  shall continue to be represented thereby until the certificate is surrendered to the Corporation. Within a reasonable  time after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof  a written notice containing the information required by applicable law to be set forth or stated on certificates. Except  as otherwise expressly provided by law, the rights and obligations of the holders of shares represented by certificates  and the rights and obligations of the holders of uncertificated shares of the same class and series shall be identical.         </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex311q22024.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i55612ef5ba2749d2ac9f9db25ee938b1_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eric M. Green, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer, Chair of the Board of Directors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July 25, 2024</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex312q22024.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ida4b3b18acd240f1a6869cce8bb40534_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bernard J. Birkett, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of West Pharmaceutical Services, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July 25, 2024</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex321q22024.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic80e21f59de642f5b896827094aab65e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Eric M. Green, President and Chief Executive Officer, Chair of the Board of Directors of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric M. Green</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer, Chair of the Board of Directors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July 25, 2024</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex322q22024.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i388c78e8b156480f9ecccc397aed58a3_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Bernard J. Birkett, Senior Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernard J. Birkett</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July 25, 2024</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>wst-20240630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wst="http://www.westpharma.com/20240630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.westpharma.com/20240630">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.westpharma.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED">
        <link:definition>9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical">
        <link:definition>9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical">
        <link:definition>9952155 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.westpharma.com/role/BasisofPresentation">
        <link:definition>9952157 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandards" roleURI="http://www.westpharma.com/role/NewAccountingStandards">
        <link:definition>9952158 - Disclosure - New Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.westpharma.com/role/Revenue">
        <link:definition>9952159 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.westpharma.com/role/NetIncomePerShare">
        <link:definition>9952160 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.westpharma.com/role/Inventories">
        <link:definition>9952161 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.westpharma.com/role/Leases">
        <link:definition>9952162 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompanies" roleURI="http://www.westpharma.com/role/AffiliatedCompanies">
        <link:definition>9952163 - Disclosure - Affiliated Companies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.westpharma.com/role/Debt">
        <link:definition>9952164 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments">
        <link:definition>9952165 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.westpharma.com/role/FairValueMeasurements">
        <link:definition>9952166 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>9952167 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.westpharma.com/role/ShareholdersEquity">
        <link:definition>9952168 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.westpharma.com/role/StockBasedCompensation">
        <link:definition>9952169 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncome" roleURI="http://www.westpharma.com/role/OtherExpenseIncome">
        <link:definition>9952170 - Disclosure - Other Expense (Income)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.westpharma.com/role/IncomeTaxes">
        <link:definition>9952171 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.westpharma.com/role/CommitmentsandContingencies">
        <link:definition>9952172 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.westpharma.com/role/SegmentInformation">
        <link:definition>9952173 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.westpharma.com/role/SubsequentEvents">
        <link:definition>9952174 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.westpharma.com/role/BasisofPresentationPolicies">
        <link:definition>9954471 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.westpharma.com/role/RevenueTables">
        <link:definition>9954472 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.westpharma.com/role/NetIncomePerShareTables">
        <link:definition>9954473 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.westpharma.com/role/InventoriesTables">
        <link:definition>9954474 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.westpharma.com/role/LeasesTables">
        <link:definition>9954475 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.westpharma.com/role/DebtTables">
        <link:definition>9954476 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>9954477 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables">
        <link:definition>9954478 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>9954479 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.westpharma.com/role/ShareholdersEquityTables">
        <link:definition>9954480 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeTables" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables">
        <link:definition>9954481 - Disclosure - Other Expense (Income) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.westpharma.com/role/SegmentInformationTables">
        <link:definition>9954482 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenueRecognitionDetails" roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails">
        <link:definition>9954483 - Disclosure - Revenue - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails">
        <link:definition>9954484 - Disclosure - Revenue - Contracts and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.westpharma.com/role/RevenueNarrativeDetails">
        <link:definition>9954485 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareSummaryofNetIncomePerShareDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails">
        <link:definition>9954486 - Disclosure - Net Income Per Share - Summary of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareNarrativeDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails">
        <link:definition>9954487 - Disclosure - Net Income Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.westpharma.com/role/InventoriesDetails">
        <link:definition>9954488 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails">
        <link:definition>9954489 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAssetsAndLiabilitiesLesseeDetails" roleURI="http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails">
        <link:definition>9954490 - Disclosure - Leases - Assets And Liabilities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCashFlowandSupplementalInformationDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails">
        <link:definition>9954491 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseWeightedAverageDetails" roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails">
        <link:definition>9954492 - Disclosure - Leases - Lease Weighted Average (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofFinanceLeaseLiabilitiesDetails" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails">
        <link:definition>9954494 - Disclosure - Leases - Maturities of Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1">
        <link:definition>9954494 - Disclosure - Leases - Maturities of Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails">
        <link:definition>9954495 - Disclosure - Affiliated Companies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtLongtermDebtDetails" roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails">
        <link:definition>9954496 - Disclosure - Debt - Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtLongtermDebtDetails_1" roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails_1">
        <link:definition>9954496 - Disclosure - Debt - Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.westpharma.com/role/DebtNarrativeDetails">
        <link:definition>9954497 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails">
        <link:definition>9954498 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails">
        <link:definition>9954499 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails">
        <link:definition>9954500 - Disclosure - Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails">
        <link:definition>9954501 - Disclosure - Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsOtherFinancialInstrumentsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails">
        <link:definition>9954502 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>9954503 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails">
        <link:definition>9954504 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangeinShareholdersEquityDetails" roleURI="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails">
        <link:definition>9954505 - Disclosure - Shareholder's Equity - Change in Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationDetails">
        <link:definition>9954506 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails">
        <link:definition>9954507 - Disclosure - Other Expense (Income) - Schedule of Other Expense (Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeNarrativeDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails">
        <link:definition>9954508 - Disclosure - Other Expense (Income) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseIncomeScheduleofRestructuringReserveDetails" roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails">
        <link:definition>9954509 - Disclosure - Other Expense (Income) - Schedule of Restructuring Reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesDetails">
        <link:definition>9954510 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails">
        <link:definition>9954511 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesbyProductGroupDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails">
        <link:definition>9954512 - Disclosure - Segment Information - Sales by Product Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentFinancialInformationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails">
        <link:definition>9954513 - Disclosure - Segment Information - Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.westpharma.com/role/SubsequentEventsDetails">
        <link:definition>9954514 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_AccruedSalariesWagesAndBenefitsCurrent" abstract="false" name="AccruedSalariesWagesAndBenefitsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DistributorshipAgreementMember" abstract="true" name="DistributorshipAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_A2022RestructuringPlanMember" abstract="true" name="A2022RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" abstract="false" name="RestructuringAndRelatedActivitiesPeriodOfImplementation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" abstract="false" name="ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="wst_RevolvingCreditFacilityDue2024Member" abstract="true" name="RevolvingCreditFacilityDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_GenericsCustomersMember" abstract="true" name="GenericsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_ForwardContractsOneMember" abstract="true" name="ForwardContractsOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_BiologicsCustomersMember" abstract="true" name="BiologicsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_ContractWithCustomerAssetRollForward" abstract="true" name="ContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_OtherIncomeExpense" abstract="false" name="OtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_The2022RestructuringPlanMember" abstract="true" name="The2022RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_SeniorBNotesDue2024Member" abstract="true" name="SeniorBNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_IntercompanyLoansMember" abstract="true" name="IntercompanyLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_ForwardContractsTwoMember" abstract="true" name="ForwardContractsTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ProprietaryProductsMember" abstract="true" name="ProprietaryProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AssetRelatedChargesMember" abstract="true" name="AssetRelatedChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_OtherFinancialInstrumentsAbstract" abstract="true" name="OtherFinancialInstrumentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_NetSalesMember" abstract="true" name="NetSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_HighValueComponentsMember" abstract="true" name="HighValueComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_SeniorCNotesDue2027Member" abstract="true" name="SeniorCNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_OtherExpenseIncomeMember" abstract="true" name="OtherExpenseIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_ContractManufacturedCustomersMember" abstract="true" name="ContractManufacturedCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_TermLoanDue2024Member" abstract="true" name="TermLoanDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_DeliveryDevicesMember" abstract="true" name="DeliveryDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_TermLoanDue2027Member" abstract="true" name="TermLoanDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_RestructuringChargesCredits" abstract="false" name="RestructuringChargesCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ContractManufacturedProductsMember" abstract="true" name="ContractManufacturedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityRollForward" abstract="true" name="ContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_IntercompanyDemandNotesMember" abstract="true" name="IntercompanyDemandNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="wst_PharmaCustomersMember" abstract="true" name="PharmaCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_StandardPackagingMember" abstract="true" name="StandardPackagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="wst_NotesPayableAndOtherDebtCurrent" abstract="false" name="NotesPayableAndOtherDebtCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>wst-20240630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fe76ad2-cb6a-4c4d-b94c-fca85d158175" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3d1e762b-b260-4805-a2a2-7d244ca70c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe76ad2-cb6a-4c4d-b94c-fca85d158175" xlink:to="loc_us-gaap_GrossProfit_3d1e762b-b260-4805-a2a2-7d244ca70c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d141b6b4-2ea8-4a50-b40e-7f15408bf42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe76ad2-cb6a-4c4d-b94c-fca85d158175" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d141b6b4-2ea8-4a50-b40e-7f15408bf42a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3bdd9d0-5b7d-4ae8-9e81-a87daa94899b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe76ad2-cb6a-4c4d-b94c-fca85d158175" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3bdd9d0-5b7d-4ae8-9e81-a87daa94899b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_38d928be-dd06-43d1-86fb-cf4c988c342d" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe76ad2-cb6a-4c4d-b94c-fca85d158175" xlink:to="loc_wst_OtherIncomeExpense_38d928be-dd06-43d1-86fb-cf4c988c342d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f59c4295-e633-4311-8d97-2ef3d336137b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_59fa6132-808e-4ff2-8340-ca8614bbd069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f59c4295-e633-4311-8d97-2ef3d336137b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_59fa6132-808e-4ff2-8340-ca8614bbd069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7e9f243e-d82f-43ca-9cb4-e7e70b71ca1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f59c4295-e633-4311-8d97-2ef3d336137b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7e9f243e-d82f-43ca-9cb4-e7e70b71ca1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f4d05762-e78c-43eb-90ad-239211bc8669" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f59c4295-e633-4311-8d97-2ef3d336137b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f4d05762-e78c-43eb-90ad-239211bc8669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cfa85cbd-8fe0-4d21-adeb-6e8f79f72e82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6b6324d3-b63c-466d-ae75-50b98e4facf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cfa85cbd-8fe0-4d21-adeb-6e8f79f72e82" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6b6324d3-b63c-466d-ae75-50b98e4facf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b6f8619c-340b-4319-9d8a-5234b8ccb4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cfa85cbd-8fe0-4d21-adeb-6e8f79f72e82" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b6f8619c-340b-4319-9d8a-5234b8ccb4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eac0785b-2c98-4c65-88a8-3e2d614e0efe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_af409b22-009b-43c5-8250-16fd17e6f87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eac0785b-2c98-4c65-88a8-3e2d614e0efe" xlink:to="loc_us-gaap_OperatingIncomeLoss_af409b22-009b-43c5-8250-16fd17e6f87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_1745248b-2dd1-4db2-812a-6cfe58597982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eac0785b-2c98-4c65-88a8-3e2d614e0efe" xlink:to="loc_us-gaap_InterestExpenseNonoperating_1745248b-2dd1-4db2-812a-6cfe58597982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_3d46f187-d6d2-4d15-a569-7227959d3708" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eac0785b-2c98-4c65-88a8-3e2d614e0efe" xlink:to="loc_us-gaap_InvestmentIncomeNet_3d46f187-d6d2-4d15-a569-7227959d3708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31251885-db0f-4a20-9a53-d9dcd7fd79de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eac0785b-2c98-4c65-88a8-3e2d614e0efe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31251885-db0f-4a20-9a53-d9dcd7fd79de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b9c9e140-96c3-41f4-9fb0-017931f3c3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_75e8490d-36f1-4b4d-966c-04d2f5e4bea6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b9c9e140-96c3-41f4-9fb0-017931f3c3f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_75e8490d-36f1-4b4d-966c-04d2f5e4bea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_98972488-e372-43bc-ae9f-7204a89ee202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b9c9e140-96c3-41f4-9fb0-017931f3c3f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_98972488-e372-43bc-ae9f-7204a89ee202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_fc69cd82-876c-4532-ae56-5e6b147755a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentAfterTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b9c9e140-96c3-41f4-9fb0-017931f3c3f6" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_fc69cd82-876c-4532-ae56-5e6b147755a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_2edd4494-7862-4188-a45f-ed067d65f2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b9c9e140-96c3-41f4-9fb0-017931f3c3f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_2edd4494-7862-4188-a45f-ed067d65f2f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_108dad0f-c64d-4e10-8411-b6d5dadda824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b27f2f9c-4513-4ad7-8752-f7fd186d9ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_108dad0f-c64d-4e10-8411-b6d5dadda824" xlink:to="loc_us-gaap_NetIncomeLoss_b27f2f9c-4513-4ad7-8752-f7fd186d9ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a69b199c-504d-445c-bc25-3725fd1f599b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_108dad0f-c64d-4e10-8411-b6d5dadda824" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a69b199c-504d-445c-bc25-3725fd1f599b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_adcb6820-3605-492b-8048-e8a044d23e59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_AssetsCurrent_adcb6820-3605-492b-8048-e8a044d23e59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_293212f8-65a6-440a-97f7-b22ef722c56a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_293212f8-65a6-440a-97f7-b22ef722c56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f5468746-0bc6-4b22-95fc-1c213a8c6c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f5468746-0bc6-4b22-95fc-1c213a8c6c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e10dd593-fa7c-4cb7-8056-385b67170e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e10dd593-fa7c-4cb7-8056-385b67170e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_44aa3539-626d-429f-a6bb-27999f5693fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_Goodwill_44aa3539-626d-429f-a6bb-27999f5693fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3bb82a0a-f820-4c1d-88d7-322faf9cd2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3bb82a0a-f820-4c1d-88d7-322faf9cd2cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_eb93a376-8b3e-450a-b0bf-04887ec09081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_eb93a376-8b3e-450a-b0bf-04887ec09081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3df608ee-3f2d-4743-9c84-d1f6ba7e7906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e09fb4a4-68c8-49bc-9f6d-6ab81b366cb6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3df608ee-3f2d-4743-9c84-d1f6ba7e7906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_68918a68-57a0-49b4-828b-4a66ce652348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef748895-1112-481f-b6c1-edb606af67ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68918a68-57a0-49b4-828b-4a66ce652348" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef748895-1112-481f-b6c1-edb606af67ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_95a61cf8-2925-4ac2-931b-5f47408fab39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68918a68-57a0-49b4-828b-4a66ce652348" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_95a61cf8-2925-4ac2-931b-5f47408fab39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1fcc3200-4aee-49bc-9909-63a4093d92e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68918a68-57a0-49b4-828b-4a66ce652348" xlink:to="loc_us-gaap_InventoryNet_1fcc3200-4aee-49bc-9909-63a4093d92e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f63269d9-5f37-463f-9cd4-a024bc7b55a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_68918a68-57a0-49b4-828b-4a66ce652348" xlink:to="loc_us-gaap_OtherAssetsCurrent_f63269d9-5f37-463f-9cd4-a024bc7b55a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_1b8cef7c-61e3-4fb2-8304-e778780e0fe5" xlink:href="wst-20240630.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_1b8cef7c-61e3-4fb2-8304-e778780e0fe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_97357359-96cf-48c4-8627-cb25ada8cebd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_us-gaap_AccountsPayableCurrent_97357359-96cf-48c4-8627-cb25ada8cebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_9d438dec-289f-4daf-89c5-a54c0dd00aa5" xlink:href="wst-20240630.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_9d438dec-289f-4daf-89c5-a54c0dd00aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f467ead3-598c-4e13-9d5a-bca95ba67b89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f467ead3-598c-4e13-9d5a-bca95ba67b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6bbd6e53-e7ae-4a84-a950-64d7e55e1b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6bbd6e53-e7ae-4a84-a950-64d7e55e1b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a0643343-9343-43d3-989e-b47bd9accb22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d53ebd56-82cd-404e-830d-6a58441de3d7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a0643343-9343-43d3-989e-b47bd9accb22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_602bfdfc-0f02-441d-b7a2-d4c52860083c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_523521dc-7bdc-4018-b664-f9ff39a01b16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_602bfdfc-0f02-441d-b7a2-d4c52860083c" xlink:to="loc_us-gaap_Liabilities_523521dc-7bdc-4018-b664-f9ff39a01b16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_23ff142e-b00e-42b1-b3f6-1717a8d93898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_602bfdfc-0f02-441d-b7a2-d4c52860083c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_23ff142e-b00e-42b1-b3f6-1717a8d93898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_69a9624b-6fe6-463b-9413-af4ad7968e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_602bfdfc-0f02-441d-b7a2-d4c52860083c" xlink:to="loc_us-gaap_StockholdersEquity_69a9624b-6fe6-463b-9413-af4ad7968e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_39a083d8-536d-4673-a7b3-32cce6e4dabc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_PreferredStockValue_39a083d8-536d-4673-a7b3-32cce6e4dabc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5b852471-6f46-4242-8605-eab9b7b1894e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_CommonStockValue_5b852471-6f46-4242-8605-eab9b7b1894e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_67095f2e-f7c6-4ff7-b698-930cb1a92110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_AdditionalPaidInCapital_67095f2e-f7c6-4ff7-b698-930cb1a92110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6143bcc9-40ef-4619-abe7-3c0f3119a530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6143bcc9-40ef-4619-abe7-3c0f3119a530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_08ea8215-fdd5-480a-b28d-e29e010ceb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_08ea8215-fdd5-480a-b28d-e29e010ceb9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_3502b8e4-6173-4f25-a35d-1bd9288d29c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_135e97f6-bf8c-4e5a-a6ad-7b66a1aba223" xlink:to="loc_us-gaap_TreasuryStockCommonValue_3502b8e4-6173-4f25-a35d-1bd9288d29c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3d0aa687-a8c5-4764-9259-545c195b0dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_LiabilitiesCurrent_3d0aa687-a8c5-4764-9259-545c195b0dcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5a4099a4-9d8d-429e-84b2-e87e0a48798b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5a4099a4-9d8d-429e-84b2-e87e0a48798b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_64cfc323-5ba8-4285-a333-46542aaa4d38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_64cfc323-5ba8-4285-a333-46542aaa4d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e9b3f208-3ca2-488b-9c85-5e5951c5d33f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e9b3f208-3ca2-488b-9c85-5e5951c5d33f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_497ac4f0-2ab1-40e6-880e-cddad5dfd91d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_497ac4f0-2ab1-40e6-880e-cddad5dfd91d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_9efdcaf6-fe47-4c4e-b71f-bb5022171d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_9efdcaf6-fe47-4c4e-b71f-bb5022171d2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f728bd42-f07c-45b4-9d02-b62959c0a503" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4691a36b-1e26-420d-9296-c732c829e617" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f728bd42-f07c-45b4-9d02-b62959c0a503" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4a362bf0-952d-4c80-a12a-41a1556d6809" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_db9b5d95-543b-4532-b846-b486e1659f41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a362bf0-952d-4c80-a12a-41a1556d6809" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_db9b5d95-543b-4532-b846-b486e1659f41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_44ae4b1c-5fcf-491e-8c69-13a0627dd4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a362bf0-952d-4c80-a12a-41a1556d6809" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_44ae4b1c-5fcf-491e-8c69-13a0627dd4ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_15e860a6-5d2c-4784-a685-8ecd78cdbfae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_NetIncomeLoss_15e860a6-5d2c-4784-a685-8ecd78cdbfae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fef3b8ae-3daa-4b88-976f-044d9f736c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_Depreciation_fef3b8ae-3daa-4b88-976f-044d9f736c72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_252db753-20ac-4a19-9774-56656a9e13b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_AdjustmentForAmortization_252db753-20ac-4a19-9774-56656a9e13b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ccdbf2f3-9417-494a-ae59-221a236a42d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_ShareBasedCompensation_ccdbf2f3-9417-494a-ae59-221a236a42d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_85bab14f-db4e-4c3f-a435-843b3cae9f33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_85bab14f-db4e-4c3f-a435-843b3cae9f33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_a183749a-7fac-458b-9740-594843bc34c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_AssetImpairmentCharges_a183749a-7fac-458b-9740-594843bc34c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_14912643-1008-4233-a50c-714d4a04fd77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_14912643-1008-4233-a50c-714d4a04fd77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_009c3b9f-9bb3-4c33-8c8c-1cc2049e39a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac709da-2cc2-4481-b602-df4a86fe3071" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_009c3b9f-9bb3-4c33-8c8c-1cc2049e39a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4904e8a6-ace0-480b-897a-19aaeca5768b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_075f434a-b7b4-49d8-ba38-51e3eb2d58ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4904e8a6-ace0-480b-897a-19aaeca5768b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_075f434a-b7b4-49d8-ba38-51e3eb2d58ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cca21b8-964b-4666-b2d7-22c90d1d162e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4904e8a6-ace0-480b-897a-19aaeca5768b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cca21b8-964b-4666-b2d7-22c90d1d162e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bb96d10a-2ded-4bd0-bdd4-0339d0e88e96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4904e8a6-ace0-480b-897a-19aaeca5768b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bb96d10a-2ded-4bd0-bdd4-0339d0e88e96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_55a907db-fd5e-4404-9249-e6479c1a4fda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4904e8a6-ace0-480b-897a-19aaeca5768b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_55a907db-fd5e-4404-9249-e6479c1a4fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16ee8a59-4189-4156-a0eb-16a9b8a8f6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cac0e91a-a946-4d56-8545-11a83f9fc5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16ee8a59-4189-4156-a0eb-16a9b8a8f6f1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cac0e91a-a946-4d56-8545-11a83f9fc5dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ad8efdb5-6e2b-4592-840f-b768fe1b23a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16ee8a59-4189-4156-a0eb-16a9b8a8f6f1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ad8efdb5-6e2b-4592-840f-b768fe1b23a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_4b3146bc-3e02-40af-8200-7984a644c195" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_4b3146bc-3e02-40af-8200-7984a644c195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_1f5a8e27-564e-439c-bb3a-de9c5a0b1ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_1f5a8e27-564e-439c-bb3a-de9c5a0b1ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1fc55b65-3141-4aca-b07e-0fb68a052c01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1fc55b65-3141-4aca-b07e-0fb68a052c01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_8edafba8-c61b-4e92-8e59-05b580537c13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_8edafba8-c61b-4e92-8e59-05b580537c13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_338a225f-ee48-49a3-ab5e-3073d8c6a1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_338a225f-ee48-49a3-ab5e-3073d8c6a1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5c4443e8-f8a2-4e0c-ad88-bab20529207c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5c4443e8-f8a2-4e0c-ad88-bab20529207c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_75924f44-3b4b-4810-98d7-db253452a95c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_75924f44-3b4b-4810-98d7-db253452a95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1fc65e24-1c2e-411c-90ac-6f4e0994dfab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0047609-a80a-45ab-8545-b4fe5db2100b" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_1fc65e24-1c2e-411c-90ac-6f4e0994dfab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#NetIncomePerShareSummaryofNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6f0c861-64ac-4adf-9c79-ea4bfe7bf549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78a19f47-5c70-48b4-acbd-426424a5a8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6f0c861-64ac-4adf-9c79-ea4bfe7bf549" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78a19f47-5c70-48b4-acbd-426424a5a8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6bb16308-a9e2-4b89-8d6c-a44b63a4b522" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6f0c861-64ac-4adf-9c79-ea4bfe7bf549" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6bb16308-a9e2-4b89-8d6c-a44b63a4b522" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_465af804-763a-4faf-8d7e-29065cbc8558" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d0312a1e-badc-4cd0-bd70-c7225af7808b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_465af804-763a-4faf-8d7e-29065cbc8558" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d0312a1e-badc-4cd0-bd70-c7225af7808b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ca4958b2-0594-4cc3-a8b1-7c4e751b6d17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_465af804-763a-4faf-8d7e-29065cbc8558" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ca4958b2-0594-4cc3-a8b1-7c4e751b6d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0c2bf49c-b4b7-43b8-8af7-6800917c505f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_465af804-763a-4faf-8d7e-29065cbc8558" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0c2bf49c-b4b7-43b8-8af7-6800917c505f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3969a3d8-1bc4-4beb-80c2-e46e4d6e9daa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_44fff910-55ff-4396-8990-9bf18b3d4c99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3969a3d8-1bc4-4beb-80c2-e46e4d6e9daa" xlink:to="loc_us-gaap_OperatingLeaseCost_44fff910-55ff-4396-8990-9bf18b3d4c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e1171eda-07ca-4168-a484-923434d13794" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3969a3d8-1bc4-4beb-80c2-e46e4d6e9daa" xlink:to="loc_us-gaap_ShortTermLeaseCost_e1171eda-07ca-4168-a484-923434d13794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_743abfa4-6530-4509-8d4e-5b0a4405445d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3969a3d8-1bc4-4beb-80c2-e46e4d6e9daa" xlink:to="loc_us-gaap_VariableLeaseCost_743abfa4-6530-4509-8d4e-5b0a4405445d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_fc5e947c-60fe-4d02-9aac-2295291c809c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3969a3d8-1bc4-4beb-80c2-e46e4d6e9daa" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_fc5e947c-60fe-4d02-9aac-2295291c809c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_23747ae9-db0e-4c3b-a9fb-3244342e4599" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_23747ae9-db0e-4c3b-a9fb-3244342e4599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c4cf1f45-aa1f-4ec5-a4da-b2a495633ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c4cf1f45-aa1f-4ec5-a4da-b2a495633ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_be79c722-e86d-4b9f-8bed-a11fd0701d21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_be79c722-e86d-4b9f-8bed-a11fd0701d21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fe322918-7656-4795-85f4-8ac44b522d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fe322918-7656-4795-85f4-8ac44b522d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9233694f-12bc-4f1a-b57f-b5efa107cf67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9233694f-12bc-4f1a-b57f-b5efa107cf67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_cd04e022-c442-4f90-bf71-90a84380c431" xlink:href="wst-20240630.xsd#wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74d80dcd-6c62-4f0e-bd43-5158e66626d8" xlink:to="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_cd04e022-c442-4f90-bf71-90a84380c431" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c56c525-7c8d-4d12-880a-ae4840a7e63b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6053eedb-f837-4a8f-9c2a-e6d2704b3987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c56c525-7c8d-4d12-880a-ae4840a7e63b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6053eedb-f837-4a8f-9c2a-e6d2704b3987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a9a73897-5efb-4fdb-8ddf-047ce60dfd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1c56c525-7c8d-4d12-880a-ae4840a7e63b" xlink:to="loc_us-gaap_OperatingLeaseLiability_a9a73897-5efb-4fdb-8ddf-047ce60dfd2f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f27b597-23ad-4938-8c23-6900388a1d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ccf576f0-a12e-4f88-8ac2-08a97d0def3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f27b597-23ad-4938-8c23-6900388a1d37" xlink:to="loc_us-gaap_FinanceLeaseLiability_ccf576f0-a12e-4f88-8ac2-08a97d0def3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c053faab-d4cf-4839-aa81-4d4d41785b41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f27b597-23ad-4938-8c23-6900388a1d37" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c053faab-d4cf-4839-aa81-4d4d41785b41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a2df1bd9-72a9-4fa5-88a1-954334bfa157" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a2df1bd9-72a9-4fa5-88a1-954334bfa157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_bbe9acc2-417e-4fd3-ba0b-86498f2a5dca" xlink:href="wst-20240630.xsd#wst_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_bbe9acc2-417e-4fd3-ba0b-86498f2a5dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_df9cefe6-ba2a-474c-82f6-6b32aaf1d173" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_df9cefe6-ba2a-474c-82f6-6b32aaf1d173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5df101ee-ee09-4968-9280-d0b142c608bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5df101ee-ee09-4968-9280-d0b142c608bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0de5817f-375c-4812-87b3-56e0b729a900" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0de5817f-375c-4812-87b3-56e0b729a900" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6a1bb4b5-fce8-4e07-82d8-c54a8e778256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5ec0720d-4ec5-4d33-8ab0-2426d736edbd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6a1bb4b5-fce8-4e07-82d8-c54a8e778256" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_53f6d512-089c-4e35-a686-99b8af0366c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3a0e990f-9818-4c9f-b137-5ad2d909b6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_53f6d512-089c-4e35-a686-99b8af0366c9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3a0e990f-9818-4c9f-b137-5ad2d909b6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_18efaefb-6f0f-4150-a9ee-a959c30c6f88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_53f6d512-089c-4e35-a686-99b8af0366c9" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_18efaefb-6f0f-4150-a9ee-a959c30c6f88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_75939973-ea24-44ce-b140-99212abe32bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ba4e7a29-a28a-4072-93e1-bfad7c7e4a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_75939973-ea24-44ce-b140-99212abe32bb" xlink:to="loc_us-gaap_LongTermDebtCurrent_ba4e7a29-a28a-4072-93e1-bfad7c7e4a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1f8b4596-53c2-4171-8506-6e11e5e2c290" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_75939973-ea24-44ce-b140-99212abe32bb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1f8b4596-53c2-4171-8506-6e11e5e2c290" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_70f280f6-069a-4b05-89cf-d7f09f101f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_442fb382-b638-4c4f-9ec3-103a6a1738ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_70f280f6-069a-4b05-89cf-d7f09f101f7e" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_442fb382-b638-4c4f-9ec3-103a6a1738ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ff4ebcca-3b73-4d6d-8d9c-95675c17cbff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_70f280f6-069a-4b05-89cf-d7f09f101f7e" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ff4ebcca-3b73-4d6d-8d9c-95675c17cbff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_9256243d-2b75-47ab-96d3-6834fb7f7811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_70f280f6-069a-4b05-89cf-d7f09f101f7e" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_9256243d-2b75-47ab-96d3-6834fb7f7811" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_385b2dc0-a8ab-4f81-bc62-39e65bb0acd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a9deff8-bba1-48c3-b8a1-5bb04aa46974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_385b2dc0-a8ab-4f81-bc62-39e65bb0acd9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a9deff8-bba1-48c3-b8a1-5bb04aa46974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_7cd7b124-06f8-4ce4-8a5c-d82e330c1405" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_385b2dc0-a8ab-4f81-bc62-39e65bb0acd9" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_7cd7b124-06f8-4ce4-8a5c-d82e330c1405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6c7caebf-2459-40a9-9083-4105055e7381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_385b2dc0-a8ab-4f81-bc62-39e65bb0acd9" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6c7caebf-2459-40a9-9083-4105055e7381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b4139132-aa5f-40bd-b057-348765b6d56d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_6cf73d66-bc10-4cb6-80e3-6aca0efba068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b4139132-aa5f-40bd-b057-348765b6d56d" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_6cf73d66-bc10-4cb6-80e3-6aca0efba068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_26293f9b-1430-4d1d-8190-267a5dbfe99c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b4139132-aa5f-40bd-b057-348765b6d56d" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_26293f9b-1430-4d1d-8190-267a5dbfe99c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_70e063be-174f-4d47-82a3-1f0dd7790f86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b4139132-aa5f-40bd-b057-348765b6d56d" xlink:to="loc_us-gaap_DerivativeAssets_70e063be-174f-4d47-82a3-1f0dd7790f86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f3f5fc71-25d6-48b0-886d-31c5d0de951b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a5cf8df8-67cb-4e63-b102-9fae23b7f9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f3f5fc71-25d6-48b0-886d-31c5d0de951b" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_a5cf8df8-67cb-4e63-b102-9fae23b7f9b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_c002df8c-666d-4af6-8a71-92688fb703a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f3f5fc71-25d6-48b0-886d-31c5d0de951b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_c002df8c-666d-4af6-8a71-92688fb703a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_60aef6a8-af72-40fc-89b1-dcf0a92020c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_60aef6a8-af72-40fc-89b1-dcf0a92020c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_25b47f0c-54d9-425b-9eee-1b9574abccd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_AssetImpairmentCharges_25b47f0c-54d9-425b-9eee-1b9574abccd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_b6a7ba01-0001-4806-b4d6-13bc43422d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_b6a7ba01-0001-4806-b4d6-13bc43422d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c8072be6-f180-4553-a4ff-b2e34a6805be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c8072be6-f180-4553-a4ff-b2e34a6805be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_af569c7d-88bc-469d-b406-563fea9c32c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_af569c7d-88bc-469d-b406-563fea9c32c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_51aa6d3a-64da-4847-807b-08aaf78a5044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_381a266b-a3d6-40fd-b091-66dc7d7079db" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_51aa6d3a-64da-4847-807b-08aaf78a5044" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a36d5a10-6208-462c-9ff8-1622381771ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a36d5a10-6208-462c-9ff8-1622381771ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_7650f3c0-1583-442a-bd17-7aa9d3fbf707" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_7650f3c0-1583-442a-bd17-7aa9d3fbf707" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4ff34fdb-f6be-4db7-90cb-580a75308006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:to="loc_us-gaap_RestructuringCharges_4ff34fdb-f6be-4db7-90cb-580a75308006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_17c93597-9b7a-4d99-aa8a-4159e5425e18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:to="loc_us-gaap_ShareBasedCompensation_17c93597-9b7a-4d99-aa8a-4159e5425e18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_37921f57-d21d-4046-9976-018494b2194c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_77e77f57-9b7f-4431-ab5a-b648ea0c1a5e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_37921f57-d21d-4046-9976-018494b2194c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5b66c5fb-4bf3-49f7-8ff4-26fac2c169d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e276446b-d0a2-41ec-b9aa-d99d13b03337" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5b66c5fb-4bf3-49f7-8ff4-26fac2c169d6" xlink:to="loc_us-gaap_OperatingIncomeLoss_e276446b-d0a2-41ec-b9aa-d99d13b03337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_684f8c39-4c6c-4e6d-a111-1f0f9fb7f4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5b66c5fb-4bf3-49f7-8ff4-26fac2c169d6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_684f8c39-4c6c-4e6d-a111-1f0f9fb7f4ab" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>wst-20240630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#RevenueRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2ae59f7c-32c9-447c-8fde-3139b6b95886_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2ae59f7c-32c9-447c-8fde-3139b6b95886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_3f43a2b0-b091-4a67-a748-5d761fe2ab29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_3f43a2b0-b091-4a67-a748-5d761fe2ab29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6c72edb3-63ba-4919-b33e-b5efacbe5d39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6c72edb3-63ba-4919-b33e-b5efacbe5d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5e36a223-9aba-4df8-ac38-bffbdf50355c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5e36a223-9aba-4df8-ac38-bffbdf50355c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_7e762e56-73c9-465c-a9a5-b11411ccfe83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_7e762e56-73c9-465c-a9a5-b11411ccfe83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_0b777437-3b92-4544-b83c-a252373da2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_0b777437-3b92-4544-b83c-a252373da2f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_89539f0f-9789-4247-8304-989bf47e9bb4_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:to="loc_srt_NameOfMajorCustomerDomain_89539f0f-9789-4247-8304-989bf47e9bb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:to="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_0d352093-bea4-4762-943f-e04cc063835e" xlink:href="wst-20240630.xsd#wst_BiologicsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_BiologicsCustomersMember_0d352093-bea4-4762-943f-e04cc063835e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_b0d05d8b-9953-4e2e-8a0a-68afb88123f2" xlink:href="wst-20240630.xsd#wst_GenericsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_GenericsCustomersMember_b0d05d8b-9953-4e2e-8a0a-68afb88123f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_040eb277-2e7a-4481-9f2e-f00bf6c3957d" xlink:href="wst-20240630.xsd#wst_PharmaCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_PharmaCustomersMember_040eb277-2e7a-4481-9f2e-f00bf6c3957d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_47442560-ee28-4058-9d04-1c6a5e08fe7c" xlink:href="wst-20240630.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_ContractManufacturedCustomersMember_47442560-ee28-4058-9d04-1c6a5e08fe7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_04859c46-cb76-4663-a9ab-2531946aae95_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:to="loc_srt_ProductsAndServicesDomain_04859c46-cb76-4663-a9ab-2531946aae95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:to="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember_ff63f89a-1950-4dda-a4df-292cd02efb79" xlink:href="wst-20240630.xsd#wst_HighValueComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_HighValueComponentsMember_ff63f89a-1950-4dda-a4df-292cd02efb79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_71a97322-42c5-4d80-8bee-fdde204a4fc1" xlink:href="wst-20240630.xsd#wst_StandardPackagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_StandardPackagingMember_71a97322-42c5-4d80-8bee-fdde204a4fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember_a19ae5ba-528f-40c0-8e53-fe0c5c7a0595" xlink:href="wst-20240630.xsd#wst_DeliveryDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_DeliveryDevicesMember_a19ae5ba-528f-40c0-8e53-fe0c5c7a0595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_602d36d1-2f8e-4808-8dc7-c32cfff11f32" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_ContractManufacturedProductsMember_602d36d1-2f8e-4808-8dc7-c32cfff11f32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e6f7bca-0414-4366-872f-c6cdfa51df56_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:to="loc_srt_SegmentGeographicalDomain_0e6f7bca-0414-4366-872f-c6cdfa51df56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:to="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_d567ff69-2d67-4b4a-8188-1abccc5a20e0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_srt_AmericasMember_d567ff69-2d67-4b4a-8188-1abccc5a20e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_2da218b6-35b6-4a7d-8200-87e485c9f63a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_us-gaap_EMEAMember_2da218b6-35b6-4a7d-8200-87e485c9f63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_0af96002-c882-4698-b098-bee990ef3bb7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_srt_AsiaPacificMember_0af96002-c882-4698-b098-bee990ef3bb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_03803adc-c595-4fbd-943e-419130cbba20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_03803adc-c595-4fbd-943e-419130cbba20" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AffiliatedCompaniesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_aeb6b707-d97e-46a7-9fc5-3cace95de6e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_aeb6b707-d97e-46a7-9fc5-3cace95de6e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DistributorshipAgreementMember_11a5808e-bd44-48a0-94cf-0cdd2dd7cd32" xlink:href="wst-20240630.xsd#wst_DistributorshipAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:to="loc_wst_DistributorshipAgreementMember_11a5808e-bd44-48a0-94cf-0cdd2dd7cd32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_48f76f18-dcfc-436e-a804-790bf39200e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:to="loc_us-gaap_RelatedPartyDomain_48f76f18-dcfc-436e-a804-790bf39200e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:to="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_2b83f026-268e-4d38-90d3-60eb16ed3954" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:to="loc_srt_AffiliatedEntityMember_2b83f026-268e-4d38-90d3-60eb16ed3954" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_4b829612-9f0a-4cb6-a46b-06ce49f6590e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_EquityMethodInvestments_4b829612-9f0a-4cb6-a46b-06ce49f6590e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_a552780d-6caf-4392-b7e4-78e848c57608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_a552780d-6caf-4392-b7e4-78e848c57608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_fadb17d1-f514-45a1-8741-f72e2bcd2cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_fadb17d1-f514-45a1-8741-f72e2bcd2cc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_41009ff3-c531-4044-9744-eed5b5ccc981" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_41009ff3-c531-4044-9744-eed5b5ccc981" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb34a6-f4c6-430d-b668-b2fed4ea9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb34a6-f4c6-430d-b668-b2fed4ea9f1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_402caedf-a435-47de-a561-9ffa1c92d816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_OtherAssetsCurrent_402caedf-a435-47de-a561-9ffa1c92d816" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_577610e6-ac7f-482e-bb9f-f45d5ec14aeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_577610e6-ac7f-482e-bb9f-f45d5ec14aeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_90a2b93b-702d-4756-ad18-94de0022e125" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_TermLoanDue2024Member_90a2b93b-702d-4756-ad18-94de0022e125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_cba7a386-7c12-4d3f-b183-6f7bb69a94ec" xlink:href="wst-20240630.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_SeniorBNotesDue2024Member_cba7a386-7c12-4d3f-b183-6f7bb69a94ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_f334f9ca-e93b-4464-b0a3-7b33d7cdfc64" xlink:href="wst-20240630.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_SeniorCNotesDue2027Member_f334f9ca-e93b-4464-b0a3-7b33d7cdfc64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a830cf9-1505-4ea1-9a7e-f2c294127a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a830cf9-1505-4ea1-9a7e-f2c294127a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3fdce802-8480-4084-a16f-78df6e65bc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3fdce802-8480-4084-a16f-78df6e65bc1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_6166ca27-df61-4d26-bdd4-90d77cae07fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_6166ca27-df61-4d26-bdd4-90d77cae07fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_25ff6b2a-6343-4d57-8a43-b9a7385e2277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebt_25ff6b2a-6343-4d57-8a43-b9a7385e2277" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c6498c78-9662-4c97-9515-8e3a6ce9c8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebtCurrent_c6498c78-9662-4c97-9515-8e3a6ce9c8f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5ce3c155-ed91-47ef-9e59-54937dd45a96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5ce3c155-ed91-47ef-9e59-54937dd45a96" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5be9c148-9f6d-4f81-a689-2f41c727918e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5be9c148-9f6d-4f81-a689-2f41c727918e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_1eb7f356-580c-4cd7-b7fd-aef64f2d5415" xlink:href="wst-20240630.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_1eb7f356-580c-4cd7-b7fd-aef64f2d5415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_2fca2279-3bf6-4e67-8218-75a05e5df89b" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:to="loc_wst_TermLoanDue2024Member_2fca2279-3bf6-4e67-8218-75a05e5df89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:to="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a3ebd89e-63f2-4765-8e87-91e687632b88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:to="loc_us-gaap_CreditFacilityDomain_a3ebd89e-63f2-4765-8e87-91e687632b88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:to="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a48a4152-8a07-42f8-87ba-2973e46dc36c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a48a4152-8a07-42f8-87ba-2973e46dc36c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2986bf86-f38b-49bb-8cb9-2d4fd0fa3e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:to="loc_us-gaap_LetterOfCreditMember_2986bf86-f38b-49bb-8cb9-2d4fd0fa3e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf06acb-732c-41c9-94b3-46f70cdd5f91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf06acb-732c-41c9-94b3-46f70cdd5f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed85e8ad-789b-4bab-9a31-7d1cd778165a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCredit_ed85e8ad-789b-4bab-9a31-7d1cd778165a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec41e-a8ac-47d3-9e7b-791072dd879d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec41e-a8ac-47d3-9e7b-791072dd879d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_85295c82-d297-4346-bebd-998a5a2c2545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_85295c82-d297-4346-bebd-998a5a2c2545" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_30727faf-7d21-400c-a716-991c69490d49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LongTermDebtCurrent_30727faf-7d21-400c-a716-991c69490d49" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1ee0e3f0-58af-463e-b510-72f70866a4a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1ee0e3f0-58af-463e-b510-72f70866a4a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsOneMember_f39023f4-5835-4961-9b48-c9c888597bf0" xlink:href="wst-20240630.xsd#wst_ForwardContractsOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:to="loc_wst_ForwardContractsOneMember_f39023f4-5835-4961-9b48-c9c888597bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsTwoMember_df9f6307-baef-4936-8884-bfb6888fd603" xlink:href="wst-20240630.xsd#wst_ForwardContractsTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:to="loc_wst_ForwardContractsTwoMember_df9f6307-baef-4936-8884-bfb6888fd603" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6beafeaf-4567-4ceb-a18e-c6704d12b8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6beafeaf-4567-4ceb-a18e-c6704d12b8b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_eee2acb3-041b-4a64-a28d-02bd7980aab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_eee2acb3-041b-4a64-a28d-02bd7980aab4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_a97af21c-5b1e-4c20-8100-1554e5b7abff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_OptionMember_a97af21c-5b1e-4c20-8100-1554e5b7abff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_22d549db-dbd7-4004-8e1b-ae59aabd7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_22d549db-dbd7-4004-8e1b-ae59aabd7fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_38634b92-8f15-4c58-aa08-b3d5f64f3eb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:to="loc_us-gaap_PositionDomain_38634b92-8f15-4c58-aa08-b3d5f64f3eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:to="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_11aa3731-d634-4081-9ad7-e493a253752a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:to="loc_us-gaap_LongMember_11aa3731-d634-4081-9ad7-e493a253752a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_607d9b86-7401-4004-a3d8-a16b8c754199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:to="loc_us-gaap_ShortMember_607d9b86-7401-4004-a3d8-a16b8c754199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_aea237b8-005f-4862-a528-1ad19c9cfeb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:to="loc_us-gaap_HedgingDesignationDomain_aea237b8-005f-4862-a528-1ad19c9cfeb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:to="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05a3d27-07af-4049-b03b-dbb92295e501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05a3d27-07af-4049-b03b-dbb92295e501" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_5662b17e-0ba1-40a8-888b-ca21056b1e97_default" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:to="loc_currency_AllCurrenciesDomain_5662b17e-0ba1-40a8-888b-ca21056b1e97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:to="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_4e03794e-028e-48cd-a150-fcba2ad1c372" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_EUR_4e03794e-028e-48cd-a150-fcba2ad1c372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1684fc09-8409-4783-9855-09e8a5e4a41a" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_JPY_1684fc09-8409-4783-9855-09e8a5e4a41a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_12f4982a-3fc6-4602-bf1e-d351c8847e28" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_SGD_12f4982a-3fc6-4602-bf1e-d351c8847e28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_95f516cb-3100-462f-92fb-c996be02a03d" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_USD_95f516cb-3100-462f-92fb-c996be02a03d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d6341eab-2cf3-468f-b888-845af639a97f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d6341eab-2cf3-468f-b888-845af639a97f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyLoansMember_bd3ec801-7e3c-4800-a50e-92993116f570" xlink:href="wst-20240630.xsd#wst_IntercompanyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:to="loc_wst_IntercompanyLoansMember_bd3ec801-7e3c-4800-a50e-92993116f570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyDemandNotesMember_9238c2fe-273e-46e9-a7f4-566c4e264e27" xlink:href="wst-20240630.xsd#wst_IntercompanyDemandNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:to="loc_wst_IntercompanyDemandNotesMember_9238c2fe-273e-46e9-a7f4-566c4e264e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8b5c6579-2081-467b-b2b7-45b6cc152956" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8b5c6579-2081-467b-b2b7-45b6cc152956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_a2935018-4440-41b3-9aef-7f1e603b546e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeTermOfContract_a2935018-4440-41b3-9aef-7f1e603b546e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_f97d56e6-dbc0-4584-81e5-fd7086269b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_f97d56e6-dbc0-4584-81e5-fd7086269b8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_f82a3939-9ae3-4cca-b660-c0d35d1016bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_f82a3939-9ae3-4cca-b660-c0d35d1016bb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e28b0076-cec2-4eb6-9ee6-fb8431f62971_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e28b0076-cec2-4eb6-9ee6-fb8431f62971_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeMember_dd64f84f-7037-469c-94c7-f1d85e7b78f2" xlink:href="wst-20240630.xsd#wst_OtherExpenseIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_wst_OtherExpenseIncomeMember_dd64f84f-7037-469c-94c7-f1d85e7b78f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_019b1b83-bcf6-4a79-a876-156caa56bb3c" xlink:href="wst-20240630.xsd#wst_NetSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_wst_NetSalesMember_019b1b83-bcf6-4a79-a876-156caa56bb3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e4fd7e1b-3a47-4ce1-9bdb-a26435d61d26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_us-gaap_CostOfSalesMember_e4fd7e1b-3a47-4ce1-9bdb-a26435d61d26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_5f50806f-e854-493f-9d51-eaeb802b7f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_us-gaap_InterestExpenseMember_5f50806f-e854-493f-9d51-eaeb802b7f0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cf949c05-6e84-43d7-aff7-648a882f7f6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cf949c05-6e84-43d7-aff7-648a882f7f6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c6c3e761-f5f1-4d08-9b7d-b7352af05fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_FairValueHedgingMember_c6c3e761-f5f1-4d08-9b7d-b7352af05fee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_402c0e4b-65e9-4dcc-865e-be0093a53874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_CashFlowHedgingMember_402c0e4b-65e9-4dcc-865e-be0093a53874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f3aab8d7-da71-497b-b8b3-bb627c7dd5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f3aab8d7-da71-497b-b8b3-bb627c7dd5c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a0a0df88-9d50-48c3-8e2a-4d5d36bac448_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a0a0df88-9d50-48c3-8e2a-4d5d36bac448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c989ee97-27f6-4720-8865-06a2acae197d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c989ee97-27f6-4720-8865-06a2acae197d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_06637bba-136c-43b6-962b-0f837bcfceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_TreasuryLockMember_06637bba-136c-43b6-962b-0f837bcfceb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_9288edfc-2be0-428b-8f37-89f4fe45708e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_CurrencySwapMember_9288edfc-2be0-428b-8f37-89f4fe45708e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_a7d4214c-41a4-45f4-8d0c-5fc8424629c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_a7d4214c-41a4-45f4-8d0c-5fc8424629c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_de5ed01d-dd96-4133-8427-1b2e7c9bf34f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_de5ed01d-dd96-4133-8427-1b2e7c9bf34f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_fa009857-b25b-475a-bd8d-b587efc9908f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_fa009857-b25b-475a-bd8d-b587efc9908f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_c0672b9a-8e7a-42e0-b8af-7a8261f5f107" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_c0672b9a-8e7a-42e0-b8af-7a8261f5f107" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_5980f1ca-b82a-46d8-ae10-21fb12c9b3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_5980f1ca-b82a-46d8-ae10-21fb12c9b3ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5cbb5a18-bb3f-4cdf-89ca-43df3462221c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5cbb5a18-bb3f-4cdf-89ca-43df3462221c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_e6b44538-ac5f-4a1f-a040-98d7293d4419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_e6b44538-ac5f-4a1f-a040-98d7293d4419" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da82328f-cd9f-4a1d-b067-141b911070ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da82328f-cd9f-4a1d-b067-141b911070ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_6470dfb1-82ac-4dc0-8c3d-c6169e890cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_6470dfb1-82ac-4dc0-8c3d-c6169e890cb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2a24eff0-daeb-49f5-a18b-c3b490ebb671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2a24eff0-daeb-49f5-a18b-c3b490ebb671" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99fdea96-a9ae-4525-8f9b-bce7123a2def_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99fdea96-a9ae-4525-8f9b-bce7123a2def_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_5b495af8-e1b0-448d-b8cd-82c5da1e8cff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:to="loc_us-gaap_CommodityOptionMember_5b495af8-e1b0-448d-b8cd-82c5da1e8cff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_45715f33-e98b-426d-9d39-520460235d83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:to="loc_us-gaap_ForwardContractsMember_45715f33-e98b-426d-9d39-520460235d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_263acc66-8152-42c3-8e42-b92dd1d90650_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:to="loc_us-gaap_HedgingDesignationDomain_263acc66-8152-42c3-8e42-b92dd1d90650_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:to="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dc4a6d07-40bc-4071-bb0b-66fe74c3bde8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:to="loc_us-gaap_NondesignatedMember_dc4a6d07-40bc-4071-bb0b-66fe74c3bde8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fb59cfe3-bc90-41dd-831c-093279aafcd1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fb59cfe3-bc90-41dd-831c-093279aafcd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeMember_68b93397-1ec7-4eab-afd0-25737be91347" xlink:href="wst-20240630.xsd#wst_OtherExpenseIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:to="loc_wst_OtherExpenseIncomeMember_68b93397-1ec7-4eab-afd0-25737be91347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a3c514d5-e060-407a-b196-f0e2cf728787" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a3c514d5-e060-407a-b196-f0e2cf728787" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d72910b0-19ba-4a3f-8fab-9db7987fd5c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d72910b0-19ba-4a3f-8fab-9db7987fd5c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bd8c28cb-7e0e-4a63-8053-8f8771a7cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bd8c28cb-7e0e-4a63-8053-8f8771a7cc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8f1db4d2-f51f-4926-9f40-8365a9f147bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8f1db4d2-f51f-4926-9f40-8365a9f147bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_97f7a8b3-8296-48c3-bcf6-33370c45352f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_97f7a8b3-8296-48c3-bcf6-33370c45352f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_98cdc7a6-b0cc-4dfa-9402-0a9b3c176b13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:to="loc_us-gaap_CurrencySwapMember_98cdc7a6-b0cc-4dfa-9402-0a9b3c176b13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_f78f18ed-52f6-4285-9433-1337fdc90192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:to="loc_us-gaap_CommodityMember_f78f18ed-52f6-4285-9433-1337fdc90192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_4d1b5ab2-e063-45e7-afe0-9a4495056d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_4d1b5ab2-e063-45e7-afe0-9a4495056d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_70fff54b-18e0-436e-9160-066dfadad11e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_70fff54b-18e0-436e-9160-066dfadad11e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b592d993-0e1f-443a-b957-d6b4d28ff8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_DerivativeAssets_b592d993-0e1f-443a-b957-d6b4d28ff8fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2abc125f-1a76-4342-97a0-de84a647b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2abc125f-1a76-4342-97a0-de84a647b5ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03a2d858-88af-460c-8eea-982b2a442aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03a2d858-88af-460c-8eea-982b2a442aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_41fc333b-37e4-42c4-8666-4acbbb7bf720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_41fc333b-37e4-42c4-8666-4acbbb7bf720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_acbb1eea-9d01-4236-8f77-208231007867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_acbb1eea-9d01-4236-8f77-208231007867" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d45fe09c-bd2d-4641-9ff2-703a05b77080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d45fe09c-bd2d-4641-9ff2-703a05b77080" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2175f773-6264-45bb-bd13-afafd26b7ccf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:to="loc_us-gaap_EquityComponentDomain_2175f773-6264-45bb-bd13-afafd26b7ccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:to="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2767ffa0-e304-4e02-8b1a-9269b23e792e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2767ffa0-e304-4e02-8b1a-9269b23e792e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociEquityMethodInvestmentParentMember_1c5aff39-74d9-465d-8ee5-1cb72c91a4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AociEquityMethodInvestmentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AociEquityMethodInvestmentParentMember_1c5aff39-74d9-465d-8ee5-1cb72c91a4cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f5e5ab26-8a07-43e0-8406-356da51edf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f5e5ab26-8a07-43e0-8406-356da51edf5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f965f9b-5a9d-4abd-811f-c7964119436f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f965f9b-5a9d-4abd-811f-c7964119436f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1b3cbb2a-c12a-4075-8c60-d935b738c9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1b3cbb2a-c12a-4075-8c60-d935b738c9cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a6e1911e-497f-4ba8-bbc4-14a2cb7e14ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_StockholdersEquity_a6e1911e-497f-4ba8-bbc4-14a2cb7e14ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_17c058bf-fc24-473a-8fc4-661395da35ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_17c058bf-fc24-473a-8fc4-661395da35ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bcf53135-62f9-4480-a940-18cf7289b57d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bcf53135-62f9-4480-a940-18cf7289b57d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4db6e7de-0ba0-4dcc-8dac-f11d4959d891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4db6e7de-0ba0-4dcc-8dac-f11d4959d891" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c35d7a39-2a77-450f-857e-d893f606807c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8eb46b46-768d-43ee-b051-35537a442fb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8eb46b46-768d-43ee-b051-35537a442fb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_2dea69a5-754f-4d05-a52c-12d0304332da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_2dea69a5-754f-4d05-a52c-12d0304332da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66255b42-c665-497a-9fe9-e58d0a6a7954_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:to="loc_us-gaap_EquityComponentDomain_66255b42-c665-497a-9fe9-e58d0a6a7954_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:to="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fbf59715-16c1-4d12-b0ed-afd87e5f1981" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fbf59715-16c1-4d12-b0ed-afd87e5f1981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b3195c7b-fb14-44cc-88bd-2dffbfeaa58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b3195c7b-fb14-44cc-88bd-2dffbfeaa58e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_adcd4e92-a59b-4281-bd6b-6f138879eecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_adcd4e92-a59b-4281-bd6b-6f138879eecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_29c641e3-a768-4ddf-8e83-311aa7d5fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:to="loc_us-gaap_ForeignExchangeContractMember_29c641e3-a768-4ddf-8e83-311aa7d5fdf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_b6089667-a452-4c95-ad8f-5f7284b7a096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:to="loc_us-gaap_TreasuryLockMember_b6089667-a452-4c95-ad8f-5f7284b7a096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_258e51f1-5971-4a0f-a86a-18cea70832f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_258e51f1-5971-4a0f-a86a-18cea70832f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b7d3cce3-87de-4f70-a6df-c3644b0527a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b7d3cce3-87de-4f70-a6df-c3644b0527a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_937361b6-40c7-4fe4-91e8-fcc2c1a190b3" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_wst_OtherIncomeExpense_937361b6-40c7-4fe4-91e8-fcc2c1a190b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_36810f74-598a-4843-81b5-d09b72c7bba2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_InterestExpenseNonoperating_36810f74-598a-4843-81b5-d09b72c7bba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_0481dab0-8419-4b7e-85d1-873efab3174b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_0481dab0-8419-4b7e-85d1-873efab3174b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_80e8905e-d9f9-4dea-a61f-74f3718eb88b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_80e8905e-d9f9-4dea-a61f-74f3718eb88b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_02320fd9-569e-4352-968c-1d48c949239a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_02320fd9-569e-4352-968c-1d48c949239a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a0f28721-6385-4563-a7b0-4026255d8fec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a0f28721-6385-4563-a7b0-4026255d8fec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20936ec7-b9c8-4146-8266-1506c1f72b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_NetIncomeLoss_20936ec7-b9c8-4146-8266-1506c1f72b2a" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#ShareholdersEquityChangeinShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff5be589-e14c-45ae-8d04-054d46f10f14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:to="loc_us-gaap_EquityComponentDomain_ff5be589-e14c-45ae-8d04-054d46f10f14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:to="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2355932d-3489-45bf-b39c-21569b3ceca5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_CommonStockMember_2355932d-3489-45bf-b39c-21569b3ceca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_39afc86f-30de-43f3-91b8-00bb184d732d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_39afc86f-30de-43f3-91b8-00bb184d732d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_838c86ad-acc8-4f1f-b3f7-df76682d25c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_TreasuryStockCommonMember_838c86ad-acc8-4f1f-b3f7-df76682d25c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b9665773-79c3-4c6a-92be-e57d509aed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_RetainedEarningsMember_b9665773-79c3-4c6a-92be-e57d509aed0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_14d4a269-879f-48d1-a543-7de701b17dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_14d4a269-879f-48d1-a543-7de701b17dd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6a25d3ba-bee4-45b8-a15a-f28937547be7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_SharesIssued_6a25d3ba-bee4-45b8-a15a-f28937547be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d45eed85-24f4-4755-b427-55109d11b9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockholdersEquity_d45eed85-24f4-4755-b427-55109d11b9cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_02f4ce59-e55c-4123-bd13-3a72941511d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockCommonShares_02f4ce59-e55c-4123-bd13-3a72941511d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0296c760-5beb-49f6-934a-d2b6e81ff383" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_NetIncomeLoss_0296c760-5beb-49f6-934a-d2b6e81ff383" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_41c18150-4642-4faf-bd01-b39d01f3afda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_41c18150-4642-4faf-bd01-b39d01f3afda" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29a92e0a-e0dd-4a55-8c0d-654587b9560c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29a92e0a-e0dd-4a55-8c0d-654587b9560c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e1d79b13-c2c7-4393-afdc-a435c8d90bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e1d79b13-c2c7-4393-afdc-a435c8d90bd0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_156b65c0-9380-4b18-81dc-91d1e5f1bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_156b65c0-9380-4b18-81dc-91d1e5f1bf3a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9db8e53e-3d04-4021-a7e5-aa48aad0aa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_DividendsCommonStockCash_9db8e53e-3d04-4021-a7e5-aa48aad0aa7e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36b8c1bb-0805-4daa-8342-10e96e8dcb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36b8c1bb-0805-4daa-8342-10e96e8dcb8f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_24f4b381-040a-4703-a17d-20711c112084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8d0af426-1cdb-456b-8bac-7684559d7308" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3a8f1164-9f66-4dce-8bd0-53ce754ce2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_20c849ec-dd34-4f14-803e-cdc178eb6e66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_20c849ec-dd34-4f14-803e-cdc178eb6e66" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:to="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40016a19-65cb-4c4a-b30d-92f3840427a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40016a19-65cb-4c4a-b30d-92f3840427a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a87e72e6-4dd2-4dcc-96d1-9f914159e824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:to="loc_us-gaap_PerformanceSharesMember_a87e72e6-4dd2-4dcc-96d1-9f914159e824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6be72b35-da1a-4703-a13d-2363392cc12e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6be72b35-da1a-4703-a13d-2363392cc12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:to="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:to="loc_srt_RangeMember_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:to="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06d0634a-a1d8-4be8-bf54-1349e81fd754" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:to="loc_srt_MinimumMember_06d0634a-a1d8-4be8-bf54-1349e81fd754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b3a458d-2b17-422c-9ea0-b1f06ee11593" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:to="loc_srt_MaximumMember_2b3a458d-2b17-422c-9ea0-b1f06ee11593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a6ec4ef2-12b4-4636-82e1-faa863cebdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a6ec4ef2-12b4-4636-82e1-faa863cebdb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1c851803-0e6e-48aa-9f12-974fcd9bd5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1c851803-0e6e-48aa-9f12-974fcd9bd5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bfa701cd-83bd-4eee-a002-d6520524c53d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bfa701cd-83bd-4eee-a002-d6520524c53d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69e27a93-209e-4b30-ba43-9736696a47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69e27a93-209e-4b30-ba43-9736696a47f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_da4022ec-34f4-496c-a10d-6528181663a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_da4022ec-34f4-496c-a10d-6528181663a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_634dda41-3198-4c02-8ef9-d1b2a4c49373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_634dda41-3198-4c02-8ef9-d1b2a4c49373" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8c45b70a-333f-48d6-92d0-363add0ea183" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8c45b70a-333f-48d6-92d0-363add0ea183" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e40eb88b-2fd6-46bf-b577-b40d3cb3bf87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e40eb88b-2fd6-46bf-b577-b40d3cb3bf87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f635805-4226-44ef-b4fe-796bb9c75a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f635805-4226-44ef-b4fe-796bb9c75a52" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40ffb1af-9318-4a85-a3fa-de1f251f2c96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40ffb1af-9318-4a85-a3fa-de1f251f2c96" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_c3638056-b76b-4892-9db5-487f76451664" xlink:href="wst-20240630.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_c3638056-b76b-4892-9db5-487f76451664" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_00a17665-5c74-40bd-874f-42e630ec91c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_00a17665-5c74-40bd-874f-42e630ec91c5" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:to="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_deee2bf5-e636-4b31-ab3b-41d56e0621ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:to="loc_us-gaap_RestructuringPlanDomain_deee2bf5-e636-4b31-ab3b-41d56e0621ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:to="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_7d6064ba-0de8-48d1-b9ef-429a00533b1b" xlink:href="wst-20240630.xsd#wst_The2022RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:to="loc_wst_The2022RestructuringPlanMember_7d6064ba-0de8-48d1-b9ef-429a00533b1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:to="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e50703dd-79f6-4218-a6fa-35cf7075a8eb_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:to="loc_srt_RangeMember_e50703dd-79f6-4218-a6fa-35cf7075a8eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:to="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d7bc5b8b-f5f6-48fa-b459-1d90ba0afd22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:to="loc_srt_MinimumMember_d7bc5b8b-f5f6-48fa-b459-1d90ba0afd22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_99d4d4ba-75e8-497c-b55e-fafeda6f9666" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:to="loc_srt_MaximumMember_99d4d4ba-75e8-497c-b55e-fafeda6f9666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_cc835786-278b-4e37-82f1-f4abc768a65a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_cc835786-278b-4e37-82f1-f4abc768a65a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_f7837842-51d2-4871-9ddb-3d82cae3e1b4" xlink:href="wst-20240630.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_f7837842-51d2-4871-9ddb-3d82cae3e1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9cb5c92b-ad30-4ae0-9e1a-5c1603a167c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9cb5c92b-ad30-4ae0-9e1a-5c1603a167c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_d2193976-9936-43a3-9113-030fffd536a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_d2193976-9936-43a3-9113-030fffd536a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeScheduleofRestructuringReserveDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_56b6ec39-6091-4500-a614-6ac36aff490a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_56b6ec39-6091-4500-a614-6ac36aff490a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7ffac373-c63d-4ccd-89e2-4de9b9819019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7ffac373-c63d-4ccd-89e2-4de9b9819019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_03ad6cac-da4b-40c0-ab99-b7a218aab99f" xlink:href="wst-20240630.xsd#wst_AssetRelatedChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:to="loc_wst_AssetRelatedChargesMember_03ad6cac-da4b-40c0-ab99-b7a218aab99f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:to="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_638e44a6-8b57-4758-8475-95878eaef39e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:to="loc_us-gaap_RestructuringPlanDomain_638e44a6-8b57-4758-8475-95878eaef39e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:to="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_1b74a89d-492b-46e5-a227-05e5a4339a05" xlink:href="wst-20240630.xsd#wst_The2022RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:to="loc_wst_The2022RestructuringPlanMember_1b74a89d-492b-46e5-a227-05e5a4339a05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_83030c84-9fb4-4857-9d24-d3a18f1ded38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_us-gaap_RestructuringReserve_83030c84-9fb4-4857-9d24-d3a18f1ded38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringChargesCredits_325d2980-7e75-4e3c-a373-eab6f8db3de4" xlink:href="wst-20240630.xsd#wst_RestructuringChargesCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_wst_RestructuringChargesCredits_325d2980-7e75-4e3c-a373-eab6f8db3de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ad9d3552-71b7-4c39-9780-449741cf5762" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_us-gaap_PaymentsForRestructuring_ad9d3552-71b7-4c39-9780-449741cf5762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2905375c-f6f5-420c-ab7f-e182ea585606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_13251df9-ae2a-4982-b95f-c99701f1f64a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:to="loc_us-gaap_SegmentDomain_13251df9-ae2a-4982-b95f-c99701f1f64a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:to="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_79e8bd09-8589-40fb-8bf1-715e25325f56" xlink:href="wst-20240630.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:to="loc_wst_ProprietaryProductsMember_79e8bd09-8589-40fb-8bf1-715e25325f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_8d0be6d1-08fe-466b-82be-c81e104d5ada" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:to="loc_wst_ContractManufacturedProductsMember_8d0be6d1-08fe-466b-82be-c81e104d5ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35e3184-9363-483d-9790-9a989d7a52f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35e3184-9363-483d-9790-9a989d7a52f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_89a10e7d-063f-43e9-b330-6a9a4d25f414_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:to="loc_srt_ConsolidationItemsDomain_89a10e7d-063f-43e9-b330-6a9a4d25f414_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:to="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d4edfae7-2bb9-4f75-9126-87d4bcee070c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:to="loc_us-gaap_OperatingSegmentsMember_d4edfae7-2bb9-4f75-9126-87d4bcee070c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d3432cc9-d3cc-4a72-aeb2-f2731f77210f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d3432cc9-d3cc-4a72-aeb2-f2731f77210f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_60e432b8-d07c-45e8-ab3e-642ea30908ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:to="loc_us-gaap_SegmentDomain_60e432b8-d07c-45e8-ab3e-642ea30908ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:to="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_4f5477cc-c84f-43fe-9372-0350dbe5b524" xlink:href="wst-20240630.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:to="loc_wst_ProprietaryProductsMember_4f5477cc-c84f-43fe-9372-0350dbe5b524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_69d38785-c6b4-49ed-92d8-2e03e551f590" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:to="loc_wst_ContractManufacturedProductsMember_69d38785-c6b4-49ed-92d8-2e03e551f590" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_00d79224-3dd3-4570-92dd-751f43d3a9ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:to="loc_us-gaap_RestructuringPlanDomain_00d79224-3dd3-4570-92dd-751f43d3a9ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:to="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2022RestructuringPlanMember_6a51dd78-2e79-4bce-87e6-feb8c9f7a6a2" xlink:href="wst-20240630.xsd#wst_A2022RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:to="loc_wst_A2022RestructuringPlanMember_6a51dd78-2e79-4bce-87e6-feb8c9f7a6a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_311867fa-9ed9-4aee-88ef-43a842a11c97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_OperatingIncomeLoss_311867fa-9ed9-4aee-88ef-43a842a11c97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9361d93b-4dc1-4413-9f66-5cbb426ab1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_ShareBasedCompensation_9361d93b-4dc1-4413-9f66-5cbb426ab1ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a8167f21-9a6c-4aba-890c-d94dd23b9f35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a8167f21-9a6c-4aba-890c-d94dd23b9f35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1078bbff-1b6a-4c50-b871-f385c042ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1078bbff-1b6a-4c50-b871-f385c042ef79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_567c9602-bbde-42be-a448-4073d86de8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_567c9602-bbde-42be-a448-4073d86de8ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_50491104-a144-4078-9246-eac39cd9f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_RestructuringCharges_50491104-a144-4078-9246-eac39cd9f1da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_122d6000-3402-4371-a41a-88583bf1da72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_122d6000-3402-4371-a41a-88583bf1da72" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d4e713-feb3-4ed2-aa6f-10c5f5767cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d4e713-feb3-4ed2-aa6f-10c5f5767cd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_f37c326f-ec97-4d23-947e-64d959fd543d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_InventoryWriteDown_f37c326f-ec97-4d23-947e-64d959fd543d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0e65c244-3d02-4e88-a519-3ca42a3aab6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_SeveranceCosts1_0e65c244-3d02-4e88-a519-3ca42a3aab6a" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9fc60eac-7f72-4708-af2e-ae2a9eb4b925_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9fc60eac-7f72-4708-af2e-ae2a9eb4b925_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9e6855d-5514-4aa3-9201-b1efeb64af14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:to="loc_us-gaap_SubsequentEventMember_a9e6855d-5514-4aa3-9201-b1efeb64af14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_aaf1eda7-7c1c-4ff1-aae3-003600cb3840_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_aaf1eda7-7c1c-4ff1-aae3-003600cb3840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2027Member_09abd014-c25b-4659-a8e6-5383e8b9441a" xlink:href="wst-20240630.xsd#wst_TermLoanDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_TermLoanDue2027Member_09abd014-c25b-4659-a8e6-5383e8b9441a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_44f23e91-a3f8-4241-a201-df987744e222" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_TermLoanDue2024Member_44f23e91-a3f8-4241-a201-df987744e222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5097143e-b1cf-4eb0-9556-e42410a1992c" xlink:href="wst-20240630.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_SeniorBNotesDue2024Member_5097143e-b1cf-4eb0-9556-e42410a1992c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8ea53f0f-8e75-4319-b8c3-ce5f8455eeae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8ea53f0f-8e75-4319-b8c3-ce5f8455eeae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_43de93c4-86f9-4751-a064-70384c9d0d80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_43de93c4-86f9-4751-a064-70384c9d0d80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ee4d976-98f5-4a1b-b35e-2447be5f5511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ee4d976-98f5-4a1b-b35e-2447be5f5511" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>wst-20240630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9002470d-cf42-4d33-b3a7-c60864d1ac4a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1975e8c3-ceb6-4239-a9d5-18ab91686693_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_ebf8b37b-a4e4-4fee-b254-519e2c9fe59e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_72e7b513-f56e-493c-bfd0-f9cb56b4b69e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aacebd22-1c9a-4677-a151-c744fe6df227_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_72b40245-6520-47fd-8cdf-1dfe0ea6a3b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b2ce400f-1a5e-464f-bfcf-26b488ebb199_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount due to affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_84c61a6d-c6cc-4e16-a131-a6dd757835d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivative gain (loss) on hedged item, fair value hedges</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IntercompanyDemandNotesMember_4a9647ef-d054-4000-8b06-172436f51768_terseLabel_en-US" xlink:label="lab_wst_IntercompanyDemandNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intercompany Demand Notes</link:label>
    <link:label id="lab_wst_IntercompanyDemandNotesMember_label_en-US" xlink:label="lab_wst_IntercompanyDemandNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intercompany Demand Notes [Member]</link:label>
    <link:label id="lab_wst_IntercompanyDemandNotesMember_documentation_en-US" xlink:label="lab_wst_IntercompanyDemandNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intercompany Demand Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyDemandNotesMember" xlink:href="wst-20240630.xsd#wst_IntercompanyDemandNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IntercompanyDemandNotesMember" xlink:to="lab_wst_IntercompanyDemandNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_10388a55-98e1-4c6c-aa28-490450b07db8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_591b7012-a272-4f55-8e59-1e920f66a5ac_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_24c25e56-a1bd-4717-af20-b0e43e53f236_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e4b50d35-585e-4e0a-af53-af3d2747f30f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_b34f3105-d7e9-4335-bd08-c652e683c8f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_571e15e1-cd34-4ba0-9e73-bce743d01f49_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_a6d99415-8ab7-49d7-86d1-37d2ce01a4ea_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_60509733-516e-455e-871c-f64e667a388f_terseLabel_en-US" xlink:label="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="wst-20240630.xsd#wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_293cb64e-0688-45d0-8e2d-ff0d5c30cbd9_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_08e889f8-857b-410e-80a9-b68fff2b3784_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount, equity-method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_c8ac3637-6291-4348-9036-d2e9f96f905e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_78da7539-70e4-44bf-8ae6-a54ba13c285d_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target award percentage</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:href="wst-20240630.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_948d4507-f82a-41ef-9c1f-6e9bed00ac55_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_0711a506-b9b5-424a-bd96-1d06257b388c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_52fa8fa6-7c17-4465-a35e-547386c0e156_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_adfbb036-4a1e-4124-8989-1101bbb6544c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_ff184c4b-8c27-4d9e-a253-1afec8c3921c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_690f1296-cea3-40b1-a346-baa47ebef383_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Investment Hedges:</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_527e228f-ed72-4ccf-a3b6-bde6894d3f9e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_bbc568ba-f491-40e8-88be-171158894f35_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6e1aecea-8373-4126-8af9-80246fc89127_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_11087d40-d5b8-4261-92c6-a50e59a47a6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for issuance under the 2016 plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c898008b-30db-443c-94ea-65ae2d2712f2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_517b0b3b-0516-4604-b615-6ac9730296d5_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedges:</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_12a782f1-8abf-4833-bd74-4b59329c4444_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_990d6c3c-b8ed-465b-b85a-ae5ce5ec8d05_terseLabel_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series C notes, due July 5, 2027 (4.02%)</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_label_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_documentation_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member" xlink:href="wst-20240630.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorCNotesDue2027Member" xlink:to="lab_wst_SeniorCNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1edcd797-4bd5-4cd7-b27f-d07b4f14f6d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_384bfe4e-c64b-4ebe-8b32-cf6ffa00d8d8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_0dfda313-e063-4dff-9c9c-e9b7a128e070_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_39713c6f-74f2-40f3-8638-12c7a1bfe144_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_abbf3412-0079-4ec2-bfa1-10cc0dbbf0f9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share purchased under share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_03e84ee9-28ec-4437-a80c-17df6b93e957_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b515f813-f276-4854-8da9-3ef79f82beeb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_155029f7-cf56-439f-a8ec-d68808636522_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b3a90ff-bca2-4006-bb48-fb26e61bdd34_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_24b4e847-0416-4357-b55d-c8198a8b2795_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6386e0a1-ba87-47d7-8ebd-59e83dc2c242_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f401c772-5790-41c5-8ff2-0e7771cb0638_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_3fec335e-4d05-4875-b83d-0658cb8d9ff7_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Finance leases liabilities payments due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3e431f47-458a-47df-a2f5-429afc67035b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_7ba5b3b4-b406-4f0f-bc8c-eabc2983ff34_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount receivable from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_f095c607-3a2d-45a7-bf48-819ea942d9e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on derivatives, net of tax of $0.3, $(1.0), $(0.4) and $(1.1), respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_2d9bf4d7-1595-4d19-aad6-22f663a963a1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, forward point components, gain (loss), recognized in earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_dd0b17f9-5828-48aa-98fa-de4a1c68ec8b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_33f0e292-32c2-4917-b867-1035a8b55447_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_254139df-af9f-4e2a-ac1c-c6a3da42ed11_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term, finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_74e2e9de-3fae-41be-a820-70efcebcaea8_terseLabel_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Due 2024</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_label_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Due 2024 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_documentation_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility, Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:href="wst-20240630.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:to="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_255b374f-4a32-4265-90a2-32f89368182f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_76bcf28f-6496-4a0d-a8d8-e6f2fe64d987_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_The2022RestructuringPlanMember_88745ccc-f434-4eb3-a378-c968b343f65b_terseLabel_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Restructuring Plan</link:label>
    <link:label id="lab_wst_The2022RestructuringPlanMember_label_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2022 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_The2022RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_The2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2022 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember" xlink:href="wst-20240630.xsd#wst_The2022RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_The2022RestructuringPlanMember" xlink:to="lab_wst_The2022RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e5c903a3-fb07-4051-adec-d2ff06d67e70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e25b607-7f53-49a9-8c70-5bc25b9da9f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_68cce304-35cc-4463-b7b0-62fdb18b8c39_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock_764d441b-d40c-48a8-9173-ecf518e6f93e_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="wst-20240630.xsd#wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_81f43400-80f6-4c77-8971-b4704c5c485d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1080c0e1-2257-468e-88fe-21369965680e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive options excluded from computation of diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_GenericsCustomersMember_b986d3a9-4f81-4375-b8b8-9d2ed98525ee_terseLabel_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_label_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_documentation_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember" xlink:href="wst-20240630.xsd#wst_GenericsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_GenericsCustomersMember" xlink:to="lab_wst_GenericsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0c76f20d-4f61-4aaf-97ff-fd6414ef73d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed lease interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_912bfa23-4df9-4f60-a2f0-43d3e0cf04ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_05bdd840-2f78-4cf0-97ad-a6d68387c9bd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2bd1298-5e9a-4c48-a10a-db938d00a5e7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, including cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a4b25b29-7842-4cd0-a572-e0fc7a75d96d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, including cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2d5b5a07-e457-4369-84f0-5a6f8280d174_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_52bfeaef-d49e-4fa3-8d81-937791e59695_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_3348b532-475c-48d2-8fa0-e48b5646cc78_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7f1bcb01-e807-438d-a44e-fac32bf99ccc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased for employee tax withholdings</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3029038-5252-4a19-827e-99d7cda308d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_5a4088d1-a186-4b94-b186-a3f5bef308d2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_95d6634b-63e7-4673-ad1d-4a6b3e8f5544_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_24761678-6983-4003-8015-99f823d273a9_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_7a7e5fdd-ea9b-45cd-9bd3-f5bb2f463a03_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_6b6b5d4f-4b55-4e26-9d60-90915ba0a531_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in unrealized gain (loss) on fair value hedging instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_6ff4d422-a5f9-400b-89f5-b4a54c5869b4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_3f23080f-adfe-456a-a2bd-07d99bab1ae4_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_9ced5e44-1d90-44d9-bbd9-a8fa0d679317_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_78105d84-aae7-4913-98ce-af219e915aea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_d6bc7d63-e167-4446-8d4f-27a4bed3780a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a896d952-245f-4cfe-b04a-e471527ebc55_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d1cd71a4-825a-4e83-87ab-e51b823c396d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_52eec15a-9098-4f8e-a8a3-c499c36befbb_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_89f1926a-8abc-4a3d-9a18-f24aca12d0c0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate, finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_b328c89b-af14-4025-8e41-9d734c2693fc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ee1005d0-bd89-4395-855c-35b1041e49a9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_38c7c3d9-1268-4060-afd7-580d25afe012_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2340ffe5-192e-4c93-a960-fb30cfffb30e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_516e7788-f789-4dd7-a568-68eef28eb14a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_bb20d997-2995-4276-ba6b-cdfef7e1a52d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_78f3749c-81a4-40bb-b687-5b51c42ca0b9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Product and Service Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Product and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_2c963b52-7522-4549-98b9-4ef7546ad4dd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e125e1b2-55ef-4b41-b58a-9124483feb11_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3deb8fbe-4fca-40a0-a4d8-9c2b008ade98_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_0625c7ad-64e7-4be2-bced-ddd31d52d6d7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_42f4525a-40a5-4b96-8d3c-fc5da7800b52_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_90cadf8f-3df1-4fa6-b365-00b273eafe81_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_413586f8-01d5-4d32-82af-bbdb482c7ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_b012bc8d-4632-444f-846c-7e216491b5d3_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_b73c4b22-8036-4134-941e-140f776f2e37_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for new lease liabilities, Finance Leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d712bc34-bf78-445a-b30d-89011ea53466_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_fe42ec7d-dee8-4d4d-aedc-9f158481305c_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4a53738a-f8b6-4204-9dd3-218e2f8371b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_51f51beb-1587-413c-a012-0255dd514f91_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_60d6a9e2-612f-488a-aa8a-be3067596027_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90a8b487-b047-459f-9da1-9c5e8f1ae4f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_4b5f54d2-fadc-4fdc-9000-2f005e1b88b8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7dac77bb-5eca-457a-9d0b-15ba6054a143_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_777fc7cb-0baf-489d-b294-a3ec48683536_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_1671e0b3-ba9e-4697-ad1d-0be3ec407cf9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionMember_e0b61a8d-bcdb-4156-84ac-2ce6bf4acca4_terseLabel_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options Held</link:label>
    <link:label id="lab_us-gaap_OptionMember_label_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Options Held [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionMember" xlink:to="lab_us-gaap_OptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ce3d1408-c9b4-44cf-9e60-1d33acde0b29_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f5b0ef89-205d-49ea-977f-1c36d6d5d61d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c838f5c9-6dcb-4e58-994c-11956e59da25_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e9cc8f59-a426-4e27-85c7-23b7dd986b15_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares assuming dilution (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_c8b1d444-8f3b-4d05-aa06-af2d7ffeac48_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and related cost, expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d6d0d0bc-027e-4909-8512-00e242f84662_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_98a2851e-6032-4f5b-95dd-ffe9e121276a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f04dc0fe-5cc0-4343-9114-abe507fd9b22_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_284ba99f-9fbf-4090-9c1a-7e4322f0d905_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0f7051d9-5eb3-4a48-9e31-705d522f52f4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_a294381a-c78b-44c7-8a57-21706fc10ec4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_93d0ecbd-fd03-4ebd-8b21-f27e744c9256_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_2dcde1fc-dc22-4301-a54c-cbedd81b6429_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_7dead33c-e783-4d95-8d94-bd1bed0162c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c6dce849-1eb1-4778-bb48-ed29cd6a00cd_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_736f716c-03c0-43e1-9222-0269cef5bfd1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9cb24b83-86a5-448c-a4d0-99651983c874_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1c85a980-bcd4-42a3-b68b-7b235e25c403_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_aab18db5-983f-423d-a68b-556b71f70ab6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_0c1899bb-3cae-4162-bdac-f9804fd8c389_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_fd71d0cf-478e-4bff-9bd1-833d85d7cd5c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_01ea04d2-a026-4cef-82d5-a557008f64ed_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_daf5f643-8b38-40a8-8fba-1db6ad08ce22_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c1855b65-60db-43ec-8396-3d5acc4db2f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of equity awards, based on the treasury stock method (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2027Member_f6f23f8f-9075-41d6-8a68-86dcb3122783_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan, Due 2027</link:label>
    <link:label id="lab_wst_TermLoanDue2027Member_label_en-US" xlink:label="lab_wst_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan, Due 2027 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2027Member_documentation_en-US" xlink:label="lab_wst_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan, Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2027Member" xlink:href="wst-20240630.xsd#wst_TermLoanDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2027Member" xlink:to="lab_wst_TermLoanDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_579adcc6-aea1-4ee4-80ce-1c578f8d57a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_064f48ed-c9f1-4a1c-9487-d57c34e27d55_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_96439ec7-b115-4b1e-8a67-e27f5148eb5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_53f95645-9fc9-4138-90ea-a5e21c5a96e4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9ad0dc2d-a694-4dae-9d9a-75bfc0ef5ca8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ef828940-9a76-4492-aa1b-48f952ca20d0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_6035bfa4-a6d2-412b-b67c-a5d6786346bc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_411a0bcc-0a8c-414a-8fb1-e8896cfa16e4_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on derivative instruments, net, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48fee704-b97d-4cbb-ab02-4a4117a0be00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_29378e36-a990-42bc-96ca-1a037385c5c4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, average price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3911e7ba-ef71-4740-8c45-16ccf161ffb8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in affiliated companies</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e3ee3d3c-5d27-4a6f-94d1-2327b8365209_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_97ea3cb8-32f6-4817-8277-6fb5e27898d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_faa20c34-5626-4123-af12-d1b063b56d96_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StandardPackagingMember_80374deb-19e1-4f8b-b5bf-5568a720c129_terseLabel_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">High-Value Product Delivery Devices</link:label>
    <link:label id="lab_wst_StandardPackagingMember_label_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:label id="lab_wst_StandardPackagingMember_documentation_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember" xlink:href="wst-20240630.xsd#wst_StandardPackagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StandardPackagingMember" xlink:to="lab_wst_StandardPackagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_dbc9fbf4-e44d-413c-b49f-31e57edda62a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Change in Contract with Customer, Asset and Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_24bb5145-9296-450f-a35d-872ee25f8849_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_9731dbf6-273b-4673-a3fe-08dadd737008_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_77b371ad-72c2-4139-be3b-13aeb4e16e5b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_683d1183-73e9-4749-b386-0f37b981e2bc_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquisition-related intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6969e15d-27ce-489a-a7ff-bf5e283cb6d0_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Deferred income, December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d46aa0bd-1b6e-48fd-9cdb-4a029b5ef9b7_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Deferred income, June&#160;30, 2024</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e289e69e-e972-4a62-9945-70efcb8d8f59_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0bc06d14-e8b2-4267-ac0b-168a7e35f171_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fe51c501-563e-4672-9243-5fab90809ffb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_961a30b5-e22f-4773-86b6-d9dc65e63ca2_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a13a4609-c1ee-41de-8e63-617cc8c7f8a9_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: imputed lease interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_fd35def4-4351-47b0-b9a3-0dbeac977a07_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_af301b8f-4606-4af4-b99c-1a5c6620474f_terseLabel_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring plan, implementation period</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_label_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities, Period of Implementation</link:label>
    <link:label id="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_documentation_en-US" xlink:label="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities, Period of Implementation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:href="wst-20240630.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:to="lab_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_dc9885b7-14e8-48b8-969d-d40c07215a5d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6be1442d-52d6-43a3-87cc-1d66d9734d6a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes and equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5063d6f-8278-4ce1-a9df-39deecbeb7dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5c1db8b1-5f2c-426c-9f90-7093aa9423eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Activity related to stock -based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_489aeb18-2475-4469-b728-ba67c8c6b856_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_2e94b94d-267d-455f-b500-27feb6bf627a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_639c333b-8f71-441b-8949-e1a2de8c3d2f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5e29983f-1111-4892-979f-66966438fe6a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f8d5dcc8-cfcf-40d6-8495-84e4440f0736_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital in Excess of Par Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_b253287e-4307-4726-bfaa-d9876ee80091_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20845f67-c60d-48ab-b9be-a77dcfb8f318_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_57748c42-ff61-482e-a320-183429255d74_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities (noncurrent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_fc265c12-876b-4fe6-be24-32c59a1ea7d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in contract assets - increase (decrease)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_1c106ec2-d376-43e3-aece-f0e38ad9dc70_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_f2e63098-fe86-47a1-b467-2a7350ce0a4c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividend payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_cf44635b-5f71-47cf-af15-cb18129bc7e4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_83e41c81-f941-4ef5-994b-6e5456b4d7dd_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SGD</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_196eadba-c634-4286-a206-dad17428e65c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standards Issued Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fe471829-d225-4e04-ad2a-3289386646a6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5a353bd5-23b1-4bd1-826e-e5dfa62a7f90_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedProductsMember_4d212c83-4efa-4e23-aa2c-dcf4cda65c54_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_label_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedProductsMember" xlink:to="lab_wst_ContractManufacturedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_152395eb-271e-4177-9e21-b67db1574d36_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_7946065f-19ed-4174-b70e-b0d7c7baf321_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_bad84731-0559-452b-b388-ed65a2ca98ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in deferred income - decrease (increase)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_d35b4e31-2f31-4c7c-b36e-f3abae6eba1d_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract-Manufactured Products</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_label_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember" xlink:href="wst-20240630.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedCustomersMember" xlink:to="lab_wst_ContractManufacturedCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_660828e8-f139-46f2-802d-2cbe405f4bf7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange transaction losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_33548446-94a8-47b1-82dc-71aae29f9613_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_984b5775-8759-44cc-9ee9-fc3263096238_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_923333bf-2ef3-4003-91f7-27cb4e7f0041_verboseLabel_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and other current debt</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_label_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_documentation_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:href="wst-20240630.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:to="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_178b9d0c-e44d-440d-b4df-c669cbef9b3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ca6b3e97-b4fb-4159-9383-c7b217bc5637_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_4e6b6a72-7b06-4397-96a2-fb7b2195c423_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_df3345fb-3eed-44b6-b0bb-2d081d57a4a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3f0802ab-8030-488e-9e33-d54b62f72b32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d8b910c5-69b6-4b6d-8dcb-26024e355fe0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension and other postretirement plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a4cece6f-b32c-4bb8-9a07-cac347bb3f48_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of defined benefit pension and other postretirement plans:</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_f95f6a7a-e295-4e07-b662-a446fc7e77c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments not designated as hedging instruments, gain (loss), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3def845d-ffd9-4379-a349-1f3a8b663d56_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_eb4cb67d-049b-47e1-9ede-b81966ca5870_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bd0fd729-2121-408c-9f65-10b8413fddbd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a2df2a75-e2b7-46b4-99a5-f7bd41a012c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4bd0ffe3-ba04-41fe-a2ec-02094ac811de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f8318794-52a7-45e7-b03f-f8095ae569a8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate and Unallocated</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_f1f75ef0-d123-4ee6-9d0e-7710a8219cf9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_c5aba5d7-0d3e-4f04-ab3c-6d46f3a2cc30_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension and other postretirement plan adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTaxParent_0e6b61bf-7802-42dd-8408-2bb8d82d8b75_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, $0.0 and $0.0, respectively</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTaxParent_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Equity Method Investment, after Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentAfterTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent" xlink:to="lab_us-gaap_OciEquityMethodInvestmentAfterTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5b1de7d-d396-426b-9da6-bd79ae5fab17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_fef79e98-508b-497f-b7dd-0dfb6bf5ae5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9c4defcc-05e8-413d-a6c2-30d01ca57e9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest (income) expense, net and other nonoperating (income) expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6b9c708c-bd7f-454b-aad3-23c936773a3b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07d00aa6-c8c8-47e6-9013-cc8f6d11f981_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3e95ad32-9dbf-4987-8b4b-b67c7420f448_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_1007f463-78a3-46af-96e2-034d3a333f82_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_b8fed9db-2baa-4fb1-96ad-b20700580eb5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c26bc914-7871-4b36-b327-d326cbcc606f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e9c55ccd-63dc-429d-a0c2-deea3c2900a5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f6639626-2444-4097-a6e5-2328b8e063f7_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityMember_13d56b00-8599-4dd6-9f90-df1f2a3352af_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commodity</link:label>
    <link:label id="lab_us-gaap_CommodityMember_label_en-US" xlink:label="lab_us-gaap_CommodityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commodity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityMember" xlink:to="lab_us-gaap_CommodityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_1da02bff-a364-4d2c-af53-c7ab79f35635_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c6b7a2bf-5090-45bf-81b5-4307ae53c3f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 (remaining period as of)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6e07747c-b100-4292-bc3d-e736c3fd68d2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_d6b4e868-3c29-4fef-96ab-9c194ebd64c5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_dae20b76-e7f2-4c37-9787-391bf341a15a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d9987e32-1817-4313-9c97-583d6ee5e954_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_2f7ef7af-ba6c-43a4-be3a-af12e8c178e3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_cf574ef7-9482-4094-9eec-e761e52e098d_terseLabel_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_documentation_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract" xlink:href="wst-20240630.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract" xlink:to="lab_wst_OtherFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_12b067dc-1bd1-4ac1-9614-331718223f96_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_508a45ac-12e0-49ae-b678-23897467d68c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and severance related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0734ae13-399f-4906-b36d-9c1f155dc87f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_adcce0fa-5106-4379-a07a-fa9aeb73a13b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_2e0a6cb5-4062-4e09-b459-8b0f2acf0b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cf42d4b2-4697-486e-8d49-b86918dfe3a4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_4e163d07-5c13-4c9c-beba-7e03cb9c184f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, average price risk option strike price</link:label>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_label_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Average Price Risk Option Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:to="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_38fe9d29-f4ff-4fe7-8328-58b283750df7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_40dbf01b-3ad0-4968-a367-40e6e71510de_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for new lease liabilities, Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_85ed4c34-9dff-4f4d-bb5d-3ba7743511ca_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ea6b083e-9c7f-4bd9-bb5c-4036867ca49d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_68d6d9b1-cf58-48c6-a837-58595137483b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_32e84e7d-7f9f-4635-a9c2-f4c5ed337645_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_79ea1adc-2b49-4ee7-8be9-17ff612b5801_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2cb8264c-5a9a-461e-bae1-7d65591008d1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Losses) gains on derivatives:</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_3a5fde1a-bbe5-49d0-97f3-0c5a8004cf5e_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_7e1633a6-cb4b-49de-b6c5-0d83af7efeb8_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_6ae27649-2779-4cc1-b9f5-cfe6b638dacb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_1ad6fcf9-3c1c-409f-b8ec-0a41fe151fee_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e70bffde-0bf6-4269-9b43-8f8da1579b14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentTaxParent_3893529d-506e-4995-8632-efb80d21763e_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on equity affiliate accumulated other comprehensive income, tax</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentTaxParent_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Equity Method Investment, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentTaxParent" xlink:to="lab_us-gaap_OciEquityMethodInvestmentTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a0904f8d-649d-49f4-ba63-ce33a791526b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_88b1d336-7676-4d6c-9a80-3fdc3384747c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_a14ace4c-bcda-48cc-a94c-53bade6538f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RestructuringChargesCredits_995186b5-f871-4871-91f8-392eaa318e2d_terseLabel_en-US" xlink:label="lab_wst_RestructuringChargesCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Credits) Charges</link:label>
    <link:label id="lab_wst_RestructuringChargesCredits_label_en-US" xlink:label="lab_wst_RestructuringChargesCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring (Charges) Credits</link:label>
    <link:label id="lab_wst_RestructuringChargesCredits_documentation_en-US" xlink:label="lab_wst_RestructuringChargesCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring (Charges) Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringChargesCredits" xlink:href="wst-20240630.xsd#wst_RestructuringChargesCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RestructuringChargesCredits" xlink:to="lab_wst_RestructuringChargesCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_ef6fee85-9f52-413a-9421-11b97c193222_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Expense (Income)</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Other Income And Expense, By Component [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Other Income And Expense, By Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:href="wst-20240630.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:to="lab_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b19ff5bd-68fd-41da-8d36-b08736141a43_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2537a362-9d5e-4733-b7b2-a81186b3cb27_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_36fc0ceb-cd53-4002-853f-471aa1ae44cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative contract term</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_67eda2b2-537f-49d3-85e1-93fbe97299da_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_15ec62d0-850f-4924-a39e-d870b6410d19_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e56277d3-6f25-4441-b4b2-eab0f2bcc31f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetRelatedChargesMember_a66e70f5-2ee5-46c9-8356-7fd012ea34db_terseLabel_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_label_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_documentation_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember" xlink:href="wst-20240630.xsd#wst_AssetRelatedChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetRelatedChargesMember" xlink:to="lab_wst_AssetRelatedChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_d290295f-a232-40df-aad1-5fb50da73e63_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_e5b3c915-dc32-4f3c-83ac-13de8ed48077_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, nonmonetary notional amount, volume</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Nonmonetary Notional Amount, Volume</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmountVolume" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b2d78248-c941-4b45-85f8-8064212450e5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_9cf47b88-1162-4245-b831-1774b61849fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_edaa6668-1d98-462d-86ec-b5e3ffb58956_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7e50b3f1-56b7-4f3e-a771-119cb49e9bbd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_6a43cfcd-8769-4f17-a704-b3720d072aee_terseLabel_en-US" xlink:label="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="wst-20240630.xsd#wst_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_wst_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_aaf214b4-63e1-4e93-b177-30325176906a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_e010f7e8-ce49-40e0-8887-12e325cac90b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_46edc683-b4d7-439d-b592-1a75caf07e40_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e25a487e-011e-4348-96b5-974268c7f2f8_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6a96e2ce-a1c4-4916-aac5-cc56e643b8c6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_8d78f564-1665-4c16-b14d-9e5a3a93bcf5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef163165-5a2e-4cc4-baed-fd6031eb6e19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_6934f592-cb42-44c0-9660-f4b0874fe044_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_0a24a262-1e16-4a34-ae3b-e2f195365b7e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f59c78c1-d58d-48a3-9fd9-27ddf8ed0a4a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lessee, Finance Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_62d92e14-908f-4f77-a219-6589e32bd19d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2024Member_05e0f4e9-bc24-42fa-b425-9477d0b872fc_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan, due December 31, 2024 (8.50%)</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_4aa18068-d99c-4521-8779-230a7e933fc7_verboseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan Due 2024</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_label_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_documentation_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2024Member" xlink:to="lab_wst_TermLoanDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5dc74de7-f813-4838-bcdc-c079818ec3cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f5180933-7a62-450f-a60c-bc8d455ea49d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c2a4c2f3-ad03-4354-a90d-e249e2ec573f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other nonoperating (income) expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0385856a-0ae7-49e7-acf6-cc4f3655af0b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_14a43caa-c52a-49bf-87a4-fa9280caa58c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_b647e5d9-0722-4e33-9d76-d78a8261c63a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost (2.7&#160;million and 1.8 million shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d7b5874a-4f0d-40eb-8174-d4925f7e449f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueComponentsMember_0080554f-3fc1-4e33-8858-1b36925e2908_terseLabel_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">High-Value Product Components</link:label>
    <link:label id="lab_wst_HighValueComponentsMember_label_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:label id="lab_wst_HighValueComponentsMember_documentation_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember" xlink:href="wst-20240630.xsd#wst_HighValueComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueComponentsMember" xlink:to="lab_wst_HighValueComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a7cd6c7d-2c8a-4d2f-9d30-b9c3c7d24c0d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes and equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_21b9fa4a-b527-4a3d-9600-72066a9a7790_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Derivative gain (loss) recognized in income, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_67c21152-e973-4b6b-9cee-0d13125bdb40_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_42b03a98-482c-4074-8669-1076e7de4aec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaCustomersMember_07432d23-6a9e-4668-9707-341c04b5501d_terseLabel_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharma</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_label_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_documentation_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember" xlink:href="wst-20240630.xsd#wst_PharmaCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaCustomersMember" xlink:to="lab_wst_PharmaCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_bb64661a-df27-40e6-bb28-6bd1096285ec_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IntercompanyLoansMember_6ca98a89-294c-4f80-8b15-d50d9a426732_terseLabel_en-US" xlink:label="lab_wst_IntercompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intercompany Loans</link:label>
    <link:label id="lab_wst_IntercompanyLoansMember_label_en-US" xlink:label="lab_wst_IntercompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intercompany Loans [Member]</link:label>
    <link:label id="lab_wst_IntercompanyLoansMember_documentation_en-US" xlink:label="lab_wst_IntercompanyLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intercompany Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyLoansMember" xlink:href="wst-20240630.xsd#wst_IntercompanyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IntercompanyLoansMember" xlink:to="lab_wst_IntercompanyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_6d0ed395-4f1a-484b-a2b9-32300ec4a6d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_43a4c28d-1c92-45cd-b930-7342fa050f59_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_5cf86a05-9b1c-4de0-b0f8-1acda855d389_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, shares authorized (in shares)</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_330b0582-a0d4-4944-b2d0-68cbe9213c25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_30244fdf-f5ae-4006-b45e-67bb733a7f7e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_60ae50c8-b5af-40b7-8362-524acc290b3f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f350486f-0df0-46f4-967a-7fd6b0bb3489_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_386fc436-8a82-40f9-805d-679639b8464a_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c88d23a1-694d-42b4-ae46-a60f53fa1130_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_1f303561-f5fd-483a-8e8a-b1dbd7d4fbcf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_d2d9f54d-bc78-4d70-b37a-03794c5902e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_96a29d2f-9c89-475e-acd9-4600f589ae77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_ba2476e9-77c1-492a-a2a9-8bfa7d76183a_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward" xlink:href="wst-20240630.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerAssetRollForward" xlink:to="lab_wst_ContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_92151d31-dd6d-4b48-8462-ae0a54b871b4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8f053699-548f-4aba-961d-5f1f64a7e072_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d6d93c1b-5a5f-4d99-9cd6-ce3a19c4c9e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e19fd0cf-e6bc-4883-997c-b2af81930225_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Activity related to stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e7297826-8fb4-471d-b422-7f25b5c2aa5b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_97faf00d-b382-47a4-b448-5134df5b80e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3bc8b7a3-0f5a-46b2-9c6c-555d9d65b58d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_24c0eb52-fa46-4eaa-be4e-20e59b493897_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_548fd66d-a09e-4f37-ab6f-e214328dd4ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect on future earnings, amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureEarningsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect on Future Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureEarningsAmount" xlink:to="lab_us-gaap_EffectOnFutureEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_31aab48f-daf3-4f90-a0e6-1ba667200d83_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation benefits</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_c9ab57e7-7f9f-4dd8-8610-96e059c0f980_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityOptionMember_4d3aee73-a96e-458a-9d31-32297db9239b_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_CommodityOptionMember_label_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commodity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityOptionMember" xlink:to="lab_us-gaap_CommodityOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c5b6d326-2ac8-4658-96f7-819ae8785c61_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cfb2c938-0f7c-4e38-bf26-97030dddff67_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_1c54bbad-2be8-467f-981f-ef4fdb8b29f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sell</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b4b7bc52-91e3-413c-ad96-e41d5fa29a93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_5385fb6a-477f-4c9e-9279-5b5ab9dae547_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NetSalesMember_87ce2ecb-832a-4c6f-9351-ba4a7b88b04e_terseLabel_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_wst_NetSalesMember_label_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Sales [Member]</link:label>
    <link:label id="lab_wst_NetSalesMember_documentation_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net sales member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember" xlink:href="wst-20240630.xsd#wst_NetSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NetSalesMember" xlink:to="lab_wst_NetSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_9148734e-8dcb-4a18-b458-abf9c454a633_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_a09029e3-0618-4b53-a028-561d7f3b13eb_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_bd1c1638-901f-4b54-97c3-dbd43bdd21c2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ROU assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aae316f3-f56a-4835-b15e-55d45d7675d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_892f6a9c-bf8e-411c-b9d8-ce1c55d5a8cd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_8aa83a28-d70e-45d4-83b2-26a04b2e2e0d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_31a1631a-db69-4d1d-a43d-ed118c9ed6d8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_fbf64b1b-11aa-45fc-a667-fcf1931c6130_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7f5d2f06-a057-4674-84a1-d146a1dc3dad_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fa7b3292-1d24-414e-9f97-c5bfa40f6e7d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_845bf276-8901-4f06-a6f7-bf6a65afadfd_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ff6709cb-60ab-455d-8950-3a130e4e307a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_902dd364-7dbd-48f3-aa8f-9cc16db3006a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_A2022RestructuringPlanMember_2a9cc74f-e6c8-40af-b3f6-bf4a47ba4f10_terseLabel_en-US" xlink:label="lab_wst_A2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Restructuring Plan</link:label>
    <link:label id="lab_wst_A2022RestructuringPlanMember_label_en-US" xlink:label="lab_wst_A2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_A2022RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_A2022RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2022RestructuringPlanMember" xlink:href="wst-20240630.xsd#wst_A2022RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_A2022RestructuringPlanMember" xlink:to="lab_wst_A2022RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_aa650ed6-9310-4755-a5e6-058d5c96141a_terseLabel_en-US" xlink:label="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Paid For Amounts Included In The Measurement Of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:href="wst-20240630.xsd#wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_61065dfa-ec4c-499c-b7a3-6932fb53a654_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_074683b6-4f73-47c9-b7c5-5f62a94bb20f_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_f0c295b6-3e2f-4cb5-a9cd-acfe433fff7c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_1daec36a-e09b-4b16-8ef0-42604820ef89_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_930de876-b7c0-40eb-a212-8eac41c2e435_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b68272b1-3e2d-4e55-841d-81fb6aa74beb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_222aba42-3118-4b7e-aa04-eed6b2011f67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_0804949e-dd17-4c9a-bacf-34897781561c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_844fb25f-38e0-4721-b2d9-3ae170b1c9e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d96c145f-4b00-47c7-9c7e-6232d269aee3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0bbf35f2-7bd2-4272-9140-746e85ffd395_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5d27182c-f395-410c-bed5-1f36c8428285_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5a11b5a6-a1a6-4498-8df3-921cc3decfb3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit Facility, unused commitment level</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0f54a020-00bd-4751-8722-741a1473857c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares purchased under share repurchase programs</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_bf049d8a-6ec1-441b-be64-ce4d44f3da45_terseLabel_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued salaries, wages and benefits</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_label_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_documentation_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:href="wst-20240630.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:to="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8f326e3e-ff75-4c3c-a590-b386e9dd5ce4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_2e8ad92a-3746-463f-98c7-abf53ce82b7e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_05ef27c6-ca09-47fc-9bb7-11ef5605993b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_ce68e3e9-5790-4664-971c-3eaebd715359_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3a19ef47-3b56-4436-b8b2-bc869b0d09e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_934e116a-a420-48dc-a8de-573627bcc887_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d0c60ebf-4d50-4f02-968d-4c88180e0c05_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1321731b-c4cc-4b71-9978-aff50413644f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount, investments not accounted for under the equity method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_3501eae6-974f-49d9-81c0-277233e52cfc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_e47352aa-5667-4560-b397-ccb1ff5d30cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_43d41c3d-20f6-452b-a3bb-792b2ca4f25b_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EUR</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_5f6b1a8b-c470-464d-bf57-c61e93fa6529_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_81e587ed-f47e-4f8e-8677-71b714fc3974_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_37e3a631-55e5-4604-91ef-a8e5e2598e1b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a10f42cd-4159-4f13-a910-27eafed3946a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_519ee5ff-0946-4b32-a49e-4e4f8e559c97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Sales by Significant Product Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_15c87baf-68c7-4c76-b85e-cce24a821da0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_06af45a4-b3ac-4cd7-bca2-ddb65d6d1489_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a0bec669-4642-4668-9931-8a5f85daaa97_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_518502d4-b2bd-4218-b641-a3c45933c82b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_5e2e8d55-a90e-42c4-ac64-5a95dd4dae04_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_cc5fc812-c804-4015-8220-b581fccb48d2_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeliveryDevicesMember_a97754f3-1883-44a6-b107-55ee2e10daba_terseLabel_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard Packaging</link:label>
    <link:label id="lab_wst_DeliveryDevicesMember_label_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Delivery Devices [Member]</link:label>
    <link:label id="lab_wst_DeliveryDevicesMember_documentation_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Delivery Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember" xlink:href="wst-20240630.xsd#wst_DeliveryDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeliveryDevicesMember" xlink:to="lab_wst_DeliveryDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_ecc3ed94-3a3b-4e46-bdb8-54115120a2c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_32544110-ed8e-4dd9-8dcd-13758a437675_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Corporate general costs</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_120cc6f0-6d13-48b4-a665-578d9fcf2bed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Obligations, Net of Current Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0e94f726-aa74-4afb-9269-f6f15ae7a867_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate, operating lease</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherIncomeExpense_76a62aed-d49c-4e9a-98bc-efcd429a2a5d_negatedLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other expense (income) (Note 14)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_8f245c2f-1b18-4583-af60-163daa3c0a35_terseLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_dced6566-6ad9-467c-b1a7-2d9b906b9b05_negatedTotalLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total other expense (income)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_label_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_documentation_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherIncomeExpense" xlink:to="lab_wst_OtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_24b8f57d-260f-4740-be91-3dbe8383dc04_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_d2d7812b-1bea-4f73-92f5-b27075ee9415_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_b8265e76-9fce-4bcb-bb44-e92ce6e1f401_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Unit (PSUs)</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_90a85313-74c2-4044-a7a8-9f307a064a20_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_8793877a-abc9-4f5a-9da3-61d53b2f7768_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5df334f6-4f53-447b-8889-2ce88364293e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c9884473-635f-4125-82e2-6d38bbf7912f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1cfd3aee-b5bd-4c41-83d8-db8b99809ed1_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of plant</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d1225871-b513-43ee-a312-e55a7d390d38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of plant</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_7286e36d-b08f-48db-8f88-027459db5545_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of plant</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_461b217e-809c-4d0c-99ea-58808a4222fd_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e3cd2130-42e1-43aa-86cf-2389f10d0cad_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b438912e-4e6d-401c-bbf8-770fec974c02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments, net of tax of $0.7, $1.3, $1.7 and $1.5, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_daa25bbb-6d07-4b97-a6ec-71201b32c19b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease - amortization of right-of-use (ROU) assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_762f36e2-f6f1-443f-b2a8-bc9da6e81747_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_7fd3cd98-c49e-4d33-9391-32184e0be81d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_681d4156-4c9a-4505-b29b-d3c6fa669df0_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_8d9092bc-4ac1-4983-a65f-296d618a9987_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Expense (Income)</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_74d695e7-95fb-4606-ae35-4762006a8b36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_50f02ce2-7139-430c-9830-c3092eb693eb_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_78e01c13-b939-4fac-a49e-badd6e8c33a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c5ad3b76-0ff6-48b3-8963-4b1adfe9508e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1e5e69a7-fa0a-43f7-8590-b098707b8f2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_74b53107-b0f2-486b-b295-db1678d7aeec_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_89ad974e-330c-44b1-a137-b39cc803a534_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_474b2e27-ee0e-42a6-b904-14b83eafdf07_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_31d101a5-49cb-41f3-b205-53883f81bad8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_09ce79f3-7524-4d37-bdfc-46749bb8e48f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d80170dc-a5cc-4210-bc7c-42973c869609_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: 75.3&#160;million and 75.3 million as of June 30,2024 and December 31, 2023, respectively; shares outstanding: 72.6&#160;million and 73.5 million as of June 30, 2024 and December 31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6aa50fec-633b-4e3d-b4c2-42859ae9a433_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_80bf0f32-78e7-4dde-a456-ebcd336707df_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_adc43b78-9d24-4e85-9127-fcd340bacaf7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_795ea950-dce2-4396-a41c-fd4745c9b2ec_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_a68a7f67-2018-48ab-bbf2-3c584e4e1959_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on derivatives, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_025b429a-bddc-4d1d-947d-97fb94fac514_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_16de7e36-41bf-4e76-ae12-c4edaf63f783_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3669479b-2780-4322-847b-16a29e4e0fcb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_3691103c-7d58-41a6-838e-9dd2268a3c89_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, 3.0&#160;million shares authorized; 0 shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_a5b8c7cb-f061-4ee0-b875-a40e4a78b858_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency forwards</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_172b6d2f-f056-4eb4-a3a9-5e61278a587f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d287f11b-cda0-422a-886b-0c7dca64d8f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_c3ade7a7-23ea-4e27-b84d-ae76a765eda3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Principal repayments on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_c5b5ab2f-5aa7-4906-90ff-dce96501ea76_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_3f2c7e19-4574-46c7-88db-4094adbb20e7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_cc2f4f3f-7b5e-4b03-bd48-15e88b6609a7_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_0faec014-82cb-4093-8142-ed5eb870162c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_05446d79-eff7-4c36-bf49-57122cd83da5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_acdc1350-f5ba-4385-ad47-335b57db1aeb_terseLabel_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B notes, due July 5, 2024 (3.82%)</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_label_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_documentation_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member" xlink:href="wst-20240630.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorBNotesDue2024Member" xlink:to="lab_wst_SeniorBNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a841d018-e860-40cd-9c50-b6bb4ea75725_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_d7939757-6866-40e2-9216-159cc25a1c3e_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f0096d57-68dc-489c-964e-fc0ace2abf85_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_1c1bc4b2-01a1-40b6-8103-03d0d87ed15b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_62d5b10c-8e4d-4b6d-8843-26c24419a492_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DistributorshipAgreementMember_d4ef3208-997a-461a-af59-f504f1b1feb2_terseLabel_en-US" xlink:label="lab_wst_DistributorshipAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributorship Agreement</link:label>
    <link:label id="lab_wst_DistributorshipAgreementMember_label_en-US" xlink:label="lab_wst_DistributorshipAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributorship Agreement [Member]</link:label>
    <link:label id="lab_wst_DistributorshipAgreementMember_documentation_en-US" xlink:label="lab_wst_DistributorshipAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributorship Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DistributorshipAgreementMember" xlink:href="wst-20240630.xsd#wst_DistributorshipAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DistributorshipAgreementMember" xlink:to="lab_wst_DistributorshipAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a1d20c75-59d4-49e3-a4fb-0eeac471fcaf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e2bcdd46-b42f-47be-8d54-40439e148fff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_d23981f1-3d81-432b-b042-b1d67a3ba33a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_d788c1bc-6acf-4fed-ab48-20b179086f7b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated Companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45588a25-be05-470f-b13d-e34544211252_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_84866b8e-cea8-4bf8-8b22-dfa2263a4890_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_ea7560b1-5416-4297-b20a-436c4260fbb0_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:href="wst-20240630.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward" xlink:to="lab_wst_ContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1ff5c0ca-bebe-48d2-ac00-5a1cb8079d9a_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_cc6a6aed-8cb2-4df7-b522-f01d5e3a1e8c_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a11246a9-f355-4362-ad88-15d5bf5cbafa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_42cbd487-8cd1-4bf4-b7cb-b223943361cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProprietaryProductsMember_b24e3446-1425-4690-8020-9732be569f31_terseLabel_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proprietary Products</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_label_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_documentation_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proprietary Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember" xlink:href="wst-20240630.xsd#wst_ProprietaryProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProprietaryProductsMember" xlink:to="lab_wst_ProprietaryProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_56f9255d-d340-4eac-aaec-36fdd0c94c70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_34563983-a17b-46a3-89e2-302bf342437a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForwardContractsTwoMember_fb120aea-5db4-46d4-92c3-fcab4914514a_terseLabel_en-US" xlink:label="lab_wst_ForwardContractsTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward Contracts, Two</link:label>
    <link:label id="lab_wst_ForwardContractsTwoMember_label_en-US" xlink:label="lab_wst_ForwardContractsTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forward Contracts, Two [Member]</link:label>
    <link:label id="lab_wst_ForwardContractsTwoMember_documentation_en-US" xlink:label="lab_wst_ForwardContractsTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Forward Contracts, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsTwoMember" xlink:href="wst-20240630.xsd#wst_ForwardContractsTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForwardContractsTwoMember" xlink:to="lab_wst_ForwardContractsTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9f11980c-a404-4d36-be75-46769c9507d9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_aeec98fd-c62b-4dba-b31c-9b1e3fcf2649_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9e209147-24cd-4a45-b552-6c0cc7cbc737_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total reclassifications for the period, net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_84bd7f19-f19c-46fe-a11a-04357f528594_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_065dca88-1457-4dd3-96a2-d7524473e233_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_4ff9178a-aed4-495c-97a7-3122c3f28207_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_7b98d4a3-e6ba-401b-a5ad-ad6205a35c51_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan contributions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_04202a83-4cd8-4bd5-b930-d584157be7ae_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_66c444a7-b546-44a5-a8d9-1cd836d66278_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_ac507c5e-1eec-4e13-8cb2-d3239ed56afe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a3090795-5a68-48e4-9224-833af2fd647a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_30cbfb59-d7da-4f9d-ab32-a394e5a96a76_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8ddac021-c6c0-40bd-99f6-dee1b3378ce7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_526cc3de-d7a6-4682-8e9a-25f5650df9d8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_61dcbb6b-e6c6-4d8f-8f5b-dfb3b606ac80_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock purchase program, cost of shares purchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5a30c551-4c22-4197-8525-683a496c9596_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_d5a218d5-081e-47e3-bc07-512274a1317f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fa87a7d-cb28-4ada-9f37-48abbdbe1189_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_8801d5af-29c1-4850-bcad-b2ff9cf5016f_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefit within other expense (income) for revised severance estimates</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_f3c46093-aa96-4373-95a7-68a6c9ae435b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_7a21ea68-d880-452e-998c-ad96ca24a407_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_787813b4-2b08-4da3-a7ea-33441a9480b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 (remaining period as of)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c757ff7f-50aa-4551-8ec1-7b892b025051_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term, operating lease</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3ca1bf33-f8ba-4370-9d14-805c0c4d7e94_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_8b673c6c-cbd7-4d2a-bb80-612a6f23c184_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForwardContractsOneMember_cd69a7d2-7396-409f-916a-02dc41f6be74_terseLabel_en-US" xlink:label="lab_wst_ForwardContractsOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward Contracts, One</link:label>
    <link:label id="lab_wst_ForwardContractsOneMember_label_en-US" xlink:label="lab_wst_ForwardContractsOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forward Contracts, One [Member]</link:label>
    <link:label id="lab_wst_ForwardContractsOneMember_documentation_en-US" xlink:label="lab_wst_ForwardContractsOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Forward Contracts, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsOneMember" xlink:href="wst-20240630.xsd#wst_ForwardContractsOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForwardContractsOneMember" xlink:to="lab_wst_ForwardContractsOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_de9683fd-e0ca-4158-849f-99592f1eb906_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_266fd265-2a1e-43c1-b5c0-ed9fa1cf9f7a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other non-cash items, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86bab9b4-37bf-4267-887a-f03aa0ab278a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating leases liabilities payments due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_5fe5f112-6d94-448f-bf86-df6f1684f5d7_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross Currency Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_c5485294-9387-4bcd-a01e-c553c15e25f0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_f80939ee-375f-4406-99d0-8d4badf4d488_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Contract assets, December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_46a2d58b-f1ac-4443-bb2d-c3825db85e1f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Contract assets, June&#160;30, 2024</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_5c3a5194-61fd-4104-9ef0-62d757a24f59_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e15dd517-bc87-499a-88e0-4f8becdf5f47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_72245353-dd11-4152-8de0-3524283f1f1d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party transaction, purchases from related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_e477119e-6b33-4c27-9e03-36f838819404_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Other Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a64eb46d-be99-4dd4-af4f-0d34a5ea2c49_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized that was included in the deferred income balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_26bdcfef-d832-4bd3-907a-d6c6df6dd408_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency hedge contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_4d58e768-7f86-474e-828a-f20ddf87cffe_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b52be2e9-033a-46d0-991f-90372bedbf12_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_dd7fe151-4d76-4808-8874-4d51279e329b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_55321dc5-dfa5-4120-b888-92b3d125d557_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension and other postretirement plan adjustments, net of tax of $(0.1), $(0.3), $(0.1), and $(0.5), respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f97364f-745f-4854-bab3-45c8e6770a2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_5dd7c5d0-ac27-4622-b9ce-cb2f9fc9ef6e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40114c8e-b34f-4a05-ad1b-3fb39205c969_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2de50445-115a-45b4-8bae-b94956000b5e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e1fd1cfc-1903-413a-bf52-aa6f858000b6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63c15178-ebb0-4c72-9734-43ec963b85f6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9d1e5559-987c-4566-9094-f23018a5fd7b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5da4a425-e653-40a8-8d62-403a1f7c9003_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BiologicsCustomersMember_af180d53-5158-47a6-bd15-f6903e3cf16c_terseLabel_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Biologics</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_label_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_documentation_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember" xlink:href="wst-20240630.xsd#wst_BiologicsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BiologicsCustomersMember" xlink:to="lab_wst_BiologicsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a8d287da-78fa-420e-b5ba-d8a8da34f474_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3e3b2006-af89-483d-af64-74040974f6d0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_982ce872-caa7-40bb-93dd-0c4838201f01_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherExpenseIncomeMember_aa5dfc8c-44ba-47ba-b756-4af02830c06a_terseLabel_en-US" xlink:label="lab_wst_OtherExpenseIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeMember_label_en-US" xlink:label="lab_wst_OtherExpenseIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Expense (Income) [Member]</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeMember_documentation_en-US" xlink:label="lab_wst_OtherExpenseIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Expense (Income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeMember" xlink:href="wst-20240630.xsd#wst_OtherExpenseIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherExpenseIncomeMember" xlink:to="lab_wst_OtherExpenseIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_b13e546c-d2cf-4bb0-9bec-e1a79bf36d8d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward treasury locks</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_2b8c3047-de27-46c0-90e9-82f4659e50c5_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_610471a7-8673-421e-9dd3-2f2fabfd4214_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_017496bc-4975-4b0c-8d08-8ed401303808_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_3dcf4150-1d7b-4999-99c9-1d31baa687a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, December 31, 2023</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_1c79f0ca-8e00-40f9-8c52-b22026d0ef2b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, June 30, 2024</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_f0d82553-0442-4e77-b30a-d74f18c57ec3_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_801ad60a-bb32-45b9-9255-abc756ee60ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4a62fcd8-8c68-4dda-b596-65f892067c8b_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified out from accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_52b3c48a-0a4b-43e1-a7ea-6de554c24c97_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derivative gain (loss) on amount excluded from effectiveness testing, fair value hedges</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_a4f59e25-687b-4858-a97d-48cfba82466f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_c7e16dd8-5708-4d35-8255-1c3c28ad80e7_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociEquityMethodInvestmentParentMember_6a72f0f0-1828-49ca-8c26-87b5b0e87489_terseLabel_en-US" xlink:label="lab_us-gaap_AociEquityMethodInvestmentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in equity affiliate investment AOCI</link:label>
    <link:label id="lab_us-gaap_AociEquityMethodInvestmentParentMember_label_en-US" xlink:label="lab_us-gaap_AociEquityMethodInvestmentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI, Equity Method Investment, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociEquityMethodInvestmentParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AociEquityMethodInvestmentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociEquityMethodInvestmentParentMember" xlink:to="lab_us-gaap_AociEquityMethodInvestmentParentMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>wst-20240630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:21fdd9e6-cbf5-4a3e-b3ff-5b337d969dda,g:fc2b1675-d33f-4e0e-8f81-c94ea65163a7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/CoverPage" xlink:type="simple" xlink:href="wst-20240630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d876457-1961-41ca-91db-cedf6273b62b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentType_4d876457-1961-41ca-91db-cedf6273b62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_47fcaccd-75b4-4539-b956-47cc22a4dedd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentQuarterlyReport_47fcaccd-75b4-4539-b956-47cc22a4dedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_836bdf15-3756-48b3-8f3c-b62bb3fc846a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentPeriodEndDate_836bdf15-3756-48b3-8f3c-b62bb3fc846a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_77f7776e-c73d-4d01-bdbd-296fad9779cc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentTransitionReport_77f7776e-c73d-4d01-bdbd-296fad9779cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_28b58a5f-2abf-4eb0-b34f-6f9e48317600" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityFileNumber_28b58a5f-2abf-4eb0-b34f-6f9e48317600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7a530c86-76fb-4b0d-b6b4-ac6a1ba446f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityRegistrantName_7a530c86-76fb-4b0d-b6b4-ac6a1ba446f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a39f68da-4778-4bdd-b64d-ab3695577928" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a39f68da-4778-4bdd-b64d-ab3695577928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5ff94820-15e5-446a-9ea4-e9637fb8c182" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityTaxIdentificationNumber_5ff94820-15e5-446a-9ea4-e9637fb8c182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7551ce6f-f43f-44bd-845a-d180e250145d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityAddressAddressLine1_7551ce6f-f43f-44bd-845a-d180e250145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5c2e5c07-7f41-4cfa-b62a-c4cb57ae2316" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityAddressCityOrTown_5c2e5c07-7f41-4cfa-b62a-c4cb57ae2316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3cec14a5-d0be-4038-933d-c64a96ec9524" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityAddressStateOrProvince_3cec14a5-d0be-4038-933d-c64a96ec9524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_48530b1a-9cfe-4050-bb8a-120f47ce7ce5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityAddressPostalZipCode_48530b1a-9cfe-4050-bb8a-120f47ce7ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c7d1bd28-d42e-428d-b7e2-35ec93ac7d46" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_CityAreaCode_c7d1bd28-d42e-428d-b7e2-35ec93ac7d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_206695b0-b61b-4d41-9a30-8d3a3303417d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_LocalPhoneNumber_206695b0-b61b-4d41-9a30-8d3a3303417d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_23547c4e-f9ac-4163-9790-44a9dfbdac71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_Security12bTitle_23547c4e-f9ac-4163-9790-44a9dfbdac71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_08e41b43-d6ec-4cf4-b7f7-65bbc0e89bce" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_TradingSymbol_08e41b43-d6ec-4cf4-b7f7-65bbc0e89bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_eb8723d2-bc72-4e24-94df-e312e41750fc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_SecurityExchangeName_eb8723d2-bc72-4e24-94df-e312e41750fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_46279068-32a0-4040-9261-9e8357a7628a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityCurrentReportingStatus_46279068-32a0-4040-9261-9e8357a7628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7609ed11-00a7-447e-bade-3a78947c2843" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityInteractiveDataCurrent_7609ed11-00a7-447e-bade-3a78947c2843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c749adb6-3e76-4449-9474-75f72c9786ae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityFilerCategory_c749adb6-3e76-4449-9474-75f72c9786ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_7acd99b6-e7b6-4200-a012-c7cd162c6a4a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntitySmallBusiness_7acd99b6-e7b6-4200-a012-c7cd162c6a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_37bce949-a4e9-488b-8a8f-4847d0b4f5f3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityEmergingGrowthCompany_37bce949-a4e9-488b-8a8f-4847d0b4f5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e212d5d3-207f-4d32-b855-59da72b5f739" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityShellCompany_e212d5d3-207f-4d32-b855-59da72b5f739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_db0b5460-8404-4fe2-84e4-fe59b897fc68" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_db0b5460-8404-4fe2-84e4-fe59b897fc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f9a3f866-1734-4d19-8dbc-0678f5011af1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_EntityCentralIndexKey_f9a3f866-1734-4d19-8dbc-0678f5011af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_514d87db-240b-4d1d-841c-7f57de021f9e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_CurrentFiscalYearEndDate_514d87db-240b-4d1d-841c-7f57de021f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0fc80052-39c2-445d-b9fe-7acebdd1bab1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentFiscalYearFocus_0fc80052-39c2-445d-b9fe-7acebdd1bab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_716b7b27-34ec-4b84-8325-5eeed1220ffe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_716b7b27-34ec-4b84-8325-5eeed1220ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ae921886-09ad-4b06-b777-3a97d636e4b8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_287a442f-272f-4782-880e-f5663be0060c" xlink:to="loc_dei_AmendmentFlag_ae921886-09ad-4b06-b777-3a97d636e4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df934707-7e35-4e44-8e81-d2e81b96a610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df934707-7e35-4e44-8e81-d2e81b96a610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_45204594-e025-4ecf-ac82-6487457bb92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_45204594-e025-4ecf-ac82-6487457bb92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a3ffbad5-1187-48af-af27-2a7ea7d2ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_GrossProfit_a3ffbad5-1187-48af-af27-2a7ea7d2ec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_63b4ba97-b1b5-4dba-97b1-52fc8b8b392a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_63b4ba97-b1b5-4dba-97b1-52fc8b8b392a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d073f341-1599-4196-8875-6a8b39aad8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d073f341-1599-4196-8875-6a8b39aad8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_577b6eaa-c886-456f-80c5-7fff065518b2" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_wst_OtherIncomeExpense_577b6eaa-c886-456f-80c5-7fff065518b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_edb1a334-99d9-4f69-8783-348302d1d501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_OperatingIncomeLoss_edb1a334-99d9-4f69-8783-348302d1d501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_98e70b51-5637-4605-9d1f-8afbfcfe9ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_InterestExpenseNonoperating_98e70b51-5637-4605-9d1f-8afbfcfe9ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b4ad8299-1909-4fbc-82cc-9aeb8245a268" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_InvestmentIncomeNet_b4ad8299-1909-4fbc-82cc-9aeb8245a268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5a2f375e-6562-42e7-aa38-484fd071e9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5a2f375e-6562-42e7-aa38-484fd071e9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f68d7b09-cd29-47c5-a74e-30c857626269" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f68d7b09-cd29-47c5-a74e-30c857626269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01d2a974-07dd-4447-90e9-495b216230df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01d2a974-07dd-4447-90e9-495b216230df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8fd86643-5480-45ba-bdd4-2d920e1d3b26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8fd86643-5480-45ba-bdd4-2d920e1d3b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_da384628-e54d-430f-9bfa-ef9ba11bccda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_NetIncomeLoss_da384628-e54d-430f-9bfa-ef9ba11bccda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a8b4bb3a-008d-483b-8e89-ad481c0aba44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_a8b4bb3a-008d-483b-8e89-ad481c0aba44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0f3bd524-a0b0-443b-bb31-1f967a94a668" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8b4bb3a-008d-483b-8e89-ad481c0aba44" xlink:to="loc_us-gaap_EarningsPerShareBasic_0f3bd524-a0b0-443b-bb31-1f967a94a668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a5ef9ca4-d37b-418b-abb4-b64e64becbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8b4bb3a-008d-483b-8e89-ad481c0aba44" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a5ef9ca4-d37b-418b-abb4-b64e64becbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_707bf8ad-5330-4d6c-b660-93c918e66461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_43c98fcb-5a1d-4016-9bc4-cb30b78667d4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_707bf8ad-5330-4d6c-b660-93c918e66461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4590b459-bbb0-4e33-871e-3e5ec3493ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_707bf8ad-5330-4d6c-b660-93c918e66461" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4590b459-bbb0-4e33-871e-3e5ec3493ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8322ac1-00a3-4c26-909a-584c5fd6b130" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_707bf8ad-5330-4d6c-b660-93c918e66461" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8322ac1-00a3-4c26-909a-584c5fd6b130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c152e8fa-1ece-4e9f-8656-797b777083a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2688c7ab-bba2-452f-bcf0-0734aa314c14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c152e8fa-1ece-4e9f-8656-797b777083a4" xlink:to="loc_us-gaap_NetIncomeLoss_2688c7ab-bba2-452f-bcf0-0734aa314c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c152e8fa-1ece-4e9f-8656-797b777083a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1d7c0824-3fa5-4f2d-84d9-eeedbca1f297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1d7c0824-3fa5-4f2d-84d9-eeedbca1f297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2f099ed9-a461-4bc1-8429-5368813201c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2f099ed9-a461-4bc1-8429-5368813201c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_b942b251-0d2b-4b10-98de-3191f39b49ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentAfterTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_b942b251-0d2b-4b10-98de-3191f39b49ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_0c25d96d-6a5f-4a23-bb63-7c13aea35c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_0c25d96d-6a5f-4a23-bb63-7c13aea35c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e2dfa9b5-0897-42fd-a1cf-d17ceae73970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1701d932-1b40-4d01-aa5f-966d535c3090" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e2dfa9b5-0897-42fd-a1cf-d17ceae73970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_76a8b390-4777-4b0f-87d1-5ca1c9ebc836" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c152e8fa-1ece-4e9f-8656-797b777083a4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_76a8b390-4777-4b0f-87d1-5ca1c9ebc836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_edab1632-a46f-4fbc-b2ef-dc17a6d3bc34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_bee5b569-3f23-4e63-b9ec-cf316723469a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_edab1632-a46f-4fbc-b2ef-dc17a6d3bc34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_bee5b569-3f23-4e63-b9ec-cf316723469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_8f56ab7d-d44f-4896-bbf2-add9476278c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_edab1632-a46f-4fbc-b2ef-dc17a6d3bc34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_8f56ab7d-d44f-4896-bbf2-add9476278c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentTaxParent_dfb066f6-f62f-4e61-8f99-c12fb0d8b06e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_edab1632-a46f-4fbc-b2ef-dc17a6d3bc34" xlink:to="loc_us-gaap_OciEquityMethodInvestmentTaxParent_dfb066f6-f62f-4e61-8f99-c12fb0d8b06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d746bfb0-3a7c-479a-b869-a0ecfd8b5a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_edab1632-a46f-4fbc-b2ef-dc17a6d3bc34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d746bfb0-3a7c-479a-b869-a0ecfd8b5a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_02b0c21a-0451-4874-998f-f8db0bda0b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02b0c21a-0451-4874-998f-f8db0bda0b7c" xlink:to="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d86ca2e2-f9c7-4989-876b-c460c90ad7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d86ca2e2-f9c7-4989-876b-c460c90ad7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e0655c07-2c07-4679-b1d8-ef57f72db91d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e0655c07-2c07-4679-b1d8-ef57f72db91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f5c6bd93-3574-4829-b614-5d902de125f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:to="loc_us-gaap_InventoryNet_f5c6bd93-3574-4829-b614-5d902de125f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_09e0baa4-7762-459b-9036-2222cdc31962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:to="loc_us-gaap_OtherAssetsCurrent_09e0baa4-7762-459b-9036-2222cdc31962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b829da9-b1c6-48f3-8403-0e1ceec4eaef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b57759ca-9851-4b0e-8834-8324b320c240" xlink:to="loc_us-gaap_AssetsCurrent_4b829da9-b1c6-48f3-8403-0e1ceec4eaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9f723d06-3167-4b2f-8438-cab285f3884e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9f723d06-3167-4b2f-8438-cab285f3884e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_422014b0-9ed8-44c8-b703-273049e7789f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_422014b0-9ed8-44c8-b703-273049e7789f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0e900b29-e06c-4d5d-a3b4-406c0c8ed8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0e900b29-e06c-4d5d-a3b4-406c0c8ed8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2384fd05-0c28-4917-ac5a-d101f502481c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2384fd05-0c28-4917-ac5a-d101f502481c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d4280292-545c-4bd7-a051-5a2c93426303" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d4280292-545c-4bd7-a051-5a2c93426303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dbc64d7f-9e0c-4820-92a8-d7ae2cfcbc72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_Goodwill_dbc64d7f-9e0c-4820-92a8-d7ae2cfcbc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8cf66b3d-31fa-4aca-afdb-bd8173d648d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8cf66b3d-31fa-4aca-afdb-bd8173d648d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_02c5679f-6696-4644-b8ee-bba11fef4917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_02c5679f-6696-4644-b8ee-bba11fef4917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fd3ed130-4d18-4e28-b0f5-22cb808ce4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fd3ed130-4d18-4e28-b0f5-22cb808ce4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c7de1486-1dae-4f88-8b24-712d99b96123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_19152b4f-0039-4e50-8992-ec07635efeac" xlink:to="loc_us-gaap_Assets_c7de1486-1dae-4f88-8b24-712d99b96123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02b0c21a-0451-4874-998f-f8db0bda0b7c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_dfff6707-8dbb-4118-82c0-dd0b05235dd9" xlink:href="wst-20240630.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_dfff6707-8dbb-4118-82c0-dd0b05235dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e0d52571-3f58-497a-bdc0-0c2cee639cae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_us-gaap_AccountsPayableCurrent_e0d52571-3f58-497a-bdc0-0c2cee639cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_f2af0534-6dea-41be-ad0a-29c6b8efb99c" xlink:href="wst-20240630.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_f2af0534-6dea-41be-ad0a-29c6b8efb99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4b6ba5b5-8f4a-4ec9-b476-5f9da336d855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4b6ba5b5-8f4a-4ec9-b476-5f9da336d855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f18c45e9-bd83-426a-9449-64bc4a2007c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f18c45e9-bd83-426a-9449-64bc4a2007c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0d80e02a-ca24-4905-b4b4-360cccdf361e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0d80e02a-ca24-4905-b4b4-360cccdf361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_483a6897-c4a1-42b8-abcd-e7dec433d538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f13947c2-dd5a-41fa-9362-8c37425528d2" xlink:to="loc_us-gaap_LiabilitiesCurrent_483a6897-c4a1-42b8-abcd-e7dec433d538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_88a002ff-2e46-45a5-9975-09a386cf5e84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_88a002ff-2e46-45a5-9975-09a386cf5e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_848d9afa-4bdb-4c7f-988b-eb8e9208e94e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_848d9afa-4bdb-4c7f-988b-eb8e9208e94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_fdfc79d8-c4d7-49d7-b463-f6105a8598b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_fdfc79d8-c4d7-49d7-b463-f6105a8598b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d3a0b480-50be-4f25-8d8a-6e933463e629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d3a0b480-50be-4f25-8d8a-6e933463e629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4b637358-47ca-4c73-a4ca-0b13f0800646" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4b637358-47ca-4c73-a4ca-0b13f0800646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3951de6b-b9ef-4118-b870-8e92a95bfb69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3951de6b-b9ef-4118-b870-8e92a95bfb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3a70e4de-2944-4e9b-a20e-280bd5faefa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_Liabilities_3a70e4de-2944-4e9b-a20e-280bd5faefa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c2948d14-1be4-4aac-a4ab-5f387fab6dff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c2948d14-1be4-4aac-a4ab-5f387fab6dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_dbb36889-26ef-402b-aa29-d3d35b58d891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_PreferredStockValue_dbb36889-26ef-402b-aa29-d3d35b58d891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_41794bee-8b07-41c0-9860-77b6ee06b47e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_CommonStockValue_41794bee-8b07-41c0-9860-77b6ee06b47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5d08e156-1304-474c-a704-bd32fc9ce8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5d08e156-1304-474c-a704-bd32fc9ce8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30713d3a-82b4-4e87-ba5a-3c73efa41ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30713d3a-82b4-4e87-ba5a-3c73efa41ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_608b0473-e7e9-4778-b00e-fb15098e122b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_608b0473-e7e9-4778-b00e-fb15098e122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_5ac5d2ec-a6d7-426e-884d-0933efc65c57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_TreasuryStockCommonValue_5ac5d2ec-a6d7-426e-884d-0933efc65c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c2a2af31-381e-4840-b37b-9ad325d6e662" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a1a183-2b5f-4ac2-89e8-6495ab06dbdd" xlink:to="loc_us-gaap_StockholdersEquity_c2a2af31-381e-4840-b37b-9ad325d6e662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b33da946-5fd0-43df-9afa-6754b3b99f41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a0907a0-67ff-4938-8dcc-b2d3553217ec" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b33da946-5fd0-43df-9afa-6754b3b99f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f7011fbe-4981-42f1-8b08-459c7046e309" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f7011fbe-4981-42f1-8b08-459c7046e309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_427063df-4052-42fe-a97b-f9cbf4454287" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_PreferredStockSharesIssued_427063df-4052-42fe-a97b-f9cbf4454287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f5371395-6b9f-4727-8276-e1dca3db82f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f5371395-6b9f-4727-8276-e1dca3db82f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_766fc8df-8fea-4cff-b939-1c60c8366ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_766fc8df-8fea-4cff-b939-1c60c8366ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6cfcde9b-b97a-4c58-8196-85aa8bbd375a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6cfcde9b-b97a-4c58-8196-85aa8bbd375a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7dbd064c-b50f-49b9-87b8-7c4cbe4aec82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_CommonStockSharesIssued_7dbd064c-b50f-49b9-87b8-7c4cbe4aec82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7e6f47b9-a463-44bd-9a51-77b03ef14465" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7e6f47b9-a463-44bd-9a51-77b03ef14465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_851e851b-d404-4e16-b37d-1fbc1c6d38c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57d3476d-69d7-44da-bfbd-b9136f303031" xlink:to="loc_us-gaap_TreasuryStockCommonShares_851e851b-d404-4e16-b37d-1fbc1c6d38c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="wst-20240630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_44732570-3d36-41bd-9aa0-a877a4ad0eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:to="loc_us-gaap_NetIncomeLoss_44732570-3d36-41bd-9aa0-a877a4ad0eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1818c36e-1ead-48f4-b412-388056a1246c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_Depreciation_1818c36e-1ead-48f4-b412-388056a1246c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_f0daea03-ccf0-4e7a-a15d-653f929ef58d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_AdjustmentForAmortization_f0daea03-ccf0-4e7a-a15d-653f929ef58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8ff46ab9-cea4-4418-a8d9-2d17b78330c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_ShareBasedCompensation_8ff46ab9-cea4-4418-a8d9-2d17b78330c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_542d52d3-fa81-4348-8116-b15a013f1b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_542d52d3-fa81-4348-8116-b15a013f1b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b7aa5345-14d9-4bc8-87de-b0539feff13d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_AssetImpairmentCharges_b7aa5345-14d9-4bc8-87de-b0539feff13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ff90c6ec-f84b-41c5-8dc3-541a91121f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_17d97363-a38f-472f-b5bc-f508d83979a3" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ff90c6ec-f84b-41c5-8dc3-541a91121f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_e32f1161-9d7d-4bb8-9786-4fc66625127b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_e32f1161-9d7d-4bb8-9786-4fc66625127b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_02925204-fe7c-4473-9a6e-d4d86a3d4469" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_860cf387-917b-46ab-9fdb-347d7a425dc3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_02925204-fe7c-4473-9a6e-d4d86a3d4469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7460cb7c-f775-4e7e-8db5-38d4433bd869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7460cb7c-f775-4e7e-8db5-38d4433bd869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bd29b404-846e-4de3-bb27-09b17c2aec56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7460cb7c-f775-4e7e-8db5-38d4433bd869" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bd29b404-846e-4de3-bb27-09b17c2aec56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afcc325d-afe0-4849-aef9-23f4a9803437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7460cb7c-f775-4e7e-8db5-38d4433bd869" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_afcc325d-afe0-4849-aef9-23f4a9803437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ac02a7d-163f-4df9-b0e1-a31854239ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7460cb7c-f775-4e7e-8db5-38d4433bd869" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ac02a7d-163f-4df9-b0e1-a31854239ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_19d1b8da-647e-4c2d-91ca-d4df2198c8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_19d1b8da-647e-4c2d-91ca-d4df2198c8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_7dba207e-5b23-41af-aca5-9a8213228411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_7dba207e-5b23-41af-aca5-9a8213228411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a710b3c8-907a-4a83-86fc-7cbc1516be4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a710b3c8-907a-4a83-86fc-7cbc1516be4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_a9e43049-ce58-4041-aa0a-27feab721c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_a9e43049-ce58-4041-aa0a-27feab721c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_11fd9b5d-45d5-417e-8450-eb7854204251" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_11fd9b5d-45d5-417e-8450-eb7854204251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_06913ac4-7392-4cec-a4a0-8307faf42580" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_06913ac4-7392-4cec-a4a0-8307faf42580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ebc0fd27-655c-493d-9eac-18b5cae51780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ebc0fd27-655c-493d-9eac-18b5cae51780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ba181161-94cf-4c29-bcd8-bf1fdf326a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ba181161-94cf-4c29-bcd8-bf1fdf326a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c59c43d-4722-4ba4-9e92-7e8e9aae239a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f521f4a-ede0-4010-935c-2c14c367fef0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c59c43d-4722-4ba4-9e92-7e8e9aae239a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8bf0fc6-c9a4-4232-a3ed-4806db853160" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8bf0fc6-c9a4-4232-a3ed-4806db853160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_594fd2f8-acba-4ea3-abe0-ad33f22dd1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_594fd2f8-acba-4ea3-abe0-ad33f22dd1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d1cf12d6-ae52-47c8-8684-50ba862acc39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d1cf12d6-ae52-47c8-8684-50ba862acc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4be59d5-fba4-4ac7-ac3e-4ec108c9a8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2ccdd736-b1a8-4b58-b70d-5edfec3a37bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4be59d5-fba4-4ac7-ac3e-4ec108c9a8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentation" xlink:type="simple" xlink:href="wst-20240630.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d1ba8124-5ae9-4168-8461-c7836295628c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c88788d3-5db7-404d-8dd9-26cbaa1313c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d1ba8124-5ae9-4168-8461-c7836295628c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c88788d3-5db7-404d-8dd9-26cbaa1313c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20240630.xsd#NewAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_c106e9c0-f367-4e5d-ba61-d54ba637a12f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d0306362-842f-4c54-8ce5-be7dcb6707c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_c106e9c0-f367-4e5d-ba61-d54ba637a12f" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d0306362-842f-4c54-8ce5-be7dcb6707c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20240630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9bd6982-abe6-4656-a332-7345282479fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_47e0842c-2d29-4c54-8130-92a26cc97d87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9bd6982-abe6-4656-a332-7345282479fa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_47e0842c-2d29-4c54-8130-92a26cc97d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20240630.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_03c839bf-9022-4b75-8fce-ef8ea5ab150e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5d87c17e-9e33-44ee-8d1f-ffd6969748af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_03c839bf-9022-4b75-8fce-ef8ea5ab150e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5d87c17e-9e33-44ee-8d1f-ffd6969748af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Inventories" xlink:type="simple" xlink:href="wst-20240630.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1b228130-624d-4b7a-91ac-ea7aa2436cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_ba0c19c2-cab3-45d8-a36f-08f5ac563b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1b228130-624d-4b7a-91ac-ea7aa2436cf0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_ba0c19c2-cab3-45d8-a36f-08f5ac563b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20240630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_18ed9778-b926-4fc6-875f-8e0692997171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_a44cba59-3dd6-49ed-9d5a-4cebf5a8934b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18ed9778-b926-4fc6-875f-8e0692997171" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_a44cba59-3dd6-49ed-9d5a-4cebf5a8934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_546f7b5e-9a4c-433e-8e7d-367d1790d2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18ed9778-b926-4fc6-875f-8e0692997171" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_546f7b5e-9a4c-433e-8e7d-367d1790d2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20240630.xsd#AffiliatedCompanies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_86c30ed0-984d-49e6-b013-2966864e569b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_4cfe6e3c-3091-4234-b5b6-e0a6e970b0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_86c30ed0-984d-49e6-b013-2966864e569b" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_4cfe6e3c-3091-4234-b5b6-e0a6e970b0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20240630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7818189b-27e4-4fca-bac3-ce54efdc6e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9ce42d32-f881-41c1-81ef-b53c3781b3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7818189b-27e4-4fca-bac3-ce54efdc6e4a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9ce42d32-f881-41c1-81ef-b53c3781b3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d68836b2-0672-412b-92eb-f0e823a4acc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_13448f9a-6953-4d2e-ae6f-ee9d67dd2ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d68836b2-0672-412b-92eb-f0e823a4acc3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_13448f9a-6953-4d2e-ae6f-ee9d67dd2ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7264dc9d-8806-4be2-bf18-171770cefd34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_bfc153f1-c1ff-4997-8090-dbfe22fcdeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7264dc9d-8806-4be2-bf18-171770cefd34" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_bfc153f1-c1ff-4997-8090-dbfe22fcdeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_07abeab0-0e64-49c9-8e32-4689879ed8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b24f8bd0-8854-45db-9805-b1b80186840a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_07abeab0-0e64-49c9-8e32-4689879ed8ad" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b24f8bd0-8854-45db-9805-b1b80186840a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="wst-20240630.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7efbe8b7-0f4f-4d7a-a486-5df79127ed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e1108df7-cc20-4add-b43e-7b4a1c6d29a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7efbe8b7-0f4f-4d7a-a486-5df79127ed7c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e1108df7-cc20-4add-b43e-7b4a1c6d29a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20240630.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef5d885e-bacb-461c-995b-143adedf63fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b0cd0896-9a8b-4c6e-b201-077765bb9541" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef5d885e-bacb-461c-995b-143adedf63fc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b0cd0896-9a8b-4c6e-b201-077765bb9541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncome"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_54b43c9a-9e04-4e1d-8278-f6ec1fcc35bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_bcf9142f-c6fe-410b-92a8-c66bc267e556" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_54b43c9a-9e04-4e1d-8278-f6ec1fcc35bf" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_bcf9142f-c6fe-410b-92a8-c66bc267e556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20240630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0c4a2dd4-8b07-45ba-a999-d4c27a2f484e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe98569a-fb36-46b1-9e44-48c4e9744afc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c4a2dd4-8b07-45ba-a999-d4c27a2f484e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe98569a-fb36-46b1-9e44-48c4e9744afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20240630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55c8d3d6-b5de-4415-873a-868e3eeb7f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5564d2e9-0d58-405b-96ff-f44569aafb19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55c8d3d6-b5de-4415-873a-868e3eeb7f0f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5564d2e9-0d58-405b-96ff-f44569aafb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e60ccb30-4f2b-4fbb-bc0e-d5012f863aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_4e1e8e09-428c-4b36-a69c-52dc82ee55a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e60ccb30-4f2b-4fbb-bc0e-d5012f863aa6" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_4e1e8e09-428c-4b36-a69c-52dc82ee55a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SubsequentEvents" xlink:type="simple" xlink:href="wst-20240630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_c43d709d-0e0b-44ea-a3c2-e4f59619a0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_31670efb-8eb7-4f0b-ab0f-af452350f66b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_c43d709d-0e0b-44ea-a3c2-e4f59619a0a2" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_31670efb-8eb7-4f0b-ab0f-af452350f66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="wst-20240630.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e3944c80-e2e2-46bf-921d-890f8df50aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7476caf2-798e-4ee0-b373-a71290d7c874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3944c80-e2e2-46bf-921d-890f8df50aa5" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7476caf2-798e-4ee0-b373-a71290d7c874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3beb6a17-5c44-4267-9c85-c6c98eec7fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3944c80-e2e2-46bf-921d-890f8df50aa5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3beb6a17-5c44-4267-9c85-c6c98eec7fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_f4644a6d-42f7-4b9c-aa8c-c892d7ad679f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3944c80-e2e2-46bf-921d-890f8df50aa5" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_f4644a6d-42f7-4b9c-aa8c-c892d7ad679f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20240630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d10d798-2f24-4a3d-956a-23f8ce6bb47b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b02a4491-bc7d-4ed9-bd6a-f353801d8a73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d10d798-2f24-4a3d-956a-23f8ce6bb47b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b02a4491-bc7d-4ed9-bd6a-f353801d8a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5acd62aa-4ef2-486d-bb34-6fde663a9b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d10d798-2f24-4a3d-956a-23f8ce6bb47b" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5acd62aa-4ef2-486d-bb34-6fde663a9b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20240630.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_584860b1-624a-42fa-9fc3-bc96a35be753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2061966-1ad9-47b5-aeb7-683f079ce0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_584860b1-624a-42fa-9fc3-bc96a35be753" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2061966-1ad9-47b5-aeb7-683f079ce0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="wst-20240630.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1f032452-719c-4c34-846e-a7bdda80e420" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e58cf961-ca91-4fbb-8062-a3eb2a4acf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1f032452-719c-4c34-846e-a7bdda80e420" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e58cf961-ca91-4fbb-8062-a3eb2a4acf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_571f9e7c-8532-45f8-a287-b03d424cc3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_f3056b43-8d70-44c8-a263-28bedc6cd6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_571f9e7c-8532-45f8-a287-b03d424cc3cc" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_f3056b43-8d70-44c8-a263-28bedc6cd6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock_e305fee4-cee8-4f5d-83cc-62b6d1a89e86" xlink:href="wst-20240630.xsd#wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_571f9e7c-8532-45f8-a287-b03d424cc3cc" xlink:to="loc_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock_e305fee4-cee8-4f5d-83cc-62b6d1a89e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_711e9e2c-6174-4f63-af45-26ea658d3bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_571f9e7c-8532-45f8-a287-b03d424cc3cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_711e9e2c-6174-4f63-af45-26ea658d3bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5dee2f85-b6c2-4a28-8aab-52a7ed0d860a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_571f9e7c-8532-45f8-a287-b03d424cc3cc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5dee2f85-b6c2-4a28-8aab-52a7ed0d860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eb8d3b9b-a3ca-40ee-b87a-60000c0a9c55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_be91f4ad-346c-4d77-bdeb-f4f9ce122d14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eb8d3b9b-a3ca-40ee-b87a-60000c0a9c55" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_be91f4ad-346c-4d77-bdeb-f4f9ce122d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09bc16f9-a3e4-456e-be42-1bf1bffcfceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_424b39f1-b665-4856-b0af-1a8062d78a82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09bc16f9-a3e4-456e-be42-1bf1bffcfceb" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_424b39f1-b665-4856-b0af-1a8062d78a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3015291d-a082-4dc4-ab04-3ce5af992ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09bc16f9-a3e4-456e-be42-1bf1bffcfceb" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3015291d-a082-4dc4-ab04-3ce5af992ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_424b01a2-66c6-486d-9897-6e58271f2339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09bc16f9-a3e4-456e-be42-1bf1bffcfceb" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_424b01a2-66c6-486d-9897-6e58271f2339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_40628c8b-0482-4599-957f-978385a75fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d69cd2e1-cfe3-4fbb-8277-fa93f469af95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40628c8b-0482-4599-957f-978385a75fa1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d69cd2e1-cfe3-4fbb-8277-fa93f469af95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_57c63ea6-f6cd-4361-9353-65876e901719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ee744e51-d170-4232-9618-a7b8065eafb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_57c63ea6-f6cd-4361-9353-65876e901719" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ee744e51-d170-4232-9618-a7b8065eafb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a76fefcd-51cd-461a-a021-126bdf1169f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_57c63ea6-f6cd-4361-9353-65876e901719" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a76fefcd-51cd-461a-a021-126bdf1169f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="wst-20240630.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f4308ec6-8287-4d7e-ae56-c5477be5527e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_1af65579-ac4d-49b6-99be-24edbb994e29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f4308ec6-8287-4d7e-ae56-c5477be5527e" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_1af65579-ac4d-49b6-99be-24edbb994e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_d3605577-8ff6-4ca0-8414-71e0fcf71fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_a2bf396f-a196-4397-b33a-c4efd3991964" xlink:href="wst-20240630.xsd#wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d3605577-8ff6-4ca0-8414-71e0fcf71fc2" xlink:to="loc_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock_a2bf396f-a196-4397-b33a-c4efd3991964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_1df15468-f1a5-4bf2-9b54-9ac34b46f72b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d3605577-8ff6-4ca0-8414-71e0fcf71fc2" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_1df15468-f1a5-4bf2-9b54-9ac34b46f72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_75e70d2c-a4ca-4c62-96dc-47dffe14b529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_863e3991-ae44-45c3-af5a-e3dd1c4cd940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75e70d2c-a4ca-4c62-96dc-47dffe14b529" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_863e3991-ae44-45c3-af5a-e3dd1c4cd940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_acfb30a6-b376-42b1-85e0-0eff9e75e58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75e70d2c-a4ca-4c62-96dc-47dffe14b529" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_acfb30a6-b376-42b1-85e0-0eff9e75e58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#RevenueRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_024508b0-a530-4c6b-87b5-7e8f0595249b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_024508b0-a530-4c6b-87b5-7e8f0595249b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2ae59f7c-32c9-447c-8fde-3139b6b95886" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb61e11f-f2e8-4058-a3bd-428d87f43b07" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_3f43a2b0-b091-4a67-a748-5d761fe2ab29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember_36f1c0ef-9564-45c7-b720-7ec2e6970be1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_3f43a2b0-b091-4a67-a748-5d761fe2ab29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72edb3-63ba-4919-b33e-b5efacbe5d39" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5e36a223-9aba-4df8-ac38-bffbdf50355c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5e36a223-9aba-4df8-ac38-bffbdf50355c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_7e762e56-73c9-465c-a9a5-b11411ccfe83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_7e762e56-73c9-465c-a9a5-b11411ccfe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_0b777437-3b92-4544-b83c-a252373da2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b0aa27cf-147f-474e-9920-20fb4f6e7f04" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_0b777437-3b92-4544-b83c-a252373da2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_89539f0f-9789-4247-8304-989bf47e9bb4" xlink:to="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_0d352093-bea4-4762-943f-e04cc063835e" xlink:href="wst-20240630.xsd#wst_BiologicsCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_BiologicsCustomersMember_0d352093-bea4-4762-943f-e04cc063835e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_b0d05d8b-9953-4e2e-8a0a-68afb88123f2" xlink:href="wst-20240630.xsd#wst_GenericsCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_GenericsCustomersMember_b0d05d8b-9953-4e2e-8a0a-68afb88123f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_040eb277-2e7a-4481-9f2e-f00bf6c3957d" xlink:href="wst-20240630.xsd#wst_PharmaCustomersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_PharmaCustomersMember_040eb277-2e7a-4481-9f2e-f00bf6c3957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_47442560-ee28-4058-9d04-1c6a5e08fe7c" xlink:href="wst-20240630.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a98e9e34-e665-4e48-89ba-2813211aa2e7" xlink:to="loc_wst_ContractManufacturedCustomersMember_47442560-ee28-4058-9d04-1c6a5e08fe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_04859c46-cb76-4663-a9ab-2531946aae95" xlink:to="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember_ff63f89a-1950-4dda-a4df-292cd02efb79" xlink:href="wst-20240630.xsd#wst_HighValueComponentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_HighValueComponentsMember_ff63f89a-1950-4dda-a4df-292cd02efb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_71a97322-42c5-4d80-8bee-fdde204a4fc1" xlink:href="wst-20240630.xsd#wst_StandardPackagingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_StandardPackagingMember_71a97322-42c5-4d80-8bee-fdde204a4fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember_a19ae5ba-528f-40c0-8e53-fe0c5c7a0595" xlink:href="wst-20240630.xsd#wst_DeliveryDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_DeliveryDevicesMember_a19ae5ba-528f-40c0-8e53-fe0c5c7a0595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_602d36d1-2f8e-4808-8dc7-c32cfff11f32" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_473ce701-322a-451a-8c26-ab7aa1a05dc1" xlink:to="loc_wst_ContractManufacturedProductsMember_602d36d1-2f8e-4808-8dc7-c32cfff11f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0e6f7bca-0414-4366-872f-c6cdfa51df56" xlink:to="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_d567ff69-2d67-4b4a-8188-1abccc5a20e0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_srt_AmericasMember_d567ff69-2d67-4b4a-8188-1abccc5a20e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_2da218b6-35b6-4a7d-8200-87e485c9f63a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_us-gaap_EMEAMember_2da218b6-35b6-4a7d-8200-87e485c9f63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_0af96002-c882-4698-b098-bee990ef3bb7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45926515-1264-4e00-8698-730003dc8a89" xlink:to="loc_srt_AsiaPacificMember_0af96002-c882-4698-b098-bee990ef3bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0435c793-2893-45b5-8e86-24acdaa0af65" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_03803adc-c595-4fbd-943e-419130cbba20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_655b39d1-dbb6-43e4-b89d-0e46a53ba49f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_03803adc-c595-4fbd-943e-419130cbba20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#RevenueContractsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_010f48da-5131-41c2-999e-8046e9a21543" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerAssetRollForward_302bc51e-9de0-44e7-ab18-d163c1b6d491" xlink:href="wst-20240630.xsd#wst_ContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_010f48da-5131-41c2-999e-8046e9a21543" xlink:to="loc_wst_ContractWithCustomerAssetRollForward_302bc51e-9de0-44e7-ab18-d163c1b6d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_d4e05aed-42e1-4ec0-a24a-0523ba27dc65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_302bc51e-9de0-44e7-ab18-d163c1b6d491" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_d4e05aed-42e1-4ec0-a24a-0523ba27dc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_1d8a5237-cbb2-43d1-b4b4-d81363269a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_302bc51e-9de0-44e7-ab18-d163c1b6d491" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_1d8a5237-cbb2-43d1-b4b4-d81363269a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_af4bd296-998d-4895-9847-9348fc8b3eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerAssetRollForward_302bc51e-9de0-44e7-ab18-d163c1b6d491" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_af4bd296-998d-4895-9847-9348fc8b3eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityRollForward_8b943394-2d65-4943-955c-a8349f36437b" xlink:href="wst-20240630.xsd#wst_ContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_010f48da-5131-41c2-999e-8046e9a21543" xlink:to="loc_wst_ContractWithCustomerLiabilityRollForward_8b943394-2d65-4943-955c-a8349f36437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_296f7ed9-a9fa-460c-9ffe-63cc81cbfc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_8b943394-2d65-4943-955c-a8349f36437b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_296f7ed9-a9fa-460c-9ffe-63cc81cbfc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7cb85f03-3ac2-417a-8126-1b3b1e88e48b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_8b943394-2d65-4943-955c-a8349f36437b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7cb85f03-3ac2-417a-8126-1b3b1e88e48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0567d7b1-d542-4b87-91ca-be25bf942f58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractWithCustomerLiabilityRollForward_8b943394-2d65-4943-955c-a8349f36437b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0567d7b1-d542-4b87-91ca-be25bf942f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_30bb1343-32a5-468d-9cfb-e9d9c1bb3113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a75ec06b-4851-46c2-b5e9-e24b84620475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_30bb1343-32a5-468d-9cfb-e9d9c1bb3113" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a75ec06b-4851-46c2-b5e9-e24b84620475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#NetIncomePerShareSummaryofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b51d8af0-cce6-4262-9509-dcc45493a455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_040a1a5e-d688-40d4-8b77-6fc262f412d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b51d8af0-cce6-4262-9509-dcc45493a455" xlink:to="loc_us-gaap_NetIncomeLoss_040a1a5e-d688-40d4-8b77-6fc262f412d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2fe1b7d7-7e43-4398-85bc-7891aba2dd18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b51d8af0-cce6-4262-9509-dcc45493a455" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2fe1b7d7-7e43-4398-85bc-7891aba2dd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_aaed9d7e-c8a4-4551-8492-4f82ce49d23d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b51d8af0-cce6-4262-9509-dcc45493a455" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_aaed9d7e-c8a4-4551-8492-4f82ce49d23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18e6f4bc-422e-464d-86ae-e417417ea293" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b51d8af0-cce6-4262-9509-dcc45493a455" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18e6f4bc-422e-464d-86ae-e417417ea293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#NetIncomePerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8def1e18-dc0b-48e8-99f8-7099bb93b519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8def1e18-dc0b-48e8-99f8-7099bb93b519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_bce0f430-0d3c-4553-9d40-12c438a8093c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:to="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_bce0f430-0d3c-4553-9d40-12c438a8093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_301445eb-80eb-4a00-bbe2-627f588344b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_301445eb-80eb-4a00-bbe2-627f588344b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b20270d3-37ae-44a6-81c5-0abd7b8f8ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b20270d3-37ae-44a6-81c5-0abd7b8f8ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6e20042b-6821-45ca-adda-73735cab5143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3f1be50-81b8-45a9-87f0-c4dfadcdac00" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6e20042b-6821-45ca-adda-73735cab5143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c4eba548-3df8-41d9-ab3a-a6ae3870d968" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_20f87004-bbc9-47b4-a239-44d16b1f98dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4eba548-3df8-41d9-ab3a-a6ae3870d968" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_20f87004-bbc9-47b4-a239-44d16b1f98dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c6af7bae-69cf-4d33-9001-efddb8e8d391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4eba548-3df8-41d9-ab3a-a6ae3870d968" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c6af7bae-69cf-4d33-9001-efddb8e8d391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a1914f58-5008-48ab-ada1-c0c33c190c70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4eba548-3df8-41d9-ab3a-a6ae3870d968" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a1914f58-5008-48ab-ada1-c0c33c190c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9daa0b10-f2da-4e3f-a9ca-b9484cf815ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4eba548-3df8-41d9-ab3a-a6ae3870d968" xlink:to="loc_us-gaap_InventoryNet_9daa0b10-f2da-4e3f-a9ca-b9484cf815ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5c643445-071f-432f-a966-a07550666f61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:to="loc_us-gaap_OperatingLeaseCost_5c643445-071f-432f-a966-a07550666f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e1be9d57-7087-4064-9158-b68d73bbe4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e1be9d57-7087-4064-9158-b68d73bbe4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_8444e628-4bff-422d-86c3-c028ea52f3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:to="loc_us-gaap_ShortTermLeaseCost_8444e628-4bff-422d-86c3-c028ea52f3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_d20459ef-ea49-4778-9936-6d3ef78e2cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:to="loc_us-gaap_VariableLeaseCost_d20459ef-ea49-4778-9936-6d3ef78e2cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b38975d1-48c3-4cb8-8258-d42e67405b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1193dc26-1826-485d-93e1-9c3333a30c4d" xlink:to="loc_us-gaap_LeaseCost_b38975d1-48c3-4cb8-8258-d42e67405b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesAssetsAndLiabilitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b45b0182-f357-479b-8928-512545a18b90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ac163afe-4a2e-4067-b20a-222b36e2fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b45b0182-f357-479b-8928-512545a18b90" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ac163afe-4a2e-4067-b20a-222b36e2fd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_18e81eea-debc-4eb1-8000-fbcb6deab248" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_ac163afe-4a2e-4067-b20a-222b36e2fd04" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_18e81eea-debc-4eb1-8000-fbcb6deab248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_5da36bdc-85be-4338-ba0b-bf6396856fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b45b0182-f357-479b-8928-512545a18b90" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_5da36bdc-85be-4338-ba0b-bf6396856fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7b6896a9-762b-49ce-8a38-c123afffba55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_5da36bdc-85be-4338-ba0b-bf6396856fd5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7b6896a9-762b-49ce-8a38-c123afffba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_99c18884-41a8-4a55-82e5-5cd3c784aed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b45b0182-f357-479b-8928-512545a18b90" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_99c18884-41a8-4a55-82e5-5cd3c784aed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77e0df33-360f-4367-8722-f02a4d8b3a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_99c18884-41a8-4a55-82e5-5cd3c784aed5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77e0df33-360f-4367-8722-f02a4d8b3a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1af84dc4-e64b-4509-83cb-1354a7a5e298" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:href="wst-20240630.xsd#wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1af84dc4-e64b-4509-83cb-1354a7a5e298" xlink:to="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e688581f-eda4-4870-8147-010fe9543abb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:to="loc_us-gaap_OperatingLeasePayments_e688581f-eda4-4870-8147-010fe9543abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_05ec12d3-1987-45e2-a7af-dd9c19f6b89d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_05ec12d3-1987-45e2-a7af-dd9c19f6b89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a1a3545b-51db-4698-a77c-1039c5ad8f98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a1a3545b-51db-4698-a77c-1039c5ad8f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_79563ad1-7af5-4e71-9cb2-5de39760fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_59cdc1b0-bd76-457b-acbf-ec1a4aa7b9f0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_79563ad1-7af5-4e71-9cb2-5de39760fb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesLeaseWeightedAverageDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_93c723e9-7bf7-4b1e-8ce1-a07efae329ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4ad54bfa-9a26-467c-b79c-c99b88798900" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93c723e9-7bf7-4b1e-8ce1-a07efae329ce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4ad54bfa-9a26-467c-b79c-c99b88798900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_71608264-6ffd-4da4-8209-18197ae8d337" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93c723e9-7bf7-4b1e-8ce1-a07efae329ce" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_71608264-6ffd-4da4-8209-18197ae8d337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d9ed23db-ce16-46c2-a9b5-30715dfead7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93c723e9-7bf7-4b1e-8ce1-a07efae329ce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d9ed23db-ce16-46c2-a9b5-30715dfead7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_702f318f-2a35-443d-a9d1-3728d154a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93c723e9-7bf7-4b1e-8ce1-a07efae329ce" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_702f318f-2a35-443d-a9d1-3728d154a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ef33025d-3c35-48b9-91b7-fbc097dc8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ef33025d-3c35-48b9-91b7-fbc097dc8e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4998c8bf-4e11-41be-ae12-e880cb4be734" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4998c8bf-4e11-41be-ae12-e880cb4be734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64c79b5b-e130-4a4b-8a40-9b7854641103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64c79b5b-e130-4a4b-8a40-9b7854641103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_11e0e11f-1e1f-443f-ac41-4002a69922a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_11e0e11f-1e1f-443f-ac41-4002a69922a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d3a5235e-bf45-402e-b402-09dfbc1d2f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d3a5235e-bf45-402e-b402-09dfbc1d2f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_47b6c800-3583-445b-a0a1-008f84412e15" xlink:href="wst-20240630.xsd#wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_47b6c800-3583-445b-a0a1-008f84412e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5eeeb725-0545-4767-80c6-233c22ea7e22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5eeeb725-0545-4767-80c6-233c22ea7e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c7818e7a-fdab-4231-926b-c51b012f30ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c7818e7a-fdab-4231-926b-c51b012f30ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_866333fe-02cb-4536-b3af-22c060f47e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_182af026-788e-4e23-9b88-889a0c260f1a" xlink:to="loc_us-gaap_OperatingLeaseLiability_866333fe-02cb-4536-b3af-22c060f47e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_4f20668a-c66e-4af8-b9c0-5d9b90aed6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_4f20668a-c66e-4af8-b9c0-5d9b90aed6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2f1dad5a-197c-4e84-83a4-8b8b81844330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2f1dad5a-197c-4e84-83a4-8b8b81844330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5d9ab685-919f-4bf3-80ca-6fe84acffd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5d9ab685-919f-4bf3-80ca-6fe84acffd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_eb84e50a-8117-4cb5-8848-b14ca7471980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_eb84e50a-8117-4cb5-8848-b14ca7471980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_53d96738-7598-47c7-b4b1-eb6cd12591a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_53d96738-7598-47c7-b4b1-eb6cd12591a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_c2547818-2334-4704-930b-07d390a75a8d" xlink:href="wst-20240630.xsd#wst_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_c2547818-2334-4704-930b-07d390a75a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_35f4e9a9-0b44-4f3c-8698-230816342cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_35f4e9a9-0b44-4f3c-8698-230816342cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b9e48664-28ea-4136-8836-931e27724d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b9e48664-28ea-4136-8836-931e27724d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3b46a7eb-15a1-48b7-9e76-1452998514c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_584727d7-3561-4025-9d27-310279f5ef83" xlink:to="loc_us-gaap_FinanceLeaseLiability_3b46a7eb-15a1-48b7-9e76-1452998514c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AffiliatedCompaniesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c3aee181-4c9f-4699-9ddf-3f427f1a2efe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c3aee181-4c9f-4699-9ddf-3f427f1a2efe" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_aeb6b707-d97e-46a7-9fc5-3cace95de6e3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DistributorshipAgreementMember_11a5808e-bd44-48a0-94cf-0cdd2dd7cd32" xlink:href="wst-20240630.xsd#wst_DistributorshipAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d69dd7ee-245d-49e8-ba40-78a9c743e021" xlink:to="loc_wst_DistributorshipAgreementMember_11a5808e-bd44-48a0-94cf-0cdd2dd7cd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76f18-dcfc-436e-a804-790bf39200e8" xlink:to="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_2b83f026-268e-4d38-90d3-60eb16ed3954" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_b0715cc1-6e03-4eda-a6f4-2433be069ed1" xlink:to="loc_srt_AffiliatedEntityMember_2b83f026-268e-4d38-90d3-60eb16ed3954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_583ee45a-7239-4314-80c9-8058032b3c54" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_4b829612-9f0a-4cb6-a46b-06ce49f6590e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_EquityMethodInvestments_4b829612-9f0a-4cb6-a46b-06ce49f6590e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_a552780d-6caf-4392-b7e4-78e848c57608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_a552780d-6caf-4392-b7e4-78e848c57608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_fadb17d1-f514-45a1-8741-f72e2bcd2cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_fadb17d1-f514-45a1-8741-f72e2bcd2cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_41009ff3-c531-4044-9744-eed5b5ccc981" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_41009ff3-c531-4044-9744-eed5b5ccc981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb34a6-f4c6-430d-b668-b2fed4ea9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fecb34a6-f4c6-430d-b668-b2fed4ea9f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_402caedf-a435-47de-a561-9ffa1c92d816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9f571360-1355-4ecf-b6a9-f4c992d4e16b" xlink:to="loc_us-gaap_OtherAssetsCurrent_402caedf-a435-47de-a561-9ffa1c92d816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f6eb300e-06b7-4caf-80eb-64d4ca098c89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f6eb300e-06b7-4caf-80eb-64d4ca098c89" xlink:to="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_577610e6-ac7f-482e-bb9f-f45d5ec14aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_90a2b93b-702d-4756-ad18-94de0022e125" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_TermLoanDue2024Member_90a2b93b-702d-4756-ad18-94de0022e125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_cba7a386-7c12-4d3f-b183-6f7bb69a94ec" xlink:href="wst-20240630.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_SeniorBNotesDue2024Member_cba7a386-7c12-4d3f-b183-6f7bb69a94ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_f334f9ca-e93b-4464-b0a3-7b33d7cdfc64" xlink:href="wst-20240630.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bf70e9be-aa31-4c09-b0a7-4c13c7941286" xlink:to="loc_wst_SeniorCNotesDue2027Member_f334f9ca-e93b-4464-b0a3-7b33d7cdfc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_56c36698-7ae6-48ad-9e69-9f1f6dad9462" xlink:to="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a830cf9-1505-4ea1-9a7e-f2c294127a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2a830cf9-1505-4ea1-9a7e-f2c294127a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3fdce802-8480-4084-a16f-78df6e65bc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3fdce802-8480-4084-a16f-78df6e65bc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_6166ca27-df61-4d26-bdd4-90d77cae07fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_6166ca27-df61-4d26-bdd4-90d77cae07fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_25ff6b2a-6343-4d57-8a43-b9a7385e2277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebt_25ff6b2a-6343-4d57-8a43-b9a7385e2277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c6498c78-9662-4c97-9515-8e3a6ce9c8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebtCurrent_c6498c78-9662-4c97-9515-8e3a6ce9c8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5ce3c155-ed91-47ef-9e59-54937dd45a96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_831b9349-d9b3-4239-987f-e79682a1d584" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5ce3c155-ed91-47ef-9e59-54937dd45a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_43c0a3f0-581d-4d12-a383-8c9ec7100143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_43c0a3f0-581d-4d12-a383-8c9ec7100143" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5be9c148-9f6d-4f81-a689-2f41c727918e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_1eb7f356-580c-4cd7-b7fd-aef64f2d5415" xlink:href="wst-20240630.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_1eb7f356-580c-4cd7-b7fd-aef64f2d5415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_2fca2279-3bf6-4e67-8218-75a05e5df89b" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239861cf-5cda-44e2-8f60-1cdd2e3aedd9" xlink:to="loc_wst_TermLoanDue2024Member_2fca2279-3bf6-4e67-8218-75a05e5df89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:to="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a3ebd89e-63f2-4765-8e87-91e687632b88" xlink:to="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a48a4152-8a07-42f8-87ba-2973e46dc36c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a48a4152-8a07-42f8-87ba-2973e46dc36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2986bf86-f38b-49bb-8cb9-2d4fd0fa3e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_82631f1c-690d-4ef1-842f-987e798f00d0" xlink:to="loc_us-gaap_LetterOfCreditMember_2986bf86-f38b-49bb-8cb9-2d4fd0fa3e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_60c72715-f437-4414-896a-144d02f9ac5b" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf06acb-732c-41c9-94b3-46f70cdd5f91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf06acb-732c-41c9-94b3-46f70cdd5f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed85e8ad-789b-4bab-9a31-7d1cd778165a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCredit_ed85e8ad-789b-4bab-9a31-7d1cd778165a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec41e-a8ac-47d3-9e7b-791072dd879d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_521ec41e-a8ac-47d3-9e7b-791072dd879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_85295c82-d297-4346-bebd-998a5a2c2545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_85295c82-d297-4346-bebd-998a5a2c2545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_30727faf-7d21-400c-a716-991c69490d49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b79a4776-fd69-42b2-8c77-ce5175326266" xlink:to="loc_us-gaap_LongTermDebtCurrent_30727faf-7d21-400c-a716-991c69490d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9c69ffb-055a-463e-a133-2af57b01a714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9c69ffb-055a-463e-a133-2af57b01a714" xlink:to="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ee0e3f0-58af-463e-b510-72f70866a4a3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsOneMember_f39023f4-5835-4961-9b48-c9c888597bf0" xlink:href="wst-20240630.xsd#wst_ForwardContractsOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:to="loc_wst_ForwardContractsOneMember_f39023f4-5835-4961-9b48-c9c888597bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardContractsTwoMember_df9f6307-baef-4936-8884-bfb6888fd603" xlink:href="wst-20240630.xsd#wst_ForwardContractsTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForwardContractsMember_4eeb1d22-0d4a-4907-8814-142bbe8d3a63" xlink:to="loc_wst_ForwardContractsTwoMember_df9f6307-baef-4936-8884-bfb6888fd603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6beafeaf-4567-4ceb-a18e-c6704d12b8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6beafeaf-4567-4ceb-a18e-c6704d12b8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_eee2acb3-041b-4a64-a28d-02bd7980aab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_eee2acb3-041b-4a64-a28d-02bd7980aab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_a97af21c-5b1e-4c20-8100-1554e5b7abff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c7270d8-8d1a-4b7c-bb5a-dbd9a0877e0d" xlink:to="loc_us-gaap_OptionMember_a97af21c-5b1e-4c20-8100-1554e5b7abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6ff12045-0ddc-4e15-b6a0-f0fcae6a1859" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_22d549db-dbd7-4004-8e1b-ae59aabd7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3f8eca7e-fa59-4da7-a1b4-30b3c6386f90" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_22d549db-dbd7-4004-8e1b-ae59aabd7fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_38634b92-8f15-4c58-aa08-b3d5f64f3eb1" xlink:to="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_11aa3731-d634-4081-9ad7-e493a253752a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:to="loc_us-gaap_LongMember_11aa3731-d634-4081-9ad7-e493a253752a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_607d9b86-7401-4004-a3d8-a16b8c754199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_2b2215d3-56e8-4cc6-a225-bedbc0120bf0" xlink:to="loc_us-gaap_ShortMember_607d9b86-7401-4004-a3d8-a16b8c754199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_aea237b8-005f-4862-a528-1ad19c9cfeb2" xlink:to="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05a3d27-07af-4049-b03b-dbb92295e501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0b721786-7a0e-4f1c-8385-82abd15c1886" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05a3d27-07af-4049-b03b-dbb92295e501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_5662b17e-0ba1-40a8-888b-ca21056b1e97" xlink:to="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_4e03794e-028e-48cd-a150-fcba2ad1c372" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_EUR_4e03794e-028e-48cd-a150-fcba2ad1c372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1684fc09-8409-4783-9855-09e8a5e4a41a" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_JPY_1684fc09-8409-4783-9855-09e8a5e4a41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_12f4982a-3fc6-4602-bf1e-d351c8847e28" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SGD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_SGD_12f4982a-3fc6-4602-bf1e-d351c8847e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_95f516cb-3100-462f-92fb-c996be02a03d" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_USD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_093e7e5f-cb4a-4c72-8274-b322cb9772ce" xlink:to="loc_currency_USD_95f516cb-3100-462f-92fb-c996be02a03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d6341eab-2cf3-468f-b888-845af639a97f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyLoansMember_bd3ec801-7e3c-4800-a50e-92993116f570" xlink:href="wst-20240630.xsd#wst_IntercompanyLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:to="loc_wst_IntercompanyLoansMember_bd3ec801-7e3c-4800-a50e-92993116f570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IntercompanyDemandNotesMember_9238c2fe-273e-46e9-a7f4-566c4e264e27" xlink:href="wst-20240630.xsd#wst_IntercompanyDemandNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b236f612-9a58-45a6-a0bd-1232fec6ff45" xlink:to="loc_wst_IntercompanyDemandNotesMember_9238c2fe-273e-46e9-a7f4-566c4e264e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_425f262a-7c14-4ee4-8c3b-fb1afd0588f9" xlink:to="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8b5c6579-2081-467b-b2b7-45b6cc152956" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8b5c6579-2081-467b-b2b7-45b6cc152956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_a2935018-4440-41b3-9aef-7f1e603b546e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeTermOfContract_a2935018-4440-41b3-9aef-7f1e603b546e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_f97d56e6-dbc0-4584-81e5-fd7086269b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNonmonetaryNotionalAmountVolume"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmountVolume_f97d56e6-dbc0-4584-81e5-fd7086269b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_f82a3939-9ae3-4cca-b660-c0d35d1016bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a5cfbbf5-cac5-4b0a-b616-4f057367a3bd" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_f82a3939-9ae3-4cca-b660-c0d35d1016bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1250d33f-cd2a-467d-8780-1ad660b4ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1250d33f-cd2a-467d-8780-1ad660b4ca40" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e28b0076-cec2-4eb6-9ee6-fb8431f62971" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeMember_dd64f84f-7037-469c-94c7-f1d85e7b78f2" xlink:href="wst-20240630.xsd#wst_OtherExpenseIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_wst_OtherExpenseIncomeMember_dd64f84f-7037-469c-94c7-f1d85e7b78f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_019b1b83-bcf6-4a79-a876-156caa56bb3c" xlink:href="wst-20240630.xsd#wst_NetSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_wst_NetSalesMember_019b1b83-bcf6-4a79-a876-156caa56bb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e4fd7e1b-3a47-4ce1-9bdb-a26435d61d26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_us-gaap_CostOfSalesMember_e4fd7e1b-3a47-4ce1-9bdb-a26435d61d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_5f50806f-e854-493f-9d51-eaeb802b7f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5f96fd8-34b6-44c5-be55-376f4d2f4919" xlink:to="loc_us-gaap_InterestExpenseMember_5f50806f-e854-493f-9d51-eaeb802b7f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf949c05-6e84-43d7-aff7-648a882f7f6d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c6c3e761-f5f1-4d08-9b7d-b7352af05fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_FairValueHedgingMember_c6c3e761-f5f1-4d08-9b7d-b7352af05fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_402c0e4b-65e9-4dcc-865e-be0093a53874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_CashFlowHedgingMember_402c0e4b-65e9-4dcc-865e-be0093a53874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f3aab8d7-da71-497b-b8b3-bb627c7dd5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fd6b3071-7f23-4a5b-aa8f-2dd47d7e2d90" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f3aab8d7-da71-497b-b8b3-bb627c7dd5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a0a0df88-9d50-48c3-8e2a-4d5d36bac448" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c989ee97-27f6-4720-8865-06a2acae197d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c989ee97-27f6-4720-8865-06a2acae197d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_06637bba-136c-43b6-962b-0f837bcfceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_TreasuryLockMember_06637bba-136c-43b6-962b-0f837bcfceb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_9288edfc-2be0-428b-8f37-89f4fe45708e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1a4d7fd6-6e2b-433e-8303-3c85e8b9d8cf" xlink:to="loc_us-gaap_CurrencySwapMember_9288edfc-2be0-428b-8f37-89f4fe45708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f02491bd-0929-41b4-8a7c-8af1151d8c51" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_a7d4214c-41a4-45f4-8d0c-5fc8424629c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_a7d4214c-41a4-45f4-8d0c-5fc8424629c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_de5ed01d-dd96-4133-8427-1b2e7c9bf34f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_de5ed01d-dd96-4133-8427-1b2e7c9bf34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_fa009857-b25b-475a-bd8d-b587efc9908f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_fa009857-b25b-475a-bd8d-b587efc9908f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_c0672b9a-8e7a-42e0-b8af-7a8261f5f107" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_c0672b9a-8e7a-42e0-b8af-7a8261f5f107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_5980f1ca-b82a-46d8-ae10-21fb12c9b3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_5980f1ca-b82a-46d8-ae10-21fb12c9b3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5cbb5a18-bb3f-4cdf-89ca-43df3462221c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5cbb5a18-bb3f-4cdf-89ca-43df3462221c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_e6b44538-ac5f-4a1f-a040-98d7293d4419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_e6b44538-ac5f-4a1f-a040-98d7293d4419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da82328f-cd9f-4a1d-b067-141b911070ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da82328f-cd9f-4a1d-b067-141b911070ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_6470dfb1-82ac-4dc0-8c3d-c6169e890cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_6470dfb1-82ac-4dc0-8c3d-c6169e890cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2a24eff0-daeb-49f5-a18b-c3b490ebb671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_fa748fd8-a8ef-4ff9-8342-714d7c8dc37a" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2a24eff0-daeb-49f5-a18b-c3b490ebb671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c137b7c-88af-4f65-b3aa-498aaf3c35de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c137b7c-88af-4f65-b3aa-498aaf3c35de" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99fdea96-a9ae-4525-8f9b-bce7123a2def" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_5b495af8-e1b0-448d-b8cd-82c5da1e8cff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:to="loc_us-gaap_CommodityOptionMember_5b495af8-e1b0-448d-b8cd-82c5da1e8cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_45715f33-e98b-426d-9d39-520460235d83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cebf55e0-43c3-4258-87ba-6bdcebb98c1e" xlink:to="loc_us-gaap_ForwardContractsMember_45715f33-e98b-426d-9d39-520460235d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_263acc66-8152-42c3-8e42-b92dd1d90650" xlink:to="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dc4a6d07-40bc-4071-bb0b-66fe74c3bde8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0a9b4597-f7a3-436f-9117-6d1a71fb7b71" xlink:to="loc_us-gaap_NondesignatedMember_dc4a6d07-40bc-4071-bb0b-66fe74c3bde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fb59cfe3-bc90-41dd-831c-093279aafcd1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeMember_68b93397-1ec7-4eab-afd0-25737be91347" xlink:href="wst-20240630.xsd#wst_OtherExpenseIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a65e57d7-2070-477a-bf00-382432c3d184" xlink:to="loc_wst_OtherExpenseIncomeMember_68b93397-1ec7-4eab-afd0-25737be91347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8b7e7bc3-cf50-43e2-96a1-1539c6d40efb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a3c514d5-e060-407a-b196-f0e2cf728787" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4b80c38e-2b0f-466a-94f6-ccb59b8a911e" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a3c514d5-e060-407a-b196-f0e2cf728787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e278c304-0aac-45a1-b9fb-2e78a818026e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e278c304-0aac-45a1-b9fb-2e78a818026e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d72910b0-19ba-4a3f-8fab-9db7987fd5c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bd8c28cb-7e0e-4a63-8053-8f8771a7cc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bd8c28cb-7e0e-4a63-8053-8f8771a7cc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8f1db4d2-f51f-4926-9f40-8365a9f147bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8f1db4d2-f51f-4926-9f40-8365a9f147bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_97f7a8b3-8296-48c3-bcf6-33370c45352f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b0c4c97-50fb-480b-ad8d-9020b6c49a56" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_97f7a8b3-8296-48c3-bcf6-33370c45352f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d94b55e2-bcdf-41d4-b003-ff9c24d5c5c9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_98cdc7a6-b0cc-4dfa-9402-0a9b3c176b13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:to="loc_us-gaap_CurrencySwapMember_98cdc7a6-b0cc-4dfa-9402-0a9b3c176b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityMember_f78f18ed-52f6-4285-9433-1337fdc90192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommodityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e671f19a-e708-4887-adb5-e3cf5c826fb7" xlink:to="loc_us-gaap_CommodityMember_f78f18ed-52f6-4285-9433-1337fdc90192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_54fa1acb-b6bc-4704-ad44-70024168c116" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_4d1b5ab2-e063-45e7-afe0-9a4495056d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_4d1b5ab2-e063-45e7-afe0-9a4495056d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_70fff54b-18e0-436e-9160-066dfadad11e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_70fff54b-18e0-436e-9160-066dfadad11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b592d993-0e1f-443a-b957-d6b4d28ff8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_DerivativeAssets_b592d993-0e1f-443a-b957-d6b4d28ff8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2abc125f-1a76-4342-97a0-de84a647b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1f2c1f3e-00b2-41fe-864c-fdcf207b792b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2abc125f-1a76-4342-97a0-de84a647b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34e90e7c-277d-4660-a395-9b76f725ebe9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03a2d858-88af-460c-8eea-982b2a442aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03a2d858-88af-460c-8eea-982b2a442aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_41fc333b-37e4-42c4-8666-4acbbb7bf720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_41fc333b-37e4-42c4-8666-4acbbb7bf720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_acbb1eea-9d01-4236-8f77-208231007867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_acbb1eea-9d01-4236-8f77-208231007867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d45fe09c-bd2d-4641-9ff2-703a05b77080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9cb30251-2337-4815-a4ee-0a44ba410a33" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d45fe09c-bd2d-4641-9ff2-703a05b77080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_48cbdb9b-a5f9-4021-9aba-dec3d7651d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract_14380686-efa1-40df-8d15-259405225676" xlink:href="wst-20240630.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_48cbdb9b-a5f9-4021-9aba-dec3d7651d01" xlink:to="loc_wst_OtherFinancialInstrumentsAbstract_14380686-efa1-40df-8d15-259405225676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_7c711e1d-2727-4eed-a0c4-43f5e2e7cc14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_14380686-efa1-40df-8d15-259405225676" xlink:to="loc_us-gaap_DebtInstrumentFairValue_7c711e1d-2727-4eed-a0c4-43f5e2e7cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6685c066-34e2-4a58-bfa4-268f97e9a326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_14380686-efa1-40df-8d15-259405225676" xlink:to="loc_us-gaap_LongTermDebt_6685c066-34e2-4a58-bfa4-268f97e9a326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8010859b-d16a-4e5b-b684-9a4805ec726e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8010859b-d16a-4e5b-b684-9a4805ec726e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2175f773-6264-45bb-bd13-afafd26b7ccf" xlink:to="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2767ffa0-e304-4e02-8b1a-9269b23e792e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2767ffa0-e304-4e02-8b1a-9269b23e792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociEquityMethodInvestmentParentMember_1c5aff39-74d9-465d-8ee5-1cb72c91a4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AociEquityMethodInvestmentParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AociEquityMethodInvestmentParentMember_1c5aff39-74d9-465d-8ee5-1cb72c91a4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f5e5ab26-8a07-43e0-8406-356da51edf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f5e5ab26-8a07-43e0-8406-356da51edf5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f965f9b-5a9d-4abd-811f-c7964119436f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f965f9b-5a9d-4abd-811f-c7964119436f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1b3cbb2a-c12a-4075-8c60-d935b738c9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d8811d5-82d4-48c9-8ce5-c4b7070d210e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1b3cbb2a-c12a-4075-8c60-d935b738c9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e921a65c-286b-4b17-9116-ca6a78b36f21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7ed30580-cea9-4e9b-a606-3d97ff543895" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a6e1911e-497f-4ba8-bbc4-14a2cb7e14ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_StockholdersEquity_a6e1911e-497f-4ba8-bbc4-14a2cb7e14ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_17c058bf-fc24-473a-8fc4-661395da35ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_17c058bf-fc24-473a-8fc4-661395da35ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bcf53135-62f9-4480-a940-18cf7289b57d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bcf53135-62f9-4480-a940-18cf7289b57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4db6e7de-0ba0-4dcc-8dac-f11d4959d891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4db6e7de-0ba0-4dcc-8dac-f11d4959d891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c35d7a39-2a77-450f-857e-d893f606807c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_db1ddca0-bbd3-4c19-94e8-176c947ca086" xlink:to="loc_us-gaap_StockholdersEquity_c35d7a39-2a77-450f-857e-d893f606807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f7cd8a8b-952e-4396-8422-cdb333cf3544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f7cd8a8b-952e-4396-8422-cdb333cf3544" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_8eb46b46-768d-43ee-b051-35537a442fb1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_2dea69a5-754f-4d05-a52c-12d0304332da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2fc6a045-24c1-42d7-b49e-b9b6e0dff530" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_2dea69a5-754f-4d05-a52c-12d0304332da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66255b42-c665-497a-9fe9-e58d0a6a7954" xlink:to="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fbf59715-16c1-4d12-b0ed-afd87e5f1981" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fbf59715-16c1-4d12-b0ed-afd87e5f1981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b3195c7b-fb14-44cc-88bd-2dffbfeaa58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b23713b-3e96-45ed-89c2-8ab6314c23cd" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b3195c7b-fb14-44cc-88bd-2dffbfeaa58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_adcd4e92-a59b-4281-bd6b-6f138879eecc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_29c641e3-a768-4ddf-8e83-311aa7d5fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:to="loc_us-gaap_ForeignExchangeContractMember_29c641e3-a768-4ddf-8e83-311aa7d5fdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_b6089667-a452-4c95-ad8f-5f7284b7a096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0d48ee77-91bf-49d2-88a6-924493b8ea19" xlink:to="loc_us-gaap_TreasuryLockMember_b6089667-a452-4c95-ad8f-5f7284b7a096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_da8ba7dd-75ac-4b25-8fa5-5c0238bc3300" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_258e51f1-5971-4a0f-a86a-18cea70832f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_258e51f1-5971-4a0f-a86a-18cea70832f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b7d3cce3-87de-4f70-a6df-c3644b0527a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b7d3cce3-87de-4f70-a6df-c3644b0527a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_937361b6-40c7-4fe4-91e8-fcc2c1a190b3" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_wst_OtherIncomeExpense_937361b6-40c7-4fe4-91e8-fcc2c1a190b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_36810f74-598a-4843-81b5-d09b72c7bba2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_InterestExpenseNonoperating_36810f74-598a-4843-81b5-d09b72c7bba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_0481dab0-8419-4b7e-85d1-873efab3174b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_0481dab0-8419-4b7e-85d1-873efab3174b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_80e8905e-d9f9-4dea-a61f-74f3718eb88b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_80e8905e-d9f9-4dea-a61f-74f3718eb88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_02320fd9-569e-4352-968c-1d48c949239a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_02320fd9-569e-4352-968c-1d48c949239a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a0f28721-6385-4563-a7b0-4026255d8fec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a0f28721-6385-4563-a7b0-4026255d8fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20936ec7-b9c8-4146-8266-1506c1f72b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b1eceb1e-751a-4198-bb18-9bc403847203" xlink:to="loc_us-gaap_NetIncomeLoss_20936ec7-b9c8-4146-8266-1506c1f72b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#ShareholdersEquityChangeinShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_92f67d94-c231-4c59-987e-b3842514a08d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_92f67d94-c231-4c59-987e-b3842514a08d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff5be589-e14c-45ae-8d04-054d46f10f14" xlink:to="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2355932d-3489-45bf-b39c-21569b3ceca5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_CommonStockMember_2355932d-3489-45bf-b39c-21569b3ceca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_39afc86f-30de-43f3-91b8-00bb184d732d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_39afc86f-30de-43f3-91b8-00bb184d732d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_838c86ad-acc8-4f1f-b3f7-df76682d25c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_TreasuryStockCommonMember_838c86ad-acc8-4f1f-b3f7-df76682d25c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b9665773-79c3-4c6a-92be-e57d509aed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_RetainedEarningsMember_b9665773-79c3-4c6a-92be-e57d509aed0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_14d4a269-879f-48d1-a543-7de701b17dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e726ea5-e839-4165-b626-8773b3ec0c13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_14d4a269-879f-48d1-a543-7de701b17dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d3d25c95-0ee8-4012-8e89-f234575cacbb" xlink:to="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6a25d3ba-bee4-45b8-a15a-f28937547be7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_SharesIssued_6a25d3ba-bee4-45b8-a15a-f28937547be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d45eed85-24f4-4755-b427-55109d11b9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockholdersEquity_d45eed85-24f4-4755-b427-55109d11b9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_02f4ce59-e55c-4123-bd13-3a72941511d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockCommonShares_02f4ce59-e55c-4123-bd13-3a72941511d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0296c760-5beb-49f6-934a-d2b6e81ff383" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_NetIncomeLoss_0296c760-5beb-49f6-934a-d2b6e81ff383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_41c18150-4642-4faf-bd01-b39d01f3afda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_41c18150-4642-4faf-bd01-b39d01f3afda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29a92e0a-e0dd-4a55-8c0d-654587b9560c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29a92e0a-e0dd-4a55-8c0d-654587b9560c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e1d79b13-c2c7-4393-afdc-a435c8d90bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e1d79b13-c2c7-4393-afdc-a435c8d90bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_156b65c0-9380-4b18-81dc-91d1e5f1bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_156b65c0-9380-4b18-81dc-91d1e5f1bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9db8e53e-3d04-4021-a7e5-aa48aad0aa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_DividendsCommonStockCash_9db8e53e-3d04-4021-a7e5-aa48aad0aa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36b8c1bb-0805-4daa-8342-10e96e8dcb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36b8c1bb-0805-4daa-8342-10e96e8dcb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_24f4b381-040a-4703-a17d-20711c112084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_SharesIssued_24f4b381-040a-4703-a17d-20711c112084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8d0af426-1cdb-456b-8bac-7684559d7308" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_StockholdersEquity_8d0af426-1cdb-456b-8bac-7684559d7308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3a8f1164-9f66-4dce-8bd0-53ce754ce2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45bd2304-4f2a-4b67-be64-bb72349497ff" xlink:to="loc_us-gaap_TreasuryStockCommonShares_3a8f1164-9f66-4dce-8bd0-53ce754ce2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_20c849ec-dd34-4f14-803e-cdc178eb6e66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e32062b5-d34d-41f7-a6bd-efddb739ce29" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_20c849ec-dd34-4f14-803e-cdc178eb6e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7100ea8-4cca-42ed-be34-68824a813279" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7100ea8-4cca-42ed-be34-68824a813279" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:to="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_40016a19-65cb-4c4a-b30d-92f3840427a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a87e72e6-4dd2-4dcc-96d1-9f914159e824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:to="loc_us-gaap_PerformanceSharesMember_a87e72e6-4dd2-4dcc-96d1-9f914159e824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6be72b35-da1a-4703-a13d-2363392cc12e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c20c1-d9cf-4892-bae7-506845b53d73" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6be72b35-da1a-4703-a13d-2363392cc12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:to="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a3dbd79f-a84d-4bc2-8dea-7533ccc2c617" xlink:to="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_06d0634a-a1d8-4be8-bf54-1349e81fd754" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:to="loc_srt_MinimumMember_06d0634a-a1d8-4be8-bf54-1349e81fd754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b3a458d-2b17-422c-9ea0-b1f06ee11593" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36955887-3eff-4bdb-a0fa-37a7f8352363" xlink:to="loc_srt_MaximumMember_2b3a458d-2b17-422c-9ea0-b1f06ee11593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4097b8d3-2a88-4405-9ea8-3f140a48b966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a6ec4ef2-12b4-4636-82e1-faa863cebdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a6ec4ef2-12b4-4636-82e1-faa863cebdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1c851803-0e6e-48aa-9f12-974fcd9bd5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1c851803-0e6e-48aa-9f12-974fcd9bd5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bfa701cd-83bd-4eee-a002-d6520524c53d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bfa701cd-83bd-4eee-a002-d6520524c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69e27a93-209e-4b30-ba43-9736696a47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69e27a93-209e-4b30-ba43-9736696a47f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_da4022ec-34f4-496c-a10d-6528181663a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_da4022ec-34f4-496c-a10d-6528181663a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_634dda41-3198-4c02-8ef9-d1b2a4c49373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_634dda41-3198-4c02-8ef9-d1b2a4c49373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8c45b70a-333f-48d6-92d0-363add0ea183" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8c45b70a-333f-48d6-92d0-363add0ea183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e40eb88b-2fd6-46bf-b577-b40d3cb3bf87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e40eb88b-2fd6-46bf-b577-b40d3cb3bf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f635805-4226-44ef-b4fe-796bb9c75a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f635805-4226-44ef-b4fe-796bb9c75a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40ffb1af-9318-4a85-a3fa-de1f251f2c96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40ffb1af-9318-4a85-a3fa-de1f251f2c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_c3638056-b76b-4892-9db5-487f76451664" xlink:href="wst-20240630.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_c3638056-b76b-4892-9db5-487f76451664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_00a17665-5c74-40bd-874f-42e630ec91c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f45b25f3-4dcc-48e1-ac3b-9dbce20a7a18" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_00a17665-5c74-40bd-874f-42e630ec91c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_babdc0c7-5ef9-48e7-8d2a-27699d68b493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_babdc0c7-5ef9-48e7-8d2a-27699d68b493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_61c20afb-5134-4fa8-9726-1244ec956951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_61c20afb-5134-4fa8-9726-1244ec956951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb1411cd-1069-4202-8b7d-7db29447e244" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb1411cd-1069-4202-8b7d-7db29447e244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3525ff73-b584-4675-a72b-921ad2fc797d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_AssetImpairmentCharges_3525ff73-b584-4675-a72b-921ad2fc797d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_c86b28bd-0731-4c75-a802-2fb60efeeb87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_c86b28bd-0731-4c75-a802-2fb60efeeb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_d988a89c-bd35-4539-a4b3-2423ef5058bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_d988a89c-bd35-4539-a4b3-2423ef5058bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_dd9250d9-c33e-4e25-98fe-c728ad6e5d7e" xlink:href="wst-20240630.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_5cc6b995-0850-4037-81fd-ce298ec9dc99" xlink:to="loc_wst_OtherIncomeExpense_dd9250d9-c33e-4e25-98fe-c728ad6e5d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_902f0433-631c-49f7-9db7-46937952c758" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_902f0433-631c-49f7-9db7-46937952c758" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:to="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_deee2bf5-e636-4b31-ab3b-41d56e0621ec" xlink:to="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_7d6064ba-0de8-48d1-b9ef-429a00533b1b" xlink:href="wst-20240630.xsd#wst_The2022RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_88ee91c3-47b7-4112-900a-af816184dcc8" xlink:to="loc_wst_The2022RestructuringPlanMember_7d6064ba-0de8-48d1-b9ef-429a00533b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:to="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e50703dd-79f6-4218-a6fa-35cf7075a8eb" xlink:to="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d7bc5b8b-f5f6-48fa-b459-1d90ba0afd22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:to="loc_srt_MinimumMember_d7bc5b8b-f5f6-48fa-b459-1d90ba0afd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_99d4d4ba-75e8-497c-b55e-fafeda6f9666" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e825335-ea63-4fc7-95d0-d52a933f1b59" xlink:to="loc_srt_MaximumMember_99d4d4ba-75e8-497c-b55e-fafeda6f9666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9d912384-aa01-4a2b-8c9d-7941d867c8fd" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_cc835786-278b-4e37-82f1-f4abc768a65a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_cc835786-278b-4e37-82f1-f4abc768a65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_f7837842-51d2-4871-9ddb-3d82cae3e1b4" xlink:href="wst-20240630.xsd#wst_RestructuringAndRelatedActivitiesPeriodOfImplementation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation_f7837842-51d2-4871-9ddb-3d82cae3e1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9cb5c92b-ad30-4ae0-9e1a-5c1603a167c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9cb5c92b-ad30-4ae0-9e1a-5c1603a167c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureEarningsAmount_d2193976-9936-43a3-9113-030fffd536a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOnFutureEarningsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d069a18-43b3-4330-8ee5-4efcb814a3f2" xlink:to="loc_us-gaap_EffectOnFutureEarningsAmount_d2193976-9936-43a3-9113-030fffd536a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#OtherExpenseIncomeScheduleofRestructuringReserveDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_acce8241-9567-4785-93b7-8b36ce81bce5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_acce8241-9567-4785-93b7-8b36ce81bce5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56b6ec39-6091-4500-a614-6ac36aff490a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7ffac373-c63d-4ccd-89e2-4de9b9819019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7ffac373-c63d-4ccd-89e2-4de9b9819019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_03ad6cac-da4b-40c0-ab99-b7a218aab99f" xlink:href="wst-20240630.xsd#wst_AssetRelatedChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_bc662777-15a7-492d-b5a2-90941c682c2e" xlink:to="loc_wst_AssetRelatedChargesMember_03ad6cac-da4b-40c0-ab99-b7a218aab99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:to="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_638e44a6-8b57-4758-8475-95878eaef39e" xlink:to="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_The2022RestructuringPlanMember_1b74a89d-492b-46e5-a227-05e5a4339a05" xlink:href="wst-20240630.xsd#wst_The2022RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_4fd7b50e-8c14-40d4-a62b-99cbc5822c61" xlink:to="loc_wst_The2022RestructuringPlanMember_1b74a89d-492b-46e5-a227-05e5a4339a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9fdb1e01-2188-4830-988b-f29453585c2f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_6b3612d0-7664-4898-abc2-cc3080bfc646" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_83030c84-9fb4-4857-9d24-d3a18f1ded38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_us-gaap_RestructuringReserve_83030c84-9fb4-4857-9d24-d3a18f1ded38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RestructuringChargesCredits_325d2980-7e75-4e3c-a373-eab6f8db3de4" xlink:href="wst-20240630.xsd#wst_RestructuringChargesCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_wst_RestructuringChargesCredits_325d2980-7e75-4e3c-a373-eab6f8db3de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ad9d3552-71b7-4c39-9780-449741cf5762" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_us-gaap_PaymentsForRestructuring_ad9d3552-71b7-4c39-9780-449741cf5762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2905375c-f6f5-420c-ab7f-e182ea585606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6d909b6c-42de-45e1-8bfc-d6aa9ccc20c6" xlink:to="loc_us-gaap_RestructuringReserve_2905375c-f6f5-420c-ab7f-e182ea585606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4f13ba72-8708-48d5-8e79-d7506c08d7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_405802ab-3f6f-4890-9ab3-de6a38a2d9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f13ba72-8708-48d5-8e79-d7506c08d7e7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_405802ab-3f6f-4890-9ab3-de6a38a2d9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2aa3af4-547f-425d-b70e-158b7d9ecb44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f13ba72-8708-48d5-8e79-d7506c08d7e7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2aa3af4-547f-425d-b70e-158b7d9ecb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d72bda64-52f1-4f3e-9b5f-d2f88bc2e3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_42861f7a-8020-45cc-ad91-b7fef9fc81a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d72bda64-52f1-4f3e-9b5f-d2f88bc2e3d4" xlink:to="loc_us-gaap_NumberOfReportableSegments_42861f7a-8020-45cc-ad91-b7fef9fc81a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2f046d58-d324-4402-a5c4-3a29a71e5d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2f046d58-d324-4402-a5c4-3a29a71e5d1f" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_13251df9-ae2a-4982-b95f-c99701f1f64a" xlink:to="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_79e8bd09-8589-40fb-8bf1-715e25325f56" xlink:href="wst-20240630.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:to="loc_wst_ProprietaryProductsMember_79e8bd09-8589-40fb-8bf1-715e25325f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_8d0be6d1-08fe-466b-82be-c81e104d5ada" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_886d2957-6173-44bd-a19e-bd589ff44682" xlink:to="loc_wst_ContractManufacturedProductsMember_8d0be6d1-08fe-466b-82be-c81e104d5ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_0e13514e-2aa3-46ef-a0b6-7379861a731f" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35e3184-9363-483d-9790-9a989d7a52f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_c6f2091e-30bb-4385-abe9-a660d8f18202" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35e3184-9363-483d-9790-9a989d7a52f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9d353baa-0283-428f-84d0-8225c1623c45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d353baa-0283-428f-84d0-8225c1623c45" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_89a10e7d-063f-43e9-b330-6a9a4d25f414" xlink:to="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d4edfae7-2bb9-4f75-9126-87d4bcee070c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:to="loc_us-gaap_OperatingSegmentsMember_d4edfae7-2bb9-4f75-9126-87d4bcee070c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d3432cc9-d3cc-4a72-aeb2-f2731f77210f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3910564b-94c6-4eba-a38b-3a7fb2bf5c46" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d3432cc9-d3cc-4a72-aeb2-f2731f77210f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60e432b8-d07c-45e8-ab3e-642ea30908ee" xlink:to="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_4f5477cc-c84f-43fe-9372-0350dbe5b524" xlink:href="wst-20240630.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:to="loc_wst_ProprietaryProductsMember_4f5477cc-c84f-43fe-9372-0350dbe5b524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_69d38785-c6b4-49ed-92d8-2e03e551f590" xlink:href="wst-20240630.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0dbdf98a-5dd3-40bf-978c-93b2e0c9b399" xlink:to="loc_wst_ContractManufacturedProductsMember_69d38785-c6b4-49ed-92d8-2e03e551f590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_00d79224-3dd3-4570-92dd-751f43d3a9ee" xlink:to="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2022RestructuringPlanMember_6a51dd78-2e79-4bce-87e6-feb8c9f7a6a2" xlink:href="wst-20240630.xsd#wst_A2022RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_90c88a12-9529-48dc-8f70-0f28c1f7687d" xlink:to="loc_wst_A2022RestructuringPlanMember_6a51dd78-2e79-4bce-87e6-feb8c9f7a6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8571d292-0e83-4ac9-bc64-b1c8b678835c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_311867fa-9ed9-4aee-88ef-43a842a11c97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_OperatingIncomeLoss_311867fa-9ed9-4aee-88ef-43a842a11c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9361d93b-4dc1-4413-9f66-5cbb426ab1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_ShareBasedCompensation_9361d93b-4dc1-4413-9f66-5cbb426ab1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a8167f21-9a6c-4aba-890c-d94dd23b9f35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a8167f21-9a6c-4aba-890c-d94dd23b9f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1078bbff-1b6a-4c50-b871-f385c042ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1078bbff-1b6a-4c50-b871-f385c042ef79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_567c9602-bbde-42be-a448-4073d86de8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_567c9602-bbde-42be-a448-4073d86de8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_50491104-a144-4078-9246-eac39cd9f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_RestructuringCharges_50491104-a144-4078-9246-eac39cd9f1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_122d6000-3402-4371-a41a-88583bf1da72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_122d6000-3402-4371-a41a-88583bf1da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d4e713-feb3-4ed2-aa6f-10c5f5767cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d4e713-feb3-4ed2-aa6f-10c5f5767cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_f37c326f-ec97-4d23-947e-64d959fd543d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_InventoryWriteDown_f37c326f-ec97-4d23-947e-64d959fd543d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0e65c244-3d02-4e88-a519-3ca42a3aab6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cb3481c7-fa5e-4988-a0ea-50bbd9a5a675" xlink:to="loc_us-gaap_SeveranceCosts1_0e65c244-3d02-4e88-a519-3ca42a3aab6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="wst-20240630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_cab9d33d-1d85-48be-b80e-44bdc0e5c517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_cab9d33d-1d85-48be-b80e-44bdc0e5c517" xlink:to="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fc60eac-7f72-4708-af2e-ae2a9eb4b925" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9e6855d-5514-4aa3-9201-b1efeb64af14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4fa40308-e87d-4bf0-ad1a-b80470ec5daf" xlink:to="loc_us-gaap_SubsequentEventMember_a9e6855d-5514-4aa3-9201-b1efeb64af14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_aaf1eda7-7c1c-4ff1-aae3-003600cb3840" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2027Member_09abd014-c25b-4659-a8e6-5383e8b9441a" xlink:href="wst-20240630.xsd#wst_TermLoanDue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_TermLoanDue2027Member_09abd014-c25b-4659-a8e6-5383e8b9441a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_44f23e91-a3f8-4241-a201-df987744e222" xlink:href="wst-20240630.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_TermLoanDue2024Member_44f23e91-a3f8-4241-a201-df987744e222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5097143e-b1cf-4eb0-9556-e42410a1992c" xlink:href="wst-20240630.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d60810aa-54f3-4569-8ac2-90ea54511a52" xlink:to="loc_wst_SeniorBNotesDue2024Member_5097143e-b1cf-4eb0-9556-e42410a1992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_95850e01-decc-4c14-a183-5cc2135ccc05" xlink:to="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8ea53f0f-8e75-4319-b8c3-ce5f8455eeae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8ea53f0f-8e75-4319-b8c3-ce5f8455eeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_43de93c4-86f9-4751-a064-70384c9d0d80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_43de93c4-86f9-4751-a064-70384c9d0d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ee4d976-98f5-4a1b-b35e-2447be5f5511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b413a7d5-ca8d-4012-888a-337bd8cc4593" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ee4d976-98f5-4a1b-b35e-2447be5f5511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex31articlesofincorporat001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDNKV2?=<2LC I\Y' &T8   ]* )/B)_R3?Q)_P!@V?\ ] -8?AW2BL^G2/\
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M;NH](L$N+?7+R.&5;9 \2AL!5.,@ <8%=?=Z):7FM:?JS^8MW8"18F1L!E<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5T&/_"-Z7+HT;-_$=[DL/K$EO^= '6:=XYGU2UM+JU\(Z^UK=(DD4Q6W"E&
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MW=7<ODVUK:J#)*P4L<9(   ))) &*SH_'%JEGJ[W^FW]A=Z5:&]N+.=4,C1
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB !EFD)]]K>E==3%AB69YEC02N &<*,L!G )[XR?SI] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^)?%
M&E>$])?4=6N1%&.$C7!>5O[J+W/\NIP*V*X[XG6EM)X UN[>WB:XBLI%CE9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?7BGT4 1);01V_V>."-8<$>6J +@^W2B.UMXK?[/'!$D."/+5 %P>O'2I:*
M*5QI-C<Z>;!K=%M2RL8HQL!PP;MVR.:MNBR(4=0RD8((R#3J* &B- S,$4%@
M 3CJ!TJ.2TMIHDBEMXGC0@JC("%QTP.U344 -\M/,\S8N_&W=CG'IFG444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !112%E#!2P!/0$]: %HI%97&58,/4'-+0 4444 %%%% !1110 4444 %
M%%% !12*RMG:P.#@X/0TM !1110 44C.J#+L%'J3BEH **** "BBB@ HHHH
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MPON4JP;C(QC@8QBHU\!0P7%M?6FLZC!J<1F,E[^[=Y_-*E]RLA4?<7&T#&*
M.7?Q+KGB&#PU-#=6MO*GB&6RF(MI52?9%(5;87#*I )*-D[MISQ@Z.G>(KXS
MKH^CVEA:7E]J^I*9I(W:-$AE.^0H&!9V++QN R2>.E:Z?#^TAT]+>#5=2CFC
MU-M4CNBR/()F4JV<J000S<$=ZFD\#V81'M;Z\M;V*^N+Z&[C*%XWF8F1<%2I
M0YQ@@]!SD9H Q;GQEK]M)_9/D:<^L1ZQ#ITDI5Q \<L+2+*%W;@0 ,KD]#SR
M"-_PUJVJ76J:SI.KFTDN=-DBQ<6L;1I*DB;A\C,Q!'(ZFF6_@BQB\B66\O+B
M[345U*6ZE9=\\JH4 ;"@!0IP H&,#WK5L]'@LM9U+4XY)#-J'E>:K$;5\M=H
MV\>G7.: ./\ %OC34=&OM3CM=0TB+[# )8[-[>6YGN/DW'=Y;#R1V!(/KTJP
M/$?B/6=9FLM%&F6L4>F6U_YEW$\IW2[_ ),*R\?)][MSP<\7K[P+#>7&K^7J
M^HVMGJYW7MK 8]LC; A(8H67*@9 -:.E>&;72;Q[J*>>21[&WL6\PC&R'=M/
M ')WG/;IP* .<TSQ=K7B@Z9!HZ6%G++I46I73W4;S*#(2JQJ%93U1LL2<#'!
MJ_\ #+S?^$!L?/14F\ZZWJIR WVB3(![\TL/@.WL+?35TO5M0L+BQLQ8_:8O
M+9IH0<A7#(5R#D@@ C)]:VO#VAV_AO1(-*M99I882Y5YVW.=SLYR<#/+&@#C
MK#Q=XD_L/3O$>H1Z9_9MS>);26L,3B5$>7RED#ER"=Q!*[>G?-.E\8Z\N@77
MBV./3_["M[AU^QF-_M#P)*8VD\S=M#<%@NT\<9S2^$O MS%H>F1ZU?7_ )=M
M<-=#2W:,Q+*)&9"2%W$#A@N[&?RK4E\ VDOG6O\ :=^NC37!N9-+!3R6<OO(
MW;=X0MR5#8Z]N* ,NY\:ZI;^+)=.N9]-T]%O5@AM+ZWEC:ZA)'[Q+C/EECDX
M3:>F"<U?\#2:I+J7BHW]Y#/$FKO'&JQL"N(X^Y<_+@K@8Z@G/.!8OO!$6H3W
M"3:QJ)TRYN5NIM.+(T;.&#8#%2ZJ2H.T,/;%:>EZ!'I.JZI>P7EPT>HS"X>V
M?:423:%+*<;N0HX)(XH P+KQ!XBO9M>N=&734LM&E: Q74;M)=.B*[@,& C'
MS  X;D9KAO$[WNOWFO:_!)IXCC\*Q7EKY]HSRP1RK,2$;S $DX.7QZ<<<^CZ
MAX*BO+K4'M]7U&PM]3YO[:V*;)CM"D@LI9"5 !*D9QZ\U+=>"M,N8]2B5YH8
MK_2TTIHXB (X5#@;<@\XD/7(X'% '&VFHKX*%[#;:3I?VJ'2K'RVM86@662:
MXDC16&YL*"02>I)8YY &[K7B+Q)X3TFZNM633;T-Y,=I-;1R1*)I'";73<[%
M1D-D') (QFM6^\%Z9J,EZUR]PPN[*&S8*X&P1.SHZD#(<,V<].!Q5:3P);WT
M5U_:^JZCJ-S-&D4=Q(R1O;A'#J8PBJ P8!MQ!)(';B@"#PKXKO-4UV?2KN2"
M\06WVB.]MK*:V0$,%:-ED)YY!!!Y&>!BG^*O$EYI>K0V-MJ6E6(:#S0;F"2Z
MFE;<1M6&-E8+Q][GDX XK6TC0)=.OY;^\UB_U*Z>(0AK@HJH@.<!$55R3U)&
M:@U#PK]JUV75[35K[3[BXMTMK@6XC(E12Q7[ZL5(W-R,=: ,#2?&6M>)X=%M
MM+2QL[R[L'OKJ6YB>5$"OY85$#*26;)Y/ '<UF^%]7UJ"TMM$LULH-5U#5-4
MEGFF1I8H%CG._:H*EB6=0.1QDUTEOX!M=.LM,BTO5+^QN=.CD@BND,;NT3MN
M*.&4JPSC'&1CKURL/@&TL["TBL]3U""\L[F>X@OMR/*#,Q,BMN4JRG/(([ ]
M10!RNFZQXATB._@@CTYM4U#Q6]G(TBN85!M@V\ '/\ ."?49[U;O_'NKV^HZ
MA8I<Z;'<:4B1RJUA<2B\G,8=@A0_NE^8 $[CGMBNCL? ME9"%FO[ZXECU4ZL
M99G0L\QB,9!PH&W!)P,8/3CBGZCX/6ZU&^N[+6=1TS^T%5;V.T,>)L+M##<I
M*-MP-RD< =QF@#G-6\?ZG!+;S+]CT:TGL8;J!]4M)F2>1P2T32J0L)7@'<">
M<XQ4OB#QOJFF:N\/GZ7IUL((I+:2^@E>"]9AE@+A2$C /&2#ZXQ6[?\ @Q;G
MS$M-:U.QMY[9;2X@C=)%DC4%1_K%8JV#@L",]^>:BN_ D$T,MI::QJ5CI]Q;
M):7%G$R.CQJFP ;U8H=O!*D9Z]>: -/Q+KIT'PQ<ZLD*SR1J@BC#X5W=@BC=
MZ;F'/I7-ZKK'B?3'?2M0N-,>>_L+B:UNK:WD00R1*"R,ID)8;6X8$<CD5U=_
MH5AJ/A^31)XC]A>$0[%8@JHQM(/4$8!!]167;^#D^U/=:EJ]_J=R+62TADN?
M+7R(WQNVA%4%C@98Y/% %7X>Z8^G?#?3%MEL(;BYLXYP\-L50NT:X:1=V7;I
MN.1G':N*T"3Q!<Q?#Z2.\LY+Z:UOBMQ<1.P1"(\EQOR[9SW7J/3GUK2]/BTG
M2++386=X;2!($9\;BJ*%!..^!6%HO@BTT633&2_O;A=,\];1)BF$CE"Y0X4$
M@;>">>3DGC !SUQ\0M1M;&"SN191:J^IW&GO=""62!5A&XR"-27)(*@+GJ>N
M!71>#O$=SKRZA#=JCR64JHMU%;R0QW",N0RI)RI'((R>1UYHG\$63B22"]O+
M:\_M"348;J)EWPRNNU@ 5(*$<$$'-:>BZ-_9"7#27]W?W-S)YDT]RPR3@  *
MH"JH Z "@#E=,T?3_%WB?Q+<^(+2*_%A?"QM;6Y7?'!&(D;<$/&YBY.[&> *
MF9V\*Q6/ASP[=)<7%_?R1P"\<RQV"!#(RX4AB% ^520?F'.!6KJ/A/[1J\VJ
MZ9J]]I%[<(J7+6OELDX484LDBL-P' 88.*A'@/3HM+@MK>ZO8;R"[:]341(&
MN#.P(9V)!5L@E2",8XQP* ,6_P#&7B#3&N]*>'3I]8@OK*W28(Z02QW+%58K
MN)4@JV1D]/>K<.I^-+K7+_1H9]#6:PM89I+AK:4K*\A?"!?,RHP@^;)QZ'/%
M^/P-9G,MU?WMU>R7UO?37<A0/(T)!C3"J%"#T '4\Y-4I_"^IWWCG6K^/4[_
M $NVN+.VA26U,9\['F;QAE;!&5PP (R<4 0:7XPUCQ;):PZ$EE8L-.CO;J2\
MB:8*[LZB)55D[QOEL],<5!;^,O$6M76D6&F6^FVMW<Q7GVMKE7D2*2WE6-MN
MUERI).,^H/;!W&\$6MLUI)HM_>:/+;6BV6^VV/YD*G*JPD5@2"20W7D^M6-+
M\'Z;H]UIMQ:/<;K"WG@0.X;S/-=7=W.,EBRYSQU/% '*:YX_U'2;V[D2]TB5
M+6\6!M.A@EFE,9=5+-,K;(VYSM*\="<U5O[W4K>Z\:27S6=_:1:M81QVTL4F
M$W&WVD'S.,!LX Y<9Z';70W/PZMKFQN]-_MK4X]+N+EKK['&8@J2,_F'YMFX
MC=S@DCZU<OO!%I?WVJ3O?WJ1:E);S3VZ%-@EA:,JX)7(R(U!&<8)[T 95WXJ
M\0O8:YKVGQZ<-*TB>>,VLT;F:Y6 D2L) P"'*MM&UNG/6H[SQ9XCN9/$EQI(
MTN.QT:*.=!<PR,]PK6ZS%3AP$/)^;!ZCCC)U;WP);7<E_$FJZA;Z9J,IFO=/
MB9!'*S??^8J74-CY@K#//3)K0/A:RV:\BR3*NLH$F"D 1@1"(;../E ZYYH
MR-5NYM-TBX\7:59-+>ZC!9K*OE-*(8@2=Y1/F?:)&) ZX'3FKO@WQ!+K]K=M
M)J.F7X@E")-9(\1P1G$D3DM&P.>I.?:K]WX?BNM M]*2\N[;[,(O)N('"R(T
M>-IZ8/3D$$'TIFB>'4T>[OKZ6^N+Z_OMGGW,X1250$(H5%50!D]L\]: .<O_
M !?K5EJ?B>Y:.P&B^'^9$V.9[C-NL@4'=M7#,!G!X/3C)J:;\0;Z.]@&HM;7
MEO-;332?8[&>$VC1QF3:S29#@A2,_+SCCFNO_P"$8T]SKHG#SQ:VP-U$Y&W'
ME+%A<#(&U1^-4;/PB]K)')=:SJ.J);0/#;6UXZ+& R[3OV("YQQEL\9[\T 9
M-MXC\4QMX:N[U-):RURX1##%'()+96B>11N+D.<+R<#!['/&1;>,+[3?#>BM
M;PV.CZ?.MRTEXUC-<01NLQ"H51P4W<L68XZXHT?PWJT^L>&XWM-<M;32)C,\
M5_<P200*(V01PE/GDY889^BCMG%=5#X)6QM;*+2M;U*PDM4EC$B&-Q(DCER&
M1U*Y!/! !'O0!@G7-4G\6>'M2>_L#9'1+JZN([3?-&^QHMY1MP!/3:2./F!S
MGAFA_$/4=0N]'FF%K-;ZG*J-9V]E.LEF'&48RM\D@' ; 7KD9 KHK;P'IUD=
M(^R75W$--CFA(RC"YCE8-(LF5_B89^7'?%+IO@I--EL4&MZI-IVGMNM+&1T$
M<?!"@LJAW50> S'MUQ0!S0\>>((/#$>NWD>EK%?7?V&RB2*4F-Q*RF20@DE=
MJ,=JC/ YYJ5/B%J%O::G$\=OJ%Q"+<6=U%:S6L,KS2"((ZOD@JQ!."<@]C72
M_P#"%Z?_ ,(Q#H0GNECMYS<P7*N!-%+YAD#J<8R"Q[8QP<U&?!<%W9ZA#JVJ
M:AJ4M\B(TTKJAB"'<AC5%"J0WS9QDD<^E &5I<>LQ_%0+K$UE._]B/Y<MI$T
M0(\],@JS-R#WSSGH*U-1U;6KSQ3-H6AO8VYM+1+JXN;R%I02[,$155E_N,2V
M?3BI]*\*G3]=;6KK6+_4;XVIM-UQY:J(]P;A450#D=>^3[8?JOAD7VK+JMEJ
MEYIE_P"1]GDEMA&PECR2 RNK#())!QD9- '!7USJ7C37?"9ECTN,J;])+6ZM
M7N(EN8&",V-Z[AW7H5R>3GBGX.N(O#VE^'M2N[+3YI;FUU&]ENHK=DGQ&JL<
ML7.]CSDD=,  8R?1]/\ !^FZ9+H\EL]P/[+2=8]SAC*9B"[.2,EB1G(QR345
MIX'TRTM])@,D\T6F03V\:2%2)$F #[\#GIVQ0!FP^(/$UCH:^(]5ATV;2VL)
M+V6"V5TEM@(]ZKN9B),_=.%7!.>E4_#WCK4K[6-+M[MK6ZBU$,'2UL9XC9-L
M+#<[Y61>-N0%Y(XQ6O:^ K2-8+>^U/4-1T^VA>"VL[EDV1(Z%""54,_R$J"Q
M. ?7FK&E>$6TZ[LY9M=U2]@L4*6EO.Z!(P1MRVU09"!P"Q./KS0 SQ!>BU\6
M^'H_LL$CR)>,LL@.^+;&#\N#CGH<@_A6+HOBSQ)/;^%=3U--+^PZ\RQ>1;Q2
M+)"S1-(K;RQ# [#D8&,CDXS77:AH=OJ6J6&H2R2K+9+,L:H1M;S%VMGCT'%4
MX/"5E!I?A^P6>X,6AR));L2N7*1M&-_'/#D\8YH Y[XIQVLT?AB.^TZ34;9M
M87S+2.,2-*/(FX"DC/K^%9%L8O#&HW_B72?#-[HFB6.ES&ZMY@L0NYLJ8PL8
M8X(PWSD#[V*]%U71;?5KG3)YY)4;3KH7<00C#-L9,-D=,.>F.U6=0L+;5=.N
M=/O(A+;7,312H?XE88(H X/2O'6IR:C;VUR]I>"ZMY9,VMC<0BTD1"X5FD)#
MJ<$9&TYQQS4VB^*O$<W_  BM]JB:8;+Q H40VT;K) QA:56W%B&!"G(P,9')
MQSLV7A!H)HWO->U6_2"!X+>.=T"QJPVDG8HWMCC+9_/FK$/A2RAL?#MHLUP4
MT(H;8DC+[86B&_CGY6)XQS0!S&E^,/$L^G:%K5ZFEC3]2OELFMHHI!*FYV19
M Y<CJ =NWH>M/T[QKJD_BE-.O9]-LG>\D@_LRZMY89O+!8*\<Q.R4D!3M5>A
MZ\5T$/@ZQ@T/2M)6>Y,&FW:7<3$KN9E<N W&,9/;%5QX(B:[MS/K&HSZ?;7@
MO8+&5D9$E#%E^?;O*ACD M^G% %.R\8ZA=0Z98F"V&M2ZI+8WD05MD:0Y:1P
M,YP4V$9)YD7K67X)UZ72=+T*TNQ"FF7BW^V<@ADFCGD?!.<;3&'/3/R&M?P_
MHDDWCG6?%%QIT]CYL:6UO%.REF( $DN%) W;(U'.2$YZU8O/ &E7WA"/PU--
M=?98YFF657 E!9V9AG&,$.R].A/UH R)/&>K-I.D74UWI&DG4HY+E#<0R3R>
M7N_=*L*N&8E""S9P#QCFF6'C;7M9L_#L=C#I\5WJ<UY!/+-%)LC,!(WJFX-S
MM^Z2#SC(Q72ZCX52ZUB#5;'4KO3+J*U^QEK98V#0[MP7#JP!!Z$5#I/@C3]'
M?36@NKR3^SIKF:'SG#%C.27#'&3@DX[^N: ,*/Q#>7MSI%OJEG8S7MMXCDT]
MYHT<*"MO(XEC!;*L00,$L.3[8@7Q_J*:S8(U[I%S%=:BME)9VD$LC0*SE0QN
M Q0L.,C:.X%=0/!M@+Q;GS[DLNJMJN-RX\UHC$5Z?=P<^N>]9UO\.K>"UTZR
M.MZF]AIES'<V5J3$%C9'W*"0FYQU'S$\'UYH T/%]TMJFB;K6"?S-7MHQYH)
MV$L?G7!'S#MG(]JP=+\:ZI<^*(].OI]-LI'NY(3IES;RPSB,%@KQS,=DI("G
M"J.#UXKL-6T>#6%LA/)(GV2[CNT\LCET.0#D=*QE\$1?:[8SZQJ-Q86MW]MM
M[&9D9(Y0Q9?GV[RH)) +>G4<4 6O$NLWUC<Z3IFEK;_;]4N&BCDN5+1Q*B,[
MN5!!8X7 &1DGK65JS:S=:=:Z%K*VK3WVIQVXFM052>V0><[%"24RJ,A!)Z]>
M:Z#7-!AUN.U)N)[2[M)O/M;JW*[XGP5/W@000Q!!!!!JCI?A"#3M7759;^[O
M;W$IDEN"OSNX0;L* !A8PH   !/<YH P)?&.O#0+GQ:D>G_V%!<.OV,QO]H>
M!)3&TGF;MH;@L%VGCC.:]"KDI/ -I)YMK_:=^NC37)N9-*!3R6<OO(SMWA"W
M)4-C.>W%=;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBCN>U6*\>T/3XK/P1X0U6.6Y:_U#5+,7,\D[L9%#MA<$X  XP!VI-,N(=/\
M$UC=M<0:G]IU>2!+VVO9(KP,SN/+GMW&&1>A Q@*"!0!ZII&K6NMZ:E_9ES
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MF7,UY&8DT_?,JF>4,!(7QD\\[>,^U '<:EXOT;2Y](BGN2?[68+:O&NY2"5
M8GLI+H,^K"MVO'Y=#U+Q#+KMMHNG6<^EVMHN@V$US>M$\/DX+.H$;;B) O.1
M_JA7H?@[6W\0^%K*^G79=[3#=Q]TG0E9!CM\P/X8H FLO$VE:CJ^I:997'VB
MYTU$:Y$0W!2V["Y'5OE.1VXK+C\?:<VI65A+IFMVTU[*(8/M.G21JS=>I'0
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MIMA%<BYCLK9)P"HE6)0P!Y(SC/<T2:982W+7,EC;/.R[6E:)2Q'H3C.*M44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEO8U10[!/+"F(#84V]B,YYSFM7P]X?CT&*\/VF2ZN;VX-S<SR*J[W*A>%4
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MVDCM(]E#? ,A'[J7=L/U^4\5YA$\VG^)6L42*TCNM#O))K:/5Y+TOM";'DW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2VMO)<,8O^>A$:L0O^T>*9=^-- LUM"]\93>0_:+9;:&2=IDXY4(I)ZC_(H
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M(ADE,JJ0&P$4G(W#(ZCGT.$7QWX<:\:U%^^Y+DVDDAMI1%',&V['DV[5;(P
M2,\>HH U[/2-,T^6:6RTZTMI)CF5X8%0R?[Q Y_&FVFBZ5IYF-EIEG;>?_KO
M)@5/,_WL#G\:SK_QKH&FW\MG=7S+)"RK.ZP2/% 6Q@22*I1"<C[Q'6I)?%VA
MPZXVC/>G[>F/,C6%V$8*[P68+M4;><D@?E0!J"SM56W46T(%M_J $'[KC;\O
M]W@D<=JBBTC38-0DU"'3K2.]E&)+A(5$C_5@,FLFR\<:!?W,<%O=3EY8VE@+
MV<R+.JC+&)F0"3CGY<Y[50\.^-E\10:-<*8K7[;+<(]O-#*';RP2/+8@#@8)
M)XZ@<@B@#I(M&TN#4'U"'3;..]DSON4@42-GKE@,FI1868@6$6D B23S53RQ
MM5]V[<!Z[N<^O-9%CXUT#4K^*SM;YFDF9E@=H)$BG*YR(Y&4(Y&#]TGI45MX
M\\-W=Y!:P7[,T\WV>.3[-*(C+DCR_,*[0W!^7.: -R6PLYVD::T@D:5560O&
M"7"G*@YZ@$DCTI396K)<(UM"4N<^>IC&)<C!W?WN !SV%9">,M"?51IRW;^<
MTYMED-O((6F&08Q+MV%L@C&[.1CK5W6-=TW0+:*XU.Y%O%+*(8SL9MSD$A0%
M!.3M./7IU- &)KWA"\U>]ED@U6"&WEC$8CGL$G>WXVDP.2/+)'J&&>:Z.QL+
M?3M+MM.@7_1K>%8$5N?D50H!]>!7/?\ "QO"X1G:_F0(_ES![.93;G( \T%,
MQ Y&"^ :MZIXST+1KN:VO+J426ZA[@PVLLJP*1D&1D4A..?F(XYZ4 7[30='
ML"#9Z58VQ#^8##;HF&P1G@=<$C/N:L+8V:0P0K:P"*W(:%!&-L9 P"H[<$]/
M6J\6N:9-+?1QW:%K%$DN." B,NY6ST((!.1GH?2L_P 0>(OL/@2^\1:9LF$=
MB;NW\U&"N-NY<C@X/IP: )=$T&73M1U'4[Z]%[?WI13*L(B5(DSL0#)Z;F).
M>2>U:MW9VM_;/;7EM#<P/]Z*9 ZM]0>#61I7B_1=7F:"VNR)EA\_$T+PAX^[
MH7 #I_M+D=*-+\8:'K-XEK97;M+*A>'S+>2)9U'4QLZ@2 >JD^M &G%IEA;V
MT-M#8VT<$#!XHDB4+&PZ%0!@'W%6)(TFB:.5%>-P596&0P/4$5FZAJGV/6=-
MM&N+>-+D3%HW1R[A%!^0C@8ZG/7M5'3/'7AW6+NUMK&_:1[M2UL[6\J1S8&X
MA790I8#J <C!XX- &E;:%H]D@2TTJQ@0;L+%;HH&X8;H.XX/K5J&SM;=P\-M
M#&PC6(,B $(N=J\=ADX';-8\'C/0;G4TT^*]9I7E:".3R)!#)(N<HLI78S#!
MX#9X-);>-?#]WJ,=C#?,TDLIABD,$@AED&<HDI78S<'@,>E &O-I]E<"<3VE
MO*+A DV^,-YBC. V1R!D\'UJ.STG3=."BQT^TM=BE%\B%4PI.2!@="0#^%8C
M_$+PO']K+ZF5CLV*7$IMY?+C82"(J7VXSO8#&>ASTYJW:>+]#O(;R5;PPK91
MB6X%U"]NT<9SARLBJ=IP<'&* ---.L8XX(TLK=4MVW0JL2@1-SRHQP>3T]33
MVL[5C.6MH3]H&)LH/W@QC#>O''-8UIXUT&\CNG2[EC^RVYNI%N+:6%O)')D5
M74%E]U!J)/'GAV6R6[BO)I8GE\F(1VDS-,VW=^[4)EQCG*@CWH U(-"TBUMV
M@M]*L8870QM'';HJE3U4@#&#W%7);>&>W:WFACDA8;6C=05(]"#QBN2U/XAZ
M7:V&G7ED)KJ*ZU!;&0"VFWPG^,,FS<&'&%(!.>,UIW7C/0;/47L9[UEDBD6*
M6002-%$[8PKRA=B$Y'#$=10!IV>EZ?I[3-96%K;-.VZ4PPJAD/JV!R?K4=IH
MFDV$ADL]+LK:0L7W0VZ(=Q&"<@=<'K6%XJ\=Z9X>L=51)]^I6=J\H3[/(\22
M;"8UD=1M3<<8!8$Y]ZVSJT%KX=&L:A(L,$=J+B=PI(1=NYC@9- #[71-*L9Y
MI[33+*WFG!$LD5NJ-)GKN(&3^-3PV5I;,C06L,3)&(5*1A2J#HHQ_"/3I5>Y
MUK3[2X@@GN DMQ#)<1+M8[HXPI<\#MN7\ZSM,\;^']8OK>TL;YY);E"]NS6\
MB), ,ML=E"L0.H!)'/I0!I7&C:7=V2V5SIMG-:(=RP20*R ^H4C'<TMQH^F7
M=BEC<Z=9S6:8V6\D"M&N.F%(P*YC4/B%IQO]+M-)F%P]WJ26C.]O((W3D.8Y
M" KD$#H36M_PF>@C5/[/^VMYHG^S&3R)/)$W3R_-V[-^>-N[.>.M &A<:)I-
MW8QV-SIEE-:18\N"2W1HT^BD8%(^CV3W6GSB%4.G[_LZ1J%5-R[3C Z8)&!Q
MS[#%6U\5Z->ZY+HUM=/+?0LRRHL$A6-EZAGV[0?J>>U8^N>-_P"S-<U32(;9
MFGM-(DOTD>&0HT@#$*2!C;A>N>2<=10!UKV\,LL4LD4;R1$F-V4$H2,'![9'
M%1K8V:0P0K:P+%;D-"@C 6,@8!4=N">GK6#X=\;:3KJV5NER1?7%L)PC6\D:
M28 W^6S#:X!/\)-6+#QGH.IW\=G:7K/),66!V@D2*<K]X1R,H1\8/W2>E &D
MND::FI-J*Z=:+?,,&Y$*B4CTW8S^M-N-$TF[M8K6XTRRFMXFW1Q26ZLB'U (
MP#61XPUC5=*&C0:1]C%SJ.H+:%[N-G1%,<CYPK*<_(.]5+/Q#K.F^*8]%\1/
MI<B3V4MXEU9J\0B$94-YBNS8&&X;/8T =)-I&FW-FUG/IUI+:LY=H'A5D+$Y
M)*D8SDDYIT6F:? D:16-M&L<GFHJ1* KXV[AQP<<9].*R].\9:%JLQBM;N3?
MY1G3SK:6(2QCJ\9=1O R.5SUIFF>./#VL7MM:V-\\DEVI:W9K>5$FP,D([*%
M8@=0#D8/H: -D6%F((X!:0"&-Q(D8C&U6!W!@.QSSGUKD[[P)/J6H2&\U6*:
MQDN%F96L5^TE0X<1>?G_ %8( QMS@8S6A9>//#>H7=M;6U^SM<OY4,AMI5B>
M3GY!(5V[N#\N<U-#XRT*?4UT^.[D,KS-;QR&WD$,DJYRBRE=C,,'@'L: -J:
M"&YC\N>*.6/(;;(H89!R#@^A /X4AM;<RRRF"(R2H$D;8,NHS@$]QR>/<UGQ
M^)-(FTRSU&.\#6MY,L%N^QLO(S;0NW&0<@@Y'&#G&*SO"/BN/7].LQ=/%'J<
M\#W!@C1@OEK*T>X$Y[@9&<\^XH UYM#TBY>V>?2[*5K4!;=GMT8Q = N1\H^
ME3PV%G;NCP6D$3(K(I2,*54G<0,= 3R?>LB7QKH,4$$RW<LXN#((4MK669W\
MMMKL$12VT'C=C'O39/''AV*QL;S^T"\5_O\ LHB@D=Y2APRA%4MN!_AQGKQP
M: -2XT?2[NT-I<Z;9S6Q<R&&2!63>226VD8SDDY]ZD33K&-$2.RMT5)!*H6)
M0%<# 8<<''&:QT\56.H?V3-IM_ 8+R\>U99H9!(S*CL4 P"C@KD[QT![D40^
M-_#]QJ$5G'>2%YIC;Q2FVE$$D@R"BRE=C'((P&[4 :#Z!HTEU-=/I-@UQ.-L
MLK6R%Y!Z,<9/XU+/I&FW5[%>W&G6DUW#_JIY(5:1/]UB,C\*N44 5)-*TZ:6
MXEDL+5Y+A!'.[0J3*O\ =8XY'L:CAT32;>W-O!I=E%"5"&-+=%4J"2!@#& 2
M3CU-7Z* ()K.UN&9I[:&5FC:(EXPQ*-]Y>?X3@9'0T2V5O*$_=(KQHR12*H#
M1 C!VGMVZ>E3T4 <;IO@>>WU>ROM1U.WNQ92&6/R;!8))I"C('F<,=[!6;H%
MY.:Z;3=-M]*M6M[92$:629LXY9W+-T '4FKE% !1110 4444 %%%% !1110
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MDYZ9J<:)KEQ)J&H:?I6J1WT6ERV]L^N7J3%I7*DHJ!F4K\H.6(&<<8S7J%%
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M1;[B:9 H1=C$;1MSN)&215O6K#6X-/\ #,%I;WHM+> QWPTTPBY1A&H0*7.
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M X.X $ \GG'6NZHH X:^\-ZA=IX2@2(Q+:64]O<R!A^X+VWECOS\WI6'X?\
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MXHO!H?VZPU9KRTU6"XO-]S#'9HBRY)AC1AN&.1D9QGOP?7:* "BBB@ HHHH
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M*_G3)&?G=.,# ['K@]*V-+\%VNEWFEW4=W/++9?:FD>4 M<27#*SNQ&,'*]
M,<^U8.G>#=2U)?$%K?ZE=6NE7VK7$DMEY*_OHBP/RN>55@,'KGG&,F@#1N?%
M6MW3ZS=:)86,VGZ0YCD^T2LLERZH'<)@87 8 $YR?2C3_%VJZ[KS0Z18VC:9
M%:6M[)+/(RRM',A8*@'&[ [D#\^+%]X+FEN-3&G:W<:?9:J=U[;1PHV6*A&:
M-C]PLH /7ID8-6[7PA8VCZHL4DB6U_90V/E*<>5'&C(-IZYP_P"E '.:?\0;
MVXU_3-.EDT*9]09XC!8W9FDLY!&S@2,/E;[I4XQSTS5#PWKMZEAX9N-<V7,D
MM_J.VX6:3=&J+.22,X;[I4 Y &,<BN@L/ D]K)H1GUR6:'1) UK"ELD2%?+:
M/Y\=6PW48[\<U)I_@2*SEL1+J,MQ:V-W<W$$#Q*,+.KAD)'49D8Y_"@"K:>,
M-:^RZ-K&H:=9QZ/J\T44212L9X!-_JF?(VMG*@@8QN[XJO!XVUYK&#69=-L%
MTEM4_L]U69S,0;@P"0<;1AL?+WP>16C9>!GMQIEI<:W<W6D:7*DUG9O$@*E/
M]6'D'+A.PXZ#.<5:'@R >&8]$^UR>6FH?;O,VC.[[3]HVX],\?2@"'XARR1>
M'K1HW9&.JV*DJ<'!N$!%;FN7\^F:+=7MM#%--$FY4FG6%.O5G;A0.I/H*K>)
M]!_X2/1_L(NWM'6>*=)D0.5:-PZ\'@\J*R;WP=J>KZ5=:?J_B>>\BE\MX_\
M0XD\N1'5U8@#YAE0"IX(H PT^)-XO]K(G]D:HUC8C4!-ILS-&8UD"R*<Y^8+
MD@@X/M6A>_$9+35]?MOLJO;:?9&>VF5O^/F550M&/QFB'U)K4LO",B:Y+JVI
MZH]_+-8-8/"8%CB$98-\JCD=\Y)SGV%9EM\,-.@TO0[)[ZYE.EWANC*X&ZYR
MP;8_ME8_^^!0!VMJT[6D+7*JEP44RJARH;'('MFI:JVEO<P2W33WKW"RR[XE
M:-5\E, ;!@<C()R>>:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@$N3W. :R8?!NMZ'X+\0>&UL1>R7EO'<0W<' +_*K0'<<X3;\G;;QU'/KU%
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MSZW10!E:3+<0QVNG2V,Z"&RB8W!V["^,%.N=PQGICD<UJT44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9&M>*-
M'\/2V\6IW9ADN S1(L+R%@N-QP@/ W#\ZUZXW6=*74_':/;^)Y]-OH-+(%O!
M A?RVDR7W2*R[<HH( S\HY&: .IL+^WU.QBO;1V>"491F1D)&<=& (_$59KF
M_!.MW&L^%K*ZU":%[N1YHQ(@"BX$<C()%7T8*&XXY]*Z2@ HHHH **** "L+
M5/&&B:/?-97-S-)=(H>2&UMI;AHU/0N(U;:/KBMVN*\#2PP7_BNVN71-1769
MYIE<X<Q-@Q-_N[-H!Z<&@#K-/U&SU:PAO["XCN+69=T<L9R&'^>,59KS:_U;
M2M1BTVQ\.Q:@8KR]NW%MILHM%NS&?WDAFW A-S9RIRQ]JQ;+4]1N=-M=/N-9
MO+2-?%K:<SI?F200_9V;R3-P6^8XR>0<8.0#0!ZW>7UO8)$]R[*LLR0IA&;+
MN0JC@'')ZG@=Z6VO+:\,PMITE\B4PR;#G:XQE3[C(KS.[O[[2M6O=(L]2O9+
M&VUK24C>6X:1T\Z0>;"7)+,N IP2>'QTJO9^5I.D:Y%#>:OY][XF>SCCMKHF
M24YW! [MB/<,Y<$' ZYQ0!ZCJ.I6FDV1O+Z;RH Z(7VEOF=@BC !/+,!^-+?
MZA::7837U]<);VL"[I)7. HKQZ[NKY+/Q7I-RUPD-I<Z1)';7%^UX\#/<C</
M,;GG:IVY./QKT?QRNER>%9X=8N)K6SEEA0W,0Y@?S%V.<\ !PI)/'K0!-I7C
M#1=9OA8VMQ,ETR&1(;FUEMVD0=642*NX<]LUK6=Y;:A;+<VDZ3P,659(SE25
M)4X/U!%<(TVK:?XET*QUR[TS6XKUY8K2\@A,%W;DQ,2X"L05*@@LNW&16!X6
MA;^RO">B#4;^WL-1FOY;AH[MU>1XWPD2OG<@(+,0I&=I]30![#52[U*TL;FS
MM[F;9+>RF&W7:3O<*SD<#CY58\^E>:'4;\:JWAD:O>G2?[>6R^W^>?."&V,I
M@\W[V?,^7=G=CC.:9XE^UZ7J&E6?AZ^DUB_M=8<06U].S?9W:SD.QI6R6 SN
MP3GG&: /6:R]:\1:;X?2)]1DG19<[#%:RS=,9SY:MCKWK/\ !=];W/A:RN?[
M1N+J:X9O.>\?]X)\G?'MZ)M((V#@8_&M^Y_X]9O]QOY4 <Y:?$/PQ?6DMW!?
M3FVBB$S3/93HFPL%!#,@!Y8=,UU%>4.K-^S=:*K;6.FVX# =#O3FIO$%SJ7@
MR_U=-*U#4+K/AZ>]"WEPUQMFCD11(-V<<.20,+P.* /4:*\V\.-J]CXGT:-I
MIEM;ZWE,RW>L_;#<X0,LL:G[I!QG;A<-TX%:OC"X>YU[3='M_P"U+B=X);AK
M.QN_LBL@*KODE#!@ 3@*N<YR>E ':45Y#H.J7^L1:'H]_JMW'93:CJ,,DT5Z
MWF2>2W[J'SQAFX+'(P6"4MM?W37D^B_\)!?R:9+XF:Q>]-T?,2);576$2=5S
M(-N0<GGG)S0!Z[17D&H7%[:77B#2M/\ $6HM##JNE6T4ANFDDMUE<!T#$DGK
MWSZ'.*NZA!J@\72^'+9]4NK*PT^.>%?[:>VE=G=]TC2?>DVX"@$X'<<T >I4
M5Y;HEW?^([W1M-US69DA&E27(DL+TQ?:Y%F*;C)'C=M0*2!QER2*J:9JMSJ.
MB:/IW]HZQJUQ<7NH%!;7@@:ZBBF90SS;E*J 5P$ZY'&!0!ZM<WEM9F$7$Z1&
M>40Q!CC>YSA1ZG@_D:GKQ:#SM8T_2H=0O;P_8_%S6<9747=D3RB=IE!!<@\!
MCR.1GDU)<ZGXCN[;7-;26:"YLM2EABGDU?R;>W6.3:L;P8VL&&,D@D[L@CB@
M#V6BN6^(-U>6O@:\FLKJ6TNO,MU6:)L,FZ:,''X$CWKD_$S7WAE_$MEIVK:F
MT9\.O>H9[MY7CF5RN]&8Y7([# XZ4 >JT5P/B;69X]?LX+/4)%5M O[EDBE.
M"0(O+<@=_O8/UK)L--NY+[P=%+K^M.NLZ=)-J ^W./-98XW&WG]WRQ^Y@D<'
MO0!Z3/J5I;:A:6$TVVYO-_D)M)W[!EN<8& >]6Z\?M8WU75?"UAJ&K7H$&I:
MO:).+AEGE2-BJH9 =V=H )!R0.M+>:QK,)_L&TO+NZL?^$@:P2Z-YY<KQB 2
M^3YYR0=Y*[OO';C.: /7Z*\BGN==AMKK26U&YLH_[9T^WC":C]IN;=)6Q(C2
M=<$8(W9//TKM_$+W/A;X>:G+IDMQ/<65G(\,MS(9I,@$[F+9+8Z\^E '35F:
M+K^G>(;:2YTR266!'V"5H'C5_="P&X>XR*XY[0:9KOAVSLM<U.]@UF*>.[$M
M^\AD00EQ.ASF,[@HRF!\_P!*T_A;;):_#312LDS>;;+*WFRL^TD=%R3M7CH.
M.M '8U5TW4K36--@U"PF\ZUN$WQ2;2NX>N" :\T\,WE_8ZSHLVJW6H7*ZC+)
M%'J-MJ7VFSOF*LR@PMS#@+D;%P",$XJGX5M9]'\)>!=4M]3U RW=Y%;30O<L
M8&B</\HB^Z,8&"!G(ZT >PT5XW=ZQ?%;#Q!8W&K&&XUF*%+VZU+9'/&UQL:-
M+525V[=PY ; W5;O;K5;/0/&7B.'5=0DO+/4+BTM8FN#Y,$6] 6V'Y25#,P)
MSC ["@#UFBO*DEUO2;NX@74#ID,^D7$I?4-7-Z4=0-EPN02J@D[L?+R..*TO
M!MQ=V'B2/3-235(+FYL3,BRZE]NMKC8RAI4=CO0_,., $'VH ]#K,U;Q!IVB
M26D=[+*);MS'!%# \KN0,G"H"< <D]!7/:DCZW\0)M&O-0O;2RMM,CN88;2Z
M>W,SM(ZLY9"&(4*O&<?-DUR^CB77/$/@V[O;^\N'CDU*".X2X=!/'#)B-R%(
M!W #<<?-CG(H ]<HKDO%DLUQX@\.:,;RXM+&_DG-P]O*8GD*)N2,.,%<Y)X(
M)VU@WUQ&EQ:>';'5]:UB07=S_HT%WY+A45"8Y+DL&(0R#H23D YVT >EU7O+
MZWL%A:X=E$TR0)A&;+L<*. <<]SP.]>26&IZA>:?INGW.M7EK%_PE4VGO)'?
M&1_*$#L(3-P6^;Y<]<XP<@&M&XU"^TS5[K2+34KR6QM==TR..22X:1U$I!DA
M+DEF7H<,3P^* /2[:\MKSSOLTZ2^3*T,A0YVNO53[CO4>H:E::5;+<7LWE1-
M+'"&VDY=V"*. >K$#\:\LL1'I>E:G:P7>L-<7WB>:U2&VNSYDVTLVS>[#R\@
M$LX(8X[U5DN[WR=<TNY>=8K+6=(,5O/?&[: O,A9?,;GL#C)QGK0![14%U>6
MUC&CW4Z0K)(D2%SC<[L%51[DD"L#QR;PZ%%%87L=M<37<2!&N3;FX&<F%95!
M*,P& 1_6N!U#;?:4-,NVUJTN++Q#IXEMKK4#*8%D=,!)E;+KC+ L=RD]N* /
M9**\RN3+?VWC#4KK7M0LKG19I(K1(KMHTMT2)61V3.)-Y))+@Y!P*6QGN?%%
MUJTVM:O?:4;#3[26-+6Y:!8#) )'F901OPY9<-D?)C'6@#T*WU*TNKZ\LH9M
M]Q9E!.FTC867<O)&#D<\5:KQF75KV/Q;J3_;)8_#]S/IXU#58&\J7#6Z[..#
M&C-MW,.0& &.2/0_&TMW9>%Y=1LIIDDTZ2.\98V/[R*-@9$/J"F[CZ4 ='56
MQU*TU+[3]DF\S[-.UO-\I&V1<97D<]1R.*\G'B76+S4KVUCU&X\OQ1,@T=DD
M(\B))VBE9#VS$%DX[G-+<VD]EH'C3Q!:ZIJ,%Y8ZS/);I%<LD0VLF=R#Y7SD
M@[@>.F* /6;>^M[JYNK>%V:6U<1S HPVL5##!(P>&'3--O=2M-.:U%W-Y9NI
MUMX?E)W2,"0O XZ'D\5YUJNK:BVO:IIW]I75O:7'B&TLGE24JT$+6BN51OX-
MS@#(QRY[FF^(]/@CN+#1;77[^8)K]IN1YFDELPT4AVK*V6.0,C))7/TH ]1K
M.OM>TO38KV2ZO(T6Q1'N< L8@_W<@ GG%87A19K'Q/XDT;[9=W%G:&VDMQ=3
MM,\?F(2PWL2Q&5S@DXR:XKQ;81I/\2)DGN1*;6SP&G=E&[G.PG'!''''('4T
M >QT5YAK]QJ7@S4=372]0U"[+>'KF]V7EPT^)XW0"0!L[>')*C"\#BI/#C:Q
M9>)=#5IIEM;^"0SB[UG[6;H!-PDC4CY2#C.W"X;ITH [S5]:T[0K,7>I72P0
ME@BY!9G8]%50"6)] ":K:-XGTG79YK>RGD%S" TEO<0202JIZ-LD4''OC%8G
MB-X[;XC>$[F^95LO+NX8G<X5;EE3;D],E1(!^/K2>,M>L=+_ +1DT^!)O$MK
MH]Q<0R)&',$8P?F/8%L$ ]=IH [2BO.)0^@:EX=.FZYJ%\-5BF%RMQ=M,)4$
M#2"=020F&"_=P,-C'2LBR@NU\+^![BX\2ZPLNN7-N+R9[Y_F!MI6V+S\NX[1
MD<D@'.X9H ]>HKRF^U&^T[4-0\/VVK7BZ7_:]E:F\>X+RVR3(S21B5LGJJ $
MDD>;UZ4SQ-=7^@OX@T?2=8OS!':65PDLMRTTMI*]R$*AV);#*,[6)[]C0!ZS
M4$MY;0W<%K).BW%QN\J,GYGVC+8'MD9^HKS[5K,V^M0^'[.X\0:DUO9FZDC_
M +6:W"!W($DD^X.WW2 HR !G%9'AMY=<O_A[J-_?74UR8M04R+=OA_*<!<X(
M#9 Y./F YS0!ZO87UOJ5E%>6CL\$HRC,C(3SCHP!'2K%>4>%[J]\2R:#IFJ:
MMJ"6[:3)=YANWBDN9?/*'=(I#$(H!P#_ !#/2DL+O4=9O]"TF76M0:R_M'4K
M4W,$YCDNX81\A9UQD@\;A@G!YYH ]8HKE? TMP+?6K&>[N+F.PU6:V@>XD,D
M@C"HP!8\MC<1D\XQ7*27M_8:_)JM[=W]S8'6/)2_T_4MT4:F78MO+:M@#!(4
ME06[YH ]+L-2M-3BFDLYO-2&>2WD.TC$B,58<CL01GI5JO'DM9]/\-:[XAM=
M4U"*[M_$<_E1)<LL(4WNUE:,?*P(9LD@GGKQ2^,M4O6M?%&KZ=/JY.F2M&EV
M=2^RV]M(BK^[6%2?-Y/.]?F+8!Q0!Z7/XDTFUNI[::["S03P6\B^6QVR38\M
M>G?(YZ#OBK5]J5IIJV[7DWE"XG2WB^4G=(YPJ\#N>_2O+]7<RZ_J\C=6UK0V
M./<I74_$>!KK2]&@6>2 R:U9KYL1PZ9?JI['WH [*BO,+Z]D\.3^*=+&JZN;
M5([ VI\\SW"23NZ%$>4\;BHY)PN2156VCUR37=<\/VEQJ&GSOHZW=O#/JK7<
MD<XD^5BQ)*AL %02"/K0!ZS17DNI>,M3U;0-:\3:1/-!;6=A;VJ1AL*EQ*R-
M.Y!XW1HRC)!P=WO6SX9_M;3_ !A!92M+%9W%B\LEM=ZN;V1F5EVRIGE1R0<'
M:<C XH ]!HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***J:EJECH]F;O4+J.V@#!=\AQ
MECT ]2?0<T 6Z*Q[7Q5H=[:&ZM]2A>$7"6S$Y!65B J$$9!)(QD=ZK>*?%]A
MX8TG4KJ1EFN;&W6<VH;#,&)"<X. 2I&?:@#H:*XX_$31[;7KZTOKR"WLXK6W
MN+>8[MTHD\S<=N,@+L7G'&[FMK4/%.AZ5#;2WFIP(ETGF0;3O,B8SN 7)*X(
MYZ<T :]%8E]XP\.Z;;6US=ZQ:QPW49EMWW[A*H(!*XSG[PZ>M95SX[M=.O;*
MVNWM9#>:G-9*UN[$1*@8Y;*_>R%4@<9;KQ0!V%9NK>']'UT1?VKIEK>>5GRS
M/$&*YZ@$]CW'>E77=+?38]16]B-I+*(4E!X9R^P*/?=QCUJCXG\5V?A?^S/M
M8S]NNUMP<D; 027X!SCCCWH U1IE@);206< >S4I;$1@>2I&"$_N@@ <5:K%
MN/%N@6NJ_P!F3ZK;)=[UC*%N%=ONJS= QXP"<G-6M<OWTS2)KM)+:-D9 &NF
M*QC+A>2 3WX]\4 :%%8TWBS0;?5AI<NJ0)>>8L7EDG =NB%N@8Y& 3GD4-XL
MT%-7_LIM4@%YYHA\O)QYA_@W=-W^SG/M0!LT5GMKFF)8W%ZU[$+:VF,$TF>$
MD#;"I]]QQ5:_\6:#IFH?8+W5+>&Y^7<C-]S=]W<>BY[9(S0!LUD:MX6T'79D
MFU71[*\EC&U9)X59@/3/7'M4^N7[:7H5[?));1M!"T@>Z8K$,#JQ ) ^@JK>
M>+-!T_4!87FJ6\-UE0R,3A"WW0S=%)R,9(SF@">]\.Z+J-G;VEYI=I-;VW^H
MC:$;8N,?*.W''%96K>!M)U"+3K:"RLK>SM[];N>W6W79.!$\6TJ..C+SZ+6S
MK5]<Z;I$]U96$E_=+@16T9P78D 9/. ,Y)[ $US$_C2^T"XU&V\16EIYEKIK
M:DCV$C,'16VE"& (;<1@]#GMB@#I+;P_H]G91V5MIEI%;1S+.D21 *) 00_^
M\" <]>*BN/"V@W37C3Z/92->LK7):%<RLOW2W')&>#UK+L_$>LVVK6^G:]IM
MM'+>6LES:BRE9R6CVEXFW ?-AA@C@X/2F:=XEUI==TO3];TVTMCJL,DL,=O.
MSR6Y10Q64$ '@XW#C/'?- &Q!X7T&VA>&#1[&.-P@=5@4!MC;USQSAB6&>_-
M:4\$-S!)!<1)+#(I5XY%#*P/4$'J*Q?$&MW=A>Z9I>F6\,VHZB[B/[0Y6.-$
M7<[M@$GJH '4L.160/&UZ;1;(:?!_P ) =3.EFW\X^2) GFF3=C=L\OYNF>W
MO0!NZ3X4\/Z%</<:5HUC9S.-K200*K8],CM[4/X4\/R6EQ:OHMB;>XF^T2Q^
M0NUI?[^,?>]^M84GC:\LK34+2\T^!M<M;R"SC@AE/E3M/CRF#$95>3G@D;#U
MK5T36[^?6KW1-8M[:&_MH8[E'M79HYHG+*"-P!!#(01]#WH O?\ "/:-_8_]
MD?V59_V;_P ^ODKY?7.=N,9SSGUI;30-'L(;>&TTRTACMI#-"J1 ;'((+#_:
M()&>O-8VI>(-8DUN^TW0+"TN&TV!)KEKJ9DWL^XK$F ><+G)X&1Q5:+QC>Z[
M+80>&K2UDDN-.34I7O9&58T<D(GR@DL2&]AM[T =(-$TL3><-.M1)]H^U[A$
M,^=C;YG^]CC/6KQ 8$$9!X(-<7;^-;S6HM(M]$L8!J%]!-/,MW(1':K$XC<$
MJ,L?,.T8QT)]JW?#6MMKNE-/-;BWNX)Y;6YA#[@DL;%6 .!D'&0?0B@"Y_9.
MG?V4NE_8;?[ JA%MO+'EA1R!MZ8&!4KV5K)=B[>WB:X$1A\TH"WED@E<^A(!
MQ[5FP>+-!N=5_LR'5('O"[1B,$X9U^\H;H6&#D Y&#63X;^(&D:Q#;0W5[:V
M^I3SRPBV#'[RR,JKD\;BJ@[<YYH VM,\-:'HMQ)<:9I-G9S2#:SP0JI(SG&1
MT&>W2I-4T#2-;\DZIIMK>&$DQF:,,5SUQGL>X[U5N/&'AZTU(Z?/JMNER)!$
MRDG"N>BLV-H8Y'!.>:>WBK0EUAM(;5+<:@I8-!N^9=J;SGT^4YY]_2@#/USP
ME'=:=#::5;Z5!;K,99K*ZL5EMYR1C)48*L#@A@?KFLZ'P'/:>&[BP@N--,UU
M>_;+F"33U:SD&T((?*SE4 5,$'.5S[5T.F>*]!UB62.PU2WF>./S6 ;&4_OC
M.,K_ +0R*72O%.AZW<M;:;J4-Q,J>9L7(+)G&Y<CYER1R,CD4 9?AOP5:Z1'
M>/>PV$LMU/%-Y-M:B*W@\H#RPB$GD$;MW7)SQ6SJWA[1]=\O^U=,M;PQ9V&>
M(,5SU )['TK2K&LO%F@ZCJ1T^TU6WFNLL BMPY7[P4]&QWP3B@#.\1^%9M4-
MDEG'HSV=M&8Q8:CIXFA4\;73!!4@#&.A![4_3/ VD6WAVSTK4K6VU(V\DDWF
M2P #S)'+N5'\(RQ& >F!S5W3_%N@:KJ'V&QU6WGN3NVHK?ZS;][8>C8[[<XJ
M.U\:>&[V_AL;;6+62XF8I&BM]YO[N>F[VSF@"P_A;0)-.DT]]&L#922"5K?[
M.NPN  &VXQG  S[43^&-!NM575)]'LI+]2&%P\"E\CH<XY(['M3(_%F@RZM_
M9<>J0->>88A'DX,@ZH&Z%A@\ YXJM'XNTZUTR.ZU74+*-I;B>*,6S-('\MV4
MX&-Q( &[C .>V* -R[M+:^MVM[N".>%B"8Y%#*2"".#Z$ _A3)-/LYKA[B6U
MA>9X3 SL@):,G)0^JY[5A3^.-)37-#TZ">.X35XWDBGC?*@# 7&!SN)(Z\8.
M:6#QII-OI5E<:MJEA'/<QM(@MW9UD ;!*9&YNW;UH N67A/P]IH866B6%ON1
MT/EP*,J^ R].A ''M5]=-LD>T=+2%6M$,=N0@S$I !"^@P ./051F\5Z%!I-
MMJCZI;_8KH[8)5;=YIYX4#DG@\ <8-6M*UG3=<MGN=+O8;N%'\MGB;(#8!Q]
M<$?G0!!=>&="O8?)NM(LIHP[R!7A4@.YW.PXX)/)/K3SX?T9M&&CG2[,Z:!@
M6ODKY8YS]W&,YYSZU7N/%N@6NJ_V9/JMLEWO6,H6X5VZ*S= QXP"<G-9FF>+
M9-7\>:GH=L;06FG*%D+!S-(Y'.W^$!20.>3VH VK7P[HUE9QVEKI=I%;QS"X
M6-(@ )0<A_\ >! YZ\5I,H92K $$8(/>L:\UN1/$*Z5;+$3%:->74DA.(TY6
M,<=V8,?HA]15:U\1RFXT 7/V5[?6+;,<]LS%//">9M!.,JR[BIP#\G/7@ OZ
M9X:T/1IY)],TFRM)91M=X(54D9SC('3/;I5ZTM+>PM(K6T@C@MXEVQQ1J%51
MZ #I5#6[S5;=;6'1[".YN+B78TL[E8H% )+/C)/3  ZD]14'A?79M=LKPW,$
M45S97<EG-Y+EXW9,?,A(!(Y'7H01VH FM/#&A6&I-J-II%E!>L6)GCA56RWW
MB#CC/?'6K*:1IT=K:VJ6-NMO:.'MXA&-L3#."H[$9/3UKE=1\9ZG NLZE9Z=
M;3:+HTYANF>5A/)L ,K1@#&%ST)YVGI4NH^+-5:[U8Z'I]I=6FCQJ]RTTS(\
M[%!(4BP" 0A4Y/=@/>@#8'A#PV+F6Y&AZ?YTK^8[_9UR6W!L].#D Y]16C'I
M]G#%<11VL*QW#L\R!!B1F^\6'<GOFN8?Q9J6KWI@\+V5I<K%8PWTLEW*T882
M@F.-=H/S$*22>!D=<UM:5X@M-4\+V^OKNBM9;;[2P;K&,98'W&"/PH 73O#&
MA:0)QIVD65KYZ[)?*A4;U_NGCI[=*72O#>B:')))I>E6EF\@VNT$04D>F1V]
MNE8&F>+M6EET2YU33;6WTW7#MM&BF9I869#)&L@( ^95/3H>.>M16GC;49HM
M/UB73[5?#^H7@M('69C.@9RD<C#&W:S8X!R P//- '3ZKH&D:ZL:ZKIMK>"(
MDQ^?$&*YZX)Z9[^M3IIMC&]JR6<"&T4I;E8P/)4@ A?0$ #CTKD9O&VHI!<:
MTFGVI\.VU\;-Y#,WGL%D\II@,;=H?/&<D GVKK]0U&STJRDO;^XCM[:/&Z20
MX R< ?4D@ =\T -U+2[#6+0VFI6<%W;DAO+F0, 1T(ST/O5*7PGX>GL+>PET
M6Q:UMB6AB\A=L9/4CTSW]>]9>J^.],MM%CU.PNK:X@6_M[2Y:1BGD"2158L#
M@KA6W<UJ67BO0=0L[R[MM4MV@LQFY=FV>2,9!;=C (Z'H: ,_5O VDZ@NFP0
MV5E;V5M??:Y[9;==D_[EXL$#C.&7G_9%:]MH&CV=E%9V^F6D5M#,)XXDB 59
M <A\?WL\YZU4M/&'A^]AO)8-4A*V<)GN-P*E(QD[R" =O!YZ4P>-O#36+7JZ
MQ;M;B<VX=26W2 9VJ ,L<<\9XH GN/"GA^[:[:?1K&1KQUDN"T"YE=<[6)QU
M&3SUY-/@\,Z%:Q-%;Z18Q1L8V94@4 F-MR$\<E6)(/K3)/%6A1:3!JC:G;FS
MG?RXI%.[S&YRH Y+#!R,9&#Z5=TW4[+5[)+S3[F.YMW) DC.1D'!'L0>"* '
M7^GV>J6<EG?VL-U;2??BF0,I[C@U13PMH,>D2Z2NCV0T^5M\EOY*[';@Y(QR
M>!R?04Q_%N@1ZM_9;:K;"\\P0^7NX$AZ(6Z!O]G.?:LS0_%LFO>,M8TRW-H+
M'32(^C^=(^U26_NA06*XZ\9H UKKPKX?O;N&ZNM&L9IX558Y)(%) 7[HZ=!V
M]*?J?AO1-9N(KC4]*L[N:(81YX58@9SC)[9YQTK"GUWQ->^*M7TG1K72?)TY
M8"SWDDBLYD0MQM!Z8-.TWQ_IW]D27.ORV^EW,%W-92H92Z-+$<-L. 6!R".,
M\XH Z.32=.F2\26QMW6]4+<AHP1, -H#>O''-3FWA-K]E,2&#9Y?ED97;C&,
M>F*R)_&7AVVNX[:;5[9)9%1@"QPH?[FX]%SD8W8SFLM?&@F\=WVBI-8PV&FV
MXENY9RP<DAR=IX50NT9)]>* .BCT;3(38F/3[9#8*4M"L0'D*1@A/[H(&.*5
M](TZ2UN;5[&W:WNG,EQ$8QME8XR6'<G JE9>+M U&"ZFM=4@D2UB,\QY4I'@
MG?@C)7@\CBJK?$#PFELUPVNVGDAVCWY.&9<9 X^;[PZ9ZT :T^C:9=17D5QI
M]M+'>D-<J\0(F(  +9ZD!0.?05%:>'=&L+:*VM=+M(889OM$:)$ %EZ;_P#>
MP>O6J\WC#P];WR64VK6R7#[/E+<*7^Z&/12<C )!.:K>)O&FD>';:]26^MQJ
M$%L\R6[L>3M)0,1]W<1@9QGM0!O1VEM#=3W,<$:3S[1+(J@,^T87)[XR<53N
M_#VC7]Y)=W>EVD]S)%Y#RR0J6:/.=I/<9 .*3^UQ'X7_ +:FA8A;+[6\4?).
M$W$#^5<YI7B/Q1>6^F:H^G:7=Z7?O&&33YWDFME?HS$C:X7(W8QCGKB@#KWL
MK62[%V]O$UPL;0B4J"P0D$KGT) X]JHZ9X9T/1KF2YTS2+*TFD&UI(854D9S
MC(Z#/;I69IOCK2+XZZT]Q%:PZ1=&"265\!EVJ=W(&,LQ4#D\>]:5EXGT34+&
MZO+?4[<V]H,W#NVSR1C.7#8*C'/- %V_TZRU6S>SU"T@NK:3[T4\8=3^!JMI
M/A_1]"ADATK3+6S24YD$,07?_O>OXUBZCX[TT:'/?Z/<P7LL$]M%)$<J5$LJ
MH&((!QAB0>AQ716VI6=Y=W5K;7"2S6K!)U0Y\MB,@$],XYQUH IZ?X8T+29I
MIM/T>RM9)E*R-# JDJ>2O Z>W2J6M^$+'6(-$L_)MDT_3;D2FT:$-&\8B>,(
M!T &\'\*V[Z_M=,LI;R]G2"VB +RN<*HSCG\ZH:=XHT/5?M'V+4[>7[.GF2_
M-MVI_?YQ\O!^;I[T 2P^']&M])?28M+LUT^3.^V$*^6^>I(Q@GW-,M?#6AV6
MGR6%MI-G%:2N'DB6%=KL"""WJ00.OH*AT_QAX?U6>2&RU2&61(C,5Y&8QU=<
M@;E]QD5/H_B+2/$ F.DW\-X(-HD,1)"[AD<_@?RH 74O#NBZS/%/J6EVEW+$
M-J/-$&('7'/;VZ4-X<T5H[2,Z59[+.8W%LODKB&0MN++QP<\\=Z=_;NEG3/[
M2^VQ?8_-\GS<\;]_E[?KO^7'K55_&'AZ/5!IKZM;B[,WD;<G'F_W-V-N[_9S
MF@"6Z\+Z%>V$%C<Z192VMN288FA7;&3UV^F?:K46E:=!]D\FQMXQ9J5M@D0'
MD@C!"X^[D>E96D^)XKRYOH+PQ6[QZK)IUL,G,Q5 _P">-Q_"M"XUW2K2._DN
M+^")+ J+IG; B+ ,H/N0PQ]10!;M[2VM#,;>".(SR&64HH&]R "Q]3@#GVK/
M/AC0FU?^UCI%D=0W;_M'DKOW?WLX^][]:FTG7-,UR*633;R.X$3;9%&0R'&0
M&4X(R/45R7B#Q7KR^*VT30H].62W,6];PL6N#(DC@* 1M4>7@MSR>G'(!V#:
M1IS6DMHUC;FVFE,TD1C&UW+;RQ'<[N<^M5+GPGX>O;Z:]NM$L)KF88DDD@5B
M_&.<CDXXSZ5<2[G&CK>7%E+'<"#S9+1")'5MN2@(X8YXXZUS=IXEUV#5=&@U
MO3+.WBU@LD*03,TMNXC,FV0%0#PI!(Z'\Z .B.BZ6S,QT^V+,\4C$QC):/'E
MGZK@8],58N;2VO!$+F".812++&'4':ZG*L/0CUKCO#OB[5_$6H*8%T%;)II,
M1?;G-WY*NRAS&$QR #UQ@UU.JZSINAV\=QJ=Y%:PR/Y:/*V S8+;1[X4_E0
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M1N"GNN.M>M44 <3X/T^<^(M2U:2/6RLEO%;BXU8QQO-M+-@1(BD!=WWFZ[B
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M44 %%%% !1110 5SWB_Q-_PC&GVMQY4#&YN5MQ+=3&&"'(8[I'"MM7Y<=.I
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MQL\LN<YSSG?Z<8I=6T7^U-2T:\^T>7_9MTUQLV9\S,3QXSGC[^<\]* .2O\
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M %(1L$,3TR!G TM"\'6WA_4;6XM+AS!;:6FG+$ZY8[7+[RV>I)Z8J'3O!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%VCO;^7(&\U5QN*XZXR,^F:2/7-+FMHKF+4+9X99S;QNL@(>7)&P'UR#Q[4
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M[2X%G 9Y5CE&0@[_ $)XSTYH Z"BN;T'Q9!KZZ;<6\EFMO=Z<;QD^T9EC8%
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M& + ' /2O6:* /'X]-U=+#6[N2PUBY_XG]A?J9[=1//"GE;G"( ,_(?E !'
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MSHFWS-BD$$C<N,$'&>:7Q)X\N?#AO+B?2(!I]HX5GGOUBGF'&6BBVG>!GC+
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M(&P5PW.%YP.!5GQP/LMUHVJQ2W%M=6DTBI=K9M=0QJZ899D0AMK8&&'0@9H
MJ2?$&]BMYT?PZ_\ :$6K1Z4+47:X:1XA(&#[<;>1SCIS[58U?QCJ^D6[RW&@
MV</D6XFG-UJBQ*S8)*0DH?,(QU.T9.*Q_#'A[4-9%SJ=[=2<^(4U**66T:$W
M$<<*Q\1DY12<A<Y.%'7.:T]6\"W5_KVK7\-WIX74XDC,EU8^=/:A4V$0MN
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M^BNS+Y7^L"2%]N,\9SC/-8K_  SO6M)[)-0TU8GO?MGVLV&;N8^<)0LDF_D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<A\0
MM+N-6L=$MH$NB/[9MFEDM=P>) 6R^X<KCU[5U]% '(S^#+&PLM0OHY-1U#4?
ML,T,,E[=27#H&4Y5 3@9('09-<Q?Z%>6/A[P'<V\%W9P:="OVP6ED)I89&@
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M%W8ZA$Y7RBSLC*Z\KDELX##@9&10!U=MJNGWEE!>VU];RVMP0L,R2@I(2<
M]SGC%6Z\@NPFHVFG6\5O+H=[;^*EBO8;.99(S.Z;S(C,I[$$# P2<BM*[U36
MYO#GB+Q7'KL]M+I5S=+!8!(_(V0,5V2 KN+/M/.X8W#'2@#TVH+>\MKN2X2W
MG25[>3RI@IR8WP&VGT.&!_$5PL5WJWB&3Q#J \0RZ)'I<XA@BV1^5&%A21I)
MMPRP.\]Q@#CGFL73M:OD\;:GI:3-9:;?:[F34X@K"63[-"5@7.=NX*3N(/&
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MU.SDOH\[[9)U,BXZY4'(JIXA\3Z=X:2Q;4)DC%Y<I;H7D5 N>K')'R@=3]*
M-=T62-HW&58$$>H-84_@K0)[:R@^Q/$MC#]GMV@N98G2+CY-Z,&*\#@DTS3?
M&>E7E[=V5U=6EE=0WTEG%#-<J'G*X^95.#SGH,UJ7FMZ5I]W#:7NIV=M<S?Z
MJ&:=4=^WR@G)H SKGP5X>N8[5#8&$6L/V>(VL\D!$7783&P++GG!SU/K2W?@
MSP_>BT$NG*@M(?L\(@D>+$7_ #S.PC<G'W3D5I:KJ=MHVDW>I7CA+>VB:5SD
M#( Z#) R>@]S5&#Q7HCZ%9:O<:I96MI>(&C>:Y15+$<KN)P2#D$>HH CF\&:
M!-865E]@\J*QW"U,$TD3PAOO!75@P![C.*T],TRRT>PCL=/MTM[:/.U%]2<D
MDGDDDDDGDTR[UK2K"&.:\U.RMHI$WH\TZHK+D#()/(RR\^X]:C/B'11>)9G5
M[ 7+E@D/VE-[%200%SG@@Y^AH ;:^'=)LIK66WLUC>U,[0D,QV&9MTG4_P 3
M<\_ABK5EIUIIWVC[)"(OM$[7$N"3ND;[S<^N*AM]>T>[L9KVWU6QFM("1+/'
M<(R1D==S X'XU-I^IV&K6WVG3KZVO(,[?,MY5D7/ID$C- &-J'@3PWJE_->W
M.G'SY_\ 7F*>2)9O]]48!OQ!JU?^%-$U*.T2:R\O[(GE6[6TKP-$F -@:,J0
MO XSCBK5QKFDVFH1Z?<ZI90WLN/+MY+A5D?/3"DY-4K'Q9I-_K&L:;'=0K+I
M143EI5QC:&8]> N=I)Q@Y% %FT\.Z38-8-:6,<)T^*2*UV9 C5R"XQGG)4$D
MY/YFH;GPIHEW9R6LUB#')=->$K(ZNL[')D5@=RMR>A'6HKOQEH%OH&HZS!JE
MG>6MA$9)OLMPCG('"\'&XG@ ]2:L?\)/HD>F6FH7.K6%O;W:@PO+<HJN>X!)
MP2/:@"O_ ,(9X?&EG3OL'[@S_:2WG/YIF_YZ>;NW[\<;MV<<5+;^%=%M;,6L
M5H?+%RMV2TSL[S*00[.6W,>!U)Z8Z5<OM8TS3+>.XO\ 4;2TAE($<D\ZHKD]
M,$GFJWAS7%\0Z4U^D/E*+B> +OW9\N5H]V<#KMS^- %O4=-L]7LFL[Z$36[.
MCE"2/F1@ZGCT90?PJW7.Z!XRTO6X(0]U:6M_-+,B637*F4B.5X\A>"<[,].]
M:DNMZ5#J::;+J=G'?OC9:M.HE;Z+G)H KOX8T:308]#>Q0Z=$!Y<.YOD(.05
M;.X$'D$'(J&#P?H4&GW5DMD7ANW22X:6:2225E(*EG9BQP0,<U?.L:8-06P.
MHVGVUB5%OYZ^82 &(VYSD @_0YJ*WU_2[^.Z.FZC8WLELI,B0W*-M([,03M^
MIH JZKX/T+6KQ[N^LF::1!'*T<\D0F0=%D", XYZ-FK]OI-A:WLEW;VR13R0
M1V[,N0/+3=L4#H -S=/6J@\2Z7;Z;:W6J:CI]@\T$<S))>(57>.,-D!AD$!A
MP<'%:T<D<T22Q.KQN RNIR&!Z$'N* ,J3PQHTN@P:(]BATZW"B&+<P,>W[I5
ML[@1V(.:BB\'Z##I=WIW]GK);WC![CSI'D>5AC#,[$L2,#!SQCC%6X=?T:YU
M)M.@U:QEODR&MDN$:08ZY4'/%">(-&DOH[)-7L&NY,[(%N4+M@D'"YR<$$?@
M: (=(\,:1H5S/<Z?;,EQ<*J3323/*\@4G;N9V).-QY]..@%,UGPGHNOW,5SJ
M%F6N8E*)/%,\,@7KMWH0<>V<57\2^,=+\.V5TS7-K/?P(K_8/M*K*P) SMY/
M?/2M75KY]-TV2Z2.*1D*@++.(5.6 Y<\#K^/3O0!GMX.\/MHB:-_9R+8I*)U
M1'=6$@.=^\'=NSWSFFW/@OP_=Z@][/IX>61UED3S7$4KKC#/&&V.PP.6!/%7
MKCQ!HUI<K;7.KV$,[2>4L4ERBL7P#MP3G."./<>M&O:U:^'=!O=7O6Q;VD+2
ML 0"V!PHR0,D\ =R10!4U'P?H.K7[WM[8>9-(%$V)71)@OW1(BD+)C_:!J:?
MPSH]S:WUM-8HT-].+FX7<PW2@* P(.5(V+C&.E9J>/-&&K&VN+RRM[0V,-XE
MY+=H(W,CR+L!/&1Y9[]_:MN]UG2]-M$N[[4;2UMI,;)IYU1&SR,$G!H ??:;
M::E;QP7D(ECCECF52Q&'1@RG@]B :B?1=/DFU"9[8&34(5@NCN/[Q%# #KQP
MS=,=:N0S17$*30R))$X#(Z,"K ]"".HJDFO:/+)-''JMB[P1F655N$)C0'!9
MN>!GC)H SYO!/A^XG65[ @B%(&5)Y%26-!A5D4,%D ''S U1U/PA]LDT'28+
M:RB\.Z7-'<A6=WEWQ[MB*",;>1DELXR,<UOVNN:3>V$E]:ZI93V<6?,N(IU:
M-,=<L#@4MGK6E:A927MEJ=G<VL>=\\,ZNB8Y.6!P* +-Q;Q7=K+;3IOAF0QN
MN<;E(P1^58^E>#M!T6[CNK"P\N6)#'#NF=UA4]1&K,0F>^T#-1ZIXPTRT\+:
MCKNG7-KJD-DA9EMKE6!/IN&<&MHWMJ/M&;F$?9AF?,@_=<;OF_N\<\]N: ,>
MT\%^'['4([ZVT_9+$[21(9G,43MG+)&6V(3D\J!UK5N].M+^6TEN81(]I-Y\
M!)(V/M*YXZ\,PY]:Q+KQKID>JZAI=M-;37MIIXOE5[I(TD!#$+N)XX4,21@*
MP/2M.YU_2K 6RZCJ5C9RW"@QQS7**7S_ '<D;OJ* *=EX+\/Z=?1W=M8;9(F
M9HD::1HH2V=Q2,L40G)^Z!U-&G>#=!TF]CN[.Q*20[O)5IY'2#=P?+1F*ID9
M'R@<<5?O]<TC2CC4=4LK0@*<7%PD?#$@'D]]K8^A]*NQR)+&LD;J\;@,K*<A
M@>A!H Y^R\"^&]/O(+JVTT)+;R&6WS-(RPL<YV*6P@.3P ![<"GKX+\/IJ8U
M!=/ F$_VD)YK^4)>OF"+=L#9YW;<YYK0BUW2)]0ET^'5+*2]B!,ENEPAD3'7
M*YR,5D>%O%R^*KS5/LL=I]BL[AH(Y8[P2R2%6*[B@'RJ<$J=QR* );WP-X<U
M&\FNKK3M[S2"61!-(L;R#&'*!@N_@?-C/O6OJ.G6FK6$UC?0B:VF&)(R2-PS
MGJ.>U<S+\1-*Q<_9C',;;58=-E'GJ-N\J/-XS\H+'KC)4]*Z.RUG2]2M9+FQ
MU*SNK>(D22P3JZICDY(.!0 Z+3+.&]N[R.!1<7@1;AR2?,"@A00>. 36;IO@
MW0-)OH[RRL-DL080AIG=( W41HS%8\_[(%:&G:OIFKQO)IFHVEZB':[6TRR!
M3Z$J3BLR^\7:=I?B1])U*>VLHELTNA=7%PL:DL[($YQS\N>OX4 7(?#NDV]I
MI]K%9JL.G2^=:)N;]T^&&>O/#MUSUJU::=:6,UW-;0B.2[F\^<@D[WVJN>>G
M"J./2F7NL:9IMFEW?:C:6MM)C9-/.J(V>1@DX-%QK&F6FGKJ%SJ-I#9. 5N)
M)U6-L],,3@YH I2^$]$FO[F]DL<SW,L4TQ$KA7DC*E&V@XR"J\XYQSFIG\.Z
M2]G<6C6:F"XNOMDJ;V^:;>'W=?[R@XZ<5)_;ND?V?'?_ -JV/V*3.RX^T)Y;
M8!)PV<' 4G\#Z55U/Q7HVFV'VEM3L7>2W:XMHOM2 W "DC9SR#CJ,T 6+KP_
MI5])?/=64<QOH4@N=^2)$0L5!'3@LQR.>:CTCPSI.ASRSV-NXGE4(\TT\DTA
M4=%W.Q(4>@.*MZ5?#4]'LM0$?EBZMXY]F<[=RAL9[XS4$'B+1+K[3]GUC3YO
MLJEKCR[E&\D#J6P?E ]Z %N]!TR^U6WU2XM0]Y;QM$DF]A\C=58 X8>S BJ>
ME^#M!T>]2[L;$I-$I2'?-)(L"GJ(U9B(P?10*A\&>*&\7:2^IK;VT-LTA6$1
M70F? _YZ * C8P=N3P12ZOXQTO3+JWLX;FUN[V2]@M)+6.Y7S(O,<)N9>3QG
MI@4 :6J:)I^L_93?VYD:UF$\#+(R-&X!&05(/0D$=#WJ.U\.Z392VLMO9K&]
MH9S 0S'89FW2=3_$W//X8ID?B&RBMIY]3NK&Q2.XEA5GO$*L$;&2>,'')7JO
M0U-+K^C07-O;3:M81SW*AH(GN$#2@]"HSD@^U #!X=TD6BVHLU\E;S[<J;FX
MG\SS-_7^_P XZ>U5)O!?A^XU)K^73P97F$[H)7$3RCH[1!MC-P.2,UHWVMZ5
MID\,-_J=G:2S<1)/.J,_T!/-4K+Q5I=]K^J:/%<Q"XTU4:;,J\@C)(&<X7@$
MGH30!HZAIUIJMI]EO81-!O23821\R,&4\>C*#^%59?#NDS:?J%A)9JUKJ,C2
MW4>YOWK-C)SG(S@=,=*?::_HU_;7%S9ZM8W$%N"9Y8;A'6( 9)8@X' /6HY/
M$_A^&W>XEUS34@24PO(UV@59!U0G/WO;K0!>O;*VU&RFL[R".>VF0I)%(,JR
MGL161;>#- M(+R%+%G6\@-M.T]Q)*[1$$>6&=BP7GH"!6W#-%<0I-!(DL3@,
MCHP96!Z$$=15&WU_1KN]%E;:M837;+O$$=RC.5]=H.<4 2/I%A)<V=P]NIEL
MHWCMV)/R*P 88SSD*.OI6=IW@S0-*OXKRSL-DL.[R TTCI!N^]Y:,Q5,_P"R
M!5]-<TB2XE@35;)IHD:22,7"%D53M9B,\ $$$]C3;;7]&O;1KNUU:PGMD<1M
M-%<HR*Q. I(. 22 ![T +JVB:?KEO'!J%OYJQN)(V5V1XW'\2NI#*>3R".M5
M[;PMHMG;6]O!8JJ077VQ"79F,V"/,9B<LV">6)J?5]6CTRUE9&MGNE3S%@FN
M5AW+N"DY;H!N'/J0.]5/$7BK3/#MA>2W%W:F]@M)+F.R>X5))@BEL*#SSC&<
M&@#3U"PM=4T^XL+V(2VMQ&8I8R2-RD8(R.::-,LQJ4>HB ?:XH#;))D\1DAB
MN.G51^54[37HI9)S=&VM8(XX&61KI2291PK+P5YP!G[V>*LV.LZ7J<,LUAJ5
MG=Q0G$KP3JZH?<@\4 9\W@W09[*TM38F..S+FW:&>2.2+><L ZL&P2>1G!JU
M:>'-(L1IXM;&.(:>'^R["1Y>\8<]>2>Y.3WJ2PUW2-4?9I^JV-VWS?+;W"2'
MY<9Z'MD9^H]:R-;\7IIGB?2O#]LEG->7VYW$]X(?*0%1P,$LS;OE7 SM/- %
MB^\%^']2OY;VZT_?+,RM,HF=8YBO0R1A@KD8'W@>E:VH:?::K836%];I/:S+
MMDB<<$5#;:WI-Y?RV%KJEE/>19\RWBG5I$QURH.13K76-,OKE[:TU&TN)XUW
MO%#,KLJYQD@'(&: ,^V\':#;6UY;BQ\]+R,17!NIGG:1!G"EI&)P,G SQ3(/
M!7A^WMKV 6+2+>P?9YVGN))7:+^X'=BP7GH"!46K>,[+0I)O[2,$,:WT%G&P
MND);S A+."1L"[B2#S@9Z&M5M>T=-1CTYM6L1>R %+8W">8P/(PN<G- $DNE
M6,U[;7DENK3VT3PPL2?E1]NX8Z'.U>OI6;IW@SP_I5['=V=ALEB#"$--(Z0!
MOO"-&8JF>GR@<<5HZG?/I]M'*D<4A>>*(B6<1 !W"D@GJ1GA>I/ ZTT:YI)U
M0Z6-4LCJ _Y=?M"^;TS]S.>GM0!0T[P;H.E7T5W9V)26'=Y"M/(Z0;N#Y:,Q
M5,@D?*!P:NZ'I*:'H\.GQR%TB+D,<_Q,6P,DG W8&2>!UIR:YI,NIMID>J63
MZ@OWK5;A3*/JF<_I4W]HV1MA<?;+?R&D\H2^:NTONV[<YQG=\N/7B@"S15&7
M6]*M]2CTV;4[..^DQLMGG42MGIA2<FKU !1110 4444 %%%% !1110 4444
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MTAPQVG'WLUZ=10!YIX-\.W4'B"Q&N6/FSV_A>TMFDF3>%?S9=R;CP2!M!_\
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M)="IZ#E@"#R>W0U/XDT;5;_5=&U+2;BUCGTV25S'<ABLH=-NW*\CKU[>AZ4
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M,#3%G=MK2NZ^6JX& HVD[22:IZ'KGB#Q5)X;MSK,E@M[HTMW=R6T,1=Y$D1
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !52^TRTU%[1KJ+S#:3
MBYA^8C;( 0#P>>&/!XYJW10!D7GAC1[_ /M'[59++_:/E_:<NWSF,80CGY2.
MQ7!SS4%MX-T.WMKZ![62Z%]&(KE[R>2X>1!G"EG).!DX /'7K6]10!A6'@_1
M=/>XD6WEN))X#;.][<27+>3_ ,\P9&.%]AU[TS3?!6AZ3J$%_;07!N;=&B@>
M:[EE\J,C!10[$!?:N@HH J3:9:3ZI:ZE+%NN[5)(X9-Q&U7V[AC.#G8O7TK.
MN/"&B7-L\#VKINNWO1)%.Z2).V=SJX(92<GH0.U;E% & ?!>A-HSZ6;23R'G
M%R[_ &B3SFF!!$AEW;RW YSVK3OM*L]3LX[2\B,L,<D<J@NP.Z-@R'(.3AE!
M]^]7** ,34?">D:IJ+7]Q'<+</$(93!=2PB9 20L@1@' R>N>I%2:9X8T?1Y
M+5["T\EK2W>U@Q(Q"1,X=EP3_> ^F,#BM>B@#)M?#.D6<]K/!:;)+62>6$^8
MQVM,VZ4\GG)]>G;%6=*TBQT2S-II\/D6_F/((PY*J6.3M!)VC)/ X'85=HH
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M;HPP5C5V(0$<<8XXZ5/-X5T>?0;317M"+*S""V"RNKPE!A2K@[@P'?.:V:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M221UW,W4$HW!X XH ]6I&944LQ"J!DDG  KSG5]2\22W/C6XM-=:S@T(*]K
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M..: .QHKA?%FOZI'XLM-"L&U&&(V37DTNG6T<TS?.$50),JJ]23@GD#BL_\
MX2;6YM)TVUO;R]L;^2YN(F6TL%EN[J.,_*ZIADCX9=^> >!C- 'I512W-O#-
M##+/%'+.Q6)&8!I" 20H[D $\=A7FFE>*=?U*"ST9KV:VO)]:N+!KZ:WB$Z0
MQ1>;R@S'YAX7ICJ<9J36K76#XB\-:<_B&.>[CU2=8[Q88S-%&;1VQ(@&S?@M
M@[<8*G'J >F45S/A"^U":;7--U&]:]DTR_\ L\=R\:H[H8HY!N"@+D;R,@#.
M.E<YJ/B#7-.\1W$FHW]]8V"7R1P21V4<]@T!*C;(Z@R)(22,D@ X[4 >DTR:
M:*V@DGGD2*&-2[R.P554#)))Z "O*[KQ;XGNI-:U#3EU,_8+Z:WMK2*SA:UD
M6)MI$LC?."V#R"-N1P>][4=3U^ZD\;70U7R;#1X'\FQ-K$X<M9K)ARRDD!FS
MCZ@Y&  #T='26-9(V#HP#*RG((/0BG5Y=+XEUW4-6FT^REU2WBL;*V8-IMC#
M-YDLD>_,F_H@X 5<=^:6^\1>*Y[73KN9=1L+=].22<Z3:PW317.6#>:C!F\O
M !&P9Z\\4 >H451T6^34M#L;U+F*Z6>!)//B0JLF0/F"GD ^AY%<_K4^KW?C
MBQT2QU=].M)-.ENIFBAC>1F61%&TNK ?>YX/'OR #KJB@NK>Y\WR)XY?*D,<
MFQPVQQU4XZ$9'%>;0Z]XEU:]TC18M8%I,UWJ-G=7L5M&QE%N5VNJL"JDYP>W
M)XZ8?;:YK%QJ9T*WOEM9;O7+NW:]2WCWK%#$KG"[=I=C_$P/&>N!0!Z702 "
M2< =Z\RU'Q!XCL9KS08M6$EW!JMC:QZA);H6,5P.0Z !2RX/( SQ73^)+.[A
M^'&KVTVIS3W*:?-NNS'&KOA2>5"[1D<<#]>: .E5E= Z,&5AD$'((I:\YT23
M6K^;3O#]OKUQ916>BV]W)<I!"TTS2E@J_,A4(H3'"Y.1D^O2>$=5O-<\,F2\
MD47D4]Q:23PJ KM%(T?F*#D<[<XZ9H VVO;5988FN81).S)$A<9D902P4=R,
M'..F#4]>+:%8:@]CX'A@UB:.:74M1VSM#&S0J%F#;1MP2<$_,#@MZ "M>[\6
M:_I]O-H_VNXN[P:Z=-2^BMHVG\GR!-D)@(9,$KTQWQ0!ZE17)>#=2UBZO-4L
MM32^>"W,3VUQ?0QQ3.&!W*RQ_+P5X( R&]JZV@ HHHH **** "BBB@ HHHH
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MV^9C>3D_,3C))R<\U#<^$-&NK>:)[>13+>&^\V.9TD2<C!='!RIQQP<5NT4
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M#31GK'SCV)4\8S6WI^@VVGZK?:F)KFXN[S 9[B3?Y: DB-!_"H+$X]^<UJ4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %5Q?V;3"$7<!E+M&$$@W
M%E&2N/4#DCTJ+5[UM-T6_OE7<UM;R3!?4JI./TKB]'=].C\ 6P$4K7T<TUS-
M)&&=I&@:5W#'E27))QU!Q0!WL$\-S!'/;RI+#(H9)(V#*P/0@CJ*DKE?",AM
M]6\3:.O_ ![V6HAX!V19HTE*CV#N_P"==50 4444 %%%% %6^U*PTR-9+^]M
MK2-CM5KB58P3Z DU5A\2Z#<%Q#K>FR%$,C!+I#M4<DG!X ]:NW5C:7R*EW:P
M7"*<A9HPX!]>:\JT[3K*+X ZI=1V=NEP=/OP95B4.1OE&,XSTH ];!# $$$'
MD$=Z6O.I=<USPG/:MJ.H)J=M/H]U>& 6ZQ>4\"(VU".2I#$?-D\9S3/#OB3Q
M)/J.C/<KJ%W;ZAQ=I+I?D16V4+*T3]2H("_,22#GB@#TBJ_V^SW[/M<&[S?(
MQY@SYF,[/]['..N*P/$>H:D=?T;0M-NQ8M?K/-+=>4LC*D07Y4#?+DEQR0<
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MYRHR>>1B@#LOM$/VG[/YL?G[-_E;ANVYQG'7&>,U)7F4$FH^(/&VF7.G:Y!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWMU>A1?ZC=/=W"J<A,@*B9[[45!]03WK<I@EC.S#J=XRN#]X>WK2&>%02TJ
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M..Y &T;U!Y^7@XQD<&MYYX8T#O*BH1N#%@ 1US2Q2QS1K)$ZR1L,JRG(/T-
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MW<ACTS74^!/['?QAXKFT**--/D%H4:%-L3MMDW%.Q&>XXSFN_HH X&8,-?\
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M(C%DD))W*N2&P?>O1]=B;5/AK?I+8,LLVE.WV24>8R/Y60ISU8-CGKD5TM%
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MK:!)[Q(8XV:U5\D!AORQPI.$W573QE+'XLURSNK*Y73-/L(+I9UB!/S>822
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MW$<:,BX39A3@C/S'GIQ5G0O"&HZ;J&A3SO;E+!]3:7:Y)(N)M\>..>.OI[T
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M6[NV"04&0=RDBMJN)T&PUOPMIOEF 2I=ZG&L5C]JDN/L5NVU6VR,,MC#/@X
MR0#Z]M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQNVM)=X RZJK$C!Z885H4 %%%4=9U6#0]%O=5NED:WLX6FD$8!8JHR< D<T
M7J*;&XDC5USA@",TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHU5%"*%3[H X7Z>E&Q<L=HRWWN.M 'D'B1M"MM-NH/"4D2::;VS_ +5,#G[
MD1+YYC/RY^3S-O\ "1FJX@M%TSQ+;V^LZ79Z48[3S5TF&22S@E\W.6P<!67
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M^S+>>'=0-SL8YG9!%M=_[S#<WS'GDUZ@8T(8%%PWWACK]:"B,<LJDX(Y'8T
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M0/$]A:0:++YOAZ:4WFA3MY# <#SHCD+(=Q(.22 :]VJ)+:")76."-%<Y8*@
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MK@R64C,I_P!6",(P"C<H]0>]=[3(H8X(Q'#&D:#HJ* !^ I] !1110 4444
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M'>)=0WE_:HR32VS1PW$H0-((V/''S$>H!QD5T$NF)!X;DTJQC"QI:&W@3.
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MC!RX965E##D@@GT(J5_ 5]!'H^H+I8>2!KK[5I]IJL\;XF96#+.SY9QM&[)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H&LK1[V.\>U
MA:ZC4HDYC!=5/4!NH'M4]% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4?D0BX-P(D\XH$,FT;BH.0,]<9)X]ZDHH **** "BBB@ HHH
MH **** "BBB@ HHHH CD@AF:-I8D<QMOC+*#L;!&1Z'!//O4E%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5''J34>G:O;:I-?Q6^_=8W)M9MPQ\X56X]1AQ0!?HHHH **** "BBB@ HH)
M!)Z"JNF:E:ZOIMOJ-C)YMK<()(GVD;E/0X/- %JBL5?%.ERO8"&1Y1?7DME"
MRH<>;&'W@YQP/+89K:H **** "BJ%GJUM?:GJ.GP[_/T]T2;<,#+H'&#WX(J
M_0 4444 %%%% !15#6M8M= T>XU.\\PP0 $K&NYF)(4 #N22!^-,DUJWM?#\
MFLZA%/8V\,+33).GSQ*.3D*3SQVS0!I45GVNL6MYJ][ID7F?:+..*67*X7;)
MNVX/_ #6A0 4444 %%%5KR[%G'$Y@N)O,E2+$$>\KN.-Q]%&<D]A0!9HHHH
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MJ:SL6:%E!CC5R@7=W !Y'&!0!U.E>/-!UB6R6TEN?*ON+6XEM9(XIFQDHKL
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MR:\>-46[OWNIV1%(!D8NRCEC@*>G6@"UJGC;1M(NKJ"<WD@LP#=RV]I)+';
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MI8>\\]A ;;9EG8[F8-P??ID<T >GT444 %%%% !1110 4444 %%%% !1110
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MUV,FTD*"V V 2>,>YJ]%X-LXM!TW2!<3F&PO4O(W.-S,LIE /&,9./I71T4
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M=S:WYU S3N"9)#&T>, 85 &X50,8^N:U]X&2\N=8\K6;^UL]8^:]MH1'\[;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC:PG3Y<O/$[9#8!!VKDD @T >@:KJUEHMB;R^E,<094&U&=G9CA555!+$DX
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M X!!;G/8B@#K:*I:Q>S:;HM]?6]H]W-;P/+';Q_>E95)"CW.,5YQ?>,+K7O
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,UG1H]:2R665X_LEY%>+M
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M&ELY,<1P-\G'R#) ^;'- &W1110 4444 %%%% !1110 4444 %%%% !1110
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MT?3KR6\LM*L;:ZF_UDT-NB._U8#)J>_TZQU2U-KJ%G;W=NQR8KB)9%)^A&*
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MT.!D=\"@#RG19[JP\:>&HD$MJFHVMPTJ2ZS)>2W*B+<KR(?E4Y&05)ZD=*-
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M >5>%+B;3]7T3[9//=MJ,4JQ:E9ZJ\\-\?++[I8).8R I/R\*>.G%-\*R?\
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M&>S@CNWMUD+-())248%BNU!R<#/O771:9;0ZO<ZFJG[3<11PN<#&U"Q';/\
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex31articlesofincorporat002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M31(AE,8=3( &*YY /0X_ T .HHHH **** "BFR2)$F^1U1<@98X&2<#]:=0
M4444 %%%% !1138Y$FC62-U=&&593D$>QH =1110 4444 %%%% !1110 444
M4 %%-:1%D6-G4.^=JD\G'7 IU !1110 445$US K,K31@JP5@6'!/0'W/:@"
M6BFO+''C>ZKN8*-QQDGH/K3J "BBB@ HHHZ4 %%0VUW;7D7FVMQ%/'DKOB<,
M,CJ,BIJ "BBD)"J22 !R2>U "T4U'61%=&#(PRK*<@CU%.H **** "BBB@ H
MHHH **;YB&4Q!U\P ,4SR!ZX].#3J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *Y_Q?J\VD:7!)!?6MD\UPD1EGB>9L$$D1QH,R/QP/J>V*Z"LK7- MM=2U,T
MUS;3VDWGV]Q;.%DB?:5)&0000Q!!!'- '!IXWUY=/U2&&6.:ZM=2L;:WN+NP
M>V+I<,H^>(D$8R>>,C!Q5^]UWQ/H\NOV+W-MJ-SIUE!J4,BVWEEXR[B6(J&/
M.V-MI'J.M;47@/2HVN9'GOIY;JYMKJ>6:?<SRP-N0]..@! P,   5?OM/%G>
M7VNV=C+?:C+:QVWV82J@D168@ M@ _.W4T 5M'U^37/$=\MD\;Z1:VT($@',
MDT@\S@^@C,?XO[5/XLU672-#:Y@O+2TD:6.,372,X4,P!VHO+OC.%'4UC>'/
M!MSHGA#2M,@N#:7,5XEY=&&5L'YMS19_B7;B/!P, 'M@]#KFA6NOV<5O<R3Q
M-!.EQ!- ^UXI%Z,I(([D<@CF@#R_7?$>KZIX6\7Z9)?2.MG;6T\5S-ISVLCI
M(S!E*-@X^3AL#J:]&\0W6J:1X.O+VUDCN=0LX/.8F+ EV89P%SP2H8#G@D53
M/@'2I(]5%S<W]S)JMNEO=RS3Y9PA)5A@ *1N[ #CI70VUH(+".TDEEN55-C2
M7!#/(,8RQP,D_2@#SV]^(]U!JNMF&.&33DLV_LMP.9[E5BRON"TZ ?[K54#^
M);+5O'-_9ZE9PR6"V\\RO:F07$J6<98?>&U3CMD\^W/56WP[\/VNFZ-8)#,8
M=(NC=VQ:3+%]Q;YCCYAG''^R/2M1_#EBYUO/F_\ $Y7;=?-V\H1?+QQ\H'XT
M <;<^+[JWOM4N;.RLUO+FUTI+=WC_P"6ER[J/,8<LJYR!]?6CQG#XDM= >"\
MU"POLW^GO:3>28G63[2@*N@)!3.T@@@]1[UT\G@G1IH+N&5)G2ZMK>V?]Y@J
ML&3&RD8(8$YSZ@5$/ NFN9)+R[O[ZZ>2!S<W,P:0"&02(@P  NX9( YSR: &
MZ'J&L0>+-0T#5KR"^\NSAO8;B.W\D@.\B%"-Q!P8\@^_>LGQ?XEUO1]:G03_
M -FZ;';J]O=OISW,$LGS;EF=#F)1A1T[DY[5V":3;)KTNLC?]KEM4M6^;Y=B
M,S#CURYK-U7PA::K?7%T+_4;-KN(0W26DX19T&0 P(.#@D97!QWH @T[Q#<W
MFN:Y;;[=[:TL+2Y@>+D$R+*2=W=?D7%8NB^(O$/BE=,M+.]M;"4Z+;:C=W#6
MWFEY)MP554L %&QB3R>0!BMRZ\#:7/<K+;SWUBGV5+.6&SG,:30ID(C<$\ D
M9!!P>M(? VG1P:>EE>:A82V5FMBEQ:S!9'@7HCY!!QU!QD$G!&: .<AA\2WO
MQ G6/4-/L+[^PK4W4L4)N$+B6; 0$KA2<DYR>WO75>'/$,FJ>!;/7[R)5E>T
M\^9(NF5!W;<]N#BIM(\+:7H=T)]/B>(K:1V80OD>6C,PZ\EB78DD\U:T?1[3
M1-%M])M0S6L">6@D.XD>_KUH Y2QUKQ-'X>M?%5[=:?-I\]DU[/8+$8VA3RC
M(@C?)WMP <C!R2,8Q1;:WXCT\>'=0U2\LKJUUF:."2VAMRAMFD0LA1]QW 8P
M<CGJ,=*T[/P%I-I+;AIKVYL[3=]DL;F;?!;[E*G:N,G"LP&XG /&*?IW@C3M
M.NK*7[5J%S#8$FQMKFXWQ6QP5!48R2%) W%L \4 <UI7B;Q/)I7AW7;V\LI+
M74[Y+.2RCM2I579D#A]V=V5!QC&#CWJ_;>*]4F^Q:.?)_MPZO)97)V?*((_W
MC2@9XW1&/'NXK>B\):;#H^F:6GG?9].N4N8,O\V]6+#)QR,DU-'X:TV+Q3-X
MC2)AJ$UN+=FW?+MR#D#^\=J@GT44 <%:>/M=OE35;6WO)X'N_+738M%N&4P"
M386%P!MW@ M_=XQ[UI#6O&%U;^)-0L'M9TTZ\GL[6P2UW/)M9?G+;QD@$_*/
MO8Z\UM#P'I8N/EN=06P^T_:_[-$^+;S=V_.W&<;OFVYVY[5=?PIIDFEZEI[B
M8P:A<M=2D2%661B&RI'(P5!'TH XBX\5W%QX9UI9[VTU)[9K5A;7NG/;SQEI
ME5A)$_!'0JP[_05IW>O^([JS\0ZUIUU906>C3SQ1V4MN7-P(1ER[[@5R00,#
MC@G-:[>!-.GBNQ?7FH7T]TD4;W-S,#((XW\Q47"@ ;N3QD]Z6_\  NF7]S>N
M;G4(+:_??>V4%QLAN6P 2PQD9  .TC/?- &%+XB\1ZO<Z[+I5[:65IIUG!=P
MI-:^:\ADA\S8QW# XZCGGVYZ23Q)Y'P_/B>2WR5TS[>85/4^7OVY_2K2>';"
M.;5)45U.IQ)%.H. %5"@"C''!JQ;Z39P:%%HQC\VRCMA:[).=T87;@^N10!R
ML>K>(](O-"?5KVSO(-8<PO%#;F,VTIB:1=AW'<OR%3GGH?:KO@"^UW6?#EKK
M6LWMM+]OMXY8K>"W\L0\'.6W'=G@]!CFI].\%:?I]Y:W#7FHWGV)&2RCN[C>
MEL"-IVC ).WC+$D#O6MH^E6VAZ-9Z79[_LUI$L4>\Y;:!@9- 'GE[X[UV6[U
MBXTV*Y==.NY+:"PBT:XG6Z\LX;=.HPK,0V,<+QG/-:.M>+=:L/%-MX?A^RB7
M6A')ITTP"FU4?ZT2IG+' ^3IDG'8ULWO@73;VYO'^U:A!:WTGFWEE!<;(;A^
M,EAC(S@9VD9[U+=^"M(OO[2:X69Y[YXW:??B2'R\>6(B!\@4\C'<G.<T 9:Z
MEXFUF[UF;2+VPMH-+NS:16]S"2+AD56<R.#E =V!M'&,G/2N<^WZ_HUGXXUS
M3[VTCMM/U66=K62W+F<B*(L"^X;1C &!UZUV5_X&TW4+BZ=[K4(X+XJ;ZUAG
MV179 "Y<8X)  .TKD#FK4OA+3)M(UG3")A;:O(\ER%8 @LJJ=O' PHH Y?Q9
MXMU.PO=5%AJL"-80"6*TM]-ENV8[-Y\]U^6('MSTYSVJ>+6_$FOZO<6NF7MG
MI\,6E6E]E[;SF,DHD.W[P&WY.>_%:U[X%TZ]N-1<WFHPV^I?\?EI!<;(ICL"
M9/&X$J #@@''(-:&F>&['2KB2>W:8R26<%FQ=@<QQ!@G;K\YR: .6TGQ/KOB
MQ]+M]/N+73))-'AU*ZE:W,VYY"55%4L,+E&).2>@]ZS(?'NMW-EHUG*PAOKK
M[;)=7%EITMWL6&X,2A(TR>>,LW QZD5J:KX4FTM]*BT?3+^>WLK'[&EQ8Z@M
MO<A0?N.6(5D/!R/F!SCK5C0? $=KX6T>UNIY[/4[ S/'<6,_SQ>;(SM'N8$.
MO('S YV@T :_@[5]1UC2)I-3M9H9X+EX!)):R6WVA!@K((W^9<@X(]0:Y.Z\
M3^+%LK_5H+O3Q!;:XVF16CVI/F(;@0AF<-D$;AT'\/OQWFBZ-:Z%8M:VK32;
MY&FEEGD+R2R,<LS$]2?RJFWA+37TZ>Q/G>3-J']HO\_/F^:)?3IN X]* .=E
M\1ZWI+>(["^U336FL$M)(+V>W:- )BRD%%)+$;#M Y8D#WJA!XN\0LVNVEG.
M;^:STY-0M9+G3)+1Y,.P>/8V"P(7"M@<GOBNNU3P=I>K7%[<SM<I/=?9V,L4
MFUHG@9FC=..""QZYJ*'PXFAW=WKEK_:&K:J]L(&6>Y7,RAL@#("KCGI@<GN<
MT &C>(WU_P 13+8.C:1!8PRM)M^9YIAO4 ^@CP2/]L5B/:ZW<_$OQ$-(U&VL
ML:?9%VFM_.+-F?:,;AA?O9[],5M>!/#?_",>&4M)(DBN9Y7N9XT;<J,QX0'N
M%4*@_P!VGZEX-L]1U>XU1-0U.RNKF%+>9K2XV!XUW87&#_>//4=B.: ./3XB
M:EK+Z;!:B:P:334O+F2VTN6_/F,[($54'RKE&.3UX [UW/A35+[6?#MM>:E9
M26EX2Z2QO"\62K%0P5_F 8 , >0#56?P5IA^Q-I\UYI4MG;"TBEL90C&$<A&
MW A@#SDC())SS6OI.E6NB:7#I]DKB"$'&]RS,222Q)Y))))/O0!YW8^)?&%U
MI/AS4SJ&F@:U>&R\@V9Q#\LA$F[?EF_=D[>!SCWJ\WBG5[33=2M;S5;"*[L]
M76P^VO:NS21M$LGR0IDO+\V,#C@GM@]-;^$M-MM.T>QC\[R=)N/M-ME^=^''
MS<<C$C?I4%YX)TV[GFN5GO+>[DOA?K<02 /%+Y0B^7((P4&""#U- '*VOCC6
MFBO].619;S^TK6QM+NZL'MB!.N[<\+$'Y0&QTSQ5?4-7U;PAX@\4ZC>S0ZC=
MPZ58+;ND!3?OGE1=Z*220S'A>H [UUJ^ =(\K45EFOIY;]X99KB6X)E$L7W)
M%8?=8<=.. ,8XI8O >E8U,WLU[J#ZE EO=/=S;BRH6*D;0-I&[C;CH#UYH H
M>&?$&LW/B$:=>+>7EG+;-+]LET::Q$,BD?(=XPP8$D=QM.<YKL[B7R;:67<B
M[$+9D;:HP,\GL/>L&U\)0V4MQ=_VCJ5[?-:M;0SW=SEH4/.%*J,$D#+8+<#D
MUI6VF9\.PZ5J,K7G^B+;7$CDYF^3:Q)Z\\_G0!PFC^,]5F\0:##)J,>H6^J2
M/%-Y6ERP01L(FD!AF?'F#*X[Y!SQ2Z5XF\3R:5X>UV\O+&2UU*_2SDLDM2I5
M7=D#A]V=V0#C&,''O70V?@2PM;G2YWU'5+IM+;-D+BX!6)=A3;@* 1M.,G)X
M'-7(O"6FPZ/INEIYWV?3KE+F#+_-O5BPR<<C)- '"Z[J&O>(/!PUMKNT33)M
M5@1;'R#O6)+Q$5O,W??)4$C&,$CKS7>>*]4ETC0GN8+NSM)#)'&)KI6=5W,
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MG]G1Z+<%1 9-FX7&-I<+\Q_AX(]ZZ?PMJ&NZQJVK7-W>VJZ;:7]S916L=O\
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M\MXGMVF5]F[A@,9&<9'H>.@_X032UMH1%<7T5[%</<C44G_T@R. KL6(P<@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCM0![?169H?]DBQD_L8Q&V^T2[_*)(\W>?,Z]]V<UIT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M66VF7=%*AC=?52,$5R]IX7.I^ 5\+ZX)E%N!;+/"X#NL3#RI5/.&PJGD<'-
M&;IGB"YUG7O#EW<6EH8+^74&LY#&?,2W0*$(.>K@;C[$>E:W@N4P_P!MZ-_R
MRTK47@MQ_=A=$E1?HOF;1[**TO\ A'K".ZTBYB62/^R(7AM8T(V[64+@C'.
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M10JJ!@ #H* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8K/:J!Y8)SET!SC/4 =J /8J*Y#P!$MI;Z]80[EM;/6)X;>(L2(H]J-M7/0
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M)<7M]_Q*)O&<BO-YI5'C-J< MG[A.,]B#Z4 >U45Q7@?[(FN>)(-&=&T"*6
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MMSL7.,=*]$&,#'2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQQ*26(10H)]>*;%:6T"NL5O%&LARX1  Q]_6IJ* (I;6WN(1#-!%)$,81T!
MQTX-#6T#HZ/!&R/C<I0$-CIGUZ5+10!&UO"T3Q-#&8W^^I48;ZCO0MO"D21)
M#&L:8*(% "XZ8':I** *M_IUKJ5E<6ES&&BN4\N4#@NOID<^OYU:HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI 0<X(..#[4 +1129&2
M,C(YQ0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&-,;-L@0'/&>-@QSZUES>![)@TEO>WEM>#4)=0ANXBF^&208=0"I!0C@@@T
M<AJ7B?6]:TNUA@N((9[;7K* W:VDT<5TCNI5@C,& !R&7)SC@C.:6/5/$.AQ
M^.-7L6TUK/3]3DGFBGB<O/B"(N%8, G X)#9)]N>MF\$Q7.DRVL^L:E+>27D
M=[]O9T,BRQD%"J[=@4;1\NW'\ZG?P?9RZ+KNF27-RT>M.\ES)E=REXUC.WC
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M-=MH$DGGMKBVF%Q;7-N0)(9 ",C((/!((((()H \^\::IKESX>UWP]?RZ?\
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M<6EU8P>(EAN08G#10E8U9E)<@!=R'&. &]1CL]%UBXU;5M:0)$-/LKA;6&0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPU>KR^/P[HNL^*_$P^::SM],LOLODW+[!E9L."K<D8&#SCG'6L.&\O\ 6IM
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "HYK>"Y0)/#'*H.0LBAATQW]B?SJ2LS7/$&F^'+2*YU.
M9XXYI1!'LB:1GD()"@*"23M./4\=Z +D-E:6]K]E@M88K?!'DI&%3!Z\#BBT
ML;2PB,5G:P6T9.2D,809]<"L&X\=Z';!=[7Q(@6XF5+&9C;1MT:4!?W?0G#8
M.!GI4NH^-=$TV39)-<3A8%N9'M+:2=(H6SM=V12%4X)&>P)Z4 2Z=X?-KK>L
M:I=W?VN341'%Y9B"I'"F_:F.=WWVR3U]*T(M+T^"$PPV%K'$5*%$A4*5/48
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M%&95E,:&1055]O(!Z@'\!^586F^--$U6\AMK>:=3<*S6TDUM)%'<JHR3&[*
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M;B%X9(F(! 96 (R""#T- %R6RM9[3[)+;0R6V ODO&"F!T&WI0+&T%G]C%K
M+7;M\@1C9CTV],5R'_"P;33]=\0V6K>:L.FW,:K);VDL@BB:%'+RLH(4;F;D
MXX'L36OJ?C+1]*N7@E>ZGDBB$\WV2TDG$,9SAG**0H(!//89H U?[,L/L0LO
ML5M]D'2#REV#G/W<8JQ)%'-$T4J*\;##(PR"/0BLZR\0:7J$\D-M=J[1VT5V
M3@A3#("4<$\$':>G3'-8Z>.-*!N=0EU*-=*CL+>[&;:175)7=0Y)ZJV!@8R,
M$G@B@#HHM.LH+7[+#9V\=OG=Y21*$SG.< 8Z@&K-8%EXRT6]>\3SY[9K2#[3
M*+RVDMSY//[P;U&5X/(INF^-=%U74K?3X'NX[JYC:6".XLY8?-C SO7>HROO
M0!K0:7I]L9C!8VT1G_UICA5?,_WL#G\:G^SPYB/DQYBXC^4?)QCCTXXK+UCQ
M/IFAW=K9WCSM=W:NUO!!;O*\NS;NP%!Z;@?ID]C5.?QWX?M].M+UKJ9TNY'A
MACCMI&E:1/O1^6%W!A@\$9H V8M*TZ!V>&PM8V9Q(Q2%02PZ,<#K[U*EK;QE
M"D$2F/=L*H!MW'+8],GKZUST'C#3X;74+R\O@\,=\MM#%':2B4,T:.L6S!9W
M^;/ Z'&.#4C>.= CTNXU">ZEMXK:9(+B.:WD26)WQM#1E=PSD8.,&@#;NK"S
MO5VW=I!<+MVXEC#C&0<<]L@?D*62RM9K3[)+;0O;8"^2T8*8'0;>F*XO6OB
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MO<7,TJ.KMY6Q?(V,2 3R2P&!QC-8?_",>(+S0TADTEK>>/PE<:1Y;SQG=/\
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MR*V-P!Z@' S]!4M 'G4_AK6K;6;G6H+$7#V_B!K^*U\U%-Q UHD)*DG 8')
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M]2$6UT4C9,LK@.@.,':QQFO1]-2[CTNT2_D22]6%!</&,*TFT;B!Z$YJS10
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M32>88VB<8="3UZJ47UK7^'^D7ND:%=&_6X6:\OY[L+<NK2A7;Y?,*_+N( )
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MV9KCS)(H8_,**JKNW,20>2W '>K$?C76[ZXTS3+.RL(M2GNKNSNVF9VBB>
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M G*XP>.3Q0!Z51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,NGW5[]LDC2TD6*>.6VECE1VQM7RF4.2V1@ <]J -B.RM8O,\NVA3S%"/MC
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M'AV\F@-O;:DURDR?9Y7D#1@%%C &7SD<A3GGI@T =K/HFDW-U#=7&EV4MS"
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M7PDBG#*-P'09ZBO5Z* /)[CPUXFU+2;CC5I+6UU"UN[*"^N(EO9%0,)!YB'
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M\9ZY-MX6UC27TB\FL]9E7^P;.QFCTJ\2.6":)3E6!8!E.[J"<$'US7K-% '
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M*B@#BKF+5]"\3Z]>VVAS:M#JT<)@,+Q@)(B%-DF]AA3P<C/4_CDW>B^*+?\
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MCS-)_P ])6.Z1OQ8L?QJS>:1IVHW5I<WME!<36;F2W>1 QB8XY7/0\#\JNT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDB=#@X/T(((([$4 6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2F]$20QER4,@3Y0Y&"<=SZYKH** "BBB@ HHHH **** "BBB@ HHHH ****
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MR@7+3W+(\LGEB0I& I'"LO+$9)Q[U:N?!L=SH/B72S>LJZY/+,TGE\P[T5,
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M -VBN0_X3(S>/[C089;**TL;99KN2<N'8D.2%_A 4*"23WXK5T_Q;H&J>?\
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M.]:5C?6FIV45[8W$=Q;3+NCEC;*L/K0!8HK/U77=+T-(FU.]BMA,Q6/S#R[
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MR,WW-WW=QZ+GMG&:8/$EG:PZE<:G?6,,%K>_9E:.0D@[5(5@1_K,M]U<\8H
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MC>7''$S#_@<;#\*ZHC((.>?0XJ&RLK;3K*&SM(EBMX5"1H.P'\_K0!/1110
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M0!Y7I=CX@TK2_#5K/9ZC911:8\4UQIMG%-<B4R9\HLZML0@ YQ@GJ1BG^'M
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M11)"C@C.X;<X) )XKU"B@#R.WT/6IKW4IWLM5D6;6M*N8Y;Y4\V2*-EWNP0
M#&T\8! QD5V_C/3I]2M]%C@MVG$6L6L\J@9VHKY+'V%=+10!YIXHT;4)==UR
M_2VWP"329HHY'5%NS#-(SQ L0-QR, ]20.]9GB)[SQ+K7B>*UT6\M[B7PQY4
M44Z*LLQ,K8^4$X&<@9YX/;%>J:CIUGJUA+8W]NEQ;2@!XW&0<'(_$$ @]B*K
M:1X?TO0_..GVOE/.099&=I'?'3+L2Q YP,\9H P-;T:[N/$NEO:6A\B/1KZV
M9U "JS>3L4^F=K8^AKF(K2]72?#LQTSQ)IE[::2EDUW81K(X=-H,4D# AD)&
MX-]>E>LT4 8WA1-1C\*Z:FJV\-O?+"!+%"BHJGL-J\ XQD#@'.*V:** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMU#;"Z+2EF$A&-R %V*[22W10<\D"2U\=W]QJK:0]MHYOIK*:X@%GJGGB)T
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M&.DV<EC+YEMG[1$S(W'S?(P*#GGOQ0!8\6>+6\.WNFV4<=BLE]YA6XU&Z-O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>0VM\[31)*5 ;:T8!QN&1FNH_P"$GT+^TWTW^UK/[;&'9X/-&Y G+$CMCWH
MUJ*P%\:>'IM.OKVUU:TN([.+S9?+E!(7L?H3P#TK-T'QY97/A>TUK7+[2[(7
MIS!'#<%\#:#M.0"77)W8&!0!V-%9%[XJT#3K&"]O-8LH;6X0R0RM,NV51C)4
M]_O+T]:(O%6@37[V,>L6374:-(\0F&55?O$^@% &O167I?B31-:\[^S=4M;H
MPC=((I =JGHWT]^E947CK2K_ ,2:7I6DWEI?B[\[S7AF!,6Q=P.!U!Y&>G%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)):6\RP++*9KZUL/M<]K\F%V)AL;LD%MIQ^-<EIVB:I,"+JPU&4-XM@O=][
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M<NS=(Q8XP">%QR?3BG6?@[50NC6.I:Q!<Z5H\J2VZ1VI2:8QC$?F-N(^7@\
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M"A>&&T'=G.<]N*T+#7-6FU*T\)/>RG4[;59?M=P<;WLH\2JQ_P!\211Y]VH
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MRV;C'*E^Y/7%6_$MHVEO:6#>()[]3JVES+:W9#S0YN0"V\8)5L< C@J<'G%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYBD9YB\=QYV-@"J5ZL"-N,5ZW10!R?A+2VMM;\4W=Q9E)I]4W1S218,D8@B
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M<8..M<#I&C:E'IVF:!>R:XU_;ZDLTD$>FHL2LLV\S_:2F"IZYW;CDKBO::*
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M26=W#)]H;57M!\ZJ&#PB%RV.H*X( (-3^+]8U7_A+-.T*P34_(DLY+N8Z9Y
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M@MD5YYHXE9U13(P4%F. !GN20 *BFU"RMWD2:\MXFB57D#RJI16.%)R> 2"
M>Y% %FBJ5AJ^F:KYO]G:C:7GDMMD^SS+)L/H<$X-&HZOIFCQI)J>HVEDCG:C
M7,RQACZ L1F@"S/!'<V\L$R[HI4*.OJ",$4RRLX-/L;>RM8Q';6\2Q1("3M1
M1@#GG@ 5SOB#QG!I.JZ/I=F+&YO-3),8FO5A18P.&SAB=QX4 <G//%:&M>)]
M-T&_TJTOIDCDU&<PQ%I%4+A"VXY/3@+]6 [T 6X]&TZ.*_B%I&8]0D:2Z1_F
M65F4*<@^JJ!CIQ5#3?!^A:3,\UI9L)&A, :6>24I&>J)O8[%]EP.*BT7QEI>
MK,8);JTM+XW4]M':27*F23RI6CW!>"<[<]*U)];TJUU&+3[C4[.*]EQY=M).
MJR/GIA2<F@"E<^$-#N[&PM'LV2/3XQ%:-#/)%)"F NU75@V,  C/..:FL_#>
MCV'V#[)8QQ?V>)!;;2?DW_?/7DGN3DU9U;5+31=)NM3OI/+M;6,RR-C)P/0=
MSZ"N<'BO7K=+>]U#PI)!ID[HI:*Z$MQ"'("L\(7IDC(5F(H T+WP7X?U#4)+
MVZT_?+*RO,HF=8YF7&#)&&".1@?>!Z5?;1-.<:F&M5/]IC%Y\Q_>C8(^>>/E
M '&*6XUO2;2_BL+G5+*&\EQY=O).JR/GIA2<FEGUO2K6[%I<:G917)) ADG5
M7) W'Y2<]#GZ4 9]_P"#=!U(PFYL3F* 6P,4\D9:(=(WVL-Z^S9')]:-1\&Z
M!JDB27-AM981;_Z/,\&Z(=(VV,-RC^Z<BK]GKFDZA=/:V6J65S<1J&>*&X1W
M4'N0#D#D40ZWI-SJ,FG0:I92WT>=]LDZM(N.N5!R* +45K;P6B6D4,:6R((U
MB50%" 8"@=,8XQ6/IG@[0='O8[NRL=DT2LD.^9Y%@4]1&K,1&#_L@5<77]&>
M6:)=6L6DAC,DJBX3,: [2S#/ !XR>]9^H^-=!LO#=_KD.I6E]:V2%G^RW"/E
MNR YQN/84 78O#NDPZ?I]A'9JMMITBRVD>YOW3*" <YR<9/7/6G:UH.F^(;.
M.UU2V,\,<HF0"1D*N 0""I![FFV>MP7EW.(Y+5K..VCN%N8[I'W!BV<J/NJ-
MOWB<'GT-/M=?T:^M)[NTU:QN+:W!,TT5PC)'CD[B#@?C0!1M?!6@64;1PV4F
MQI8IB)+F63YXVW(1N8XP>??OFLSQ5\/].UNSO)+*WCAU&XECFWM-(L1=74ER
M@.TOM!&[;GWKI;/6=+U"YFMK+4K.YG@.)HH9U=H_]X Y'XU=H Y_4_!/AW6+
MVXN[[3O-EN4"7 $TBI, , N@8*Q Z$C(P,'@5:G\,Z-<Q7L<]A'(E\D<=P&)
M.\1C"=^".Q&#WJGX;\9:7XALK-A=6EO?W*%Q8&Y5I5 )'W>">!GI6F=;TD:H
M-+.J60U ]+4SKYOK]S.?TH S8O WAR*"]B_L[S!?1+%<M-/)*\JJ25W,S$Y!
M/!SD8'/ J2T\':%97374=DSW+0/;O-//),[Q-C*,SL2R\#@].V,FEL?%%G<0
M:M<7K0V%OIM\]F\T\P"':%.XDX SNZ4W2_%=AJ=QK.R6W2RTV2-?MGGJ8Y%:
M)9-V>@ W8ZGI0 ^R\(Z%I\*PP:>OEK:M9A99'E'DLVXI\Y.5SV_#I3=/\&Z#
MIC2M;63;I(3;EI9Y)2L1ZHI=CL7V7 J];ZWI-W8&_MM4LIK,,$-Q'.K1AB0
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MG2_A-O<M//)+))&01L+NQ8+@G@'C-7K/7-)U"[EM++5+*YN8?]9##<*[IVY
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M>46:1C)MW.^0 , $ #/WB<UTM4;/6]*U&ZFM;'4[.YN(?];%!.KLG;Y@#D4
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MTFNWUG3UMH9/)EF-R@1'_NDYP&]NM3OJ^FQ::-2DU"T6P*[A=-,HB(]=V<4
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MUF$=_?)9(A(RK-,8MQ]LC-8D?@;4I/$EEJ5RVDI+:W9G?4K6$Q7=TF3B.15
M7!! )R<@=!FFP^"M?CM-.TC[=IW]E:?JJ7\3A'\Z5!.9=C#[JD9/(SG Z<T
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MT3Z@67:#*@ 4<G=QNY Q@4 =%K7B%M,O[/3;.PEU#4KM7DC@C=4"QIC<[LW
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M]IXU4'3KV:WM;>&WMS:.(C@^<SG?EL')!&T$8SWT;W5=>U2U\5ZI::Q)I?\
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M<VD\4\#\I)$X96[<$=:Y#Q':S3?$SPC(E_<0J(KLF.-8RIVA"1\RD_,#@\]
M,8.37,>%)=8T;PGX3U!-9FDM[O4$LWL&AC\D122.N0=N_<#@YW8[8Q0!ZY17
MDD'BSQ1?6KZ[;1ZLW^FLB6@@MQ9&%9C&5+D^9OP"=V1\W&,5=O/$'B"QT[Q=
MXA.J/+%I5Y-:6EAY$?EGA K.V-QP7SU' YZT >G45Y<_B;Q)X?6ZN9HM7O;9
M--N;E_[5@MXBLT:;E*>4<E#R""#CCFM5;O7-"OO#LEUKLFJ1ZPY@N(9(8E6-
MS"T@>+8H(4%,$,6X/7- '>4UY$CV[W5=S!1N.,D]!]:\RT+5_$:Z5X+UR^UV
M6[.LS1V]S:-;Q+$%>)V#+M4,&!0$\D')X XK:^(-K-<W?A017]Q:_P#$Z1<P
MK&>3%(0WSJW(P0.WS'(/& #M:;)(D,;22NJ1J,LS'  ]2:\WN]9U^;P]X@\5
MP:TUL-+N;E8-.\F,PM' Y4K(2N_<^TG(88W# K6^)>^\^%^J2I++;[H%D(4+
MDC(^4Y!]>W- '7)=V\MU-;1SQ/<0A6EB5P60-G:2.HS@X^AJ:O-/[,U5_&?B
MD6GB*\M'M=/LV:9(86>>0++M+Y3;C@Y"A<Y[8JI%XOUW7I],MXCJL"MHMK?S
MMI%O [O+,#U\[("#:> ,DGD\4 >K5#/=V]J8A<3Q1&:011[W"[W.<*,]3P>/
M:L7PUJNHW?@Z'4-5M]M\D<GFHN/G*,P!PI(!8*#@'@G%<0W]KZCIW@?7[_6W
MN!J.IVUP]F8HUBB+QNRB,A0WR@X.XMGKQ0!ZO35D1RX1U8H=K '.TX!P?0X(
M/XUY5=>*M7CGMM4L]4U2[MY-6CMF*V44>GF%IQ'M5F E8@'[P)R1Z5 -1U3P
M[;^(7L;Z\GN+_P 4"Q7$4+M%NC1F=%VJ"Y V@,=O"\=<@'KU%<=X1U'6GUF_
MT_4%U&2S2&.:WFU)(4G#$L&4B+@KP"#@=QSBF2RZSK_BC7;&TUR;28-)$,<2
MP0Q/YLCQB3?)O5LJ,@8&.AYH Z:]UG3-.N[6UO;^WM[B[?9;Q22!6E;@84=3
MU'YU>KRWPO=WGB3QQH6NW%[-%)<>'S.]O&D?EY\U591E2VTGYNN>G..*]2H
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M8BUO29[Q+.+5+*2Z==RP)<(78>H7.2*MO/#'+'$\J+)*2(T9@"^!DX'? YH
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M.:)]4T^VL!?SWUM%9D BXDF58R#T.XG'- !8Z9::<UVUI%Y9NYVN9OF)W2$
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M_P"M>&=7"?[Q!X_&EL=6TW4X7FL-0M+N*,X=X)ED"GW(/% $?]AZ;YFFN+8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-!O)Y',[;_M$<4DAD>,+C:3EF 8L, ].*Z71]%ETW7->OGDC:+4;B*6)5SE
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M4IB>*X .2 #N5@2&4YX(]_2N;_X3*/3I+B-;?4M1GGUJ73X8AY>5D$>_:IR
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MYZCAV_.@#L(+ZTNI#';W4,LBQI*5CD#$(V=K8'8X.#WP:L5Y_P"!/^1EO/\
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M! C^9)YSHP!<'",%^O3!ZYZ'Q9>:I'JGAW3M,U 6/]H7<D4\OE([;%A=_EW
M@-\O'OU!'% '4U$EU;R7,MLD\;3PA3)$K@L@;.TD=1G!QZX->;W^O^(K2:YT
M*'5M]U!K5I9IJ$EO&7,,\>[#* %+KZ@#/''6EO=;UG1M4U;3([])[LOI=G%?
M36T896G>16D<* &P!P#QGZG(!Z94375NETEJT\0N'0R+$7&YE! + =< D9/N
M*\X\1Z]X@\)KK-B-7?4)$T=M0M;FX@B$D+K(J%6"*%93N!'&1@]:=K::Q:7D
MNE7FM-=R3:%?W#7/V6%'4JT("KA>%Y;CGKSD@&@#TE'61%=&#*PR&!R"/6EK
MS32=?NO"6D^'I-4OWN-'N-",BEXT5HYXHQ+M!4#.8\@ Y_U?J3GM_#AU)O#M
MA)K#AM1DB$D^%"A&;G9@?W<[?PH MRZC8P-<++>6\;6T8EG#R >4ASAFYX'R
MMR?0^E+8W]GJEE'>6%U#=6LN=DT+AT;!P<$<'D$5YG\1)[JZA\9V*W'DP6^F
M64H\N*/<^YY0RLQ4D@X'?C'&,G/=ZI</H'A&ZG?48TDM;9C]LNHAM#8X9DC
MSSCA0,]!0!LT5Y=;^)M<LM8>U>]U:>"?2;JZ1]4L8;<K+$$(:-54-M^;D./3
MD\U<TO4/$:7'A.6\UY[E?$%NXFB-M$JV[_9S*K1X7/!&"&)!SVH ]%HK@=!\
M4:KK%UH6DM*J:A ;@ZV51?\ EB3%C&,#>Y5ACL#BNSU2[6PTF\O&FB@$$#R&
M6;.Q,*3EL<X'?% %NBO,-)\2:XGB/1;=K_4KNWU*"<NVI6$=M"72+>K1859
MN1_%G@]<U9\)Z]K)UVPL]>O]1AN[J%]]I>6,0@ED"[LVTT0P5 !.&))% 'HU
M1-=6ZW26K3QBX=#(L1<;V4$ L!U(!(Y]Q7)^-+[7+6^L%T]M06P,<C73:5##
M-<JP*[#LD!RG+9V@G.*YZVGO?$GBCPQ-9Z^5E?2+P3WT%HJ.VV:)6 CD!"-N
M !R#T. ., 'J51375O;O"D\\<;3/Y<0=P#(V"=JYZG )P/0UYQ'XGU6;1[&T
MN-8N$O\ [?>VDCV%BLMU=+!(R!D3:43^$L2,<\8S52QUC4-7DT%=2>:2:R\5
MR6JO<1I'*R"UE8;U3Y0WS8./2@#U*VNK>\MUGM9XYX6SMDB<,IP<'!'N"*+:
MZM[VW2XM9XYX)!E)(G#*P]B.#7,_#7_D0=._WI__ $<]<=X2GUK1O"7A"^76
M&DM+R]2S>P,$8C6-V< AL;]P(!SNQ[4 >N45Y3J7BW6()&U2RU6_N[=-32W*
M1:?&MAY1G$17S'42,PSC<I(W#IBM:Z\2ZQ#=7OAP7(_MI]6C@M)O+7(M)!YO
MF;<8.V-95SCJ@SUH ] J*YNK>S@,]U/'!"" 9)'"J"2 .3ZD@?C7EDWB[Q/=
M#5-4L$U1OLE]+!;V4=G";61(I-A$DC?.&;:3D$ $C@]^I^)GF2?#^]$3+'*T
MMKL:09"G[1'@GVH Z^BO-]>\2:WX)FU*&;4&U@?V1)?0-<0HC12I(B8/EA04
M/F \\C:>:C@\2^(]&GDFNTU:_M%L+BXF_M"SAM]DD2;QY?E\E6P1@Y(XYH ]
M,HKS3P[X@\32W^ASW)U2Z@U @7:7-G##!$&0L&A9?F(! &&+9!SQBHM%UOQ*
M=&\*:]>ZX;D:I>1VL]E]FB6+8^\!@0NX,-H/7'7@4 >CW^H66EV;WFH7<%K;
M1XWS3R!$7/ R3Q19:A9:E 9[&[@NH@<%X9 XS@'&1[$'\:Y+XD6<UW;^'TBO
MI;8'6;93Y:(V26X;YU/*XR.W/(-94_B'5-)T76=6AN(F72]=>&2U\E%-Y%A%
M\L%5SYF6RI'4@ Y'0 ]+HKR^;Q7KKZ3X;"7DTL^OO-<O+IMO'*]M"JAA#&&&
M"1N +,">&XZ8D@\1^)9?LVBRRW-I/=:J+2'4KJVB6;R/(:4DQC*"3*E0<8((
M.* /1X[JWEN)K>.>-YH<>;&K LF1D;AVR.F:([JWFGF@BGC>: @2QJX+1DC(
MW#MD<\UQW@ZVN[3QEXNAO+\WTJM:8G=%1V7RCC<% 7/T SZ5FZWKVKVNK:]!
MIUS#;RC5]-LXI#;HVU9EC#;N,M]X]3D= 10!Z117*>'KK5+;Q;J^A:AJ<FI1
M06UO=0SS11I(OF&164[%4$9C!'&>>]=70 4444 %%%% !1110 4444 %%%%
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M%E<^:@**&D&X?(",\^G%8]SXJL(M5N=+@99[Z&P^W+&)459%.=JAB>"=N>>
M"#TH BLO!&A6%[!<P03[;:0RVUN]S(\%NYSEHXRVU3R<8'&>,5&_@'P_)=M<
M-;W!!NA>"#[7+Y*3AP_F+'NVABPYP.Y]36RVJ6D$%L][<6]H]PH*I+,HR2.@
M.<-U[5)=:A960)N[RWMP "3+*J8!X'4T 49?#&DS:9J.G26Q-KJ,S3W*>8WS
MNQ!)SG(Z#I4%]X.T34;V^NKJWE:2^C2.X47$BJ^P@H^T' ==HPPP1CK6K<ZC
M8V<*375Y;P128"/+*JJV?0D\U8#!E#*05(R".AH R](\.V&BS3SV_P!HEN;@
M*LMQ=7#SR,JYVKN<D@#)X'')J.\\*Z/?ZE=7US;-))=VWV6Y0RMY<T8S@,F=
MI(R<'&1FK\.I6-Q<?9X+VVEFVA_+256;:>AP#G'O2KJ-B\CHE[;L\:%W42J2
MJYQD\\#(/- &;I/A72]&O#>0"YFNO*\E9KNZDG:./.=BEV.T9 Z=<#-6M4T+
M3=9GL)K^V$LEA<"YMFW$;)!T/'7Z'C@>E3PZE8W, G@O;>6%G""1)592QXQD
M'&?:H]3U'[!;,\4:3S@H1!YR1DJ7"ELL0,#.??&!R: *)\(:&;;6;?[%B/6F
M9[X!V!E)&#SGC\,=35J^T'3M2N(Y[J O)';2VJD.PQ'*%#C@]]J\]1BH/$7B
M2Q\.Z5>W<\D<DUM;O<"U$JK)(JC)P#SVZU9@U,275U%/&D$4+1K'*TR'S"Z@
M] <KR<<]>U &==^"=$O! #'<P&&V6TW6UW+"TD"](W*L-P^OJ?6K]EH&F:=/
M/+9VJPM/;Q6SA"0OEQ!@B@=!@.W2K5M?V=Y"TUK=P3Q*2&>*0,H(ZY(I+74;
M*] -I>6]QG)_=2J_3@]#VR/SH ;IVFVNE:5;:99Q[+2VB6&)"Q;" 8 R>3Q6
M;I/A#1]$DM'LH9@;..2*W\RX>3RDD*EE&XGY?D7 [8XZU'J?BE;/Q3I_A^VM
MDN;JY0S2EKA8Q#&&52<'EF^;(4=<&MF'4+*YN);>"[@EFB_UD<<@9D^H!R*
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M9F]-D+N W8&XP>8-^/7;G- O[,W'V<7<!G )\OS!NP.IQG/% &59^$-&LUO
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MO&W!E&&= %0E<\A:7[!:7]OXCG2]N+NPDL8([B31]&\B(NLNY6"LY\UE&=P
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M1ABL@B.\HQZ'<.2/05Z#10 4444 %%%% !1110 4444 %%%% !1110 4444
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M6T&J,$\EW+;5.-V\*S<!BH'(]:T_"^BMH?AZ*PFCLTEW.\B6<7EQ LQ.%'7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_8<L?\ T<M8-EKNJ7FIQZ)93P6#WFL:DKW45NA98X&' 4C:78L,LP/0GDT
M>DU'-<0VR!YY8XE+! SL%!8G '/<D@"O/K;Q)K]M<"SO+V&XDC\3)IC2I"%W
MP&W#\CLQ)R2.^<<4_P 0>(;Y-4UBS/D206>I:3'"DD*OM$LB[SR.O<'J#R*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *S-:T&SUV*W6Z,\<MM*)K>>WE,<D3X(R"/4$@CH<UIT4
M <P/ .AB*\4K=M+=R132W#73F7S8\[)%?.589[=N,8XIW_""Z.UK-'*U[+<2
MS)<->O=.;@2("$8/G(V@D #C!/')KI:* .<_X0?1FL)[:474TLTZ7+W<ERYN
M/-081Q)G*E0,#&!C/')I!X'T=M,U"RF^UW!U HUS<S7+-.Y0@H=^<C:0" ,
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M;[2H5QT;&203SGFB[\$Z3<NCH][:.+=+61K2Z>(S1*,*K[3S@$\]>3S71T4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@$[<,2#A@<, <5H:QKBZ3);01Z?>W]U<EO*@M$4DA1EB69E50,CJ1UXS6<=
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MWHUZX^\?5CR:\WT#1Y-:^&$&GV?@**:\N;=XXM6E:V15<LP$N[<9/E//3/%
M'N=%><W6O>(-,O/$#OJ$+Z?X;LXII(C;[I+QC!N(+Y^097.<'K[4FB^(_$MY
MJ-A;R->3IJ$3B:5]#EMX[&3865E9N'3(VX8Y.0<]J /0+>]M+MY4MKF&9X6V
M2K'(&*-Z-CH?K4]>*^&=8O\ 0O#'AO3+.5DEU2*>[GNK72S<2HB,!MV)G<Q9
MLEVZ#CN*Z!?$_BF\M]*L8_\ 0KRZU66Q^UW>GO'YL*PM()1$Y!!XQC.,J>U
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M >E4=1D5SM_=WFI?#RXO#')IUY/IK2O'(GS0,8\E2#CD<BN)LO$FK6.G^&]
MAN[E#_8D-[+=6NE/=.0WRQQA%R% "G+'K@=,T >L45YQ'XC\5ZJWA[3XRFDW
ME\;Q+B:XL6R1"5V2)$Y!&X'.">-W?%5[[Q)XLATW6=7AU"Q\K3-6%A':O:<3
MJ9(TRS!LK_K.,>G?/ !Z?17G]UK/BS3;C7]+BEBU:^MK2VN[9X[4(P621TD
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M58M3%W?6=XD)MVEM)MADBSNVMD'C.2",$9ZU';>,-,O)-(%OYKQZH\Z0R%0
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M4#@B/;N)/;[P_.K@D0R&,.I<#)7/(_"@"OIFGP:3I5IIUMN^SVD*01[CD[5
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MW%S<EI(55PZA" ,895;/4E1DFGCP'I,EQ<W%]-?7\]U9O8SR75P6+Q,0<8
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M7HO@62'4/ EBIT];:V9)(A;M(TJ,@=ERI?DHP&1D?=('2NF959=K*"/0BEH
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M>]TB?Q.WE1VT#1VP3[-)N2(,QW1%@>AVG+ <5[054KM(!7IC'%     &!TH
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MV.=I Z5UWQ$@TH:CX2O=6@M&MH=6V237,:LJ*T,N 21P"X3\0OH*[D*H8L%
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M#X[GD9/K7JY56QN4'!R,CI2T >.Z!ID=GIWP\U+3[=$U:]MIA-<D?O)R;1V
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MW;H6:$.,9)+D.Q&!T*XYKI(?&^EF'4GOHKS37TZ)9YXKR':_EMD*R@$[@2I
M YSQC-8=[X6UJ:]UB"."W-K=ZU9ZI%/Y_.V,P[T*XX($1(.><BIO%G@N]\1Z
MAK;1R0QQ7FF6L$+.Q_UT,[RX;'(4Y49'/)H W]*\46VJ:@=/DLK^PO#%Y\<-
M["$:2/(!9<$@X)&1G(R,BLS5_%5SI/CN#2Q:W=Y;RZ8TZVUI"'<R"0#=DD
M+GJ1V[U6\,^&KFV\1)J5QH=MIJ0VS1*3?RW<K.Q&=I8[53"^F3QTQ5S5[+7;
M;QI#KFEV%M>VXTYK22&2X\I]QD# J2".W.?7VY )V\<:4]EI\]G%>7LU_O\
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M=&4E65E/0@@UQ^M?$!2EB-(@O1%/JUO9+?-;9MY@9@DBJW7IN 8@ XX)K?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.!0I.XJC.<GMPIH N45GZ+K%OKNF+?VJR+$TLL0$@ ;,<C1MT)XRAQ[8K0H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF#'9Y!LX\;R/^69D\O/;'7C-9.H1:%/'XRM= E0Z6TVC(OV60^4I-R=WE$'
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M'6O:$@ACE>5(D61_O,% +?4]ZSM5T&UU6:REDS%):WD=V&C49=D! #''3YJ
M/,KC6[&'P1<Z-)?1C51XD*FUW_O5']H!\E>H780<].1ZT^>RAU;6(K"\#26L
MWC"Z22/<0'46C':<=CCD=Q7K9MX3(TAAC\Q@ 6VC) Z<T[RTSG8N<[LX[^M
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M6#2DN[.,11R:E.SW6\0AE-K$,; 2>&!Y;)/2O:%54&%4 >@%,:"%IA*T49D
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M08':@#2HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&G+0^84X<;1P>>>HXXYL6OB37?$E\8=#-A:);V%M=S&\B>4R23*66,;67:H
MY;GKTXH [>BL+PEK-SKO@_3]7O(XH[FXA\R1(\A <G@9)XXKDM-\>:C+K>C1
M2W^EWL.HW)MY8;*TFVVYV.PVW!)23E<'@9Y(Z4 >E45YS8^+O$TFFZ7KES_9
M?]GW>J+I[6L<+B0*TYA$@<OC.0#MV].]7QXPU'RVTTPVW]NC6O[.";6V>7_K
M?-VYSCR/FZ_>'X4 =O17.^,M8U'1-*@N-/AR'N%CN)_LSW'V:(AB9#&A#-R
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M0NLEN8HE?!8L0^5R,X7FJ^A?$#5-0N]'FF$,\&IR*CV<&G7"/9JX)5C,WR2
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M!O\ -T^98)MPP-Q17&/48<5?H Y[QUIMWK'@;6-.L83-=7%LT<488+N)[9)
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M+A@RLI&,@@]!Z5KT4 <[IW@VQTZ_LK\75Y/=VS7#M-,ZDSO-MWL^ !_ H 7
M '2J]QX&MY;B[$.K:G:V%[.;BZL()$6.1R06(;;O4,1DA6&>?6NJHH Y*^\
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M:Z>B@#/L='M]/U35+^)Y6EU&5)90Q&U2D:H-O'3"CKGFM"BB@ HHHH ****
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M5U(*-DM@G'('8YJ"7PAJ5]I^JRQ:1=6TUQ)9)$E_J;7,\D<4ZR.6+2,BJ!G
M!)Z^N* /0;+6;6]T<ZIMGMK959F^UP-"R*N<DJP! XS]*S].\9Z/J4QB5KFV
M)MVNHVO+:2!981C+J7 ! R,^Q%;&H0O<:;=0Q1PR220NBI."8V)! #8_A]?:
MO,K/PAKMU:W6E6]O?Z+IESID]K<6]WJ"W4 E= J>0-S,J@Y)R5XXQ0!VNF^,
M]'U6ZBMX6NHVGC:6V:XM9(EN449+1E@ W'/'..>E4(/'6FZRNG3:5=31V]Q>
M0Q":>QE"7 =7.R-B ,_*<GD#&#UK#T/PQJ)U/27N]%OK<Z?&YDGO-:DN8_,\
MLH/(3S#P=QY<+@<8S5ZR\,ZI!X/\#Z>ULHN=*NK:2[02+\@2-U8YS@\L.E &
MVGC;1)-06U66XV-<?95N_LTGV=ILX\L2XVDYXZXSQG-*OC31FU,6(>Z^:Y-F
MMS]ED\@S@X\L28V[L@CKC/'6N&T[P+J5I:6NA3Z5?7,<-X&-Y)K,@LVB$N\/
MY D!W]/EVXW<YQ6@WA[7X/$9GTO3KK39WU'SI[JWOP;&X@+Y8O S%O,9,@X4
M?-SNH [O5]8LM#L?ME_*4C+K&BHA=Y'8X55502S$]@*Y?Q#\0;>T\)ZI?:7'
M<?VC:%(FMKFSD#PL_P!UG3 .W&2#T)XSFM3Q=I=]?1:5>:="EQ<Z9?I>"V9P
MGG*$=&4$\!L.2,\9%<UK/A[7?$2>(-2;3/L4UY:6MG:V<DR&1ECF,C.Y4E0?
MF( !/ H Z'5=6U#2/AQ?:OYPGO[:PDN%DFM3#N8*2-T1.5[9&:Q[O6/%/AV+
M2+[4-5TO4;:^NH+9K6.Q:"7]Z0,H?-;<1G.,= >E='XRTZYU?P7K6G648DNK
MJREBB0L%W,RD 9/ J#1/!'AO13;75IH.GV]]'&!YR0+O5L8.#V[]* &+X]T!
MI-0'GW"Q:>9%N;AK601(Z/L9-^W!?.,*,DY&.M5]2\>V4&@:Q>6UO>+?6%HU
MR+2ZLY8Y",':^T@$ID<L.!SG%95WX.U.\\#ZMIH18[R36IM1A3S]@E7[495&
M]>5+*!SU!QZ55'A74;VWUZ9-&OK6:;19[&W_ +2U9KJ:220?=&9&14R%Y)SG
MT% &UI/C*.UT:P&K37E]J=S ;EHK72Y5D2/.-S1@$JN00"?O=LU?NO'6@VWV
M#9//=-?P^?;+:6TDS2(" 6PH)&,\YZ<US.H>%=2MM>34TL-2OHI]-M[9XM.U
M0VDD,L6[[V'0,AW=<D@@X'-:'ACPK?:/K6C3R6<4$%OI-S#*(YVE$<TLZ2;0
MSDLW1N>GZ4 :<?C_ ,/R+?2">X$%EO6>X:UD$8=7\LQAMN&?<1A1DG(Q5BW\
M9:-+;WTT\L]D;&(37$=[;O"Z1G.'VL,D'!'&>>.O%<S<>#=4N? $FF^6$OHM
M8EU".(7'E^:OVII57S%.5)0C!Z@XZ8JE+X+U'5[?594TRZL)VM(XK9M5U1[N
M61TF67:?WCJL9**/7DF@#H].\9#5O&]OI%M#<0V[:=+=2)=VCPR[A)&J$;@/
ME(9OQ'M3?&'B.[TO6=+TN+4K'1X+U)7;4KZ/>@9=N(E!95W'<3R>B\ T:?%K
MFI>.[76+[0VTVS@TR:V_>7$<CM(TD3=$)^7"'!^N0.,V_$BZVM]#):Z7!K6D
M/"8[G3G:-'#YRLBE_E88R"I([$4 95]XKUSPYX7O+[4X+?4&CNH8;2\LHV,=
MS'(R@N44L4(RPZX)P!UK8OO'&C:?,\4WVUFAB2:Z,5E*XM589!EPOR''.#R!
MR17(#P=JW_".^(S8Z+%IBWUQ:3VFC)<)A##(KNV1\B,^.@./E&36HMKXBTN;
M7OLN@&[76V%U&3<Q+]FD:%(VCFR>54IG*;LY- &_J7C+1]-E6)I+BZ<P"Z86
M5L\^R$])&V X4X./7!Q6=#XWM$U;6&NKJ(Z7!#9/9O$A9YC.KD!0,ER<#  S
M69H^A:YX)F9;'3#K4<^FVEMNCG2,QRP(4^8.1^[.0<C)'/%4[GP3KL^O7?B3
M;;IKEI!9R6)AD*V\LJ(XFCV$\*P;:">1D$=Z /0]0U.TTK2Y=2OI##;0IO=F
M4D@>F!R3D@8'.:Y;7?'L%OX9U:\L%FM[_3TBD>"_M7B94=PH;:P&01NY'<5M
MZ_:W&K>$[JW73()YYX1NL;N3"L>"4+*>#U 8'@X-<++X8\27>BZU8P6VHPZ=
M/! MO8ZI?I<2"590S%7W-M3:,8+')["@#M+3QIHMTUXKRW%H;2W^U2"]MI(#
MY'/[P;P,KQ5?_A-]/NHKJ*V2\@O!9RW=LMY9R0B94'WEW 9 RN1UYJGXGT;7
MKG7KK4=$$23?V'-:P2R,N!.TJ,!@^P/)&,]:P8O#&MW.N6U\--U..)-.N[:1
MM3U1;B4R2(H7"ARBKE<97&<\@ "@#H_#/B6_U?5K2VN1#Y<N@6>HML7!\V5G
M#=^GRC IM]XU72?&>H:5>17$MO#8P7,26EI)-)\S2!V;:#A0%7TZ]Z9X5\/Z
MEIFLV=Q=P!(H_#ME8,0ZG$T;2%UX/;<.>E:=II5U%X\U?5'B M+BPMH(GW#)
M9&E+#'4<.OYT +<>,]'BBLG@>YOFO;?[5!'96SS.T/'SD*/E'('..>*GTSQ3
MI&KS6<5E<F1KRV>Y@S&R[T1@C]1PRL0"O45PFG^'?$^GZ9H%A<V>H365MI20
M26^FZ@ELR7(8Y,CAE8IMVXVDXP>#4D/A+Q)I_P /])6P@BC\2:5<W+1*9PR,
MDSR!OG/4;75^><H.] '72^-M%2&%X7N;IYY)8X8;:V>623RFVNP4#.T$8W=.
MG/-:VEZK9ZSI\=]83>; Y(!*E2I!P593@@@@@@\@BN#U/P1-IE_HMQIUK?WM
MG9:;_9TD-AJ!M)P0P82!MZ!@2#N!8<X/-=/X,TB;1]#>.XM!:3W%Q+</#]I>
MX92S?Q2,26;&,D<9SB@"&/Q_H$ETD*RW11KHV9N/LD@A2<.4\MI-NT$L,=>X
M]:DO/'&AV-[/;S2W!CMI!#<W26TC6\#G'RO(!M4\C//&><5A'POJO_" S:6+
M9?MC:U]K">8O,?V\3;LYQ]SG'7MUJ"[T3Q#!H?B+PQ;:2MQ%JUQ<O#J)N$$<
M:7#$L9%)W[EW'&T'.!R* .ZU/5;31[(7E[(8[?S$C+A20I=@JYQT&2.>@JKJ
M/B?2-)N+J&]N_*:UMUN9OD8A49BB]!RS," HY/85)J&BP:EX:GT2X8M!-:FW
M9CUQMQN^HZ_6N'M_"/B*Z\+SWNI) _B5[^UO&B,@\N1;9DV1[AD ,$9O8R<T
M ;>I_$"QMO#^LWMM;W8O].M#<_8KJTDBD(P=K;2,[,CEAP.<XJ1?&=G;M/>:
MA=_9[.'3H+N2"2TD22+?(Z;R3V)7&,9&,]#6/K&AZ[XJEUB]DTLZ87T*XTVU
M@GGC9Y9)2#EBA*JH*@#G/).!575_#6O:U;:G-_99@EN]&M+18))XR1+'.[,I
M(./ND'/3GUH ZZR\9Z->RW<9DN+5K6W-TXO;:2#,'_/0;P,K[]J;IOC;1]3U
M*UT^+[9%<W:-+;I<V<D7FH!DNI90",?YYK$\<^'9M4O-2NI9H[73V\/7-J]W
M(PVQN9$<;AUVX4DG'2JL.JZEJ_Q!\*"\TV"T\JTNY3Y5TD^\%$&Y=O2/)&"<
M$YZ#% '7ZSXFT[0KNTL[LW#W5XKFW@MX'E>79MW8"@]-P/TR>U5V\::(-+M[
MY)YI!<3-;Q6\=N[3M*N=T?E8W!A@YR.,<UC^*;N\L_B'X8FLM.:_<6=\&A21
M4?;F#E2Q"YSC@D<9K/MO#>O:?J-KXF&GK/=G4+NZGTR.=0R1SHB *Y(4NHB4
MGD [FP?4 ZNR\7Z-?R6L44\JS7-P]JL4L+QNDR(7*." 5;:"1GKVS1!XPT2Y
MM9;B"\\R.+4!IC;8V)^T;@NT#'/+#GICGI7*WGAO7KVSUK7(K*.WUJ?4+:^L
M+)YE.SR%5 '8';N==X."0 PY-,T/P'J.E>*-+#!&TB"UAN[A]XR]^D30DXZG
M*MNSZJ* .HA\;:)/?I:I+<;))S;1W9MI!;R3 XV++C:3D$=<$C YJ?3O%>EZ
MMK%SIED;F6:U>2.:06SB)'1MK(9"-N[OC/3FN TKP-J5G:Z?HEQI5].EK=HS
M7LFLR?8VB23>'$(DSOX'R[0H;G.*[KPGI=UI5OJRW<0C:YU6ZN8\,#NC>0E3
MQ[=J 'ZMXNTS2+R2TE6\N)X8A-.EI:23^2ASAGV@[<X/'7@\5#=>.-$MY+:*
M.2ZO);JU6]@CL[629I(6Z. H/''?V]16'XCTGQ!?^(=07[-J%UI\T")8BTU$
M6L,;8(?S]K+(W)SQNXXQ4G@SPWJFDW^D37UL(EMO#L&GR'S%;$R.21P>F,'/
M2@#:D\:Z(MEI]U!+/=C4$,EM%:6SRR.B_>;8HR ,@'.,'CK2>#-?D\2Z+<:@
MY1D^W7,,+*A7,22LJ$@\YV@9KF-"\/Z]X9;2-272S?216ES9W-I%/&LB![@R
MHZEF"D=B,@\CKC%=+X(T[4=-T2Y35+:.VNI]0NKDQ1R!U422LXP1UX- #[;Q
MIHUWJ,5G$]UB:9K>"Y:UD6"65<Y19"-I/RMWYP<9K'\,_$.TU"RLTU/SH[N>
M[EM/.2TD%OY@E=43S,;=Q4+WZGUXK.L/#VOV?B&VDL-.NM*'V]I;UX;\/83P
MEB6*PLQ978$=%7!).:M0>%]5C\":3IAME%W;ZREW(GF+Q&+PRDYS@_(<XZ]N
MM &Y<>.M$MKR2"1[LQ17 M9;M+21K>.4D+L:0#:#D@'G )P:RI?%NI)K,MJ!
M!Y:>(XM,'R'/DM;B0]_O;CU]*Y[7?#/BK5K/4K:XL;^YO&O3+#-_::Q6?DB4
M,H6%6&6V@##KUR=W2MN;PQJSZW-<BW7RF\30Z@#YB_ZA;98RW7^\",=: .KU
MOQ!IWAZ&WEU&21!<S"WA$<32,\A5F"A5!))"G'O@52B\;:(^EW=_)-/ MI,(
M)X9[=TF21L;4\LC<2VX8P#G/%+XETNZU*_\ #LMM$'2RU07,Y+ ;4$4JYYZ\
MLO2N>U?POK$VMZMJEK;QR,FJ66H6L3RA1<B*$(ZY_A/)P3W [<T 7=:^(5G9
M>&=6U"RM[DW]@BE[.YM9(W3?]UF4C.P\_,..,9K7\1:U-8>!]3UNR1DF@L9+
MF)+B)E(8(6 93@CW!Q7)Z[X>U[Q1'K^H-IGV":?2EL+2TFG1I)2)#(68J2J\
MX Y/<G%=1XCM;_7O &JVD=DT-_>Z?+&MM)(I*R,A 4L#MZGKG% ":/XSTK57
MC@\R>"9[?[0AN;=X5FC&-SH7 #*,CIV(/2G:9XST?5KV"VMWND-TK-:R3VLD
M4=R ,DQLP ;CGW'(XKG;_0=<\6RVL%_IHTB*SL+JW,IG23S99HO*_=A3D( 2
MV6P>G%5?#WA;44U'0TO=&OH?[-.^6YNM:DN(=ZH4!@C\P]<G[RKA21@T =UK
M&NV.AQP&[:5I;A_+@@@B:665L9(55!)P 23T'>LZ3QSH,6F0W\EQ.L<MU]B$
M7V:3S5GVEO+,>-P;"GC'.1CJ*S_&_AZ\U/5-$U6T@NKI=/,R36UI>FUF9) O
MS(X9>04'!(!!-95CX2U%6TV[&F/;-_;ZWT\<]\US,(5@>,-([,P+Y*C"DX&.
MN#0!J:O\0[.UT&2_L+:ZDGAOX+.>VFM)5DA,CK]Y,9'RME>Q) ')Q46K^.FT
MEYV0/=C^U;2S\E+*7?;I*L;,&Q]Y\.2.G)"X)%5M?\-:Q<S>)[BTLUF:YO=.
MNK6/S54S" QEQDGY3\A SBHM1\/:[,VK:A#II:676K#4H;4SQAI$B2'>N[.T
M$%&')QQ0!M6/C&**+7+C5GV16FK?8;5(H6:23,4;*@09+.2[< =O:KJ^,]%_
MLR[OI9IH!:2+%/!-;NDR.V-B^61N);(Q@'.>*Y'4?!VL7:W=Z+67S$\0'4H[
M6*\\F26%K9(B%D1AM<'=C)&=I'0TB>$-4DCN=5M]*FM[N*^M+J"VO]2:XGN5
M@+$J[EW5/OMMP3@]?8 Z70?%C:YXOU/3HHY8K:TLX)?+N+=X94D=I P8-CC:
MJ$<=^M=57):#;ZO<>--4UK4-).G6T]C;V\"/-&\A*/*6W;"0#\X[GC'.<@=;
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5%-;07)B,\$<IB<21ET#;' (##/0\GGWJ6N/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %CU/O3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:%J%AK-W<75MLCDT:QM5;<IS)&)=Z\'MN7GH<T :B^);)M25QJ=G_9QTS^T
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M03P* .KHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** (7M+:6[ANI((VN(598I2H+(&QN /;.!GZ"IJ** "BBB@"O?6-IJ5G)9
MWUM#<VT@P\4R!U;Z@U#I>C:;HMNUOI=A;V<3-N98(PH9O4XZFKU% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(DT)WUY=4_MC5%
M4$'[$LR_9SA<?=VY]^O6L?QS<^(MEG8Z)I][+;7!;[;=63Q+-%&/X8_,90&;
M^]SM XYQCKZ* ,3PK''!H4=K#H=QHT-NQCCMKAHV8C@[LHS Y)/).2<DU)IF
MA/INH3W;:QJEX)@0(+J96CCR<_* H(QTZ]*UZ* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex31articlesofincorporat003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]G1[HQR16_DD'S8-P(W$$=,'KR<UH>+-<NK#4[.QMM5BLA+"\A6&QDO;IR"
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M;*-#<M*L"2[E\]?EPW ['/M5'Q/X3BL=-M_MM]<ZC=ZMKEBM[<2[8S(@<($
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M18\%MJJ6('O@55OM=ALO#,FN_9YYH4MA<^5&!YA7&< $XSCWKS)CX,7PL_\
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M;L5S>D:797^J>$WN+*.XL?[6U!-.:YCW,;14D:$ MSM!&5SV - 'L1(4$L0
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MLY&V/A)^1A3V).-P% '2:AK-MIM[IEK*LC/J,YMX60 @,(VDRW/3"'IGG%:
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M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,"G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 444QI8T;:TBJ<9P3CCUH ?12.ZQHSNP55&2Q. !2T %%%% !11
M10 44$@ DG %1QW$,K;8YHW/HK T 244@92Q4,"PZC/2AF50"S 9.!D]Z %H
MI&947<S #U)I: "BBB@ HI%974,K!E/0@YI: "BBB@ HI&94&68 >I-([K&I
M9V"J.I)P* '44R.:*4$QR(^.NU@:<K*V=K X.#@]Z %HHI&95&68 9QR>] "
MT4BLK9VL#@X.#WI: "BD9E12S$*HZDG %+0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUT9;*&QGN8[2SM?LL=KYF8R,@[V&,E^.N>YK6H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBD5E==RL&'J#F@!:*** "BBB@ HI&944LS!5'4DXI<Y&10 4444 %%%%
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MMPB[2Q#!\(<-QP<D=!1XGU?7M9T?QA'I?V"/3M-AFLY$GC=I;AO(#N58, F
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M6@M-4B=O[-)3S&78GS,@494 G._J!T['5O"@O]7&KV&JWVDZB8A#)-:;&69
M25#HZLIQDX.,C)JL/ =@--,/VZ_-_P#;!?\ ]IF13<?: NT/]W;C;\NW;MQQ
MB@#GSX_UA=+OE@AM+R\M[RS@@NC:S6\%PL\@3[C'<K*<YP2.0?:EU/Q/>^%M
M0UBZU.UT^ZU*VTJT)GMHY(Q*TES+&BD%F(09!XYY;V Z+_A"XIK>1;_5=0O;
MB6[M[MYY60',+AD5550JKD<X&3D\U8U7PAINLWFH7%XT[&^LXK1U5PH01NTB
M.IQD,&;.<]AQ0!S-GXYUDR7]M'!#K-PFGR7=LUG8SVP\U,?N6$A.<YR"#DX(
MQG%:?@WQ3<Z[?W-M/J>EWGEPK(4@MY;6>%LX*O#(6.WI\V1Z8JY'X.\U;HZG
MKNJZA)/;&U5WD6+RD)R2HC51OR!\QR>/2IM*\+_8-8_M:]U6\U.^6W-K%)<K
M&OEQ%@Q&$5<DE1DG/3M0!Q7Q,U*QU+7X="FU1+$Z?9OJ$<A)_P"/L_+;CC^[
MAV/U%=]X7UV+Q+X7T_68L*+F$.Z_W''#K^# C\*DTO1+?2[W4[R.266XU&X\
M^9Y2"1A0JH, ?*H7CZFHM,\-V6EP:I;1-+):ZC<27$D$A&U#(/G5< 84G)QZ
MDT 87B:8P_$#PO.F&*66I.N>APD1J6U\67T^D>"KMH;<2:Z\:W("MA-UN\IV
M<\?,H'.>*ET7P+;:3>6\\^IW^HK9VS6=E%=E-MO$V,@;5!8D*HRV3@5'IW@"
M"PGTEFUG4[FWT>3=86TK1[(EV,FTX0%L!N"22,#WR 9-AXO\2RZ=I.MW2:6-
M.O=26P:VCBD$H#3&(2!R^,Y .W;T[TFG>(;][]]%T:UT^TO+O5M1W3R1N\:1
MPR ,Y0,"SL77^(#J?:NDB\'6,6@V&D">Y,%E>)>QL2NYG64R@'C&,G'3I4$G
M@:T#">TO[VTODO;B]BNXRA9&F.9$PRE2AXX(/0<Y% &+=>,O$,+)I$<&FG6D
MUE-,EE97\AD>W:9957=D'&,KD]",\@C3\?BZ7X3ZX+UXGNAIK^:T*E4+;>=H
M)) SZFK5MX)L8#:RR7=W/=Q:C_:4MS*R[YYO+:/YL* %"M@!0,8'OG6UW1X/
M$&A7ND7+R1P7D+0NT1 8 CMD$9_"@#S6WT.SGO\ 17\+^#;_ $6\AO(99[^2
M%;=! #^\4X;+[AD;<=^U:&I>/]1L-19A>Z1-%'J*6CZ?!!++(L;2B/<TZML5
M^<[2O'3.:](C01QJ@SA0 ,UQK?#JV:P.F_VUJ:Z6MU]JALU,06-_,\W[VS<P
MW9.&)Z^PP 8?B/7/%.I>'/&LMK/IUG8:8+JU5A%(9WVQAMP8. IPV <'GG'8
MV+KQ'=>'[Z_EFL[*ZU&+2+$+-&CQ>;)+/)&BMEFP@)!]>6YZ8ZL^%+!])UW3
M7DG:#69)I+@[AE3(@1@O'' XSFJ3>!+&YAN4U"]O;U[FQBLI)9"B-B)V='&U
M1AP6Z_[(XZY ,SQ'=>(=.\/WO]N6^D:C;;[0QR11/$N]KA%*LA<DXR&#!AR.
M11=^)?%&SQ-J%HFEBPT*XD00R1N9+I$C61AO#X0X;@X.3V&.=&7P+%?17']J
M:SJ-_/,L,8FE\M3&D<JRA55$"\LHR2"3[5F6O@F[U"^\3"_U#4+/3]1U%F>T
MA>/9=0^7&,YVEER0RG!!(% $/B+QW>V;W,MAJ&DP)%:)=0VLMO+<SW&Y-_S"
M-AY([ D'UZ50O]7U.\U?5]1=K633G\(K>_8)8W8$,LIVDAP,EAR0!E<#@C-=
M1=^!+>>YU,V^JW]E9ZHH%Y:6_EA7P@CX8H67*@ @$=.U$W@.SD$:KJ-]&@TC
M^QYE4QXFAVLJELKPP+$Y&.>V.* ,N'7_ !)>7%W8Z,NDVL&G:9:W0-Q#))N,
MB,?+ #C ^3[W./0U-I_BO6_$\MC#HBV%FS:5;ZE<O=QO*,S9V1*%9<?<;+<]
MN*Z"P\,VFGW-[/%-.S7=K!:N&(P%B5E4CCJ0YS7*:EX=GT*XTR+2K376BM=,
M2Q%[I<\'FRJAXCE24!<8Y#KR"6Z4 =1X.UF[U_PM::E?PPPW4K2K)'#DHI61
MDP,]?NUY'HFD:3?^")$MO ^H7>N2FY6'4H85C'F^:X1Q,7!&WCGV[UZQX&T:
MY\/^#--TR[ 6XB1FD4/OVEG9]N[OC=C/?%7] T6W\/:-#I=K)+)#$SLK2D%C
MN=G.< #JQH Y.'7_ !'9ZG=V$\E@UIH6GVUQJ$[QN\LY,;%PF& !_=L<D=QQ
M5+1OB!JNH76E%VLY4U0[/L\%A<*UB64LC-(QVRJ#@-C;UR.*[>/0;1-5U6_<
MO(VIPQ0SQ/@IM0,  ,9Y#G.:S-,\&C39[$'6]4N;'3_^/.RE= D?!4!BJAG"
M@X 8G'O0!Y_X?UNY\,:-;/G34U/7M1O/-OS8RN56&63<T@5BTAR0%&5 #<GC
M)WAX\UN?3XH;2"REOVU>+3EN9+>6*"9)(V82JC$,"",%<G[IP>01T)\#V::;
M96]K?7EM<V-S-<VMY&4,D;2LS.,%2K*=Y&".@'<9J2+P=;[+9KK4K^[N8M07
M46N)G7=)(JE0N H54P>B@?SH QO^$F\2VVJZQ'>'2C9:#:QW-])'!('GS$SL
ML8+X7[IY.>HJEHWQ"OY[S3'O3:W%M?@F6&UL9T>R^0N"9'^60<;20%Y((R*[
M1/#UD+_6+J3?+_:T<<=Q$Y&S:J%,#C/()SS6=IG@T:?/9>;K>IWEG8*5M+2=
MTV("NT;BJAI,*<#<3CZ\T <I=ZCX@UNU\':S>C3UTZ_U6VN(K>&-Q+ K*Q3<
MY8A\J><*N#ZUU7CO3+K5]"AM+0P2/]JCD>RFG,2WJ*26AW#ID#/0CCGC-06_
MP_M[>33D&L:FVGZ9<K<65BS1^7"1G"YV;F4 D $G K:U_0+7Q#9107$L\$D$
MJSV]S;OLEAD&<,IP1T)&"""": .#TQ;+3M5O8;'1;KPGJ\VFS;+-D1K.YVX/
MF*8VPSI[%3AN]3^%]9\17.C>&M#L[FP%Y)HT=_/>W,#R!8B%5%V"0%G)SEMP
M'&<<XKI;#P@L6H?VAJFKW^KW2PO;PO=>6JPH^-VU8U49.!DG)XJK;> DL+73
MELM=U*"[T^ VL%V!$7-N<8B92FUE&T8)&<]Z *%OXRUG4IK+1K:&QM]:DN[J
MVN9I%:2",6^W<Z*&5FW;TP"PQDY)Q63XJ\27_AG6O#VI^(;6.2YMH]115L0=
MLXVQ[7P<^6,<G).T G)KJQX%LH;.S6SOKVVO[2>6X34%97F>27_6%]RE6#=Q
MC' QC J2S\$V%M=6MU-<W5W<0FY:5[@JWVAIPH<N H&,(  , #M0!JV#ZG)H
M<<EU)9-J#Q%MUNK>0&(RN,G) XYR,]>*XNS^(]Q<:AX:BEM8([>\@_XFDAS_
M *-,WF*BCG@>9#*ISGM79:%HT7A_28M,MYYYK:$D0B=@QC0G(0' RJ]!G)P!
MS7/W?PUT6[T_7;0S7<:ZQ<K<RNC@-"ROO C./E&XL>_WV]: .8U#Q#J6J:9>
MWRV]I9WMQX7NKV"Y5'\R.'S<HH^<8)CVG/9L'H,58T]/$<GC&Q2RN]-6\/AJ
M!I;B>W=DQYS[0$#@Y/&26[$XYP.SO/"6G7EQ+(YE1)-+?2C$A 40L1G'&<\8
M'\J-&\+1:1>PWC7]W>7,5BMAYD^P;HU=G4D*HY&['T [Y- $OA/69?$'A>QU
M2XA2&>9#YB1DE0RL5.,\XR#BMFL[0M'@T#1H-,MI))(8=VUI2"QW,6.< =S6
MC0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !117'?$&W%['X<LGEF2&YUF**81
M2,A=#'+E200<'H: .QHKQG6+41>(]?L+A]-M[/3+>%=/%_JD]NUO!Y0/F1;0
M=QW[LMDG*@4W6#+.L-WJ&HV&IW$.BV\D]O<W4UA)'\K$SV[%0-S=\J""H!QT
MH ]HHKR>"?P[K7BB_E\07LT%NVB65S!!>71B*!ED+N<$#S!\O/49..M9,%SJ
MVK7&A6^O-9R0G0TGA35KV2V25][!I"54[I @C)SR-V>YH ]NJK+J5I#J=OIK
MRXN[B-Y8H\'YD0J&.>G!=?SKRS29(]1D\-67B754NM&>RNW@E,\B17,JS*$#
M,X4N5BS@D?-@L,]:L:=!H#>.?"L]K=S7-M]EOXK2XO)B2[)-'M5&.-ZC+!>N
M5 Y.* /2[G4K2TO;*SFEVW%Z[) F"=Y52[?3 !ZU:KAO&5KI[^-_!=Q?;%47
M4Z!WD*#/DL4'4<[@,>O2N2@GM1X3LM92_D/C9]2CCD3[2QF:8W 5X3'G[@3<
M-N,!0#[T >S5DS^(;2&^O[)8;J:XLD@>6."$N2)6*J0!UQM)/H!FL?X@RF/2
MM-CFG>#39M3@BU&57*;8#NR&88*J6V*3D<$UPFH+IMA<^-4T&Z)MXUT@?NIR
MZQ,;AMRJ<G P>@/<T >TU7M+P7?GXAGB\F9HCYT93<1_$N>JGL>]><ZDUW%X
MCN_!"23;-6OX[^*4,<I:'+W"ANWSQ%?^VPJD\XGU$6FJW,B:)-XGO8KHM,40
MD1YBC9LC"ENW0D 4 >FV6K6U_?ZC9P%_-T^589]RX&YD5QCUX85>KP^[EBL;
M3Q##H-XK:5)XBM8+B9[MUC6$P(&4RC+*F\*F1T''2IKT7%KHOB6TM-0LX;93
M8?Z-I=W-,MM(UPH++(R@*67&5![ XYY /:JHS:M;0:W:Z2Y?[5<PR3QX7Y=L
M94-D^OSK7FOB2VE\+ZAK]KX>>ZMHY-!6Y=(Y7<JPFVO*N22'$9;D<\ ]:9<V
M_ARQ\6P_\(_JIAC/AZ^>6:VF>X\@'RMLP ));J>.3M% 'K=!.!DUY9X(NK;2
MO$4%K)]B/GZ:\QO--U%Y8)40H3)-&_*/SPV3G+"O27^RZII;;'2XM+J'AHWR
MLB,.H([$'J* *-KXGTN^GTN.UE>4:I!)<6KA"%9$VY)SR/OC%;%>*>%-'TG5
M;?X?6A_>0'3[U[F.*=@&D ARKX.?0E?8<4MS+>16]EHZS1_V-'K]]:LM]>21
M1%4!,,3R %MN2V >"5 H ]JJCIVK6NJ2W\=N7W6-R;6;<N/G"JW'J,.*YCX>
M&5(]9MQ>6<]G#>!88K2:6>.V.Q2\:R.HW#/.!D*6(XZ5R>JZ/:R:-\1=;+3K
MJ%C?S26LJ3NODND$3!E . <]3W  [4 >PU1BU:UFUNYTA2_VJW@CN'ROR['+
M!<'URC5Y[=G1]0USQ._BJ_-O+:1Q-8AKIH?)@,*MYL0!'S&3?DC)RH'M6%)J
M&KG3KZ\O)9X+V30-(-_,F5DCC:>03/QRIV%B?3GTH ]?.K6PUU='R_VMK8W0
M^7Y=@8+U]<D5>KQS518Z1K^N/X,N ]Q%X8ED5+><S"-_,7#+R<-CG ZX![\K
MI(-KJ-HVGZAI4<=QIMR\\=CJ$]T]T@CRLC[DPK!L?,Q!.2.>E 'L5%>.C1+2
M#P5X3FCOX$O-2CAGN(M4N)_(OW\@G:\@)V$;B5'0X P<<=M\/+V*[\.2QQ02
MPK:WDT!1KK[2@(.2(I,#=&,X'I@CM0!UE9%IXAMK[7[W2+>WNG>RP)[CR\0J
MY56V;L\MA@>!7F$L]K_PB=QK+7T@\;+J31JOVEO.$WVC:L CS]S9@;<8VG/O
M77^"-+L[3Q-XQG@AV2#5!'G<3\I@A8CD^I)H [>J-CJUKJ-YJ%K 7\RPG$$V
MY<#<45QCU&'%>6^+IH;/Q#KFJ27-OJ"6DL1:(7TEI?66$0A8 1M=3]X8QN+$
M9-2:IHUG>Q?$G5Y/M"WEFQEM769T,#I9QN&4 @!LXR?8"@#URBO'?$=[;ZK<
MZH9TMWFLM.@,DVHZF\"Q,T6\&WB1<ECD98D9( '2KOAZU_X2/7M%N-1EGNGB
M\+6%XB&=U5K@LY\Q@",G([^IH ]5HKP[PY->RQ^']2DU#3(=8N+]$N93?SR7
M<S%SYL+PA" ,;AC[J8!R,9J_IEQ#I_B:QNVN(-3^TZN\"7MM>R17@9G<>7/;
MN,,B]"!C 4$"@#V*L_6]9M= TF;4KP2F&,JNV)-SNS,%55'<EF _&N=\=21F
M]\.VFH3M!HES>LE\XD,:L1$QC1V!&%9P/8D =ZXG6K2PN;'Q!8V;FYT.SU73
M!:8F9XXI7E03(C9Z8*\9P"QZ4 >L2ZS:VFA/K%^)+&VCA\Z47"X>, 9P0,\^
MPS678>-+*\U*VL9[#5-.EN\BU:^M3$LY W$*<G!P"<'!XJ3Q8FF6?@B^AU"R
MN+C2X[<1RPV^2ZQ9 +#G/RCYL]<+WKD;?59-.UG08+'Q;;>*+.\NUC2TN%BE
MN(4*MF99(\'Y1U+#H3SF@#TZJ]_>"PLI;IH9YA& ?+MXS([<XX4=:\4T^?4)
M[>#4Y[[2[;76U7RY)I+^=KH2>?M,!@5"-I7Y=O0+AO>M'4-/B_X1;QKKC2W#
M:A%J=Q;PRF=\11^:GRJN< 9R>F>: /8J*\6UZ2YNM8\6S:C=Z;;7%E,5M9KO
M49H)K2+RU,;PQHISDDG(R6.0?2G^)9&2\O\ 4;Z]L]0FM;&WDN(&O);&ZM&$
M88M;9&T[CEN@.?E/3% 'LW2L?P[XGTSQ3:3W.ERN\<$QA?>NTYP""!_=(8$'
MN#63XVU:Y3P4(M.#+J6L>796:R_*RO*,$GT*KN8^FVL'1DU+PIXWT^.^TVST
M_3=5M$TY%MKMIU\^!28BQ,:8)CW+WSM% 'H]S<):6LUS+GRXD:1L#)P!DU%I
MFH0:MI5IJ5KN^SW<*3Q;A@[6 (R/7!K!\4>*=)T^+4])OKI+6X_LU[E&G8(D
MBG<N%)/+ CD>X]:YCPKJ$6B:IH46JWB647_")6N%N9!&N]6^?KQD C/>@#T^
MJ\]X(+RUMC#.YN"P$B1ED3:,_.?X<]!GJ:\F\,VT?B*3P?;W\MQ-:2Z;J$LD
M1F=1+BXC"[\$9 ST/H*ETNXOK:XT2TM)II#:ZGK-O;))(6RL:R"-"2<D#  S
M0!ZY17D&ER:=%IO@[4=*U&2;Q'>W=NE]_I+/+,&'^DK*A/1?F/(^4J,8KIOA
MII5NNB'6G,TNH7,]U')++,[?(MPX50"<  *.@]?6@#3O/&]G::S>Z7%I>L7L
M]D4$[6=F954LH8#(/H16OHVLV.OZ9'J&GRL\#EE.Y"C(RDAE93R""""#7$65
MGKUU\0O&)TC6+6PC$UJ)!-8F<L?LZ8(.]<?D:J:SI-IH/]C>'Y&;4;F\FN[Z
M9[Z]^QVT\A(9WDVJ22"_RH!CJ3TS0!ZC69/KMG$]_%&)[F>P\OSX;>)G<;^5
MP._'/'05Y+HZC6+#2=+ENV>P/BFYMMMK=2&,PBW=_+5\AC'GIZ@U-J]AINB7
M'CJ&P(M[F*.P$*B=BXB/E[B,G)&<<T >SU7M;P7;7 $,\7D3&(F:,IO( .Y<
M]5YZ^QKS6Y;1+B]\4WGB;4KBVU&ROMEJ8KADF@A"(8C F>2Q)Z [B2#GI5#4
M+B"6Z6/5+^:"Q?QE)#*QG:/Y#:'"$@C"EL CIR: /8:JZEJ5II&G3ZA?2^5;
M0+ND?!.!]!S7E=W?V=A'KNG64D\^AOJ=G;6B0WQBA$SKNEB,WS%(N%W!>[$#
M&:Q+](FT?QYIS?8EM;:TL[A;:QNY)H(9"SAB&8#G &< #CUH ]QBO!+?7%J(
M9U,"HQD>,B-]V?NMT8C'/ID58KR'Q Z;O$EMIUY(EF&T..W>WG/RHT^"48'N
M.XJ3Q';R>&;_ ,1V6@O=6ML^CVUS*D4KN8\W#)+*N22&\H$Y'IGK0!ZU6#K?
MBNTT/4;73Y+/4+NZN8WECBLK<RG:A4,3@\<L*Y30QX?M_B?8VWAN^66V;1YY
M)H8+IIH@WF0[6^\1N(SGOP/6KGB:#4[CXFZ$FE7\%E<?V9=DRS6WGKMWPY&W
M<O/3G- '2Z'XEL=?>ZAMTN8+JT*BXM;N!HI8]PRI*GL0#@CCBMBO,O%/AN[T
MW0=1U&^UF:ZU34KS3K>2XMX_LXCB6Y0!4 )(^^QSDDYJAK6FQV?C Z&(].CT
MBVTY9;*WU+4IH(RS2.975@&+./EZG*@C'6@#T75O$-MI%_I]@]O=7-W?,PBB
MMH]Q"KC<[9( 4;ES]:UZ\@TRS:\U+P9?3S)J6H#3+]X;D-)B7RWC,)^<*6P"
M.2/FZ\@@U1\+R73MX7U :CID6IW5T@NI!?SRW5R2#YT4D.S QSUPJ%1R!0![
M;17C$>D0OX#M]3,]X+^_UQ+6:X%S(&$7V_9M7G"@ =O?UJSK&G1VOC"XT5H]
M.CTFST^.2Q@U+4YK= &9S+(A .Y@< DG*C&.M 'KU4=(U:VUO3Q>V9<PF22+
MYUP=R.R-^JFO,M)>#4[O0[;Q9JJW-A_8IFM9I)Y(8KB42L"^6V%G6/R^2,_,
M6'7-=3\+?*_X0"T^SS/-#]IN_+E<Y9U^TR88D]21S0!-<_$'2K=KF3['JDMA
M:R-'/J,-HS6\94X?YNI"D$$@$#!YKH(M5LI]2_L^*=7N?LZW.U02/*8D*V>G
M)!_*O+7O]/LM'U34-"\6+I(CDG>YT#5EBE19=S%X]A.]0YSPK$'=P.U1ZM-)
M'K>I:O:6OV+7IO"45S;VX8AXY?W@8(O<JH QCM0![%4=Q.EM;2W$F=D2%VP.
M< 9->7.VGZ9J>AMX)O#=75U:7+W"1W+3^>@@9DDD!)^;S=@!."2Q%)I(\-IH
M6DWEMJES+K=[I\IG$=RTC7#^03)YZG. K>N,-@>U 'IFFW\&JZ7::C;;O(NH
M4GCW#!VL PR/H:M5Y7\,YKE+G3(=?;_2Y-'MWT?8Y\G[,(U#JJG_ ):@X+$Y
M.",8 K0\>P+<^([!#=:=,4LY'_LS4KB6VCD&X9D25?E\P=,'. <\=: .V.K6
MHUU=&R_VMK8W0^7Y=@8+U]<D5>KR;0[/3O%WB'07NX;Q[3_A'7(AN+EF9\3J
MH+NI'F#N">O!ZU3MKU+O1O#VD70-Y(&U#8NH:DUO;&.*<QKYC;6:1E7 5?3)
M- 'J]YJUK8ZAIUC,7\[4)'C@VKD95"YR>W"FFZ3K-IK.AV^KVA?[+<1>:F]<
M-M]Q7EGA*Z:YN_"Z^>DT4&OZC#"8Y6D18Q!*5",W)7!X)[8KLOAY_P DIT7_
M *\!_(T =+I.IV^M:19ZI:%C;7<2S1;Q@[6&1D5<KQ?PFNE6GA_P'<Z'>M)K
M5Q-#%=(MRSL\6P^<KIGA$ XXXPN.O-329]0FMK'5)[[2[;77U01RS/?SM=&3
MSL- T"H1MVY7;T PW;- 'N=%<5\3KF\M_#]BMO(D5O/J,,5Z\DS0H(3NR'D4
M$HI;8I(['WKBKT7%MHOB2TM-0LX;8/IW^CZ7=S3+;2-<J"RR,H"EEQE0>,9P
M,\@'L5]?6^F:?<W]Y((K:VB::60@G:BC).!ST%4KSQ#8Z?#<W-V)XK2VM%NY
M+DPMY>PD\ CJPQDJ.>1ZUYQXKT:STMO%NE622I8R^&'O&@,SNIF1GP_)// S
MZXYJCXGBLY]&\06]HXEL(O"=M-"L<I9 PFGRP.>>1^E 'KEOJUK<ZS>:5&7^
MTVD44LN5XVR;MN#W^XU7J\=U^X:P/BR30)U2W&GZ4@GAF.$@,LH=@XR0 I;+
M#) R>U03R:AI4&O#0[S3H0-&:5[72;R:ZVG>H$X+)M1]F_OEL X.,T >MSZM
M;6^LV>E.7^TW<4LT6%^7;&5#9/\ P-:DFU*TM]2M=/DEQ=722/#'@_,J8W'/
M08W+^=>>Z9:^'+7XF:"OAZ[297TNZ>1([DS+@M#M<Y)PS<Y/4[1GI5[Q;;VJ
M_$?PS=NL?VHV=ZL!DDVAY5\HQJ.<$Y+<=Z .^HKQ[3);"/1O"6IZ=J$LOBB\
MO;=+T&Y9I9BQ_P!)21,\*HW\$?+M&,5U_P 0+9;Y_#%C)),D%SK*1S"*1D+I
MY$Q*DJ0<'&#0!V5%>+:O;^7KOB*SN9=-MK?3(HDL/MVISP/:P"$$21!5.X[M
MV6R6)&*U(#8ZIJL\?C74EQ!HUI+:N\SVZ-N5O.F13M.[<!R1E>.!0!ZK5<7@
M.I-9>3/N6$2^;Y9\LY)&T-TW<9QZ$5X[<SMJ>M7JWEU;2V-OIMK)82:UJ$MI
M*(3%EIE")RY;.YNH( XK1M[75=>8V3:F\M_)X6MIH;E-Z!YUF=DDPP!&2JYR
M 2,T >LT5X_J&OZGX@\+>(/%NG-/;+':V]C H9E,0W(]T_&2"N\KN R/*)%:
M?A,IIWB[;!?:/!8G3GFN;:QOYKE" R[9F9U"H?O#).6![XH ]-HJ.">&ZMXK
MBWE26&5 \<B,&5U(R"".H([U)0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3'BCE*&2-7*-N7<,[3
MZCT/-/JG<ZG:6=_964\A2>]9TMQM)#LJEB,] < GGK@T /N=.LKV2.2ZL[>=
MXCF-I8E8H?8D<476G6-\\;W=G;W#1',;2Q*Y0^V1Q69;^+]#N[4W-O>B2(7_
M /9V5C8YN-P7;C'J>O3'.<5B>%?B'9:K8:<NHM)%>W<SP"1;25;<RAF C$A&
MW=@=,]??B@#<'ABQ?Q#?ZM<QQW+7<<""*:)66,Q;\,,]SYA_*M.[L+._C$=Y
M:07,:G<%FC#@'UP:QI/&NAQZB]FT\V$G%L]R+:0VZ3$X\LR[=@;) Z]3CK45
M[X^\/Z?=75O/<7.;.417<B6DKQVY(!!D<+M4'(Y)H WKBQM+NV%M<VL$T QB
M*6,,HQTX/%*UE:N( ]M"P@(,.8P?+(Z%?3\*GZUB:MXKTS1[S['/]KGN1%YS
MQ6EI).T<>2-S;%.T9!Z]<'% &M/:V]TJK<013*C!U$B!@&'0C/?WJ,:?9+>F
M]%G;B[(P9Q$-Y'INQFL>X\;:)!#:2QS7%VMU;B[C%G:R3GR?^>C!%)5?KCOZ
M&MBVU"TO--BU&"X1[.6(3)-G"E",AOIB@">2..:)HI45XW&&5AD$>A%5XM,L
M((3#%8VT<1 !1(E"X!R.,=B2:R-.\:Z+JE_:VEN]VK7BLUI)-9RQ1W( W$QN
MR@-QS[CD5%8>/_#VIW-G%:W%PR7C^7;W#VDJ0R28)V"0J%W<'C/8CKQ0!T9A
MC,RS&-#*JE0^T;@#U&?3@5')96DL$L$EK"\,I+21M&"KD]21WKD/$/Q"LK*'
MRM+:26X&H06?FO:R&W9C,J2(),!2P4MQGJ.^"*Z+7M1.F64$PN8K?S+N"#=+
M$T@;?(J[0%Z$YP#T!.3Q0!<CL;.*!X([6!(7&UHUC 5AC&"._'%-ATVQM[7[
M+!96T5OG=Y21*J9SG. ,9R!7,^%/$E]XB\1:X'9XK"RG-M#;O821L2 AWM*V
M!GEODQD#!^K_ !5XZT_0;'5XX7EDO[&U>0E;622&&0H3&LKJ-J[CC@D<'MF@
M#JO*C\WS?+3S-NW?M&=O7&?2H+;3;"S;=:V5M <DYBB5>N,]!WP,_2L23QII
MEC!:I>-<27;VB74\=I:23>2C#[[[ =JYSC/H?2K%]XPT:Q%KB::[>Z@^TQ)9
M6[W#-#_STP@.%Y')Z]J -&+2K"VCG2UL[>V\\$2&&)5+9[GCG\:EL;.#3K"V
ML;9-EO;Q+%&N<X51@#\A7,0^-K-M9OI'O+?^PH-)M]02Y .3YCRJ?KPBX&,Y
MX]JN0^-]%D2^:5KRU:QM6O)H[NSEA?R!G+JK*"PX[9H VH;"SMWWPVD$3;F;
M*1A3EL;CQW.!GUQ2R65I+!)!):PO#*2TD;1@JY/4D=ZP5\=Z')91W4;WCK-,
M8;>-;*4R7!"ALQIMRZ[3G<!C'>IF\9Z(NDQZB+B5HY)S;)"MO(9S,,YC\K&_
M>,'(QP.>E &U;V\%I L%M#'#"G"QQJ%4?0"@VMNT<L9@B*3$F52@PY(P<COP
M!UKGO"WB<^(]2UY$&+6QNHX80T+1R#,2,P=6Y!#%AT'2J$?Q M+/7/$%EJQE
M2+3KM$66"TE=8HFBC;?*Z@A1N9N3C@>Q- '67&G65W)%)<V=O,\)S&TD2L4/
ML2.*F\F+S'D\I-[J%9MHRP&< GTY/YUGCQ#I9_M/_2@!IBA[LE2!&I3>&SCD
M%><C/0^E4_$?B9-&\$WGB*VA><1VOVB&,QO\V1E=P RHY&<XQSG% &M:Z=8V
M/_'I9V]OU'[J)4Z\GH*2WTVPM&E:VLK:%IO]:8XE4O\ [V!S^-<C_P +!AM_
M$=Q:7<%W]E_LZ"\BCBT^9YP6:0.60*2J@(O4#KWR*VKGQCHUO;V,T<TUW]OB
M\^VCL[>2>22/ )?:@)"C(Y..N.M &M-8V=Q:"TGM8);8  0O&&0 =!M/%2PP
MQ6\*0P1)%$@PJ(H55'L!5?3=2L]8T^&_L)Q-;3 E' (Z'!!!Y!!!!!Y!&*Y/
MPO\ $*RU2QM$U)I(KR>YDMO,6UD6W,@D94C$A&W<5 XSU..O% '7'3[(WOVT
MV=O]K QY_E#S,>F[&:F2*.-G9(U5I#N<J,%CC&3ZG %8$WCC0K>_DM9+B;;%
M.+:6Y%M(;>.4D#8TH78#D@<G@G!YI-2\<:'I5U<PW$MT5M&"W4\-I+)%;D@$
M"215*KP03SQGG% &U-IUC<74=U-9V\EQ'_JY7B4NGT)&14AMH"LRF&,B;_6C
M:/GXQ\WKQQS6/+XOT:'76T8SS->IM,HCMW9(E9=P9W VJI'<G'Y&L<^/[6^\
M0^'[#2O-:'4;B16DGM)8UEB6%W#Q,P 8;E7D9X/N#0!U<FFV,MS%<R65L\\0
MVQRM$I9!Z XR*EBM;> @PP11E4$8*(!A1T7CMSTJEK&NV&A10O>O)OG?RX(8
M8FEEE;&<*B@D\ GIQWKE_$GC^*+0+:XT-I6N;B_CL6+V$TC6S%@'#Q !MX!X
M4X+9XS0!V*Z=9)>M>I9VZW3##3B)0Y'NV,T+IUBEZUZMG;K=L,-.(E#D>[8S
M5:ZU6WT70DO]6N@$CC022^2REW.!Q&,MDL>%Y/.*Y.?Q\9M0UN.WE%E;:?86
M\Y>]LI5>*5Y'4AXSAB-H0C [YS0!W4\$-S"\-Q$DL3C#)(H96'N#4<=C:16J
MVL=K ENA!6)8P$!!R,#IUYK(?QGHB:S<Z4UQ+]HM-WVEOL[^5 !'YF7DQM4%
M>02><$4[2_&&CZM=+;P27$4CQ&:'[5:R0":,8RZ%U 8#(Z=B#0!NU4M=+T^R
MF>:TL+6WED^^\4*HS?4@<U@CX@:'+&[6[W<A:&26V8V<H2Z"#+>4VW#\<_+G
MCD9%1:9X^L+CPYHU_>172WNHVXE6SM[.621B%!<J@4L4&?O=#Q@G- '2_P!G
M67V[[;]CM_M>,>?Y2^9CTW8S3S:V[121&"(QR,6=2@PQ/4D=S6#<>//#UO86
M5Y]KEECOBZVZ06TDDDC)]Y=@7<&'<$ C!]#2CQQH9O5MO-N@#,ML9S9RB%9F
MQB-I-NT-D@8)X)P>>* -J?3K*ZN(KBXL[>::+_5R21*S)]"1D47&G6-U<1SW
M%G;S31?ZN22)69/H2,BH]5U:RT2P>]U";RH%(7(4LS,3@*J@$L23@ #-9D7C
M71'L[NYDFGM_L;1K<0W%M)%+&9&"H2C -@D\'&.OH: -UX8I'1WC1FC.Y&90
M2IQC(].*)(8IMGFQ(^Q@Z[E!VL.A'H?>L+Q+XKM/#]CJ1"O-?6FGO?+;K&[;
ME!V@D@' W=?09)X&:T-+U2/4-"MM3D#0))")7\Z-HMG')(;! Z]>W- %BZL+
M.^,9N[2"X,1W1F6,/L/J,C@T7-C:7IC-U:P3F)MT?FQAMA]1GH:Q++QSH=_,
MD4$EWF6-Y;8O92H+I5&3Y)*_O#CG"Y)'(S53P%X@U#Q+H]QJU\^$DF<0P"RD
MA\I59AC<Q_>9 &2 ,'(H ZE+6WC9&C@B1D!"E4 V@G) ],FD6UMT=76"(,K,
MZD(,AF^\?J>_K7%>%/&TFLZO=K?3O#%-?RV5A:MITL1S'O.3(W!;;&Q*X&T\
M'DXK>OO&&AZ:+DW5VR?9KI+.7$+L1,Z!U4  DDJ1TSR<=: -2+3[*&[DNXK.
MWCN9/OS)$ [?5L9-3111PQB.*-8T!)"H,#DY/ZU@P^-=#DTZ_O9+B:V2P94N
M8KFVDBEC+8V#RV4,=V1C .>U9=OX_M)/$.I13M):Z98:=%<S?:;62*9)&D=<
M%6&3D!, #G/&: .R6&-)'D2-%>0@NP4 M@8&3WXJ*[L;._C6.\M8+E%.X+-&
M' /K@]ZHZ1XCL-:GN+>W%S%<VX5I;>ZMG@D56SM;:X!(.#R/2L]O%*67B#Q#
M#J<T,&FZ9;6LPEVG=F3S 0>N>54  9R>^: .@6SM48,MM"&#[P0@X;&,_7'&
M?2FRV%G/,9I;2"24IL+O&"Q7.<9],\XK)MO&.BW$%[+)/-9_8HO/N([VW>W=
M(SG#[7 )7@\C//'6H['QOH=]>FS$MS;7 MWNO+O+26 ^2N,R?.H^7D<_7T-
M&U+86<]U%=36D$EQ%_JY7C!=/H2,BL[5O#EIJUQITD@1%L[PW;1B,$3,8WC(
M;\'_ $JM8^-=(U.ZCM;9KM);B)I;5KFSEA2X51DF-G4!N,'CMS7/Z+\0)7@T
M^\UEH(;.308M2N)(HF.R1I AP 3\O/X=<T =S_9UB+'[#]CM_LF,>1Y2^7CT
MVXQ1'IUE%$8H[.W2,Q^456)0-G/RXQTY/'O3&U2T75X]+\W-Y) UP(PI/[L$
M*6)Z#E@!Z\^AJAJWBO3-'O#9S_:Y[E8O.DBM+22=HX\D!FV*=HX/7K@XH TD
MT^RCC\M+.W5,*-JQ*!\O*\8[=O2HM3TU=0L[B*.>6TN)8_+%W;X$J8.1@^Q[
M'CKZU#I_B+2M5N$@LKL2O):)>IA2 \+DA6!(YY!R.H[UGMXYT/[/:2V[W=V;
MN)IX8K2SEFD,0;;O*JI(7/0G&>V: $T/PH^FZPVJWM^MW=" V\0AM5MXXT9@
MS':N<LQ5<G/;H*Z(PQF99C&AE4%5<J-P!Z@'\!7*:CXPA:RBOM)O[>6&;2[N
M]@C>!RTIB"X.>-H!."IY.>V#4R^-K"VT^P-X+F:^FL8KN:&RLY9_*5E^\P0'
M:,YQGT/7% '2R11S)LEC5UR#AAD9!R#^!J*[L+/4$5+VT@N54[E6:,. ?49%
M<G<^/;6#Q+801E[K3;[2_MMN;2UDFED;> ,!03MVDDY''Z5<7Q;%>:]H*:?/
M!+I6HVEU</,0008C&!UQMQN8$$9!';% '2^3%O1_*3?&"J-M&5!Z@>G0?E4,
M>G645X]Y'9VZ74G#S+$H=OJV,FLG3/&>BZM>P6MM-<!KD,UK)-:R1QW(49)C
M=E ?CG@].1Q6?XW\2WNC3Z/I^G%XKC4;KRC<?8)+H1H$9CA4QELJ.,],G&!F
M@#J?LMN(EB$$7EJV\)L& V<YQZYYSZTR[T^ROU1;RSM[D(=RB:,/M/J,CBL4
M>-]#6^%HUS,<3_93="UD^S^?G&SS<;-V>,9Z\=:L67BO2=1UR?2+22>6ZMW>
M.8K;2>7&Z]59\;0?09YH T[FQM+V)8KJU@GC4AE26,, 1T(!J6**.%-D4:QI
MDG:HP,DY/ZUQVO>-I=-UK6=*@M)#)9:,]_',]O(4,@#D MC;MPHYSR25SD8J
M[X?\;:9K7V.V,DT=W<6HG0RVLD4<P &\QLP 8 GL3QSTYH W)=+TZ>\6\EL+
M62Z3[LSPJ7'T;&:F>UMY+B.X>")IX@1'(R LF>N#U&:Q-/\ &FB:I>P6MM//
M_I)86TTEM(D-R5!)\N1E"OP">#R 2,BK>M>(M-\/BU_M"616NI## D<+R-(^
M"=H"@G) .* +EMI]E9R226MG;P/*<R-%$%+GU.!S1'IUC#/-/%9VZ33_ .MD
M6)0TG^\<<_C69;>+M&N8(I5N)$,EX+'RI8'21)R,A'4C*G'.3QC%+J/BW1=)
M^WF]O/*%@81<DQL0GG'$?0<Y/IT[T :PM;<>3B"(>0,1?(/W?&/E]...*9=V
M%GJ"*E[:07**<JLT8< ^HR*P#X^T0/#$%U%KJ:$SI:KITYF\L,REBFS( *GK
M[>HS8G\9Z)%9V%S%<2W8OT+VL5I;O-)*H^\0B@D =\@8/'6@#;6"%9!(L2!U
M78&"C(7TSZ>U03:7I]S"D,]C:RQ(Q=4>%656)R2 1P<GK64_C71!8V=W#//=
M"\9U@AMK:225BGWP8PNY=O?(&.]*_C/1%TVSO8YYIUO69+>&"VD>:1ER' C"
M[@5P<Y QWH V5M+9'#K;Q*P8N"$ (8C!/UQQFGQPQ0Q+%%&B1J,!%4  >F*J
MZ5J]EK=B+RPE,D6YD8,A1D=3AE96 *L#U!&:35M8LM$L?M=_*4C+K&@1&=Y'
M8X55502S$]@* )8--L;6<SV]E;PRE0ADCB56*CH,@=..E TZR%\;T6=O]K(Q
MY_E+YF/3=C-8T/CC09H[MOM$\36DD$-Q'-;21O$\S;(U92H.2?T(/0YJ_>^(
M=*TZYNK>\NUA>TM!>S%U.$A)9=V<8ZJ>.M &C)&DT;1RHKQL,,K#((]"*@AT
MVQM[7[+!96\5ONW>4D2JF<YS@#&<@5C6WC;1KAKE&:\MGM[5KQDN[*6%FA7[
MSJ&4;@..G/(K+?XD:?/JNB6VG6U[<6VH7+Q-.;"<*5$3.&C.W# D#D9 &3T&
M: .R:"%I#(T2%V386*C)7TSZ>U11:?901F.*TMXT*>652, ;<D[<8Z9)X]S6
M./&VAMJ/V,3S8-Q]E%S]FD^SF;./+\W;LW9XQGKQUXK)\1?$*RM-.U9-(9Y]
M0T\E)"]K(84=7565GP%S@Y SZ&@#L(;*TMD*06T,2E0A"1A05&<#CMR>/>DM
M-/LK!&2SM(+9'.YEAC" GU.!5"3Q-I,5AJE[)=;8-+D:*[)C;,;* 2,8R<AE
MQC.<C%6]1U6RTC3)=1OYO(M8E#.[*<C)P!@<DDD  <DG% #K?3;"S;=;65M
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M+.+S)(]2LYV&X+A(YT=CSZ $UT%% '/^%],N]-GU]KJ+8+O59+F'Y@=T92,
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M1DB:,+$%8MM)?)+!< =*W/!.F7>C^$K.QOHO*N8VE+)N#8W2NPY''0BN@HH
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M13&YN(G1Y)(PH ",28\CJ<'GH*@\):+KFFZY8B&QU+2]+B@=;RTN[]+FW+8
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M9M)N=(M--E,.C65H\#VY(.]OD"$\9SPV3GOWSP:_X;36KBSO8+^YT[4K+?\
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MD&G6D%T7O-[-)YB,VP!2,?=/S=N.#5B_\ K>#6K>/6[VVT_67:6[MHDCR79
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *K7NH6NGK UU,(A/,D$>03ND8X51CUJS7$?$JTL[FTT!KTE8E
MUFV5F\YHP%8D')!&/KVH [>J6K:K:Z)I<^HWK,MM  7*KN(R0.@]R*\OU":V
MET'Q=K-[JUS!K^G7=PED%O'0P;/^/=%C!P0XVGD'=O/6NJ^(9FG^%FI&<&*=
M[>+>%_@8LF<?0T =G17EGB&.[\(ZIJT?AZ:\WOX<N+K9+<23YFCD0"4;R?FP
M[?7 JIIAN[+4;)K2\L(HKK3KAYEAUJ>]>[41Y67#1@*P;'S9'WB/04 >O57N
M[R.S$!DCF?SIEA7RHR^"W0G'1?4G@5Y"UK<V/A;P5Y,\TJZXL4FI27NJ30I/
M)]GW(AD&XH"2>% W;0#5JUN=0M3':"^@^S1>)+.*."TOI;D0!ER\1E=%W+G!
MV\XW$>U 'KE%>0/:O'X6OO$@O;\ZG;>(7C@D-W)MCC^W^68PF=NTJ3P1W]A7
M<^/+Z*R\-;9'NU^TW,-N@M9Q SL[@!3(?N*>A8<X)QS0!TU%>,+//:77BS2T
MU*WT6%=/M9,0ZC-=Q6\K2LIW.0&0LNT-MZ @YKJ? DXMM>U/29+5[:X6WAG:
M.#4C>6I!+*&0L-R,<<J>H - '?5#>7<-A93WER^R""-I9'QG:JC)/Y"O,_&-
MQ#?:[KL01Y#IMI'YDEWJ[V<-J60N&B2-278@C)/<  UV7A.0ZS\/]&DU'%T;
MO3(3<>:-PEW1C=NSUSDY^M $T_BO1[;2[C49[KR[:"40,=I8M(0,(JKDLV6
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M7&=C(5W*WL1W'J* ->'3K&WLVLX+.WBM6!#0I$JH0>""H&.:>UI;,8"UO$3
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MK';R.<8YJ&\\<>'+"UL;B;40T=_&TEKY,+RF55*AMH12<C<,CJ.?0X .AHI
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MR1;X)H8RI1M[ ;3G.X$X.:E\'>%=3T/6=)DO($V0:/-#*\; K'+)<"7RQW(
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M#RZVTG7X-!\.>&3X?F8Z3J=M)-?^;%Y+11RY\Q/FW%B.2"HQ\WMGN/$PU?\
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M[016]OJ#7"O<B8PR321LH+=V.&)QP#GGIGT&B@ HHHH **** "BBB@ HHHH
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MZE<:6UIY<EC,WDW"SR;, GH1@]R.E3ZGXZU+2-2@T74)] L]2%M]JGFGGD$
M4N51$& Q8[22> /?-7Y/ )NFU66]UJXN)]3%IYSF%5"&WD+J$4= >F#GUS6G
MJOAN>YUI=9TO59-.OS;_ &:5O)65)8PQ9<J>ZDG!![G.: )_"OB!/$_ARVU5
M(A$9"Z.@;< Z,5;#=UR,@]P17(V?B34+;PM;>(+2VBN[_P 0:J(HTGD*I'&S
M,D0R,X"JBDX'4L>IKNM)T\Z7I<%FUY<WCQ@[KBY??)(2222?J> . , =*Y;1
M_"\G]F0:)=>;#'HNK?:K24+E9XMS21C/L'*'OE/<4 /CU[Q3>7][IUC9:2UU
MI<<8O&DED"2S.N\1Q\9 VE?F;NW3BK'AWQD/$6IVL4%MY=O<:3'J +'YU9I&
M0H>W&WK4VH>%KJ35[W4=)UN?3)+]$2[584D#E1M5UW?=?;QGD<#CBJP\#"PF
MT^70=5GTQK2Q&GG]TDWF0@[@?FZ."2=WN>* ,^R\:ZWK!T.WTZPL5N-3MKJ=
MWGD?9"(953H!EL[NG')ZT^U\:ZKJ,6G:?:V%FFM7-Q=P3>;(Q@B%L^R1Q@;F
M!)7 X^]R>*T]"\%6^A3:1)%>32_V;:W%JGF 9<2R*Y)/J-N/QJ(^!UA\JXL-
M3EMM0@O;J[AN?*5P!.Q:2-E/#+T[@_*#F@#E[+QC>>'+'6&U);2/4;OQ'):)
MY]P1;P_N(V+EL9V8!(&,Y8#WK1M?B3)<6UW:P1V%]JB7=O:6\EK,WV:8SYVL
M21E=NU]PY^[P>:THO (CLI,ZS=-J1U,ZI%?F--T<QC"$;<8*%01M]#CMFK$O
M@Z:]L+A=1UV\N+^2XBN8;E5"+:R1_<,<?*@=<YSNR<GI@ I^'9M8;XC:W#K"
MP+(FFVFS[,[&-P7F^8!N5/8CG[O6JFL>(]1T'QSKEW<NDFD6&B1W7V=6;<3O
MD' Z;BRX)] *Z'1/#=QINMWVL7VK2W]W>010/NB6-$6,N1M Z#YSU)YSZU%K
M'@Z#6M9N;R>[D%M>:>=/N[4(")8\N5(;JK N3QZ"@""TU_7;/6]+L-?LK&--
M5#K UG*S&&54+F-]P^;*AOF&.1TYIGB&[U>+Q_X6M;.:);.87!FC9F&_:JYR
M!P< _+[YJS8>%+J/5;&_U;6Y]3?3D=;-7A2,(67:7?;]]]N1G@<GCFKNKZ"V
MI:OI&IPWSVL^G2.1B,.LJ. '0@],@#D=* .&\(>(=>TWPSX>FN[:TETN\O?L
M08S.;@%Y759#D;<9XV]<<Y[4^7XLQI+->+)I7]GPW9MS:&X;[8Z"389 N,=<
ML%ZE1UKJ8?!D$/A[2=(%W(4TV\CNTDVC+E)"^"/3)Q4$?@NYM6>ULO$%[:Z.
M]T;DV<**KJ6?>R+*/F5"Q)(ZX)&: -'Q;KEQX>T$W]I:I=3_ &B"!(7?8&,D
MJIU[?>KG[[QUJ'AM=:C\06=FTUC9PWD+6<K!)1+(T2HQ<?*0X'/3!SCM74Z]
MHT>O:<EG),T2K<P7&Y1DYCD60#\2N/QK/UGP;9:Y?:A<7<\P6\L([,K'@&/R
MY&D613_>#,#_ ,!% &'H_P 09;O4IM/D;2=1N#9274#:9<G;N3&8G+\*3D88
MG!P>!BH]+^(-S<:Y#I\TVB7OVBUFF!TRY:7[.\:AMCGHV03R,=.E:\W@Z\U.
MSOK;6_$5[>QW-F]F$B18$16ZN57AGX')X'.!R:9#X)N6U#3[R_UR2X:Q@EMX
M8H[9(8PDB;2=H_BX!SG'' % &)_PL/5K;P_I&HZE;Z19MK?EFR\RX<)"GEEW
M>8D>FW 7J6 SWIX^)DIT6^ECCL;B>RO(;>6\MW>2T6.0$B8X!8 8*D=CWQS7
M02>#8QH6A6-KJ$UO>:(B+:7JHI/RQ^6=RG@AESD?K2_\(OJ+64I?Q/J!U%[E
M;D7*X6-=HVB,0_=\LC.5[GG.0, ',ZIXFUS4]"TFYT^ZTIF?7+>W^T65TSPW
M"$@C[O*C)PRGGCOFNS\2ZW)H.CK<Q6ZW%W-/%:V\)?:KRR.$7)P<#)R3Z"L0
M_#X-971_M:1=3N+^'4&NX[=%598L!,1=,8'.222<DUT&N:)%KVC_ &&XGDBD
M5XY8[B+ >.5&#*XSD<, <?A0!SFL>+=;\+:;/+KECI^]YH8;.YBN"D#O(2")
M-V60( 6)P01TYXK,_P"%G2Q:=K)"Z;J-W8017$<EA,QAF5Y A4YY5@3ZG((-
M;D_@F;48YI=4UV[N-0+PO;7$2+$MJT3%D9(^5SDG<3G(..!3KGP==ZGIVH6^
MK:_=7<EXL296,1Q0JCAQMC!QN)ZL23TZ 4 96M^(_$EK::]I=W#807RZ++J%
MK<6DKD(%.UE.0#N&00PX)["IOM=]IUOX,U>ZD1KBZ:/3[L1L2LB2H2A.>K!U
M0Y_VG]:WM4\+V^K:G<WDT\BBXTN73710.$D8$L#Z\5EOH-\\_AC1YYY+NWTN
M3[9/>-$(PYC!6%,#C.6!..T?/44 6?&7BY/# TZ!6M([G4)6C26\D*0Q*J[F
M9B.3V  ZDCD5BV?Q&FOK8VEI#8W6K-J*6$4D$S&UDWQF3S=V,X"J^5ZY7&><
MUU.O:!_;#V-U!>26.H6$IDMKE%#[=RE65E/#*0>1QT'-9TO@Z:ZL#]LUV]FU
M-;Q;V&](4""15V@)']T)M)!7ON.3GF@#-F\::SITFK6VHZ?9_:+"YL(0\,C%
M)EN)=A8 \C /3GD'DUKZEXENK+7-3TZ"RBG-II27Z;IA%O9G==I9OE5?D!R?
M>L"W\&W^H:GXJM=6O[I_MGV&6#4%B5,21%F&Q>F%8+P<^YYJ]=?#YM475'U;
M7+FZN-1LX[5Y%A2-8PCEUVJ,C&3R#G//KP 8MQXZN-2M==TA[O2+LG0[N[CN
MM)G9UC9%"E"3U/S@@@]N@KI[ZYO8/A;+=64H2[CTCS$D<G@B+).1SGJ1[XJO
M+X&GO;J2ZU'7)9YI--GTW:END<:1R[>54=""N>2<^V*Z!M(AD\.-HLDCF%K3
M[(SCAMNS9GZXH Y32=?\174&F:-8PZ?)J$>EPWEW<W,DAC ?(C4 ?,6(4DD\
M#'?-=%X=UN3Q!H'VT6ZVUVKRV\L#-N6.:-RC#(ZKN7KZ5DV_@N^LOL=Q9>(9
M8=1@M!8RW!M499X58E R= RY.&![G(-;V@Z+;^'](BT^WDEE"L\CRRD%Y9'8
ML[MCN6)- 'F&E:EXEN+;P;,9+>YOIM2U!$,LSA&4+,"9#R2%P< =@HX[;UW\
M1+G3--GBU&"PAU6+5?[+WM,RVV?+$OFDD9"[#TZYXSSFM?2O!"Z9<Z<YU.6:
M'3KNXN;:)HE&T3*X*$CK@N3FG77@B&>6\N8M0GM[V74AJ=O<(JDP2B)8L8/#
M*54@@]=QH 3P?XO'B.YU*R>2RFGL3&3<6,A>&5'!P1GD$%6!'/;GFJVI>*=<
M,NO3:-86,UEHF4F^T2LLD\@C$C*F!A<!EY/4^G6M[1=)N].>ZGO]6N-1N;EE
M+%P$CC"C $<8X7U)Y)/4]*X7Q9I^I+?>(K72[?7(/[4B \NSACE@NY#$$W>8
M1^X/ 5LGD+D<T :]MXQUB^U18H+*QCL;?3K74;V:61]RI*&+*B@<D!"1GCCW
MK.T;XH_VA?:29GTEK?5)EB2UMK@O<VV\$H9!C![!@,;2>]=/H?A6/36DFN)?
M.>XTVUL)HL?)B%7&0>^=Y_*H-*\(WNF-I]M_PD=]+I6G$?9K0(J,5 (5))%Y
M=5!Z<9P,YQ0!BW'Q#N[/6K:WG;1"LVH)9-80WGFW<2O)L5VVY4'D$KV!QG-4
MH/&>J>'['7;K5);.5I=?:PM#+,RQQ,5!.YB#MC55S@#.<^M:\/PY>#3[33%U
MZ<:=97J7EO"MN@8LLOF 2/U<=1V/<YQ5N?P(LLFH,FK7$0GU!=3M2L:;K2Y
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MK->6M]MC#&4K)\T;<\8 'S$<\5I:5;CPW)X)NHM0U K?64@OA+<R2I(JVOF
MB,DJNTKQM XXH ]1HKQO3K^[AU3P?J4#7T::K>!3/>:PTTMY$\;MEK<9C4?=
M/!&TX&.::7U&T\!0ZU%J6H2WFHZH;*YEFU"1$BM_M3J IY$7W57>!D;C0![-
M17">#AJ%GXHU+3I6CAM%M8I?L1U.2^>&0LPW;W4%58#[I)Y7(ZU2\5S_ -H^
M(]3MHEO9QIUE&\V[5FL+>UW;F#Y3YG8@=2"!@#N: /2**\H\._:O%EWX:@U3
M4]0:";PT+F=(+N2'SI?,5=S%""3R?J>M1Z!]L@TKP1K;:IJ-S?W]Z;6Y,]V[
M)+%Y4V%*$[>/+4YQG.22230!ZW17D5G<RIX/T/Q1'J][)XAN[^".:)KMRDKO
M,%EM_))V@*I;@*"-N<U:N]=GA\ ZRS:I*EZOB.2VC)G(D ^W#"#G./+[?W?:
M@#U.J\5]:S7MQ913*US;*C31CJ@?.W/UP:\MUB&YFT;QYK9U74TO-)O938>7
M>2(D&R&-^$!VD$DY!!&*Z'PW:6Z_$WQ1<>9-Y[6]FVQKARI#*Q8["V.H&...
M<8R: .YK+U+Q!8Z7J-CI\WVB2[O2?)B@@>4[00&9MH.U067).!S7,7D,.N>.
MM9L-7U&[M;:PLH);2&"\>V&&W[YLHPW$$ 9.0,=.:P/"J2:UXH\):IJ,]U+=
MOH]V_F_:)$$HCGB6-RH(&&7#$8PV02#@4 >M53N]4M+*]L;2>0K/?2-';KM)
MW,J%R,CI\JD\UR_C.?[3K>DZ/%'?7,\T<TYM(+[['%(J[1NDD'S<%N%7.<DD
M<5RGAJ^N+V]\,+<7!G%MXAU"WB/VEKC:BV\N%$K %P,X#'J,4 >IZ7J=IK.E
MV^HV,ADM;A-\;E2N1]#R*N5QO@"26'X3Z3+;Q^9,EB6C3^\PS@?G6'HUQIEA
MX<T'Q)=>)=2_M"]M7EN,3O.+E_)9Y%\HY5=A!(P!C;@]>0#TZBO(-'N[NS\2
M^#YT-[!%JAD\Q[O6&N9;R/R'<,T/*)R%.5/!.,5/X8N;G3]9T.?4+FZO%U&6
M2*+5+35&F@OF*LP\RW?_ %> I^X,*1C..* /3-*U.TUK2[;4K&0R6MP@>)RI
M7(^AY%7*\=\+6+:1X2\!ZK:WU_\ :;N\AMYU:Z<Q-$ZO\GED[ !@8P,Y&<UV
MOC6:1KWP[ITEU-::=?WYBNY893$S 1.R1[P05#.H'!!/3O0!LOXATY+RYM/,
MD:>VN(;:54A=MKR@%.@Z889/0=\5J5X^NW2=:UJ#3-1N9(QXDTF$N;EG<*?+
M#1ER<L!RN"3QP:U8[W43KR>!S>77GQZH;QKCS6WG3Q^^ +YS]\B'Z T >AV5
M[#J$!F@\S8)'C.^-D.58J>" <9!P>AZBH[#4[34C=BUD+FTN&MILJ1MD4 D<
M]>HY%>::9=7&KWFBZ7J>HWBV%S?:L7*W3QM/)%<$11%U(; 4L0H/.T=A63%<
M7-I;-IFF7<MS8WGBFY@FF:_:%I0L(*QF< L,L,9'+;<9YH ]MHKR"675XK:X
MTHZC):PC7;"W2.VU.2XFMED($D9E90<$8(!SC=]*L:Q-=>')_$^F6&HWT-@G
M]F,99;IY7M$FE=)G5W)8?*N>O!R: /2_[3M/[8_LGS#]L^S_ &GR]I_U>[;G
M/3KVJY7DNJ65KH_BG6X=+UZ6S8>'"1/<W4D_V5FF&&W,690>O7CJ*V?"%V=+
M\07FG:C%=V,OV%;LH^JF]M&16P95>3YT)R,@X! SVS0!Z#169K^HPZ=X9U+4
M9)Y8H8+624S0*&=0%)W*#P3W&>*\XTF>]TWQEH$ %U:IJ%G<-+'<:R]Y)<!8
MPRR.ARJ'/0J>Y'04 >M53U#4[32XX)+R0QK/<1VT9"DYDD8*HX]21S7F6@17
M-EHG@#6QJFI3WVI310W;3WDDB3(\$C;2A.W@JN"!GC)))-4A'#?>&_"VNWNJ
MW;ZQ=Z]:BXBDNW*&07 W1>43M79CC !&WW.0#V5F5%+,0J@9))P *HZ1K-AK
MU@+[3+A;BU,CQK*N<,48J<>HR#ST-2ZCIUIJUC)97\"SVLN/,B?[K8((!]1D
M#CO7,?#][:Q\)W3.T5O;Q:I?C+$(B 7,@'L!0!JZOXNT;0[LVU[<2B5(Q-+Y
M-O)*((R2 \A12$7@\MCH?2G:KXKT?1I(8[F>6226(SJEK;R3D1#K(1&IPG^T
M>*YV&YM+'Q!\0#J,D<8,<,Y\P@9@^SA<\]MP<?6LSX>%M,U()J\@AG/AK370
MS-C$:"42=?[I(S]10!VM]XJT>PMK*=[B2<7R;[5+2%[AYDP"654!)4 @DXQR
M/6M'3M1M-6T^"_L9UGM9UW1R+T(_F#VP>17E_P /?]%U?P\]U^ZCN-!G^Q^9
MQE?M._ S_P!,S&<>@]JZOX>XET"_FC.;2XU:^EMBIX,33O@K['DCZT ;J:YI
M\OD&&8S+-<O:JT2,P$B;MP) XP489/&1BM&O(O#2#3(M"BLKJZ7SO%-[#<(;
MJ1]RK]JPK!F/]U2?4C)R>:ATZRN9O#WA'4GUK6#>:GJC6EU)]OEP\!$WR!<X
M7A%^8 ,.N<\T >QT5X]J5[J6EB]T*RNKEK >(X[3,U^\;+"]LLOE>>=S(&<X
MSUYQD9J5SJ\-GK>E#5;:PC2ZLUAM9-6FF*,['? ;C:'C$@ QR2,GH#0!ZY67
M?>(M*TZ*^DN;M0+'R_M(52QCWG"9 '?-8'@.Y*W&LZ7-!?VMS9RQM):W-]]L
MCB#KQY4I^8@[22K<C/09KCO%5A;I/\1GCFG6X86.,W#L &*$D(21P1P<<=!@
M<4 >R45Y9XBDOO!U_K,>AW=_(3X>FO-MS<R7&V9)%7S1O)P=K$D#@X'%3^&A
MJ-CXJT=$GCCM;VVE>9)-;DOFNP%!6559 %(.,D$ AL8X% 'IE%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !44UM;W)B,\$4IA<21ET#;' (##/0X)
MY]ZEJEJFK6.BV?VO4+A8(=P0$@DLQZ*H&2Q/H 30!))IUC+]I\RSMW^U*%N-
MT2GS@!@!^/F ''-5;7PYHEC8RV-IH]A!:2D-)!';(J.1T+*!@_C5>'Q?H$^E
MW>I+J*):VC!+@RHT;1,<8#(P# G(P,<YXIMKXS\/7D=X\6IQJ+*(37(F1HC"
MAS@N& *]#P>>GJ* +^IZ-I>M0K#JFG6E]$AW*ES"L@4^HR.*>-+T]4@06-J%
MMT:.$"%<1J1@JO' ( ! K)M_'/ARZ%SY>I -;6SW<R2121LD*XRY5E!QR.<<
M]LT#QQX<:P^VIJ2O 9S;H4B=C)(!G"*%R_!SE01B@#873[)4M46SMPEIC[,H
MB7$.%VC9Q\ORDCCL<52@\+^'[6X>X@T/38IG<2-(EJ@8N#N#9QU!YSZ\U&_B
MW0DT>/5CJ,9LY)/)1E5F9I,D; @&XMP?EQG@\5'%XT\.S:?<WR:I$;>VD6*9
MBK I(V,)M(SNY VXSGC&: -"?1=*NK.:SN--LY;6>0RRPO K)(Y.2S C!.><
MGFHI_#NB76H1:A<:/82WL./+N'MD:1,=,,1D8[>E8FK?$/1[+PY?:M92-=-:
M21Q/ T<D;JSD8W*5W*,9.2.<5HWWC+0--,(N[_RVEA%P%$,C%(ST=P%)1?=L
M=#Z4 ;$=M;PS33101)+.P:5U0!I"  "Q[D  <]A534]"TC6Q&-5TNSOA$<Q_
M:8%DV_3<#BK3W=NEDUZ9D-LL?FF53E=F,[@1U&.:R=,\8:!K-W':V&HI-+*A
M>+Y'595'4HQ #X[[2<=Z +=_H&C:K;0VVH:58W<$'^JCGMU=8^WR@CC\*DET
M?3)TM$FTZTD6S97M@T*D0,.A3CY2,=JH6GC#0+_4ET^VU%)+AV9(_D8)(R_>
M5'(VN1@Y"D]#4FE^*=%UJ^FLM-OEN)X 3(J(V%PVT@L1C(/;.: -.:VM[AX7
MG@BE:%_,B+H&,;8(W+GH<$C([$U3;P_HSZL-5;2;$ZB.EV;=/-'_  +&:JZA
MXOT'2]0:QO-06*="HD_=N4B+?=WN 53.1C<1UK)/Q!TRQU_7-.UBYBM5L+B.
M.-EC=OD:)'WR$ A1N8C)P.* .I6QM%CN(UM8 ERQ:=1&,2DC!+#^(D  Y["H
M['2--TP*+#3[6UVQB(>1"J80$L%X'3+,<>I/K5#5?%VA:-/Y%]?;91&)F6.)
MY2B'HS; =J\'DX'%)=>,- L[JTM9M2C\^\2.2W2-6<R(Y(5AM!^4D=>GYT 6
MET+3X[VPN8;>.$V$<D=O'%&JJ@?&[&!QTZ#CGD'C&BZ+(C(ZAE88*D9!%8D'
MC#0+G5!IT.HHURTC0K\C!'D'5%DQM9A@\ D\&M#4]5L=&LS=ZA<+!#N" D$E
MF)P% '))] ,T 176B6-U;6-L84C@L9HYH(XT550Q_< &/E ]L<<="05DT+2)
MM6359-+LGU%!A;IH%,J_1L9JC'XT\/2:;<:@=3CCMK:5(9VF1HS$[$!0ZL 5
MSD<D8JJWQ$\*I%)(VJA?*.)$,$H=!@'<R;=P7!'S$;>>M &Q=:%I%]J$.H7>
MEV4][!CRKB6!6D3'(PQ&11J&A:1JT\,^HZ797DL!S$]Q KLGT)'%5=3\6Z%I
M#PI>7ZAYHO.18D:4^7_?(0'"_P"T>/>KEOK.G7=U#;6UY%-+/;?:HA&=P>+(
M&\$<$9(_.@"\0""",@]JS8/#VBVL+0V^CV$431O$42V0 HYRZX ^ZQ R.AQ5
M2X\9>'[6VMYY=20)<M*D&U&9I6C;:X50,D@\8 K/U'X@Z1:P:+<6DGVNWU.]
M-J)$1_W6U6+$J%SN! &TX/.>QH Z86=J)XIA;0B6%#'%((QN1#C*J>P.T<#T
M'I56YT#1KW3Q876DV,UF',@MY+=&0,226"D8R22<^YIGB'6!H>BS7JQ^;-E8
MK>'./-F=@B+^+,/H,U3O/&&C:/,;+5-1C6_AB62X2&&1MH(Y? #%4]R<#N:
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M5957J49@ X'JI-9OA+X@:5XBT_25ENXH]4O;<.8$1PA?;N9$<C:2.<@$D8H
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MSGTK)T[2M=NM?\,7<]GK4R6@F6[_ +1\F*&)FMW4*D<8X7<<9P< CKS7JU%
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MW+O],5>U>RU;3[;QGID6@W6I'6S)-:3PE-AWP+'LD+,"NTKD<'((QSQ7I%%
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MJ2<?.<@Y/4Y[4 6+_P 63QWNJ0Z;8Q7L=A:0S/(UPL2F24G:I8\!0@WD^A&
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M]2N8M/EOH5T6^^T!_+QNB;@%6Y&#@@C/IBMU_!=K-X?U?2)[J5H]1O9;SS4
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M>^3=7"-MS+$K#:RC<<#.3M/0X%;GASPY+H=UJMS/J+WLVHS)/(S1"/:P0)@
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M97^J6\%QA2R,WW W0N>B@]MV*G\0:S#X?\/WVK3C=':PM)MS]X@<+^)P/QH
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M;+Y_F";SC&6'&&QG=NXKO?&]A=WFG:=<6EJUV;#48+R6U0C=,B$Y"YP"1D,
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M,DA>M=_X=T7^P-)^P_://_TB>??LV_ZR5I,8R>F['OBDL-#^P^)=8UC[1O\
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M>WTO'E;=WE%COZG&=W3VZT 0:-XYCU2;2?.LS:6^I:?)=QRO+G;)&P$D1X[
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M1! /!&,XQ69HL^IVOASP?HVGOJ,L&H_;)YUAO!%*YC8 1I(Q^4<EB 03@^]
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M:2.I4'(YYXK9L_&>E7>O:UI1N88FTE5::1Y0 1C+GV"D@$GO0!K#2K ?8O\
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M;@,D8Z5'XBAN_$5SXHO-/T+4HTG\.-:1O/:-$\\N]CM"D;L@$#D<]N*]7HH
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MNQ:&6&9X9(R1@[70AAD=>>:ETO2;'1;%;/3[<0P!BV,EBS$Y+,Q)+$GJ22:
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MNXOEMYIED!($*%3YA '/*C/&:DU?QX;+6+K3;*RM)I;*))+G[9J"6I!<;@B
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M)V7YY"&.1E5  /3T%:2_$5[NUT]=,T<7>H7=Y-8M;B[4)'+$A<GS "&3;SN
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M'H<]Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !574=1LM)L9;W4+J*VM8AEY
M96VJ.P_7BK5<QXWMK.\L-.MKC4O[.NGU")K"=H?,3[2N60,O0@X/4CG&#G%
M&AI'BC1->:9--U&&>2$!I(^5= >A*L <>^,5IP3PW5O'<6\J2PR*'21&#*RG
MD$$=17GUQ+JB>(%T_P 1VU@VH7>FW26>J:6[HZHH4NKHV=N?E(.2,_6L[PDE
MY>6'A/P\NKWUI9MH":@[PR!997.Q1&&QPB@YP.>1DT >K57EOK6"]M[*695N
M;E7:&,]7"8W8^F1^=>;V&LZOJNI6'AN;5[A(1?W]O)?P[4FN4M]FQ=V,!CO.
MXJ 3Y9Z<U1\2W^KZ+J^CMI5V?$5_9KJ<:LP7?" L1VO@CS&0'H,%N!QUH ]>
MHK'T,1WGA:U:VU::^6XM]RW[$;WW#._ &!UZ8XQBO.;?QUJL-UHUU>WA6RTA
M!::\,#YIW,L6X^A#PJWTDH ]>HKR6+5?$]_?:7I<XU:5I-*_M2=-/G@AEWRR
MMA2TA'RQKA<+W(S5BSO/$6N77AK2[W6+FQ,\>H"ZELIH6DE$,D8C)9-R*_/S
M8[[AQF@#U*BO'Y==\575MJVLVHU)9+._EA@+7EI%9(D4FS9*KN&RP'+'!RW'
M&*[CQ]K%_HOA":ZTX,MU)-! KKM)C\R14+#=\N0&XW<9QGB@#J*1F"J68@*!
MDD]!7DVHZKXET33O$,>_4K:*/1I;J$ZE>6TUQ',I #((V+;"#SD8!48QG%:>
MHP:EIVK+IDFNZA=PZGHMW--YS+\DL?EX:/"C:#YC#'3I0!W2ZOIS36\2WL+-
M<0-<PX<$/$-N7!Z;?F7GWIT6J6$]U%;0W44DTUO]IC5&SOBR!O!Z$9(Y]Z\N
ML6NHO#'A[2DU"[^RW/A&XN'&\9W!(-N#CH S >QJI'?W7AG3+#4K-Y+BYMO!
M33Q&8[L,7B(_X"N>GH* /9ZKSWUK:W-K;SS*DUTY2!#UD8*6('X G\*\TCU;
MQ-H,R7#1ZE+"^GW,TB:I>6LGG21Q;U>%8G+=1@JHQA@>,9J2&RN4UWX?ZA<:
M]=Z@][+)+(D[*4+M:2-OC  VJ,XP..10!Z//?6MM=VMK-,J3W3,L"'K(54L0
M/H 35BN:\07]U:^*?#%M!,R0W,URLR#HX6!V&?H0#7$:.^O76F>";J7Q/J9F
MUW,5W@Q[0@A>0;!M^5OD W=>2: /7**\K2_UIY+/14UR]55\33:<;HE3,UN+
M=I-I)&"<G ;&> >U0W4^MV6B>)=07Q)J3MH.IBWM$=D(=/W3D2_+E\^:5YZ
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MN+-Y8+' *BJ^HZOXFT?2O$$(EOK18[2">V.H7=O/<PR&8(W$;$E"/[W<, :
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M?7-;M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJJ:5-J]C'J#D!;9YU$A)Z#;G.3V% %;3O!_A_2;DW%CID44NPQJ=S-Y:'JJ
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MN!N! R3QMXZYK3LO$NA:E?&QL=8L+FZ";S##<*[[>N< ].1^= &F %    '
M I:R4\4:!+J#Z>FMZ>UXCB-H!<IO#DXVXSG.>,5K4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<MXUT]]1D\-(MHUS'%K4,TH$98(JI)\S>@!QR?:NIHH \OUO09Y-)^)?D
MZ5(TUZZ&VV0$M/BWCQLX^;#[NG?/>G:S+=:=<>.K)M*U*XGUBW4V)M[1Y$E/
MV58B"X&U2&4YW$<8QFO3J* /)-1T?4WT?Q,%TV[=GT;2EC40L3(T9D+JHQRP
M'4#GD>M,\5@S+X@U*73+J2PN[O17CBEMV0SJ)5W(%8#GG!!Z$X->O54U'3+3
M5K9+>]B\R))8Y@NXKAT8.IX/9E!H \R\3V]SXB;Q!J>DZ9?K:MI4-IB2SDA>
MYF$X;Y8V 8[%R,X_BP.E7/$6F7)\<_V#!&3IOB5XKN[QT06^/._[[40+^)KT
MRLVWT*PMM:N=71)6OKA!&TDDS.$3@[4!.$!(!(4#)H X*[T6[N=;G\W39Y(&
M\807/S0DJ8EM%'F=/NAAC/3(I-?T>];7/$%S'ITTUH-1TR[>!8_^/M(Q^\5
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M%).W.2..]8LEOJ>H:ZURAU74(3H-];":323:1J[!"L:+L#=C][([#G->OT4
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M$L<'&.!QU]L3Z?X8\16UA9:/-K5M_9=A"88S#"RS7"A"B+*22  ""<=2HZ4
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M&D+AM@Q\S$X/+'J> *L^(/!DVM3^()$O4B_M33X+2/*$^6T;R-N//(.\?D:
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MXB25R\D:G.T@DMAB,@-T.* %\/W6J:G\2?$+79N$L[#RXK>-+S,(#1JP)C
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MZ,^G:UKM^TRNNI7$<RH!@H%A2/!]>4S^- '&>([R2V\4ZB?$>H>(M.TH"/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNH]S?O';&3G.1G Z56U/P=H.L7LEW>V.^:552;9,Z+.HZ"158"0#_:!K=HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** (;NZBLK*>[F.(H(VD<^BJ,G]
M!7&Z7J]R8?"\^H7-X+K6//NC%$Z^6@,)D6-@1G"K@#&/F&3G)KKM2LEU+2[N
MQ=BJ7,+PL1V#*1_6N/T/2[K5K#PK<2ND-QH2S6EY"P.3((3"<>V<,/52#WH
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MJYR@6%(\'\4)_&N8U_P-J6MZM+,[:3\UPDL&J"$QWMJ@(.Q2@ ;H0"3T/(-
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MV.>Q6:XMF48>:8*L?(/;!;_9;CDUD>,?&U^OAS7)=&TZ\$%E(;4ZG&Z ),K
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M72!IK+;[L,5<%6^;_9 S[T (OCZWNK#2I+#3KBXOM265DM'D2,Q")MLA=B<
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M-.(B@9P)&8 XW*3\P]*2-[W2I_$=Q%J,TOF>*[2 I-%$RX<VX8CY,YVMMSV
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MUW6O'<L2Q:I-HJ1:3:W;BUBC9I9IM_/[Q6_=KLZ#!.>M8MUXBU+3_%UWY5U
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M<2TLH8%BI)!VCC/&.,9-=GXGU.Z\,^!K^_BE:[N[.V)26<+\[] SA0!U.3@
M?2@#:>[MX[J*U>>);B96:.)G 9PN-Q ZD#(SZ9%35YAK*ZEX8\5:;J-WJ\VL
M&WT?4;A4GBC1MZ+$S!?+4?*<# .2/4YHT3Q!XF2XT:\N1J]U!>J3>)=V]M'
MN8RX: H=_! &#NR#GJ* /3F8*I9B  ,DGM4=M<P7EK%<VLT<T$JAXY8V#*ZG
MD$$<$5PFBW&M7V@:3XBO/$J;-3B\R6PECB6';(C,L<1 #[UXZLV<'BL71=3N
M_P#A&/"VF66I:JC+H<$SVND6D<DV2,*SO*"BIP0!P20><4 >M45Y;I&N^)/$
MR>%;9=:?3WO;&\ENYHK>)G=H9412 05!.><<<GV(KR>*_%%U'J6KV2:LQM;Z
M6&"U2"W%FT<<A0K([$2;CM)+ C!(P,=0#UJBO--5U[6].\07=SJ&H:C9:='>
M(L$]O:PW%B(?E!6; \U')+ DD $CMUZWQ?J3Z7H#2PWQLII9HX8Y$MS/(2S
M;8TYW.1D#((SR>!0!O4A( ))P!U-<-X.UC5)?%6JZ1>S:G+;16D%S =4BA2=
M2S.K?ZH ;3M&,@'KVQ4U[-J^M^*-;TZTUF32X-*MX2BQQ1MYTDBLVZ3>I.P
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M<YS784 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<?<KVEPT/G?:$MS>3>3%)NW[DCW;5.[G@#J?4U;E\(:)-?W-Z]K(9;F>*YE
MN) C2Q%2C[ VT$;%Y YQSFGZ3XAAUA[22U6)K2YLA=+*+A"RDG!0H.>.<MTR
M,=:MVFM:5?K.UGJ=G<+!_KC#.KB/_>P>/QH KR>&M(ETR]TY[7-K>SM<7$?F
M-\\C,')SG(^8 X'%<;XJ\#:CKU[JT2Z?IICU$!!?"\FB,:[0N9(%!25UYVL2
M/X>F*[NVUC3+VZ>UM=1M)[B-=SPQ3JSJ/4@'(%2WE]::=;-<WUU!:P+P99Y
MBC\3Q0!%<Z5:7NC2Z3=1F6SF@-O(A8C<A7:1D8(X]*M11)!"D,8VI&H51G.
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MEP%4@%BJ9&<?Q =JO:G>1^*?$MY-IMI=SVQ\,WD"R26DB*\K/$0@WJ,MP/\
M(./3J* /&;BRO-6T=5T>TN<MX3%N4$+1%G69?,CY ^8@./?.:T]2-CK.I6TW
MAK39X8K32;V*\9;)X $:+$<)!4;FW@':,XP?6O4Z* /.--T6.PF^'#VVG"!X
MH'6X9(=I7=:,3O..[XZ]_>M3Q<L=MXJ\.ZIJ-M)/H]JMPLI6%I5AF8)Y<C*
M3C ==V."W;-=G10!Y&FD?VA>6TT>ERKHEUXK2YMK>6W*CRQ;,&D*$?*C2 D9
M SG/>NQ\-67V+QCXM$=MY%M)/;/&%3:C'R0&(['D<XKJZ* /)/%=BLEUX[L?
ML$S3WPL98=MLQ$L8,:R88#!YZC.>_:KGC'0+MM7U:WT"Q\AY_#4L*_9X]BNP
ME7" C W;2P ]Z]/HH \O\+6\=UXOTFXM+FXE6SM)4D6/1OL20H0H$4K$C)W
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M,I2,@;^!R/XL'UY+O3+K6(/$%QI4]WJ!?3(X9?(TS['%.!*K&,9(+R; Z\#
M#XSVKV:B@#SS29M*U#XFV%[HNG2PVZ://#-/]B>!,^9"5C^91\RC=QVS6CX@
M2.#XC>&;R:V=HFMKNV$RP,X65C"4#$ [<X;!.!UKLJ* /)]#T);'P5\.WATP
MPWD5_"\[+!MD0-')O+'&0"2,Y]JQY'NKNWTS;:?99XM=AGFTVVTF3?:C[2"S
MRW#9W$@YR,9W<< U[A10!P7AS4+'P]=^*A>P36[_ -L>9D6KX:.7RUC8$+@C
M=GH>.2<5J_$."6X\%W44$3RR&>V(1%+$@7$9/ ]@371W%M#=1".>-9$#*^UA
MD94A@?P(!_"I: /*=5T%9_"GQ(G;3/,O9KV8P.8,R.%AC*%.,G#9QCOFNP\>
M6DU_\.=<MXH&GG?3Y-D:KN9FV\8'<UTU% 'G^C:?IVL^-M0U Z:LMF^BVL4#
MSVI48+S;U 8#'1<CZ5R&FV>H6,7A:]U&:6RLTT!+:.6;3&NQ%,')="O5"R[,
M''.W%>WT4 <Q\/[-['P?;0D72H9)9(DN8!"Z(TC$#8"=J\\ \@8&!TKIZ**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "LG7]>AT&VMV:"6YN;J<6]M;0X#2R$$XRQ   !))
M. !6M7,^-/"P\3V=CL2SEGL;H7$<-['YD$WRLK(XYX(8\X." : (5\=6\>^.
M^TZYM+F"[@MKJ)F1A")CB.7<I(*$\9Z@YR.*FU'QM9:?=W]L+6YN);6:"U18
MMO[^XE&Y8ER0,A<,2<  UG:=X%7^Q==LKRRT?3QJD8B6'2K<(L("G:Q?:K.V
MX[N0,8X[U6F^'MQ>>#K>QOI[*[UA-0_M2>2>+?;W$Y)RK+UV;#L]L ]J -"X
M\?P:?8:E+J6EW=M>:?Y#2V@9)&=)I B.A4X89R.QR",=,U-:\<W]KHOB"-=%
MNK#5['36OH(YGB<-&=P#Y5B/E()*GTXSFJP\ 74NE:G$MGH.ERW4EKY<&G6X
M5$6*99&+2;%9RV.!@ 8'J36QXA\)W&M:CJTZ7,44=]H<FF+D$E79F.XCTYH
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M7?+3*%:0EP,8"C"\]3R:6^T#Q=K.AWFE:A?Z;#"^FS6BBV#-]ID=-JO)N7*
M==JYY/7C% &UX?\ $46N2216D<DT%M&JRWW'E/-CYD7NQ'<C@'C.<X9J?BA[
M36'TNPTF[U.Y@@6XN1;LBB%&)"_>898[6PH].U0>'O"TGAG591IS01Z/<P(9
M;-01Y5PH"EXP!C:R@9''(![FB^T76K3Q+=ZQH4M@3?V\<%S%>[P$:,MLD4J#
MGAR"IQG Y% %+P)XIDU/2M"LKTS37]WI;7SW#  $+($(/O\ ,.W:GR_$"-H]
M/6QT:]O;J_FNX8((VC4YMWV.2S,  <$@Y_6J6F^#]?T&/0;C3[G3KB]L=/DL
M+E;DND;JSJX=2H)R"O0CG/458T#P7J&E7&A375Y;S/I\FH/,T:E?,-Q)O4J.
MV.XS^= !%XT2RWQBTU._N;G6)K&* F/<DBQ[]H.0 @P>2>.2:LKX\A%E-YVE
M7D>J17RZ=_9VY&=YF0.H5@VW:4.[<2, &H;;P;>0ZS;7K7,!2+7+G4RHSDI)
M"T87I]X%L^E9OB;1FT>YO=?EOH;=WUF"]M97C9XHL6XA(FQ]U" PW#IN4T =
M1H/B4ZSJ>I:;/IES87FGK$9DF9&!\S<5VLI((PO7W]<URGB3Q7KEO)XYMH8I
M+>+3-,CFM;A3'^[<K(=W7)W8&..-O;/-SP%<WFJ>)O$VL3W%K<V\XM889[-6
M\@E%<LJ,WWP-XRW3)/I4WB#PAJNIW?B86D]FMKK>FI:DRE@\4J!PIX!!4[^>
M_% %NU\;(ER8-8TN[TM38R7\4UPR,)(H]N\D(Q*L RG!]:DTSQF+V^L(+S2+
MS3X]3!-C+.\;"4A=^U@K$HQ4$@'T/?BD\0^$3X@U"V:6=4M!IEY83 9W_OQ&
M R]N-AZ^U9/AWP)<:9JNG3SZ9X9MDL5(:XL+(>?=-MV@DE1Y77)VDDGC.* .
MBU[Q)_8M_IMA#IMS?7>HF18(X2J@% "=Q8@ 8/7V^E4/^$\MOL:@:==G56O6
ML/[-RGF"8+O/S9V[-GS;LXP1WXJMXO&I_P#":>$VTH6YN%^V?+<[A&P\M<@L
MH)7V.#R.AK/OOAU=:C%_:-[_ &9>:NVHM?RV]S$7M'!B$7E<@G 55(;&=PSC
MM0!J3_$"WM+&9KC2KU=0@O(K*2P0HS[Y1F,JP;:RMV.?7.,4P^,4T^]U.XU2
MWU&WF@L[5VT\F.3#RR2(BQ[3R[, #SC[O3FJMIX$N8X(V%OHNGR?VK;7IM].
MMQ'&D<)SMW!0SL<DY8 #.!BK>N^"[G5]6U6^BO(H'GALC:,5+>7-;RO("P[J
M2P'!]: )V\=06'VU-=TVZTJ>VM#>B-V27SH@0IV%"06#%05XY8=0:J6OB/5K
MSQ]I.GW6FWFEP2V%S.\,SQNLI#1!3E2<,N6R.V>]1ZEX,U;Q3+=W&OW-G:RF
MP>SM8[$M(L;,Z.96+!23NC3Y<= >3FKUEH_B.Y\6:?K&LRZ8L=G:36XBLR[%
MFD,9+Y8#&=GW>WJ<\ #/$.NZGIOCG1K*QM+B^CN;&Z9K6)D4%U:+#LS$   M
M^>,<T\>/+::TM!:Z==RZG<W$ML-.)1)(Y(O]9O8MM"KQSDYW+C.:GUW1]:E\
M3Z;K>CR6):TM9[>2"[9U$HD:,C#*#MQLSG!],<Y'/77PWGN(K.^N%TK4=4CO
M+F[N;>]A)M93/MW*."5VA$VM@GY3D<T 6-6\=7QM]._LS3+A+O\ MB.POK61
MHM\9V[M@);:=P((8'&/0UHS_ !!TVVM;"6>WN$>[U-M,:+ )A=7*%GYQMSMY
M]'%9J^!]1@T6$646AVE_%JL>HI;VUOY-LH0;1&65=S'!)W$9SQ@"EU/X>3:C
MK&OW1NXDM[^T<6L6#FWNG6,-)TZ9AC/_ 'UZT :USXXMH[B2UM;"YN[LWSV-
MO"C*OG.B!I&W,0%1<X)/<8 -,/CRU2R?S-/NUU1+Q;#^S<H9#,R[U ;=MVE/
MFW9Q@'OQ63=_#N2?1-!61--U#4=-DEFN([^+=;W3S9:7/!*G<<JV#C'2H9OA
ML]SHZA[+P_#=QZ@+V.RAL@+,J$*>4_RAGR&8[R,@XP,"@#8G\?V]E8WKWNEW
MD-[93V\,UDI21SYS!8V0AMK G/<'((K2T7Q&^IZI>:7>:7<:;?VL<<QBF='#
MQN6"L&0D=58$=O>N<@\!77V&X"VNAZ;)-?V=P+?3K<)&D<$JN07"AG8X/4 #
MMW-=/#HTT?C2\ULR1F">PAM509W!DDD8D]L8<?D: (M8\17>G7<MO9Z#>W_D
M0B::962*-0<X56<C<W!X'3C)&:H#QY'=R:;#H^D7NHS:AIXU"%%:.,+&2!\Y
M9@ 1D#OR?QJGK_@R^U;Q+=7[0Z3J%M/!'%"NI!W^PLN<LD>"KYR#R5.1UJQX
M5\(7NA76D2W%Q!(+'11IKB//S.) VX9'3 H NZ1XTLM8GTJ-+:X@_M*":2(R
M@#$D+[9(C@GY@<GT(!K3T/6(=>TT:A;Q.EN\LB1,^/WBJY7>,=CC(]L5Y[XC
MT:72/!VE:'!?QIXE;4I9=-,*DD^;,^\_[JQ3'<>@Q]*]*TVP@TK2[33[5=MO
M:PK#&/15  _E0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR2)#$TDKJD: L
MS,<!0.I)IU<;\0E6=/#MC=8.F7>L0Q7BG[KKM=E1O]DNJ#'?@=Z -_3/$FAZ
MU-)#I>L6%[+'RZ6UPDA4>I /2M.N"\>+IUM%I-QI_P!F36K+5+2*V6':) )'
M :,@<[6C+\=,#/:F7?B?58?!/B745N@+JRU:6V@?RU^2-9U0#&,'@XR>: /0
M**\O\7>)]7M6\076EZMJ#G2P2D-EI\;VT91 S+/+(O)]0C# (X)K0^U:]K_B
M'6K>+7)-/L+*TMY%A@MXG9VEB8L"SJ>!CCZT =\CI(@=&#*PR&4Y!IU>.:'K
M.KV?A[P?H5G=:H4FT87TLUE:PRSJHV*L:AQM"C<<L0QZ#OFM:+7/%>HMH>EM
M>RZ9<75[=VTUT]K&99(HX]Z/L.55ST(Z9SQT% 'I$-U;W+2K!/'*87,<H1PV
MQP =IQT."#CW%2UY?I^H7^@R:M?K=&2TA\4>3J)9%^>*2"&/S#@?+M=D;C Q
MFNQ\*ZE=ZU!J&I32YLIKR1+! H&(8_DW9ZG<RLW/8B@">;Q;X;M[Q[.?Q!I4
M5RC;'A>\C5U;T()R#[5I-=VR300M<1++."84+@-)@9.T=\#GBN,\&Z;87P\5
M+>65O<!M=NE82Q*V1\O!R.E<]X7N[X6^@Z7I]RL=K)<:O;V-P\:R,L4980LI
M8$X'Z@ '(H ]8DD2*-I)'5(T!9F8X  ZDFDAFBN((YX9$DBD4.CHV592,@@C
MJ"*\Z@\7:GK-G:10ND4]II5S<ZPAC5@)DW1+'@@XS(LC?1/0T_0]1USQ))!9
M6NK_ -EI9:/97#>3;1-Y\LR,>0RD",;,;5VGD\C H ] MKJWO;:.YM9XYX)!
MN26)@RL/4$<&I:\:\/Z]JL6A>%M!L7U"*/\ L@WD\VF6T<TK'S-BJ/,RH7J2
M<$\@<5M6VN>*=3G\/Z9+>2:9-=37L-S/]FC\V1(@"CA3N5'(/(Y )/'2@#TN
MHHKJWFFFABGCDE@8+*BL"8R0" P['!!Y[&O.K77]?N9[;PZ=5*73ZS=6+ZF(
M(_,,,,7FC"XV;SD#.W& 3BM7P1;W5KXB\80WEY]LG6_AS.45"X^S1XW!<#.,
M X &><#I0!O7OBKP[IUX]G?:]IEK<IC?#/=QHZY&1D$Y'!!_&M2&:*XA2:"5
M)8G&Y'1@RL/4$=:\UMY-07Q_XS6S\,V^KJ;FVW/+<I'L/V:/CYE)-)#!J/A/
M1M+T0ZE)9W5W/=73V>D6GVF5%9]PCBWJ56-=X!9AZ8Q0!Z=17FFD>*]<73[*
M_O[B1K6UUR72[[SX8TD,;';$[[>%979 =N!R:<FO>(=8NM%^R:I]CM-;U"[$
M#K;QLR6L<9V%=P/S-L+9.?O]P,4 >DT5Y8-8\46ND7NJ3>(&F&E:TNG>2;6)
M5NHC.D9:0A<A\2=4VCY1QS3;[Q7XFN[G7KO3?[3']FWDMO:VT-E"]K+Y7!\U
MV^<%CGE2NT$=: /5:;O3S/+W+OQG;GG'K7G-]J?B2_NO%D]KK4FG0Z1!%-;6
MZ6T3Y8VRRLLA922N?3!Y//2IO#SW6H?$I]3DO956X\/V<[6X1-GSM+\N=N[
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MN"<(7VICTSDX[4 >OT5Y;=>)?%-CH^KQK)>(\,]B+.\U*UB27][.L;HZ)A2
M.A !PQ[C-6=7\0:]X3N-<LY-4.J-'IL%W;374$:&&228Q'/EA04!PW//!&:
M/1&NK=;I+5IXQ<.AD2(L-[*" 2!U(!(Y]Q534M>T?1FC75-5L;$R@F,7-PD>
M_'7&XC/45R-II^HZ?\4M+6_UF34PVCW15IH8XW0^;!N^X -IXQQD<\FF>+7N
MD^).@&TTB/5)/[-N_P!Q)*L8 WP_-E@1Q_6@#M[#4K#5;?[1IU[;7D&<>9;R
MK(N?3()%6J\U-MJ?A]-?\17"V?A^74C:VT%M;J;HAE8KNVJH#RMOPH (X&<U
M!!KWB@SZ_IUG=:C+<6VFQ:A9G4[2&.9F#L&3:B@;6"8&0&!)]C0!ZC17FFL^
M-M2O=,UC5_#UVD=C9V5IY3/$KA[B9D<YR/X8V0$?[9[@59=/% \47^A#Q9<>
M5'IJ7ZW'V.#S5<NZ;!\FW9\F>06[;J /0J*\HM_&>NZXVDV\3ZE;[]%M[^XD
MTJTBE>267(Z29"H-AZ#))QD8J_9ZSXHUJ[\.:?+>OI,UW:7KWC1V\;.QADC5
M&4,&"DALD<@;B,9 ( /1F=$*JS*I8X4$XR<9P/R-5]0U.PTFV^TZE?6UG!N"
M^;<2K&N3T&20,\5YBMQJVL:KX46\U:7[39Z]?V331PQKYOE1S .05(!*KM..
M/F) S@CJ/B"B21^&D=59&UZT!5AD$?-0!T.FZWI.L!SIFIV5Z$^_]FG63;]=
MI.*OUPWB:SL]-\9^$;K3H(8-0FO)()/*4*9+;R79PV.H!"'GH:PH?%FL?;]&
MO8=4U"]M;[4X[:0G3XXK%HW8J/*9E$I(XPV2#@]J /5%='+;65MIP<'.#Z4Z
MO'K35-6\/Z9>06E]>7$^I>)[BT\Q;>)Y(@I=W=%P 7;;T;('8=CVG@[4M8N;
M[5++4TOGMX/*>VN+^".*9@P;<K+'\O!48( R&]J .MHK)\3ZBVD^&KZ]2\AL
MWCC^2>:-I%1B0!\J\L<D8 ZG KE?"^N:L_C<Z1=W.JW%G-IKW:MJEI%!('61
M%^4(%.TA^C#.1UZT >@55AU.PN&A6&^MI&GW^4$E4F38</MP>=IX..AZUSNJ
M76JZEXU_L&QU232X+?3UO'EAAC=Y6>1D5?G5@%&PDX&3D<BN0\+SZJNF>'-,
MM+N".[N8-:_T@0HVV99_E9=P) RQ.._?.* /6)IH[>&2::1(XHU+N[G"JH&2
M23T%"2QR0K,DBM$RAE=3D$'G(/I7F[^,=1UO2C)9LD/V/0;B\U.-HE<"XPT:
MQ$$'H\<I([[1G@U8L+[7/$<US:VNL?V9'IVFVK[8[>-A/++$7)?<IP@P!A=I
MZ\\"@#OK>Y@O+:.YMIHYH)5#QRQL&5U/0@C@BI:\<T+7]6&D>&="L'U.""+P
M_;W<DFFVL4TKLQ*J#Y@("C82<#))ZBMJUUKQ1J]SX:TZ6]?2IKN*^%Y(EO&9
M'$+H$=0VX(Q!R1R!N(QP, 'I-1175O/)-'#/')) VR548$QM@'##L<$'![$5
MYU9^(-?OI+#P^=5,5U)JE[9RZDD$?F-%;@D84@H';(&<8P"<5K>!(+FVU?Q=
M#>7GVR==40-/L"EQ]FAQD#C.,9P ,YX'2@#M*IRZOIL.J0Z7+?VR:A.I>*U:
M51(ZC))"YR1P?R-<1=:KX@OK#Q/KEIK7V*/1KBXB@L?L\;12"!<L968;_F.?
MNE< CK2^$TGO_B)K>JO>3[9=/L9?L[QQX42+*0N=N[Y><<\Y.<\4 =9K/B?0
M_#S0KJ^JVMDTQQ&LT@!;G&<>GJ>@[UH/=VT=FUX]Q$MJL?FF8N @3&=V[IC'
M.:\]\8V%RGB@ZII,FGW\[FSM[O3;B3;(H$C-'AAG:'W,"",'&>U0^(;32O$?
MP6FO;2*ZL["UTNXDAL$E*HKHA #X^\$93@9QWP>* /1+W4[#3K/[9?7MM:VW
M'[Z>543GI\Q..:FM[B&[MX[BWFCFAD&Y)(V#*P]01P17&7,:7/CGPC!<HKVZ
M:;=3Q*PR#,/)4''J%9L?4U9\!JL(\26L2A;6WUN=+=%&%12J,P [#>S\4 ==
M17F-SK?B2#0?$/B7^W,QZ5J5S'%8"WB\N2&.4KL<[=^XC@$$=L@\U'J/BGQ)
M>:AK\NF'5(ETRX:WM8+>RBDMY&1%8^<[_,-Q/\)7 P>: /4J*XC1[_7M<\97
MROJ3V.GV,5I*;%88V+M+%N9&<@G ([<\]:[>@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JK
MJ6FV6KZ?-8:A;1W%K,,/$XR#W_ YY![5:J*XN8+2!I[F:.&%?O22,%4?4F@#
ME$^&N@1:G!JD;ZC_ &C;LI@NY+Z662)1GY!O+#:02,$'@U:O? /A_4+FZFN+
M>X*74OGS6ZW<JPO+Q^\,8;;NX'..V>M7=2\26>GOI)#)-!J5R8$G20;$Q&\A
M8GH1B,C\:T8[^SFLS=Q7<#VP!)F60%,#K\W2@#"OO F@ZC-?-<0W)BOV+W5L
MEW*D,KD ;S&&"[L <XZ@'KS6K9:)8:?<7-Q;PD2W,<4<I9RVY8U*J.3Z$_6I
MH-2L;FV-S!>VTL ;;YL<JLN<XQD'&>1^=,;6-,2U2Z?4;1;=VVK*9U",WH#G
M!- &,G@+0HK"TM($O(5LF8VLL=[*LL 8 %$?=N"8 ^7...E7;+PIHVG&P-M:
ME&L'EDA8R,S;Y 0[,2<NQR<ELUL A@"""#R"*@34+*2\>S2[@:Z09:%9 74>
MZYR* .=\1>'9I/#^K:=HEE;/)K4K_:WN9V"QET"-*!@Y("KA1CZUT&F:?!I.
ME6FG6J[8+6%88Q_LJ,#^5']I6'VE+;[;;>>^=D7FKN;!(.!G)P01^%5M>UVR
M\.:4VHW[$0B2.( $9+.P48R1W.3[ GM0!DS_  ]\/W-U=SR)?C[7*TT\4>HW
M$<4CM]XE%<+S]*UTT#3(IM-DAM$B.F(\=HL>56)64*0 ..@'6JMKXJTZ?5]1
ML)9H;<V<L42223*!.9(UD&WUX8"M2ZO[.Q\O[7=P6_F':GFR!-Q]!GK0!1M_
M#.D6DNK2P6@1]6.Z](8_O#M*^O'!/3'))[U4N?!6B7*V@\JXA-M;+9JUO=21
M,\"](W*L"Z^QSW]370,RHA=CA5&2?05Q<'CVZFL(-8/AN\&@3LNR]$R-($9L
M+(8A\P7D'J2!SB@#3?P1H9L=/M88;BU&GQF*UEM;F2*6-#U7>I!(/'!R.*M6
M7A;1]..GFUM/+.G^;]G/F,2#)]\L2?F)ZDG)K0GO[.UFBAN+N"&64XC220*S
MGV!/-)/J%I;R"*6Y@29B L;RJK,3G  )ZG!_*@#,N?".C75O/"]O(IFO#?>9
M',Z2).0!O1@<J<#'''7UJ?1?#NF^'Q=?V?'*K7<@EG>69Y6D? &XEB3G J2#
M6+<:3:7VHO!I_P!H124FN$(5B,[=X.UOP-6;K4+*RB66[N[>WC<X5Y9 @)]B
M30!%::59V5_?WUO$5N+]TDN&W$[V5 B\'@?*H'%5M7\.:?K5S;75Q]IBNK8,
ML4]K</#(%;&Y=R$$@X''M6JK!E#*05(R"#P17.:7XQL]4\6:CH,<$B/: ^7.
MQ&R<IM$H7W0NH/U]J ,_6O!PB\*7GA[P]80);ZI*WVJ2XN'/D;P TJ@ABS<
M@9'S<YZUT*:!IL9THI!@Z4A2SPQ C!38>.A^7CFM.LC1?$%OK*W9">0UO?SV
M(5W&9&B8@D?7!.* "3PQI,EA=V36Q,%W=B]F7S&^:7>K[LYX^95.!QQ52_\
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M(Z1DHPROUZ4Z?P9HDMK8P16\MH+",Q6SV=Q) Z(<;EW(02#@9R3D\]>:@O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU3Q#%+/#!JUS''=W5IB5X#%*L#R*%^4L=G8<X/%>L44 >,"&U_X1--'%B_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW\%S;64:&.XDML@_>.1G&5 /5L'BI;'2/&>BW>LIIL>@R6U]J$UY'+<W$V]
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M+_=/!Z>ISQ ?A_J;1Z+=WNF:'J5W8Z:NF36EQ.XB9$/R2(_EDANN5*XYZ\4
M=]HNL6VNZ8E]:B1%+-&\<J[7B=6*LC#L0016A7-^'=&U'0-,L+*.'2D0S2R7
MJVZ-&J!LE1$,?,0=H);&0">O%=)0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 A56QN4'!R,CH:6BB@ HHHH **** "BBB@ HHHH ****
M $*JQ!*@D'(R.E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%8FG^(AJ:6L]K92O:74LJ1S[U *(#B3!.<,0<8SQ@G
M - &W16-%K=W-;K(NCSB1K'[4(S+'G?_ ,\N"?F]_N^]7]-U"VU;3+;4+-]]
MO<QK)&V,'!&>1V/J* +5%%% !1110 45C>)=?'AS38;K['->237,5K%!$RJS
MO(P51EB .2.IJE9>+G;5[;2]8T.^T>XN]PM6N'BDCF91DJ'C9@&P"<'&<'%
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M=M#=6'CN.!-/NX'TJVGC.G6!AMW=6DR\:DMO(& 7![8[5TLNF0:[?>*3H*Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N;\<:IJ.D>'Q<Z<7B)N(X[BY2 S-;0D_/*$YW8
M'L>N<'%=)6/XBM-8N;."30[N*"\MYUE\N?/E7"@$&-R 2 <YR.A H Y_PQK3
M2W4]Q#XPM->T2.V:2>67RDGM74@\B-5&PKN^\ 1BM/3?&EIJ%W90OIVHV46H
M FQN+J)5CN<+NP,,2I*@L X4D"L2;PEJGB;5IK[6+#3]'5M/N;%OL4YFEG\Y
M0I+ML0;5QD#DY/:H?#W@B]LM2TEKK1M'MET[F2\BN))GN&"%5*(P CZY.2?0
M>M %^V\>6^MP:5=6<&K6-G=7L,44\MK'LN=P?*#+$@ J<L!V&,@U>7QWI[3*
MXLM0_LQKG[(NJ&-?LYEW;,9W;MN_Y=VW;GO5"R\(ZC;^$_".EN]OY^D7D,]P
M0YVE4#@[3CD_,/2L2R^&]U9"+3!I.DS6\=WY@U*:XD9S#YF_!AQCS,<9W8[^
MU '70^,[:XU)K:#3-3EM5O&L6ODB5H5F!VE2 V\ -QNV[??'-6O%NL2:%X9O
M+VW4/>%1#:)UWSN0D8QW^9A^&:Y2Z\&ZO-XD-[;V>GV5R;]9SJ]G=20O) '#
M%)( -KL5^4DG!Z^U=!XF\-2>)M6TB&[*G1K1WN9XUE9)))@NV( K@@#<S9SU
M H 7P;JE]>65[IVL3K-J^EW36US($">:/O1R;1P R,I^H-.\>:I>:)X'U;4M
M/E\F[MX0T<FT-M.X#H00>M5-,\'_ /"/>,O[1T?Y--N[0PWT4UQ)(YD0YB=2
MQ)/!92,CC%5/%.B>*M;75=%C>QET;4FBV7$LI22S0;?,4($_>9*D@EARW/ H
M Z%_$EDC:X"DV=%4-<X4?,#$)?EYY^4]\<UF3^/+1;DVUII.JW\ZV<5\R6T2
M';%("026<#/RGCJ>V><9^L>'_$7V_P 3II<.GRVVOP*OG3SLC6S"'RC\@4[P
M0 1R.>M:'A_PW>Z7JMU<SM"8Y=*LK-=C$G?$) W;I\XQ^- #1XSTO[6NH'4I
M5TQM&_M+8T V>66^_N^]N[;<8_&IH/&UJ93%?:7J>FR-;274"W<2 SQH,MMV
ML<, 0=K8//2N9A^'&I2Z);Z=<W-O$4\.IIID0EMLZR!PV,#*Y ]ZU+W0O$?B
M.\@N-5M]/LOL-I<QQ);W#2^?-+&8]Q)1=J $\<GGVH Z#PYXBC\2V/VVWT^^
MMK9@K0R7<803HPR&4 DX^N*XF#6[^]N]?EN_B!%HXLM2N+>&VDAM=JQIC:3N
M7<1SZ]J[[0+&73/#FF6$Y4S6MI%"Y0Y&Y4 ./;(K%T#P?;64^KW&IV%A<3W>
MJ37<,AB5V$;$;021D'@\4 5=$\;7EUX<T:>XT6_O-4O;/[3)#91*JJH.-^9&
M4 -P0N2>>E3R?$/3?LNE2VFGZI>RZHDSV]O;P R9B8+(K L I!)[X^4\],P^
M)_#VJZGXBAN4MH=1TL6OE"RFOY+9(YMQ/F,$4AP5P,'ICCK57PIX+U/1)/#?
MVIK/;I<6H1R^03@^=,KIM!'3 .1V]Z $L/&E[?-<B\AO-.$6OQV$1$$3>8I(
M'EM\YP?[S#IN&,]MA/&]G+>[(M/U*2Q^U_8_[22)3!YN[9C[V_&[Y=VW;GO6
M0WA/6C?7,6VS^R'Q##J\4WG-N9,C>A7;P1MXY.<]JLZ5H_BC1($T.Q^P+IR7
MKS+J#2DRB!I3(T?E%<;_ )BN[=C'/7B@!;+QQ!%9Z;#Y6IZM>ZA+>"W$5O&C
MMY,I5@?F"J " "3R%R>3@WT\:6<VG0W%MI^HW%U)<O:?88XE\Y)4!+*^6"K@
M#.2V.1@G(KD(]-UOPYK_ (4L[:"SNKQ$U:1XGF**\<DZ2 !]IPV&7MC@CWJ[
M/X.U\P1W#F"X-UJ4U]J6G17LEO')O14C42J,L$"*2" &.?:@"YJOQ E33[6;
M3M)OA<C6(M.O+66./S(B2I*_?VDLK#:02.>U6SXTM=-%VUR=0O&;6#IT,,=L
MFY)/*#B-<'YEX/S'G+<\#-85KX&UNPTJ]%M;:8DYURWU6WM8YW$6U%0&,N4R
M#\I^;'/7 SBM./PCJ?V]+ES;*/\ A)#JK*)"<1&W\O'3[V[].] &BOCO3Q8W
MDUQ9:A;7=I<QVKV$D2F=I9 #&JA6*MN!R"&QUSC%7-%\4P:SJMYI;:??V-]9
MQ1RS0W:*,!RP7!5F#?=/()'XY Y7Q3HTFG7VI:_/>VEJ&U.QNK)YRWE;XX_+
M*S$ [%.XC=R!D$U8\&W]WK/CSQ#J4[6+Q+9VENK6$YGB5@TK%/,VKN8;@3@#
M&X"@!-9U:_D\?7VEGQ<NA65O8031J8[<^8[M(&YE4GHJ]*9HWCY[32)Y-3DE
MU@#5VTRQN["!<WA\O>I !"]0R9'&1V&2-L^%(KKQQJ&L:A:65U:364$$*S1A
MV5T:0L<$8 PR_E5G7-"DO9?#PL4@BATW4ENG3[H$8BE3"@#KEQQQWH J3^.8
M(FE5-%U>=[6%)KY8HD)LPR[@KY<9;;R53<<5D7?BZ>;QU$B75W;>';72UU*2
MXBCA,4R'<=[LV7$>U<#: V[/;!J'6O UV_B'6+^UTK3=275"DB/=W4D)MI @
M0Y"J=Z?*#C@]1[U;NO 4MVMW9&6"&SG\.QZ2K0J1LD5G.X)V7YA@9]O>@#6L
MO&EK<W$4-SIFI:>;F%Y[1KN)%%PJC<VW:Q(;'.UMIQVZU0C^)=A+IUG?)HNM
M&&_D2*R_T=,W+,C.-HW]/D(R<#D'IS6=I'@J^CO[::?1-'L6M;>5#/#<R3O-
M(R% 4# >6N"2<Y/./>M2U\*W\.D^![5F@\S0VC-UAC@[;9XCLXY^9AUQQ0!8
MN/'5M TX31]6G%I$DM^8HD/V/<H?:^7R6"D$JFXBG:AXVLX7DAT^SOM2,=JM
MU++91JZ01N"49MS#.0"0JAC@=*Y[6/ EX==UF[M-)TS4DU1Q+'+>74D1M9-@
M0[E4'S$^4, "#U'O6C!X<USP]>W3:'!IUQ#?6=O XFD:$6\D4?EAE4*VY"N/
MER",=><T ;?A#4;O5/ ^C:E=MY]Y<V,4TC8"[W* G@# R:X71O$NK:B+=_\
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MES@+LA7YN.#F-NF>U &MXXUV[\.>$;W4[&W,UQ$%"C (7+ ;B"1QS^>*Q/\
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M'.& XK*F\=3W^J^&(]/LM1M++4K[ N+B!!'=0>3(WR\EER0A&0I(Z<9J[?\
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M@@^Q]JI7W@G5YM6BUF^M-.UR\FLEM[J*2X>U6.179E:,JIRN'VD$ _*#U)%
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MV@A>N,C XYK"T[QEJ#Z9X?TRS1K'S["2\GDT_2FN2H$I142- 0HSDDD>@[T
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MP"CY(ZY&.O-0Z/XJUZ=;^V%R+G6%TZ2>+3+_ $]K.83KC 4_=>/)QP2>G/-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "J.I:3:ZJ]BUR'S97*W46UL?.H8#/J,,:O51U/5K325M6NV9?M
M-S':Q;1G+N<#Z#WH Q[3P+I5I<VSK/?26MK,9[:QEG+00N<\JN,\;C@$D#/
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MN+VQ>PGFGN-S-"Q!P!C"XQQ@#J>N:L:7XNAO]3;2[O3-0TS4?),\=O>(@\Y
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M25.& /3ZT"1&<H'4L!G /.* .:LO VGVE[IMV]]J=U-IA/V,W%SN$2E"A7
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M&,X&6^]P.:9'X"TDJZWT]_J2FU>S07MP7\J)\;E7&,$[5^8Y;@<UT[,%4LQ
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M)TR;3)+2*1&TZ.9(<R%MWFE3(SD\LQ*@Y/<FMRFJZ,S*K*2O! /2G4 %%%%
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M=W*5^:>,P2MLD/5DRB_*>,#&,5ZKHF@IHS7D[WES?7EY('GN;G;O; VJH"@
M*!T '<GO6O@>E 'BFIVILK"^L;=+6VT&W\5LMQ%-$S6L41MT90Z*1B+S6!(R
M%R1GBFM:07&DZC#;7EC<:7/K>F1^7I4#16J.9E$GE-N()(*[MO (]2:]LP,$
M8Z]: JJH4  #H * /'?&&AZ=8)XXT[3]-MX;/^Q+6[%M#"!&LH>8&0*!@-M4
M<CTKO-=?3I/ACJS:1]G_ +/.DS_9_LP CV>4V-H'&/I73XI, # ''I0!Y5J?
MBK1M;^&*>'-(NXM2U>]T^.SBM+?+LKL@4EL#"A>22<8Q65XQ?3Y[[Q+:W,.C
M+?6UJD"/J:M/=SD0@J;:/(V#)ZJ3\P)/2O:@ .@ HVJ6#%1N'&<<T >+W8'V
MZYN[*.'_ (2"^\'P26,P0>?-,%DWLC=2^S;TYP!5SP;'8?\ "6:(^CW^B?+;
M2_:HM(LW5WCV<?:6+G#!\$;ANSGU->N8'' XZ4!54DA0">3@=: *^GZA::K8
M0WUC.L]K,NZ.1>C#I7DOA/2+'6;_ ,)VVIVD5W;II%_)Y,R[D9A=1@;E/!ZG
MKWP>U>N6=G!86D=K;)LAC&%!8D^N23R3GG)J? ]* .2^'4:Q>%Y[11B"WU*]
M@A0\A(UN'"J/8#@>U>=R/=Z7=#(F%OX#FR0H/[R&:;C'KMMOYU[C1@>G6@#R
M;2_#EM?^(/":ZY917,EWI]_J-S#.NY3++)"^&4\';OQ@_P!T>E1:5%+;WNA6
M=B-HM=;UB"TC/W8U6.;8H] .*]>HP/2@#R+P\?":Z/HHBA+^*OL\@O?(_P"/
ME9?*;SC=<AMF[/WL\[<4[0-$T[2=*^&>HV-G%!?731I<W"+B297M)&97;JPR
MJX!Z8&,5ZT%4,6"C)ZG'6EP/2@#BO'OV7[?X=.LA/^$>%V_V[SO]3N\MO*\W
MMLW>O&=N:Y74[SPNJ6%II=E9#2)=2G>.XU24KI:R+&N2BCY64EB%'"[E<BO7
MB P((!!Z@TA12NTJ"OICB@#PVR2RE\-7D$]_I]K:6_B5F@,EBW]FD&W4JKQE
MOEB8L2ISC=@CJ*?+/Y^A:=&EKI-IH4.MRK=RJ9)M,F/E91PN1B'><8SL#@=:
M]P*@@@@$'J#WHVKMVX&W&,8XH X;X;QHAULVEY9SZ>URODKI]NT=I&^P;_*R
MQ!!."=O ;-<AXL7P_P#V9X\7Q$L'_"0%IC8&8?OC#Y0\GR>^S.=VWC[^ZO:
M H    Z 4%5)!(!(Z'% 'E=UIUQ?7GBJ6R4M?V$6FWUF/66*-F"_\" *_P#
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M6WA/4##:>'[=6T^;6]/6Z-F0+-V)8%8]IQNVXW[1W7/->N  #   H"JJ@*H
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MW1@Q(487Y>.I&,]\57T?PCJD?BO2-5DTT6D5M#/%<-/J<EW/(SH &RW 7(Z
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MW;@>M/\ #/A36-,\06%S'I\&CVT*R?;X[2_>2VO&*D+Y<!&(QN^;/!&,<]:
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M9;CR0RM$Z<-M/=L]*I_V-XDUO64UC4DLM,EL;2>+3H()C<%9I5 ,KL548
M4 ]3S0!>L_'-C>7=G#_9VJ0)?AC93SVVU+G"E\+SD$J"0&"YQ6?H7Q %WX;M
M;[4+"[%]=W<UO;VEO#EYRCO]P;NBJOS$D $'VK'TOP=KBZSX<O[JP5)M/G+W
MMS<:I)<R3DQ.A9 W"KELXXZ].*8? VL'3]+6XL+>X?1[V[*0K?/%]KAG<MN#
MJ 4925X/!P>>: /0-%URUUR"9[=)H9;>4PW%O<)LDA< '##Z$$$$@@\&LJ^\
M=:787-XK6U_-:V,GEWE]#;[H+=N"0S9R< C.T''?%+X-T*;1X+^:XL+:QDNY
MPXAAGDG8(%"KYDCD[FX/0  8'.,UBW?A_P 1V^G>(=!L+6SFL]9GN)([Z6X*
MFW6?_6!H]I+%26Q@\\9Q0!T,?BVRG\2RZ%;6M]<7$)03S10YAB#H'4L^<8(/
M'N*WZYOPWX?GT76=;E<J;:Y-L+=MV6*QP+&=WIRIKI* "BBB@ HHHH ****
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M&6$[!NV&&?)25N%..^3C&*N_$K5;:#3-/T6XD9$U:Z6*<I&SD6R8:4X4$G(
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M.0>A%+5+1_\ D"6'_7M'_P"@BKM !1110 4444 %%%% !1110 4444 %%%%
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ML@N-2?2U*IC;.@?=G.. 8V&1F@"C!X"TR":!!=Z@^G6]Q]I@TQY@;>.0-N!
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MB,5KN8<@Q^7\_'/R^F.:9!X1TVWU&"^1[CS8;Z>_4%QCS)D*,#QTPQP*WJ*
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MO;-K%[FYE4R1PGJJ;5"C)P2<$G SFMW5=1AT?2+W4[A7:"S@>>01@%BJ*6.
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MP!@"NPHH S[+1K:PU;4]2A,AGU%XWF#$%040(-HQQP*6[TBVO=6T[4I3()[
MR&$*<*=Z[3D8YXJ;4;Z+3-,N[^<,8K6%YG"#+%54DX]\"G65U'?6-O=Q!A'/
M&LJANH##(S^= '/7O@:QO+F]=-0U*UM;^3S+RSMIPD4[8 )/REER  =K+GO5
MNZ\):3>MJWVB.1TU2**&>/=@ 1@["N.5(SG.>H%;M9]QK%O;:Y8Z2ZR&XO8I
MI8V &T"/9NR<]?G&./6@#('@>TEBO4O]4U34'NK-['S+J92T43C#! J@9/'S
M$$\#FM1M!M&U#2KTM+YNF1210#<,%755.[CDX4>E:=% '+W7@6PNKF[*W^I6
M]G>S>?=6$$X6&9SC<3\NX;L<A6 />DU;P)I^JRZ@?MVHVD&I+MO;:UF"1SG;
MMW$%20<  [2,X&<UU-% $5O EK:Q6\>=D2!%SUP!BI:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KEO'LFEQZ';_ -LPW(L3=Q[KRV<HUBW)6;<.5 8 9[;N>,UU
M-! (((R#VH \OL;X76M/H=IXBB\6:5<:?.TYD6.62TP!M#2Q@!@Y)&TC/&:Q
M/#8\-S6/A&WUA[#^P3HN0DSJ+9K\;/,$G.WS N<!O]KO7L\-O#;J5@ACB4G)
M"*%&?PI&M;=XC$T$31D[BA0$$^N* /'[)[.8Z/!JTN[P:VI7ZVK7;GR)$ 7[
M.&+<%,^=MW<'"^U-U6%[J[T6V\!7+1*/[46VDE;*8 B++;MR I.55N@Y(Z"O
M9'BCEB,4D:/&1@HPR"/I2B-%V[44;!A<#H/:@#$\'7&EW7A6Q?1X3!:A"IA?
M.^)P<.KYYWALY)Y)YKSGPGI5GKUWX5M-4A%U:C0[R5H)22CL+F,#<O1L;CP>
M^#VKV)45,[5 R<G ZFD6-%(*HHP,# Z"@#E?AR#'X4:W#,8K:_O+>$,Q.V-+
MB157)[   >PKS*:^L)YM,UBUCTNUO9-=BRSW#3:GM-R%<2GCRUP2-IRH! ZD
M5[PJJHPJ@#.>!48MH [N(8PSXWG8,MCIGUH \?U'2+(^%_%VO-%NU6SUN9K6
MZ+'?!MF7 0_PCDY ZY.:[_X@7L-AX+OI;B*22)S'$P2<PC#2*N6D )5.?F..
MF:Z3RT*E2B[6.2,<$TK*KJ58!E(P01D$4 >#W3V]H?&%MI[:/% WAF65XM%9
MC )%;&2>C. W) '!&:ZR/P=H/_"?66G/8(]G<:*]Q<PNQ*7$JRQJLD@S\[ .
MW)R>:](6V@1 B0QJ@!4*%  'I4FU=P;:-P&,XYQ0!XUH;:=<P>%K?Q7+$VAC
M3[E;<7TG[A[A)]H#EC@L(Q\H;WQS4^D:A!I^H>'[V:[\GP_%K&H0V-S<2$1B
M Q'RQO;^'<'"DGH!CM7K;V\,D7E/#&T?]QE!'Y4LD,4L7E21H\9_@901^5 '
MCQ>T\03864SV%UXVVY1R%EC^QG@$=5./H0?0TSQ%I.E6%GXKT\6L$6DV.K:7
M/' 1^ZMP[1"5@.B@@MGMR:]D$48QA%X.>G?IFE:*-@X9%(?A@1][ZT <A\0/
MLY^&MV;0QFVVV_E&,@J4\V/&,=L8K@/$ $VL>*Y-8O-'MK^&X(LY+UI/M<,6
MQ?*:V"GUR?EY+9!S7MWEH4";%V 8VXXIKP0R2)(\2-(GW&902OT/:@#QCQ5]
MFM]4U&_U"XTK4+V"UMWEM;]I+2\C81@YLY.?O')P!]XD$]J7Q3-8PZ]JVK3'
M3[VX1H)#8WLCVVHVYV)M6U<9R">< #+%ADU[,\$,DB2/%&SI]QF4$K]#VH:"
M%Y4E>*-I$^ZY4$K]#VH Y'XH00W?PUU9IX ZI$LH#KG80PY_ 9KGH_#WAS7?
M$?BES:VUW8P:99_8O+;=$BF.7#)@XSP,,.1VKU(@,"" 0>"#WIJ11QC"1HHQ
MC"KCCTH \9>_LM6M?#\&KQZ5-,GAZVN'GUZY/DMO'+1Q8^>3(Y;(/0=ZD\)V
M-MXC;P7;:LAO+<:/?;XIBQ5]D\:J'4GD =FS@@>E>PM;P.8RT,;&/[F5!V_3
MTIRQHI!5%!&<$#UZT <I\.U$/AV[LU+>1::I>VT"LQ.R-)W"J,]@.!7GUMI.
MB30VNE1PVZD>-9X[J"%MK",?:?+5@.0I48'J,U[:JJH(50,G/ [TWR8MY?RT
MWD@EMHR2.AH \;UZV;1E\2Z7I2QV>C1:K8&XA!9888'C!DSMY5"P7=C'!/O7
M1^ (XH?$FK1Z?=Z2U@+>(O;:0'-M'+EOF#'Y0Q7J%]%)KT+8N6.T?-][CK]:
M2*&*"/RX8TC0?PHH _(4 >4>+XH[/QAXJFT](XM;FT"&2T:/ G<AIEE:/N6"
M =.>!4B6OA>7Q!I5KX1%K/;75E<C5(K5]Z20^7\AF'/S[\ %OF.6]Z]4,:-(
MLA12Z\*Q'(_&FQP10EC%$B%SN;:H&X^IH \1TRXT";PSX/TT0:-(G]EM/*VI
MW6RS68",2!D (>8$YP2-HR>]:'@J8RW7A%!(KQPZGJT46P,%5 K[0H8DA<$8
M!/ Q7KC6ELRA6MXB V\ H.&]?K[U((T#;@B@Y)SCN>M '!_$*YLFU31-.O;>
MQD683RJ=5N3%9C:%'SK@B1_F^53C')KCM#@M]5LM&TV5XIM/'BJYA6.W+K"8
MOLTCA%!.?+.>F<$'T->URP13J%FB210<@.H(SZ\T[RX\YV+G.<X[],T >,7V
M@:99^'/&%Y;VPCGTG5PFG,K'_0U_<OB+GY 6=L@=<U:UC^P7'C&;Q%-&GB*&
MXD&G&20K<1Q[!]G^SC.>3_=ZMG->NF-"&!1<,<L,=3[TUH(GE25XD:1/NN5!
M*_0]J /,8=;CTB^\3IX@O([74+G2+-UBE8*TS^2ZL(U_B._C"]\5!X;T/3O$
M.L:7!J]LMY GA+3V$,I)3<6D&['3<.QZC)Q7JSPQ2.CO$C.F=K,H)7Z>E*L:
M*<JB@@;>!V]* /'_  VEA+J?PZOM4,+7#Z;=0QSW)&YY$>+RE#'JP!;'?DUU
M7C?[$_B/P[!KS1CP_)]H\\3MB!YP%\H29XQCS, \$CZ5VIAB(0&-,(<J-H^4
M^H]*62..:,QRHKHW56&0?PH \8ET[2]1$,4-O%=:!'XI@ATTN-\8B:-?.6,G
M_EGY@.,<<''2N[^(D-L_A:.&>]BLH/M4(W3Q%[=L-PDP!&(SP"20.E=8(XPJ
MJ$4*N-HQP/I2LJNA5U#*1@@C((H \8MK^UM-- 2WL;.ST[Q%927-QIURTEAA
MAR4) $8&5W+T!/7FK.MZO#J6H^+KC3[TS:8)-*CO)[5R1]G\QQ,59>VW()'8
M-Z5ZVMO"D'D+#&(L8\L* N/I2I#'$NV.-$7 &%4#@=J /(]?M?"<EG-8>&V'
MV:6_TP70L)!]E4M<@#:5.%E(ZXYQM)YKJ?#^FV>A?$76--TNW2TL7TRUN3;Q
M<)YADF4L!T!(5<^N*[)+>"*,1QPQH@.X*J@#/KBG[5W%MHW$8SCG% 'FFNKH
M,OC/7AXNEB1([*%M*^T2;=J;6\QH?^FF_NOS?=K&\/Z4==TW2M*$K1M/X,A\
MIP<;)!("C?@P!_"O8GABE*&2-'*'*EE!VGU'I2K&BD%448&T8'0>E 'C6I:E
M<^*?"'B3Q+<1R0&UTZ/38XSD;9@5>X(_X&53/_3,U'XM709='\=R>(98E\0Q
MRS+9>:^)A#Y8\D1#KL/.[;P?FSWKVGRT*%=B[3R1C@TUX(9'#O%&S@%0S*"0
M#U% 'C?B 13^*=:77)]%CAAM(#8?VL\BLD7E#<]O@CYM^[)7YL@>U:VDZ';^
M(/%-E;^(E_M/9X9M&<7",JR.991YC(W1\>HR,FO3I((9BAEBC<H<KN4':?4>
ME/VKNW;1NQC..<4 >,Z$^FWD/AA/%\T3Z.-)E%L;^3]RUPLVT[BQP7$87;GG
M&[%4[6#3;CPOHBK?Z>+9=0U,VT&N([6ETOGMCS'SQ(!RN[)Y;BO;WMX9(Q&\
M,;1@Y"LH(S]*)+>&6(Q20QO&3DJR@@GZ4 <W\/[R*[\&VS06K6\44DL2()S.
MC!9&&Z-S@M&?X?; [5Y=!?6$UYX<U:S32K6[N-:AW$7#3:D4:;:XG;C:.<%3
MD#(%>\ !0   !P .U1BV@5G988PSD%R$&6([GUH XKX<VVEV=SXHMK..VBNX
M]8F$T4> ZQY_=Y'4#&['XUQ^NV&DK/XWLT2"&]FUK3BRQL$E\IWMB6&.0"Y8
MY'<^M>T"-%=G5%#MC<P')QZTAAB9R[1H7( W%1G YH \E\46#^'+SQ/9>%X#
M9))H=O</%:Y S]H=9) !R&\O/(YX]:M^"HK2'QG -(O=#%NU@[7-OHWF/'(,
MKL>0DE0X.<$_,06]*]1VKNW;1NQC..<4R*"&#=Y,21[CEMB@9/J<4 <'XDM]
M+C^*.CW5[';)-+I5VD$DN 7E5XMH4GJP!? Z\FN>\*:+I_B&Z\/6VK6XO+=?
M"5L_DRDE"Q<C<1W(&<'MFO7WCCD*ET5BIRN1G!]J%C1<;448&T8'0>E 'CWA
MO3X[33/AYK%JA.K7WF1W%R[EGG4VTK!78GE057 /3 Q6;X8!>3PY<F_TB+7Y
M+Y!=F/S6U"1LGSHYES]W&[.X;5X(QQ7N8C0!0$4!?NC'3Z4T00K,TPB02L,%
MPHW$?6@#D?B-=VT.EZ;;7<$4L5W?I%_I5R8+8$*S?OF .4X^[W.*\]M9TAM/
M$=I!-:)HB:IIYO!I1=;:.W;B8H<\*=H#%<#AO>O<9(HYHS'*BNC=589!_"A8
MHU&%C4# 7@=O2@#R?5SX8MX9;?0)"FAG4+/^V39R?Z$D1WY *G"DGR_,QQM(
MS2:M9^%[J2UTS0"QTV77;-+J.UD_T0EHY-R1E3C)7&\#U'<UZQ'!#%%Y4<2)
M'S\BJ /RH2"&*-8XXD1%.555  /L* /-7O-'\*:SXPTV2>#3X6TZV^PVS-M,
MBB.1<1J>6.[C R<US8Q<RZ)%K4FBBP7PY9/9KK3L(2VP^:R8('F#Y,GJ!C'>
MO;WABD='>)&=,[6902OT]*;);P31JDD,;HI!564$#'I0!Y'I@T^>7P]'XQO8
M;K2/[)D:SFO]T<,DOFGD^9C+B+9M+<XR177?"W[/_P (-']D=WMOMMYY3.26
M*?:9,$D\YQCK782PQ3)LEC21<YPR@C-.55484 #.< 4 >#RWUA//I6L6B:7:
MWDNNQ99KAIM3VFY"N)3QL7!(*G( ('7%:FIZ19-X7\8Z\T6[5;/6IFM;HL=]
MOMD3 0_PCDYQUSS7L MH [N(8PSX+G8,MCIGUI_EH592B[6.2,=: /&_%:Z#
M+9^/'\22Q+KD9D73_-?$H@,*^4(1G.TMNW;>IW;J[;Q8Q7X0ZJRD@C1G(([?
MNJZQX(9'5Y(D9U! 9E!(!ZU3UO28M<T&^TF9WCAO('@=X\;E##&1GZT >;PW
M.@6&KZ==>$W\]%TNZFU46,FZ21%C!0R?]-B_ +?-G=61H!TX^+/"#6::)$M\
M)DN$L+AIYI(VMW(%S)P&8D#@C)(..AKVFWMHK6/9$BKP-Q"@%B!C)]32I;01
M@B.&-,MN^5 /F]?K0!Y?H<ET^J0>'KI;B2+P>)Y9BH):;@K:8]3Y3,?]Y16#
MHEQ8C7?!M]IXT>WGN[L>;]EN6N+QXWB?(N9. 3G&01]X<=#7K>@Z#_8PNY9K
MV:_OKR42W%U,JJSD*%4 *    , #U/>M-+:",L4AC4LV\X0#+>OUH \3T9-!
MC\-:9-I,L1\7_P!L!4"/_I&/M)WJ1U\KRMQ(^[CGK4FH&9C##.]DND2>)-3%
MU_:!86S2;CY2RD=B=V >"0,U[2MO"DGF+#&),;=P49QZ9I6AB>-HVC1D;[RE
M00?J* .+^&Z[+35TM[RTGL%O<6Z60?[/#\B[UB9NJ[N?EX!) KDM7.B-8^+[
MC69D7Q9#>3C3MTA%T@_Y=1 /O8/R_=X)+9[U[$B)&@2-51%& JC %-:")Y5E
M:)#(G"N5&1]#0!Y5<:%:ZS=^.+G6K99[VUL[=H]Y.()?L@8L@_A;<!R.>!78
M/,UU\*Q-<WES"\VC!I+J!2\J$P\N .21G/'-=/L3YOE'S?>XZ_6E "@   #@
M 4 >&Q&WAT?Q'IVFV^D7$L_AZ>07>@3-Y;A1QYL7.V0Y.#DDX(KHM6\0PZOK
MNDGPU?Q7EY%H.H/']F<.%E*1>6#CC=D=#S7IL4$,&[R8HX]QRVQ0,GU.*([>
M&'_50QIR3\J@<GK0!Y$H\'1^%P^CRE]8FT.Z-R;:3<[_ +@ES=<YSNX&[G=P
M.]:FCZ+8:'KG@6;3H!!-?6<J7DBD[K@" ./,/\1##(STKTE;>%&D988U:3[Y
M"@;OKZT[8N5.T?+]WCI]* .!^(\%K<7^BK<WFEQ[?/*6NLQL;*X.%^\P.%<#
ME<YZM@5S^DVFF^)M0\&6]UIW^@QV^IJ+=[AIXI DD2@JQQOB/5<C&,>@KUV6
M&*>,QS1I(AZJZ@C\C2A$!4A5RHPO'0>U 'C3S65MIT&ASV]M)9KK]_#;)J-T
M8K*)(\E4DX.X#<=J'C(]JIZ;#;ZAI@THR6[Z?_PE\42Q619(/*:WR5CR<^6Q
M+=#@Y)'!KV^2W@EC,<D,;H3N*LH()]<4OE1YSY:YR#G'<=* /&-=L+&T\3ZY
M8Z@="M+&SMH5TR/4VD4Q0>6,M;X/WM^[)7YL@#TIFMQ1,EI<:OJ&DW]Y'HD!
MDM]<$EJS !B9;>0\K(W\7RD@A>17M,D$,Q0RQ(Y0Y4LH.T^H]*)8(9BAEBCD
M*'*EE!VGU'I0!3T*Y^V>']-NO)F@\ZUCD\J=BTB94'#$\DCN:T*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K-UG7+30X('N5GDDN)1#!!;QF225R"<*![*3D\ "
MM*N;\9Z3-J^F6T4>E6^IQQW DEMWF,,H&" T4@(VN"1U/(R,C- &9J_CN."/
M1+JTCN5AGU1K&[MWM&\\$12-L"8SNW!.1D8/7%:<?C?2'TVXO'6\B>WN5M)+
M22V83B9L%4"=26# C'&#UZUS^F>&?$(?1WO6F:"TUEKN.&ZN_/EM[?[.Z!6D
M_C.]LXR< ]3BI-8\/>(_[0UVZTTNL5[J-K,R6]R(9IK=(%1U5_X&W =QP#R,
MT 6]7\<*=!OY=.CN+74;*YM(YK>]MRCHLTR*#@\$%2V"#VK7\,ZK=:I+KBW)
M4BSU26UBVKC"*J$9]3EC7$+X)UIE\0&/3_LZ:@VFO!'-?M<2#R)RTGF.Y)W8
M.>"1V!KMO#.E76ERZZUTJJ+S5);J'#9S&RH 3Z<J>* ,2P^(,$%UK46K)=>3
M8ZG);&ZBM6,,$?RA/,<<#KR>W!.*V-2\::5IEY<V\B7LXLU#7DUM;-)':@C(
MWL.G'.!D@<FN9NM"\32:;XGT&/2[8VVM7D[1WQN5Q#%* K%TZE@ 2 .O&<8J
MM?\ @>_M=1UI;;2I=3BU%Q+!+_;$ULD1,:H5FC1UW+E<Y4$D''84 >CW.HV=
MIIDNI3W"+911&=YLY4(!G=QUX]*Y]O&UK<0W4$5M?V=[]AEN[47MJT8F5!R5
MSUP2N0<'GI5S4-,U*#P/)I>ARQ6VH160@M7!.Q&50!@MDCIP3DCC.:XR+PCK
M,VM07PTVYMXUTZ[MI&OM6:[F>21%"GEBJKE<?*>_(&* -;2O&DBS+/K-Q%%8
MIX=L]2F<)TED9PV,<G.U0 ._UK:L_&>E7#W$=RMWITMO;F[=+^!H281UD&>H
M'?N.,@5R<_@76+JQ\D"".5-"TVVC+OE3<6TQE*MCG:?E&??VJUKGAK6_&\LS
MZA91Z/''IES:0JTZS,\LVSYCMX"#8/<YZ"@#=MO'>C3>8;@7EBBVKWB/>VSQ
M"6%<;G3(YQD<=>1Q34\<6,AEB^PZG!<BU>[@BN;1D-PB8R4]2-RY'!YZ52O&
M\<ZII=S;VME::/.EDZ+(TZRF2<X"^61]U1AN6&>1QQ65IWA35F\46&I-IUS:
MP1V5S;S/?:JUW,SR!<'EB OR_P /KR!Q0!LZ1X]@N?#>B7EW9W;ZEJ5L)A9V
MMLS.V%!=U':,%AAB><BK[^-M'&GV=U ;FY>\D>*&U@MV:<NF=ZE."I7!SG&/
MQ%<5;^#=9CM?#UU>:1+/+IVF?V7/:6NJM;N0I4K*CHR@@X.58CJ/2M'3_"VK
M:))I6LV>E6[7,$EV;C3TO7=BDY0[A+*QW2#RUW<@')Q[@'0^#/$,OB.#6+A]
MPCM]3DMH5>(QNJ*J'#*>0P+-G-1R^/\ 18;F[C9;WR;*X-M=W0M6,-N^<8=^
MPY'(S@$$XJ3P;IVIV,.L3:M;16T]]J4EVD44GF!49$ !/K\IS[UQ]O;ZYK.E
M^,- LM-@:VO]6NX#?-. (5; <LF,D@'(QUXSC% '92^-M(AUB]TU_M6ZPR;R
M<6[>3;@1B3+R= "O3W&*?I?C#3M5OX;-8;ZUFN(S+;"\MFB%P@QDH3UP"#@X
M.#G%8T_@V[O=-\::>SK"NKNOV64MNX%O&@+8_P!I#GVJ>&RU_6_$6AWNJ:7#
MIL.D>;*Y6Y64SRO&8\)CH@#,<M@].* -;7?%6G^'[JTM+F*\GNKM9&@@M+=I
MGD";=V OH&!^@-5+CQWI%M<2*\5^;:*X%K->K:L8(I2P7:S^S$ D< ]ZL:AI
M5U<>-]$U1$4VMI:W44K%AD-(8MN!_P  :N&USPEXHU>UU*"YM)[N\>\,L%U)
MJK+;"$2AD5( <!MH"_,O7)W&@#I[;QU"FI^)8M1MI[>TTFXCACD%NY,FY4P.
M,Y9F?Y0!R"#6QI'B:SU>^N+!;>\M+V"-97M[R QL8V) <=B,@C@]17+ZKHGB
MA-0\3?V5%LBU&YMKJ.XBNECD=$2))8@2,HY"-ANGTJ;PKX<U'3_&5UJTUA+:
M6<^GI HN=0:[F+K(6)=F9L9!X )''J<4 =!JWBFQTF_6P,%[>7AB\]H+*W:5
MDCSC<V.@)! [G!P#52;QWHJBP^RFZOGO[=KBUCL[=I&D12 W'8@GG.,8]>*@
MO++6=(\77VM:9IJ:G!J-K##)%]H6)XI(B^TY;@J1)SW!'0U1\*^$=2T36=*N
M;HPNL.G7:7#1M\JS37*3;5!Y*CYAGV]Z .LT;6+/7M+AU&Q=V@EW !T*,K*Q
M5E93R""""/:LC_A.M(^UI%Y=]]F>Z^QK??96^SF;=LV[_P#>^7.,9[U/X0TJ
MZT?1Y[:\55D>_NYP%;/R23NZ_HPKAKKPEXHU"*$7UI/<ZA#J4=S)>2ZJWD/&
MDX?$, .U3M X91C!Y)H ](UC6;30[);F[\TAY%ABCBC+O)(QPJJHZDUS&M^.
MX[;3;2\M8[F IJT%E>6]Q:MYRJ_) 3&22",%<YSQ6QXPTR;5M"^S1:;:ZB!,
MCR6T\AC+(#SY;@C8XZ@^WO7*V?A;Q"T-NLPN%LX=9M;NWM+R]^T2V\,8._,A
MSG)Z+DXQUYH Z:+QOI#6.H7,ZWEJ]@T:7%O<6S+,#)_JP$&2VXG QG-,_P"$
M[TF.WU&6\BOK%]/A6XGANK<HXB8D!P/XAD$<'M63KN@>(GU3Q#>Z2WE_;5L%
M3RYQ'))'$S^<BM_ Q5L!O>L&[\#ZW>+XA:#37MTU#2%M(4NM2:YE,@D+'>[L
M<9!Z D<>IQ0!VG_"<Z<8K<I9:JUQ<E_)M!9.)G1<9DVG&$^8?,<=<=>*V=)U
M:SUO3DOK&0O"Q92&4JR,I(964\A@000?2N4\6^&+J\\46>N064^H1)9M:2VU
MOJ#V<B_.&5U964,.H*D^A[4[1_ L3:-$E^+S39S/+.T.G:K<@ NV?G<OF1L
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M5)(XHRMQ/I+QYD'(MY TGY <>M'C?09KBZUS5)KB"TLFTNU2.XF)V+-%<-*
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M#?Y,21[W+OL4#<QZDXZGWK#\7:U/HMA;207FGV9FG$33WH9P@P3\D:D&1N
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M?+B(*J.F[G)S@<53T[7=6U_Q'X<U7SK:&WN_#L]S+:&)V7.^+< =XY)(P<<
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M)HX2FR6)\\'<I((+$@@CGKD<5OU6U&_M]+TRZU"[<I;6L+S2L!G"*"2<?04
M9S>&+%VT4N\S#2(VCA5B")%:+RSOXY^7TQS5'3O!,.G362+K&J3:?8/OM+"2
M5/*B." ,A0[A0> S$#\*VM(U/^U]-BO19W5HLHRL5T@5\=B0">OUJ]0!E:YH
M,.MQVS-<7%I=6DOG6UU;E1)$^"IQN!!!!(((((-8Z> +#[+>I-J.I3W5W=QW
MQO7D02QSHH573"@#@=,$8)&,<5UM9%IXBM;Z=HK:WNY-E])8R.L65C=%))8Y
MX7C /J0* ,Z3P3;W>F:I:ZEJNI7TVHHB2W,KHKH$.5"*JA%P>?N\GKFDG\%>
M9/+<6^OZM:7%S D-[+ 8@;K:-H=LH0KXXW(%_05U). 3_*J]C=B^L8+H03P"
M5 _E7";)$SV9>Q]J *&G^'++3-4^WVS3!Q8Q6 1WW*(XV8J<GDM\YR2>:JVW
M@_3[;3-&L$FN3%I%U]J@)9=S/AQAN.1^\;ICH*TM'U:VUS34O[3?Y+221C>,
M'*.R-^JFK] '/2>#]/DU![PS7/F/J<>J$!EQYJ1"(#I]W:,XZY[T+X/T]= @
MT837/V>&]%\K;EWEQ/Y^"<8QNXZ9QWSS70U0MM6MKO5[_3(]_P!HL5B:7(^7
M$@)7![_=- '-W?PYL[NSOM/.LZK%IEY</<M9Q/&%65GWDAMFXC=SM)(]JN:A
MX(LM1O=4N)+Z^2/4_(:X@1DV;XF0HXRI(.(P#SC!/&>:Z>B@#E;_ ,#6M[/J
M CU34;6QU)]]]8V[H(IV( 8Y*EEW  -M89K0C\,6,,FKM&TJ#5(DAE12 L:I
M'Y8V<<<>N:VJR+?Q%:W<\L-O;W<IAOSI\I2+(C<)O+,<\)@@;O4@4 31Z)9+
MX<30I4,]BMH+-ED/+QA-G)&.2/3%9>F^#HK+4+*[NM6U'4CIZLEE'=LFV#*[
M2?E12S;<C<Q)P372U4TW4K35[!+VQE\VW=F57VD9VL5/!]P: (M#T>W\/Z):
MZ5:O*\%LFQ&E(+$9)YP ._I6='X/T^/0;+1Q-<_9[.]6]C8LNXNLWG $XQC<
M<=.G?O5J?Q%:VUS!!/;W<33W_P!@B+Q8#OY9DW YY3 (SZ@BM>@#D[CP#97#
M7,']HZ@FDW5P;F?2U=/(D<MN;G;O"LW)4, 23ZU8NO!6GW/VUQ<W<-S<7ZZB
MEQ$ZA[>98UC!3*XQM7!# YW&MG4]2M-'TRXU&^E\JUMT+R/M)P/H.33HKL2W
M]Q:^1<(8%1O->/$;[L\*W<C'/ID>M '.+X L'AU(7FHZC=W.H20S274DB+)'
M+%_JWCVJ I''&,<=.N72^!X;VRU&#4]8U._EOHDA>>5XU*(K;@$5$"#GJ=I)
MKJJ* ,75O#SZCJ$=_:ZQJ&FW21&!FM3&RR(3G!6167(/0@ \U8TS0K#2M AT
M2WB+64<1BV2'<7!SNW>N<G/UK2JAI&K6VMV)O+3?Y0FEA^<8.Z-V1OPRIH Q
M=/\  ]M97&GF75-2O;33&W6%G<NAC@.TJ#D*&<J"0-Q.*V=$T>WT'2UL+5Y7
MB6664&4@MF21I&Z <9<X]L5H50O-7MK'4].T^;?YVH.Z0[1D91"YR>W - &+
M_P (1;M=PF75M2FT^&\%[%I\CH8DE#;P=VSS-H8Y"EL?AQ5@>#]/'AY=%\ZY
M^S+>_;0VY=^_[1Y^,XQC=QTZ=\\UT-% '&WOPZL[VTU&P.L:K%IE_.]S)9Q/
M&%65VW%@VPOC=SM)(SVQQ6R/#&GD:XLXDGBUILW<<A&TCREBPN "!M4?C6S5
M!M6MEUY-&._[4]JUT./EV*RJ>?7+"@#(LO!J031M>:UJNHQ00/;V\-S*BK&C
M#:>452S8XW,21]>:73/!T=CJ-E>7.KZCJ+:?&\=DEV8\0!@%)RJ*6.!C+$_G
MS6M<ZQ96E_\ 8993]I^RR7?EA2?W2%0QSTZL.*DTO48-7TFSU*VW?9[N!)X]
MXPVUE##(]<&@"AK/AR/5;ZUU""^N].U&V1HX[JUV%C&V"R,KJRLN0#R.".*K
M6G@S3K-=.V373RV5[)?F:1P7GF=&1FD..<ASTQC [#%='10!EZ]H%IXAL4MK
MIYXFBE6>"XMWV2PR+T=3V/)'.1@FLVT\%P+>-=ZMJ=_K4WD/;)]N*;8XW #A
M515&6  ).3BNFHH YG2_!R:;<V3OK6JW=M8 K9VMQ(GEQ97;R54,^ <#>3CZ
M\U+!X/T^WT71=*2:Y,&D3QSP,67<S)NP&XP1\QZ 5T-% '*Q^!K:&410ZMJ<
M>EBY^U#3$D00A]V_&=N_9NYV;L9]N*6?P1;W-RXFU;4GTU[L7C:<SH8C*'#_
M 'BF\+N .T-C\.*ZFJ$VKVT.N6ND/O\ M5S!)/'@?+MC*!LGU^=?UH 9=:);
M7FOV&KS22M-81RI!%D>6#)@,^,9W8&!ST)]:;+H5M+XEMM>$DT=W#;/:L$(V
M2QL0V&&,G!&1@CJ:MSW8@N[6W\BXD^T,R^9''N2/"ELN?X0<8'J<"III5@@D
MF?.V-2QQZ 9H Y;4? 5CJ.IW5P^H:A%9WD\=Q>:?&ZB"XD3;@ME2PSL7(##.
M!2ZMX%M=5N]4E_M74K2#58PE];6[H$FPFP')0LIV@ [2 <#-=!I6HP:QI%GJ
M=KO^SW<"3Q;QAMK*&&1ZX-6Z ,>P\.6FGWMU=Q23L]S:P6CAR,!(@P4CCK\Y
MS^'2LV+X?Z,EE%9RFYGMX]*&D[)''S1 @AB0 =^0.1CZ5U5% '+Q^"89)'EU
M+5]2U.7[+)9P/=-&#!'(,,5V(H+$ 99LGBM_3[*/3M-M;&%F:*VA2%"YR2%
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M"1@"Z!PPR,C'&>*];ELK2:V-M+:PR0$Y,31@J3G/3IUYIRVT"+$JPQJ(O]6
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M%;. H&PD9P"QKUM[2VD#![>)@S%F!0')(P2??''TH2SMHK7[+';0I;X*^4J
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M@4S 22JY7",8M^0ISA0V.]=%X?M_#MK\54C\.SPO#_8<C2);S^9&I,T>".2
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M3RG\WS5)X*N<<CC.!UKMO';0M=^';;4I3%H<]\R7S%RB,?*<Q*Y'\)?'7@G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M C9 8!@,J2",C-;5 !163K?B&TT(VB3PW5Q/>2F*""UB,DCD*6/'H "2:UJ
M"BBB@ HHJEINJVNJBZ-J6(M;F2UDW+C#H<-CVH NT5S%]X[TNRN[N%;74[J.
MR8I=W-I9/+% P&2&8#D@')QG'>MBWUK3KNZM;>WNTEEN[4WD 3)#P@J-X/3&
M77\Z +]%%!.!F@ HJEI&JVNMZ1:ZG9%FMKF,21EEP2#ZBKM !15*75;6'6K;
M27+?:KF&2>,!>-J%0V3]76KM !15+4-5M=,FL8KEF#7UP+:':N<N59N?080T
M:3JMKK>G)?V;,8'=T!9<'*.4;CZJ: +M%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5Y?=7EY;>$?'5]!-+#>?VT\<T\
M?WXH084+ ]ML/S ]NM>H5F6VC):ZW?ZA%)B._1//MRN09%&T.#ZE<*1CG:OX
M@&)H5IX;L]>N++2+^:;S;$236@N&G@V[L"0EB<.V2.OS $X.,U+\-Y))/AWH
MID8MM@V(3U,:L0G_ (Z%K3N-!M1H]YI^EQP:7]J4JTEM JD9X+ #'S8S@GH>
M>>E:%G:06%E!9VL8CMX(UBB0=%51@#\A0!-1110 4444 ,EBCGA>*5 \;J59
M6&00>"#7EVD++>WFE> IBSKH=Z\UV6_CMH=K6H/^]YD7_?IJ]4J-;>!+A[A8
M8UFD 5Y H#,!T!/4XH \?>XA_P"$0DUXZC/_ ,)D-2,8C^U-O$WVC:+?RLXV
M;.-N,8Y]ZD\JVTZ[U[[)*T5V?%UDCJL[;O*9H#R,]"6;GOT[5ZK_ &7I_P#:
M']H?8+7[;C'VGR5\S'^]C-*VFV#W+W+65LT[E2TIB4LQ4Y7)QDX/3TH \IO+
M/'AKQ'XA^U7O]IV6OS+:R_:I,0H+H+L5<[=I!.1CG/L,,\2SZ?)I'CF]U?59
MK77;.6:.R47CQ/%&(QY(C0,,J^>3CG)]./7#96K0R0FVA,4C%W0QC:S$Y)([
MG/.:Y76_!%QK=U>++K(%A>962-[-'GCC( >.*8G**PSQ@XR<4 2^,B6^%&MD
MDDG1Y22?^N1KD]>L]8M-,T7_ (2/6VO/"L[P)?+!:I"T)RIC+MR3%N"AB,$<
M5ZH]O#);&WDB1X"NPQLN5*XQ@@]11+;P3V[6\L,<D#+M:-U!4CTQTQ0!Y9J]
M[*=7UBWN[V:'2)/$EM!>R"9D$<!M$(7<#\B-)L!((^][UE:NFGNGC'3M)U&:
M73XY]&2,)=-(MNS7!W"-B3CL>#P?IBO5-8T+[?I[06%PNGRF19&=(%=),#;M
MD0X#J5XQD=!SQ530?"<.DF]FO)8;VXO&B,FVV6*%%C_U:I&,X ))ZDY.: .%
M\7:3;:8GB_2;0W L'\-_;3 ]Q(X$RO(-XW,3D@#/KCG-1Z]#:K</)97EK?V5
MKI43BS?5);66V7YSYT$G*.3W)Z% ,]J]<>VMY)'D>")G=/+9B@)9/[I/IR>*
MJ2:#H\L<$<FDV#I;_P"I5K9"(N<_*,<<^E #-%U6TU#3K QSGSYK**Z$$[#S
MQ&P&&=?KP3TR#6'\3?\ D1YO^OVR_P#2J*NK%O"+@W AC$Q0(9-HW;<YQGKC
M/:B:"&YC\N>))8R0=KJ&&0<@X/H0#0!QOC33X=5\6^#[.Y:40/<76\12-&6
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MK0!Y-H%T\Z:9 9XY8K7QDT,*PW#3QQI]E9MJ.W)4%FQ7=_#?_D1[7_KYN_\
MTIEKHDT^RC*E+.W4JXD!$2C#!=H/3J%XSZ<5-##%;QB.")(HP20J*%&2<G@>
MY)H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7.>+_$A\,PZ3<$QB"YU&.VG9D9R$9'/RA>2
MV5 '!Z]*Z.N>\5:9=:E/X?:UA\U;35HKF;Y@-D:I("W)YY8=.: '0^--"ETV
M[OS=20Q6<BQ7$<]O)'+&[8VJ8V4/ELC  YSQ38?&^A2Q7#O<7%N;:2*.>.ZM
M)87C,K;8R5900I/&[&/>N>US1_$2:IXAO-,MY-EW<V#!H6B\YX8U(E\K?\JN
M.,%L>W:J^E>$;S4-5\0KJ5EJ,.G:II<=K'+J%XL\VX-)DG#'81N! ''&>"2*
M .VO_$>DZ7/<0WMZD+VUL+J;<IPD98J"3C&200!U..!3=(\2:;K<TT%H\Z7$
M*AW@N;:2"0*>C;9%!*G!Y'%<(W@_Q'JW@S4;C5(U7Q%=7-M,T23A0R6Q7:@<
M?=W;7<'L9.<8K9\*Z/<KXGEU:?3=6M42S^S))JNH">5BSAF555V 4;1R3DGM
M0!9UKQH=.\17NC16LAE@TF2^25H)"AD7)"D@;0N!USUXSGBIO#7CC3-=BTZ
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M%M^]=Q& IR5&#Z6)O#&K?VU<3):EX3XCM+U7,B_- ENB,_7^\",=?:@#I/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***QM>N=:A:UBTB.SC1R[7%[>Y:.W51Q\@92Q
M8GU &#GM0!LT5A>$M<F\0:']LN(XED2>6 R0$F*;8Y7S(R>2K8R/YGK6[0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 9$FA.^O+JG]L:HJ@@_8E
MF7[.<+C[NW/OUZU!XCN-0@:V$>BKJ^E2ATO;= K2CIL*J[!67.00>>01T-;U
M% '+^!M*O-*TN]%S:FQAN+Z2>TL-X;[)"0H"?*2HY#-A3@;L5HZ9H3Z;J$]V
MVL:I>"8$""ZF5HX\G/R@*",=.O2M>B@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex31articlesofincorporat004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5T895E.01[&@!U%%-\Q/-\K>OF;=VS/./7'I0 ZBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"GJU[_9NC7U^%W?9K>2;;Z[5)Q^E<5H[-8+X"A>.">>_6:XN+B2,-
M)YKP-*[*W8EB<^W%=[/!'<V\MO,H>*5"CJ>X(P17-Z!X<>"PT6/4Q(;K03)!
M:RJXQ-'L,:N1ZE",@XPP/;J )X1D-OJ?B311_J-/OPUN.R)-&LNT>P9WQZ#
MKJ:PO#&EW%E%J%]?($OM3NVNIDW!O+& D:9'!VHJ@XXSG%;M !1110 4444
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M&2UNF@**\<\_E%9$!X((;D'D$<<53U.UUR#Q5J$>HZU%=E/#-P\FRT\H."[
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MS?>S0!ZCJ>I0Z5I-]J,P9XK.!YY%CP6VJI8@>^!4UK<I>6<%S&"$FC610W4
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M CZ4 ;L&N6MQKESI*K(LUO;17+.P 0K(7"@'.<_(<\=Q6D6"C+$ >IKS#2]
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MKG4M0EA6 33JB".,$MM5450,DY)Y)XK0U75;/1-,GU&_E\JVA +,%+$DD
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M!&1D4 =&RJRE6 (/4$4;5P1@8/48KF;+QUIM_<10QV>I(UQ;O<V9EM2@NT4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/E%,@\C/.[.:9-\/K"\.HO?:GJ=W/J-JMI<32R("45MR[0J!5P<] !R>,\T
M9&K>)]>T?4K+0[R_M%O9H9+N:\M]*GG6.,,%6-8D8DG);+D@8 XR:Z;PAK5W
MKNB&XOK9H;B*>2!B8'A64*>)%1_F 8$'!Z<CM4FL>'(=6O;:_BO;O3]0MD:.
M.ZM&4-L;!9&#JRLN0#@C@CC%6M&TB#1-/%I!+/-EVDDFN)-\DCL<LS'U)/;
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M&(*@I&L8V\<<*/7F@#DM*TFP\3^+_$]SKMG!?/87:65K;W48D2"+RD?<JMD
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M$P"W'/7%:EOX!M;.TT^.SUC5;>YL(3;V]VCQF00''[I@4*LHVC&5)&.M3?\
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M!>&.0QL&]21Y;CV?VKN: &"&(-N$2!MV[.T9SC&?KBF26EM- ();>)X1TC9
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MOHM*>QLHY)TD9W=U=F)7*J,( N>Y)(%=Y/;PW41BN(8YHR02DBA@2#D'!]"
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M1XV<2JC$,,8P5R>5(SR".EN?!]D^G:1;65S<Z?-I"A+*YMRI>-=NT@A@58$
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MKJ$DC212.D/DS@ JH<%L[CD$CDYR ,&W:>,-<U#[#I$*:?%K,U]>6LURT;M
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M:VAF$LPC9&5R2K+GJ"1R#ZBNC/@6REL+B.XOKV;4)[I+QM2+*LZS( $9<+M
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MQC>0N<$J/2IAIFA:OXH\-Z?9W5Y>:3%)J:@23L4.!%F-'&"T0)XY(XQD@8H
M]7JO9W@O%E80SQ>7,\1$T90MM.-PSU4]CW%<UX !AT_6+%7D:WLM7N;>W61R
MYCC!!"@GG R<5Q5T'O8O)DU&TW?\)!J02RU*66.WN@KG"F1?NE1RH.0>>..
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MB61BTMM&',)SGYAZ'N .M=7\1(A<+H\!OK.(O<L5M+]Y([>[(0_(\B?=(^\
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MJ;B>FX*!D]@*[?X@WD-OI%A;3)*_VR_C@6,7?V:-SAFVRR8)$9V\@#).!WH
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M^O  J.[L;2_B$5Y:P7,8.X)-&' /K@UEIXKTF7Q')H,4D\E_$^R94MI&2(E
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M6*1L;0R%=W.1@XP<T2^.=&BCA)74&EEB,Y@33YFEBC!*[Y$"[D&0>H&<<9H
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M#^]C.,@=<]JUO&VE3:E'I[QZ3/?K!,S,UG=_9[J E<!XG+*/8@GD'OBNJHH
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ML\%G=6=W9V\\8>/S)_-5T+L%8<8(R#R/3%;6DZ9K<WC&QUK4["VM5&G743I
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M+E;5O[7LL3L 1$?.7YB#P<=>?2K.D22-=R1WWC6RU:&2)U-M''#$>F2V4;/
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MRH..5()&,$G)%;?CN&:ZUS2X(KBVGVP32'2KF]EM!.,I^\61."R],-V8GWH
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MT =3::-I>GW,MS9:;9VT\O\ K)88%1G^I R:6UT;2[*[EN[33;.WN9O]9-%
MJ._U8#)J&75H-*T&+4-6ND"B./S)5@=-[M@ +'RP))P%Y/..:P-9\?6-MHAU
M&PE7]Q?VUM=I=P21/ DDBABR,%8?*202,?6@#8UGPW:ZYJFEW5WY<D-BTI:W
MEB#I,'0I@YXXSGH:T8M.L88(((K.WCAMVW0QK$H6(\C*C'!Y/3U-95MXST&Z
MM+^Y%ZT,=@H:Z%S!) T2G[I*NH;!QP0.>U-@\;:#/%?.;J>'[#;FZG2YM)H7
M6$9RX5U!9>#R : -.[T?3-0N(KB]TZTN9H?]5)- KLG^Z2,C\*L2V\$[1--#
M'(T3[XRZ@E&QC(ST.">?>L%?'7AY[%;R.\FDBDF,$02TE9YG W?NT"[G&"#N
M4$8[U,WC'0ETR"_6\>2*>4P1)%;R/*T@SN3R@I?<,'(QQCF@#7:TMF>9VMXB
MTZ!)6*#,BC. WJ.3P?4U!9:/IFFC%AIUI:@@KB"!4XSG' Z9HTK5K'6[$7FG
MS^;"69"2K(RLIP596 *D'J" :S7\:^'X]3-@U\PD6?[,TOD2>2LN<>69=NP-
MGC&[.>.M &E8Z/IFEO*^GZ=:6C2G,AMX%C+GWP!FDMM$TFSN&N+73+*"=F+F
M2*W16+$$$Y SG!(S[USWA_Q1=Z[XSUNQ1DCT[3G$*QO93+)(VU&+&1L*.6("
MXR1@]*TM4\8Z%HUX]I>WCK+$@DF\NWDD6!3T:1D4B,'U8B@#9>"&2:.5XHVE
MBSY;LH)3(P<'MD5%)IUC-!/!+9V[PW#;IHVB4K*>!EACD\#KZ"LG4/&OA_3+
MN2VNKY@\2JTSQP221P!N5,CJI5 1S\Q''/2FZGXW\/:1=36UW?.)H8UEE6*W
MDE\N-AD.Q12 N/XCP* -6#2=-M;6.UM]/M(;>-Q(D,<*JBL#D, !@$'G-%_I
M&F:KY?\ :.G6EYY9S']H@638?4;@<5F6OC7P_>W$T$%^6:*![G<8)%22)?O/
M&Q7$@&1RI-54^(OA>5E6._E=I$\R +9S'[0.,^5\G[PC(R$SB@#H9;"SGW>=
M:02;HC"V^,',9ZH<_P /MTIYMX&FCF,,9EB4K&Y490'&0#V!P/R%8S>,] &D
MVNI+>M)!=NT=NL<$CRR.N0RB(*7R,'(QQCFFOXV\.QZ9!J+ZB!;SW!M4_=/O
M\X DQE-NX/A3\I .<#J10!K7VFV&J0"#4+*VNX0=WEW$2R+GUP013TLK6/R-
MEM"OV<$0XC \H$8(7TXXXJIHVO:=K\$LNGS.XAD,4J21/%)&^ <,C@,#@@\C
MO7-ZAXDU>Y\87V@Z9?Z-IK6<<3*-1C:22[+C.44.F%'0D9.<T =E/;P747E7
M$,<T>0VR10PR#D'!]" :H'2([+2Y[708[/2I9/F5XK52BM_>*#;N_.L%O&=Y
M87'ANQUC2GMK[4Y98KA(E>58]BMAE*J<AB%//(4Y/0D:2^-?#[ZF+!;YO,,_
MV82^1)Y)FSCRQ+MV%L\8W9SQUH N:!HT/A_1+?389&E\O<SRL #+(S%G<@=R
MQ)_&K4VG65RLZSV=O*+A0LPDB5O- Z!LCD#)ZUE3^,]!MM3;3Y;UA,DRP.X@
MD,4<K8PC2A=BL<C@D'D55T7Q?#=1E-1DBBNI=4NK&UAA1F:012,H.!D\  LW
M 'M0!N6>E:=IP466GVML%4HOD0JF%)R0,#IGG%/33K&..WCCLK=$MSN@58E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?V?*5A2-8TRQ!0#IC<>#GD]:DF\$&]NA-J&JR7*SZ8=-OH_(51<QY<J1C[C
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MF$P2P/"L\,BDYSL;@,/7TX.:FTKPY8Z5X7A\/H'FLD@,#>8>75L[LXQUR>E
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M#T\Q1:A?I#.8HY)0(W9(0XXWL 0@/;<10!T-%0W-U;V=I+=7,T<-O$A>25V
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M7\6V.DZ9*DT$UG/<2L\;QNNUHPA 8#*L';G&#C@]: .LHHHH **** "BBB@
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MI9G=/S4@_C72W-M%>6LMM.F^&9#'(N2-RD8(X]J?'&D4:QQJJ(@"JJC  '0
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M$DMT$!,CM$0F%8Y VG!Z'G%=M10 4444 %%%% !1110 4444 %%%% !1110
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M1M#8&00>^",T_7?!-WK45W9MK?\ Q++R-4EMKBT6=HL*%)A8G]V2!GHV#R*
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M \-Z4+UF71)XIED\O!FV*RX(SQG=[]* .HHHHH **** "BBB@ HHHH ****
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M>0[2,2(Q5AR.Q!&>E8'@.XU";1[R'4+A9FMKZ6"(_:1<.B#!".X'S,I)&>O
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MFI?\?+W6L?:%O%,18F.+&$8$ _)@  @T >G7=];V/D?:'9?/F6"/",V7;H.
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M7]HL;>7[9&L5SOC!\U%SA6SU W'&?4U%%X>T:"'R8M+M$C_=?*(AC]U_J_\
MOG QZ5 _BS08]7_LI]4MQ>^8(O+W<"0]$+= W^SG/M45WXT\-V%Z]G=:Q;17
M$<@BD1F_U;'& QZ+G(Y.!0!:U;1UOK6\-H\5IJ%Q (/M9@60A020K!N&7);Y
M3_>/2L'PSX)_L?6I-5N(M)@?[,UK';:79^1$%9E9V;))9B44>P'>NMN;F"SM
MI;FYF2&")2\DDC!511R22>@KG;CQQI$NC:O=:5>0W=UI]E)=^0VY2RJI(."
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MM5T][N6;)5D*NB@$'& 0V<UHZ=XMT#5I98K#5+>=XXS*0I(R@ZNN?O+[C(H
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MMT!-7_LMM5MA>>9Y/E[N!)_<W=-W^SG/M0!;MM$TJSAM(;;3K6&.S8O;*D0
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MQIMK+;W$IFEB>(%7D/\ &1_>]^M2:;H^FZ/$\6FV%O9QN076",(&(  )QU.
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M/B_Q+JTFE75A;7B6@A:YCV--L60,Q7J.H&#SC%9?B;P[JFJWOC%;6U+"[LK
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M(9-X^9>S9'?CFI++P%-;2B6?5Q,_]M)J[$6P0;A#Y9C #<+W'H!CGK0!3O\
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M2N$#NL2[""5##EBN3Q[T6'C&\UKQ"MEI&EQ36"V]M=S7DUSY9$4P)7:FTY;
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M:B+_ ,[ROO8NC<;<9]]N<^^.U '5T444 %%%% !1110 4444 %%%% !1110
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MU 'K-5_MUM_:1T_S1]J$/G^7@_<SMSGIUKRO4=0\1Z9I.O6:W=U9"/["]O\
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M*&TA6)]JK+&Q&[<!DEN?FX(XK2U"75)CX^U4ZSJ,)TB&3[':Q3[8HV-DKDD
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MES-;V\P>6%(WD4 C"N"5/X@&K=>4:MJ^K0V6O0VFI3VY@314MV0_ZGS9 KD
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MJ]%96T%Y<7<4")<7&T32 <OM&%S] 37,#QW!;/H%OJUD^FWNJS20O!</@P%
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M=<L?LLDC1)()00[K]X#UQ[59NO$FB66FP:C<:K:)9W&/(F\T%9<\_+C[WX4
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M))[B5(H8U+O)(P554=22>@K*L?%GA_4DN7L]7M)EM8S--MD'R)_?/^SQUZ4
M%UX3T"]U3^TKG2;66\W*YE9/O,OW2PZ,1V)Y%7'TC3WCOXVM(BFH9^U@K_KL
MH$.[U^4 ?056T[Q1H6K7SV6GZM9W5TB[FBBE#' X)'J >#CI4^J:UIFB0)-J
M=]!:QNVU#*^"Y] .I/TH ;J.A:5JUE%9W]C#/!"08E=?]60, J>H..,BHF\+
MZ&VC+I!TJU_L]6WK (P &SG<.^[/.>M-;Q5H"Z9!J3:S9"RG++%.9EV.0"2
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M:7.>IC15QCU]:S3X%U Z8WAX:O /#C7!F\K[,?M C,GF&'?NV[=W&=N<<>]
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MM-]ML!.\$@0(7B.X=0!\K C(SWQ0 VY^(HDU!+;2+"WN]UE#>HMQ?+;2W"2
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ME/+-\EO]KT^25K:'^XA$J@9ZD@9)Z]A6C/:W&I>.]+D=?W6C6LDDLH4A7GF
M0*N?10Y/7&Y: +.L^(+JSUBUT?2M.2_U">%[EEEN/)CBB4A2S-M8Y)8  #UZ
M8KE/#7B"ZGN-,_M 7XN+G6-301-=<1!/,(C<<APH& ,X! (KJM9T*^GUNUUO
M1[R"VOX8'M76YA,D4L3$-@@,I!#*""#ZCO67I?@>YL9M,GN=56YFM+V\O)7$
M&SS3<*PQC)VX+9[T 4[?XDW,GA^QU:YT*.U35&C33DEOU'FEE9F,C;<1JH4G
M/)((XR<58A^(L36EY&]C')JMO<P6J6MI=K-',\W^K*RX'R\-DD C:>.F9)/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"1X5B"<D@ XY%0IX*OY='GTZ:[L+:"_N@]]%I]H(%^S@8\E".3NQ\S,<X9@
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M)XEGD56#>7E2,<@'G!K9U1]0MM430[?7/$>HRVUJ))$L8K<3!G=MKRRN%0#
MP% 'W23F@#T2BO,/#NN:SXN7P_8W&KW%CYND-?7$]HL:R7$@E\L#)4@ 8W$
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M2* +FGZ?:Z5IUO86,0AM;=!'%&"3M4=!D\UG67A/1-.NH[BUL?+DBN)+F/\
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MSSGZ F@"MX+\+2>'?[3N9X[6"?4)UD-O:NTB1*J!0-[@,['DEB!DFKNH^#=
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M\AO(+21KJ%&CCGFN9975",%=SL3MQVZ"I?\ A%=%$6DQK9;5TC'V'9*ZF$
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MTAE51T=M@'R]Q@=ZS[^RFU.R\2W=E-J-^Q\/S6Q8:3]DC=CRD87 9W&#C (
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MWDMJD<$[PY>3%D%.PXY^8D<=^*])HH \JU?1)=-M/!-U;0O8V%G;L+IX-/\
MM!AF:) CO& 2>CKNP2"WO5:TTZ2V%EK$T&H7FC)KLEW<))8>7D& HLZ0*-VP
M28;IG.6QWKUZB@#B?! AD\0^*[VSL)[2RNKJ&2$RV[0B7]T SA6 ."P/;GKW
MKMJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%=O. UJT*2,K?=,BV9,>?<')'N* .^AUC3+BQAO8-0MI;29UCBGCE#([$[0
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M!RIX'0TV_P!7FTK7O$7B73KRXDC3P]9W%O;SJFS#M*$W_+NPOWOO9Y;)(Q@
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M,MK#-ITT3.5C19$&])#\HRY^]D8[51TBYN]&\/WD2:]?B>[\1WD"B*TCFN)
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MYQS@]#ZYK%7Q=K]S;Z+I7G7TEQ--?I=7>GV\)GE6VF\M=JO\BDY!8X/3@<\
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MQO8TBNI)[J622948LNYF8G()ZYZ8'0 5L7^J:?I4:2:C?VMFCG:K7$RQACZ
ML1FL37_&$6D:MI&E6L=K=7FI$E%EO%A58QCYLX).2<* .3GGB@#:_LNS_M9]
M4\G_ $Q[<6S2;CS&&+!<9QU)YZUC2> _#[QV2QVUQ UC;"TMI+>\FB>.(?PA
ME8''KGK5[6/$FG:)J&EV5[,J2ZC.88BSJH7",V3D]/EQ]6 [U6T3Q=INKCRW
MN+:UO#<SP):R7"^8_E2M'N"\$@[">E #Y_!VASZ?8V2VC6\=AG[(]K,\,D.?
MO;74AN>_//?-26?A71M/%C]FL]AL99)X6,CLWF2*5=V).78ACDMFKLVKZ;;W
M\=A-J%I'>2_ZNW>91(_T4G)JMXCUI?#WA^[U5H#.MN%)C#;=V6 Z\^M %O4=
M.L]6T^:POX$GM9EVR1MT(Z_@<X((Y!%9=KX.T6U@OHO(GG-] ;:XEN;J6:1X
MB"-F]V+!>3P"/7K6G9ZKIVHM,MC?VMTT)VRB"97*'T;!X/UJ!=>TRX@O'L;^
MTO'M$9I8X)U<K@'@X)QT[T 6OL5M_9_V!H5:U\KR3$_S IC&TYZC'%8EKX&T
M&T611;W$JM;O:J+B\EE$4+C#)'N8[ 0 /EQT%6;#Q-IUQH.DZI>7-M8#4K>.
M:**XG522ZAMH)QN(SVJ/2O%>GWWA>SUV]F@TVWN0<?:9U55.2,;C@'I0!<DT
M#2YOL'F6H<6$;16X9F(5638P(S\V5XYS6;:> _#]E-92QV]R[6+A[,37LT@M
M\#&$#,0JX.,#CIZ"MB?5M-M;5+FXU"TAMW7>DLDRJC+Z@DX(Y'YTP:WI)OH[
M$:I9&[D4,D N$\Q@1D$+G)&.: *[>%]&;0/[#:R!TX,7$1=LJQ<ON#9W [CD
M$'([55C\$Z"EE>VLEK+<"]V?:);FYDEE?8<I^\9BPVGD8(P>16]--%;PO--(
MD<2#<[NP"J/4D]*PM8\8Z1I?A:]U^*\MKVVMD)'V>X1A(X'"!@<9- %O2/#V
MGZ))/-:K.]Q<!1+/<W$D\CA<[06<DX&3@=.35;5/!NB:Q>RW=W!,)9T$=P(+
MJ6%;A1T6148!QVYSQQTJQ:ZVH\,G6M4%M:QI"\\Q@N//C1%R<AP!NX&>![5A
M?\)GJ\=G%JUSX4N8M&D*GS5N5>X2-B ': #IR"0&) [4 =+#H]A;ZC]OAMUC
MN!;+:!E) $2DE5"]  2>U.;2[-]8BU9H<WL4#6Z2[CQ&S*Q&,XZJO.,\4ESJ
M^F65U#:W>HVD%Q-_JHI9U1W_ -T$Y/X4EWK.EZ>^R]U*SMGR%VS3JAR>@Y/?
M!Q0 _4-,M-5@CAO8O-CCFCG4;BN'1@RG@]B <51U;PMI6M7:7=U'<1W2QF'S
MK6ZD@=H\YV,8V!9<]C5V+5M.GN;BVAU"UDN+<9GB292T0_V@#D?C4(\0Z*3,
M!K&GDP())1]I3]VAQAFYX'(Y/K0 EMX>TFSFL9;:R2(V-N]K;A"0J1,5++C.
M#G8O)YX]S5&Q\$:#IM]!=6UK*#;,SVT+W,CPV[-G)CC9BJ'D] ,9XQ6JVKZ:
MFFC47U&T6Q(R+DS*(B/7=G'ZTHU73C9QW@O[4VLO^KF\Y=C\$\-G!X!/X&@"
MHGAK28],M-.2UQ:6EPMS!'YC?+('+ALYR?F).#Q46K>$])UJ\^UW4=PER8O)
M>6VNI(&DCSG8YC8;EY/!]36E8ZA9:G;_ &BPO+>[@R5\R"59%R.V0<5@WWB?
M43KMYI.AZ(NHRV*1M=/+=BW5"X)55^5BQP,] />@"S=^#M#NX[-/LKV_V.'[
M/"UG/);LL7&8\QL"5X'!K1TG2;'0M,ATW38!!:0[O+B#$A<L6/4YZDUB0^.M
M-*:*+R*6QN-4FD@$%R51H70-NW9/(RNT$9R6'K6Y_:^F?VE_9O\ :-I]NQG[
M-YZ^;CK]W.?TH PI_AYX:GN)I&LYUBGD,DUK'=RI;RL3DEH@P0Y/7C![UI7/
MAC1[S4C?SVFZ9K4V;J)&$<D//R.@.U@-S8R#C-6Y=6TV'4(]/EU"TCO9.4MF
MF42-]%SDU2TGQ';:E;W4TVRT$.H36"^;*/WCQN4&,XY;' H CTSP?HNDW/VB
M"":241&!&NKF2?RHCU1/,8[5X' ]*@MO GAZUWA+29D,$EO''+=2R)#&XPRQ
M*S$1@CCY<<<5NW=[:Z?;-<WMS#;0)]Z6:0(J_4GBLC4O%=A8+I$T<L%Q::C=
M&W%TDZ^7&!&[E]W0C]V1U[T 7(M TR"_L[V*VV7-G;?9(9%=@1%Q\C<_,. 1
MNS@\U%J_AG3-:N(;FZ2=+F)#&EQ:W,D$FP]5+1L"5/H>*MPZMIMQI[:A#J%I
M)9+DFY293&,=?F!Q69JGBW3K/P[/K-C/;ZE!#+'&?LTZL,O(J?>&1QNS0 7'
M@S0KBRL+1;22VCT_<+5K2XD@>(-]X!T8-\W?)YZGFFCP1X?33K>PBLGA@M[H
MWD/E7$B,DISE@P;=SN((SCFKFC:TNKSZK$L!B_L^]:S)+9WD(C[NG'W\8]JF
MDUO28;I+675+)+F1S&D+7"!V8=5 SDGVH SD\$Z%'J(O%MILK<&Z6 W4I@6;
M.?,$6[8&SSG'7GK3)O N@S23R?9[B.2:Z-YOBNY4:.8[MSH0WR$[FSMP#GG-
M:]UJ^F6-U%:W>HVEO<3?ZJ*:=4=_]T$Y/X54A\2:=-XIN?#R3+]NM[=)V&]>
M0Q;Y0,YR N3QP&'K0!6M_!.@6OF>79.6EN(;J1GN)'9Y8CE'8EB20>N>O?-7
M+SP[I.H37TMW9I,U];I;7.]B0\:%BHQG P78Y&#^0JQJ&K:;I,:/J.H6MFCG
M"M<3+&&/H-Q&:P?$7C:UT6_TJR@-E<3:AND#37R01QQ*,[RQ!SG.!QSSSQ0!
M-%X#\/QK>;[:XG>\M6L[B2XO)I7>$]4W,Q('ICI6G'H>G12WTJ6^'OHTBN#O
M;YU52JCKQ@$CBL;PYXWM-;T2?6KLV6GZ<)2D4LE\C$C)'S\ 1D\';D\&N@;4
M[!-/_M![ZV6RV[OM)E41X]=V<8H XW7?!]PUU:+INCZ?=65O8I9P"2_GM9(E
M7(VNR9\V+&/E;N#US71^&-"7P_X3T_1)'2?[- (I&VX5S_%QZ9)X]*BOO&&B
MV,ND*;ZWE35)S#!+',A3A68L3GI\NWC/+ =ZGU_Q'I_AN&TDU"546ZNH[9,N
MJX+'&XY(^4=2: *ECX(T'3IHY(+>=A$C1P1S7<LB6ZL,,(U9B$R.. ...E7D
M\/:7';:3;+;8BTDJ;)=[?NL(8QW^;Y6(YSUJGIWB_3+R]O;2XN;:SG@OFLXH
MY;A0UP55#N4'!/W\8&>E:EWJ^FV%Q#;WFH6EO/-Q%'-,J-)_N@G)_"@#$A^'
M_AR!K?;:W!CM9UGM8GO)FCMW5MP,:%MJ<^@Z9'0XK1M_#6D6MU!<PVNV:">>
MXC;S&.V28DR'D\YR>.@[8K6JC;ZUI5XUPMMJ=G.UN"9Q%.K&+'7=@\?C0!7U
MGPWI>O2VLU_%*9K0L;>6&=XGB+8!*LA!!X'^35=O!NA-HZ:7]C80)-]H5Q,X
MF$V<^9YN=^_D_-G-:ZWUH_V?;=0'[2-T&)!^]&,Y7^]QSQ45MJ^FWMW-:VNH
M6D]S#_K88IE9X_\ > .1^- $.CZ%I^A13)8Q.&GD\R:665I9)6QC+.Y+'@ <
MGBN=A^']E=:WKU]JZ-+'J%XLJ1174J))$L4:A94!"O\ ,K'!!&#[D5TJ:YI$
MBSLFJ6++ @DF*W"$1J>C-SP#ZFHFURVFCL9M.EM;ZWNKGR#-%=)M4;6)*G/S
MG@#:.><]J )X=)L;>]O;N.W437JHMP220X0%5&#P, D<5EZ=X)T'2[R&YMK6
M4M;AA;1RW,DL=N&&#Y:,Q5,CC@#CCI6I!K&F75]+8V^HVDUW%GS((YU:1,>J
M@Y%+'J^FRZB^GQZA:/>H,M;+,ID4>ZYR* ,O3O!6AZ5>P7-K;SYMMWV:*2ZE
MDBM]P(/EQLQ5."1P.AP*2S\$:!8WT-U!:RCR)#+! US(T$#G.62(ML4\GH.,
M\8JUKVO0Z -.>= 8[R\2U+LX0195FWDGL-M6[?5]-N[>*XMM0M)H)9/*CDCF
M5E=_[H(."?:@"J/#6D+I4>F"U_T.*Y%TD?F-Q*)?-W9SG[_..G;IQ4MCH=AI
MNI7U_:1R1SWSA[@><Y1F QN"$[02 ,D 9QS5T3PFX:W$J&95#M&&&X*<@$CK
M@X/Y5R^I>/M,L3K<<(%Q<:3)"DT0E4%C(RJ2.IPN\ Y'7B@#6?PUI$EW)=/:
MYFDO([YF\QN9T0(K8SV4 8Z>U6X-,M+;4KO4(HMMU=K&L[[B=P0$+QG QN/2
MBRU73M2\W[!?VMUY+;9/(F5]A]#@\&DL=6TW4VE6PU"TNVB.)!!,LA0^AP>*
M .9D\!VNH^*=<U/5 [P7WD+&D%U+%O18]K)*%(#*3V.?U-:VI>$='U.:&:6"
M:":&'[.LEG<26[>5_P \R8V7*^QZ=J75/$UGI&O6>G7K100W%M-<-=33!$C$
M;1K@Y]?,]>U7Y-5TZ'3AJ$NH6J6) (N6F41D'H=V<4 067A[2M-N+:>RLT@>
MVM39P["0$B+!MN,XZJ#GK[U2MO!6A6E_'=PVTP\J8SPP-=2M!%(<Y=(BVQ3R
M>@XSQ4VH>)+6T&CR6WEWD&IWJVD<L,H*C*.VX$9!'R8_&HM9\6Z;I,L-NEQ;
MW-X]Y;VKVR7"^9'YLBIN*\G W ]* &P^"=!@U!+R.TD!CG-Q' ;B0P1RDYWK
M$6V!LDG('7FK;^&M)DTRZTUK7-I=7+74T?F-\TID\PMG.1\XS@<?A5J35M-A
MU!-/EU"T2]D&4MFF42-]%SDT-JVFI=BT?4+1;DE@(3,H?Y0&/RYSP""?8T +
MJ6FV>L:?-8:A;K/:S##QMGG!R#D<@@@$$<@BLF/P3H2V=];26\]P+Z,17,ES
M=2RRN@Z+O9BP4>@(K5L-6TW55=M.U"UO%C.'-O,L@4^AVDXI;_5=.TM4;4;^
MULUD.U#<3+&&/H-Q&: +?;%<WIG@3P]I$]K+9VDJK:$M;PO=2R10L1@NJ,Q4
M,<GYL9Y/J:;KGB^+2]>TC1K6*VN;S4=S 27BPB.,;1GH2Q.[Y0!S@\\5+XD\
M1W6BWNDV-CI8U"[U*62.-#<"$+L0N220>P- $.AZ#=)XKU7Q)J=M:07=S&EK
M"EO(9,0H2=S,5'S,2.,<!5&33O%?A@^)+S0MY'V6RO&N)P)6C?'E.JE&7D,&
M93G(Z4W3?%LCZO/I6N:9_9%W':_;%+W*2Q/%NVD[QC!!(R"!U%:SZ_HT=H]V
M^K6"VR2&)YFN4"*XZJ6S@-[=: *MOX2T6VMHH$M781W:WWF23.\CSKT=W)W,
M?J31JWA+2-:O#=W44Z7#1>3));74D!ECZ['V,-R\G@YZFJ?B;QE;:%'IBVHM
M+RYU*;R[=)+Q88RNUF+E\'Y?EQD Y) [UM#5]._M :<VH6@U KDVOGKYG3/W
M<Y_2@"M'X9T:*X$R6$619_854Y*)!_<5?N@'O@<X&>E8FH^$#>7?A[2XK2W3
M0-'F2[626X>28N@8)& P/RC*G)8\#&*Z.36])BN&MY-3LDG4$F-KA0P .#QG
M/!ZTQ_$&BQV9O'U>P6U$AB,[7*! XZKNSC/M0!/!I]O;7MW>1*XFNRIF)D8@
M[5VC )PO'H!FFW^EV>IM:-=P^8;.X6Y@^8C;(H(#<'GACP>.:6XU33[.Q6^N
M;^U@M&P1/+,JQG/3YB<<U3T'7HM>74'@C"QVEX]J'5PXEVJIW@CL=U %QM,M
M'U>/56BS>QP-;K)N/$;,K$8SCJJ\XSQ69/X.T2>SCMOLLD0BN)+J*6&XDCEC
MED8L[*ZL&&2QR <=L50F\6ZK<7^I1:)X=.HVVG3&WGE>\6%FD"AF6-"IW8##
MDE035NV\::5<ZCH]AN>&XU2T:ZBCGPC(!M&UE)R&);@8YVMZ4 :>D:-8:'9&
MTT^$QQL[2.6=G>1VZLS,268^I-7ZIP:OIES?2V,&HVDMY%_K+>.=6D3ZJ#D4
M+JVFOJ)TY=0M#? 9-L)E\T#_ '<Y_2@"Y16-H/B.VUO1;#4'V6K7I<10R2@L
MQ5B"!TR?ESQ6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5Q_Q!F>*PTO%I#)$;]#)<SVSW
M$=IA6(D,:$%N< 9X!8$UV%% 'A\]I+/:^)&GLKO4+2;5=*F(736A^U1AU$A2
M+&2,*1[XSWK9U:VL=<N_$%]I]AJ T5].MX)WL[0H\LZ3;PRQN!O\M?O<'(^7
MGI7J]% 'BUY;ZMJFBZ_!911ZC 19R2ZC;:6]M)<HDN7A,1.)2J9/RXR#M[XI
MU]9OJ&G^*;NQN+J^W:!+;LT.DFTB=B<HF#\SR ;N@X#8SVKV>B@#S?Q!H$T.
MJ:;#H%D+6=_#^H6RR0Q[ 'VQ>6K,.GS9(S[U0F6QU3PQ%IGAS0;F+6X-'G@$
MOV=[<V;&+!C9B &9FX R>?F]Z]7HH \I\*VJ7'B;P^]M<7+&QMY%EBCT7[(M
MNACV^5*Y(S\V,*,\KGIS70^*!%9^-=$U75;:2?2(;6XBWK TJV]PQ0J[* 2,
MJ'4-CC/;-=K10!Y-::2T\FFW$>ER1Z;-XK:XM(9+<KY=N;=P6V$91&D#-@@?
M>![UU?Q"E>+1[#%E%/&;^+S)IK=YX[4#<1*T:$%\$ 8SC)!/2NNHH \]^'R3
M_P#"5^*)I#+)#.EH\5PUB;1)L+(&9$/;@#/4X';%4M?-CINH^-1KNG37#:C
MAL76U:42Q+ %\M6 (4JX8\D8W!O>O3ZBNK:.\M)K68$Q31M&X!P<$8/\Z /-
M- U&/0=3TF^O8+LVUWX8L88'@MGE#RH7)3Y0<-AU(!ZUG^&(ET9?#5_XBT^<
M6*Z*UO&7M6E%M<>:2X90"5++M ..=I%>L6-G#IVGVUC;@B"VB6&,$Y(50 .?
MH*L4 >2Z)H!N=9\.&\TEQIGVW5;BUMKB#Y8(7*F(,A'RYY(4],^U0ZY<&R\,
M>-M -C?-J%W?RS6T,5I(PDB?80X8#;M ![]1CKBO8** /*_$.ABYM?B?<MII
MEN9DC%NYAW,^VUCQL..<-GIW%=#8Z5%I_P 1;%K.Q6WMAH+Q,T46U=PECVJ2
M!C.-V/QKLZ* .$UA[/3/B%+J6NVDDNGS:8D%I/\ 96G2-P[F1"%!VLP*'ISM
MQVK'\-:-<0:EX/>YTV2*)&U-XHY8OFMH6<-"C?W2%(P#TZ=J]3HH X[QLD46
ML>%+^XMGDMK;4F\YT@:7RPT$JJ2%!.-Q7GIG%<O_ &$L?@"\G32R-1;Q&;@.
M(/WO&H##@XSC9W]/:O6:* /$]4TVY67Q1IVH372WE_J$DD$,.CF>6X1B/):*
M;( VC Y(V%3TKO\ X@VDUU\-]3M!')<3/#&A55RS_.N>!^/2NMHH \S\7:!<
MG6K^W\/V(@>;PQ<P(;>/RU9Q+'M3(X!P6 ^IJ*<Z?JVJ:&?#>ESVPL+2Y6\/
MV)X/)B,#*L+949;?M.T9^Z37J-% 'DN@1VVCG3)_$FFSS6UQX:L;:U)LWF".
MJMYL)4*2K-N0X(YQCM67IUA?6%EX1O+KSM/L(--GA5IM.-T+:8RYPR=5+(,!
MO8CO7MU% 'DNB^'TGO?"JW%G<7-A]OU"X5+NR$2(K)E2(LG8A;+*&P>1P*AU
M&$Z=K]Y%IMM)<2OJT<W]CWVEEO,;>G[Z&X3[B@#<-Q(7!!QTKV"B@#D_B!;2
M7&CZ?(;62ZLK;4H)[Z".,R%X%)S\@Y8 [6(P<A:XOQ+;1ZU;^+K_ $/3ICIT
MNCQPDBU:,7%RKL044@%BJ'&X#OCM7L%% &#XNT-];\$ZMHUD$CDN+5XX0/E7
M=C@>PSBL8^/_ #-+BM[#1]0D\0N%C_LV6TEC$<G .^0KM"#D[LX(Z5V]% 'E
MM^ME92>,K/7=)GN]1U*5FLREF\WVF(PJL:(P4@%6##!(P>>^:9:^'IW3Q-_:
M]A]IOT\.6=OYLD>\O((9?,"GN=P&<>U>JT4 >8#1OL?_  B1M-.,3#0+N.X,
M<.#N,4) <@=2VX\\YS3-)\-6J?\ "M0VCQCRK*1KC=;_ '7-NI^?CKOYY[^]
M>I44 >1VME_9FIV5YJ&GS'0[/7-4+1K;,Z0L[?N9-@!^7[X! P-P-(VDC4]0
M2X@TN4:%=^*;>>W@DMRJE5MF$DNPCY49QW SU[UZ[10!R?ARQ^Q>-/%GE6WD
M6TKVKIM3:C-Y6&([$\#-8?B;^PV\3W3>(-/U/3+A$06.KZ9YX:>/&2I:('YE
M;(VL#Q@CK7I%% 'E4+:AY7A#4==@O)X;?5KE$GN;4F?[.T<JPM,JKE225R2!
MV)P:I"V3_A#E\/#3+C_A+QJ0D,GV1]WF_:-_VCSL8V[.=V>GR^U>Q44 >7P_
MV?9'6]-UC0KB_P!8NM9>XAC6W?=<(9 8764#"JB[>=PV["/K3T73K_2?%<FO
M7\$UWIK:W?6Z0&$YL3),=EPH_B#<J6QP&&.,Y]<HH Y#X@V\,VG:;+,]Y!]G
MOEE2[M[87"V[;' :2,@[DY(X'!(/'6N1LK*;5ET2.[TJWEM$\2M+]HAL7@CN
ME%LY\XQ-G;\^!GH2..M>NT4 >4:U;R:;>^)5ATF,V4NM6+AY+5Y((!Y"%I_+
M3&\!E&1G&3D]*RI;:\N(_&#QI<72W*Z6\4RZ<ULL^V<[BB8R0!CDY/&>F*]L
MHH Y?P?!+#?>*C+$Z"36G="RD;E\F$9'J,@\^U<?JFA"3P9X_G_LPO?2ZE-)
M"_D9D8*(RA4XS@')&.^:]8HH \OU 6%C=>,K77=*GN[W4I"UD5LWF^TPF%5C
MC1@I *L&XR,$Y[YJYX6M)]+\:V\.K0R?;Y_#UE$9_*+*\T?F>;F0#&>1U/.1
M7HE% 'GGBVY>/QK&KQ16:?V> E^^F27KS$N=T,8!VJ1@$Y!)R.PK(\(:3(T?
M@07FFR P1:E',L]O@Q_/\H88P/8=/2O6J* /%+?2[RQT7P5>2J]E96T=T)Y&
MT\W AF9AL=X^HRH8!L<9]ZN66G_9(=,U.YAO;O0DUR>ZF5]/,:KNA*I,L R1
M'YF6Y (+%L8YKU^B@#RZ^;2WU#1M7L]#N+;3$UYGEF^RN?.W6SIYHCQE5+[5
MS@ D9[YKHOB'$ATK2KJ6V>:"TU:UFGV0F4I&'^8[0"2,=<"NOHH \FU+0X[C
MP;\1+E=++WEQ>S/;N8#YCA8HRA3C/!SC'?-5]>LYX/$/BD:I-*BZ@$^S*-'-
MX;J+RE41QN/NL&W?+QR=W?->PT4 <O?Z=JC_  OGTVTDG;5#I)@C:4A96D\K
M')!(#$]P>O>N+\.Q0?VWH4Z7%T5TVUE,\4>B&V%O'Y>#'*Q.3SC"@,25STYK
MURB@#QW0=)U*SFOV&G7-K_:VG7*^'MY)_LX$NWDMQB,ME7'IC;GY13O"MEYF
MH^%8(YKH7.G9,L$>B_9S:@1E7664D9!)QQDL<'WKV"B@#R'3]!CL/ASX2N)-
M(;R8+V.XU6)+8M(\8\S#.H&YPKLC8P< 9QQ6G<FRU'6=+O-%T:XAMCK\,DMT
M(6C6X(MI07"$# 'RKNP 3ZUZ710!X_X<BDLM;T:STZ&2Z2*XE4VM_I9BNM,!
M5]SF=<(XR<<YW;A@FJ/A_3+I;;0-+NI[M=7M-026>WBT?$D<BN3)(UP2 489
MRV3N#8 )XKVZB@#B_B/%%)9Z"]S8RWMK#K,,L\44)E(0))EBH!) X)XK#DTA
MO$+>++_1+=[>V=;6?3G:$Q"6]@W/YBJ0#@_NT+8YP?2O4*HZOI<6LZ;)8S3W
M4$<F-S6TQB?'<;AS@]#0!SO@"5]8L[[Q7-$T4FLS!X4;JEO&-D8_'#/_ ,#K
ME/%-BLMUX[L/L$S37KV,T06V8B6(&%7PP&#\V<C.>I[5ZM:VL%E:0VEM&L4$
M$:QQQKT50, #Z 5+0!YAXRT"[?5M8M] L3"]QX:>)?L\>P.PF&$!&!NVE@![
MT>%H([KQ?I5S:7-Q*MI9RQR"+1OL4<2$*!%(Q(R<@$* <;3TKT^B@#D-9TR.
M_P#B5X>FN+,3P6]A>,'>/<J.6A YZ XW8_&N2L[(:7?:==:AI\W]AV.LZJ#&
M+=G2 O)^YDV 'Y<;P"!@;Q7KE% 'D]O933:S!?V%A<0:1<>*(KBUC,#1X46K
MK)+L(!56?/) SU[U1B@M8_#_ (>T>?2;EO$5GKMO+=/]C<E6^T@O,9-N"K ]
M<\Y'IQ[-10!XA?:9=A-?TN_N+M=1N]4EEBA@T?S9I@TF8I(YR0H"KMY)&S:1
MQBNE/A^VN4^(,]]I5S<2SSF-7MXA]HDC^RQ@^43WY?@<'D<]*]*HH \Y\#RS
MOXIF5/)U&U%@ =3&EM92QD.-L+CA7."QX QCGK5G5'LM*^(%_?\ B"SDFLKG
M3H8;*;[(TZ(5:3S8\*IPS;D/3YL>U=[10!Y=X6T6ZMM3\&&\TZ2+RK342%EC
MRT$;2QM"C'L0A  /3!':MSQKI<^J^)_",4,U[;(MS<F2YM.'B'V=\?,00,GC
MD=Z[6B@#SOQ7X.AL/!?B6[AGU+5-4N=.:W$UU*99=G4(@   SS@#DU5\4:0-
M(\3Z)=6ZQZ=H\-E+$LD>F_:8X9R4Y9%^Z61<!_;'>O3J* /*-'T8K_PBK_9K
MF:W.N74ZFXLA"$B:&;!$>3LC+<@''WAP.*QK;2[P6?\ 9%[<W:ZQ_:QF:&#1
M]TQ?S]XG%P2!MVX.[/ ROM7N%% 'DVI:"'\&>/YQIA:_N-1N!'((<RNGR8VG
M&<=>G'6K?BG21I'B_2KJ 1Z=H\5A)#')'IGVF*&8LN<HOW2R  -C^$CO7IU%
M 'D6E6*Z2_A[4M1M[V;0XI[]E\ZP*"W>5E,;^2NXHA D"Y V[QP,UU7PYBBC
ML==>VL9;.UFUB>6"*6$Q$H53#!2 0#R0,5V=% 'ENLG0CKNI2ZO9ZUH6LB8K
M#>:2+@_;(Q_JW!C4H[8P"K D$8Z4BIK+W_A.[UF"1-5GTF\M?M!MR2EPS1&+
M?M!"-@$\X .ZO4Z* /)=-BM9]+\&Z3INDW-OKFG7=N]Z6M'C:W" BX+R$ $/
M\PZG=N!YJUX:_L^UT_2M&O\ 0KFX\10:BTDY^SNI23S&+7)EQ@KM.<Y.00OM
M7J%% 'D?P_TZ_P!!O='O=5@FNH-0ADM;=WA(;37$CMLQV60=6ZY4 \$5ZY11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5DZ]KT6AP6W^C37=U=SBWM;6#&^60@G&20  %)
M))P *UJP?$NBW>IMIE[ILT,6HZ9<_:(!.#Y<@*,C(V.0"KGD9P0.#0!S'BKQ
MKJ'_  B^JPV6GWEAK-K-;0SQ^9$6A29PJR(V2K!AE01R#U Q73W>JQ^%O!W]
MHZ@+N06T2>8LLB/,68@!6;(4G<P&<X[YQ6%>>#=6U>WUBZU"XLH]2U%[-5CA
M+&*&*WE$@7<0"S'+\X'45U6NV5UJ&BW-K92P1W$B@*;B$2QMR"5=3U5AD'ZT
M 8[^,GM-*N[W4=$O;46[0 ?,DB3"5PBE)%.TX)Y'4?B*MZMXMT_1;^[MKU95
M6UT\ZA)*HR-F_;M ZEB?YUR<?PYOFT_6HHO[-TC[;'!Y-E8M(]LLL4GF>8P8
M+@L0%(4# '<U<OO!FM>(KO4[C6[JQMOMFE_88TLM[^2PD\Q7RP&[GM@=,>]
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M8Q971E4G@LW!'(/48H :/&&J3>,4CL-(U*ZAGT:*Z%@X2!H7\V16+[R,'@#
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M['I^GI$D$:S1^2VY,[F4?,Q;.X>@'-1W?A#7O[.UC0+*[L%T;59YI'GDW^?
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M$150P4$#J23@<CD';\9:K/8C3K6VU&>TENIF&RSM/M%S*JJ21&I5E&."688
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MHM3(A1@-V1LP=Q.<GI0!Z=17E5OXLUG^T-$O8M4U"]M;_44MI"VGQPV+1N6
M\IF42DCC#98'![5JVGB76)KFR\.M<C^VH]6D@NYO+4$VL8\WS-N,#?&\2YQU
M<XZ4 >@4UW2-=SLJC(&2<<G@5Y1IGB_Q/J-K::Y#'JDB7%V ;(V<(M! 9=A
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MGAT_23;07$A8[%7YR6EYQD#@$9(Q5-=/U'3_  =KNF:W!/-XC=K*9[DDR^?
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M8Y/-C9VWHBKM()?&,C&.] $&N>+;[1O&8L1IEU<Z='I$]]+Y C+,49.1N<'
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MX/MG5LO$=EJ&H7EI;K*QMK6"[,A "NDH<KMYSGY#G('45FR^&;QW\8D2P?\
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M''!(WEXP8D;!PQ)+;BPX^Z0#@Y%3ZQXIDTRYN8;?0M3OUM(A-<RP"-412"<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "LW6]#L]?L5M+PS*J2I-')!*8WC=3E65AR"*TJ;)(D4;22.J(H
MRS,< #ZT 8TGA72Y=)U33)(Y6MM4D>6Z!D.69@ 2#VX45!J?@K2=5O;FYD>]
M@:[01WB6MT\27*@8 D"GGCC/!QQG%2+XHBFO[^TM+22Y:SFMHV9'3:PF .X$
MGHH.3W..,ULBX@:7RA-&9,$[ PS@<'B@"O=Z39WFB3:/)"%L9K<VK11_+B,K
MMP,=..*J:GX9T_5(K)9#<0S6/_'K<V\S1RQ9&" P[$  @Y!K3@N8+E2T$T<J
M@[28V# 'TXJGJ&N:?INE7^I37"/;V,;23^4P8J%&2,9Z\=* ,[_A"=&&EI9(
MEPC)<F[6Z6X?[0)SP9/,SDL02#GC'&,<5E:9X!@0:_9WWGO:7>H17EK,+IS.
MKK%&/,WYW!MZL?\ ZW%=:FHVC6D%TUQ%'%, 4+N!G/;KUJ:6X@@_UTT<?^^P
M'?'?WH YZ+P+HL<%]&XNYFOV@>YEGN7=Y6A;<A+$]C^& !TK0'AS2_L6J6<E
ML);;4Y7FNHY&)#LZA6^G"CI6@MS;O<-;K/&9E&6C#C<![CK3Y)(X8VDE=411
MDLQP!^- &!8>#-*LKAYY&N[Z0V[6JF_N6GV1-]Y%#'@' SW..33-.\#Z1INH
MV5]$]]++8!DM%N+MY%@1E*E5#'I@_7@<\"M];JW:V^TK/$8,9\T.-N/KTIT4
ML<\:R12))&W(9#D'\: *MSI5K=:I8ZC*K&YLA((2&P!O #9'?@"LR[\&Z1=V
M\T;+<1/)?'4!-#.R21SD;=RL.G'&.G)K;-S;BX%N9XQ.1D1EQN(]<=:SM*\0
MV>J27<2D0R6]Y+9[)' ,C)C)4=QS0!2MO!&BVJ.JI<.SWL5_(\MPSN\T>-K$
MDY/W1D5=G\.:=<'6#)&Y_M>$0W>'/S*$*#'I\I/2M"6ZMX)$CFN(HWD.$5W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;^&+6UDTH>'+H7IM8 +=IA@P# &TR+ASZCCVKU^B@# T[3;4> X+".RA$+V
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MY8@C  Y(;I7#WNG:OXN\5:]<V1T\:?;V[:*HOHG;?D!IF7:PQR57/^Q7I5%
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M<Y/(.2,'@XK&M?!6IV,5KJEG9:7:ZG:ZBUXEE'*YC>)HC$4:4@DOM).[;@'
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MXNM-%AIK:3I,D%G<JYU.2XD9Y(E?<H\G  DZ#.[ QGGI6[INC^*-%B;1M/\
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MM<F)5Q)D_-DX/&.!S6GX3\*:CHM[I$UVUN5L]!CTV3RW)S(K@Y&0/EP/_K4
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MO+4L<X!;EB!@%CC)YP*YB/PEX@_X1R#P>Z6 TB*X0_V@)V\UH%E$@7RMN _
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MUXQCF@#T>BO/M/\ $GB/7I])T@*-'OI;:XN;N::S;<5CE6-?+C?&W?N#?-G
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MO<6TFR2)\$9!]P2""""#6G69KNN6^@6"W4\4\[2RI!!! H:2:1CA54$@9^I
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MD]LUFS7\_F;86^\@X  /&3U.!S3=.\%6&G:I9ZC]LU*ZGLXWAMOM5R9!%&P
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MDS<#)CGS*2V#_&"O7J.?6M?QM!I2>,/!M[JD%IY2WDT1FN(U(#&%C&,D<?.
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M\27L-E/I<5K<>';M)6\,VYV@AH\88'$DJ@DC !&?<5[<%51@  >@%"JJ@!5
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M8XA^T:5>0SW.'XVJ'!VGN?F%8EE\/+VSCATEM(L[B&.[W_VC-J$Q1H?,WC,
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M6AX=\.WVF:M=7-P(O+DTFRLUVMD^9$)-_P"'SC!H D'C#3#>K>G5"NF-H_\
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M6^S$;H!G:VP_,,XSTINL^%=;\9RW<^I06^E8TR6RM8UG\\F1W1R[D #:#&H
MZG)Z4 3>(/'IB\-:K+96E_IVHPV)N[7[=;!1(@(!9>2.-PRIP1D<5U6GZY::
MIJ%Y:6?F2BS81S3JO[KS.Z!N[#OCIT//%<KK^G^+_%/A[4M-N+*QL(Y;%H1$
MMSYIFF)7#!MHV( &]SGMBKND:'J?A)M3LM%MH;C2&C^T6%O+.4,,Q^_%D@G8
MQ^8'G!+4 =?12(6**7 #8Y .<&EH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** &&*-I5D9%,B A6(Y4'K@_@*?110 4444 ,EBCG
MB:*:-9(W&&1QD$>A!IEM:6UE"(;6WB@B'(2) JC\!4U% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIFF7>H3AC#:PO,X098JJECCWP*=9W4=[8V]W$&$<\:R*&ZX89&?SH GHHHH
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M*** "BF32>3!)*(WDV*6V(,LV!T ]:;:S_:;2&<Q20F5%?RI1ATR,X8=B.]
M$M%9ESKEK!=WUG''/<7EG:K=O;P1Y=D8L%"YP"Q*, ,UHHV^-7VE=P!VMU'L
M: '4444 %%9^IZQ;Z3)IZ7"R,;ZZ6TBV '#E68$\],(:T* "BL?3O$,6J:UJ
M&G6UE=^78.8I;Q@HA,H"DHOS;B0''.W'7FMB@ HJAK6K6^A:)>ZK=+(UO:0M
M-((P"Q4#)P"1S^-.M=6M+S4;NPA=C<6B1O,I4@*) 2O/?A30!=HHHH ****
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MNOW!C/OC%:.K:3%JVCS:6SM#;SJ(Y!$,$QY&Y!Z C*_0U>1%C1410J*,*H&
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M\_\ ST/0G:3D*3C->TRP0S[?.BCDVG*[U!P?49HE@AF*&6*.0H<KO4':?44
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M_GL8YB6QL"G&[&"P'^SGDUZXD4<<0B2-5C P$48 'TI$MX8HUCCAC1%.555
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M[6>GO7"^&$TR+7=(DM-0T!;:2SF:_CL#([3P^7RUR22 0V#N?G.1W->R
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MDG:?9163JO@S4(]8UZ2#29-2CU27SX)%UB:UCB9D5&6:-'7<H*YRH)(..PH
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M3J"002#C'09ZUT?BG2[^YN]&U;3(8[BYTJZ:7[-))L$R/&T; ,> P#9&>.*
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M=)Y3&59"Y.1M."&[BK_BKQ9?Z'>ZK#;16[K::#-J4?F*Q)E1L '!'R^W7WH
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M7EVCP6*6+PY0I-&F[86^7.06)R"*AL_&VF:A!#):0WDS3Z<^HQ1I#EWC1@I
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M.L7T]F$\]K.V$BKO7<O.X=JU=$UNR\0::M]8.YCWM&Z2(4>-U.&1E/(8$=*
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MXL'\97VV$>';*XLFN+DQ*SLK&>4'(S(#LYZ@$>M>L+;PINV0QKN 5L*!D#@
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MXW<1DQ([ CY2V>#P2 *XO4;+3KQ+^SM,76@VWB#38[/$A>-&=XQ.D;9^[R.
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MR-B">52=PH_ 5UZ65K%=/<QVT*7$@P\JQ@.WU/4U*D:1 B-%0$EB%&,D\DT
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M'Y9:+<#;Q*N2QSRV02P '2M_P+<RWOB'3;J>5I9IO"5@\DC')9B\A))]<UZ
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M6L"3R??E6,!F^IZF@6-H+LW8M8!<D8,WEC>1Z;NM 'D=C#8V%S<0V3)%<_\
M":1I-&DGS"/)V!AGH<MCUYH338(O"!\1JT_]K1>(BD=P9G)1#J'EE ,XV%2<
MKT.37KGV.U\YIOLT/FL0S/L&XD="3[=J=]F@\KRO)C\O=NV[1C.<YQZYY^M
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M'*<-*!;[E?!]<$J>X'%)<R745OI^D>;!_8D6O:A:LE_<R1P80GR8G<9.WEL
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M8Z*F0O.<Y]!3]8\-Z]K4.K3_ -EFWDO-*L;=8))XR1)%<.SJ2#C[I!STY]:
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MJ+B.>T95GM[F!X9(]PRI*L <$=#7'R>&M;U/57UJ>P6V>YUFQN/LC3(S100
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MR:26VDVF%VB#GD?>^=L =MIP<\]#X'LKBW\-I>7T>S4-3D:_NE_NO)R$_P"
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M*4B#*BA4+L[L<*JJH)9B2  !7+Z))JGABVNK6[TEF6XUV3R95N$Q)%<3LV\
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MEFUS92.521HI$DC:-XG'565@"I'H?45YW<>"M726SU!K2ZF-KJ6I2/:V=_\
M9IGAN)=R.CJRC("KE2PR">XKK/!6C3:5:7\UQ8R6<MY=&;RYKQ[J4J%509'9
MF&["]%. ,=: .GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY )!&<  ])HKSN_\>ZIH4&J6FIQV$FHVU];V<$\22) WG)O#.N68;0&R 3G
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M6WI&;)74V\JH9-C;F.\%5;YAMY'3FNNH **** "BBB@ HHHH **** "BBB@
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M?8&NAET?2[B:":;3;.26W $+O I:,#H%)''X5%XAT=?$'AW4-(>8PK>P/ 9
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M]E.D::;22T.G6AMI  \/DKL8  #*XP< #\J(](TV*+RH]/M$CVA-BPJ!M!W
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M,,F=QPQ)8=?F YSBO5BH92I ((P0>]5+72=-L898K/3[6WBE_P!8D,*H'^H
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M[A60*C$$9PI=@N>>O.*Y 6=MJLND0R2SWFG6_BN2TL)FN';=;_9W8J'SE@)
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M@@2X$L:JKFSB7][N8';CG*AN_'3(!VFI^+M&TFX6">>:25HA.5M;:2X*1?\
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M.U'3G;4S-<E;R.33I8#(2[B-F+J[*>BJN&/7'- '>ZMK-AH=F+K4)C'&SB-
MJ,[R.>BJJ@LS'T -9O\ PF_A]=,FU"6]:"&"=;>=9X)(Y(I&QM5T90RYR.HQ
M47BS3[Z:[T/5K"U-Z^EWC3/:!U5I4:-XR5+$#<-V0"1G!YKF[WP_K6M:E>:R
MVEO:BZU'2REI+)&9!#;REGD?:Q7.&/ ).%_"@#M-&\2:;KTES%923">U*^=#
M<6\D$B!LE25=0<'!P<=JYWQ!X\DTR_\ $>GVUJQN-+T@WT4DEO*8WDVR'#'
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MR_$'PS#)?+)?N%L&9+J7[-+Y<3+((RI?;C.XCC/0YZ<U;L_%^B7JW9%T]O\
M9(?M$RWD$EN5BY_>8D4$IP>1Q7&:]IM[I'PR\2+/:J)IM:>YBC9AB17O%9"2
M,XR,>XJ;Q!X?UOQK/?7)TQ]*\O2WLX8[N6,M/*TL<A!\MF C'E 9)R=QXXH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU-4]0U2TTPV@NG*?:[A;:+"DYD;.!QTZ'F@# F\'W>H66I0:MXBO;PWEB]B
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M;G.W/7&1G%5]1TC3-8B2+4].M+V-&W*ES"L@4^H# X- 'G7A+4Y+GQ)X=O\
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M#:2VD6FV<=M*H62%8%". , %<8(QQ26NAZ38VT=M::790012>='%%;JJH_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%9NN:Q'HFF-=-&TTS,(K>W0_-
M/*W"H/J>_89)X% &E16'X.UFY\0>$=-U:\CBCN+F+?(D(.P')'&23VK<H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** ,B30G?7EU3^V-4500?L2S
M+]G.%Q]W;GWZ]:IZ[X:O-6UJRU.UUN:QDLXW2-%MXY5#-U?# X;'&?3/J:Z.
MB@#E?AWH^IZ%X*L;#5I6:Y0']VRH/)&?N97@]SGWK3TS0GTW4)[MM8U2\$P(
M$%U,K1QY.?E 4$8Z=>E:]% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex31articlesofincorporat005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIJR([NBNI
M=,;E!Y7/(SZ4Z@ HHHH **:DB2;MCJVUBK;3G!'4'WIU !131(C2-&KJ73!9
M0>1GID4>8GFF+>OF!=Q3/./7'I0 ZBBB@ HHHH ***:)$:1HU=2Z %E!Y&>F
M10 ZBBB@ HHIJ2)(6".K%&VMM.=I]#[T .HHIHD0R-&'4R* 64'D ]"1^!H
M=13?,3S?*WKYFW=LSSCUQZ4Z@ HHHH **** "BBFO(D>W>ZKN;:NXXR?0>]
M#J*** "BFR2)$A>1U1!U9C@"G4 %%%-$D9E,8=3( &*YY /0X].#0 ZBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HIK2(CHC.H9\A5)Y;')QZTZ@ HHH
MH ***;'(DJ[HW5UR1E3D9!P?UH =1110 4444 %%%% !1110 4444 %%%% !
M113?-C,IB#KY@4,4SR >AQZ<'\J '44U9$<L$=6*G:V#G!]#^8ID-S!<AC!-
M'*%.UMC!L'T.* ):*@AO;6XA>:"YAEB0D,Z2!E4CKDCIBG^?#MB;S8\2G$9W
M#YSC/'KP": )**** "BH;>[MKM7:VN(IE1BC&-PP5AU!QT/M4AEC5U1G4.^=
MJD\MCKB@!U%%% !1110 444WS$$HBWKYA&X)GDCUQZ<T .HHHH **** "BFI
M(DA8(ZL4.U@#G:?0^_-.H **** "BHY[B&UA::XFCAB7EGD8*H^I-.1TDC62
M-E9& *LIR"#W!H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_P"+]7FTC2X)
M(+ZULGFN$B,L\3S-@@DB.-!F1^.!]3VQ705E:YH%MKJ6IFFN;:>TF\^WN+9P
MLD3[2I(R"""&((((YH X-/&^O#3]4@AECFNK74K&VM[B[L'MBZ7#*/GB)!&,
MGGC(P<5?O=>\3Z/)K]D]S;:C<Z=90:E%(MMY9>,NXEB*ACSMC;:1Z]ZVHO >
ME1O<R//?3RW5S;74\LT^YGE@;<AZ<= "!@8   J_?:>+.\OM=L[&6^U&6UCM
MC;"54$B*S$ %L 'YVZF@"MH^OR:YXCOELGC?2+6VA D YDFD'F<'T$9C_%_:
MN?\ %7BC6]'UZ[1[E=,T^)(VM+B?3I)[:<D982RH28L'CH..>>E;_@7PW_PB
MOA.UTYT1;@EI9PC%@'8YV@GJ%&%!]%%)JO@NQU6\O)VO=1MDOT"7MO;3[8[D
M!=OS @D?+P2I!(H Y26;7$\2>.=1T?4;.WBMH[>XP]OYWGL+8,%SN&%P.HYY
M]N;>I^+M0N&M?L>IQ6;2Z=#=K;6NG2WTY=P3\X48C3I@GD\\C%=9'X9TZ$:J
ML:R(NIQK%.H;A56/RP%]/E%9_P#P@FG)-OMKW4K5'MHK6XC@N-JW$<:[5WG&
M0<'&5*F@#"TGQ/XB\37N@PV=S9V"7>C1ZE<LUN93NWA2B@L, YZG.,=ZH6/C
M[7;](=6MK>\G@EN]@TV+1;AE\CS-FX7 &TN%^8_P\$>]=OHWA/3="FM);,SE
MK2Q%A%YCY_=!MPSQUSWJHO@/2TN!MNM0%@+G[4--$_\ HPEW;\[<9QN^;;G;
MGM0!QT&H:]H>F>*M;LKVT6RL]=N&:S>W+&<&10^7W?+P>,#MSG/'07.L^(]1
MD\0WFE7EE:VNC3/!';S6YD-RZ1J[EVW#:#NP,?7GI6Y-X2TV?1]4TM_.^SZE
M</<SX?YM[,&.#C@9 JOJ7@G3M1O+V;[7J%K'?@?;K>UN-D=S@;?F&,@E0 2I
M4D#F@#CH?%-P-5U?5=.BC2ZU>+1HK<3@LD33AP"P&,A0Q..,XIVIZKJWA'Q-
MK^J7\\.IW%OH4'V=D@,6\M<.JAU!/1F[=1[UVEQX,T:Y6_5X9%2\CMXV6-]G
ME>1GRC'CE2I.<^PJ"+P)I6_4)+Z>]U*34+46ER]Y-N+1@D@#: %QGMCUZ\T
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M-EFCV J");C 5'Y/ /' YJ]JVN^)S<>+Y["^LK>UT##Q126ID:?%NLI5FW#
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MHG.48",1X [#:!67;^ M)CPEY-?:C"EL]K##>S^8D,3C:RKP#R !DDG'>@#
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M:*2]G#F&-L;@F !DX&6.2<=: *7PZTY[/X:Z1'#)!'+<6,4JR1VX0*S1K@L
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M!LY1=H 4'.<@9)QDG% '/W>MZI81Z9IBZ[#',-/24BUTN6[N)&)(&8TR$0
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MUL6VB7]U:&?3_$5O:S2"TW1W*O&)(W*%L @-RN2"?2O6(HQ%"D:A0J*% 5<
M >@[5@V_@S2[>V@BW7,CQWZZB\\DNZ2:<<!G..>,# P, 8Q70T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#<GFD\7W.BWX\3M!!H<<EO ([5KQVFNG @5HS:1KC8G(VLI(R"QH ]R+!>I
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MD2"X4LBR@!A@D<X)':O'O#T^GKXG\%W.G#0X'N)769=/=IKC:T#G;<S<;F+
M<,,E@2.AKT;X:?\ ).M&_P"N3?\ H;4 =71110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %(RJZE64,IX((R#2UE:]X@LO#MM;37HG87-PMM$L$1D9I&!*J .>=I'U
MQ0!IA%5555 "] !TH9$=65E4ANH(ZUR#?$G1XXKF26RU:,6<@2^#V9_T/.,&
M0YQ@@@_+GCFKVI^---TR]NK8V]]<BR4/>RVMN9$M@1N&\C_9^; R0.<4 ="$
M0  *H & ,=J'C25=LB*Z]<,,BL"^\9:=:7(M[>"]U&00+<R?8(#*(HFSM9C[
MX) &20.E9DWC@3>(X;&R1Y--N-'DOX[Z.'>!R-K=1\H!.1C.2!0!V3QI*NV1
M%=>N&&13JY"'QU90V]C;>5J.J7TFFP7S?9+(Y>-P?WFW.%Y4_+GN ,U;D\;Z
M4;?3I+*.\U%]0@^TP0V<!=_*&,NP.-H!('/.>!F@#HA&BNSA%#MU8#DTX #H
M,5FZ#KMEXCTM=1T\R&W:1XP9(RC91BIX/(Y!ZUG:?XTT[4KVW@@MK\07,CQ6
MUX]N1!,RYR%;M]UL$@ XXH Z, #H,9HP,YQSZUP7A/X@QZAI>E#5(;P3WDS6
MPO/LI6W:;>P5 WKQC.,9XSFM:;QUID-T5:VU VBW0LVOQ;'[.LN_9C=UQO.W
M=C&>] '2^6GF>9L7?C&['./K2X'/ YZUP:>*M4;5(X#+'Y;>)WTTCRQ_J!;F
M0#Z[AUK5\7>(Y_#U]X?V+))!>7K0310P^9)(/)D954>NX+S^?% '3+%&B;$1
M53^Z!@4[ SG'/K7.+XWTC^S+B\E%U#);W"VLEG) ?M F;&U @SDL"",9!'.>
M#5W1_$%KK,MS;I#<VMW:[?.M;J/9(@;.UL<@@X."">A]* -3RT\SS-B[\8W8
MYQ]:#&A?>44MC&2.<>E8&K>,M/TF]N+1K>^NGM(A-=FTMS(MLAR07/T!.!DX
M&<5#?^.M+LC.8[;4+V"VB6:YN+2W+QPHR[P6.1GY<-@9(% '3TQ(HXV9DC52
MQRQ48S]:X'7/&&H6UQKC6$\1M[:#3);9O+!XN)V1S[Y4#'I6YJ'C?2]/N[N)
MX;Z:"Q8+>W<%N7AMC@'#M[ @G . ><4 =&8T(8%%.[[W'7ZTH150(% 4#&T#
MC%<IXC\;VFEP:G#:17=S<6=J999K>W,D5L60LA<^_!XS@<G K6TO50WA&RU?
M49DC4V*7-Q*1A5_=AF/L.M &HL:(@5455'0 8 I< $G R>M<0OCEK[Q3H5E;
M6M]:VEY%<3/]KM3'YT:QAE9"??MP>1D<UO0^*=-GT[1;Y#+Y.LND=IE.261G
M&X=N%- &P8T,@D**7 P&QR*#&C.'**6 P"1R!7&_\)Y9:G' ^GM?VT!OH;?[
M5)8EHI6,HC:)22.2>"PZ>^,59;XA:.MQ*A@U#[/#>&QGN_LI\F&8/Y>UF]VQ
MR,CD9Q0!U6U=P;:,CH<=*1(TC!$:*H)R0HQS7,:KX]TG2)+_ ,V#4)K?3N+N
MZM[8O%"^ =A;UP1G&0,C)%7/%.O2:'X,U+6[2 SR6]HT\2%<C.W(+#(^4=3[
M9H VO)B^3]VGR?=^4?+]*<% Z #\*X1?'=Q#XF>UFT[49X6TF"\2UM[3=*C,
M\H=FYX&%7 SWXS6S)XVTHV^GR64=WJ,FH0?:8(+.$O(8N,NP. HR0.2.>* .
MA:-'0HR*RGJI&0:7:OH/7I5/2=5M-;TV*_L9"\$F1\RE65@2&5@>00000>XK
M"L_B!I%Z\#)!?I:3W'V5+R2V*P^=N*A-WJ6&,XQGC.>* .IVC&,# KE[CP6+
MNX9+G7-2FTQKH71T^1D9"P?>%WE=^P, 0N[MCIQ3YO'.DP7<T;1WK6D%Q]EF
MOU@)MXI<[=I?V8@$XP#U(JIK'CJRBCUNTMOM\,VG1R_:+U+(RPVS+'O!.2 Q
MQT&>?;(H [# !)QR>M+@9)QR:YN_\::?IUS-;?9[^]DM8EENWM+8R+;JPR"^
M.Y'.!DXYQ2W?C72H)HH[9+O4"]LMXS6,!E$4#?=D;'8X. ,DX/% '1;1@C P
M>O'6D6-$CV*BA,8V@8%<WX7\037GP[L/$&I9EE:Q^TS^2G+8!)VKZ\=*MQ>+
M-(GUC3]+CN";G4+/[;;_ "_*T74'/8D9/X&@#:"J,84# P,#I1M& ,# ]J\_
MUGX@K;Z3J>KZ5))<+%I*WEO:R6O',DBB4MNR5.WIV SGFK#^.)[;Q9/92Z=J
M,\!TN"[CM8+3=,C,\H<MSQPJ<9^F: .WV+N+;1D]3BE*@YR!SU]ZY5O&6G><
MNHQZ@[Z;_8LFJ>4MORT:E27W$Y! .-F._7BK6E>,M.U;4X;%+>^MWN86GM7N
MK<QI<QKC)0GTW X.#@YH WEBC2/RU10G3:!Q^5'E1[P_EKN V@XY ]*Y#QAX
MH?2]7T_28M2@TW[1%)<37<D7FLJ*54)&G\3L6]#@*>*IP^(]8OK/0=/M-3TZ
M6[U2><#4[:/>GV>($[_+/ D/RJ5)(!)^E '>A0.@ I&C1@ R*0IR 1T-8'A;
M5;Z\DU;3-3DCEO=+N_(:>--@F1D61'VY.#A\$#C(K%\9?$"/2=%UMM+BNY+F
MP4QF\6V+V\4^!A&;UY&>" 2 2* .ZVK_ '1^5(R*R[2.,8XXKG=5\:6&DW%W
M$]GJ-RMB@>\EM;8NEN"N[YCD9^7DA<D"KD7B?2YI-143E186\=U,[+A3$Z%E
M=3W&%;\0: ,^S\&^3>V,M[KFI:C;Z>_F6EO=&,A'VE0S,%#.0&(!8GKW/-=.
MRJZE6 (/8BN6?Q_I:@NEGJ<L4<,4US)%:EA;+(H9?,YSG:02 #@=:T_$VHC2
M_#-]?B[-J(8]WGB'S=G(YV9&[\Z -;:,$8&#UXI&C1V5F12R_=)'(^E<OJ7Q
M TC2[S4+>:&_<:<Z)>S16Q:.W#*K!F;TPW;)X/%.7QYI/EZ@\\%_;?8K,WY%
MQ;%#+ ,Y= >HXZ'!Y'% &SK>DPZ[H5]I-P\D<-Y \#O'C< PP2,Y&:MQ0QPQ
MA$4 8Y..ON:Y9?B%IKW(M8].UA[F2+S[:$63;KF+NZ9[#C[VWJ/459/C?2GL
M--N;2.\O9-11GMK:W@+2E5X<E3@*%/!R1SQ0!T;(K(4905(P01Q0%55"@ *!
M@ #BN<;QOI/]GVMS"EW<374SV\5G% 3<>:F=ZE#C:5P<YP!Z\BL;2/&4^IS3
M/)<R6L?_  D/]GPQ26GSLOD!S$P)!4[MWS<],<YH [S XX''3VI!&BNSA%#M
MU8#DUS7_  G6F?:XH_LVH"TENOL:7YMC]G:7=L"[NN-WR[L8SWJEIOCV-X]<
MFU.TN+>.QU+[%;JL!+3$A0J* 26D+$\#L1[T =DT<;IL=%9?[I&12X&0<=.E
M<7K7C;'AZ_FL([BSU.SGM5EMKR':Z)+,B;L<@@@L 03R#W%;,GBS2XM+U'4'
M:81Z?=&TG39\_FA@H4#ON++CUW"@#::-'4JR*RMU!&0:4 *H50 !P .U9NNZ
M]9>'-.6^O_-$+2I"!%&78LYPH"CD\GM67)X\TFVL=0N;Z*]LFT\1M<07$&V1
M4D;:C@ D,I.>03T/>@#I?+3S/,V+OQC=CG'UIV ,X'6N8/C>SVV\:Z7K#7LZ
M-(MB+0B=8U.#(RDX52>F3D]A4DGC;2?L>GSVBW5])J <V]M;0%I6V'#Y4XV[
M3P=V,'CK0!T)12<E03C&2.U*0#U /&*YL^.=*>ULY+6&^N[B[,@CLX;<F=?+
M.V3>IQMVMP<D<D8S2MXWTG[!:7,"7=S-=RO!%9PP$S^8F?,4H<;2N#G. /Q%
M '1-'&S*S(I*_=)'3Z4ZN"TCQC-J;222W4EM&?$1TZ&-[3YV00AO*8$@J=V[
MYN>F.]:5M\0M'NIK<)!J MI[K[&EX]J1")MQ4(6]2PQG&,\9S0!U*1I$NV-%
M1<YPHP*18HT7:J*J], 8%<O?_$+1]/:Z>2#4)+2UF^SRWL5L6A67(4IN]03C
M.,9XSFK?C;7[CPSX5N]4M;<SS1E%5=FX#<P&2,CCG\\4 ;%S9Q7-I<VY&Q;A
M&1V0 'D8S]:BTG3(-'TJST^WRR6MO';J[ ;F5%"@DCO@5R/_  GKV?B+6[>[
ML-1FMK6WMKA(K>TW/;HR%G,F.G(Z9)X. <&MJ[\9:;#);QVD-[J4L]LMXL=C
M 9"L+?==NF ><#J<' H WA%&I8JB@L<L0.I]Z<54J5*@J>HQP:JZ?J=GJFEP
M:E9SK):3)YB2=!CWSTQW!Z5Q]UX^2\U#P]%I4%XEMJ.H"(7,]J5BN8?+D)*,
M?<*1G!(Y&1F@#K]0TV+4-,FL?-FMED38);5_+DC]"I'0@UF:5X9-EJS:K?:I
M=:G?>0;:.2=(T$<98,P"HJC)(!).3P.E5_\ A.M,^UQ1_9M0%I+=?8TOS;'[
M.TN[8%W=<;OEW8QGO5+3/'L;Q:Y/J=I<6\=EJ1LK=5@):8D*%10"2TA)/ [$
M>] '9/&DB[7167T89%9^JZ+;ZM-ITDSNAL;M;M F/F8(R8;(Z8<_D*CT?Q#:
MZS-<VZ0W-K>6NTS6MW%LD0-G:V.00<'D$]#Z5QWB#Q9J</BK6;6.\NM-T[2=
M-%P\JV"3!F82?.Q)SM&T8 QD@YH ]%5$5 BJH4= !P*=@9SCGUKG;SQII&G2
MWEO=O,ES:B']SY7SS^:<)Y0_CRV1QT(.<4FH^-=.TV[N;=K:_G^QJKWLMM;F
M1+4$;OG([[>2%R0.: -2XTF&?6;+55=H[FV1XB5Z21OC*-[;E5AZ$>YJX8HV
MD60QJ77@,1R/QKG-5\:Z?8M-#;1W=[)':BYEDLX#*D$; E&<CL<$X&3@9QBI
M_#VLW-WX"TS6KN-[BYFT^*YE2!.78H&.T?7M0!H2Z3#/KL&JRNSR6T+101G[
MJ%R-[?[Q 4>P!]34]G906%OY%NA6/>\ARQ)+,Q9B2?4DFN$\)^.+B3PWIUWJ
MYO[_ %35%,\-G;V2JRQ@*25 /^K&X#<QR2:VIOB!HT5E97$<=]<27DLD$5M#
M;,TWFQ_?C9.H8<]?3/3F@#J-HQC QZ4AC0N'**7' ;'(KG?%_B2?P_X1?6+6
MSEDF+1*L;QDE-[*#N&1C ./KBL<>/FLO$&O07MCJ,MK9QV\RI;VA9K:-X@[F
M0CWSQR>#@<4 =Y34C2--B(JKZ*,"L"\\9:=;SQ0VT%[J,LENMT4L8#(4A;[K
MMTQG!P.IP<"M:SU.SU'2HM3M)A-:31>;'(H^\N,]/Z4 64C2-0J(J@< *,8H
M6*- 0J* QR0!C)KF-*\?:3J]QIR0V^H10ZD/]#N9[8I%,P4L4#>N W7@X.":
M?!XYTFXNXHTCO1:3W'V6'4&@(MI)<[=JO[L" <8)X!H Z; SG'/K37C20 2(
MK '(##.#6 GC329+A+13/]N:^:Q^R>7^]$@&XDK_ ' N&W=,$>M1^#?$MQXE
ML]0FN+*6V-O?3VZ!X]H*H[*.Y^8 ?-[T :3:';-XB?6G9VF:T6T,;8*;0Y<'
M&,YR:T71)$*.JLIZAAD5S6H^.M,TV:Z$MMJ$EK9R"*ZO8K8M# W&0S=3C(R0
M#BDU/QYI>F7NHVKVNHW#::%:]>VM2Z0(R!PS'TP>V3P>.* .F9$="C*I0C!4
MCBE"J   !C@<=*YJ^\<Z99WLMI#;:A?316Z73"SMC(!"^</G@8XZ=?0&M#3_
M !)INJ7EM;6<K2M<V*W\3A<*T+$ 'Z\]* --8HTSM15R=QP,9/K3P !@# KF
MSXVTU[.RGM;>^O)+QIA!;V\&Z1A$Q1V/(  (ZDCJ*J+XO&I:MX;&FLZ6U]=7
M5O=13Q;9$:*)R4(/*D,M '7T444 %%%% !1110 4444 %%%% !1110 4444
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M@3:=J>H:A/I,>G":..&)&O9+J8JI))=V8J!D\ >^3SBNOI-R[MNX;L9QGG%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5SGB_5]3TJ'2(]*^S?:+_48[,M<H65%9'); ()(V@XSSTXSFNCK/U/1[?5I+
M![AI%-C=+=Q;"!EU5E .1TPQH X*]\3^+]/L/$EP]WI4@\.R#S"+1P;Q3&DF
M/]9^[(5L9^;)],<R:OX[U,ZSK$&FR)"FEN(HX6TJXNC=R;%<@R1_+&/F"CJ>
MYXP*ZN\\(Z=>VFOVTLEP$UP@W15QE<1K'\G''"CKGFJ^H>"K:\O;RXM]4U/3
MUOU5;V*SE14N,+MR=RDJVT $H5) H YN\\?ZA>:H]K9$Z6(+."=UGTFXNW:6
M5-_EL(\>6%& <\DDX'%01ZOJ^K>)K/4Y0MI%)X9GGFTZXMVRI#J&4Y8=6QR1
M]T8QSD=;=^#+66[-UI^I:CI,KVZ6TQLI%'FQH"$#;U;D D!AAN>M$G@K3C/8
M26]Q>VPL[)[ +%*")86QE7W D\@'.0<T <[HNL^(=5;3-*TB32].@'AZSOMS
M6K2!'?</+50XPORCN2 .^>)M)\6ZYXI&CVNG-9:?<SZ8-0NYI86F4'?Y81%W
M+P65B23P,>N:Z;2/#%CHMU#<6SSL\6GP:<HD8$>5%NVG@#YOF.3T]A7,:GX6
MET7^QXM'L=7FALK62W6[TZ[ACN@"P;8XDVHR'KGJI''7- '0^#=7U#6M">YU
M1+=+R.\N;9Q;@A/W<K)QDD_PUS:>+?$'_".P>,':P_L>6X4?V>(&\U8&E$8?
MS=V"_(;&W';WKH/ FAW/A_PI!97:[+AIIIWC\WS"GF2,X4O_ !$!@">YS4">
M =/21(OMVH'2DN?M2:49%^SK)NWC^'?M#?-MW;<]J ,WP#ITZ^(?%FHWDEG/
M<G5'MS,EILEP(XCC>6)V8Q\O8C.><#F_$YU7;\0"]Y#/''>Z>L,)B9=I+0,@
MW;C@ '!P.3D\=*]1TS1[?29-0>W:0F^NFNY=Y!PY55(''3""LK4/!-AJ-]J=
MS+=WR)J7DM<01NOEEXF0HXRI(.(P#SC&>,\T 8>I^+]:\)S:O%J[6>HFWTP7
M]NUM T/S&3R_+(+-D9*G/7&>*G\.>*M5NO$-MIUVYOH+F%W:>/2+BS6VD7!V
MDR\,I!.#P<CGK70:GX6TS6+ZYN;Y))?M-B;"2(MA#&6W9]0V>^:BTOPLNG:C
M'?7&KZGJ4T,1A@^V2J1$IQG 15R3@?,V3QUH S/&7B'5-%U"TCAD%CIKPN\N
MHMI\EXJR @*C*C#8""3N/TXK%BNM8UKQMI%SINH:5%<7'AYGFNHD:XA_URY\
ML94G)]3P,]379:MX=&I7\-_;ZIJ&FW<<1A,EHZ?.A.<,KJR]>AQD>M1Z/X1T
MS0[JUN++SU:VLVLT5WW JS^8S'C)8MSG/<\4 <P/&NI7'A[1YY;_ $W3;FZD
MN8KA_L\EP[-#(8_W,*G<02,DD_*,#G-06?C3Q%JMGI%K9FRCO[O5+K3Y+B>T
MD5=L2.PD\IF#*V%^Z3UXXKH4\!V5L;.73]2U&QN;7[0JW$+1EF2:3S'1@Z,I
M&[IQD8'-2Z;X'TS2Y[.6&>]D>UO9KY#-*'+22H4?<<9(^8GUR>O:@#E;SQYK
M:W6JI;2Q&32I/LXMTTBYF^W2H@+_ +Q,K$"Q(4?,1U/%/BN==NO%OB>_T::U
ML0-/LKETO;9I&+>7(PC(#+M[Y/)]JZ:_\$VMY=WTL.IZG8PZ@0U[;6DJK'.<
M!23E2RD@ $H5SBM&#P[96UYJ5S$90VH0102KN&U5C5E7;QQPQZYH YG3?$VN
M>*Y[>'1Y++3@NEVM_<27$#3Y><,5C4!EPH"G)SGD5ACQBYU.W\3W5JHGL_#V
MHF:"-CM:2&XC1@I/\)9./8UUX\"VEO'9?V;J>I:=-:V4=@9[:1-TT*#"APR%
M21SA@ 1DU+!X&T2W2")89&MXM/FT\PN^Y9(I6#.6SR6)7.<]S0!S%_/KNG^*
M_#.HZ]<V5S$EM>W!6T@:,Q,(-S(,LVX8'!X/'OP:#X[UB_N]&GF7[1!J;JLM
MI#I-S']C5U)5O/8;' . QP <Y' KHK/P-:6VHV5Y<ZIJFH&QBDAMHKN5&1(W
M7:RD!!NXQRQ)X'-.T[P1:Z=/9;=4U2>RL&W6=C-,IB@."!T4,P4$@!F.* .<
MMO$_C&?PD/$&VSDBN)_)$-K8R326T:RLC3%0^9.%^Z ,9!YP:Z;P;KLFN6%T
M\FI6-^89_+66UB>%MNT'$L3\H^2>,\C!XZ4\>#[&/P[:Z-!=7L"6LQG@N(I0
M)8WW,V<XVG[Q&"",'I2V7A.*S2Y<:IJ3WMW<13W-Z9$667R\!4.U0H3 Q@ <
M$T =!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB,0 E=MQ(8H6QNYVDX_#BK>I>"+34KW59Y-0O8XM42$7,";-A>(J5<$J2#A
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MSP_9'5=P5FDR'4@$;OEYQQS5[Q?XNFT;5].TBUE@MIKJ*2>2ZN+:2X6)$*C
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MV.);9"B2+MEP=I+%3VQD]*T'\%03:=)#<ZIJ,]\UTMZNH/(OFQS*,*4 78H
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M+>-X8Y&N9&B4.I9B-K+DD'D>AJAXSU;6K/0-?T+7'L;@W6AW5U;W-G"T0!0
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M$-C!X.3CVJ/18]"N[G0M/U.ZB&B+H$4]I&UT5ADN"Q\\D[@&=?EX)^7<<8H
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MLS_VGJ36UM&K.WSHBJ2[_+R<@  #()KF;*235_#GA62YU"QO9AITQ-AJMU+
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MXOM,M-;BU62)+B>_G^TP$38CC6!$(*%=H"C(8-DU[G0 4444 %%%% !1110
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MLI=\J0>",<U?A\?Z!<6"WD,MV\4DBQ6X6REW7+$$CREVYD& >5R!CF@#1M-
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MY 0#R,\UG>(?'<^FW_B73[:T?SM+T<WT4LEO(4:3;(<,<!=OR+@YY.X Y!H
M[FBN=T;QGI.KRQVRRS17#VWVE3/;20I*@QN>-G #*"1R#T(/3FGZ9XST75KV
M&UMI;@-<AFM9)K62*.Y"C),;LH#\<\'ISTH WZ*Y"U\>:5!IVF&]O6NKN^B:
M6(65C,WFJK[2P0 D =\^F:Z^@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO'F@WFLV^E7%
MDDTTFG7HN&MX+DV\DJ%&0[),C:PW9&2 <$9YKK:* /-H?#^KC2]>-KHD\5QJ
MXBLE_M2_^U2+%A@TLN79<*';"*23W]JLO@?6+7PQ%H-O \\&C:G'>V<\5R()
M+V([BREE(*RKO;YC@'"G/7'J=% 'EMQX1U+4--UB6+2+V":X-E%$NI:E]HGD
M2.X61]Q,C(J@9P <GGUQ72ZE;:KI7C237;+2I=4M[K3TM'B@EC22)T=V!_>,
MH*G><X.01T-=;10!YS=^'->OI;^YO]&T^Y>YT6WMWM$E,<+2+/([1J<[E(5A
MAN!NP>.U";PGXCU71-9L(QJ=M8/';R6EKJU\DLQFCE$C 2HS%4(4*,L2#SQ7
MJM% '#>&-$NU\3_VI<:3J=FD-HT"R:GJANI69F4LJ 2.H3Y1R<$G'%6]0MM5
MTCQI<:Y9:3+JMM>6,5L\<$L:20O&[L#^\905;S.<'((Z5UU% ' :#X5U;3M0
M\-W%S#&#"^HW%V(Y 5@:X<.J#N0,D9 [5H?$'1-6U72[:XT%5.JVTCK&6<+^
M[EC:)^3Z!@_U05U]% 'G.E>";[3?$VH(D*#1+:WD;3!O&?.FCC1QCMCRVZ_\
M]35VT\.:G#H?@"V:V ETEXC>KO7]V!:R1GOS\S <9ZUW-% 'FNA:!KOAG^Q-
M2_LF2^D@L;BRN;2&:,21[Y_,5U+,%(XP1N!Y'7%;&D:9K<OC"RUK5+"VME_L
MVYA=(&!$3/.CHAY^9MBG<PXSGVKLJ* .?\&:9=Z1H,EK>Q>7*;Z[F"[@WR/.
M[J>/56!KGH/#&JQ^!-*TPVH%W!K27<L?F+Q&+TRELYP?D.<=>W6O0:* /&]:
MFOM/\":OH=O:6]Y:'571-02Z0@E[K>8RGW_-#-MQC'&<]JZJ[\.:G+H/Q MD
MM@9M7>8V8WK^]#6J1CG/'S*1SBNG/AS0SJW]K'1[ ZCG=]J^SKYF?7=C.?>M
M.@#DM&T[4].\:WUQ+8LUE>Z?:1BY61,1R1"0%67.[G>,$ BEE#6/Q0^TNC,E
M_HXAAQCYI(9&<H,\9*RY'^Z?2NLJ*:V@N'A>:%)&A?S(BRY*-@C(]#@D?B:
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M [B V/N^]>BT4 >;:AX>US6[O4=7;3#9O=76F+%:231F016\_F/(Y5BN<,<
M$G"^IQ4.KZ)XCA\-^(O#=EH9O1J%Y-<P7OVB)8]DLGF$.&8-O4D@<$' .17I
M]% 'E^J^%-5@UGQ"T6FZIJ$6JR^= UIJQMH5+1JA29-Z\#;U4,2#CM6]H?AN
M\TO5-8_T6#[/+I=E:6^]]Z.T22*RG)+;?F7KR0:[*B@#SKPGHNN:;KE@(;'4
MM*TN*%UO;2ZOTN;<MM 46XW,Z@-SSM&.,5M:S9ZE8^,;3Q#8Z=)J</V%[*:W
MAD1)4RZNKKO95(X((R#T/-=710!Y[IOAC6$O])U"XM4C=]=N=3N85E5OLR20
M/&JY_B.2N=N>6/;FMGQSX?D\26>D6@M$NK>/58)KJ-V 'DKNW'D\]1P.:ZFB
M@#FF\':-I>C:I%H6CVEM=75I)#NB0*SY4@*6/;..^*Y_5O"FI/H_@Z:.VNI9
M=&MO)N;2RO/L\Q#1*A*2!E&5*]-P!!/->BT4 >;6_A34FM$N$TR>WFEUZTO'
MCNK\W$_DQ%07D=F(W8'W5)X ')JC?^#=5CGU^Q&EZE?QZG>2SPRQ:NT%ILE.
M66:,.&^7)'RJVX 5ZO10!Q \-W\4/C>..W!&I6Z169WC]YMM5C[GCY@1S]:J
MZ[X6U&:R\)W4-M=3/I$!AN+6RO/L\Q#QJI*.&494IT+ $$\UZ#10!YE;>%M5
MM3;Z[;Z1.+J#5?M9L;G4//GGB\@PY:1F*"0!L@;L84#-='X6M=4_X2#Q#JNH
MZ8=/COW@,$;RH[E4CVG=L) /XGMR:ZJB@#B=>M]5DU*\@U'PK!XFTB4J]H%,
M >W^4!D82D9&02&!)Y]JS-.\-:[H]IX7F%@9_L&I7,SV45RK&T@E21417<@,
M$#C/Z9KTFB@#S)?#_B#_ (1&+P2=((B2Y7.J^?'Y)A6<2[PN[?YF!C&W&><X
MK2LK3Q'HBZAI%IHD=TMUJ4MU#J$TJ&!8Y9?,;S%W!RRY(  (.!R*[NB@#S31
MO"&K^'_$$WB&TMFDN;K5+I+RV:=2'LY)BR.F3A2O#8XSN8'G%=+XUTR74]/L
MUCTI]16&Y$CI;W/V>XB^5@'A?<H# GH2 037344 >=:9H'B2271)-06YD@L]
M:>YC6]GCDN(;8V[H/,93AFWMV+$ C)..':QHGB2/4-=NM-@F\F\U2UF;[-+&
ML\MNENJ/Y9<X5MRCK@X!P>17H=% 'D__  B.NS+XB9--NT2_?3'MQ>WZSS$0
MW&Z3>Q<@$+S@$C&,<Y%=QX8TR[TZY\0O=1;%O-5DN8#N!W1F.-0>.G*G@\\5
MT%% '"6EIXCT3^U-*L]$CNQ>:E+=P7\TJ&W5)9-[>:NX.67)  !S@<BLZYT#
MQ OA35/!L6D>;'>7,_EZH9X_*6*64R%G4MOWJ&(P%() YKTRB@#@[KPUJ<GA
MOQ]9I;!I]6EF:S!D7]Z#;1HN3GCYE8<XK/\ $/AO7;D>*;6UTQITU;1[>&&9
M9HU"RQ!P48%@>=XP>GO7IE% '&3Z!J+_ /">[;<$ZM&%L_G7]Y_HJQ^O'S C
MG%4;;3?$&A:K)/;:,U\M]H]I:%DN(T%O-$) =^X@E?WG5=QX/%>@T4 >2VG@
MS6=+30KN:PU.Y,6B0Z?<6^F:D+>6&6,ELY\Q5=3N(^]P1GG-=YX.TF71O#4%
MK/;"VF9Y)I(1<-/L9W+'+L<L>>3TSG%;U% 'GWA/PQJVF7_AN6\M0BV6G7L$
MY\Q6V/),C(.#SE5/(KH?"&F7>E:?J$5Y%Y;RZI=W"#<#F-YF93QZ@CBN@HH
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MB;1]U,%F)8 #(Z&LZ+X@W8\--KLMK;O9Z??-;:F\(?!BP,3PYP2/F4E2"?O
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M<&F/J-K+;*Z1R!&"NC*Q)!!9>0>0>V*U9O ]O>)?M?:C=3W5ZEJ&N5"1O')
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M6?BGQ%H8/^CP/%>VX_N+.&W*/;>CM_P.J6B:(UW\0]6\3RZ?<V<0A6U@CN,
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M8[1_)+ 1NV3G@,1N.#CIFJVFW5W<2>,;R[9EOH]&M ISAD4V[N<>G[QG_$4
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M/$-GHDUE!/'<S7%ZY2"&VA,CMM&6.!T '4US6LI:ZI\0CIFMW<D6G1Z6L]K
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M+/:KI,.D1:C]JW=F>0$[LXV[4!'UJUIOBW1=4>9+>Z>-X8O/=;J"2W/E?\]
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M1())C';2RK ISAI&12$!P?O$>M $:>#M+;7KW4KJUM;I+B.W2*":V5E@\H,
M5SG&=W8#&*W?L\(N/M AC\[9Y?F;1NVYSC/7&>U<W#XVL6\3ZQI4^8+?3;6*
MY:Z>-PA#!RQ+%=H "K@YYR<9P<7-,\7Z)JTTD-M=NDB1>>4N;>2 M%_ST7S%
M7<O^T,B@#8@@AMH1%!%'%$N<)&H4#)R>![FLRPT"WLH]2M6\N?3[RX:<6LD8
M*QE^77G@J6RV,<%C6/??$#27T34[C2KCS;NWT^>\MEN+:6-)Q&I.Y"P42+G&
M2I/!K:TS7K/4)H[)9E:_%M'<3Q1JQ$0<9&3T!/8$YQS0!#J'AFRN]%71K:*"
MRTYI5:>"WA"K)&#N*8&  Q !/ID=\B:71(G\0#54=5\RU-I=0LFY9TSE,^A4
MEO7(<CTI;KQ%I-B-3-S>+'_9D2S7FY&_=HP)!Z<Y"GIGICK61XI\:VFC^'I;
MVQG@EN3:)>PK(K%&A,B*7)&,#YQC)'Z&@#H3IE@R,AL;8JR)&08EP54Y5>G0
M'H.U5K71UAUZ^U>67S9[A(X8QMP(8ER=HYY)9F8GC.0.U9<GC;2;K3=5DT^^
M6*YLK-[H_;+69%5 #B3:5#.F1U7-3WWC/1-)9(;Z\;SA L\OD6TLJQ(>CN54
M^6IP>6Q0!IWVCZ7J9S?Z;9W9P!^_@63@$D=1V)/YTZ\TO3]1M5M;ZPM;FW7!
M6*>%708Z8!&*Y4_$33;+7]<LM3G"6UBT+0RV]O++^Z>)7+R% P5<L<,<#%=@
MUS MJ;IIHQ;A/,,I8;0N,[L],8YS0 L$$5M D$$211(-J1QJ%51Z #I48L+,
M;<6D VRF<?NQQ(<Y?_>.3SUY-8UIXST;5!+'87+M/Y#3PK-;R1"9 /O(74!U
MZ<KGK533O'-@/#>AWNJR,M]J-A'=FWL[:69@"H+-L0,P0$XR?SH Z2*PLX&B
M:*T@C,081E(P-@8Y;'ID\GUJ*UT;2[&ZENK/3;.WN)O]9-# J._U(&3^-4;K
MQ=H=I9V5T;TS1WREK5;6%YWF4#)*H@+$#/)QQWK.B\>:==^)M*TRRWW%MJ%I
M+<+<I#(0"KJH7[N!U;=DC:0 <$B@#>31-)2]>]33+);IV#O.+= [,.A+8R3[
MU/=65K?1B.[MH;B,$D+-&' .".A]B1]":R+#QGH.IW\=G:7K/),66!V@D2*<
MK]X1R,H1\8/W2>E9.L_$+3K>XL[73)A/<3:I!8LSV\GE-NE"2!),!&=03P"<
M8Z<&@#<O]$?^PGTS0IK?1PWRAH;565%/WMJ @ \]?7L:NZ7IUMH^E6FFV:;+
M:UA6&,?[*C S[UE^+?$R>%M.M;IX))O/O(+;"1N^ [A6/R@G(!) [G ')K(@
M^(VFV^J:W:ZO,;>.QNUCC=+65@D311L'E(!"?,[#+;1Q[&@#LFMX'N$N&AC:
M>-2J2%064'&0#U .!^55IM'TRXOX[^?3K26\C^Y</ K2)]&(R*H:IXOT31KH
MVUY=2>:L8FD$-O)-Y49Z.Y12$7@\MCI6N+F!K070FC-N4\P2AAMV8SNSTQCG
M- #&T^R>\-XUI;M<F/RC,8P7*?W=V,X]NE1V&D:;I0D&G:?:68D.7%O"L>X^
MIV@9KF5\?V-_XDT33=)D\V&^,QD>:VECW(D197C+ !E)&,C(_.I[3QWH\=AI
M7]H:C%+>W]NDT8L[69EE!.-RKM+!<^O3O0!T%_I>G:K&L>HV%K>1H=RK<0K(
M%/J P/-2BTMPT+"WBW0 K$=@S&",$+Z<>E8Z>,]!DU,:>MZQE,YMUD\B3R6E
M''EB7;L+9XV[LYXZT3>,]!M]4;3Y+UA,LRV[N()#"DIQA&E"[%8Y'!;/- &I
M?Z;8:I (-0LK:[A#;A'<1+(H/K@@\T^WL[6S#"VMH8-V-WE1A<X  SCT  ^@
MKE])^(.F7FGZG>WOF6<-G?O9KO@E#2_,53:"N6=L'Y%!(Z$5?_X3;P\-+N-1
MDOS#;VTJ0S^?#)&\+N0%#HRAESD<D8[T =!1533-2MM7T^*^LS*8)<[3+"\3
M<$@Y5P".0>HJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5SOBK3+K4I_#QMH/-6UU>*YFY
M V(J2 MSUP2.G-=%10!Y[K/AS5+G2?B%##9EI=5939C>H\X"WC3UX^96'.*H
M^)=(\2ZC-XBLS9ZK*MU&4L!97$,%JRF(+F9LB0MNW9!R", <5ZA10!Y&=$U&
M^U#5+:WMP]_8V6AW!M9' $C0O*[1%N@)VD9Z9QVJ]XGTC7/%JZQ?0:)<V7_$
MCFT^W@N9(Q+<2R.K=%8@*NS&21DL:]"L=)T_39KJ:RLX8);N0RW#HN&E?U8]
M^I_.KE '):YHE[>^)K&>V@'V:/2+VU9]P 5Y/*V#'7G:WY5R>K6VLV'@OPK=
M6MH]AK]K$NB^3,ZY82QB(D%200'5)!ST4]*]9JE-I&G7&J6^IS64$E];*4AG
M9 7C!ZX/;O\ G0!4DT"*+P=)X>LF\F(6#6<3_P!T;-@/U[UREM8ZWJD/A72I
M]!FT\:-<1375U)+&8CY4;(%BVL6;<3W P,YYXKT.B@#GO!&G7>E>%HK2^A,,
MZW-TY0D'Y7N)'4\>JL#^-<O'H.L-=_97TJ41P>*O[3$Y>,I) _F'<OS9RN1D
M$ \C&><>DT4 >;>)_">KZGJ>OW5K!(5:YTZZMUCG$;7'D[MZJV?E;G@G R!6
MGX3TFX7Q'=ZM-8:M;I]D6VCEU6\$LS_,6("JS!5'8DY))XQ7;44 <P-&NI/'
M.L7S1F.UN=)@M8K@$9WAYBP SG@,IKC= \*:I;Q^'])O-,U@OID\3S32ZDOV
M)1%T>)0Q8DX&%*C&3FO6:* /.[;PUJB>%=%LVLL7%OXB-[,FY?EB^U2/OZX/
MRLI]:36](\11:KKUYIUK,8KJ_LI"\!B,S0)$%D,6_P"4."!C..^.U>BT4 >2
M2>%]>N5\3.FG:B5OX].^S&_NTEF?RIV9]V&(7 .0!QCWR*V[[PYJDWA3Q_:)
M9DW.J7,[V:;E_>JT$:J<YX^96'..E>@44 ><:KX9U:YU;5)4LB\4^I:3,AWK
M\R0LOFGKVP?KVS2^,]"O+C4=>O\ ,$%L]CI_DRW$JI'++#<O(8V)/&<JN3Q\
MPKT:HKFU@O;66VNH8YX)5*212*&5P>H(/44 <-INH7NI?%F%[K2)=.,6ARC9
M/+&\AS/'R?+9@%X..<G!X%:&I0ZEI/C=]=MM*N-3MKK3TLREL\8DA=)'8<.R
MC:V_J#P5K<TGP_I&A+*-+TZVM/-QYABC +XZ9/4X[>E:5 'E=AX5UU-)T>.;
M31%-#INKPS1K(A$<D\BM&H.><@'GVYQ5W5O#&I_V5X,N(K>]9M'MO)NK:PN%
MBG7=$JDH20I*E<$9Y!.*]'HH \PA\-:I#%%K4&DWIFAUE+YK.[O%EN+B)86A
MW$D[ X#9"[NB@9S5_64U[5([;5$\-O$MIJ]O<I:AHA=31(C*S/\ /LSEN!NS
M@5Z!10!YE=Z1KL7AG7_"<6ARW#ZG<W+0:AYD?D".=RV^3+;PR;B,!3G:,>VM
M!X>O8[;QK%+IT5V-0D7[/%/)M6Z06T:8+#E<LK#/&.OO7;T4 <)X/L-:M=?<
MF+68-&%H5,.L3Q32+-N&!$ZLS; N[.XXZ8J7Q'INIR>*YKFUT^6YMKO0Y[#S
M8W0"*4DLNX,P.#TR,\UVU% '"MX<U&2S\#VX@,7]GP-%=LK+^XS:-'Z\_,0.
M,U@:!X4U2"/P_I5YIFL%],GB>::;4E^Q*(NCQ*&+$G PI48R0:]9HH \UF\(
MZM+\.(+!+=TO[;5GO_L\<RQO*HNGD 5\X5BI!!/0XSBJMUX6U+5M+\2R0:9J
ML<]SI+65LVK7RR33,26VA0Q55!Q@D]2>W->J44 <);2:SI7B#4M97PU?W4>K
MV\!6&.2$2V\D:LOER9< *<@A@2!DUG:9X(U:W@L+";8@_P"$<O;&6>-@5AFF
MEC8*.Y &[!Q_#7IE% 'GMM9:WJD7A72[C09M.&C3Q375U)+&8CY4;(%BVL6;
M<3W P,YYXJI)X1U=OAGH%BMM,E]IEZEW+:PSK'(X#OD(^=H;#[ADXR.M>FT4
M <9X0TFXBUS4=5GL=4MEE@BMXWU2\$L\H4LQRJDA5!;CG)R>E9.M:!J=IXOU
MK48K/6[RWU..%H?[+O4A"ND>PI*&9>. 0PSU->DT4 >47_@'5I],N=.M;98%
M_P"$>M+6+_2-R^=%.\AB#GG&,#<1CFI)?">H>(1?H;'6;-VTJXM([C5[]92)
M)0!L549LI\HRQQT&!7J=% '"7G]O>(-%N=,'AG[ 1I5Q;O+=/&3YS1[52$HQ
M^4GJQP, ?AC-HNL+J=EK4NEZ\D<NE0V4EOI]W''/!+$S?>&\*R-NR"&..X&:
M]4HH \VT?0M4\+7.CZHFBW%RBV-Q;7-E!<I++;M),)@P9RH?)R&P>#C&0*Z/
MP-8W]AHET-2LOL5Q/J-U<^0'5]BR2LR\J<=#7344 >7#2-?N/#%[X5?0)H6O
M-4FF%^98C"D+71E\PX;=OQT7']WD<XM7FD32_%(:9$5.E7+1:Y=H#]V:(&,
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ML;/P_=:?K-P8+Q6:X.I*MB8UE\P2A0V[=P#MV_>[XYKH-/M]=T6"]T.+P_\
M;&GU.6YBOI6C-L8I)O,+2#=OWJ"1@*<E1@XKOJ* /,AHFN6UW)<+H\TQT[Q%
M-J:1^9'B[AF61?W>6^^H<'#;?8TNIZ#K.OWNHZO_ &3+:I=76F)':3/'YC1P
M3[Y)' 8J.&( R3A??%>F44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[=8[NVCP 95/R3*?X7&![' STH YZ+X@7E]]KTR*ZT6XO);":XMY]/G=TB9
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M.:ZW5M=CT;PM<ZY=0G9;VIN'B1@Q)VYV@]#SQGI5'7?#-YJUS</;ZW-;6]U
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M=6L"VR*24;<!(PY?C(SQUR<FNYH **** "BBB@ HHHH **** "BBB@ HHHH
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M>I.#\U< +N]TC3-<LI!J%K?R^'KFY@DM]7>]MYBB_P"N4O\ O(WRPQT!]R*
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M34+VSE:"=8T!F0<Q*SJKN/\ =4L?PH V=4U.TT;3Y+Z^D,=O&5#,%+8+,%'
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M44 %%%% !1110 4444 %8OB/P[#XC33HKAH_)M+U;IXI(A(LP".I0@G&#O\
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M]2C6VLCBY:96B,)[;E8 C.1CCGM0!-;>&- LX+F"UT33H8;K_CXCCM459?\
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MC)96.EV=M:RY\R&&!41\C!R ,'CUJ.V\-Z'9V$]A;:-I\-G<?ZZWCMD5)/\
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M HHHH **** "BBB@ HHHH *YCQQ:WD^GZ9<6=G->-9:G;W4D,&W>R*WS;02
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 0W=U!8V<UW=2K%;P(9))&/"J!DD_A6'?>.=
M TV\6SNKBY6Y:%)S$EC/(RHV=I;8AQT/!YXJMX]8MIFE6K?\>]WK%G!<#U0R
M X/L2H'XUBW4>KR?%76?[)U6RL"-,M/,-U:F;?\ /-C&'7&.?7K0!UMKXGTF
M\M(+J*:98)[@6J--;21?O",@$.H(ST!/!) ZFMBN-\5178^%^N_VGJ%O=7<-
MG+,MQ;0^4JN@WQD*6;!#*O>NKLI9)["WFE7;))$K.OH2 2* )Z*** "BBB@"
MI+J=G#JMOIDDV+RXB>6*+:?F1"H8YQ@8W+U/>K=<1XC=H_B+I#HQ5ET;4""#
MR#F&N;TFROIX? CR^(-:9M<M&.H'[:_[P" 2 +S\A! &Y<,1G)R<T >MT5Y/
M:2:C=WFDZ&VLZDML-?O[)I%N6$LD$<;LJ-)G<>@&<Y]\\U#)'?V6@:SJ::[J
M[SZ/KJVEF)+QV40^=$"CC/[S(D89?)QCGB@#UZH;NZAL;.>[N7V001M+(^"=
MJJ,DX'/05Y'J.H^(+U_%&II-/;RZ;?2PV\YU;[/!:K'C9O@QM<-PQ+9R&XQQ
M5W5_.UW3O&]SJFK7=E-IL)B@MX+IHXHD-LK[F0'$@=F8?,#P,#% 'I%GJUEJ
M$S16LI=Q#'.?W; ;),[#DC!SM/'4=\58N;F&SM9;FYE2*"%#))(YPJ*!DDGL
M *\L.MSV-IJ,+ZA?PPC1](CMTM2"ZR2M(I$>XA59L*"QQCKV%9^J-?)%XPT6
MY-_;6W_"-R7GV6?5GNY$D4M@ER25# 8*[B"/8T >S1R)+$DD;!D<!E([@U7;
M4K1-5BTMIL7DL+SI%M/,:E58YQC@LO?/->8R'4[G7H-"MO[0GL;/2(+B&./6
M'M7=G+;I"_WI N  ,X'IR*33!J>OWND17&I :C<>'+^)+ZUFS\PN(E1PZXR>
M%)QWS0!ZS17!^$=?O?%NLV]RTDL,.F6 BO858A6OG.'5AWV",_\ ?RM0W\L?
MQ-ELY+IEM?[%681,^$W"9@S8Z9Q@$_2@#J**\DT"[N/$,WA"VO==U!;>\L;^
M6017CQM=,DZ! 64AN%)/!!P".F:EL-1OM2U#3/#]SJ][_9;:GJ%N+Q+@I-<I
M"%,<9E7!ZLX)!!/E=>M 'JU%>37-WJ/VXZ!;:UJ!L8/$D%FEVMP3,8GMF>2$
MR=6VMQDY(XYR!75^$A-9>(_$NC_;+NYL[.2W>W^U3M,\?F1Y9=[$L1D9&2<9
MH W;[7M+TZ*]DNKR-%L@AN< L8@YPN0 3S6C7CGBNP1)?B/,EQ<B4Q60 :=F
M4;MISL)QP1QQP,@<&M/Q!<ZEX-O]632M0U"ZSX?GO0MY<-<;9HY$42#=G'#D
MD#"\#B@#U"BO-?#C:O8^)]%1IIEM;ZWE,RW>L_;#<X0,LL:D?*0<9VX7#=.!
M5SQI=ZI/XOT?1+9+A[2:UGN&BM[\V;3NK( OF#YL*&)V@C.<G@4 =]17D\NK
MZ[8>$X;R+4'N-8LM7>UL;-+K[1]M0G!@E(P&906^8\KLR3UJ:"=]1A\$P-XE
MU!XM5DN9+R5+AH6FDV;C$,',85@5"C!&".O- 'I5U?6]E);).[*US*(8L(S9
M?!;!P..%/)P*L5Y?!J=_:ZQ;Z7#J5W/8VWBA;..:29G9XC:-(T3L3EPKG'.3
MP,]*JZ?+<1>![75;O6M>N-0U:^^QI%#=<O\ OW"QIN(6/*I@OG.,\]* /4[R
M\MM/LY;N\G2"WB7<\CG 44D5];SWUS9QNQGM@C2J48 !L[>2,'H>A..]>+ZP
M]V^B^.=(NY+V&"SMK.XCMI=4>Z>%G9]P,A.<$!3M)('![UOZWJFH:9J6NZ?;
MZI=PV:2:3:_:'G+M;12NRR2!FSAB,98]\'M0!ZC17D_BJYO?##:]INDZOJ#0
M_P!A/>YGNWFDMIA(JJRNQ+#<"W&<?+Q716%K/H?Q!LK"/4]0NK>]TN>:=+NY
M:4&6.2(!U!^YD.V0N!TXXH [:LS6?$&G:"ENU_+*&N9/*ACA@>:21L$D!4!)
MP 2>.*P-8635_B!!H=S?WEK8)IANTCM;EH&GE\S:<NA#$* #@'^+)KD[!9-:
MU[PJUYJ%[<K;:KJ-I!=+<NAGBB238Y*D GC:6_B YSF@#UZBN3\;WA0:3IT3
MZBUQ?7)5+:PF$#SA49F4RDC8HZD@Y.,#J:I_#N\O)+CQ'874LK)8WZQQ1S7A
MNFA!B1BGFGEL,3USCD9.* .PO[ZVTS3[F_O)/*M;:)I99,$[449)P.3P.U31
MR++$DB'*. RGU!KR?Q,C:SX=\?WVH:Q>VTVGM/;06\=RT<21"%2H:/.UO,W'
ME@3R,8Q1=W6LZIKVKVJ_;!;Z9:6WV?[/JWV(0AH0YF8#[_S9'S94;<8ZT >C
MWOB#3K#5[32II93>W8W1110/(0N0-S%00BY(&6P*TZ\DMIF7Q!!XAU749UN8
M_"GVR>>UG9XMP."ZIG:RD?-MQ@GGKS4FC7>I67C#PQ&3JD,.IPSF5;_5?M#W
M(6'>'\H%EC.0/ND=<8H ]7K.L]>TO4$M7MKR-Q=/*D (*M(T9(? (!X*G/\
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M^K^3;VRQOM17@QM8,,$ELD[N".* /9**;&6:-2X 8@$@=C3J "BBB@ HHHH
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ML8X9XO)F18% D3).UN.1EB>?4U+#H&CV]K+;0Z9:)!-$L$D8A7:\:@A5(QR
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M27$EK"\TL/D2.R EX\D[#ZKDGCW-8=OXYT-M!TS5+R]BMA?Q"2.+EFR!\X
MR0IX)QBK-]XQ\.Z;96MY=ZQ:1VUVADMY-^X2J"H)7&<XW+T]: +.E^'-%T0R
MG2]*L[,RC$AAA"EAV!QV]NE1V'A70-+NQ=6&C6-M< DB6*!589&#@@<#D\>]
M,3Q;H#ZJ-,75(#=F3R@F3@R==F[IN_V<Y]JT-1U*RTFRDO=0N8[:VCQNDD;
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M-O.,X!.%) KTZB@#S/6K#6[76-=NK/3Y3!<:Q:2^?%:I/+'$MLJM+"C @N'
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M8@^6%7<X&>""W&2<5L'0-0'P\NK-=/D%X^OFZ$87YBGV\/O_ .^!G/I7I-%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8# #((/?!&:6Y\$WD6H3WFD:G:V[W<$4-R+JP%P-T:[%DC^==K;<#!R.!Q0
MVU\<W6M:MIUKH6DI<V]UI\.I//<7/E>5$[LI7:%;+C;TZ'GD8Y3PMXYN?$U]
M"([&Q%M+OWK%J >YM"N<">$JI4G&/E)P?;FM;3?# T[6EU#[=+-MTR+3R'4;
MFV.S>86'<[^@%9=IX'O/[=TS4-3U6VO#ICL\,Z6(CNI<JR@2R[CN #<@*,D
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M&8D8Y8@'Y5X.21L7'CJ_CL;S7(M&BD\.V=P\,MP;HB=E1RCRI'LP5#!N"P)
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M:(DUQ>VLMQ(MU=>4+<Q2B.16(5LD,2 1[=J?HOCJYUK6S:PV-B8!<R6\L(U
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M3$"9%V^9*-Y$C = -HR2?IM2Z!YNMZ+J7VG']F6\T/E[/]9Y@09SGC&SWZT
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MUJ%I!<2M<R[E1F0$A!CY1S^E<HE_JNJ:O8Z<=7O;>*X\1:E;2-#)A_)C1V5
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M[:*X\0:G;R/;R[7\F-794![ ;0/;M1/<ZMIUAXUUN+5]2N)-#ED@LK:27=$
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M;4Y#(;2]:&'S+E)Y43:IV2LAQN!)Z\XQFN3O+K4$T'Q=XA7Q#?"\TG4;A;2
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M<,0.F?;-:UOK&FW9M!;7]O-]LC:6W\N0-YJ+C<RXZ@;AGZT 2Q65K!=W%W%
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MQ<ZU91172EX7:48D4=6'^S[]*T8=1LKFY-M!=0R3")9BB."?+;.UOH<'!]J
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M[W2[:2W_ -I4,JN!]&=3_P "%>;V'AV(>"M-M-/\):];^+8(HO)NWBDBBAN
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MOD7[4K*X]?E&0?04S4-(N5EUBXGL=7C \1&ZM[O3ES- OV6-!*J%3YBYW(0
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M7/@6QTN=1/8,\37+VY>+"VS+\Z@C ;&.O&: +C>.I8XI+.32#_;RWZV L%N
M4:1H_,#B3:/W>S+9VY&",9J.]\?7&EVNH1ZAHA75+*6U4VD%R'69)Y-B/&Y4
M9YW#! Y'OFE;P->2*^I/JL0\0G4%U 72VY\E66/RA%Y>[.SRR1][.3G/:DG\
M$7NI-=WNIZG"^I75Q9N6A@*Q116\HD6-5+$DD[LL3U/3B@"Q>^*-<L88A/H%
ME;S>499VNM5$4"?,0$63RSO8@9/R@#(YK,M/&&I:WXC\+S6%LJ:5J6F7%S+&
M\X#!E:,$\*<E<\<X;<>F!G1UCP?=WOBJ36K:XTYC+;);[;^R^T&VVECNB^8
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MU2.WM8KJ:22Y\CB5=Z(@VMN<KS@X'(YYK*'C:_T[7?$U[JEJT>CV%A:3I"9
M)8VDWX79M'S,>#EN"HY.>-67PKJMC?W-SH&K6]K]MMXH+G[5:F0JT:[%E3:R
M@-MP,$8X'2JM]X EOI-2@EU4R66I:?;VLYECW3^;!DQRA\X/+9(*\D4 )!\1
M[>"6>/6;>TMMEE+>HUE?K=@I& 71L!=K@$8'(/.#Q42Z[K]WXT\+17VF-IEK
M=)<R;([SS1(!%D+( JX8<''S#T/%6(O US>I=0ZU<Z;]FFLI+/RM-L!;[MXP
M9&8ECNQT P!D]:GLO#.NG7-'O]6UJUN8]*22..."T,9FWIMWN2Y^;IP!CKZ\
M '7T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 57NKZULFMUN9EB-Q*((0W\;D$A1[X!_*K%<7\
M1('N4\,P1WCV;2:Y"HG3&Y<QR_=R",GH..IH [2BO,[_ %#6M&D\16UIJ=W>
MQ:$UGJ*F4AI&B;<9H&;'S?(A8=^1[5T_A?4Y]=U'6=42Y,FE^>+6Q4?=81C$
MD@]<N67Z(* -BZU?3[*.>2YO(8UMV19LMGRRY 4,!TR2,?6KM>-^);"1/^%A
MR1WUSO:^TY5#L&52QMV!QCMT'MQ6KX@U?6/!=QKD-KJEWJ 311>Q?;BKF*;S
M?++ @ ;<')7I\O84 >GT5Y]X>G\06?BFPM;H:F+*[MY3,-5O;61V=0I#Q"-R
MV.2& &T97I6AKOVR_P#'VEZ/'J]U8V<NG7$\J6S!6E99(@H#$$C&XGCG - '
M8T5Y5;ZAK>L7^D:&VNWD,7]H:C9RWEOL66XC@P4.=I ;^$D#L?6I;B[U:;P[
MXG\0CQ#>6]SHUQ<Q6UN"GDA;?@"1<?.9,9)S_&,8H ]0JO;WUK=SW,,$RR26
ML@BG5>L;%0V#^# _C7GNI>)-7LY=1T<3R)J&L"VDT@L,F'S@$D _ZY%6?GL1
M3;^_UZ:;6K&POY)'@UJ*W6 7*0SS0_94=HXG<8WECN]<!N10!Z)=7UK9-;K<
MS+$;F400AOXW()"CWP#^56*\SL_$%X(=*M$OM4$Z>(DM+F#48T6>*-H7<1,R
MDAQT(8'D8]*KPZKK \&6/C4ZW=/>SW<0?3R5^SE'G$9@"8R& /WL[LCGTH ]
M4HKRF^O-;30_$GB%=?OEFTO5Y8K6V4KY/EK*HVNNW+9!(Z\<8]YM<U75M.US
M4M1N[_4ETNVNT6.\TV6*:WMD 3='/ </G);)Y(W C&* /4*BN;B&SM9;FYE2
M*"%#))(YPJ*!DDGT K \;:E>:=HENME<?99+R^M[-KH*"8%DD"LXSQG!P,\9
M(KBO&:7FGV7B7P^=8O[NS?P]-J ,\@:2)T.W:6QDHX/0_P!TXQ0!Z;I>J66L
MV$=]I\WG6TF=DFTKG!QT(!J6\O+?3[*>\NY5AMH(VDED;HB@9)/X5A:C=7'A
MOX=WEY;/+=7%EITDT;3G<S,$+#.,9 _D*Y3Q-9SZ=X(U*2;Q5<7C7VAW3/;7
M6QOM#B+=YD6,; ,G(&1@CTS0!Z:CK(BNARK#(([BG5Y;KVIWTS:FNG7FN2'3
M;&,D6!A@@LW\K?F1Y&S(2"IP 0!QC-;7A77K[4M=B^V7.8I?#EC?-'P%$LC2
M;V'UP/RH [BBO([/5/$6K:#X>NENM1O8I--,US%I=U%'=ARY E*OC>F 0 ".
M<\&I?^$CU;Q!J.F6&GS:Q?6@TA+MY;!H+2:>4R-&6?S&& I3[J\9;GC% 'J]
M%>5_VCXIU#3='\Z6XN6CCN1=VVE7]LEW)LE")+P2K  $,JD?.?PKN?"6I#5/
M"ME=B[GO&*,CRSPB*1F1BK!D' 8%2#CC(H U(+VWN9KB&"4.]LXCF _@8J&P
M3ZX(/XBBYO;>S\G[1*(Q-*L,9;H7/09[9Q@9[X'4BO.=+O[W3_A?HGB6&=P5
MN1J&IJ.?.CED;SL_[N_=[>7BK=[<3Z]X%\8ZK-<M]C<3MIH!XB2W7"R+[F1"
M^?3;0!Z%17-ZOK3V_P /WU:6[:PF>SC?SD@\UHY'"@;4R-QW,  >,D9KB6UG
M6]+U+5[3S=:MXCX=N[Z--5GAEE66,J%D7RR=GWCP3VZ<4 >M57N;ZULY;:*X
MF6-[J7R85;^-]I; ]\*3^%>>"]UC0+C0KPZM>ZDVHZ;<S7%O<%2C21PB12@
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MYTC4[TW*"0<G:>#D4W2M5U?6'T/0;G5[J)9)]22>\BVI-.+:;8B[L8!(.20
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M4!L  6=V;<X'X5HZWJ&L>#=0NS#JMYJ>_0KN],=WM8+/"8\,H4#:/G.5''%
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M **** "N4\:V\WG:!J/V2:\LM.U$3W4$,9D?;Y;JKA!RVUF5L $\9'2NKHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQNQUVY[]*KV6N:3J4,TUAJEE=10?ZUX+A76/_>(/'XT 06/AG1M,^Q?8K".
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MMY0VD]ASTSWKK:* /)KJ&YTU+Y%TQ8K5O%$LJW,MB\Z6B^0I$JQ+C=ELJ&Z
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MJ=Y,]V(8;C2C9*57+I)YHD5\=" 5'% $=SXNNUAN+._TBZTB\N+&>XLG>5)
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M9R@2)4.?Q&: ./\ $NIR6WBN^3Q!K&MZ-I*I'_9]Q81GR&ROSF1PC88-D8;
MP!ZU9B\1:[;W/@VT2YM]7CU!YA<7MJZ!+A%1BI&>A PQQW! ]*U[O3?%=EJ]
M[<Z-J%A<V=XPD-MJ9D_T=PH4^6RY^4XSMP.<X/-9UIX(O]+BT&2SN[22ZL+Z
MXN[D21LD3^>&\P1J,[0-_P H]N: +,7CY)(H=1.D7:Z#-<"WCU,NF"2^Q7*9
MW",M@!O<'&*G'C*6:[F:ST*^NM,@NS9RWL)5OW@;8Q6/.YD5N"1Z$X(%9<7@
MK65T6W\+R7MB?#\%PCB4*_VEX4D$BQ$?=!R "V>@Z9JY;>'/$6F&XT[3-2LX
M-*GOGNQ.48W,*O)YCQJ.5.26 8] W0XH K>&?%TEQ?76DMYNH:B=5O%95(Q:
MVR3,JLY[#@ #J>W0FNJUG4YM+M8WM].N;^>6411PP <$Y.YF/"*,')/L.I%<
MK9> I]+U'^U]/GMHM4.J7%S,X4A;BVFDW-$^!DD#:0><%?0FM;QEX>NO$-I8
MQV[6TB6UR)IK.[+"&Z7:PV/MYP"0PX(R!D4 4'^(<%O8W[7FFRP7UG=PV;VW
MGQLI>4 H?-SM"X/).,8/%=!HFJW&J0S&ZTR>PFB?:5=E=) 0"&1UX9>?P((K
MD;+P)JEC!K7V=M#A_M"6WE%DEF/LNR-2K0LI'W2,?,.<\X'2MCP9X7F\-G4I
M)%M+>.\E1TL+$MY%OM7!V[L<L>3@ <#B@!&\:L^MWEA9Z/<WD5C<+;7,D4J>
M8C,%.X19W,@W#)]CC.*BO_'T5G-J,D6EW%SINF2&*]O$E0;&4 OM0G<X4'G'
MH<9Q6?XB\#:EKNJ3R,VDX>=)+?4_),=[9J,912@&_&#@DCKR#BH+[X<3'4-5
M:SM/#TT6HW+7/VR_L1-<6K/RX4$%7&<E=Q&,\Y% &YH.OZCJ7C;7["6#_B76
MJ0-;2!T(&Y<YXY.[.?;%8^M:_>6?Q%N#?/>VVAZ3I8O7\F=0CY+Y9U^\V=H4
M+Z\]ZZ'3-!O-+\6ZE?QR6S:=>P0J4VE9(WB7:, ?+M(^F*K:YX._M[4]7EGN
M1';:AI*Z?\HRZ,'=M_I_&./:@!8/&4J74%OJNAW>FM=PR36ADD1_-V+O9&VD
M['V\X/'!YXK"N/'FMWUOX<O=/\/W-M9:G?1*C33PYN(FB=\ 9)7.W.3C@>]:
MC>&_$&KWUE<:[=Z>!I\,P@%HK_OI9(S'YC[ON@*S?*,\GKQ3KCPIJ2>%?"]C
M97-H;[0WMY,S!O*E,<31L..1G<2/I0!E:9XWU"PBUB?4--O+K3K76[BUDOO,
M0"%#-L0*F=S*N5!/\\&M_P"(.IW6C^#;J_LWE2>*>V ,0RY!GC5E'U!(_&JE
MQX-NIO">MZ0+J$2ZAJ4MXCD':JM.) #[X&*V?%.C2Z_H$FGPRI$[3P2[GSC$
M<R2$<>H4B@#+/CJ.Q.IIKNEW.F2V-HM[L+I+YL18J-I0XW;AC;ZD<TB>.?(:
M:+5-(GL9Q92WL"&>.43)& 77*D[7 (X/'/!.#2>)O!)\2ZAJ,DMRD5O=Z4+$
M?+N9)%E\Q6(/!&<<=ZS;7P'=E;PRV/AO3C)836J?V98A3))(NW>SE0R@#/RK
MZG).!0!>C\>S26=A(?#]W'<:F=VGV\D\0,T00,96.<1J 1P>>1QS2GQ?!J#:
M8C)>V5VNLK87%LCH=LGDNX#GD-&5PP*X)XZ8(J/6_ [:C8^'F$>FW=WH\)A\
MC4(?,MYU9%5@>"5.44@X.,=.:;9>"+F"+36;^RK62WU<:A)!86HAB5!$\8C7
M !8_-G<WOT&!0 ^U^()N%M+MM"O(]+N+[[ +UI(\"4R&,'9G<5W#&?T[UJ:=
MJ$\'C+5-$N)6E1H8[^U9CDJC$HZ?0,N1[/CM6='X-ND\(6&C&ZA\VVU1;YI,
M':5%T9]H]\''UJUIL+:A\0-5U901;6=I'IL;=GDW&20CV&47ZAAVH Q-9\07
MEE\1+MK][VWT/2=+6\<03H$?+2 LR_>?.P*%]1GO6Q%XSEBN8H-6T.[TU[FW
MDGM/,D1_-\M=S(=I.Q]O.#QP>>*37/!O]O:EK,L]R([;4=)CL!M&7C=9)'W^
MA'SCCVJO+X;U_6;VTN-=N].'V""9(%LU?][+)&8S(^[[H"D_*,]>O% &QX7\
M03^)--746TFXL+69$EMFGD1C,C#.["DE?QZY%86B>+=9EMM;EN]&NKJ2#5FL
M[6&W*$XX&UB.%5>I=N.?PKJ/#^G/H_AS2],E=9)+.TBMV=>C%$"DCVXKC]0\
M#ZQ<QZC;)<V$ME-JXU-+>;S%6X4@AX9L?PYVD$9Y'(H 36_&MS+H6JQK#)I6
MI:;>6*3_ +Y)%\N69!D.O&"N\'."*T;OQ;!?Z4E_;)?1:>=3M;:WNX65?M6Z
M95)4$']UDX)XW#..QK&'PUN9+37+=UT>W@U1K%A:6D!2&)8)2S+C'S;AWP,D
MG@"M*3P1=Q13Z=974":1_:=MJ-K P.;<I*LDL:XXVDKE1V+$=* 'S_$$P_;;
MG^PKQM,L+YK&ZO/,C 1@X3<J9W,N2"?3/?!J;5?'36']KS6NB7E_8:1E;RYB
MD10KA0S*JDY;:"-Q[>^*9<^#;J?PIKVD"ZA$NI:A+=HY!VHK2AP#[X&*Y'Q7
M=S:9'XOT73-0AC?4S(XLKBTD:YDEDB"D08.'5S@9_A);/2@#U*74TBT,ZH+>
MXE46_GB&",R2-\N=JJ.I[5S\?C:2&_FLM4T6>QG%C+?1+]HCEWI'C<IVGY6^
M8=>.O/%:&J:+=ZCX(ET:"[-G=R6:PB9<_(P !Z'.#C!QV-<M;?#R\341=I;:
M'IJ?V=<V1@T^)AN:4+B1G(!;E>A''J<T :^G^.9;VXTU)= O+:+58'ET^226
M,^<53S-K '*97)&?QQTJ[9>,+/4+;P_+;02N^M;BD9P#"$0M(7_W2 I]R*B3
MPS/$?"3-<18T.,K-P?WG^CF+Y?Q.>>U8O@/38+GQ+KFNV<S3:1YSPZ62A50)
M");@KGJIDX!_V30!T^M^(&TR^LM.M+"6_P!1O [Q01NJ!43&YV9N !N4=R21
M6>?&DTKVEG:Z!?OJ\ZRN]C*5B\E(VV,[.3@J6("E<[L_6K.N:+J$VMZ?KFCR
MVPOK2*6W>&ZW".6*0J2-RY*D,BD'![BLU?#GB2VU&UUV/4K*ZU<12P7,4Z,D
M!B=PZJA7++L(P"0<@G.* %D^(*-#8I9Z+>W.HW=S-9FQWHCQ31#+JS$[<8YR
M#C&/6DD\?31KJDW_  CM\UKI,FR_F66/]WA%=MHSE]H;)Q^&>E&E^"[NSU33
M-2N+V&6YCO;J^O-B%59YH]@5!S@* HY/.,UCVNE>(=6F\::;9W%E;Z=?:G)#
M+)-&YEB5H8@[(!PV0<#.,$9YZ4 =%=^,V^V7D.D:-=:K%81I)=S02(@7<H<*
M@8C>VTAL#'4<Y.*;#XX34-9M+#1]+N=0CN+2"^-RCHB1P2LPW'<<DC;G:.3S
MZ5!_PC&MZ/=ZB/#=U8)::BD>Y;Q7+6\BQK%O7;]_*JORG'(Z\U/H'@TZ!>L;
M>[_T==(MM.B;'[P-$9"7/;G>#^% #8_&TRW^G17N@WEE:ZE/]GMI9Y$$F_!*
M[XL[D!VGZ<9Q6;HWCJ^31)KG5=/EDO9M7GL;*WCDCS*5D<!<Y 4(J'+'TSS5
M'3?AOJ%K-HKR)HB3:;=QW$][%$[7-]MR"7=AE2<DXRP)[@"K5U\/KVZLI;>9
M]+N!;:O+J5DES"9(Y!*SEXYE/'_+3@C." <4 =3H/B)=9GO;.:T>SO[%D$\#
M2+(-K@E&5E."IP?0Y!!%4M>\77.BM?R)H%Y<65A&)+BY,B1*1MW'RPY'F$#K
MC SQG-/\)^')=#>_GFM=(M'NF3;;:7:K''&J@]7VAG)))R>!V'7//Z]\/[[5
M]3UN5AI%RNI+M@N[Z)I9K%?+"%(U^[C()!!!!8D@T ;ESXR9[I[?1M'NM5:&
MUCN[@QND8C20$HHW'YG(!.T>W/-8&H>,M0:Z\4^=;7]MI=GH\%W$\92.>$N)
M"3AAD.< 8(^4IR.:TK?PQX@T6=KC1;K3C+=V-O;W2W0?$<L2;!(FW[PP?NG'
M0<BJ^J>"-9O$UB%-3MYTU71XK">>X0K)YL8<"3"C&&\PDCMVH U+WQC+#=W\
M.G:)>:E%IBJ;V:*1%V$J'VH&(WL%() QU SGBHI/'1N;TVVB:-<ZJ?L,.H"2
M.5(T,4F[;RQ'S?+P,?EBF3^'-?L;S5_[#O-/6VU8B27[4KE[>7RUC9T"\."%
M4X..1UJSX>\(_P#"/:C*\,X>U_LNTT^('[_[GS,LW;G>/UH V]&U6WUS1;+5
M;3>+>[A6:,.,, PS@^]7JY[PSH^IZ!HVBZ2TUI):V=GY-PP5M[2#&TH>FW[V
M<C/2NAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMO'9O!>/),D<BQW* Q*P)#D$\].@Y.>*M_;[,WOV+[7!]KQN\CS!OQZ[<YH
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MSR21W47FPI!.EO>2Q+<1J,*L@5@&P..><<=*UUU?376)EU"T82D",B93O))
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M<A;>61-VU3NR>!W..M=*98Q*(C(OF%2P3/) ZG'IR*B>_LXHS))=P(@W99I
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M% &X/']G<S:7#IFF:CJ$FI6:WT2P(@V0E@"6+,,$9''Y9IP\>6A?[1_9M_\
MV/\ :?LG]JX3R?,W[,XW;]F_Y=VW&?;FJGA'P?J&@76D274UJZV6B_V<_E,Q
M+/Y@8,,@<8'US^=8EI\,YK)TL$TK0);5;LS#4YE9[CRO,W[#$5VE_P"'=NQC
MG&: .J@\9QW6J26]MH^HSVD5Z;"2]B5&1)@=IR@;>%!X+;<=^G-:FNZY;Z#9
M13S133R3S+;V]O H,DTK9PJY('0$Y)  !-<=?^"=5O/$?VU+?2K:?[:LZZS;
M2R0W/DAPWEO$J[9#M!3+-@CG&:Z;Q3HMWJT&GSZ=)"E_IUXMY )\B.0A60HQ
M&2 5=N0#@XX- '.>*/'5Y!X6UE;/3;ZPUNS6(/#+Y+-"DAPLP.XHZ\$<$D-U
M%='*VJZ?X(GDLX[JZU:*S=X8[THTKRX)57\OY2<X'R\>_>N>U+PAK>OP:W>7
M[6%MJ%_;V]K!!%*[Q0QQR&0EG* LQ+'HHQ@?6NQUFRN-1T>[L[6]EL;B6,K%
M<Q?>B;LWOSVH X'PYK<E[JNGI8^-I+V^9Q_:&E:M"EN^W!W>6@C5U93T&2".
MI[UT,OCRTB>:<:;?OI$%R;675%">2L@;83C=O*AOE+!<9SV&:H76A>*/$-SI
M<>N0:)!%87<5TUW:22/-(8SN 160>6&(P?F/!(YK(_X5G-#+<64>E:!<6TUX
M\ZZE=*S3I&\A=D,6W:[#)4-N QCCB@#9UKQU&+7Q!#;V.K11Z4DJ7.HP1Q%8
M75 XVAV^8X(QQCD9QFM"^\:16EQ>16VE:CJ$6G(K7UQ;+'M@RH;&&8%V"D,0
MH. 1WXJG>>$+^X\->,M-2:V$VMW$TMNQ9MJ!XHT&_C(.4/3/&*R=4^'MRVKZ
MK<VNE:%J U(K()M1+A[238$; ",)%^4,!E>210!OW/CJV6[EATW2[_5D@MH[
MJ>2S$9V1R#<A568,Y(&<*#^?%=%=W]O8Z9/J-PYCMH(6FD9A@JH&3D'VK@M?
M\"7]Z$@M[#1;E8K..WM+QG>TGL65=NY3&I++G#!=RXZ=*Z'Q#X=OM9\+VFA?
M:TDC=X(]0FE)5YH5(,F, _,^W';ACS0!E>!==UJXOY[#Q%)FYO+9-5LUVA?+
MA<X:'@#)C.WKS\]=M.Q2WE93@A"0?PKC[CP#:6&LZ1JWAR&*TN[.XQ/YLTA6
M6W92LB<YYZ$>ZUH>(+;Q0=06?0IK"6WDMF@DM;UVC5')RLJE58GC(*G';F@"
MEX'\4OJFD:#:7[2S:G=Z2+^2<JH5@&53TQSEAT&*D;Q]:.FG"STO4;NXU&2Z
MBMX(EC!+6[['W%G 4=2"3T'K@50L_".L^''T&;1FL;R2PTHZ9.EW(\(;E&\Q
M2JMW4_*1T/6G^'O!NJ:5/X>EO+FTE;3FU%KAHMPWFXEWJ5!'IU!/';/6@"W#
MXNM]3N-%*&_L9)M1GLIK5XXSB2.*1F20Y. -N04)SQV)I;7Q[:7+6<YTS4(M
M)O9Q;VNIR*GE2NQPORAMZJQX#%0#D=,BJD/@N^75;>XEFMC"FMW>H.H9LF*6
M%XPHX^]EAGMCO5>V\)>(#H^E>&;N33O['TV>%_M<<CF>>*%PT:&/: IRJ@MN
M/0X'- '0:#XK3Q#?74-KI=_';6TDL+7DP01M)')L95PQ8^H.,?B,5S&JZN\G
MCW6-/O?&S:!:6MO;/;QA[9!(7#[SF5"3C:O3UKK/"VCW&AZ5/:W+Q.\E]<W(
M,9)&V29W4<@<X89]ZK6WAA?^$QUK6+V&TN+>]@MHX%==SH8P^[.1@9W#&#VH
M QO#/C"^DT&22:*ZUV0ZE-9V-Q:0HGVN)1D2DDJBC[PW9 .WCK5V3X@VD&G/
M/-I6I+=QZ@NF/8A4:43LNY1D-M(((P0>_;FIO%_A^_U?^R_L*6\]I:RLUQIT
MUP]O'<*5PN616/RGG!!!_ 5A:5X U*Q/W=*MXO[>AU00VNX)'&L01D V\MD=
M>-W).,XH +OQOJ?G^*$O-.U+2[6PTN&Y5T6W>6W9A(6.-Y#$[1@=/D.<9&>@
MO_&<=G>7EO:Z1J6HKIZJU]-:JA$.Y=P&&8%VVD,0H/!'?BLSQ+X1UC5+WQ*+
M)['[-K6E1VFZ:1U>*6/S-O 4@J?,Y.<C'0U8ET3Q+I>HZP^@OIQAU9UF,MU(
MRO:2B-8RP4*1(,(I )7GVH 27QK:Z;/J3NNI7W_$SALHH(X4RKR0(ZJG()4Y
MY+<@L>PJ]'XRA^SZB+G2M1@O[ Q^;8!%DE<2'$938Q5@3D9SQ@YQBN4\1Z+J
MVD7$=U%<6TUU?^)+.:W:3(#;;<1GS !\N2C?=S@'\*T-1\)^(M735=1FGM+7
M4KS[+$MK!<R>6;>%RS1M,%5LOO8$A>!@<\T 2ZYX\N[/0?$ CT:\LM9TZP^U
MI#<&)P4.X"3*N5(4J<C.>. :EF\:1:7)?WFI1ZC&MKIMK<S67EQ-Y?F2.F5*
ML<L2.1G& ,<YK(3X=W\G_"0%+72-+CU31VL$@M9'DV298AW<H"^=W)P", 8/
M6KFI>#=<UB'4I;A]/AN;W3K.UV),[(KPSN[')0'!5ACCKGZT :Z>.K2"2_CU
M?3K[26M+,WV+H(WF0 X++L9N<X&T\\BI-/\ &/VK6[/2;S0]3TZYO(9)X#<B
M,JR)C.2CG!^8?*>16;XU\-?VC+J6I7-QY5A_8DMJ[1(TDJ/YBR!P@'S ;.F<
MGI63HNL7WB3XA:),U[H][%96%RTK:3*TR(7\L NQ VEL'"<D;3R: /3J***
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M"Y Y.!P,^U $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6\LH(.]H\X/(!(Z$C)!JW-X7TN?3-7T^2)S;ZM(\MV!(<LSJ%.#VX4=*V:*
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M^SE/GSD;2. , ?B:WK: 6MK#;B2601($#RN6=L#&6)ZGWJ6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6.9MI8# 8NN0I(W*,XJO;_$73;BRFOET[55M$D\B*5H%Q<S;_+\J,!LLV[V
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ML<A*N5*$]2"<>E8U]X4\17L-]J):"*\O[^":YL(+QXU>VB0H(?.50VXD[B0
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MW 'RWW+D$ ]/?BE%X.U^VT5?($ >#5X;^TTV:_DE2&-  8Q,REN3ENF!G H
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MO=5DO(B7.T(UR)1DXZ[1^= '<5S>I^,K;3]0N[2#3-2U!K%%>]>SB5EMP1N
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MQL&VM=+DEA8*%W":;&U')SP#\O'6@#U.F"6-I6B61#(@!9 PR <X)'O@_E7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^ES%-MEBF8;6*MZ$<$'(.>:(/!>E0Q(&:ZFG%]'?R7,TNZ669!A2Q] ,# P
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MQ\'Z5I[Z?)")VELIY;E99)2S2RRJ5=W)^\2"?TI+KP=I5W'>J_VA)+J]6_\
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MRE5!<_\  C6!XI&C#Q[;-XL%J=&_LQA:&^ , N/,_>?>^7?LV8SSC.*[G['
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MUG(+&':5>*,%1*F.Q#;0V>XKJ<5 ]G!)>PWC)F>%&2-LG"AL9XZ9^4<]?S-
M$]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN:+9:K:K(L%Y"L\:R !@K#(R 3S5Z@ HHHH ***CN)X[6VEN)FVQ1(7=L9P
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MW43>Q-?ZG!97LWVB>R@G586ER"7P5+#) ) ."><58U'P59W][>W$>HZE8IJ
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MZT_RTPHV+\GW>.GTH \;^'AFM9-#?7BLEO=6<B:(ZDB."0,_F(P_YZLN"&]
MRCWD\'Z/8:_<^&;;5K=;RV7PNDGD3$LC-YH 8KT) )QGIFO7_*CVJNQ=JG*C
M'0^U*L:)C:BC P,#H/2@#QO2FTY[/PQ#XJEC;P]'%?Q1F]?]P9TN-L:R%N#B
M(,%W>AQS77_"]K1M$U;[ [O9#5[D6Y=B?W>1MP3SC'3VQ6]K&ASZC);2V6JW
M.G2P!AB)5>*0-C.^-@5)!&0>HY]34VA:)#H.G&UBFEG=Y7GFGF(+RR.Q9F.
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M>6PG7@ G] :YSQ!KVFZSXDN&TK4(;N./PMJ#,]O('4$F(@9'&<<XZC(]:]0
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M00VZE88DC4G)"* "?7BI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX-0NIA:QWACM;1I"L+@D,<<#ITZ_6L?6='\11ZAXKBTW38+J#7H%$=PUR(Q
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M#>:L:Y150#(8DC=G &#C.: .Q\%^))O%&C2WL]I);NEU/" T90%4D95QGJ<
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M>^N;EDA?>@$DK.,'CL: ((_B#HDB7DJI?_9[1VBDG^R/Y;2B01^4IQ\SEB,
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M!BDV$D!P#U&01D=#P<5ROB;P7J.M:CK]Q"(\3_V=-:AIFC\UK=W9D++\R9#
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MF=9MNW(&W8%V_+LV[<=N]7-!\-Q:%<:A<B^O+VZU"19;B:Z92695VC 50 ,
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MFN;A+B.SALOMLET828Q'SD9'5L#.W&<4 9+>!HKF\-[J.M:I?71LYK$O*8E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)&TS>6-^/3=UIPMH!&L8AC"(VY5VC .<Y ]<\T <I\14CFT.RBDU"WLP]]&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&Q?*ADQO V*,LV!ECSP.E06?@7R;RRN;S7=0OFL;>2VMEF$:JD;J%.=JC+8
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MNT5&+QROO9'5E*LN<$<9&![U/8>"K&PN-.N5NKJ6YM+J>\DFE*EKB65"C,^
M!T/ & ,"MC2M5M=9M'NK0L8EFE@)9<'=&Y1OU4T_4-1M-*LS=WLPB@#HA8@G
MYF8*HX]68#\: *^F:-#I5WJEQ%)([:C=?:I ^,*WEHF![80?F:QK_P $KJ,\
M\4^M:@^ESW2W4E@VQEWA@V%<J75-P!V@^N,"MZTU6UOM0U"QA9C/82)'."N
M"R!Q@]^&%7: .<N/!UG<:'K>E-<3B+5[B2XF<8W(7VY"\=/E'6JE]X#CO)-9
MCBUF_M;'6"7O+:$1_,Q0(<.5+ $*,C/Y9KKB0!D\"N3C^(>BR-'+Y6HKI\L@
MBCU)[-Q:LQ.T?/CH3P&(Q[T :&G>%K/3Y[R4R27 O+2"TE27&TI$K*.@[ASF
MJ>F>#6TZ6QC;7M3N-/T__CTLG9%51M*J'95#.%!P Q],YQ744UVV(S$$A1G
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MD"1V%JBC9@+"H'R'*]NQZ>E-U"RFGMYVL)HK._D0(MV8!(5 .<$9&1R>,]Z
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M"<D\=_>NPM=)TZQN);BTT^UMYI?]9)%"J,_U(&34UQ9VMV8C<VT,QA<21F1
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M\MM]FDMXG@P!Y3("N!TXZ<8'Y4Z:"*YA>&>))8G&&1U#*P]"#UH DHI  H
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M11(4(=-Y"G!CP1D'!H @U/X@Z=;6VCW%BLUW%?W_ -C?9;2EH2 2X9 NX."
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MVSH6R<$D#Y36#=ZOK6I^(/!MS8#33=W-M?AF2Y,MK@&(;P5Y88' X(W8)X-
M'I-%<(?&NHKH!GN%TBRNH-1ET^ZN;JYV6T9CS\Z@D,V[ PHYYY/%4H/B'J=U
MI!-I;:==7XUE-*61'=;>0/&'609&X 9&1ST."<B@#T*ZM;>^M9;6ZACGMY5*
M212*&5U/4$'J*E    & .@KSK4O'^H6&K7&D2W&A6U]801M=-<R2!)I77<$B
M Y "XRS9^]TXIE]\2K@IILUNEAIEO>V"7<<VK%UCDD8D&$.N%4KCDL?XA@4
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M\L-N2&&.5Z4[X66)M/A_IEQ)'")[V%+F22,L6E+(#N<L3ESW[4 =G17G-O\
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MPF%=1EL\GL.:Q-.\536_CW7= M(T;5;W48W5+E\1V\0M82Y./O'AL*IY()X
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M =5!?VMS=W5I#,KSVI59T'6,LNX _4$'\:LT 8<7A:S$VMF=FGBUB-(IXFX
M58O+P"/456TGPO>Z?=637/B._O+6Q0I;V[*L8(QM'FE0/,('3.!GG&>:Z6LK
M3/$.GZPMH]DTTD=U"\\3F%@I56"G)(P#D]#R>?2@!NM:/=ZC-:W%CJ]QI\\&
M]<*HDBE5L9#QG@XP,'J.?4UFZ/X(L]'NM,N8KJ:26R^U,Q95 E>X96=L  *
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MW6HPZ7DV4,L:)L;:4#.5&78*2 >.I.,UU-% &9X?T:/P_H=MI<,KRQP;L.X
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M!QGID8-;5[K=E87RV4[2?:'MI;I42,L6CCV[L8'7YEXZG-78)EN;>*= P21
MZAE*G!&>0>0?:@#F)O MG)%=F*[FAN9-274K>X4 O;R!$3 SU4JF"#U#&MC6
M]&CURTM[>65HQ!=P70*#JT4@<#Z$KBM.JTM[%%?V]FRRF6='="L9*@+C.6Z
M_,, ]><=* ,*;P;;3>']5T@W4HCU&]>\>0*,HS2"3 ]LC%:FO:+;^(-)ET^Y
M>6(,R2)+$</%(C!D=3ZA@#4UWJEI97UA9SN5GOI&C@4*3N94+GGM\JGK5R@#
MF/\ A%]3F@OOM?BB_EN;FW%LLD:+$L*9R2J#C>>1O.2.V*@/P[TA(+ZRM6EM
M-.O;:.&6TAP%62/&R93V<!5Y[[03TK=77+"3RS#*\P>[:SW11LP65=VX,0.
M"I!)XSQ6C0!R%SX(GU.WN5U?7[N\EE2*)&\M(UC5)5D^XO!8E1ECVZ8JUX@\
M&6?B*YO);FYFC%UIQL&6/'R@N'W#/?('!XKI:* .0;P3/=7R7NHZY<74R64]
MBJK D<:QR@ D*!PWR@YS^5:'_"*V^SP^IF=QHL92-6 Q,#"8OF_ YK?HH \E
MT[0]7N;WPYIR0Z[;V>EWRSM:WJQ>1:QH&PJRJ-TW)"KUP#STKKK?P5-9LMI:
M:_?V^C+<FY6QB"J5)?>8Q*/F$>[MUQQG%=958WL0U(6&V7SC"9L^6=FT$#[W
M3.3TZT 5=>T:/7]*-A+*\2&:&;<@!.8Y5D _$H!^-8]_X,DN+K4S8ZW=Z?::
MJ=U];Q1HVYBH1F1F&4+* ">>F1@UU=4[O5+2QO;"TG<K-?2-%  I.YE1G//;
MY5/6@"EI'ANTT74KN[M&94N+>WMEA_AC2%65<'KT;]*-9T:\U"ZM[JPUBXT^
M:)'C90@EBE5L9W1MQD8X(P1DCH:T+"]BU&QBNX%E6.4942QE&ZXY4\BK- ',
M:'X)L]"NM-GM[F9S96]Q#APH\PS2+(['  'S+P , &JK> UBN;:\L=5EM[VV
MN[NYCD:%9%_TAMSJ5/IQ@YS^==C10!R5EX$AM&1Y-3NKF1=7_M=I)57<TIB\
MLJ< #;SG@<=*EOO"5Q)J6H7>EZ[=Z6NI!?MD<,:/N8*$WH6&4?: ,C/0'&:Z
MBJB:C;-JLFF[BMU'"L^UAC<A)&0>^",'TR/44 8&I^#KB]2:"WU^^AL[BV2U
MN()@MR&505W*9,[7(/)YR>2,\UJW/AW3[KPN?#LJ.; VHM0-WS! H (/J, Y
M]15R:_M8+ZVLI9E6YN0YAC/5P@!8CZ9'YU9H YBT\)3_ -HP7VK:U<ZG-:PR
M0VN^)(Q'O&&<[1\SD#&>G7CFM71]&BT?PY9:*DCRPVMLML';AF55VYXZ&K-Y
M?VM@L)NIEB$\RP1Y_BD8X51[FF:?JEIJ;78M7+&TN&MILJ1B10"1SUZCF@#E
M;/X>O:VVCV;Z]=26.CW$<]G ((T'R9P)"!EC@D9XZYP36A_PAMM_PC7]B_:I
M?*^W_;O,VC=N^T_:-OTSQ]*Z:F32QV\,DTSK'%&I=W8X"@#))/I0!QEOHIU/
MXHS:\UC=6UO8VP@#3@*MS/EP)$&>0L;L-QZ[\=JZ36M+FU2TB2VU&YT^XAE6
M:.: CJ,\,IX=2"<@^QZ@5E67CW1+Z[M85^W0QWCA+2YN;&6*&X8] CLH!)[>
MO:NGH XQO "/9W1.K3#4[B^AU!KU((U"RQ !,1XVXP.<Y)SDFGW?@1KA=1M(
MM;N[?2]3D:6]LXXT^=G_ -9M<C*!^XYZG&,UU5W<I9V<]U*',<,;2,$0LQ &
M3@#DGCH*?%(LT*2J&"NH8;A@X/J#TH Y>\\%L]U?-IFL76F6VHJJWD$"(=VU
M FY&(S&Q0 $C/0'KS27'@.RFBOQ'=3PSW%Y#>V\ZX+VLL<:1J5)Z\)SGJ&(K
MK** ,O7-$AU_2?L5Q-)$ZNDT5Q#@/%*C!E=<Y&01T.?2L67P.;^#56U;5Y[V
M]U"P?3O/\I(Q!"V<A$'&23DDYS@= *V=)\1Z7K=YJ-II]SYLVGS>3<+M(VMD
MCC/495AD=U/I6K0!6ELHYM,>PD+&)X3"Q'!P5Q6'H/A'^Q;JPN9=2FO)++3S
MIT9>-4S%O5ESCN @'O6QI&K6FN:9%J-A(9+:7<$8J5)VL5/!]P:NT <BG@5+
M2&R?3M4N+2_LYKF2*Z$:ON6>0R/&Z'AER1CH1M!S6[HNER:59/%/J%U?SR2M
M+)/<-DEF[*HX11V4<#ZY-6+N]BLC;B593Y\PA3RXRV&()&<=!QU/%6: .6N?
M"5U%J5[>:'K]SI(OG\VY@6".:-I, &10X^5B ,]CC.*C7P';65KIW]DZA<V=
M_8M*RWK!97F,IS+YH(P^X@'M@@8Q76US^K>,=,T?5O[+FBU">\$*SM'9V,L^
MU&)4$[%..5/Y4 5K3P1;V\MG<RWUQ<7D6HMJ4]Q(%S/*8FBP0!A5"L  .FT>
M]97_  BNK:AXI\62#5+S3;#4)(4(CC1A/&+=%8H6!*MG<N?TX!KK-%UW3O$%
MF]SITS2)'(8I5>-HWC<=59& *GD<$=ZTJ .5D\&&UNFGT'5I]($MM%:S1Q1)
M(K)&-J$;A\KA>,^F,@XJSH_A"PT._MKBR>41V^G+IZ1L<Y4.7W$]2Q).:T[G
M5[*UGN+>24M<6]L;N2&-"S^5DC( '.2I '4XJW#*L\$<R!@KJ& 8$'!&>0>E
M '%6WPZ-O8Z=IPUZZ.G:;>1W=I;B&-?F23>!(P&7[CMUR<FKJ^"$%]++_:<Y
MMVU9-62 QK^[E&=PW=2&R.O3%=%#>Q3WES:HLHDMMN\M&0IW#(VL>&]\=*LT
M <=_P@*^3_9O]L77]@?:?M/]F^6F,[_,V>9C=Y>[G;U[9Q5NX\&VUQH&N:2U
MU*(]7N9+B1PHS&7*D@>WRUT5Q/%:VTMQ/(L<,2%W=NBJ!DD_A5:WU6UN[B&&
M R/YUL+I)!&VPQDX'S8QGGIUH A\0:-'X@T2?3)I7B28H2Z $C:X;O\ [M4-
M3\,37?B--<L-5EL+LVOV.0B%)0T88L-NX?*V2>>0>,@XKHJ* .6T7P1;:*^C
MF.^N)AI?VL1&4 EQ<.'.X^H(Z]Z=%X+M8M0ANS<R.8M3GU+8RC#-+&T90^P#
M9K0UWQ+I_AW[(+T7+R7<AC@CMK=YG=@I8X5 3T!/X4S1O%6EZY=S6=JUS%>0
MH)'MKNVDMY A. P5U!(SQD4 9]AX'MM/FT_RKZ<VVG3W$EI P!$22H5\L'KM
M7)QZ=.U36_@^WM]'\.::+J4IH<L<L3D#,I2-HP&].')X]*Z2LO6]?LM MX);
ML3NUQ,(((;>%I9)'()PJJ,GA2?PH \W_ +!U:YFTW1K:VUNUM+75H[HVDRQ&
MU@C2;S"5F #2*0/E7J"PSTX[/QE#=7UQH%E:V=Q,PU2"YDE1/W<4<3!F+-VX
MZ#O74*VY0V",C.",&EH XJY^'QN%N;1==O(]+GOO[0^QK$G$OFB4C?C)7<"<
M>_7M6C<>#[>XT?Q'IQNI0FN2R2RN ,Q%XU0A?7A >?6NDHH Y:]\#VM[/J%Q
M]MN(;FYGM[F&:,+NMY84"JRY!!R,Y!Z@D5#/X$&H0Z@^J:M<7=_>I#$USY:H
M(XXI!(J(@X +9))R3FNCL-4M-2DO$M7+-9W!MILJ1MD"JQ'/7AAS61J/C?2-
M-OKBT9+^Y>UQ]J>SLI9TM\C/SLBD X.<=<4 =#(BRQM&XRC JP/<&N)TOPI<
M2^'--TV:>XL=1\/W#1V-[&H.Z, JAP1AE:)@&'J#Z5U,&MZ;=-8K!>12&_A:
M>UV'/FQ@ EA[#<OYU?H YC_A$))XHCJ&M7EY<KJ$-^9'P$!BQM1$'"+QSCDG
MDDU&G@A$N9&.ISM;G5UU:. QK^[DRQ9=W4J2W?IBNKJGI6J6FLZ=%?V3E[>4
ML%8J5)VL5/!]P: ,74_!=GJEWJMS+=3QRWWV9D>+ :WD@),;H2#SDYY]*ANO
M!ESJFG:G;:OX@O;Q[Z!;?(18XXD!SE8QQN)ZL<GL,"NLHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "N3\>7:166FV7^F-+?7JPQPVMR+;SB%9BCR]50A>=O)P .IK
MK*K7^G6.JVIM=1L[>[MR03%<1+(I(Z'!!% 'D5O<7K6OB72(]4@L$@U&R2*!
MM4FFB!<9>#[1@.@<C!QT)(KLO -UB;6=,>WO+6XLYHVDMI;[[9%%O3($4A^;
M!P25;H3VS72+H.CI:RVJ:58K;RHL<D0MT".JYPI&,$#)P/>IM/TRPTFV^S:;
M8VUG!G=Y5O$L:Y]<* * /*M6*Z3K7C:>TO+BTDEU&PBN)UN7W06\HA\V0 D@
M8R<-CY1TP!73Z0D.D_$,:3I-Y<3:?+I;7-S!)=/.(9!(HC8%R2I8%^,\[<UU
MKZ5ITEW+=O86K7,T7DR3&%2[Q_W"V,E?;I3=.T?3-'B>+3-.M+*-SN9;:%8P
MQ]2% S0!R.II;ZKX^O['6=0N;2SL]-BN+-(KQ[<$LT@DERI&2NU!SD#/3FN7
M\*07.IZ5X?TBVU*YACNO#=]LEBE9,2>?$$DX[C/ZGUKU;4-'TS5?*_M'3K2\
M\EMT7VB%9-A]1N!P:D@TZQMGB>"SMXFB0QQF.)5*(2"5&!P"0"1ZB@#RJZ\0
MZEXD\-Z[JRSW%H=&T&6WF2*0IB_929>G= BX]-YJQJ2V^K?\)>^M:K=6TFG6
MD8LT6\>)8XFMPWF;00'W.6!R#G;MKTW^SK'[/<6_V*W\FY9FGC\I=LI;[Q88
MPQ/?/6H;S0M(U">&>]TNRN98!B*2:W1VC'HI(X_"@#RFWEU#4;S3=-DB26SM
MO#UG-;PR:Q)IXRRG?*"BDN1M Y.%_&K^A177B35?#]GK&JW%U VB3S2&SO)4
M2Y*SJJ,S+L+?*>N!D\]*]%O= T;4H((+[2;"ZAMP!#'/;HZQ@<?*"..@Z5;2
MSM8YDF2VA66./RD<( RIP=H/8<#CIP* /*]'GFU/_A&]'U?4;S^S6EU.,N;I
MT>Y>"?9%&\@(8X3<<9YV\YQ5*R@,FFSV6F:LEQ&WB2Z"V]S?2P_;U6,?)YZ9
M;(ZC/WMO.:]8N-$TF[L38W.F64UF7,A@D@5HRQ));:1C)))SZDTV30-&EL&L
M)-(L'LV;>UNULAC+8QG;C&< <T 8W@&]2[T*XA5;U'L[R6WDCN[D7)C8$'8L
MH^^@W  GGL>E<5=W+'P=JWB9]5O$\3VVH31Q1"[<"-UG*1VXASM*LH7@J2=V
M?>O6+2SM=/M4M;*VAMK>,82*% B+] .!5=]#TB35%U1]+LFU!>ETUNAE'_ \
M9_6@#E_"MA]N\5^(]4NKN]DEL]4>WMXC=/Y4:&&,D;,[3DL>H/08Q5J34A:?
M$ZYANKWR;7^Q(Y5267:F1-)N;!.,@;<GTQ7416T%NTK0PQQM,_F2%% +M@#<
M<=3@ 9]A5>_T;2]5>%]1TVSO&@;=$;B!9#&?5<@X_"@#ROP[.FN3>#[;5=7O
M/LUUI=Y*8_MCQ_:G69-H8A@3A<GKV],U-IMY+J=_I.BW^IW;: ]]J,4$_P!J
M=6O!$RB%&E!#, #)W^;RQUQ7<7O@S2]0UJSO+BUM)+*VM)K86$ELK1DNZ/NP
M>!@IZ=ZUKC1],N].73KG3K2:Q4 +;20*T8 Z84C'% 'EYEN+F]@T6WU:_?28
M_$XM(9X[M][0_9&=X?,!W,JOE<YR,=<@8Z[P?&UAK_BC2(I[B2RL[J$VZ3S-
M*8@\",RAF).-Q)QGC-=)%I>GP06T$-C;1PVK;H(TA4+$V",J,?*<$]/4U-';
M0132S1PQI+,09750&<@8&X]\#CF@#RGQ*EMJFD_$"YUC5+FWO+#S8+6%;MXU
MBA\A2F(P0&$A9@<@YSCM3[ZYO)/[<M(]8^PJ++1UB,TTD<67:3<FY.8]^ I8
M<\BO2+W0M'U&Z2ZOM*L;JX12BRSVZ.P4]0"1G')X]ZE?2]/E2=)+&U=9XUCF
M5H5(D1<[5;CD#)P#TS0!Y9]HF&EZOHJ7$VCWL5W9EK>YU5Y[9Q(3B)+A?WD8
MDV'.>F1C@TG]IRP6KZ*[ZCI4?]LVL&H@ZD;A((9(V($4_P!]59D4$$@C?QC-
M>G0>']&MM.DTZ#2+"*QEYDMDMD6-_JH&#3K?0])M=.?3K?2[*&QDSOMH[=%C
M;/7*@8- 'E_B7;I__"1:-IUU-<:5#'ITY26X:86T[70!0,Q)&556VYXZ\9J_
MK&N/9>%OB3YNIO#<V]S*MMNG*O&&MXM@3G(RQ.,=\UZ#;Z'I%I8&PMM+LH;,
ML'-O';HL98$$':!C.0#^ IMUH&C7UX;R[TBPN+HH8S-+;([E",%=Q&<8)&*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R?C;Q3-X=.E
M0V]SIMK)>SNK7&I,1#'&D;,2<$<YV@<_Q4 =9165X=O;G4-'CN[J\TV\,A)2
M?3B3"R]L$D\]>]:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D
M2:$[Z\NJ?VQJBJ"#]B69?LYPN/N[<^_7K5;Q ]Y:ZEIE_!H4>JP0^8LIC5#<
MP%@,-%O8#!P0PSGIZ5T%% ',>"M*N].MM5N;NT%E_:.H27D=EN4F!&55 .W(
MW$J6(!(RU:&F:$^FZA/=MK&J7@F! @NIE:./)S\H"@C'3KTK7HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex31articlesofincorporat006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J:IJ5MI&F7.H7;%8+
M="[;1DGT '<DX '<D5@WGC0VVL/I4/A[5[V[BMHKB=;40D1"3=@$M(N3E6Z9
MZ4WQ[G^S]&W?\>W]M67VCTV^:,9]M^RLB3Q%HWA_XJ:XVKZG:V(FTVS$9N)
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MQR*&(W(8(PPX[$9'XU!X@T[3]/\ &%]87Z^'K/28+"(:9#J\;>2J?,9?)PP
M?=UQ\WW<4 >R$X&3TK%\.>(H_$FE_P!IQ65S:V;G,$ER4'G)V<!6) _WL'VJ
MMX6M6NO &G6NIN;\26@21KF$J94(XWJW/*XSGK7FWARRT.UTKP8NO06<.@3Z
M9+,?M"JMO)>DH TN?E+>6&V[O0XYH ]K) &20!ZTM>,V.G66L7VA:?)&T_AZ
M37;X6$3D^7);"V+ #UC\P/@=, =J[CQY";3P,UO:H\5C%+;1W*V^04M!(@E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLRK'?ZB;><%<Y3R9'X].5%2IXKTR31K355:7[-=W:V<1V<^893$,CL-PZ^E
M&W@9S@9IK11NNUT5ESG!&1FN7D^(6CQW$Z&#4#;VUX;*XNQ:GR890^S#-Z9(
MY&<9&<4\^*[/3VU9[N[FN3#J*V4-O%:_O/,:-&$2 $^8>2V>.I[#- '3[1G.
M!GKTI&C1V5F16*G*DC.#[5S,GCW1[?3KR[NTO;5[*:*&YMIK<B:,RL AVC.0
M<\$9Z'TK2.K/<>&+C5(;:YM)%@E=(KN+9(I4'&Y?PS]* -1HT=E9T5BIRI(S
M@^U.KRAO$_B'3O!5AXGD\46%]-+#;S-I;6B*TIDVYC5E;=N^8XX/3D5V.I^.
M=-TJ:\$MKJ,UO8L%O+N"V+0VYP"=QZG ()V@XSS0!TBQHF[8BKN.3@8R:<
M, 8%<OJ7CBRLM1O=-MK'4;V\M(Q)+]FMBZ1ADWJ6;. #_0U1T#QG_:%IHU]J
M5P;(7&C27]Q ]OM0[?+W2A]Q(4;C@<Y!SVH [,Q1F42&-3(!@-CD?C2O&DFW
M>BMM.1D9P:X^[\>6,NDWKJ-0TR3[!+>6UQ=61Q)&BY+HI/S8R#M.TD&K-SXY
MTZSN[FS^S:C=SV4,<UTUM:EA&C+N#GGTSP,G@\'% '4X&<XY]::T<;IL=%9/
M[I&16!=^,=/@>".SMK[4WFMENP+"#S,0M]UR20.<' SDXZ5G+XY2\\1Z'::=
M;S3Z;J=A+=BY$)XP4"]2, ;CNR,@E: .P>-)$V.BLO\ =89%+M!&,#'I7&V'
MCNR73M*B(U#5K^[L$O5^RV6&EC)P7VYPG/8GN!SFKQ\<:3)8Z=<6<=Y?/J*/
M);VUM 6E*H<.64XVA3P<D<\<T =*1D8/2C&!@5EZ#K]EXCL'O;#SO*29X&$T
M9C8.IPP*GD8/K6I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5C>(&UV%;.YT.*&Y\J8FYM)
M'$9GC*D85R#M(8J??!%;-->1(EW2.J+ZL<"@#SN+PMK]KI]EJ2VMM+J<>NS:
MO+8BXPH2573RUD(P6 <') !(-*/"^OWM]=W]Y;6T$ESKMCJ B2??LAB5%()P
M,M\OY]*]"CECE&8Y%<#NIS3Z .#\1>%-3U._\0S6ZQ%+Z/35AW/C)@G9Y,^G
M!&/6H[K0O$=I9>(]$T^QM+BUUF>>6*]DN-GV<3C#ATP2VTDD8SD8!Q7?22)%
M&TDCJB*,EF. !]:5'61%=&#*PR&!R"* .:\,^'KC0]8UB1RK6TZVL=N^?F81
M0A"2.W(J/7_"L6O>,-%O;ZPL[W3;2VN4ECN8UD&]S'L(5@0?NMSVKJJ* .9U
M_09X/"TMAX4@@T^0RQN8K3%MO0,"ZJRCY&900&QQ7&W7@76;L:^]OIR6B:AH
MQLX8Y]1>YE,H?=F1W)Z@]B0,>]>L4@92Q4,"1U&>E '-ZQIFHOXL\.ZI9V\<
M\%HL\%RIEV,BR^7\XX^;&P\>]<[H/AKQ!X6CT>]@L8+Z>+2_[/NK47 C*D2%
MU=6(P1\Q!'';K7H4US!;[?/FCBW'"[V"Y/MFI: /*O&&D:XOA_7=9U<VK2-X
M<EMY?(/RK)YK.% /) 4@9[D=!6W<Z9XHUZ^@OY8+32;G3["YCM9%G\X27,J!
M0^-O"+C//)STXKMY8HYXFBFC22-QAD=00P]"#3Z /,]'\)ZRGB;P[JEQI\D)
ML3*+R:ZU5[J65GA9-RAB55=QZ#!YZ#%2:-X3UVWM] M[JV@C&DB^A9UG#"59
M%^1P,#&22,'IBO1U96SM8'!P<'H:6@#B+?PMJ":!X&L9%C$FCO$;S#] +:2,
M[3W^9A7(6]]=C1O"'A^VDTRZM+;5[6.*YAN299XXI,_ZDJ"C!5R^3Q@^O'LU
M58M,T^"\DO(;&VCNI/OSI$H=OJP&30!B^-- D\1:?IMHL$,\,6IVUQ<138*M
M"CY<$'@\=N]6QX;TK3].O8='TFPL9+B%XS]FMTBW$@XSM K9HH \\U#P7?3>
M&?""?9TN;K0X$CGM%NF@\T&$1N%D7!!! (['D'K3(/!M^=/D>/3;>QEFUBRN
MO)^V23R"&&1&)DD=B"V V O &!DUZ-10!Y?J/@6_2_UU(-(BU%-4N7N(;B75
M)H(XO, #++$C#< <GY>H.#BM^V\,7EK)XI5$B$6H6D,%KM;CY(#'SG) SZDU
MV&Y=VW<-V,XSSBEH \_U?P;>W.A^$RMNMS<:+"L<]HMTT'F@Q!&VR+C!! ([
M$9'>JT'@W4[>./5K32[2UOK?4TO(K)[V29IHUB:(K)*Y8;\.Q&!@8 YZUZ31
M0!R_AJPUA?$6NZOJMG#:+?BW$$,<PD91&K [B !GG/''/M4>L1>(X=5NS'IE
MGKVC72)LM)Y4B:V<###YE(=6Z\G(.>U=910!YO:^#]9TO2-*DMK.T,]MKCZD
M=.AGVQ01.CIY4;$8^7?NZ 9)QVHF\,>(?^$8O?!L5I:MI]S<2[=3-Q]R"24R
M-F/&3(-Q48X/!R*](I"0JEF(  R2>U '$Q:=XGT2?5[+2+2TFBU"^>[@OYIL
M"W\S&\/'C+$$'&#SD9Q5"U\%:GI.O7GB73UC_M235)7DC,ORW5E)MRA[*P(W
MCW'/6O1@<C(Z44 9VEZA<7TVHI/:>0MK=F")@^X3($5M_08Y8C'."IYKDKK1
M/$=C!XCTG3K&TNK;69YIHKR6XV?9S,H5Q(F"6VG)&W.1@<5WU% '+^%_#EQH
M.KZH[E7MI;>S@@?/S,(8MA)';FJ_BS2M9O\ 6;&2"*XO-)2%UFL[?4&LV,I(
MVNS*067 (VY[YP:["B@#SGPUX-U?2[K1'N8;:-;+4K^YD6*8NJI,K; I(R>6
MQSSQ3?$6E'2?#/BR]O[FWM99-3_M/39&D&3)''$8P.^XM$1@<D&O1]R[MNX;
ML9QGG%0W%M:W;1I<PPS&-A*BR*&VL.C#/0^] &3X/TR?2O#5M'>#_3[@M=7A
M]9I27?\ (M@>P%<I)X5UL>)/M=C81:;<MJ GFU&ROG2&>#?N(DM^0TA7Y3VS
MSGM7I%% '!R^%-3?P/J>DA(OM5QJ[WB#?QY9O!,,GUV#IZUC>)_!WB77(/$%
MK+;F\FNI)#8W,NJ.EO#"0-J>0.-XZ9(P3R3VKU6B@#CG\*75]_PF<-PRP1:Y
M#'%#(IW%?]'$9)'LV?K61H?A#4(M1TQY]#M;5["-R]S-J4]TKR>64!BC+ *#
MDD[ATX [UZ110!YUX8\+ZSIFOV$\6GIHUI"K_;X;?4&EM;IBN%\J$_ZL;OF[
M8 QSFM[6].U2#Q38^(=*M8[UHK26RGM7E$3%'9'#(Q&,@I@@XR#[5TVY=VW<
M-V,XSSBEH X&T\)ZO]HL+^Y6W2YD\0/JUU#')E88S;O$J@X&XCY,G Y)K<\9
M:3-K&DPP1:9::E&EPLDMM<2-$Q4 \Q2 _(X)!!],CC-=%10!YK'X8\2PZ-"R
MQM.UKK,5]::?=7YE>*!4VE#,P.3DE@.0!QDU+<^'?$<>A:YX7M;*UDL]4GN'
M34'N,>3'.Q9PT>,LR[F P<'CD5Z+10!PT.E>)/#MQK-KH=G:W4.I3BXM[N>?
M;]F<QI&WF)C+ ; PV]<XXZU17P1JMCK^I>)['RCK1U(21@RE4NK0Q1H\;#HI
M)5F![%5[5Z&]Q!'((WFC60J6"LP!('4X]*6*6.:-9(I%D1NC(<@_C0!B>+M)
MNM:T.*UM%4RB]M9R'; VQSH[?HIK&\1Z+K=_XE>7[/+J&E-;(EO;IJ;VD<,H
M+;FE"<N""OKC!XYKMZ* .!\&^$M5T2ZT![U(0MAI%Q92E'S^\:='7'L54UGS
M?#:;5TTVTU>)39Q7FISR^7,0RB>1FB88[C(/L17IU% ' 2^'O$FH'37U(6\E
MU9Z??V4LZR8$[2"-8Y,=MP0DCL:MGPO>O:^"X9 @32H6CO-K\KFT:+Y?7YF%
M=F2%!)( '))[4H((!!R#0!XY::C>3:?X'T.%]+N;6VU&W2*YMKDM)<1Q*V&\
MG:#'A5^;)X/'>O0?%.E7]W<:/JFF1Q37>E733BWE?8)D:-HV4-@X;#Y!/''O
M6O#IFGVMU+>0V-K%<2?ZR9(E5V^K 9-6E8,H92"",@CO0!Y[=>%M<U>^NM8N
MK:"UGN;_ $UUM!,'\N"VEWL68#!8[FX'H!FNEMM)NHO'>HZNP3[)/I]O;H=W
M.]'E9N/3#K6]10!P7B+0-=U+Q#?,UO)?:?- B62#4Y+:&V;!#F6-,&3)(.?F
MXXXK6T;3;G1_AI:Z9>*JW-IIGDR!6W#<L>#@_A73TW*2H?NNC#![@T >:^&+
M'7=?\-^"H[JRMK2PTZ&WO1<K/O,^V K&JI@%?O@MGT(&<YJI#X.\2W$NC2ZA
M:M-J%EJ4-S>7]QJKRK,JOD^3%]U!CG&%QC'.<UZI"L20HD 18E4*@0 * .@&
M.U/H X/_ (134_\ A!?[)V1?:_[8^V8W\>7]N\[KZ[.WKQ5?5-'DM-'\:6^K
MR6UGI]]<-?6FH-< ;9/+3:"I&05>('WKT2H;FTMKR(175O%/&&#;)4##(Z'!
M[B@#GO 5G=P^&8[_ %% NI:K(U_=C&-K28VK_P !0(O_  &L+7/ -YJ_B;5F
M+Q+I%Y:2S1C=\R7SQ"'?CT"+G/J:]$I-R[MNX;L9QGG% '!:;X4UB.S\.37W
MDMJ,>KRZEJ;*_&7CE7"^N-R+]!4>B>&-:M+G0(KJV@2'2=3O9C*LX;S8Y5E*
ML!C(.9 ,>V:]"HH P= TFZT[5O$5S<!!'?WZW$&ULDH(8TY]#E#7-ZCX8UJX
MO==@BMH&M;W5K+489S. <1M '0KC@@1,0>_%>A44 <)XN\&7WB/4=8:)XHXK
MK2[>"%G<C,T5PTN&QR%/RC(YY-.\->&[FW\1IJ4^AQZ<D%LT2F74I;N5G8C.
MTEMJIA>XR3CIBNX5E;.U@<'!P>AI/,3.-ZYSMZ]_2@#GM?3Q%#J<5UIEM;:G
MIS0&&YTV>18CNSD2*Q4@\9!4\=,5R,GP_P!1OM+U:86-EIDMU?6M[;Z5!.PB
M4P_>W.@&UI.<E1QA3DFO4:* /+KGP1J%_IFM^3HL&GS7-FEK L^H27,KGS [
M;G9BJIP, #.<G(Z5N^+?"%WXDU6YV2)%;7&B7%AYI/*RO)&R\=Q\IS79LRKC
M<P&3@9/>EH \YTGPGJ']IVUQ+H-G926MO*OG76HSWBO*R%!L0O@)R<[N2#@
M=:D\*>&=7TK7K2:.P_L:PCA=;RUBU!I[>XD(&TQ1G_5@')SP<8&*]"HH X^]
M\(OKWC*YU/59+F*TMK9+?3Q:7LD#\DM*S&-@>3L&,_PYJQX0\/W7AB?5].4E
MM':X%Q8,\QDD7>,R(Q//#@D$DYW&NF1U<91@PR1D'/(.#^M.H X2+2_%>J:W
MHB:W;V@@TB\EN6OXY@3=?(Z1A8PHVG#C.?3C-9\7AOQ/'I>G:!]@M/LEAK*7
MIO?M7^MA%R9<!,9#8;G)Q\O&<UZ72,RKC<P&3@9/4T <)<^%-3E\&>(-+18O
MM-]JLMW"-_!1IPXR>QVBH[KPIK$>J7>KVD<$MQ#KHU*W@DEVB>(VRPLI.#M;
M[Q&?0>M>@44 >=W_ (7US7+J^U:ZM8+6XN+C3EBM!,'*0V\_F,SL!@L=S8 S
MP!SS7<ZI;R7>DWMM%CS)8'C7)P,E2!5NB@#E?"?@K2-$T32/-T/2X]6MK6))
MKB.VCWF4( QW@9)SGFN7\4>$/$FN)XAM9;=KR2[:3[!<2:H\=O!$5&U/(7@N
M.>2""3DFO4J165QE6!'3(- '+Z7H-[!JGB.XG6-$U&&W2(ALD%(=C9^AKF;?
MP/K6HZ-I^G:A##9^1X<N-&=TF$GSGR@CC '!$9..W2O3Z* .#U2S\8:]X;O]
M)FT^QL4?2Y[9L7'F?:)F3:FPX&Q!R23SR!CO5*TEUZU\7>*;72],MKPM!9QE
MI+CR_*D\C +<'<OTYXZ<\>D!E+%0P+#J,]*8D<*S2NB1B5L>8R@;C@<9_"@#
MSC_A#M;T_P"P:=Y<NJZ7:Z;!:P1IJ3VD<<R AWE5.75OEQUP!C%2Z#X5US15
M\)%K:"8V%C<V%X%GV[/,="'7(^8?)TX/->C44 <+X.\*ZGHEYH\MXL06TT".
MPEV/G]Z)-Q ]L=ZQK*QO/!U_HDK/8/J)MKV![.XNO)$D37'FATD*E=PRN5/.
M#[5ZEN7=MW#=C.,\XJ"\T^RU&(17UI!=1@[@D\8< ^N"* .4^&DD]QX>O[RX
M\DM=:K=S!H&+1L#*1E"0-RY!P>_6NSIL<:11K'&BHBC"JHP /0"G4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<+\4UA?1M%6XL6OX3K5J'M%17,PRV5 8@'/3!.*[JL[5M
M&MM9%D+EI5^QW<=Y'Y9 RZ9P#D'CF@#S^UTU[/7UUW0?"<GARSL;"Y-UYR11
M"[8J#&OEQN<[2,[CCTJ1_&7B*STC09+ZXLEN=>43Q/;Z?-,+.(1AV!1&+2,=
MR@= ,G/ KT>[MDO;*>UE+".>-HV*GG##!Q^=8UUX1LKC2M*LH[F[MI=)55LK
MR%U$T>U-G4@J<KP01@^E ' :]JFK>)] AL;DPB.+7;.W::?3)8XKV-W0JWE2
M," #D,O(..",U:G\=:G;-J<>F)$L.CS-9PZ=%H]Q(+KR@ P$J?)%D@A1SC S
M78Q^#+(6JQ7%Y?74WV^+4)+F:13))+&05SA0H7Y0-J@#%17O@>TN[F]:+4]3
ML[34)/-O+.VF58IVP 3DJ67< ,[67- &3/XE\17&I^(I;-[*WT[1K=)A%/;L
MTLI>V\P*3N 7#>QSG'&,FC<>,/$-A8:$M]<V27.N(;E)+?3IIQ:1+&K,NQ&+
M2-EU&?E Y-=G_P (S8YUHAI@-8C6.X 884"+RQLXX^4=\\U%>^$[.[L=+@CN
MKNTN-+4+9WD#J)8QMV$<J58$#D$$&@#F+7QIK=[';:7%%&FI76I&SAOY[&6&
M)XA$93*(G(;< I7;G&X9SBK_ (-CU"+Q=XN34Y8)KD36N98(RBNODC!VDG!Q
MU&3S6@?!%B^G>0]_J+W@N_MJZBTP^T+-C;N!V[0-OR[=NW':KFA>&H-"N;^Z
M6]O+RZOW22XFNG5F9E7:"-J@#CL!CCB@#DM=T267Q=J6J-X=T[Q9:21Q0F"2
M:/SK$JOS(JR#;ALANJGGZ50LY3)/X&M] O[FWLXM0NX'MM1B+RPND4I:)\,/
MNC* <X^4Y.,'LM1\'0W6KSZI8ZMJ>DW5R%%R;&5 L^T8!975AN XR,'%-'@?
M38[/3(;:YO;>73[IKN.Y24-+)(X82%RP.[=N;/'?C% &"OBWQ!_PCJ>,"UA_
M8[7 ']G^0WFB R^6'\W=C?\ Q8VX[>]:%GJWB?6IKW4-+?34L;74)+-+*:)M
M\R1R;)',H;Y3D,0-IZ#/7BR/ .GB00_;M0.E"Y^U#2C(OV<2;]_]W?MW?-MW
M;<]J?<^!;"YNKD_;M0CL+NX%U<Z<DBB":3())RN\ D D!@">HY- '*^$_$5P
M?%6H^&[%8X7;6;ZYGN+F-MKHL@S'%T#/\P).<*.<'I7J5<X_@O3&CPLMU',N
MI/J<<Z.HDBF9LL%.,;2"5((.0:TM*L[NS:_-U=/.)[MYH0[[O*C( " X'&03
MCMG&3C) .!U'X@ZK]NUF33P"FF7+V\5@-*N9VNS'P_[Y/E0DY"\'& 3UK1UG
MQCK.G^(;718(+4S:TB/I4DPV^1@?O1,N[)*CE<8W$[>HS6M>^![2ZN;UHM3U
M.SM;^3S;RSMIE6*=L $Y*EEW #.UES4E[X'TG4'U&6Y:Y>XO/*VS[P'M1'S&
M(3CY-K?-WR2<YH S_P"U?$^KWVLG1)=-B@TJY^RK#=0L6NY%17?+AAY8^< <
M-ZGTK%U'X@:L;[66L JKID[6\=C_ &7<W#7;(!O'G(-J9.57@XQD]:Z:_P#
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M5"C;MQA1@#%(/ =A''!);:AJ-OJ4,LLW]I)(AGD:3&_?N4HP.U>-N!M&,8H
MPY/%WB26>UT:#^SDU7^UY-,GN6A9HBHMS,LJINR#M*_*2>01GO5;Q!J/B76?
M"GBX0W6G+:Z9;364Z-;-NNG$ ,K@[_W8^<[1ANG)YKK;+P7IMD]C*LMU)/:7
MDE\9I9 SSS/&T;-(<<_*W08 P.PQ4&K>!++5I=2QJ.I6=OJ:XOK:UE58YSMV
M[CE25.  =I&<#.: ,#5/%.H:='%:6>J6%L;?3H98[=;&:]FE8H3\ZQD>6O
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M2INV*Q8;0$"KR>PQ^.36IK'AR+5;ZWU"&^O-.U""-HENK1D#&-B"48.K*1D
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MOKQS;)=NEG:/*8HG!*L^!QG!P.O!XH T=1T:"]T2YTJ$BS@N%\N0P*%.P_?
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M<"SU5KJ:-I19K82&=(U8J7=,949'&>O;- '0+:VZW#7"P1"=AAI @W$>F>M
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MJRJ1ELM\N!DYXQDTZ/QMH_V>]ENC=6+64(GFAO+9XY/+)P&52,L">.,\\=:
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M4LEK;S0>1)!$\/7RV0%?RKC+GX@6]WJ>@6^DI<>3J%^(?/GM'6.>'RW):-R
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M<C/;'%,T?PUK0\5^']4N-.OHDLUF6[EO]5^TR,SQ$ HH8JJY],'GH *]+HH
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MMQ*X+;45&/EJ!CDECST.*GL/%OB#7]7TNUTVUL[&.XTR/4+D7L;M)&?,*-&
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MB?!3:@<# QGG><YK+TWP6NG36*'6]4N+#3SFTLI70)'P5 +*H9PH. &)Q[T
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MF:2<* 2Z)MRR893O^[R.:IWOQ L4;07L(KBY@U*]>UD(M92\)17+*5"Y#AE
MVGG&X] 30!V-%<Q%XOL+:P,U[>?:99+ZXM8(K.TD:1S&[ H(P"S%0.6''&>
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M$:2V:>UDB2Y4#),;.H#\<\=N>E3>'O%>E>*(GFTF2>:!55A,]M)&CAL_=9@
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M&#*DDC. .N!N&#BN>\*6^L:_X(\,:6NCM;VEO=PW;Z@9H_+,<4N\!5!W[V(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKVTTY=):]%K)#'O\X(9_)$H8G'WB#MQT[]J?<>,]<71[_P 3P6E@=!LKB5#
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M=AY( .#M JQ<Z=I&H>(O#NE66IW]W81:I>QOFX?,>+?<84EX8H"<?>/4KGC
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MDGBTFPCFD<2/(EL@9F!R&)QR0><^M:-% %%=&TM-2.I)IMFM^W6Y$"B4_P#
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M8&F7&C:7=V4=E<Z;9S6D6/+@D@5D3'3"D8%7:* *<FDZ=-9R6<NGVKVLAW/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG?R#),!-&78D[=H4E2<#>>QJ3QIK-T-1\71:?JDT9M=+L=ODS']Q(T[Y( .
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M>;<EA'MC8K\HR<D#"\>O6K%>4Z-K-Y=RZ#*FHW$L-QJ&L_,)F(D13)Y??D
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MEH_+5B@7@;BV%X /7'6NF3Q=H,FBMJXU*/[$DODL[*P829QLV$;M^?X<9]J
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M;:Z790V,F=]M' JQMGKE0,'-5[3Q5HE]:PW%O?HT<UU]C3*,K>=C/EE2 5;
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M$(G,6#GRRVW=Z=0163/XU\.VT%K-)J2;;M9&MPD;LTH1@K;5 ))!/0#/?H*
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MB=H.1CD<&@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8D9P1QQF?6/BC#8ZAJL=M)HWD:6VR2*\U$0W%RP4,PB3!Z9P"?O'(XZUH3>
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M*W6%((6R2%0$Y.3DDD]!TI4\):M:W(OK'Q"D&H2VR6UY*UB'CG"%MCA-PV.
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M_EFIW,VU<9V_6E$WB"?3&TP:@C-%K!BCLCK!6XGB$.XVYN5&[>K'=SR5 !-
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MTK3]'M!:Z;9P6D&XMY<*!02>I..I]ZJ7/A7P_>7_ -NN=%L)KOS!(9G@4L6
M !)QR?E'7T%:]% &7J?AK1-:N([C4])L[R:(;4>>%7(&<XR1TSVZ47_AK0]4
MNHKF_P!)LKF>%0B/+"K$*#D+R.F>W2M2B@"E:Z/IMB\3VEC;P-#&T49CC"E$
M9MS*,= 6 ./6JD_A3P_=:B^H3Z+827CD,TSP*6)!!!SCKP.>O%;%% $5U:V]
M[:R6UU!'/;RJ5DBE4,K#T(/!K/M/#.AV&GW-A:Z39PVET")XDA4+*,8PW][C
MCFM6B@!-B[-FT;<8QCC%9%CX4\/:;<&XL=%L+>8[OGB@53@C!&0.!@GCWK8H
MH J6NE:?9/&]K900M% MLACC"E8E.508Z*/2JD?AC0H=7.K1Z/9)J!8N;A8%
M#[CU;..I]>M:U% &6WAO1&U@:NVDV9U$'=]I,*[\XQG..N.,]:23PQH4J7R2
M:/9,M^XDN@8%Q,XZ,W')YZ]:U:* ,VV\/Z/9V4=G;:7:16T<RSI$D0"B0'(?
M_>! .>O%,U/PSH>LW,=SJ>DV5W/&-JR30JQVYSC)ZC/;I6K10!0CTBVBUN75
M57%Q););<  !%9F';/5N_3''4U%JOAO1=<ECDU32K2\DB&U&GB#$#N,GM[=*
MU** ,N^\-:'J<EL]]I%E<-:C; 98%;RQZ#CIQTZ5'=>$_#U[;PP7.BV$L4*>
M7$K0*?+7.<+QP,^E;%% '.GPY)_PE&EWT;VMOIFEVTD5K:00E6W2!0<G. H"
M\ #O5RR\,:%INH/?V.CV5O=OG,T4"JW/7! XSWQUK6HH RX/#>B6VK/JL&DV
M<>H.26N%A4.2>ISCJ>Y[U8T_2M/TE9UT^R@M5GE,THAC"!W/5CCN<"KE% &5
M)X9T*5+Y)-(LF6_<270,"XF8=&;CD\GGK5G3=*T_1[3[+IME!:0;BWEPH%!)
MZDXZGWJY10!FW/A[1KR]DO;G2[26ZEC$4DKPJ6= P8*3W *J?P%6GL;22Z-T
M]M$TYB,!D9 6,9.2N?3/:K%% &7I?AO1-$FDFTO2;.SED&UW@A521UQD=O;I
M4NJZ)I>N0)#JFGV]Y&C;D$T8;:?49Z5?HH RKSPQH6H65O97>D64MM;#$$30
M+MB&,848X&/2K46EZ? UJT-E;QFT1H[?9&!Y*G&57'0' X'I5NB@#.N= TB\
MLY[2YTRTEMYY3/+&\0*O(>2Y_P!KWZTVU\.Z+90I#:Z59PQI,LZK'"J@2*-J
MOP/O  #/6M.B@#-C\/:-%>27D>EVB7,DXN'E6%0S2@$!R?[V&89Z\GUIB>&=
M"CU<ZLFD62Z@6+&Y$*[]QZMG'7WZUJT4 4FTC3GM)[5K&W-O<2&6:(QC;(Y.
MXL1W)/.?6JUQX8T*ZU5=4N-'LI;X%6%P\*E\CH<XY(['M6M10!6O].L]5LI+
M/4+6&ZMI,;XID#*<'(X/O5&'PKX?MX)(8=&L4CEC\N15@7YUSNPW'////>M>
MB@"!K*U>\%V]O$URL9A$I4%@A()7/H2 <>U9^G^%M TJZ^U:?HUC:W )(DA@
M56&>N"!P/:M>B@"&2TMI;N&ZD@C:XA5EBE*@L@;&X ]LX&?H*S[CPQH5WJJZ
MI<:/92WZD,+AX%+Y'0YQR1V/:M:B@#)N?#&A7FJ+J=SH]E+?*5(G>%2^5^Z2
M<<D=CVJ27P]HT]]-?2Z7:/=3;/-F:%2S["&3)[X*J1Z8'I6E10!6DTZREGEG
MDM(7EFA$$KL@)>/).P^J_,>/<U1L_"V@:?9W-I::/8PV]TNV>-(%"RKC&&&.
M1@GBM>B@#.@\/Z/;6TEM#I=HD$L*V\D8A7:\:YVH1CE1N/'N:AM/"V@V-C<V
M5KH]E%:W0Q/$L*A91TPWJ/K6O10!7EL+2>X2XEM89)DC:)79 2$;&Y<^AVC(
M[X%4]+\-Z)HDLDNEZ59V<D@VLT$(4D=<9';VZ5J44 9VJZ#I&NI&NJZ;:W@B
M),?GQAMN>N">F>]3QZ980R6SQ6=O&UK&T5N4C \I#C*KCH#M7@>@JU10!#;6
MEM9B06T$<(ED:5PB@;G8Y9CZDGJ:H7?AG0[^U^RW6DV<T'G-.$:$$"1B2SCT
M8DG)[YK5HH R+GPMH%WI]O83Z-8O:6W^HA,"[8L]=HQQGOCK3KOPQH5]I]OI
M]UH]C+9VW^H@:!=D7^Z,<?A6K10!D3^%= N;)+.71K%K:.0RI%Y"A4<]6  X
M)]JE@\/Z-:JJ6^E6<*I*LZK'"JA9%7:K  =0O&?2M*B@"I+I6GS_ &OSK*WD
M^V*$N=\8/G*!@!L]0 3UJK:^&="LM.GT^VTBRCL[C_70"%=LO^\,<_C6K10!
M0TK0]*T.%XM+T^VLTD;<XAC"[CZG'6H=2\,Z%K%VEWJ6D65W<( JR30JS8!R
M 2>HSV-:M% &5J?AG0M9GBFU/2+*[EB&U'FA5B%SG'(Z>W2K$FD:;-J%KJ$E
MC;M>6BE+><QC?$I&"%/4#!/%7:* (7M+:2\BNW@C:YB1DCE*C<BMC< >P.T9
M^@JA:>&="L-2?4;32+*"]?),\<"JW/7G'&>_K6K10!0DT32YM)?2I-.M7T]\
M[K9H@8SEMQ^7I][GZ\TL6C:9#;7%M%86R07*!)XQ&-LBA @##N-H"\]ABKU%
M $$ME:SV#V,UO$]H\?E- R@H4QC:1TQCC%#6-JUQ!<-;Q&:W5DAD*C=&K8W
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M]](R78MR8&+3F1;@S?=&%(."=V5QBIM8TN^N)_$NFMI5Y*+K7;"\1_(+12P
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M%PDJ[1L)53T+#(QFK^NZ_<:;?Z?IFG6"WVI7WF/'')/Y,:1Q@;W9]K$#+*
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MV"<SQC!_//U K/(U'5;OQ-GQ%?V T1EM[58W0 ;8$D\Z7*_/N+'KQ@?C0!Z
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M6PM$O)[599;@;'\N1D!#' ^;;G'OWK0?Q%HD>F1:D^KV*V,V?+N3<*(WP"2
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M>LZ7K<#3Z7J%K>Q(VUFMY0X4^AQT- %&#P=X?MK&\LX]-C,-XH2YWLSM*HZ
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M73;;[-9PK##O>38O3<[%F/XL2?QJMIWB+1=7N9;;3M6LKN>'F2."=791G&2
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M;@GCH*O)KVD/I!U9=4LSIP&3=B=?*'./O9QUXK-N/%]@W]C2:9-;ZC;ZC?\
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MW24-=>8)Q*!M^X0,9W#&,8KT?Q0UTOAVZ-KI<6J-A1)92 'SHMPWJ >"VW.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "L[6M2N-,LTDM=.FOIY)!&L<;!57.?F=CPJ@#D_3UK1KF_&/AR;Q':6
M,<+VS"UNA</:WB%X+D!6&QP.PSN'49 X- &7_P +%6*PU"2?27:\L;RWM)+>
MVN4F#F8J$*/P#][H<<BDF\>:K ^JP/X5E-UI40N+M5O4*"%E+*5;'S,0K?+@
M?=Z]*KV_P]O$:^=[K3XOM5]87@AM+8Q11"W<,45<]P!SZY..U;MSX8EGOO$U
MP+E -8LH[5!M/[LJDBY/K_K!^5 $#^,;B\NWM]!T674S#;17-PS3K"$$B[D1
M<YW.5YQP!D<\U9T3QA9:_J%M;V<4GEW&G+J"2/P0"Y385[,"#FLVV\*ZYHD[
M3:'J%BK7-I;P7*W<+,%DB38)4VD=5QE3Z#FH[3P3J6@3Z;-X?U&UWV^G_8)_
MMT+,'&_S/,&UA\VXMQTYZB@"2+Q[+>)HZ:=HDMS<ZK'<O%&;A46/R7"'>Q'
M.<Y /88YJE<>-=5OKGPW_9^G-"9]5GL;^VDF7(>))-R;L'(RNX,,9V@=ZO\
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MTZS,8D\Q-N]F)R3D#CZ\G-=9H^CMIOA*QT268.UO8I:M*HP&VH%) _"@#F-
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M;SXXY'W-&IW;>1QDCC)Z\8=K'@O6KE/$EEINIV4&G:Z"TOG0,TL+&)8R%(8
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MR*(\!3\[94#!!'3&:DT/P4VBZCI-T+[SS9VMW'.S)M::6>5)6<#H!N5N/<4
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MMK*"W)#&*-4)'? Q7$Q>"-572;;PW)J5H?#MO<)(N(6^TO$D@D6(G.W ( W
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M5#R$0R80$YY)YPIQ0!ZQ17EYU3Q:^EW%DAO!)#J2(JR7%HE_-;&(NR#!,?F
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MZJTXNIAX:O;T[D7#RI-&JL<#H 3P.,4 >L2WEM#=P6DDZ)<7 8Q1D_,X7!;
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M?7E](FJV=G;W++$;A(YXP[ 9VH6R"%+=V&<XKH?"-[K0UV_TZ_CU'[$MO'-
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MK.>R3.^XCG5HUQURP.!B@"AIG@W0='O8[RRL2DT*LL.^:218 W41JS%8P?\
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M/E&%+U%-IUQ/9W=]86%Y9:6GBDWCQ_V>6;RC;J!,(2,LOF'=C&1UQE:]IHH
MXCP';,=4UW45GO)X;IX0)IK$6D<KJI!9$X)X*@L0,[1C.*P?$^GW,^K>,K2'
M3[F66[CL;A$C@;%S!&R^>BOC:6(!&W.3GI7JM% '"Z;);:O\0+'4M$LIX+*V
MTZ6"\G>T>W60LR&.+#*"Q7:YZ<9QWJ'Q3$8_&L\AM)W%WX>N+:&6.W9U,P8M
MM+ $*=O3.,]*] HH \U@T*2UM?AZMA8?9IX;:1)9%AVF(M9M]\XXR^,Y[^]8
M/AO3+GRO"^ESR:DNH:?=QR3VRZ2(_(9<^8SSD ,C<C()+;N]>T44 <GXXT[^
MTIO#,36AN84UJ*25?+WJJB.7EO;..OM7+:[H]PNMZ]+'IDTNF)JNFW=S;Q0$
MBXB6/]X54#Y\':2!G.VO5:* /(_$<#:W+X@U+0]/NA826%K [?97B^TSK<!L
MJA +;4R"V.^.U+XBBAM=*\=Z;J.CW=WJ>I22S631V3S>>AB41;7"D#RRIX)&
M,9'6O6Z* /']0L[JQ\0ZQ+J,MW#;WUE;);!-(^VB9%B"M"#@[6W[CM.,[LUL
M^&?#S0>*+-[ZPGF-IX;M88I;R,%U<2R$J6Y4. %S@UZ/10!Y+X3CFLM=T&RL
MH+FZMK<RH]OJ.E&*XTM"C9_T@ *^3A>Y;.<]ZZCQ6JVGBWP_J]]:S7&E6L=Q
M'(8X&F\B9PFR0JH)QA77..-WO7944 >40Z7-<S0WD&F3Q:;<^*XKFUADMRI6
M'R=KR%",HK.">0.N>]=;X^MHKC0;<RK?*(+R*99[*$3-;LI.)&C(.]!W !ZY
M[9KJJ* /(8K.[U>"WBN=.CO+3_A)+64WD>G/;"\41G=(\3?W2 I;H<5<\0VM
MQ8ZGXK>WT99K6>73"2]J\L2@%M\OEI@R;,*2H]!GBO4J* /$=4L[_4!XN>-+
MV_2ZT6"..<:8ULLS+,V0BXR<!AR<GKV KI/%>EMI?B[2+ZWW:?I,-E+ DMMI
MHN4@F+*>4 .W<HQNQ_#CO7I5% 'C\>F"QTC2;PS:S8E;V\FMKUM+61(%D(R'
MMP"41\$KP"/;-=UX#-TWA2,7-C%9,)IA&L5NT"R)YC$2^4W*;L[MI]:Z:B@#
MQ^VMB?!VE^&DTJ[3Q3;ZA%)+*;1P(Y%G#R7!FQM*LH;G)SNQ[5VW@NS>TE\1
ME[9H?,UF=D+1[=R;4P1ZCK7544 >:>(1HC^([Y_$&E:KIM\C 6>JZ2EQNN8M
MHQEX0?G!R-K#L,<5E30>(L>%M5UN>]ABMXKN,W$E@+F6$LX\EYHP#M9HQ@L!
MP>#C)KV"B@#R72M!,]SX=,MI>7-C)KMU=D7=D(5"FW?#^6/N(7&X!@#D].14
M6O:/J U#4YX;>XBT^W\1P7$OE6?G?NA9HBR+'CYU5\< '&,_PUZ_10!Y =-2
M[L=<U!Y-:N+>6\LY!=P:8L6)(R3YRP$9D5<J&RO('&<9'5> 9;N6;6GGBBEA
M,T;1ZDE@UFUX=F&+1MW7 &X8!_"NUHH \J7PGK_B[3-?U$ZC'IRZW,3';7%@
M3*D<)VP'<7!0_*'Z<%LUU]EXAU.3X?Q:VVCW$VJ);;IK @QR-(IPX (SU#$<
M<\8ZUTU% 'DNNQW'BX^+]1TBQO9+>30HK.$RVSQ--*KR.RHK@$X# =.IQ5G6
M]0_X276KBYTVQU![=?#6H0^;+9R1@RL8B(P&4$MQV_#.#CU&B@#SM-%^QW7@
M4VNG&+R;&>.8QPXV9MQPQ XRP[]_>LCPQ&N@'0+[7].NC:'PY;VL+_8WF^SS
M*6,B,JJ2I8%.HYVX[5ZW10!Y3X<\.ROK7ADZAI#K9(FJS06]Q#D6L<DT9B1@
M>%.PG /3D=JZ?XC6$^I:!86UN+C<VK699[8'?&OG+EP0#C YSVQ77T4 <JGA
M"VTV9]6:XU/6-0MH)1:K?79?:67!"# "ENF<9Q7!Z0+NXU+P4Z12JMK=#SK6
MWT9[:*P#0NI1I'!9CDXZX.,GJ*]FHH \EBT1;'X4:?,=)<7,6IPW-T%M2TQ1
M;W<Q*@;CA>?I3[VSG?4K_4I-/N9M)C\26]Y/$+9B7@^QHH<)C+!7*D@ XVGC
MBO5Z* /-[@V^J:[I5]I&B7,%L=>CDENC \8N,6TJF380"JC*KN(&36!H36NH
M^"](TC3-,N5U@:PMQYPM'"QA;HL\QEQM(V KUR<[<5[/5/2M+M=%TZ.PLD*6
M\98JI8L1N8L>3[DT >.Z^;^\TS5[=+.:VN?[4,QTVUTAV8A9P?.>X;(.5&[*
MXZ@"M?7+67[=XOLX["Y-Q<:IIUU"4MG*R1!K8,P8#!P5;(SG@FO5Z* /*M3T
M)I/!GQ <:6[WMQJ4TD)\@F20 1E"O&2 <XQWS3?$/V?3+/QY!K&D75W<:@'F
MM9TLVE22(0*%7S "$\ME8G<1CJ.M>KUSNH^"=(U.\NKB<WB+>8-W;PW<D<5S
M@!?G0'!X !]0.<T :'AT8\,Z2#U^QP_^@"M*D551 B*%51@ #  I: "BBB@
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M*%)C9<_*< E<=<D'FLVV\$:AIL&BS6EY9R7UEJ4]]<!XVCA?SU=75 ,E0-_
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MQQL0TGR\\8].O%9>J?#R:35]6N;*S\/7"ZG+YWGZG9"6:T<J%8ID$..-P4D
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M5K&S5OMBOC/[[#*5ZXYRO?(Y&.=+PYX-/AW5+.:*Z$MO;Z2EA\PP[N)"[/Z
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MY(&T*><DGC&PUYK>OWGB*>UUR32H])<0V\$<,3*[>2DA>7>I)4[\ *5X'7-
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M;QW45J\\2W$JL\<1<!G5<;B!U(&1GZBAKNW2[CM&GC%S(C2)"6&]E4@%@.I
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M:A$=64@J0HQ\N/UJ_;ZMIMW;Q7%MJ%I-!,_EQR1S*RN_]T$'!/!XJP)X6G:
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MI+I9/?H3.LRO$F/,Y &&7*Y'/7@FETGQ=<7FHV%KJ.C2Z<NIPM-8NTRR>8%
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MOIE]<2V]IJ-I<31#,D<4ZNR#U(!R*8NNZ.\4\J:K8M';JKS.+A"(U894L<\
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MP3CVK3AU.PN;>">"^MI89VV0R)*K+(W/"D'!/!X'H:>UY:IY^^YA7[.,S9D
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MOGKYO3/W,Y_2@#+O?!.@W]]-=W%I*3<.LEQ"MQ(L,[C&&DB#!'/ Z@YQSFM
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ML(K-2UE>VUJSO<*@82HK;AGJ0&^[U..*?IGC#1=3M]1N4OK>*#3[EK>:269
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MV.M &S10"" 0<@T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*RNY-)M/$-W-.DEBR%0\7[J8P@<+N8GI\I;/8U*B6YU"YN;&QEM+&X\76,D
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MTL^5A$>481R6"KTSD;LGK4OA:P\Z_P#"ULLMU]HT_/G6Z:+]G-L/**NDTK$
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M1/$%^TND.UEW6;E]YQD9?&<]ZTO'LUA;^(_!\VI6[3VL=[.S*L)EVD0,0Q4
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M#B%HY9)C&WH2# F/]DUV_P 185;0;*X>V>>*UU2SGF"0F0K&LRESM )( SG
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MQVX(>/CGD=#CBNSH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*&7+!AP#P1FHF\0>)M,BU+>^JS0C2;JX6XU*S@A:">-,J4"<,IR>"#C Y.:
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M$TI[I5(#>5+Y1;'.0<'^58PU/6= U31O[1UQ+ZWU2VG>;SH8XX[9XXO-WH4
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M-MW;@#P01T&03DG;\#VUQ%X@\9227\TZ'5RHC=$ !\B$[LA0<X(7KC"CODD
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M$;!#,L85L  DH&( S@\9R>:LWOB?Q/I&EZ^V_4WC@TI[NWNM3M(8I(YE8#:
M@"LI!R,KQ@\G- 'JE%>;ZMJ?B/2]6TW0&U74KN6Y@FO;BZL;&!IE52BB.-6&
MT*"Q))#-T'O4=OKWBF^?0],DNY=/GN=2NK22YDMH_-EACA,BOLY57[>F03C'
M% 'IE%>:Q^(-?61O#YU3==MKQTU=3>!-ZPBW$^=H&PO_  @XQWQ4NNZSKV@&
MUT9-7?4+B\OQ$ES!;Q/=PP^49""F A<E3@D8VG."10!Z+17)^#=2UB[N-4L]
M42]:*V>,VUQ>PQQ32*P.5=4^7*D=0!D$<5SWB[Q+JUO-K\^EZMJ!.EQEDAL=
M/C>")EC#D3RR+R><D(P(!'4T >FT5YY_:/B'7=7U>*UUQ],@L]-M;J-(;:)R
M9)$=B"74_+\O3K[CNFBZWKOC"XLX8=5.DB/1;2_E,$$;F::<-_?!Q&NSH,$Y
MZB@#O[:ZM[RW2XM9XYX7^[)$P96YQP133>VHFAA-S")9BPB3>,R%?O!1WQWQ
MTKE_AO'(WPTTN/SMDIBD7S8P#AM[?,,Y'OSFN%\/6&H267@*&#6)HI99M0(G
M,,;-"FULA!MP2<$Y8'&X^@% 'M-%>6W'BW7[.T.D?:KBYO/[=DTT7T-K&TYA
M2$39"<(9,';TQP3BNF\&ZEK%U<ZI9ZFEZT-LT;6UQ?0QQ3.K Y5U3Y<@CJ ,
M@CCB@#=U37-)T2))-5U.SL4<X1KF98PQ]LGFK-K=6]];1W-I/%<6\@RDL3AE
M8>H(X-<AX?MX;SXA^+;B^C26]MI+>"W\P F*W,(8;<] S%R<=2/:JM[<V>DW
ML>A>%+J.RGU+6#%>2HN];5_),K[%;Y0S!!Q@C+$D9H [^BO,M6\0>(M&FU/1
M8M6%S<P7.G?9[Z:W3<$N)O+9)%4!21M/( .&]>:6ZG\4PW?BBR3Q5/MT:SCO
M(9FLX/,D9T=MC_)MV QGH WS=>* /3**\W?6/$6M7UX+366TV&#0K740L-O&
MY,T@E)&74_+\@R.O P1SF*V\2Z_I\.@:Q?:B;V'5M*GO9;$0(B1,D F41D#=
MZJ=Q;.<\4 >FT5Y];:GX@TZW\,:O>:U]OCUF>&&XLS;QI''YR%E,14!OE('W
MBV1D\50TO6_$O]C>'O$%UKAG6_U-+.:R^S1+%Y;RM&""%W;Q@'.<=L4 >H44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %4]0TNTU3[+]KC+_9;A+F
M+#$;9%SM/'7J>*N5%=7,-G:375PXCAA1I)'/15 R3^0H HWGA_2[[7-/UJXM
M5;4-/#BVG#$%0ZE6!QU&">N<9K,C\ ^'XKN*X6WN,0W(NX(3=RF&&7=NW)'N
MVKDYZ#N1T)JQX2\40^+-(:]CM9;26.3RY;:8C?&2H9<X]596_&I+GQ-8PZUI
MNF0R1W,M[/) QBE4^2R1M)\P'^Z1B@!__",:3]B-G]F/D&^_M#;YC?Z_S?-W
M9S_?YQT[=*CU+PEHNKF^^W6AE^W& W \UAO\D[H^AXP?3KWJ[IFH_;[*WEEC
M6WN)H_,-OYR2%1G'5201[CBI)M2L+:W%Q/>VT4!;8)))55=V<8R3C.0: ,RU
M\'Z+;V]]#);RW?V^,17+WL[SO)&,X0LY)VC)P!ZYZU#;^"-$MUN0T=U<M<6K
M6;/=7DLS) PP8T+,2H/MSP/2KMUXCTZTUG3=+DF4W&HH[P$,NW"@=>>^0!CK
MS5L:KIS2&-;^U,@3S"HF7(3^]C/3WH GMX([6VBMX5VQ1($09S@ 8%80\/M?
M:]J^H:C_ *NYM5T^W2*0JRP<EVW#!5F9CTZ!%[ULI?V<MG]LCNX'M0"?/60%
M,#J=V<417UG-;)<Q74$D#D*LJR JQ)P #TZ\4 #6<+:>;%E9H#%Y)!8DE<8Z
M]>G>BPL;?3-.MK"T0I;6T2PQ(23M10 !D\G@5GZGXGTG2] O=9:[BN+2S4M(
M;>17)(_A'.-WMFKMQ?"/29K^V5;D)"TL:K(JB3 ) W$[1GIDG H R/\ A!]"
M^W_:OL\^W[1]J^R_:9/L_G9SYGE;MF[//3KSUJW'X8TF*[CNDMB)H[V2^5O,
M;B:1"C-C/=6(QTJTVK64$,;W=W;6S.%RDLZC#,,@9SS_ %JXS*J%V8!0,DD\
M 4 <]:^!]"L[Z&YBMY]L$IG@MFN9&MX9#G+)$6VJ>3C XSQBI;CP?H5T^M/-
M8AFUI$COCO8>:%7:O?Y< ]1CUK2_M33_ "9I?M]KY<&/-?SEQ'GIN.>/QIYO
M[,67VTW< M,;O/,@V8]=V<4 4)/#.DRK9JUKA;.TDLH KL D+JJLO!]$7GJ,
M5(N@:<@TG;"0=)4K9_.Q\O\ =F/GGYOE)'-6AJ%D;9+D7EN;=\[)?-7:V 2<
M'.#P"?P-.BO;2>T^UPW4,EM@GSDD!3 ZG(XH \YL/ >H/K&DO=:;964>GWGV
MMYK>_FDB<C=Q#;M\L(8D$X/&,#-=YK6B6.OV*VE^DA1)5F1HI6B='4Y#*RD$
M$?6K5M>VEY;_ &BUN89X>?WD4@9>.O(XK,U3Q5I&EZ)-JSWD4]K$ZQDV\BOE
MV8*!UQGG\LT .D\+Z3+I6I::]NS6NI2M+=+YK9=FQDYSD=!TJOJG@O1=7O;B
MZN([E'NE"72V]U)$ERH& )%5@&XXY[<=*WDD22-9$=61AN5E.01Z@U2?6],%
MC=7J7UO+!:J6F:*56VX['!X- %7Q)I#ZEX-U71[!8HWN+&6V@4_*BED*J..@
MY%5-*\$Z/IT2EX);B3[*;7%S<R3+'&P 9(PY(53CH,<8'05:\*Z[)XDT*'57
MLUM8Y\/"@G64E" 06*\*>>5[8K0BU*QGNWM(KVVDN4^_"DJEU^JYR* ,6S\"
MZ'97-A<(EY++I[9LS/>RR^0-I7:H9B N#C'? ]!4?AC0;FUUK6O$&IVEM:ZA
MJCQJ8;>4R"..-0HRQ RQ.2< ?P^E+H_C.#6+K2H$LY(SJ$-U*I9@=@@E6,@_
M4MFN@NKRUL8?.N[F&WBSC?,X1<_4T 9]OX8TFUM-)M8;8K#I+^99KYC'RVVL
MG7//#MUSUJ.Z\):->0744ML_^DW8OFD29T=)PH42(P.4("@<$=_4UKBX@;RL
M31GS1F/##YQC/'KQ69J_B33-$6V-W<)_I%VEHNUU^5V_O9/  Y/X4 5[?P;H
MMO 8_(FE=KN*\DFFN'DEDFC(*,SL<G&!@=/:K%_X9TG4WU%KNV,AU&V2UN?W
MC#?&A8J!@\$%VY'-7O[0LA>BR-Y;_:R,B#S5WX]=N<U1TSQ+IFK#4C;W"!-/
MN&MYV=U !4 ENOW><9/H: +8TNU.D?V7,C7-H83"ZW+F4R(1@AF8DMD=S6;I
MO@_2-+N?M,*7,TRPF")[JZDG,,9ZHF]CM' Z>@K5@U&QN;;[3;WMO+!NV^;'
M*K+G.,9!QG)'YTMM?6=ZKM:W4$ZQG:YBD#;3Z''0T -TW3K;2-,M=.LHS':V
ML2PQ(6+;548 R>3Q69IW@_1M*GMYK6"93;32S0*]P[K$THPX4$D 'TZ DFF3
M^++,:K'I]EY=Z\EG<70>&=-N8B@*$YP"?,')/'>M$:O9Q6D,U[<VUHSHC,DL
MZ?(6&0,YP>AP1UQQ0!2NO".C7=O<PRVSC[1=_;F=)G1TGVA1(C Y0X4#@COZ
MFK.CZ#8:$D_V-)3+</YD\\\S2RRL!@%G8DG X Z"K=S?6EE&DEU=00(YVJTL
M@4,?09ZU+'+',F^)U=<D;E.1D'!_6@#,NO#.D7RZJMS:>:NJJBW8+M\X0;5Q
MS\I [C'K6?'X"T%4O!+%=7,EY:M9W$US>2RR20G^'<S$@<<8Z?B:W8M0LI[J
M2UAO+>2XB_UD22J73Z@'(K-\.>)[#Q%I=E=12113W4(F%HTJF15]QU_&@"]:
M:39V-[=WEO$5GN_+\YMQ.[8NU>#TP/2LJ^\$:)J-Y>7%Q%<XOL?:X([N5(9R
M%"@NBL%)P .G.!FMC^TK$7OV(WMM]KZ^1YJ^9_WSG-.%]9M<_9ENX#/@GRA(
M-W'7CKQ0!1M?#6E68F\F!AYUG%8R$R,<PQA@J\GL';GJ<TY/#NEQC2P+;(TR
M%H+4,Y(1"@0@Y/S?* .<U<M;^SO@YM+N"X$9VN8I ^T^AP>*2UU"RO\ ?]CN
M[>X\LX?R9 ^T^AP>* ,?3O!6B:7>V]S;PW!-KN^RQ374DD5MD8/EHS%4XXX'
M X&!44/@'P_!=PW"6]QB"Y^U6\+7<IB@EW;BR1EMJY)/0=R.AK>N[ZTL(Q)>
M74%NC':&FD" GTR:Q=?\5QZ/J6E:;;VZ7=[J+-Y:&Y6)511DL2?R  Y- %L^
M&-);29=+-L?LDMR;MT\QN93+YN<YS]_G'3MTJ6ST*QL-7OM3MEE2XOBIN!YS
M&-F  W;"=H;"@9 SQ4'B'7QH<=G'%9RWM[?3_9[6VC95+OM+'+-PH"J2346B
M^(+F_P!2N-,U+2)]-OH8EG"M(LL<D9)&5=>,@C!! /2@!-4\&:-J][/=W,=R
MCW*!+I8+J2%+E0, 2*C /QQSVXZ5HP:/86VI'4(+<1W'V9+0%20HB0DJH7H,
M%C4L&HV-UYOV>\MYO).)?+E5MG^]@\?C59M8A>^M;>T,-T)93',\=PG[CY"P
M)7.3G &!SSGH* &:CX>T[5-2MM0N4E%U;1O$CQ3/'E'QN5@I 93@'!SR*6/P
M[ID5MI%ND!$6D%39#S&_=[8S&._S?*Q'.:N17]G/=26L5W!)<1?ZR)) 73ZC
M.121:A93W<EK%>6\ES']^%)5+K]1G(H Q8/ V@VU]%<QP3[(9S<PVIN9#;Q2
MDD[UB+; <DD<<$Y&*U=7T>PUW3I+#4K9;BV<@E22""#D$$8((/0@YJ'Q%K<?
MA[1I=0>![APR116\9 ::1V"H@SW)(J71-6M]>T2RU6UR(;J)9 K=5SU4^X.0
M?<4 9^E^#M(TJ\-XBW5U=>68EFOKN2Y9$/55WL=H..<=:9I_@C0],O;>YMX;
M@_92QM89;J22*V)&#Y<;,57@D<#@' Q5W7M;CT&TMKB2%I1/>06@"G&#*X0'
MZ#.:T#=6ZQR2&>(1QDJ[%QA3Z$]C0!FQ^&-)BTNPTY+8BUL)UN+=/,;Y'5BP
M.<Y/)/!JG)X&T&2_>Z:"?8]Q]J>U%S(+=YLYWF+=L)SSTZ\]:V9M2L+>58I[
MVVBD9]BH\JJ2V <8)ZX(X]Q38KYGU&\MI(1'%;I&XF,JG?NW9^4'*XQU/7/'
M0T 9,O@G0YM0DNWAN-LMP+J6V%U(+>28$'>T6[:3D ].2,GFM6XTFSNM5LM2
MFB+W5DL@MV+'";P QQTR0,9^OK3X-2L+FV>Y@O;:6!#AI8Y595^I!P*EM[JW
MNE9K>>*958HQC<, PZ@X[CTH K7&D65UJ]EJDL1-Y9+(D,@<C"N &! X(X'7
MN,UF:GX+T?5M5DU.<WT5W)&L3O:W\T&Y5SM!", <;C^=:\6I6,]Q]GAO;:2?
M;O\ +252VWUP#G'O0=2L1>BR-[;"[/(@\U?,_P"^<YH SD\):,$D66WDN1)9
M_89#<S/*7AW%MK%B2>6//7WK(M? T%AXOBU"(RSV+:9-93B\NI)W;<\951O)
M^0!6XSW]ZVM:\3Z3H.FW=[>7<1%K$\K0I(ID8+U 4D9/;ZU8M-46[O)(XXT-
MLMO',ERLR,'W%LC:#D8VCD\'/'0T 9>G^!-"TR[MKF&*Z>6T1H[8SWDLHA1E
MVE$#,0%P>GT]!3I/ ^AO;6$$<5S;BQMQ:PO;7<L3^3_SS9E8%EXZ$FK]QK4'
M]GM=Z<T&H!94C(AN4 &Y@I^8G&0#G'4XP.35E]2L4N$MWO;99W8HL9E4,S#J
M ,Y)H Q!X$T&*WL8;6&YLQ8H\4#VEW+$ZQNVYD+*P)4GG!Z8XQ3E\#:!%806
M<%M-!%!>&]A,5S(KQRD$$A@V>02",X.36S<ZE8V<L<5U>VT$DGW$EE52WT!/
M-9MWXHL[?5KW28@)M0MK'[9Y)D1 X^;";B>#\I// !!H 9-X,T6:UB@$$T)A
MN);F&:"X>.6*25BTA5U.0&+'(SCVX%2VGA/1K*.R6"U8&SN6NXW:5V=IF5E9
MW8G+DACRV?T%76U:RA@C>[NK:U9PN4EG4;2PR!G.#_6I;F^M+,1FZNH(/,;:
MGFR!=Q]!GJ: ([73+2ROKZ\@C*SWTBR7#;B=S*@0'!Z?*H'%)::59V-]?WEO
M$5GOY%DN&W$[F5 @.#T^50.*MQRQS('B=70]&4Y!KA;?XA:C/H3:\/"5XVD(
MKR//'=PLXC0D,P0D$XVDXZT =A/IEI<:I::E+&3=6B2)"^XC:'V[N.ASM7KZ
M5D7?@;0;V]FN9H)]EQ*)[BV2YD6WGD&/F>(-M8\#.1SCG-:T.KZ=.ELR7L'^
MDJK0JT@#.&&X8!YY'-/CU*QEEFBCO;=Y(!F9%E4F/_>&>/QH IW/AG2+Q=46
MYLQ*NJ%#=JS-ARBA5(Y^4@*.1CD9ZU13P-H?V6^@GCNKLWT'V:>6ZNY99#%_
M<#LQ*KWP,<TGAWQA;Z]8WFI/'#9Z;#*T<5Q+=(?,"LREF ^YRO&3R#6Z;^S%
MLER;N 6[C*RF0;6&">#T/ )_"@"EK'A[3];-M)=+,EQ;$F"XMYWAECR,, ZD
M'!'4=#45EX4T;3_L!MK5E:QEDGA=I69C)(I5W8DY=B&/+9J^FJ:?(\2)?6S-
M-_JU$RDOQGCGGCFGP7]G=32PV]W!-+$<2)'(&9#[@'B@#,NO">C7D-Y'+;/_
M *7=+>2.DKJZSJJJ'1@<H0%'W<?J:A_X0G0SITEF\$\ADG%TUR]S(;CS@,+)
MYN[>& X&#P..E3ZGXFL=.N[*U62.XGN;U+-HXY5+0E@Q!8=1]VG^(=>30+&&
M;[-+=7%S<):VUO$0#+*V<#)( & 22>PH DT?0+#0DG^QI*TMRXDGGGF:665@
M, L[$DX' '05GWW@;0M1N+V6XBN?+OCNNK>.[E2&9MH7<T:L%)P!V["F6?BR
M9+NXM-=TB;2IH;5KM6,RS121J<-AQC# D<$#KWK1L?$>EWV@6>L_:X8+.ZB2
M1&GD5=NX9VDYQN'0C- #K/P_IUA)<26\+*]S;Q6TI,C'='&I5!R>P8\]3FJ$
MW@C0Y8+&)(KFW^Q6PM(GMKN6)S /^6;,K LO'?-;<U[:VUK]JGN88K? /FO(
M%3!Z<GBJ$VOVZ:[I6F1KYPU&">>.='!4"+9^>?,'Y4 6=)TJRT/2X--T^'R;
M2 %8X]Q.T$D]3SWK/T[P?HVEW%O-:P3*;::6:!7N'=8FE&'"@D@ ^G0$DUM0
MS17$8DAE21"2 R,"..#R*@34K&6\:SCO;9[I/O0+*I<?5<YH SKGPEHUW;74
M,ML^+F[^W,Z3.KK/@*)$8'*$!1T([^IJQH^@6&AK<&S65I;EP\\\\S2RRL!@
M;G8DG X Z"K(U*P:Y2V6]MC.X)2(2KN;!(.!G)P0?RK/\1>)K'P[IMU<RR1R
MSP1B3[*LJB1E) R!UQS0 FK^%-+UJ]COIQ<V]\B>4+JSNI+>0IG.TLA&1GL<
MTP>#-!70UTA+(I;+-]H5DE<2B;.?-\S._?\ [6<_A6Z2%!)( '))JO;:A97D
M+S6MY;SQ(2'>*5652.N2#Q0!DP^#=%AM7A,$TIEN8KJ6::X>2626-@R%G)R<
M%1@9Q[5=DT+3I9]3F>$F34H%@NCO/SHH8 =>.';IZU8@U*QN;9[F"]MI8$.&
MECE5E4^Y!Q3&UC3%CFD;4;0)"VR5C.N(V]&.>#[&@"O;^'-+M7F:&W*F:SCL
MG_>,<PQA@J]>V]N>O-$7AS2X5TI5MOETJ$P6@+DA$*!"#D_-\H YS5R?4+*U
MC\RXO+>&/;OW22JHV\#.2>G(Y]Z$U"RDN5MDO+=IW3S%B652S+_> SG'O0!C
MZ=X)T/2[VWN;>&X/V4L;6&6ZDDBMLC!\M&8JO!(X' X&!5J/PQI,6EV6FI;$
M6ME<+<P)YC?+(KEP<YR?F).#5\:A9&]-D+N W8&3 )!O ]=N<TUM2L%N$MVO
M;83R$JD9E7<Q'! &<DB@"U16?KNLVWA_1+K5;L.T%LFXK&,LQ) "CW)('XUD
M6?BC45U2TLM9\/7&FK>;A!.+A)TW*I;:^W[AP#CJ..M '3T5CZ3XFTO6-)EU
M."YCCM8II(G>5U4*4<H2>< $KD>H(K12\M9+3[6ES"UMMW><L@*8]=W3% $]
M%8U_XDL[1=*>!DNXM1O5LTD@D#*I*LV<CK]S'XUK1S12LZQRHYC;:X5@=I]#
MZ&@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7'_$-;S4M)M?#FGX6XUFX$#R,A9(X5
M&^0M@C@A=N,C.ZNPHH \MO['Q/HNO:@&FM)9?$.F2VT+Z?;/"D-W%&?)+;G?
M!*DKG(^XM0:5_8$WB'P(FCZ:T%W9B6.[(M&C,'^C."DI('S;O7T)[\^LU7O;
M8WEE+;+<3VQD7;YT# .GN"01G\* /)_!VH6^A#PGJ>HF2*QET"6V6<1,Z^;Y
MR,$.T'!(!QZXJK!#%_8&@WMW++I<Z7&IF*2_T[[1;#?<L?+E0D%'( VGC@,,
M]J]=TC2[71-(M-,LE9;:UB$488Y.!ZGN:NT >3:1Y"W_ ($O;[1H;&-3>VT?
MEV[^6&+KY+*&!9 W+*&Z9JKI7ABP/A7P"TFD1&9]5)NF:#YF4QSDASC)7(3@
M\< 5['10!XSK&EW$#:DEO"MMH]OXH6:X4V1FB2,VJ8<Q*1N02$$XX!Y[4V33
M$OM(U@PRF_L;S5M,5_L^FFUMI")D$C1KO8M\I 9L ?+WYQ[110!Y/XQT***X
M\9VVGZ6BPS>'8)!%!!A7E6289  P6"@>_2NPUZ2UO?A?J[Z8@:VETFX\A8XR
MN08FP N 1],5U%% 'F6FZ#9ZAJ_B.74-,CN"-&LHXC/#NQF*3<%R.N0N<>@K
M?TE9V^$-FDJR&<Z$@96!W;O(Z'OFNNHH \>O]"33?#7@:>"VMK&P2)9-1EDT
M\W""8P#9),@(+88N-Q/!8&HO[/M6T.YNGO[E;)M:2X@NXM&"V<4@B*ES"SL6
MA)."W'S\CUKV:B@#Q.6XLSI>D-JFF6ITU/%(9IK*UD6"\'V:0F41-D@!OO8R
MIVD^M2ZU:2W\.M7VB0&/PY+JEC++MLV>*544^=((1M+IN\K=C[VQNN*]9U'2
M;;4Y]/EN-^ZPN1=0[6Q\X1DY]1AS5Z@#Q>:PEO;#Q%<Z;<-J%I(EF+Q-/TLV
ML$Z),&E"#>Q=_*W!L#D8&2>*O^)QX;U70=:FT#1C(L4%JTUU!;,L)"3@[ F!
MN=4W$D#(!P3VKUFB@#E/&,;ZE\-[Q=%C>6.:WC:.*W4JTD&Y2RJ.#DQ[@![X
MKE[J/1M8UR*3PS81_8H=(NX]0:*T,<9!5?)C8%0"X8$@=1@],UZG10!S7A.$
M:?\ #C2!#9D2)I<+M!&NQG?R@2/9B>_K7FNCLLVI>#);6*QA,5ZOFVMCIDJ-
M9AHG!2:=V)9LD @@;CD]J]OHH \M\&6T\>J^$R\,BA+/5@Q9"-I-TA&?3(K9
M\3&RM/'FFZAK\ DT9;"6*&26$R10W)=22PP0I*# )]".]=S10!Y#IC#1;O1-
M7N+>>TT!-7U!K8M"P$$$L>(\KC**S!B,@8##I45P;:[TZ\U6ZLI&L5\8)<,T
M]JQ(@,<8+[2,[3QV]*]CHH \<NQ!9>)IS90QWT\FLK.=+OM/9;H,9%_?0SH?
M]6!\P+9 48..E%V]GIUMK]F=*MC*WB19)3<VTAA@A8!HYI%3'F1@J<#.,GG%
M>QT4 >&S6C7EGXRA55N;>Z?265[:P:UBF'VC#LB9.0 ,%LG.*WO%VA20:MKU
MMH.G>2L_A^/?%9Q;!+MG.Y0%P"QCW*._.*]4HH \BOVT*_\ $,T_ANPV1CPU
M?PRR06C1(3^[V1_='S#GCJ,BM#PYH-GJ&NW3ZGID=P$\.Z=$GVB'<!E9=X&1
MUX&:]-HH \?\/+;647AR\\46,L]@WAR&WMFEM'G6*8,?,0J%.&9=F,CD*176
M_"P1K\/;+R(7BB%Q=^7$XPR+]IEPISW'2MG5O#<.J7T=ZE_J%A=)$83+9S;"
MZ9SM8$$=>AQD9ZU>TK2[31=+M].L8S';0+M12Q8]<DDGDDDDD^IH \I\*+#8
M>(=#M;"*._5)Y5:*YT]K>_TY2K[FED4['&>#N^\6!!/6I=#T*WL?!7@*ZM]-
M6&_&IPM-*L.)<,) ^XXS@@X.?:O7:* /"KN;[5!;R16MI9W4>N1326$.G2O=
MP?Z4-TDUPS'&1SG &" #BMR[\/2S^$_'=S8:?G6)M3N5298<S-#N3<J'@D%=
M_ /)/O7K-% 'CMI9VE_>7;V=U)>6ZZ+<P7,>B:*;3Y& "QDM)S*.2JXR/FSC
M-:?@.14\4QPVHL=1MQIY5M1MM/>SD@ 9=L4R_<9CR1@ C:> #7I]% ' ZZVF
MV/Q":^\26ZR::^F+%92S0&6*.3S',J]" S Q_4# Z5B^'-'8:IX.DN=-9(5E
MU)[=+B'YX;?=N@5LC*X4C /2O6** .2\>-8?8K%-8TF>\TIKC,]U;E_,LF"G
M9*!&-V,\%@1C/?-<9(^JWVF^(M.\)ZMJ^K:6^DR%);P,S1W.X 1Q2L SY3=Q
MS@XYYKV"B@#QS3;:"YOXI--O(IOL^E74<L5AHC6BHACPL<S-(?FW8(7!.0>G
M6KEOH7V'1?  TFQ2VO9(F>61(MK&4V$N&D..NYNI[FO5Z* /%/"MEF;PK;+=
MJFIV<ZM<6UOHC1W$)"D2B>9I/NMR"V#N)! -6?#*Q6/B/1K:PACOPEW*&@NM
M/:"_T\,'W-)*IVN.<'=][(P2:]BHH X?Q3#JNN>,M)TS2WMX4TQ#J4TMW \L
M32',<2X5E)(S(W7C"FCP/%J.AZSK7AS4S%)^\_M*UEMX6CB*3,=Z*"6QMD!.
M,G[]=Q10!YQXF\0+KUS:>'X[.ZBU6#7K8F Q,<P12JYFW8V["HSU]JQ=<OX[
M/POXTT*2*Y.IW.IRS0VZV[L7B=D82 @8VX!YSVQUKV&B@#R[5=!M+U/B==7&
MF1SW+)B"22'<WRV2$;"1_>].X]JHZG:7MR=:=[:YGMS!HLE[&B,S30*S&90.
MK?+G('49'>O7Z* /&_$Z66IQ^([OPQ:D:<?#\D-R]M;F..6?S%,:@8&YU7?G
M'0,!7K&F:98Z39):Z?9P6L P=D,80$X R<=3P.:N44 >)>%SI-WX4\)66C61
M77XM1BGE=;=E>-!(3+(SX^XT>0.<'( ]J]]-]JMDDBM;2SNH]<CFDL8=.EDN
MX2+H;I);AF.,CG( &" #BO9]&TFVT+2+;3+/?]GMUVIO;)QG/)_&KU 'DU[X
M<MKGPA\1+HZ3'-J4EW>^3(T :4J$7:$)&<9R1COFH=9A_M(ZY+I%K++I\FE:
M83';PLOFP+<2F9%7 .=F[*]3G'>O7Z* /*M>DT#4;&]D\-:4_P!_3UFN[:%H
MX6VW:$1[> 649)..!P2.E9MZ^AR6WCVQDL&GUZZU":.SVV[-)))Y:>5Y;@<;
M7.3R-O4]:]GJCINDVVE/?/;;\WMTUU+N;/SLJJ<>@PHH \E\4%[B7Q-9W5M8
MPZ@;5(MLFG27=UJ!$ PT3;MJ)N)' .""3@U-J$4*O>R36Q-U?>"E6"0P$M)*
ML<N\;L?>VE<Y.<8KV*B@#S+2]!L]0U?Q#)J.F1W!&BV,41GAW8S%)N"Y'7(7
M./05GZ$MI9_V3=>*]/ENK:?PW906C26;W 5PK>='@*<.V4/(R<8[5Z[6)JOA
MF'5+\7R:AJ-A<&'R)'LI]GF("2 001P2<$8//6@#+^%P4?#?1]B-&FV3:C=5
M'FO@&N=\%^"I=6\!V<6H:[KD5I.)5ETY'CCC*F1P5_U>_!'7YN]>CZ;IUKI&
MFV^GV,0BM;=!'&@). /<\D^]6J /.3X=27Q/XRDL["(7T.GVT6ERO&/W+^2X
M7RR?NG(7D>@KGO"MC#/?^%[:*YC-U: BXM;?0VAEB7RRLB7,C28VDG!R"6;!
M KV>B@#Q)=+EM/#_ (3N#'!9:?#>W[7<DVGFXC20R.(7DC!7@#< QX&15FVT
M:*^MM-1@U]IEQXI279_9_P!GMV MWW-'&6;]V6'). 3NXP:]DHH \T?PVCZS
MX[DTW388]0CM(8=+D$(7R6^RX7RCCY><#C'0>E8GANS\[4/#\>F7L:WUI!('
MBM=$:W> >404N)&DZ;L=B2P!'K7LU% 'C.G1Z/\ 8_ UC#IDD>OV5_"+\_96
M$D3[&$ID?'(9^02>>".E=_XZ:T&BP+J>CRZCIC7"BZ:'=YEJN"1,H0;CM8#.
MW! )/:NGHH \LTJ07>HW6G:!J>J:WH,NG3_:EU!7E2"7 $:QR.H8DY;*Y.,9
MJAX?ET>V'A>]U>U7^R(="6U1I;5C'!>@KYH9=ORNP &2.=I&:]BHH \>TZVB
ML9]%OM7L98_"Z7NHO:13P,4M@[+Y#.A'RKCS=N1QN'3(IFL:1-KEWI$/A&"?
M1[>2+56C,D;*LP+0GY>08DD.<8P0,D#FO9** ,/PU?6MUX4M9K#3FLTCB*?8
M-FQH77@QX]B",]^O>O*=-D6XN/",MO!9V\D>J1M+96FFRB6S#!@PGN'8DMEL
M'(&XG/(%>Y44 >10Z%;Q> X;]--5=3_X202^>(?WH_XF&W.<9QL_#%4?$,6F
M1^&?$^G:GISR^))=3EGB/V5GED0R@Q2(X'W!'@=<#!'M7M=% ',?$*VN;KP5
M>Q6\,LPWPM/#""7D@$J&50!R<H&&._2N/U_^PM4M[F7P[H\TMG&;,ZI+9P,D
M<ULDP+0[ !O8+DG )V\9YQ7J]% 'C7B=+/4XO$MWX8M3_9IT!H;E[: QQRS^
M8#& ,#<RKOR1T# 5TZ^%=&3XEPQ+HMI]C31" OV=?+W"4 9&,%MI(SUP3ZUW
MU% 'DG@W1H[Z^\()J=@)X[?0+@!;B+<J-YT:@8(Z[20/:FZ)H4%CX9\%W,&F
MK#>+KK"258<2"/,ZX)QG;M"CGC 'M7KM% 'C$$-K_P (I9:0EBX\;IJ222/]
MF;SEF$X9YC)C[A3<=V<%2![5:OM"MSX,\7WW]FJ=1.NS2Q3>3F4;;A=I4XR!
MU(QZGU->NT4 8OBQMGAB^)T@ZO$4 ELA]Z6,D!\#!R0N2!W(P*X72+JSB\0Z
M3;^#M7UF]MI9ME]I]X)98(+?:V6W2KF-@=H W<YQBO5** /&--AL+2WTE;ZQ
M(TW3M;OSJ<7V4E8W9Y?L[R+CYE (P>0,KTJ6YMHIYK[4+2QE/A!M<M)Y84MV
M$<B+$1+((\9,?F>43@8.PGFO8J* /)=<@L]9:T_X1&"73A-KMOG4HH#Y3OY$
MH,D:' ^48!; !..N*Z7P=J=EHOARWTV_MC87\%X+"X4([B:Y;I)NP21)][<?
M7!.17:U#/:PW7E>?&'$4@E0'H&'0_AU^N#VH FHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *QO$?B.#PW:VDTUI=73W=RMK##;*"[2,K%1R0,';C/OZ9-;-8GB'1[C5Y
MM%>!XE%CJ4=W)YA(RBHZD# /.6'7% &?+XW*2310^']5N);2%)K^.+RLVFY=
MP0Y<;WV\X3/!'J!1/X[M6G$>E:;?:N%LX[Z1K/R_EADR5(5V5G)"DX4$_B<5
MC:YX"N)_$>JZG::5HFI#4PC;M29U:UD5 F1M1MZD*#MRO.>>:;K7@2^N8+6V
MBT[0[Z."RCM[>>0O9RV<B@@O&T:L2A)!"9&,=>: -ZZ\9B/59]-LM#U6_N8+
M:.ZE$*(FV-]V/OLIW?*?EZ_D:#XWM+G[$NC6%YJ\UW:"]$=ML0QPDX#.9&4
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M(/-C**J<?,1\N6;&<?A0!>A\;K<WLL4&A:I+!!<):W,\:QMY$K;<AD#ER%W
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M5 1^!EMQZ9 K:B\*ZE;^!GT8#3+F<WDT[PW2%X)HWN'EV-E<@[6 R <$<9H
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M-2"!)$",D9YR#G_9]S63X2O-<T7P_P" Y)M32YL-2BBM6LQ;*HB7[.SHRO\
M>+#8,Y)!R< 4 >I$ @@C(/4&HX)H)T)MY8Y$1C&?+8$*RG!7CH01C%>7:+XT
M\2:G%IFL1PZA-#>W*"2Q&F8MXX'?;E9NI900Q).#@C J>WUG7;RZL-,TR\MM
M.-[J^J0RS):(VU878J0O0L<<D]<DG- 'I]%<SXSU'4]&\+1S:?<1B_:ZM;<3
M2Q@J2\R(Q*^X8]*Q-5U'6K"_BT?_ (22ZGNHK;S7.GZ2)IW9G;:9!M,<:8
MY!)!.10!Z 6 (!(R>@]:6O*])U34=?\ $/@?6[F^6!IM'NY9HUC4(2K0[^3D
M@-Q]-O'>GZ?XOU@ZKH$W]IW%]:ZE>"WF_P")88+3#([ PR, [8VC!.X$9/%
M'IL%Q#<Q"6WECEC)(#QL&&0<$9'H01^%$-Q#<!S#+'($<HQ1@=K#@@XZ$>E>
M4Z#=ZYX?\$P:Y'J<<EC'JDD;:=]G7#127C1GY_O;\N2.<< 8[TD7B&_TIY=,
MT_[1')J/B'4C)/;6OVB6-(VR0B="22.3D 9X- 'K=%<QX-U35M0AU"'58;G-
MK.$@N;BU^SO/&5!RR= P)(., X!P,URGBOQAJ^G?VY>Z=JLTO]F2$+;6NF&2
MV4* 66:9@/GZY"-\O'4T >I45Y]J6I^)+O5?%0L-8CL;?1X8IH(Q:I(9&:'S
M"KEOX<CMSSUXI]AK6O>*[V6.PU"+2TM=.M;EE^SK+YTLZ%\-NY$8  XP3D\\
M4 =U!/#=0)/;RI+#(-R21L&5AZ@CK4E<C\/W:'X5:&ZD;DTU"#[A:QM(USQ'
M!I'A/6]1U6*\CUJ2"&>T6V5%C\U"59&'.00-P.0<G &* /1Z*\PL/$/BF3PU
MIVIRZM T^LWZZ?;QFT4):?O'!DX.7;:AX.!DC\9M>\1>(O#0UC3/[2BOKJ*S
MM[RSNYH%0KOG$3)(JX4CN" .I],T >DT5YUKGB;6_!<UY%>7J:N&TJ6]@:2!
M8C'+&Z(5.S'[L^8#SR-IY-6;[4O$/AG4+&WO=734UU&VN>3;)&8)HHC("NWJ
MAVD8;)Z<T =V6"XR0,G S3(;B&X5F@ECE57*,48, P."#CN#P17E<J>(M2M?
M FIZAX@W27]]%.L45I&JPEK61L#J6XR.?4GTQ>T[7=6O[^#1+&>#3WN]2U1I
M+J*V0LL<$VT!5(VEV+C+$'H3R30!Z517FL_B3Q''=IH*:A!]NBUU-.DOC;@B
M2%[9I@VSH'' XXR!Q@D5-)XCU?3+?7].O=:A-Q8WMM!!?26FZ1UF16VB*,?/
M(,L% &#QGH: /0V8*I9B  ,DGM2UXSK^MZQJ/ACQCI5S?7K16ME;W,4MY8K;
MS,KLX9&4 #;\@P< ]:W=2\1:\?$>H:-:WFHJ-+AA4SVFEK<&XF=-^Z3C"KC
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M/%K,KAL%E(PCIR.YYQD\U7;QUJ.DZ-K4KWMU=7UO!"\-GJ>F_9KB-WE$>XA
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MYA:^D;3F8V23W;R);J4*%44G 7#?H/2M&+Q#9OKFHZ7(1"]DL!:25P%<RAB
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M[8/49K8@NK>YW?9[B*78<-Y;AL'WQ4%QJ42:==W5IMO6MT9O*AD7+,!G;DG
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M:RJ=RODD$ $YP:];HH \PL]$L-=U[Q+=ZMHJ-*=(L@D-VGF- 6BD+*"W\0(
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M^26C*G@<KG=CMUK3M]/N?^$OC\&&!QI=KJ#:VK[?D,!^=(O3BX9CCT2O3Z*
M/"+*UE9([6\O]/@\2?VMYCQII+OJ/F>=G<)/- ,97^+&W8<5T#QOIVGZGXE6
M-_,T7Q+<W,F!RULQ"3 >OR$M]4%>KUE:]H,/B&T2TNKJZCM=^9H8'"K<+_<?
M()VGN 0?>@#&\%2QVNGVZWS&/6-;,NJR1%3D!B,+G&!L0QKC/:NNH P,"B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKLUO*8';399,XW<;"2/Q&1GMG-<W9V.NS>.?(L]9AMIE\/6IEN6M Y8^;-M
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M5K%3XB@)919<6V(O-#+\WS,0",'C)Z8&* /2WECC>-'D17D)"*6 +$#) ]>
M33^M>;V>NZG>:GHMC>M:37D6LWVG_;#;#=^[MY"LBC/RL> <'D9'>M?X7)<K
MX!L6NKK[0SO*RG9M*CS&X]^<G/O0!V-%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 444A('4@4 +135='0.K*RGH0<BD26.1=R.K+G&0<B@!]%(2!U(%-\Z+:6\Q
M-H.TG<,9]* 'T4UY$C +NJ@G R<<T,Z(I9V50!DDG&* '451N]7M++4-.L9G
M/GZ@[I  ,@E4+G)[#"U+=7;6TMJBVTTPGE\LM'C$0VD[FR1QQCC)R10!9HIO
MF(7V;UW$9VYYQ69XAUV'P]I@O)8)KAWFCMX8(=N^221@JJ-Q ')')- &K14-
MM,\UI%-+"UO(R!GB=E)C)&2I*D@D>Q(K#N_&-C9ZA=63P7!DM[VULF*A<%[C
M;L(YZ#<,_IF@#HJ*"<#)Z5FZUKEIH>@W6L7&Z2WMXRY$.&9^P"\XR3QUH TJ
M*S#K(MO#DNLZG:RV"00O//"[+(\:KDG[A()P,\'O4=OXBL[C6#IJAU<645[Y
MCX";'9E Z]<J: ->BFNZ1KN=E5?5C@4Z@ HKD+CQ\D:WEU;Z#JMWI5E))'<:
MA"(]@,9(<JI<.ZJ0<D+V.,UU,5W;SVL-S',AAF56C?. P89&/J* )J*:SJGW
MF"_4XJO9WOVFS-Q-!+: .ZE)\ @*Q7=P2,'&1[$4 33PQW-O)!,H>*12CJ>X
M(P17-Z%X::'3]'AU,.USH9D@M)5<8EBV&-6(]3&1D'N#VQ73-(B)O9U"==Q.
M!3@00"#D'H: .5;PL(I/#>E6R,NC:.?M&YW!9W12L2>O&XL3ZJOKQU58'_"7
M:</&8\,;9OM9A\SS=H\K=C=Y><YW[?FQCIWJ[KVM6_A[26U&YCEDB66*(K$
M6S)(L8ZD=V&?:@#2HJMJ%TUC8RW*6TUTT8R(80-[\]!D@?K4Y=%8*SJ&/(!/
M)H =129'J*KB[8ZD;3[--L$(E%QQY9))&WKG=QGIC!ZT 0ZQH]KKEB+.\#F(
M313#8V#NC<.OZJ*JR^%].FL=;LW$OE:TSM=X?DEHUC.WT^514S:W;#Q#;Z,
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M8Z=$\4"DY!5T",&'?@5FZ?X&TO3[JSD6>^G@L6+65I<7!>&V." 47V!(&XG
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M]W/.+Z._DN9YMTDLJ#"ECZ <8  I^J>$;+4]1EOTN[^QN)XA#</97!C\]!G
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M-Z_*:US(@<(74.1D+GDUCP>(EN_%-WHEO8W$@LT4W-WN01QLR[E7!;<21Z#
MS0 V'PGID&H0WJ";SH;Z:_7+\>;*A1OPPQP*L:%H-KX=LI+.REN&MVE:5(YI
M-XBW')5?1<Y./>M)9$=2R.K*.,@Y%)YL8!)D3 ."<]#0 ^BFET#A"Z[R,A<\
MXJCK>L6V@Z->ZG<AGCM('G>./&]E49. 2* -"BFQN)(DD&0& (S[TZ@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH0*Y+0M$\,^(/%MOBPT^]TR/PY;^3&(U:$,9I0Q"_=W9W<]02:]4I  .@ H
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M=:V=Q%)'<HK_ +QVC*D*01T5N:?XC\,I<^$Y-)T6SM+4-<V\HBC01)A)D=N
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MS,>XCJ/IG\:Y[0=0\07<&C^'['4+."2#1H+VXO)+0N6#Y6.-4WCH$.YLG/&
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MYVANAQGMD4 ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(EN%Q'&A4,[%F  &]>F3Z"MB@#E+OP':7HN(Y=6U86]XB)?6ZSKLN\*$+/\
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MUJ?BS3-+BU1Y3+(=+\K[2D:<CS,;<9P#U!ZUN4 <V? N@F)H/LS"V;3ETSR
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MF;8$)SMW#( ! 8 XY%:.M>(8M&O-/LQ97=[=W[LL,-L%SA1EF)9E  !'?//
MJY>ZI:V%U8VUPY66^F,$"A2=SA&<_3Y4:@##NO FFW6X-=WZ+)I?]E3*DB@3
M0A6 +?+]X;V((QR>E.O/!-G<W,L]OJ.I6#7$*070LYE47"J-J[LJ<''&Y=IQ
MWK6T?6+?6[26YMED5([B:V(D !W1N4;H3QE3CVK0H R-.\-Z=I6HK>64;1%;
M&*P2('Y%BC+%0!US\YYS5C1-(MM!T:VTNT,AM[9=J&0Y;&2>2 /6K]% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(+;3T0!@T48=&NVXYZLRDCG$1Q7L$4$5NFR&)(USG:B@#/X4]551A5 '7 %
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MC\]@?N[B< _+G:#QBO:$MX8BYCAC0R'+[5 W'W]:5HHVB,3(IC(P4(XQZ8H
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M4BC61_O.% +?4]Z /%?#,L6FW]A'I!TK4[^YL[A8+[3Y'CNBPB+!KR$YR=P
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MW[L1#KM)ZXX/S9Z5[6+: .[B&,,Y!<[!EL=,^M+]GA\T2^3'YBYP^T9&>O-
M'CVOO=*-=7?#'8OXIB74&G+"$1?98\"0KR(R^P'MZ\9KIOAW''%JNN1V5WIL
MFGKY.+?2U<VT,N&W;&/RY(VY"]"!GDUWIC0A@47#_>&.OUI(HHX(Q'%&D:#H
MJ+@#\* /(_$L5M8^(O'+V2I!JDME92*8>)S 6(N'3'S'Y1R1W K9T1= @\?:
M;'X,>U-D]A,VI+8N&AQE/)9\''F$[^3\Q&<UZ(8T,@D*+O P&QR!Z9IL4$4
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M08)" 2>!EE7\0*[DJI8,5&1T..E(\:2KMD177.<,,B@#QO\ L6P@\'7WB&.
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M?""]E\B"[DM76%Y>?DWGC/!'ID8SFIO"'B:7Q+%J;S6<MM]DOI;=-\13*JQ
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M(.2#Q@YQ5N;QUI]L@$MGJ3R1VR7-TL-F[&V1LX,@'3.UC@9.!G%<TW@N^O\
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MU8XZD^M6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *I+H^F)J)U%=.M%OCUN1 HD/_  +&:NT4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M ;*T:]6]:UA-VJ>6LYC'F!<YVANN,]JGHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5TZWU"QF6:UN(Q)%(O1E(R#S7(^#_"=]X<U:(3[98(="M+$3AA\TL;REP!U
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M"L1CGD9H T-5\=V]IJNC"U+S65S=7=I.L=N[RF6$$;44#)^<$=,8YZ<UI_\
M":Z)_9(U 33E3<?9!;BW?S_/_P">7E8W;N^,=.>G-<E8:%XFTR31M1;1H[B>
MVU+4;JYMXKE,A)V8KL9B 3\W?'OBIAX;UY=47Q7_ &>IOO[6:\.E"=-PA-M]
MGQOSL\S W=<=LT 7+7QN]_>ZKLN%M+:VU.RLXOM%FXD_>A-\;*<$,68J"1@<
M'D5T8\4Z2=)&I?:&^SFZ^QX\MM_G>9Y6S;C.=_'3WZ5Q\F@>(-3NM3OI]*6T
M:ZUK3;N.$SHS"&$Q[RQ!QN 4G )]!FM >%-0'Q!\_:G_  CWG_VJ%W#/VW9Y
M6W;UQC]YGINH T8/&%E;6"R7=T]Y/->W%M!%9VDAD<QR,"H09)V@8+=.,]Q5
M/1O'MK<Z7J.H7TC>4NJR6-G'%;OYTN I5/+QN+_>R,#&#G&*S+#P[KFAWMCK
M$>FF\DM[O4EDM$F17,5Q/YB2(6(7/RKD$CAO48JC+X0UZZB75+C3I([F/7+B
M^-C:7_DR/#+$$^656&''H2 ?F&<&@#T31]<LM<AF>T:57@D\J>&:)HI(GP#A
ME8 C@@CU!XKCM:^(<]DGBA8;9H3HUS;1K+-;R;&1WC#DDX&<.=H'4 'D5K^#
M-%GTZ75+VXT^>R:\D3:EU?/=3LB+@&1B[ 'DX"G@8R:Q==\.:W=WGBFW@T[S
M+?4[BQNH+CSD"GRC"'0J3D'",<XQ@>O% '36?C+1KO[:'DN+-K*'[3,M];O;
MD0\_O ' RO!Y]J?I/BO3-8O!:0B[AN'B\Z)+NUD@,T>0"Z;P-PY'N,C/6L#Q
MAX1U#Q'J>J"#9'#=:)]DCF9\#SA-O"D#G! &3[U'X>T"]/B:RU"ZT;4+-;.&
M0&74=9>[/F. "(E\QAMQG)8 GCB@#J=8\1V&BS6]O<"XFNK@,T5M:P/-*RKC
M<VU0< 9')XYIEEXIT?4#IPM;HN=0,H@'EL#NC^^K C*D=P<&L[6+/5+#QC;^
M(;#3FU*(V+64UO%*D<B?.'5UWD*1U!&0>AYK M_#NOZ7=Z=KPTU;JZ_M*]O+
MG3X)T#1+<*% 5F(5BNU<\C))Q0!M:[X[MM-DM$LX)[HOJPTVXV6TC^60NYL;
M1RV"N/7GK@U>'C31CJ8L=]US<_8Q<_99/(,^<>7YF-N[/'7&>.M<H- \1K8O
M?/I*M>#Q,-5%G'<IEH?+"X#$A=PSWQT/M3I/#^OP^(WGTO3KK3+B341--=6]
M^#8SPE\L7@9B?,*9!VJ/FYW4 ;&E?$"SN;/4[F_@N;9;74FL84%K+OF.<(JK
MC+.<'*@<=\=:O?\ "=:$FFWM]<2W%JEC+'%=1W-L\<D+2$!,J1G!W#D<5S,^
MC^*K:'4K6TLKA;=]=>]>2TNHDEN;:3<2L;,1L96VYSMR,X-4X_!VN21:_C3I
MXDOKK3)H$NK_ .T2E89@TF]V8\@#. 2.0 30!VMMXUT2>+4))9;BR_L^(3W"
M7MM) RQ'.'"L 2#@CCN,=:Q)O'OVC79[.U\VSMX=$N;^1KVQD1XV1D"/M."R
M89C@=<8X-'BWPGJ>N:QJDUJL:QS:5;Q0O(X"M-%<-+L8=0",#..]5M4T[Q'X
MBU.]NY-!-A&WAZ\L(UEN8G=YY#&0/E8@+\IP2?7('% &[-XZTBQVV\[W=U=I
M:QW4JVEE+)B-@3YA"@X7@]>E6+KQGHULMF8Y+B\-Y;BZB6RMI)V\@X_>$*"0
MO/?KVK/T#0=0L=8U*XN(%6.?2;*VC.\',D:RAQP>VY>>]<[H%IJ?A"[TV,6M
MO=WW_"/VUO=V9O$CDMS$SX<%N#&2S D$D%>AS0!Z)HVL6.OZ5#J>FS>=:3;O
M+DVE=VUBIX//4&KU<C\,#(WP\TQY50/(9I/D^Z0TSL"OL001[5UU !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %,EBCGA>&:-9(I%*NCC(8'@@CN*?7)>/9YS:
MZ+ID4\MO#JFJ16=S+$Y1O**N[*&'(+; N1ZF@#JXU2.-8XPJH@VA5Z #M3!;
MPBY:Y$*"=D$;2[1N*@D@9] 23CW-<U%X-T#0M4LM2TL+I#Q,4D2W(5;M2I^1
MP?O'^('KQ65;>,=>.CZ=XGN;?3QH=_/$@MD#_:(8I7"1R%\[6.64E0HX/7B@
M#OZ*\WF\9^*!:RZE#::2UFFLOI20-Y@DD_?F%)-^<+SMR-IS@G(X%37OC+Q!
MI,.LVMS;Z;=:C8W-C'$T2O'%*ERX7!!+%2.><GL<=J /0J*\]G\1>,H;O7;$
M#0VFTBU2\:?RI0LJ.KD1A-^5.8V^;<1T^6KEKXFUWQ'=O#H$6GVRV]E;W,S7
MRO)ODF3>L:A2N !C+'/7I0!VU%>?V'C/7/$EYIMKHUO86ANM-:\F>\#R>4ZR
MF-D 4KN&X<'(Z9]JZ;PGK4WB#PS:ZE<PQPW#F2.5(R2H=)&1L9YP2I(^M &U
MD9QGGTHKQN\T6'3K6_N/$/AZ\NY'EEG3Q3I<PFEC4L623&0Z!%P,*"OR]Q6Q
M>>);[1_%.M:L;R.^TFUT"VNHHE# R[FE"D'.T%F'+;>FWCCD ],JM=Z=8W[P
M/>6=O<-;R"6$S1AS&XZ,N1P?<5R5QXGUOPW=VP\2QZ?+;W=O/*K6".K0O%&9
M60[F.\%5;##;R.G-1MJ'BJ\\.2WM_;Z:;"^TV:5DMMRR6F8BR LS$29Z' 7!
M]10!W5%<%\-O$LOB#3+6"T6)-/TVQM[>9I0?.EF\I3E5XVQXZ,0=QSC@9/;7
MUW'86%S>39\JWB:5\=<*"3_*@">BN&M/%'B&&'0M4U2WT[^S=9FBA6"W#^=:
MF49C+,3A^P. N,\9J_X*UG7?$-B=4U&/3X;&4R)!% K^9E)&0LQ)Q@[3P!^-
M '59&<4$@#)Z5PMSKB6>M>+M?ND:6'P_;+;P1 XY,8FD(]"Q:-<_[ K5L$\1
MWK?9?$%KI=QIU[:MYHM0RF%C@>6P9CY@()^88Z=.: .EHKF_!%_/=^&%CNY6
MEN+"XGL996.2_DR,@8^I(4$^Y-9VC^(O$>IZ=9^(3;:?_8EUNE-NNX7$,&"5
MD+EMK'@$J%'7@G% ':T5P=IXL\0+8:)KM_;Z>-(U>>");>$/Y]NLY B8N3M?
MEEW *,9X)Q5)?&?BJ2PM-3CM-(-K=:J^EQP-Y@?/FO$LA;)  *C*X.1G!&<
M ])HKRSQ#K.NW5O+IEREC+JFFZ]IRQ20!XH90[*Z[@2Q7&<'DU=\0>(M1L[+
M5](UZUT^\G@BM+N)X5DCBEC>X"89=Q965ES][!X]Q0!Z-17GNI^+_$D%OXFU
M&TM]+^P:!<,CQRK(9+A5C1V (;"'#<'!R>PQS'K/Q#NH=;U.RT^;3X%TU4!2
M[AFD>ZD9 ^U2G" !@,G=SVQ0!Z-17/7NJ7&I?#^;5K -:3SZ<;B,3 [HB4W8
M."#D?SKB=%?Q'-KOAD6MQ8&]D\,;I)[B.1D">9&0=H;+/T!.X=S[4 >KT5YJ
M_P 2+M]/T:$BQLM0O?M7VB>:.2:&(02F)MJ*0S;FZ D8&<FNI\'>(I?$>E3S
MSQ(LUM<O;.\2LL<N "'0-R%(8<'H<C)Q0!T-%>?S^,M=71+[Q3#;Z>="M+B1
M#;,'^T20QR&-Y ^=H.58A=IX'6M"Y\77<.A>,K](("^AR2I;@@XD"P)*-W/J
MY'&.* .PHKS8ZUXAL_$GBZ^@2.^2VTZSEALD20G+"0C;\QZ?,6 &6P,8[T=8
M\7:GJW@+Q.UIK.DSR6UJ'$]DDL$L><AE:)FWH< 8;/.3QQ0!ZO17!^(/%6K:
M/<BS;4=!M[B.U67$L4LKW+G.0D2/N1>!\QW9STXIMEXNU_Q!=:5;Z/!IUK]M
MT6+4WDNU>01LS8V *RY[<Y&,'KTH [ZHA;0"Z:Z$$8N&01F78-Y0$D+GK@$D
MX]S7#Z;XRUGQ!'HUGIL%C;:C=VLUS=27"O)%$L4@B(505+;GZ9(P!WK(\,7D
M\.HZ9'?V=NUY/K^JAF#,1"P61CL.1D'&.1T/8T >J56N-.L;RYMKFYL[>:>U
M8M;RR1AFB)ZE21E2<#I7"Z+XQ\1W-EX8U;4;?3%L-;E2W\B!9/-B9D9E?<6P
M0=GW<<9')I#XQ\1R:+:>(X+?3#I%Y?16\<#*_G)$\XB$A;=@DYSMP,9')P00
M#T2BL/Q1K5QHMA:_8H8I;V]NX[.V$Q(C#N3\S8YP "<#KC%9%]KOB?2%AL;N
MVTV>_OKR.UL+J/>D+;D9W9XRQ8; AX#?-D=.: .SHKS_ %3QGKNA1:I8W=MI
M]SJMI]CD@>(/'#/%/.(N5)8HP(;N1T/M1-X@\91:AK.F@:&T^F6B7IG\J4)(
MCA\1[-^0<QM\V[T^6@#T"BO/SXO\0ZI<%-&M]-@C71+?52UVKN<R;SY>%8?W
M1\W;!X.>$LO&^L1KHVI:K;V*Z7J]C+>1Q6X<S0!(O-&YB</E<] ,'UH ]!HK
MA[3Q/XA@CT+4M5@T[^SM9FCA6&W#B:U,JDQ[F)(D[ X"X)XS5/3_ !EXDFL-
M'UJZM]+&FW^HK8-!&LGG+NE,0DW%L?> .W'3O0!Z)0"#T.:YSQQI][JGAI[.
MPD03/-$3 \QA%R@<,\.\<KO4$9'\JY;0(M/T_P 316]GH=YX4U:>UF2.TD57
ML[Q@ 0<QL0S)C/&UL$T >F45Y?X/U_Q%/X<\,Z1;S6<VI7MB][)>7:2.(X5*
MK\R[P7<L_7<!6G%XSUBZFAT.*VLH]>.H364LK[FMT6*,2F4+D,<JZ87(Y)YX
MH [VBO+O%7B._P##FI>'M3\26Z%[.>] ^P E;E?(^5@I)*9S@@DXP3G%>@Z+
M/?76D6]QJ)M?M$R^81:$M&JGD ,3\W&/FX![ 4 :%%>;:/XCU5[?0M,T2RTV
MU.HR:FSM,)'2'R;@C<%W9;=N)(R.3P0!BHKG7_$&JS^&U$UG:W,.OSV%V(UD
M,<S1QRX(&X':0"=ISSM.>.0#TZBO/Y?&>NC0[GQ7';Z?_8,%PZ&V*O\ :7A2
M0QM)OSM!R"P3;T[YKJ_$FIS:/H-Q?0-9K)'M >\F\J% 6 +,WH <X')Z#K0!
MJT5Q?A'Q=<ZSK]_I5Q<6-ZL%M'<Q7=G!)"C!F92I5R<X*_>!(.?457\6>,M1
MT/77LEET[3K9;=)(;C4H93%=2$MF,2J0L6,#EL_>Z8H [RBN#U+Q3XC?4-8A
MTJ+2EATO3H;YWGWR>875VV*5(&/D/S?H<\2:;XKUQ]1TDZA;:?\ 9=8L);RV
MBA9E> HJ.%=V.ULA^H"X(]* .XHKSK1?'M]>>)-'T^>\T>]BU(R(ZZ>DA^RN
ML;/CS2Q20?*1QM]>E<WX;UQ/#^G:/K$ZO*EIX2GF,8/+D3I@?B>,T >TT5YS
MIGC^_DOXK:Y?3[PW%K-*IL[>:,6TB(7V.7X92 1N&WD=.:Z3P;J.MZSH5OJN
ML)81K>P17%O%:A\HK+G#EB<GD=,8Y'/6@#HJ*\[G\9>)(K+5-9%OI?\ 9FFZ
MJ]B\)60S31K,(]X;=A2 1P0<X/2M6Z\67D&C^-+Q8("^A/*MN"#B3;;I*-W/
MJQ'&.* .OJ.>"*Y@D@GB26&12CQNH964C!!!ZBN#U+Q;XD$VOMIL&EK;Z-91
M7CFX61FFW1&0H,,-OW3\QSU'!ZU!J7B/6Y+"ZM-3BL5M]4T&[O;86P?? 41<
MH[$X?B0<@+R#Q0!Z,JA5"J, #  J-;>%+B2X6%!/(JJ\@4;F"YP">X&3CZFN
M"T?Q!K6@V'AQ=<2Q;3[^U$:?9E?S;=D@,@#$DA\JC9("X/J*JZ+\2;S4+K2)
MI?L,EMJ<R1_8[>";S[57^XS2'Y'[!L!<9X)Q0!Z917*^#=9UWQ!;R:E?QZ?#
MI[23101PJ_FDQRLFYB3C!VG@#\>U5KKQ!XAO;S7&T.'31::/)Y+K=JY>ZD$:
MR,JE2!& & !(;)[8H [/(&.>M%>9Z0[^*/B=9ZU(EG)9C0[:]M(Y86,D E,G
MW3NP'R.6QR ![UK>,?%U_H&L0VD<MCI]H]MYHOM0MY9(9)=Q'E;D($? !W,>
M_ XH [:BO./M6O7_ ,05FTA]+CFG\.V\LLDS-/""99#A-A7<"3][(X'0YJ5O
M'=[<:#H=\+C2-*:_@=Y7O"TW[Q3MV1Q*RLV3DYSP,=2: /0J*\XL_'.OZQ9:
M!%IMMIJ7VI37D$LDZR>4AMV(WA<AL'!^4\C(]*K7OQ,OH)]3DA.G%-,G:W:R
M,$S37;1\2%''RISN"@ALXY(S0!ZA17GFJ>/-0M/$4MIYFF6$"O%]FCU**6,W
MJ,JDLD^=B$9*[2&.5YQFO0Z "BO)_&4^K-=?$*)[N(V,6@PLD6ULKN$V"OS8
M!R#DXY^7ICG=?Q7K/AVY">((K"2V?2KC4$%DKAXO("%HV+$A\AQA@%Y'2@#N
MZ*\ZT'Q_?7NJZ9!=-87$>HA@8[."97LVV%P'9^''&TD!>2.,4[1?&/B.YLO#
M.K:C;Z6NGZW,EOY$"R>;$S(S*^XM@@E/NXXR.30!Z'17.>*;I+:^\-*]M%,9
MM66-6<G,1\F4[EP1SQCG(Y/%<]8>,O$DUAI6M7-OI8TV]U);!H(UD\X!IC$)
M Q;'W@#MQT[]J /1**YOQIXG/A?2K::-8C<7ETEI$TP8QH6!)9@O) 56.!R>
M!QUK"L_'E[)8ZRK/ID\]@D4D5\0]K:NKL5._S"2I3&2 3G(Q@F@#T&BO-(?B
M3<VRZT+A['5!9V4=U;S64,D"2,\AC$9#EOXMOS D8)]*?XVE\4P^"=:35H].
MGB-M')'-9;HMDGFI^[(9F)&#D,,=#D4 >D5GZEH6D:SY?]J:797WE',?VF!9
M-GTW XK&TK6-<C\6G0]:73W,MB;V&2S5UV;75&1MQ.[[PPPQWX%4O&/BZ_T#
M6(;2.6QT^T>V\T7U_;RR0R2;B/*W(0(^ #N8]^!Q0!VB(D4:QQJJ(H 55&
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MN(R)=J[0X+*2C[0!D>@[C-=15:QO$O[;STBGB7>Z;9XRC?*Q7.#V.,@]P0:
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MHLT<T+'&YRBLH#<=,,>F*X>7PWJUW/::1;V6M6=K#JR71MY)86L846;S"R.
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M>5#;=X0MR5![GMQ6SXAT&'Q#IJ6DL\MN\4\=S#-%@M')&P93A@01D="*UJ*
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MVE6=7)]<Y054U?P]<:A?_;+/6[W3Y'@^SRI$J21R)DD'8ZD!AD\C\<\5NT4
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M\[<CUKK8=&TJWCN(X-,LXDN/]>J0*HE_W@!S^-6C!$TR3&)#*BE4<J-R@XR
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M$DXW(W(.>FX=ZTM7L==M-7\5I9:++?1ZY;1K;SQS1JD3B$QD2;F# =#P#G-
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M.ZM)89%A&?W@1U#,O'4 US.N^'=:O=6\2I;:>7CNY+&^M97E012M;E"86YW
MMM.#C'O3/$>DZ[XM_M*\31)]/\O0[NQ@AN98O-N)IMO'RL5"C9U)&2U '<Z-
MKEAK]H]UISRR0*Y3>\+QAN <KN W*01AAD&J$/C;0+C44LX[N0F28V\<YMY!
M!)*,@HLI78S9!& >O%;-K"8K""$C85B5"!VP,5YQ;:'KS>$]*\&2:,\7V*Y@
M\S5/-C\DQ12B3>@#;][!0,%1@DY- &]X0\37OB76=;9F\NPL[AK>"!K":)^,
M?.TCX!)YR@ (XS[ZTWBW0[>T2YFOUCB>^_LX%D8?Z1N*[,8R.0>>F.<XYJ#P
MIIMWIO\ ;?VN'R_M.K3W$7S [HVVX/!XZ'@\UR>O^!M3U7Q'K$*1A=(G@EO[
M63>/EOWB6(<9R,!2^>F6H WO$?CBUT75+"VCE1D_M 6=_P#N7=H]T#RJJ;?O
M,<)P,_>QC)JT?%UC>VUK-I]ZD6[48[*:.[M95D5VY,>P@,CD$8+#%8&F^&]:
M,/AN]O[-1J#:S-J>IJLBD0[XI549SSM!C7C/2G7_ (;U:;Q+?7<=IF"77["\
M1O,7F*.!5=L9SP01CKZ4 ='_ ,)IH1U0:>+N0R&X^R^=]GD\CSNGE^;MV;\\
M8SG/'6LCPU\1+#4[6UCU*0PWT]U+:AH[640>8)65$\P@H'*@'&[.3[XJ#1+;
M7]%T^#PXF@K.(KYY/[1F>,VY@:8R%]N[?YF&P!M^]SG%10>&M5C\!:5IIL\7
MD&M1W<D>]?EC%Z92V<X^YSCKVZT =?K>HG38[%A<00>?>PV^9HV??O;&U=O1
MCV)X'>J</C/0Y]32P2XFWR3-;QS&VE$$DJYRBRE=C,,$8![&F^+=-N]3@TA;
M.'S#;ZM:W$OS ;8T?+'D]AVZUREIHFO6?B* Z;IVHZ;_ ,3$RW8%Y'+ITL!<
MEV2-F+J[ ]%5<,3VH ZKQ7XI3PP-*W6TTWVZ]2W/EP22;%())PBG)XX'4\XS
M@UEZ?\1+!;O4[;5Y#"UKJ<EFLD5K*T4:A@J>9( 54DGN16AXUL[^YM=)N=/L
MI+V2QU.&Z>"-T5W10P.TN0,_,.I%85YX:U:7P1XNL([/-WJ&I3SVT>]/WB,R
M%3G.!P._I0!TNI>,M#TF^EM+NYE#P!6N'BMI)([<-R#*ZJ53(Y^8CCGI6I?Z
ME::9I=QJ5W,$L[>(S22@%@$ R3@9)X]*\VU3PMJMOJGB)$T[5[^+59S/;M9Z
MD((#NC5"DREP0!MZ@-E<#J,5UOB#1;F;X:7^AV,(DN3I;6L,8?[S>7M W-C\
MS0!-9^-M!OIYHHKJ56BMVN@9;:6,20KUDC+*!(HR.5SUJ^NNZ:_]E[;C/]J*
M6L_D;]Z-AD]./E!/./SKGM<\/WVH:OI#00JL$6E7MI+(6 $;R+$$&.I^ZW3/
M2LO2;+Q!<WW@N*YT">RAT1'CNYI9XF#-]F:,% K$E2<<G!Y''7 !M1?$GPM.
M(6COIVCN%)@D%G-LG8=4C.S#O_LC)SQC-5]6^(%C;Z?I6HV,NZTGU46%V)K>
M02Q?([%?+P&#Y50!@YST.15'2/#.JVN@> ;6:SVRZ7<F2\7>I\H>3*N>O/S,
MO3/6H+W0==M[F6\M])-V4\5?VDL0FC4O;_90A89.,[L@ XYQT'- '61>,=#D
MTN[U%KQH8;-Q'<)/"\<L3G&U3&P#Y.1@8YSQFF)XUT$Z?>WLUU+;1V.S[4EU
M;20R0ASA2R,H;!['&.OH:X[6/"^M^(9-3UQ;">SE>\LIH+ W*QSR);[\DNK%
M4<^8=O/&Q<D=HKSPIJ6J:;KDT.D:FDMQ;V]M"-4U!9IY0LP=AC>RJHYQ\V3D
MT >D:5J]IK.GB^M#-Y!) ,T+Q'COAP#CWK+L_'&@7]U'!;W4S&;=]GD:UE6.
MXV@EA$Y7;(< \*3GMFMC4[,ZAI-Y9"0QFX@>(./X=RD9_6N%M=.UW4++PMHE
MSH;V*Z-<02W-XTT;1,(5*@1!6+'=QU"X!.: -;P+XCOO%$.HW]PRK;+=216\
M'V*6%HU1W7)=SAR0H)  VG(// OQ^,]#DU1;!;F;S'G-JDQMI1 \P)!C$NW8
M6R",9ZC'6F^"]-N]*\/-:WL/E3&]NY=NX'Y7N)'4\'NK _C7*1:)KUKXB1M+
MT[4=.=M3,UR5O(Y-.E@,A+N(V8NKLIZ*JX8]<4 :VB?$.PN&FM]4D,-PNISV
M(>.UE\E2LS)&KR8**[ +P2.O09%:E_XXT'3;N>WN;F<"WD$=Q/':RO# YQA7
ME52BGD=3QGG%<_+X:U5O .IZ:MG_ *9/K3W:1[U^:,WHE#9SC[@SCKVZ\5C^
M*= \4ZQ9^)+%K'5)Y[B60V0@O(H+(P\;-P#!V? P0P()[@4 =]+XOT2'79=%
M:[?[=#_KE$$A6$;-X+N%VJ"ISDG'7T--TWQEH>JW*P6]S*K21M+"UQ;20I.B
M]6C9U <#KE2>.>E8LOAB_P!0'CJ!D%L-:ACBMIF8'/\ HJQG."2 &R/SQ65H
M_AS4IM1THW.C:I&UA%(9'U/5/.@$AB,86)59BRG<<DA<+[\4 =AI7C#1=9O8
M[2TGG\R:,RP&:UEB6X08RT;.H#CD=">#GI5G6/$.G:&T$=Y)*9[@D0V]O \T
MLF.6(1 6(&1DXP,UQ?A/1]<T[7--2WL=4TS388G6]M;V\CN+93MPBVQW,X&[
MGG VC&,UNZU:ZC8>,;+Q#::=+J4 L9+*:"!T66/<ZNKJ'901\I!&0>G6@#/\
M1^/%6UT0>'[@,VJ79A^TMI\UP(557+ QK@[\J!M)!')(P#C=\3Z[/H6G6HMH
M$N=1OKF.SM8W)5#*V3EB,D* K,<>F*YG3_#6LK?:7J%Q9B%I?$%QJ=Q )5;[
M-&]N\:@D'#'.W.W/+'ZUT/C'1[W4[&PNM,6-]0TR]CO8(I&VK,5#*R%NV59@
M#ZXH 99OXOL=6M(]1.G:G87)99I+.!K=[5L$@D-(V]#C'&",CK4UOXVT"ZU"
M.SBNY"99C!%.;>002RC.424KL9N#P#SBJD6H^)M:U*SACT:XT6PC8M>S7<D+
MO*-I CC",W<@ECC@<=:YVUT37G\+:-X/ET5X?L%S;F74_-C\DQ0RAPZ -OWL
M% P5&"QR: .EE^(?AB"=XI+^15CG>VDF-K+Y22J2#&TFW:&RIP,Y/&.HS,OC
MGP^=-O+^6\DMH+*6.*Y%S;2Q/$SD!-R,H8 [A@XQ^1KGO^$9U7_A&?LGV+]^
M?$WV\IO7F#[9YF_.<?<YQU[8S2^(?#6JW^H>(Y(+/S([R?2FA.]1O6&8-+U/
M&!Z]>V: -=OB-X;19]\]ZLD W30G3K@2QIC/F,FS<$QSN(Q[U=U#QCHFG/"D
MEQ+.\T N56TMI+@B$])&$:G:ON<5GW&BWTGB3Q1=K;YAO=)@M[=]R_/(OG;E
MZY'WUZ\<UD:%IVN>$IH[G^P[C41=Z396[I;31![>>",J4;>P!4[L[@3@@\4
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MQK(40CA,!E&YL\GL.:Y\:UXBTO4/'.IV-M9/:6%PMS-%=RMO8+:Q,T:;>%(
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M)3E=R'C())!&.IZUT>D:<=*TR&S-W<WC1Y+7%U)ODD8DDDGZG@#@# '2KM%
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MRS2,\D3#NAW8]?E!ZBM'Q%H)UZWLUCO9+*XL[I+N":-%?#J&7E6X(PQK9HH
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MNF<6[23XFC\QB3MVA25)P-Q[&D^(%W'J;>.+5;QYK>UT.V?RXYVVQR^9*3D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%<OXK\32:-=6%A;3Z?:SW2R327>H-B"WBCVAF8!ER2SHH&1
MUZ\4 =1161X:U"]U/1UN;X6;.9&5)[*4/#<(#\LB<G /H22"#6O0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 9$FA.^O+JG]L:HJ@@_8EF7[.<+
MC[NW/OUZUC>*M'F/BC0O$46EMJB6"3PRV\>SS%$@7;(@<@$@J01G.&XZ5V%%
M ',>"=+NM.LM3FN;3["M_J$MW#9;E)MT8* IVDJ"2I8@$@%JT-,T)]-U">[;
M6-4O!,"!!=3*T<>3GY0%!&.G7I6O10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex31articlesofincorporat007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC!-=#K?AS2],\1W%AIVG0QP7OAN]:>%$R)W1XMC,/XG!8_,>>: /2+*^@O\
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M@09W%MPQC.<_6FOX[TFVT[4+N^CO+)M/$;7-O<0%9461MJ, "0RDYY!/0]Z
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M,NHV$/QD%=IZ$$$8]16?!XTT6XN-!@CG<R:Y"TUF"G557<=W]TX[>H(H Z#
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M8T1F9456;EB!@GZUR=WJ.LZYXKO]$TB^CTVVTR*)KJZ, EDDDD!940-\H 4
MDD'J *FAUC4?#NF73^*9(YQ'<+#9W%K%^\O-^-J^4,X?<2,#@XSP* .H(R,&
MFQQQQ+MC147KA1@5S3^/-(M]/U"ZO8[VR?3_ "C<V]Q 1*BR,%1@!G<I/<$]
M#WJNWQ#TY);BW.EZU]KMXQ-):_83Y@A.?WN,XV\$=<YXQ0!UJQHC,RHH9N6(
M')^M9^K:+;ZN+$3/(@L[N.[3R\<LF< Y'3FLFZ\>Z3!+#%;P7]_)-8IJ,:V=
ML7)MW)P_;'W>AYY'6G:;X[T?5;VS@@2\6*^C9[2ZFMRD,^U=S!6/.0,GD#H<
M9H Z1$6- B*%4= !@4+%&B;$157^Z!@5S=CXZTF_NK1$BOHK:]D\NSO9K<I!
M<-R0%;W .,@9QQFHK;XA:/=3VX2#4!;3W7V-;QK4B$3;B@0M[L,9QC)QG- '
M4O&DF-Z*V#D9&<'UH**PP5!&<X([UA>,]6O=#\+W5_I\8:=&C4NT9D$*,X5I
M"J\L%4EL#TK&\/:QJ$]XL]KXDL?$^E&%VG-ND:3P.!E0%0_,&Y&" 0<<T =L
MT:.A1D5D/52,@TNT<<#CI[5Q.A?$%+WPQI=_?V-V=1U!I%AL[: EY=O)9 3]
MP C+$@9K3_X3C2#IB7BB[>5[HV:V2P'[1YX&3'L[$ 9STQSG% '28 S@=::8
MT,@D**7 P&QR!]:XV?QO%-JVBI [V=N]W<6^HQ7D?EO#Y=NTN&STZ*V0<$'K
M73:3JD&M:='?VT<RV\I)B::,H9%[, >=IZC.,CF@"[M&",#!ZTAC0R!RBEP,
M!L<XKFCXZTP7<:&VU#[))="S6_\ LQ^SF7?L"[NN-WR[L8SWI#X]T=;C4D=+
MU(--:1+N[-NWDQNAP4W=V.1@#).1ZT =/M7^Z/RI:Q-)\46FJW[6#6M]8WGE
M>>D%[!Y;21YP67D@@$@$=1D9 S3M7\2VFDWL-C]FO+V^EC,HMK.'S'$8."[<
M@ 9..3R>F: -98HT38B*J_W0,"GX&<XY]:Y^/QIHCIITIN&CM]060PSRH40-
M'DNCD_=<8;@X^Z?2HCXWTYK33YK>UU"YEU"-IK:VAMR97B4C,A!(VKRN"2,[
MA0!T1AB:/RVC0IUVE1C\J=@<<#CI7"M\0$?Q+8I9P7EY87>FRSK;V]J3-YR3
M!&# XV[?F!R0,^^*V/\ A-M+ETW3[RTBO;QM0WBWMX+<F4E#A\@X"[2,')'-
M '1D ]1FDVC!&!@US#>/M'6PM;KR[XO<W;V2VPMF,RSH"3&5['Y?IR.<<TY/
M'.DG2Y[QX[V*6&Z%DUD]N?M'GD J@0=20000<8YSP: .EVKNW;1NQC..<4B1
MI&NV-%5?11@5S4/CS1WAU1[A+RS?2UB-U#<VY5U,A(10!G<21QMSG(Q4D7C7
M2O*OFODN],>R@^TS17L)1_*Z;U SN&1CC)SQC)% '0M&C,K,BEE^Z2.1]*4*
M!T 'X5QUCXOFU/QS8Z5':7MG;R:?/<R0WMMY;L0\01@>>,,_&<^H%-\2Z_J5
MOXUT+0[-[BUM[A)9[FX2V60,J%!MRQPJC<2QQD<8H W-;T!-=-I%/>3QV4,H
MEFM(PNRY*L&4.2"<!ES@$9SSFMBN9L/'6E7]U:1I#?16]\YCL[R:W*07+8)
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M#@X.#T-+0!YMH>@>)O#,FC7$.F6U]]FT*+3[B(70C82JY;*DC!'K]?;%.M_
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MKMO=V*W$I2.?%L(61F .PGY\$C&0/6O2JCGMX;J!X+B&.:%QAHY%#*P]P>M
M'DITS4?'&H>+_DLXYT?36A2&Z9XB\)>0QM*H!R0PR5^[N'I6@W@.\U2WU0C2
MH-)DELU@MVN+^6[D:02+)\Q+%5CRBC !)Y/'0^B116.DV@CBCMK.V4\*H6-
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MC 5'7:PVHBCT.<9R!DD<5;A\*V$-AH%FLEQY>ALC6I+#+%8FB&_CGY6/3'-
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M>KJ#:@)5-PTZC <DKMZ<8VX [5:F\(:?/HVM:6\MSY&L2O-<L'7<&=54[3C
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MEJP!W.R "5B<X(WDJ/\ <-9.M>'&L-'\0)IEI>:H=;9P]BTT:Q1.ZE6D!;!
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ML;44L2% RQ)J?5_#46J:A!J,-_>:=J$,;0BYLV3<T9()1@ZLI&1D9&0>E '
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>&YH ]1T?Q5I^MW%K#:K.&N=.BU)/,4 >5(2%!Y^]QR/UK;KS'X>?\A;0_\
ML3['_P!#:E\:3Z;>^,);&]@TQOLVGI(7UF[9(%5F;F&(#YW^7EL@CY0* /09
MM3M(-5M=,>0B[N8Y)8DVGE4VACGH,;U_.B[U.TLKRQM)Y"L]](T4"A2=S*C.
M?I\JGK7D_A3[#<:C\.[_ %1HFN9-+NHHYKAL,\B21"-06.2P!; Z]:ZKQS;:
M8?%7@RZU-+<1+?RQF6<A5!,$A49/'+A<>^* .KT?5[;7-/\ MMH)!%YTL.)
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M8]N0#Y>2=O?WS0![95"[U>VL]7T_391(9[_S/**@;1Y:AFR<\<&O)(Q<69U
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MO**ODYS)\S88\\T >FT5XKH$EK;>,_#/V#^Q[?[7;7 F33KQ[B21?)++Y[D
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M;Y%4MM'4X)P.YP*:?'&F:;&8+V6]N&LT1;^\CL7\J!RH/[P@$(<$$CG;GG%
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MYST)4<4[Q)XIDT#Q1H5D8Y9;:^ANB\4$#2RN\?E[0H7_ 'F)[<4 =2RAE*L
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MW>[MGA2>-1EF0L!G YQUQSC% '0&.-F+,BDE=I)'4>GTJ*.SM88Q'%;0H@R
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MG6WGD&?E20C!)P<=CCC- &]'96L,;QQ6T*(YRZK& &^H[U*40N'*J6 (!QR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y7QW&T=CI.IG_4Z9JD%W/_ +,7S1LWT42;C[*:ZJFR1I-$\4J*\;J5
M9&&0P/4$=Q0!YUXI\.ZU=:YJ%YI.F2PW\Z(+35;#4?LX!"@#[3&3B0*?16RN
M!Q3]4T;Q-#+XKM;/38KY=>MU"7?VA8UB?[.(6WJ>>JY&,]<''6O0D1(XUC10
MJ* %51@ #L*=0!P%E8^)/#^M7-W:Z(E_%<:99VPVW21LDL2N#G=_!\_)'/3
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MFGVWA;5(O!.@Z8T*"ZL]8BNYE\P8$:W1D)SW.TYQ7?44 8'BW2[K5M.L8;1
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MW>^)-.UNWM;J^BAMI+6:VM=0>TE 9E975U90>5(*DCJ#VKLT@ACGDF2)%EE
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&CMTE ):28KODYSC: R#IUW<UB77B#Q%>S:]<Z,NFI9:-*T!BNHW:2Z=$5W
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MMK AE<*3@@XSV(K7/@*U2&TDMM3OH=2MKJ2\_M#]V\DDLB[7+JRE""N!@ 8
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M(8H6QNYVYQ^'% %'6O&NJ:;XGN;&2?3=.@BEC2V34;>55O48*69;@'8A!+
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M7(LM#7S)+Z5D"W  79& #DG>B.<@ ;..M=3KNCP>(-"O=(NGD2"[B,3M$0&
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MM6/VRT+F+S98?G7!W1NR-^JFIKB\%M/:Q&&>0W$AC#1QEECPI;+G^$<8R>Y
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MVCN7^],D*AV^K 9-.ET^RGNX[N6SMY+F/[DSQ NOT.,BL=O&NAKJ9L3/-D7
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M6B+)<BWM)9A#&R[@[%%("X[_ %]#6Q/J=I;Z/+JK2AK..W-R9$Y!C"[LC\*
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MHP0'Z[OK[TZZL[:^@,%W;0W$1.3',@=2?H:XG7O'!FD\/V_AZY.W5IG4W?\
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MCECD?!4%"N[D$$''.: -]K6W=95:")EF_P!:"@(?C'S>O  YIWDQ^:)?+3S
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M4DFE,S["HVAV5%.T_=/KD#BO4;:V@L[:.VMH8X8(E"1QQJ%5%'0 #@"I: .
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MDX)P.*=+%XHU+PTVBMX=BM/*TN:VEFFFC<2R&$HBP%6R 3R2X7CC'IW]% '
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M;FST2*X5W9LOF9UV$9QCJ<XSS70V7AJWT_7?[4M9Y8WDM4MKB(8V3[.$=O\
M; R,^AQV%5M=\&VFO7&HS3W,\9OK!+%PF/E59&<,,CKEL4 8FJZ]XFM3JFDW
MHTV.YDT:>_M9[7S!Y10JK*V3DGYP0PQR.E)HFN>(KJTT?1+(Z<U\FD0WMU=W
M*R,FU\K&H4,"6.TDL3CCISBNGU'PW:ZGJQOYY903I\U@47 !24J6/U^08^M9
M,'@>>RCL9;/Q!>0ZA:6OV(W7DQ-YT .45T*[<KV88/)SG- &MX7UN37M'-S<
M6ZV]U#/+:W,2-N598W*-M/<$C(]C7(?\+"OHM;L8);C1)DN=06RDL;5WEFMP
MS%59I5)3(X)7 ZXS7;:'HEMH.DII]L\LBAGDDEE;+RN[%G=CQR22:YNV^':V
M]GIMA_;M\VGZ7=1W-G;>7&H4H^X!V"Y?N.HZYY.#0!J^,==N_#VCQ7=I K;[
MA(I9Y(GD2V0@DR,J?,0, <8^\.:P1XVU6;1=-FL6T74+B]U8:>D]M,Q@*&-G
M#D9+(P*\H23QUY&.MUK2I-5MH5@U&ZL+B"43136Y'4 C#*<AE()R#_,5C6O@
M6VAGBNY[^XN+T:DNI33E$3S9%B,07:H "[3VYSU- &%=>,O%=C8Z[=36NCNN
M@3A+HIY@^TJ51_W8S^[(5QU+9/I4_BWQU?Z#>:DL%SHD8LHA*EG.SRW%R-FX
M\(?W0[ L#TSP*W;WP=:7MAXBM'N9E77)!),PQF,^6D?R\>B \^M4[[P&+M]:
MBAUJ]M;'627O+>)(R68H$.'*E@"%&1]<8S0!RFOWK7=SXDN4+HLIT"15W?=#
M7&2/UJ]JGQ-GM[W5WM#IWV?2[A[<V<RRFXNC']\HR_*G.0H(.<<XS70R^ [.
M:*Z1[RXS<I8JY 7C[*^]2./XCU_2EN?!;O<WXL==U#3['4)C/=6MOL&7.-Y1
MR-R;L<X/J1C- #=,\0:UK'B_4+.UAL8](L&A\R24/YT@DA60!0#@$%N<]C[5
M+KFM:U%XIL-"T>*QWW5G-<O/=AR(]C(OW5(W9WXQD>N>,'5T[1(=-U75+^*6
M1GU%XW=6Y";(UC&._10>:671H9?$EMK9E<306LMJL8QM*NR,2>^?D'YT <YH
MOC.^U"[T.TN;2WCFN[B^MKKRRQ57MB5RF>Q(SS4-WXSU?SOLUC9V;7#^('TA
M#,6"A! 9-YQSD$=.XXXZU>?P-$D=L]CJEU:7MM?7-Y#<JB/@SLQD0JPP5^;'
MKP.:=8^!;:R-N[:C=W$L6JMJK22[=TDK1&,@X &/F)X Q]* ,*?QGXJL]/UF
M\GM=(:+0KL07>SS ;D$(Q,8S^[(61>N[)STIL5_XCL-9\<7VF16$MG9WBS/'
M<E]\VVUB+(A!PG ZD');H.M=-=^#;2\TS7[%[F=4UJX\^9AC,9V(N%XZ8C'7
MU-5;WP,UU>ZQ)#KU_;6VL.&O;:-8R&41K&0K%24)5<$CU]A0!B7_ ,3'FU":
M#2Y]-M8[>VAG_P")@DC-.TL8D"+LX0!67+'/)Z<5?L/%^M:_K>G6NDV=G;VL
MVFV^HW#7N\R1AW96C 7'S?+P3QP?7C2N?!NR]FN=%U>[T?[3!'!<1VZ(ZNJ+
MM1EW@[6"\9'8#CBK^G^&[;3=774(KBXD=;"*P F?>2L;,P8L>2QW')- $'B'
M6K^SU+2M'TJ*W:_U$RLLMSN,<,<8!9B%(+'YE &1UZ\5Q'BO5-8UNP&@WD=@
MES;:W:6EXH#F&Y20J\9 W A3G#*2>G6N^UWP^NL2V5W#>36.H6+L]O<PA6*[
MAAE*L"&4C&1[ ]JSXO!%L(0UQ?W-Q>/J4.I7%U(%#2R1XVK@ !5 4  =!0!/
MXBU&X\+>%$ET^RC<P>3#M2)VC@CR%+E$RQ51S@<X%<=JWB2_UOPU9SVUUI-_
M/%KUDD$MC,RQR$R*<2*<M&<\$'/'->AZSI;:M8?9X[ZYL94D66.>V8!E93D9
M!R&'8J0016#'X$@::6[O-2N+F_FO;:\FG\M$#& Y10JC '7)ZG/7I0! /%&M
MV)\066HQ:4][IMO!<Q3+*;>!DE+#YRY.W:4)//(Z8-9,7Q&O4CUU?.TK4FL=
M(DU*"XLHY$B8ID%&#$YYQRIKI-:\$V>MSZG/+=7$4E]%;)E-I\MH)&D1@""#
M\S<@Y! JM<> _M\VH7&I:W>75Q?:9)ILC%(T5(W(.451P1SUSG/TP 9>H>-M
M:THZ;9ZBVCVE]J*O<K*RRO%;P*$PK $%W+/C@J.,^U1/\1KY]!ANUAM8-M_)
M9W6H-!-+:Q!4W+(%7#[7RH&2 #G)XYZO5/#(OIM.N[34)[#4+"-HH;F)5;=&
MP 9'5@0P.U3[$#%5_P#A$[F.SMQ!XCU1+^*=[AKMV5Q(SC#*T9&S9C&% &W'
M'?(!>\,:M+K6AQ7LTMA,S,Z^;83>9#( Q 93U&1U4\@\5C^/Y]5@CT :7<Q0
M-+J\$;^8&PV<X!VD97(Y'?BK-AX9N=%CLXM.OY6\S47O-1ED"#S]Z-N&T+@#
M=LP%QC'4\YT/$6@C7[&"$7DUG-;7,=U!/$JL4D0\'# @CD\&@#@K?7-?T&T\
M7:O;Q6$NFV.LS/-',7,LJ_)N"$'"8!XR#DYZ5=UKXC7%KK&KVUC)IL<>EL(S
M#=K*9;MP@=E0KP@^8*"0V3V KHI_!MK<:!KFDO=3^7J\\D\T@ W(7"Y"\8Q\
MM,OO!\DM]J$^G:Y?:9%J1!O(;=4.]@H4NA9248J "1Z ]>: ,S_A*_$&KZA>
M1:%;:?%!;Z=;7P>^60L?-5V$952,'Y>O;T/;>L]876/ L.M&W"B[TX7)A+$@
M;H]VW(QZXS4EGX<MK+4=0O(YIF:]M8+9E=MVU8@X!R>23O.2?2I-.T*'3O"U
MOH$<LC006@M!(V-Q4+MSZ9H Y'1_$.O7XTO2="M-+MH_[ L[_?=>8ZH7W+Y8
M ;)'RC!)R,'.<UUGA;6F\1>%].U=X1 ]U"'>,'(5NA /ID&H-%\*VVB7<%Q#
M<32-#IEOI@#XP4A+$-QW.XYJYH&C0^'M"M-)@E>6*V38KR8W'DGG'UH TJ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***XCXE7=]!9:-;VSJEM=ZBD-TSW36RLFQR$:5060,P
M49 YZ<9H [>BO(/MTVF6&M:?<76+5[VSMX++3=5DD,,LA.Z-KB1%\M' 7(4D
MKDXQN%4I-2U#2#XNL[.=;&.&ULGDBL]1DNQ:!YF65P[@%6$?)P,# - 'K^JZ
MK:Z+I[WUZS+ CHA*KN.7<(O'U85=KR;Q?8Z%9Z%JFGZ/JUV7FBLI)+=+EYXT
M!NXP)0S;MKG/KR!G!QFNDT>QCT/XC7&F6,MR+*;24N7AFN'F'FB4KO!<D@D=
M?7 H [6BO,O'$<LWB6Z=;B&\CMM/1WL&U*2QFMOF?]_$P^1B<8YZ;!R,U9T+
MQ);'7[V[NK^:"TF\/V-W M]*%;:?.W,1TW?=W$=\>U 'HE4O[5M3K9TC<WVP
M6PNMNWCR]VW.?J.E>7^&I(];7PW8^(;^?[#_ ,(['=1*]V\0GF+D2,S!@695
M"=3QN)JUIFE:5XB\86*'4-0U'3TT#]W-)/)$\X%PRAG*[2V.Q/7@\\&@#U.B
MN6\ W5U<> K&6::2YG031AY6W,X25U7)/4X4<URWARXT>+0]!U^_UN_77+EF
M-R([AY'FEVL9(6BY 5<'C:-NT<CN >I45XMIEZ\6K>#M0M6>$:E=@&:?67N+
MJ[B:-R3+$!Y:C.WH?E.  *M^'[EM/U[2+JXN&U$7U[)#%J5GJ4A:<L'^2>VD
M' 7'\/W2HZ4 >O56O=0M=.CBDNYA$LLR0(2"=TCL%5>/4D5XUH=WK%Q9Z1K,
MUW8V^JW&HI'//+K$[2R,9</;FV$94<94+G"X#9[UW'Q,M+2YTG1VO"5B36;,
M,WFM&%4R@,201CCOVH ZFPU6UU*6^BMF9FLK@VTV5QAPJM@>O#"KM>.ZAI4'
M]B_$+6XKF\CO+"]EDLWANI$6)DMXF#  X)/&2<Y  IVLW&H:GXC\1F\DM$2Q
MAA-L]QK,UD;:,PAO-1$1@V7+?,?[NWMR >P45S1U26S^&O\ :FIW4CS1Z5YT
M]S9+AF;R\EXPX&#W&X#'<5P>E33:?XOT**$+:+?6-RTL:ZS)>2SJ(@RO*" J
MG/(()S\W:@#V&BO'=%T=9K+X?2RW^IM)K%NPU!C?2YN%%N9 I^;@ J!QCC([
MFI;:0B\L]!O;^ZBT$:]?6K%KIU)"(&AA:3.[:26XSSM H ]=HKR1]0.G:E+:
M6>HS-H=EXCLHHIGN&=8P\9,D7F$\J&*\$G!;%.\2:K)>7/C)+'5)@D=SI$*2
M6TY_=%I0'VD' //./QH ]1OKVVTVPN+Z\E$-M;QM++(W15 R3^53(ZR(KJ<J
MP!!]J\D\7:5!ID?C#2+62[^P/X;^VF&2ZDD F5Y!O!9B>0HR,X..<UW<XMK7
MX?W'V+4#:0)I[F.]5FF,/R'YP>2V#S^% '14C,%4LQP ,DUXPFI7_A^PU2*S
MB8:H^AS7%O/8:F]Y;3;"N9BCC<C_ #9!Y!Y'.*O:/;3#6-/MH[JQ2TO["?[3
M%!K=Q>27B;,B3YHU",&Q\V1G<1Z"@#U*POK;4]/M[ZSE$MK<1B2*0 @,I&0>
M:I:+X@L]?-T;&.Y,-O*8O/DA*1RL&96V$_> *D$UA_#2VLV^&&BQ0L7CELD\
M[;,S$,4&X9SE?H,8]JXKP_9VL.F^%].N+BXMM)U"]U'[5_I4B+-+'*XBC+;N
M 1N. 1N*\YH ]FK)U'Q+I6EPZE)<W'_(-A2:Z5%+&-'SM/OG:>/:O-;@O<W7
M]B6FI7CZ(GB:"UAECNG+&-K9FEA$F=Q4-D=<C.,\"JGB71]-TH?$&WMFD22/
M2+40K)=.[%2'W'#,=W1>3G'XF@#VNJYO(QJ2V/ES>8T)F#^6?+P"!C=TW<].
MN,UR%CIT>@?$>RLK*XNS;WFE3RW"3W+RB21)(@KG<3AL.V2/6J'CV\NK?5M7
M6&YFC5?"=]*H1R '#IAACN/7K0!Z-5:;4+6WO[6REF"W-T',,>#EP@!8_AD?
MG7#Z?8+H?C'PR+6ZO&_M*PN3>^?<O*)W18F5R&) ;+-TQP<=*L^)K2R?XF^$
M+BY8JYCNE4F9D!91&4& 0"<D\=^ASB@#J])U6UUO2X-2LF9K:=2R,R[21DCH
M?I5VO'/#NFQZ7X2\&:Q:W%XM[<:G%!*QN7*-$[NICV9V[<8[=1GK5."[UBYL
MY-9DNK&VU8:JT1N)]8G$D;"?:(/LJQE=I7"[><@[LT >WT5R'Q*G%OX4C=KZ
M6QB.H6:RW,4AC:.,SH&.X=.":X_Q-*-(C\3V/A_4+@6*:3!.Y2Z:46]P9L J
MQ)*EDY(SS@'O0!Z_17E6NZ9)I_BS3O#UJHETMK*2Z6'4-8G@$\^\!B9 '9RJ
MX.W@#<34.ESSZ@_AS2]:U99M(FEOPLEO>RE)VC91%$TQ"-)M!DYZ-L!YQ0!Z
MW17D%_.)]8TG1=+OFU'1,WFT7^I2VR2S(ZCRA,J,TBH"VT'.<'D[<4NGSW%T
M=$TK5]51]%EU*\B+6U]*Z'8H,4#3L$9P&,GL=BC)Q0!Z3'XAL99YX8A<2/!>
MBQEV0LVR0H'YQT7##YNG-:M>/Z6\-E/<1:7?S2VI\:Q1"3SV<LOV=,H6SE@"
M,<D_=%+!:O#X4MO$@O;]M47Q!Y2R-=R%1$;\Q&/9G;M*D\8[T >OT5XMXAN;
M1_"OB?5+_6;FV\1P:A-!$BWSQM$@EVQ1K&& *M'@].=Q;W'H_CHL/!]ZJ:FF
MFL[1(+ERZH,R*-K,GS*K?=+#H&S0!T5%>+7FJWNDZ+K>FVL4NGW*2V)N3%JS
M3VL4$DA1GCEVEX20#NR,@88"G:C)J&E:7XJ@MKNTM(4T0S_9++5)[QHI=V%E
M#NB[,C<" <G ..IH ]DEE2"%Y96"QHI9F/0 <DTRSNX+^QM[RUD\RWN(UEB<
M C<K#(//L:\YU71X=*U[^S[>>]>WU'0;U[I);N5_-DC,6U^6X;YVY&.M<_8^
M;/%X2TBV^S3Z8V@)<K#<ZM+:QRW'RB3YT5BQ48^3@+N)QQP >V45Y)ID=UK$
M_A/3]0U5[JSDFU%6:SO92LT28V(TI"-)MZ;OXMO4Y-)!*Z36V@W=_=1:$/$=
MU9N[7+@^6L.^*$R9W;2YQUYP!0!ZY17D6M3107VG:'HFHR7FDOJ4\=S'=ZA+
M!"LHA5DMQ<!68KDLVW)Y&W/:NK^'S7:Q:Q;375M-;V]YL@B@NY+H6WR*6C\U
MT4M@G('.-V.U '957N+R.VN+6!XYF:Y<HI2,LJD*6RQ'"C ZGO@=Z\C\07VL
M6M]J&@V5U<^=H]Y-KP(<YDM5"R+$3W4O(ZX_Z9UI6=Y/JVJ:%JINK@VFMZU=
M&.,2LH-LMK+'&, \ ^7O^K9ZT =Y#XETJXETZ."X\W^T7E2V95.&,>=_/;&T
M_6M:O$_#NCZ?>V?@>R6681R7NHFX6*Z<-D*_RDALJ" N0,9_$UW_ ($#6X\0
MZ>)9I+:QU>2"V661I#''Y43[=S$G +MC)H ZVBO(M02[M]!\;^(K6[O6U.TU
M&>VMW^TR!+> F,.54$J,*SMNVDC ]*(?M6FW5Y%;ZK8Z5;3:-<2RFUU6XU%E
MP!LN<-&-I4DY.?FSWQ0!Z[17C*7<FDZ7KUD5:&[E\.W-Q%/8:L]U;2[%_P!;
MA_GC?+#!S@\\DBKYG729M$N/"VH3W][>:9<S7*-=-/Y^V LDK*20#YNU00!]
MXCV !ZO17COA>74$NO"U]#>6"SWYS</_ &S/=27ZF-BX:(Q[58'G.0%QM[UH
M>&4TB\T?0M4U+6KY==U"=HKE8[J0M-*VX/ T>2%1>>@&W:#D=: /2=/U"UU2
MRCO+*836\F=DB@@'!(/7W!HLM0M=1CEDM)A*D4SP.0#PZ,58?@017)_"J"UA
M^']FMLV2SR^:/-+[7WD8Y)V\ <<>O>N-TN*SM(+73?M<UKIMUXFOK?466[=3
MA6F,,;-NRH9@ >A;N3F@#V>LF_\ $NE:=%?O/<?\>!B6Y5%),9D("#\<BL/P
M<Z0>)/$FEV%S)<:1:-;F#?,THAE96,D:N23@80XSP6-<7XHL;-+CXB>7(\=U
M))88Q.Q8*YB+,%)Q][H<<=!QQ0![-17E/B1;OPC?ZY#X>FO%+>'I+O9)<238
ME64+YHWECN"L2<=<"K'A9;FS\7:4EO=:?';75I*\\,.LSW[72@ K+AXP%(8C
MYLC.XCG% 'IU%>=^.);ZY\::1I6R!]/DLYIEAN-0DLXYY@RC!=%8L54Y"\=2
M>U8CW^K6_A*PGT_4EO->AU6:#28+>XDN$N(\X>&1W">8J+N^<]-BG.>H!Z_5
M*;5;6#6+72W9A=744DT2[>"J%0W/;[ZUYO9266HGPE8W.JWDNE7L%U/=233M
M$]Q>*4S'(005P3(?+SCY<<[:(],TC6/%WA^PM]2O[[388=33<UPX+;9(1Y8D
M&&=%)P#DYV@9.* /5:*\ACO";&ST"1KV](UG4+>VMY-1-O')%"QPLTW+D*&&
M%&<XYR!533KBYO=*33?M\J6Z^+ULP+._DD"0F#<T2RG#%<EN>/;H* /::*\D
MU-I-$NM>T>VO;NVT5-1TY9V-RY-M!*/WNUR2R*2%!.>-Q/%5-=OET2[\51>%
MM4FDA@TJT8JMX\J6I>=ED*L2Q7$?S9&<=: /9J*\X\))=67C..VAGT^&TFL&
MEEL[?5I[XN0R[)LO& G4@G/S9Z'%7M:2UU/XA#2];NI(M-CTL7%K"+EH$EE,
MC"1B5(W%5"<9XW9H [FBO']*CE\2ZAX:T^_U"_GTQAJJQR+=/&UW!%-&L+.R
MD%N,$'/.,]SGL_'L[V^DZ9!]IEM;&YU*"WO9XY#&4@;.1O'*@L$4G(X;K0!T
M&H:K:Z6;,73,IN[E;6+"YS(P) /IT/-7:\HU[3]&-U9:/I>J7TD(UZS\Z!;E
MV6V+1R96.3J"P&2 W&01C/*ZA/#X>D\4Z1'/J2V/VC3TMH8KPJRO-PRB5R3&
MC%1DYX!.,$T >K45X??WEYID7C.QM94L1%I$,XM[34Y+H02F1ANWN 5<KMR!
MQC%=!KMO=^%-9OXO#\UZTTWAR\N=DMP\Q>>-XPLF')^?#MTZT >H45Y+YFFZ
M=X@\,MX9U>>]N;BSNII(3?/.+AA;DH[J6.&+?3/X<4_"\VHL_A74EOK%+J^F
M07,QUB>XEO 4)D1H/+VJ1R>H"%<9H ]FJAK6L6F@Z7)J%Z9/)1E0+$A=W9F"
MJJJ.222!^-<]XVEW:CX<L+NZDMM)O+QX[R1)3%O(B9HXRX((#,/49QCO7$ZU
M:VUQ'K&F07$]SH]CK.EK:G[4[B)Y)4$T:ONR0 5.,G:6XQ0![!:7'VNTAN!%
M+#YB!O+F3:ZY[,.Q]J@U35;71[,75XS+$9HX057/S2.$7_QYA6+XVC\CP7-;
MP:DNFC=#$D\KR!<>8HV.Z_,H;[I;.1NSFO/;]P^@ZQH;PW%C<1WVENZ0:D;J
M",/<JH:%R-R,=I)4^Q'6@#VFBO+-9DM_".I>([2"ZU.'3FT>WGV0W;-(DSSO
M%N1Y"=A/RY;MC/45DRW%SI>JZ_90>78*WA>[N6MK;5I;LK(I4)(Q8#:^&;I^
M= 'M-%>1ZG83Z>WA73;=WGM=3BDN;S[?JLT"W5P(X]H:0!B.KL$  )'MBHE^
MWW.C0V+:SI\B)K,L=O9/J-P8ID$63;FYV*Q*L2PSD' 7G% 'L-%<I\/[V.[T
M&YA2.ZB:TO9;=XKB[%R$88;;'+_&@W #/(P1VKB+FY4^#]1\1-J=ROBV'49(
MXXQ=N"DHG*1VXBS@J4VC;CD-GWH ]-M_$%G=^(+O1H([F2>T \^40GRHV*A@
MA?INVL#CWK5KB/!NF6MKXP\9SQ+()!J")EIG88-O"YX)QU/7\.G%=O0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@=1O7W7/:@#271M+34CJ2Z;9K?GK="!1*?\ @6,_K4]U:6U];/;7EO%<0/\
M>BF0.K?4'@U0T/Q'I?B.&6;2KAYX8R 9#"Z*V1D%2P 8>XS7,V6L>,=9GUF7
M3Y]!AM;#4)[2-+FWE+,(R.6<28&<]<4 =D-/LA;S6XL[<0S_ .MC\I=LG 'S
M#&#P .>PJ*\T;2]1EAEO=-L[F2'_ %3S0*Y3_=)''X5S^E_$'3+KP[I.HWJS
M0W5_;F<6EM!)<N #AFQ&I.S/1B .15NY\=^&[2RL;N34=T5_&\EKY4$DC2A2
M V%52<C<,C&1SZ' !T3*KH490RD8((R"*H6F@Z/88^QZ58V^UBP\FW1,,003
MP.I!(^AKFM/\=QZJUP(MMGY&LIIX^U6TP\U#@ #Y1AR<\'[O&>HSK_\ "9Z#
M_:O]G?;6\[S_ +-O$$GD^=_SS\W;LW]MN[.>.M &NEC:1K;JEK"HMAB +&!Y
M0QCY?[O''':HYM,T^XMIK:>QMI8)V+RQ/"K+(QZE@1@GW-8,'C;2[>PLWU&_
MCEN;R2X6W6RM9G,WE2%"%0*6+#@'UP2.*N-XQT)=*M]1%Z7@N)3#"L<,CRO(
M,Y01A2^X8.1C(QS0!HC2=-&F_P!G#3[46)&W[-Y*^5CKC;C'Z4D6CZ7;P>1#
MIMG'#\O[M(%"_*<KP!C@\CTKF]4^(>EVNFV5[9":Z2?44L)5^S3!X22-X9-F
MX, 1A2 3D8S5S_A,--L8KN;5-1MUC746LH?*@ER'\L.(V&"2^,].#P!S0!OO
M:6TLCR26\3N\?E.S("63^Z3W')X]Z+>TMK.U2UM;>*"W086*) J*/0 <"L>+
MQGH$NDW.I?;C';VLHAG66"2.1)#C"&-E#[CD8&,G/%3Z/XGTG7;JXM;"XD:Y
MME5IX)8)(GB#9V[E=003M/'I@]"* +5CH^EZ6TK:?IMG:&4YD-O L>_ZX S1
M9:/I>FRRRV&FV=K)+_K'@@5"_P!2!S7-WNK>)KOQI?:+HTNDP06EG!<,]Y;R
M2,QD9Q@;74 #9^M1Z9X]@M]/O6\2R6]K<6>I-IIDM5>2.>0)Y@V  L"5R-O)
MR,<DB@#KK2QM+")HK.U@MHV8N4AC" L>IP.Y]:CETK3I[$V,UA:R69))MWA4
MQDDY)VD8ZDGZUCW'CKP]:[/-NYANA6X?;:3-Y,;#*M+A?W0/^WBLZZ\8R-X_
MBT2VN((;"&R%Y<SRVDKB0'<<+("$10JYWG()XZC% '5Q:;8PV\$$5E;QPV[;
MH8TB4+&W/*C& >3T]:;<:5IUW.9[FPM9IC&8C))"K,4/.W)'3VK-T[QCH6JS
M&*UNY-_E&=!-;2Q>;&.KQEU&]1D<KGJ*I+\2/"CV:W:ZDYMW=8XY!:S8E9E9
M@J?)\QPC<#/(QUP* .F,$+7"W!BC,RJ460J-P4X) /7!P./84R:RM;AF:>VA
ME9XS"Q>,,2AZJ<_PGTZ5AW'CKP]:LHFO)1F))Y"+25A CC*F4A<19'/SXJ36
M?&.C:,[P3W9-P(//VQ0R2JB'.'<H"$4D=6('6@#:-M 98I3!&9(05C;8,H#C
M(![9P/RIMS8VEXT+75K!.T+B2(RQAC&XZ,N>A]Q6=X<U:;5_!^EZQ<1+Y]U9
M1W,D<(.-S(&(4$^_'-<GHGBOQ/K>FV^M6,FAWT,C(9M(M]PN8$+ $&0OC>H.
M2"H'!% '>+86:P10+:0"*%@\48C&U&'(*CL?I43:-I;:D-2;3;,WXX%T8%\T
M=OOXS^M85MXYT]M:\16=YNM+?1MF^XEBD56!4%B25 ZL  "2W49!J_8^+M$U
M!;HQWC0FTB\^=+N"2W9(^?G*R*IV\'YNE $OB'0T\0:?#9R3>4L=U!<D[-V[
MRY%?;CWVX_&K$&C:7:V3V5OIMG#:R'<\$<"JC'U*@8-<SK'Q#T^/PWJE[H\O
MF7UI:_:8X;NVEB$B9 W@.%+KSU7CD5T]MJUC=ZE=:?;S^;<VFWSU521&3R%+
M8QNQSMSG&.* 'W^F6&JP"#4;&VO(0=PCN(ED4'UPP-)<:5IUU8+87%A:S6:@
M 6\D*M& .GRD8XK.U7Q?HFBW;VU]=2K)%&)9C%;2RK"ASAI&12$'!Y8CI63-
MX_L=.\3:OI^I2;;6UA@FA>WMY9F*.K%W?8&PHP.< <]: .EGT?2[FP2PN--L
MY;),;;>2!6C7'3"D8%.DTK3IM.&GRV%J]B  +9H5,8 Z#;C%9U_XOT33C LE
MU),T\ N8TM+:2X8Q'I(1&K$+[GBL76?'#P&6;23:W5F?#UUJT$I#'>\93:.H
M^4[CD=?<4 =7%I6G6\:QPV%K&B.)%5(5 5P,!@ .H  !]!3_ +!9_9Q;_9(/
M)#^8(_+&W?NW;L=,[N<^O-96KZU<:?X$O=<B2)KF#3GNU1@=A<1[L$9SC/O3
M-$\8Z/K;1P071%RT'G[9()(ED08W-&7 #J">JDB@#+U7P)/J]]<_:M5BDL+B
M7>ZO8J;D)N#&)9\\1Y&,;2<'&:[&:&*XA>&:-)(G!5T=058'L0>M8NF^,="U
M>^CM+.\=Y)@Q@9X)(TG"]3&[*%DQU^4GCFKFKZYI^AQ1/?S.IF?RX8XHGEDD
M;!.%1 6;@$\"@"2TTC3-/M)+6RTZTMK:3.^&&!41L]<@#!IMMH>DV=I+:6NE
MV4%M-_K88K=%1_\ >4#!_&J"^,M!;1GU47I%LD_V9@8)!*)O^>?E%=^_D?+C
M-8EOX[%_?:JMM/;0VMI>65O&]S;RJY,Q =&3AE?/ R  2,\4 =JUO TZ3M#&
M944HLA4;E4XR >P.!Q["J4GA_19;%;&32-/>T5RZP-;(8PQZD+C&?>HY/$>D
MQ:=>:@]V!:V<[6]Q)L;Y)%8*5QC)Y(''%5KKQEH5GJ3V$]VZRQRK#)(+>1H8
MY&QM1I0NQ6.X<$CJ* -=+*UC,!2VA7[.I6'$8'E@C!"^@P.U,ETRPGMY[>:R
MMI()V+S1O$I61O5@1@G@=?2N?T_QUI]Q=>(EO-UG;Z-<>4TTL4BJR[$.<E0,
M[F("C)(P1D$5>M/%^AWEO>3K>- ME'YMPMW#);O&G)#E9%4[3@X.,<4 7SH^
MEG31IITVS-@!C[+Y"^5Z_<QC]*GM+.UL+9+:SMH;>!/NQ0H$5?H!P*YC3_&U
MOK'C*VTC3]QMWT^6ZD\^VEAE!5XU0@.%^4AVYQSC@\&GZQXPBT/QA:Z7> _9
M9["2X7R;>2:9I%D4!55 21M+$\=NM '2-:6S3O.UO$9GC\IY"@W,G]TGN.3Q
M[TBV-HB6Z):P*MM_J (P!%QCY?[O!(X[&J-CXET?4I;..SODE:]@>>WPK 2(
MC!7P2,9!(!4\CTJW8:E::G%+)9S>:D4SP.P4@;T.U@,CG!!&1QQ0 D.E:=;S
M&:"PM8I3(TI=(55M[##-D#J1P3WJ>*"&!I&BBCC,K[Y"B@;VP!D^IP ,^PKF
M4^(_A60Q[=38I+D12?99=DC#JBMMPS_[ );MBK]GXNT2^MX)H;QL37?V%5DA
MD1Q/M+>6RLH*G )Y _6@#6CMH(A((X8T$K%Y J@;V/4GU)JO8Z/I>F"46&FV
M=H)>9!! L>_ZX'-8_B#Q4FG?N;!XI;N+4;*TN8Y$;$:SR*N<\9.UB1U]ZH67
MCI-3DNDCV6AM]933P;FVFQ*I(&%.T8<G/'1>,]1D V+WPKI<N@ZKIEA9VFG?
MVC;2022VUNJGYU*[B!C=C.:N:5HFGZ/%BSL[:&9D599HH51I2!U8@<GZUFKX
MZ\.->M:B_?>ER;223[/+Y4<P;;Y;2;=BMD8 )&>,=14>C^*X[K4[ZQOWBAE7
M59;"S"HW[T)$DG)Y&[!;TSCB@#9MM&TNSO);RUTVS@NI<^9/% JN_P!6 R:6
M/2--AU!]0BTZT2]D&'N5A42,/=L9-9UQXCM3K5KI]K>V_F?;3:7$<D4A)?R3
M+L1A\H8#:QSQC(ZXJ"R\>>&]0N[:VM;]G:Y?RX9#;2K$[\_()"H7=P?ESF@#
M=M;&TLO-^R6L$'FN9)/*C";W/5CCJ?>H7T?3)%NE?3K-ENR#<@P*1,1TW\?-
M^-9-SX\\-VEW);37[*T<XMVD%M*8O-SCRQ(%V%LG[H.1SZ&M?5-5LM&L6O+^
M;RH%95R%+,S,<*JJH)8DD   F@"6SLK33[9;:RM8;:!?NQ0QA%'T XJ.;2M.
MN+AKB>PM99W01M(\*LS*""%)(SC(!QZBLZV\7Z)=0>:EVZ?Z5'9M'-;R1R),
M^-BLC*&7.1@D8]ZLW7B'2;*2_CNKV.%K"%)[G>"!&C[@ISC!R5;@<\>XH OF
MWA-Q]H,,9FV>7YFT;MN<[<]<9[56L='TS3))9+#3K.T>4YD:W@6,O]2!S7,:
MU\0M.MM"N;[3IAYUK/:K/%>V\L+)%+,J%]KA6QM+$'ID?A6]H_B72M=FN(+&
M>4SVX5I8IK>2%PK9VMM=02IP<$<4 7+[3;'5+?[/J%E;W<.=WEW$2R+GUP01
M3HM/LH6A:*TMXS ACA*1@>6IZJO' X' ]*SM6\5:1HET+6\FF-QY?G-%;VLL
M[)'G&]A&K;5R#R<=#4%UXW\/6B6C-?-*;RW%S;K;P23-+'_>544DCU]* -.?
M1]+NK:6VN--LY8)9#+)%) K*[GJQ!&"?>I8K&S@\GR;2"/R$,<6R,#RU.,JN
M.@X' ]!6-8>.?#NJ7MI:V6H>:]V/]'D$$@BE(7<5$A7:6 SE<Y&#D4Z/QKX?
MEU);!+YC(TQMUE\B00M*./+$NW86R,8#9SQ0!HW.BZ5>VYM[K3+.>%I#*8Y8
M%92YZM@C&3Z]:D33-/BQY=C;)M=9!MB4891M5NG4#@'L.*J/XCTF/3;O4'NP
M+6TN&MIY-C?)(K["N,9/S'&1Q5&_\=^'-,O+FUNK]UEM'"7.RVE=8"0""[*I
M"@AAR2!UYX. "_K&CG4;&XCM+@6-U,4+7"0J^_:>%=3]]2,@@]B>E9WAWPF-
M'O+R^NI[>XN;F%+?9;6@MX(XE+$*L8+=2[$DDYS3[#Q7#?>--2\/+#(/LEO#
M*LOE/M<OOS\VW:  %P<\Y..AQ5U/QK!HWC231[[<+;^SH[N/R+:6:4L9)%;A
M 3M 0'..,]>10!T%AI&FZ4)!IVGVEF)#E_L\*Q[CZG:!FEO]+T_58EBU&PM;
MR-#N5+B%9 #Z@,#S5>R\0:5J5S#;V=ZDTD]J+R+8#AX2=NX'&#SP1U&1FK&G
MZG9ZI8B]LYQ+;%G428(!*L5;KVR#ST- $HM+97A=;>(/"I2)@@S&IQD+Z#@<
M#T%.G@AN8'@GB26)QM>.10RL/0@]:P[#QMH&IW]O9VMW*TESN^S.]M*D4^T$
MGRY&4*_ )^4GBJ7CKQ1<>'8=+M[+"W6H78@$LEG+<)$FUF9ML>"S< !<@G)/
M0&@#H+?2-,L[>.WMM.M(((I/-CCB@551_P"\ !@'WJ2?3K&Y6X6>SMY5N %G
M$D2L)0.@;(YQ[UAQ>.O#V^\ADU,&2P#B\D%O(L<;(VQQN(QNW<!<DG(QG(JS
M8^+]$O\ [6$NI(&LXO/G2\MY+9DCY^?$BJ=O!YZ4 78M#TB" P0Z58QPE/+\
MM+= NS.=N .F><5+>6,=W'+@F&X>%X4NHP!+$&Z[6(XY /U KEM5^)&C6OA_
M4]0L6FGN+.T-REO+:S1&5>BL-R E,XRPR!GDBM"'Q79?:+R>YOH(+&WL8;IE
MEADBEB#LXW/O X.W &,Y!]10!4T;P7+8ZU;:G?W]K<26B.(5M;!;;<[@!I),
M,=[X&.PY/%=#!H^EVM])?6^FV<5Y+GS+B.!5D?/7+ 9-9D'C70)[:^G^UR0K
M8P?:;A+BVEAD2+GY]CJ&*\'D U+I?BW1=9U V-C=N]QY?G(LD$D8ECR!O0LH
M#KDCE21S0!JW5I;7UL]M=V\5Q XP\4R!U;Z@\&HHM+T^"S2SAL+6.UC8,D*0
MJ$4@Y!"@8!!&?K63JOBF+2_%VC:$T$K'44E8RK%(P3;@*,A2.23DY^4 $XR#
M67X3^(FG:YIVEK>SB+4KW*82WE6$R#/R+(05+8'W=V: .RFABN87AGB26)QM
M='4,K#T(/6JEMHNE6=I]EM=,LH+;>)/)B@54W @AL 8R" <^U9Y\9Z"-4.G_
M &UO-$_V8R>1)Y(FZ>7YNW9OSQMW9SQUK>H @ELK2=I&FM89&EC\J0O&"73G
MY3GJ.3QTYJM!H.CVL/DV^E6,,6UDV1VZ*NUL;A@#H<#([XK0HH K76G6-]9_
M9+RSM[BVX_<S1*Z<=/E(Q4<FCZ7+IRZ=)IMF]BO2V:!3$/\ @.,?I5VB@"&U
MM;>RMDMK2WBMX$&$BB0(JCV X%0-H^F-J0U)M.M#? 8%R8%\T#_>QG]:NT4
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MH8I(\@[65 "...HKD]&^'FF75UKMUK^CI+-<ZM<31&20D/"Q!4X#8P>>"*]
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M,L8?#J&7!4\$$,:I3>#()O#VK:0;N0)J-[)=O(%&4+R"3 'ID8H YS6?B?\
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M_#EOJ4,^XEIE5 )0<_Q [/KO%;$'A;47W#4_$MY>QBUDMHHQ&L2_.,%Y O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFAMBMI IM05MR(P/)!&"$X^7CCCM4D\$-U \%Q%'-#(-KQR*&5AZ$'J*DHH
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M:MFBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M61#'G:X=CC# ]<#%5M3-Q83^/-4@NKVVOQ%8-A;J3]V7"EL#...0/09 X)H
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M3RIE4YV/M#;3[X8'\:\LFO;W_A";SQ@=9OUUR&_D1;47+"%2MP8UMC#G:<J
M.1NR<YKI/ ]C%;^(O&4BS7#.=6VE9+AW&#!$V=I.,Y)&?0 = * .KMM2M+N^
MO+.";?<63*EPFTC864,O)&#E2#Q5NO+[G3X+GQ3X^NY-;O;&6S6"5!;730B(
MBU4B1@" _3&&R.#QS5"'5?$/B;4O+NHKP>1I%G<B&VU0V&QY4+/*<<OAAMP?
ME&WD<T >OT5B>#[N\O\ PCI=UJ$\-Q=R0 R30,&20]-P(XY&#QZUMT %%%%
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MBB@!LL:31/%*BO&ZE65AD,#U!JK-I.GW&E?V7-8V\FG^6L7V9XP8]@QA=O3
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MG"X;US5K2=/O?"%_+YVAW]_!=Z5:6L(A*W#1-$K*T+M\HP=P._ 4\YQ7H]%
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M '3(SM8#/(Z&I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>>-98G (W*1D'!YZ5/7CVGZOX@UY]%L2=4N$7P]:7C_8[Y+:2:60$-(SL06
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M.1RJ@9(7^(J>PP>R\<MJ1TZQ@TNY"32WBA[=;L6TMT@5B8XY#]UN W;A3R*
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M;?1X7TVS1QY=U%@*\S$?>8''R'[H8'DG( /39+^VBU""P>4"YG1Y(X\'YE7
M8YZ<;E_.K-<3XRU._LM=@AM;J6)&T349BJ-@&1!%L;ZC)Q]:CCUFZ:\\ 1B^
M<_;[:22X7?\ Z[%MNR?7YB#]: .ZJO8WUMJ5J+FTE$L)=T# $<JQ5ASZ$$?A
M7F&@SZK!H7@G7I==U*YNM3NXK>ZCFFW0O&Z/QLQ@$;5^;J><YS4NBZCJ6O3Z
M'I-YJUY;V]R=3GDEAE*2SM#=%$B#CD *<X'.%':@#U*H;JZM[&UENKN:."WB
M4O)+(P55 [DFO+C?:M>7=IH*ZY?""/Q'-I_VV*0":6 6K2%&;'+*Q*[NOR@]
M1FNB^)%D(_A3J]M]HN6\BS'[QI27DVX^^>^>_K0!VM%<#':3ZMXFUK2Y]>U.
MSMM(@MUMO)NBCMO0LTTC=7YXY^7Y3Q6MX:U^>]^&]IKNIS+'+]A:::<1\84'
M]YM'J!NP/6@#J*S+#Q!I6IR6T=E>),]S;M<P@*1OB5@I;D>I _&O.]'U+5K;
MQ-X4<RZT+?53(LKZE>1L+I?(9PZPJS"+D*>,8S@BCX<_\A3PO_V+=Q_Z4QT
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M$/*XY.6.,],#WKM* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJGJ6JV&CVANM1NX
M;6#<%WRM@%CT ]3["@"Y164/$VAG1SJ_]JV?]GAMOVCS1LW9QMS_ 'L\8ZTB
M^*-!;2O[4&KV?V#?Y9N#* @?^Z3V/L: -:BL*P\3V%_)>7$5_I[:9!;Q7"W"
M7'(5B^6<$85?DX.><-TQ4]CXGT+4K2YN[/5K.6WM1NGD$H B&,Y;/08YR>*
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MFWY4$G)4*,=S73:AJ=EI%DUYJ5W#:VZX#22L%7)Z#GN?2@!DFC:9+I TE[&
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MLHDBM=+M88TG6Y54C  E50H?Z[0!FII]$TRYEFEFLH7DG>*25F7EVB.8R?\
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M+HFGV-O>W6JVD=M<C,$IE!$HQGY<?>XYXJA?^-M'LM2T*U%U!*FL,PAG28%
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MRN!@$.< CTIW]F^(Q/H@U..YDU"Y\/76GRW<2%Q#<.8RID9>G"G+=,BO3J*
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MO=7UUJ37LD]A;VKR2+AV>,R%G...?,Z=L5=\+Z,_A_PMINCRRK,]G;K"TBC
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MU>&==R[)-AD5,99!P3R".< XK<\,:++H>F20W#VC333-,ZV=JL$29P JJ.2
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M8PK'S&P"1N&<D9X%.C:\TF?Q)<V^HW+-)XKM(&60(R[7-ON_AZ[6VY] ._-
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MA%?6$ZSVLH)25.C8)!_4&K5>87^HZ_-XDU72+2?Q!+#I,,*136/V3<\CIO\
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M<MU/OTQ7-^)/$NK6\6KZOIFHZS<+8WOEH\4$$=A&JR*C1MO.^0YR"R]^F,4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2QI]Y8&RC:TO)))+B%\LLC2'+DY]2:IV7@[0M/6Z$-F[&Z@-M*\UQ)*YB/\
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MU=M;16=K#:VZ!(846.-!T50, ?D*EHH P3X,\/G5#J!T\><9_M!3S7\KS?\
MGIY6[9OSSNVYSS6I9:=::>;DVL(C-S.UQ-@D[I&QEN?H*M44 %%%% !1110
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M:07MCHEQIVGG2=9*J\;*#O,1#E2/W>_#,%.#[5ZQ4-Y:Q7UE/:3J6AGC:*0
MXRK#!Y^AH \PT>2#48O!2Z#I-S%/I<#2W1:U:%4C-NRF/>P 8NY4C!.<;O>L
MK31>74W@_;;RQFVU&-Y[&WT:2".P!1PRM*^68Y;!.<'DGM7LEI:Q6-E!:0*5
MA@C6*,$YPJC Y^@J:@#RG2;65;G2+-;&YCFL_%=W+<9MG55C<711]V,%2&7D
M''('>C3=":V\">$RFEO'>1ZY#-+B B10;AMS-QD#:>2>WM7JU% 'BVK^1I_@
MBXT?4='NFUE=869[HV;&-RUV&6838V\JP7&<\[<5WGQ+LY[_ ,"7EM;1S/*\
M]M@0*2X N(R2,>@R?PJR/ ^C"^$^+LPBY^UBS-TYMQ-NW;_+SC.[YL=,\XKI
M* .;LO!=E;:I;:A=:CJNI3VI+6XO[HR)$Q&"P4 #=@D9.>M< /#ES;_"[PTT
M%A);O!?I<ZB$LO,E*!I/F:,C+[69&V\\#..*]CHH \=N]-FU#1/%5Y;&_OQ<
M_8U$CZ;]G29TD&61,;B0IP6QS@=<5-KUC/9>*?$_VZ2ZBM]0CB6U2'2/M@N8
MA$%\I6 .TAMWRG ^;->N44 >>^%] ,'BWS;^REE>UT"PABGNXP7#JTI8;N1O
M&%S@^E<\GARXM?A7X0-O8R6QM[B"XU)8[+S)=H5_F:+&7VNP;&">^.*]CHH
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MM-5M;V_N[*'S/.M5C:3?&5!#C*D$]>AZ=""*O5%';PQ32S1Q(LLQ!D<#EL#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*0"H[<@D'!-4Y/&&NZ*=?@,NHS"'3X+BU;6((4EC>28Q%B(@,H.#A@#\I[4
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MLIQ\NTN2" 6!Z^P%7[JYU/2=7T73IM;BU(/K*Q%I(H_/2)K:1PLFU0 V5R&
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M:2&VMEAB9'*0K(7EW*6.XMQ@C  /-;FN3RW7PHU*XF;=++H<KNV,98P$D\4
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M,.I'3AJ-H;X#)MO/7S<=?NYS^E9NO>,=$\/:;>7=U?VSR6L32&VCG3S7VG!
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MXK6WDGGD6.*-2[NQ "@<DDGI6/IGB[1M2\-6NO&^M[6RN%!#7,R)L)&=K'.
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M$6C)#:RS:M8PBZ4-!YER@\S_ '<GG\*TZ ,.;PAHEQ?W5Y):R&6ZEAGF N)
MC21%2C[ VT$;%Y YQ@YJ*Y\$Z#=W\MW-:2$S2B>: 7$BP2R#&'>(-L8\#DCG
M'-=#10!F2>'],E@U:![;,>K9^VCS&_>YC$9[_+\J@<8_.J%[X'T&_G>6:WG7
MS8EAG2&[EB2X11A1(JL ^!Q\V>..E=%10 U$6-%1%"HH 50, #TIU%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2&:6/['O+7,IC,89@P 0 ,QVC=R>O%:NH:-->>*M%U5)(UBL([E)$.=S>8$
MQ]-IH HV_C%KO2A<6VB:A+??;'L9+)0N8I4R6WOG8$P,[L\Y&.3BHK7QW;R,
M(KO3KFTGCU)--N49T<0R2(&C8LI(*ME1D<Y;D5EZAX%U*=9=DME=0R:Q-J$E
MA<2.D-Q&Z!55RH)RI&[&"#3M/^'\\.B^);"8Z?;+JSI+;)81&..U=44+@8_A
M9%;/<Y.!TH U[[QO9VES>6T=G<W,\%Y'80I%M_TBX9/,**20!M7EB< <U>T/
MQ"NKW%[936<MCJ%D4\^WE97PK@E&5E)#*<'\0017-7?P]EN_"FFVMPUA=ZK:
MWK:C.;J+?;W4S[O,5AC.T[R <9&U>.*V/"/AJ30Y;^XEL=&L6NB@6VTNW")&
MJ@_>?:K.223R !V[T <SXF\7:Y:GQM%%%+;PZ7;V[VTZ%"4+'GC))+#IQQCL
M:Z.+QM%!=7<&LZ7=Z2;>Q?4 T[(X>!2 Q^1CA@2,K[U0U_P=JNIWGB,6UQ9+
M::S;0)F4L'BDB/H 05(S[YJ]XC\'GQ%JLTDTZQVD^CW&G/C)=6D=&##M@;#^
ME $NF>+S>:E96=]I%WIIU!&>R>=XV\W:-Q5@K$HVWG![ \Y&*J^)M<U+2_&?
MAVTL;6XO$N[>\+VL+*H=D\G:S,Q   9N??O5/PYX)N--UJQO+C2O#-F+.-@9
M=.LP);ARNW<24'EC!)PI.<XSBM;Q!H^LW'B+1]9T>2RWV$-S%)!=EE$HE\O
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M?&\*"I$@SD@$KC.#D4 =+;^+?MWB>;1K#2KJYCM_*:XO5=!%&LB;T/+9;/H
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MT6$,ZLI&"R@D$'!!Q0!A^&?%,K3BROVEN)KW7-0L[=^,1I"9& /L%3 JY?\
MCJUL6N473[RXE@U1-+$<.W=)*\0D4C) Q\P')'Y5FP^"]8L+#2KJUNK&76;3
M4KG49EE#I!(TXD#H" 64 2<'!Z=.:6V\&:NT[75]=V33R:_%JSB$,%"+"L90
M9')!'![CGCI0!/=^,1-8W<5W:ZAI5]97]G#-%&\;MB:1 A# E2C9P>^,]\5/
M>>/([8W]U'H][<:1ITS07FH1E-L;*<.0A;<RH?O$#L<9Q4.K^#;S4=2U>YCN
M8%6]N=.F0-G*BWD#,#QU('%5[OPCKW]G:SH%C=Z>NC:K/-(\\N_SX$F),J*H
M&UN6;!)&,]#B@#9M/%9U#Q1=:-9Z3=316;JES?!T$4>Z(2(1EMS9SC@<?0UT
M=86@Z"^C:IK=QYB-!?3Q/"JYRBI"D>&]\H:W: "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$\)G,@MTM\R3NXV)G;P21GDY;J>YJ_110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-N<J<@9!-2\T#QE<Z'=>')WT;4K*97B34+UY#,L;9P7CVD,Z@\$,,X'2C4_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6B]Q!'$)'FC6,C<&9@ 1C.<T 2T5#]KMO.2'[1%YKKN1-XW,/4#N*E)"@DD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX(7C!!P>>:LQ>$-7GU2#6+UK1+R76X]0N(8I&9(HDMVA5%8J-S<@DX Y/IR
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MUJA -\.0Y4YQ&O9<G.XYZ"@#?NO&45O,EO#HVJW=V+5;NXMH(D+VT;9QYF7
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M&0!&2>223CH.M=1XHT.\U,Z;J&E2PQZKI=P9[?S\^7(&4H\;$<@,K'D X(%
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MWTEJK2';MD+(#O  8;3ZYH @N_'LDLOA\Z9IEX\=[J4ME=Q/&@DB:-'W(<N
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M0/>7%M$GEPC;N_B92V%Y.T-BE;QI8MKJ:3;65_=2&*&>2>&-?*BBDSM=F+#
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M1RC<HV ,J>AS7(0>)/$T7AM?%-S?6DEHFH&W>Q2VQNA^TF'._.=XZ^G&,=Z
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M[FO3?K<FX8SI<$ &17ZY('/8Y/:NHR,XSS4%W=16=M)/*>$1GV@C+8&2!^5
M&'#X)TN.)O-EO+F=[R&]EN9YMTDDD1!CR<8VC'0 #K5F_P#"NE:G/J,MY$\A
MU"WBMYUWD#;&S,A7'(8%R<CT'I4ND:XFL0VD\-G<QV]U8Q7L<T@7;B3D(<'.
MX#!/;GK4NJZS9:/H]SJMU+FUMUW.T8W'TP,=\T 4-)\)V>E:PVK?;-0O+YK?
M[,9KR?S#Y>X,%Q@ 8(_4YS4FK>&+35=0CU!;J]L;Y8C ;BRF\MGCSG8W!!&<
MD<9&3@BM>298T+9W'&0H(RQQG ]ZR;3Q);W.J1:=+;3VMR]A'?,L^T>6K,5V
M-@GY@1SV]Z #3_"FE:7<:?-9PO$;"WEMX5WDC;(RLY;/)8LH.2>Y]:N:7I-M
MH\,\5J'VSW,MR^]L_/(Q9OPR35[(SC/-4;S5[2POM/LYW(FOY6A@ &065&<Y
M/;A3^- &/;^!M+M[N&19[YK6WN3=06+W!-O%+DMN5<9X)) )P#T%6D\)Z8FB
MVVD@3?9;:[6\C^?YO,$WG#)]-W;TK2L[W[3:-<302V@#NA6? .%8KNX)&#C(
M]B*L[EP#D8/0YH Y.[^'>D7D%Y:R76I+874S7#6:7)6)96;<6 QG[WS8)*Y[
M5L+X=TT)J\<D)FBU=R]W'(<J^8UC('H-JBM1'5U#(P93T(.0:1I$5E5G4,WW
M03R?I0!SEIX'TN"4/<W%_J(2W>VA2^N#(L,3C#*HXZCC)R<=ZDTKP=8Z5?6U
MW]KU"\DM(FAM!=W'F"W1L A>!V &3DX[UOM(B??=5YQR<<TZ@#&U?PW::O>6
M][]HN[.^@1HTNK.7RWV-@E#P05R <$<$9&*CL_"6DV']E_9XY5.G2RSQ,TA9
MGDD5E=G)Y8G>QR>];;.J#+,%'N<4>8GF>7O7?C.W/./I0!2UC1K'7M->PU"(
MR0L0P*L59&!RK*PY5@>0169IW@ZQL=3CU&XO-1U*[A1HX)-0N#+Y*L,-L&
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M ]3277@K3+F26=);NWNGOSJ"W$$NUXYC&(SMX(P4&"""*Z$.I4,&&T\@YX-
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M\MXSI?379LOM.ZW+^<[QOM'<#:<9QD9QFNZ)"@DD #J32+(CH'1U93T(.0:
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MYO+*^BC,(N;.;RW:,G)1N"",\\C@],5K^=$5#>8FTG:#N')]*5I$0J'=5W'
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M$@ YW#(4XW 9K-TOPCJ.GS^''C2RMS86EZDPMRY1)9F1AM#DLPR&R2>>N!G
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M9):/)! ))'/!S1IS>)=*\:WMO!;VVKWJ:)81W4LL_DEI09AOSM.5)W9[\C%
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M\O;GS,?+UQWSVKI_&-AJVHZ+'#I$K+(+B-YXTN# \T(/SQK(.4)XY&.F,C-
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M(^T"9>08]N[<,=1CFL73_&=G?:A;V<FGZE9/=Q--:O=P!%G50"=N"2#@@X8
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M=0Z;%917>A76GJDVHO=2F9RI5G=\\<$<$XQGOQJQZ%XBU6;1DU2SL[2/1X)
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MD6EO>WD[QQ3&6VAWQ)')G:[-G 7C_/-7=8UZ#1Y+: VMY>75R6\FWM(M[L%
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MN"_,V>G(Y . 1G%5_%OCJ+2M+UY-/M[V:ZTZV??=0V^^&WF,>Y%<]SRI. 0
M1G%07GA/4Y_!_BG3$$/VG4M0FN+?+\;&92,GL< U#JWA_P 1P67BK2M*L[.Z
MMM=:6:.XFN/+,#21!'5EVG=]W*D>O.,4 =SI\KW&FVLTAR\D*.QQW(!-6*KV
M$+V^G6T$F-\<2HV/4 "K% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF+S=A'F?)@ C(SG(Z8Y74O'6ISZUJ-IITAM$L(HBJ_V1<7OVB5XQ)M9HQA%
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M:?)J,#Z5 ;AH"@G:5]C%P&)P,G SQGO4VH^*]>\-3ZQ8W\MEJ-Q#:6UQ9RI
M8%WS3&$*Z[F^4-@Y!SC- 'H5%<CIU_XAL_&UOH>JWME>VT^G37:S0VQA<.DD
M2[2-S#;\YY]_;FAX@N[W3_B5:7HNU%E;:%=W,EOY1)94>(L =V,GY<''&".<
M\ '>T5P=KK_B.SA\/:KJ<]A/9ZS-%"]I! R-;&524*N6._!P&R!G.1CI7>4
M%%>8ZSXZU33[NZN(-1LKB.VOUMVL;;3YI4$9E5#ON1\J28.<= ?EYJQJGB;Q
M1':^*]4M+G3H[/0+ET6WDMF9KA5B21@S;QMX; (!YH ]&HKA]4\97NE2Z_;2
MQ1/=1P03Z0FTCS_._=JIYY(EX.,<,*WM?O-7TSPI<7.GVZWNJ11+A$C+!FR
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M5CM8@;2!QG.:?X6LY;GXE^*-3GEM9M@MUB)M,2HK1!E <L2  2" /F)SQTH
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M0R">P$HB"GY3Y@ ;(QST%8UYX%L+NYO&6_U*VM+Z7SKNQMYPL,[\9)^7<N[
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M2XP-N6RI*G: ,J5) JU)X3TF::Z>6!GBN=/339(&;Y/)4L0!WS\YYSZ5MT4
M<U:>"[6"427.J:K?^7;O;0"[G5A CC#;=JC)QQN;<?>KD7ABPBAT&)6FVZ(
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M;>=K:0)NV_=D'!PX!P&]/H*VZ* &HNR-4W,VT 98Y)^M.HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "N$\0^+;^UTSQ3J=C)&EMH^RVC+(&WS?*TC'V =5 ]0WM7=UYM<:/>W>B^
M-_#=JD9U&6_-Y;B4X5XYBKJV?3<LB_\  : .JL/$UIK<\^FVWVVQOC;F:$7=
MJ8V:,\"1 PPP!(X/(R,CFI_#&L/K>AQ7,Z+'=QO);W4:]%FC8HX'ME21[$5E
M6EIJ^I>++77-6L(M,@TZSFA1/M"RF5Y"A9LC@(!'QGDYZ#%2> 87_L&YU!E*
MKJE_<W\2D8(CDD)0_BH4_C0!U-%%% !1110!4U2XDM-)O;F+ DB@>1<C(R%)
M%<'!J?C.V\#VOBUM6L;^/[!'?SZ>]CY1:,H'=5D#\,!G!(P<=*[S5()+K2+V
MWB ,DL#H@)QR5(%<%;Z?XRNO UKX2.BVNGK]@CL)]0DOA)M0($=EC5<EB,X!
M(Y/6@#>'C&P@GU"YFO7DM4ALWBMH[4EP9]P0*03O+G Q@8Q[U4USQ^EEX?N+
MVST^]^UV]Y;VTMM<6K*\?FNHR1W!4G!!(+8%5+_PA>++KB6^F6=]8SV^GPPV
MUU*5\U(=V\!ARC@$;6]:HGPMXCD\.:Q;117"P-<6<VGZ=?:AY[H895DD'FG.
M P4  DXQVS0!T5_XYT])=2T^!;^.\M+=I)YA8M(EIF'S5:3H.AZ9Y((K/@\=
MM;>(+VSNH[N^MX]/M+J(V=DS, X<R.P'0<+@=?3/-3_V!JEQ:^-GDMDBEUJ%
M?L\9D!PWV18RI(XX<$9_&JMCIWB;P_J]S=6FC07T=QIMG;#_ $I8RDL2N#G/
M5/FY(Y] : .JL?$6F:E>PVMG<><TUDE]&ZJ=K0L2 0?J.E8?_"=Q7/B#P]:6
M%K/-9:HEPS3>0V5,;!!] #DMGH,>M9FE>&==\(W>DS6-E#JHCT@6$X6X$.R0
M2&3=\PY3+$<<C X-&B>&=>TA?!\DEI#/)I_VN&]6.8#8)G!#KG[P &<=>: -
M>Q\:6::-I3R37.JWM[$TL:6=F1)(BG#.4R=BC(')Z]*GD\>:(MKI\T375PU^
MTD=O##;.TIDC^^A3&58=P<8P>U<[H/AO7_"ZZ-?Q:?'?31::UA=6JW"HR'S3
M(KHS?*1R01D=NM6=&\)ZM:ZYI.IW:0!S>W][=I')E83.H"HI.-V, $XZYH Z
MW1-<L]?L7NK/S5$<K0RQ31F.2*1?O*RGH1_6LNZ\=:-:7=Q%(+MK>VF^SW-Z
MELS6\$F0-K/T&"0">@SR15CPSI5UI<VNM<JJB\U26ZAPV<QLB $^ARIXKE[K
MP]XBCT#6_"EMI]O+::E<7#1ZDUP L44[EFWI]XNNY@,<' Y% &II&OZEJWQ$
MUG3MT\&G::$C6(VF%E8KDL9#R.3E0.H&:B\;>*]2T748(=*C25+.W.I:FK)N
M/V5752J^C$&1A_US-:VA:-<Z;XCU^ZD ^S7;6WD-NR6"0A#GTY%8\'@8ZMJN
MMZIKL]]#-?3F*.*SOY(E^RH-L:L$8 D_,Q!S]\T ;^I>)['3GM(ECNKV>\C:
M:&&RA,K-&N,OQP%^9>2>XQ5:3QMI?DV3VL-]>R7D+3QP6UJS2"-2%9F4XVX8
MXP><],UR0\):S%H^F:??:,NIQ:6T]O;7%O?&WO$BW#R720, !L&UE)ZJ#S4D
M_A?7I=+TC^UM/.KW5O%,IN+?4&@O;=F?* 394. F WJ5SS0!U<WC/2D@L'ME
MN[V6^A,\%O:V[/*8QC+,O&T D#G'/'6L^?QU#)J_AN#3H)KFTU9YEDD$#;HR
M@(VD<;6##Y@1P :Y]_!NO)/I.J:G%<:S=)IYL[J.WU-[653YC.C;U*"3 ;:V
M<9(!%7K'POJNE-X:N[?2[</:WMS-=VT5V[[%G!&[S)22[#(+<C)S@4 =#IWC
M32]3OK>W@BO1'=,Z6MU);,L,[+DD*_T4D9QG'&:Z*O-M&\,:[8^(+*6VT_\
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M2T<PPL"!AGZ=P?IS7(ZAX2\4:E;M'>6D]U?IJ*7!NY=586[1+.' B@!VJ=H
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MD5H;:UO8I"6 (:5$"<?4&@".W\:V$.G:8KO=ZC=7%A'>2-9V;$B)A_K609V
MG.%R3P<9Q6AI7BO2M9DL$LI9'-]:O=P$H0&C1E4GVY8<5S&AZ%X@\*FSN+73
M8;]Y]'L[*YB^TK&8)H%8 Y/!0[SG'(QP#FLSPA9ZQ#HOA+7]/T^._$>FW%I/
M;K.L17?*K!E+<$ H01UY[T =BOBBSN]3TU;:_P#*@EFNX'CD@_UC09#?-GY
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M5V&#]&%<U:^'?$4GA_1?"ESI]O%::;<6[2:DMP"LL4#AEV)]X.VU0<\#)Y-
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MF^[MZ=\UJW'B[Q!_86H^*[<:?_8UC<3*+)XG,TT,4A1W\S=A6RK$+M(Z9/-
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MENZ>1&X;<O.W>5#<A2Q P/2M@:]:2&<6R7%TUO>K8S""(L8Y"%.3_L@.I+=
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MF,J8]Q8@JZ,"<GKVP,>^EI^KVVI76HVT&_S+"X%O-N&!OV*_'J,.*OT <O\
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M25M@0G<4+KE0,@, <4Z3P%IDMM<0/<WA$]M9VSMN7.VV<LA^[U)//Z8KJ:*
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MV P &TXZ;:[N*&.")8H8TCC485$4  >P%175A9WVS[7:07&PY7S8P^T^V>E
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M,^V)[U2NQ)3G@[-Q"GJ1TKO/A_*K0ZW#9S-/HT&I/'ITA<N/+V(65&/5!(7
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M$KO:L64-OBP#NVME5.-V1C-:3>-M)T__ $:]N;F5[98TO;Q+*00PR$#_ %C
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M[9!)<1-@[?*10S.3T"@$<GU%5=*\8:3K%Y%:P&ZBDGC,ML;FUDA6X08RT98
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M!C .[:2P)R 1D<'DC<\3Z=J#ZMH>MZ=:B]DTR67S+02*C2)(FTE"V%W#@X)
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MRI(*DC/KBN*L?#?B2XOO#5S?6&I&ZL+Q)K^>\U-7C;]VZL88E;8%RV?NJP&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !40MH%NFNA!&+AD$;2A!O*@DA2
M>N 23CW-2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5%-;07)B,\$<IB<21[T#;''1AGH>3S[U+10 5!>65KJ-I):7M
MM#<VTHQ)#,@=&'N#P:GHH 9%%'#$D42+'&BA41!@*!T '84^BB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\,B1!@I?9*CD D@9PIZT 90^(EC::]K5KJ7G1VMFL$L316,SND;Q!V>8!3L
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M&5TSR.I!!S@@\F@#IJ*\HBO[_2O&'B;5IK6SO-1;4;?2[$%W78TD<15<G(5
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M9"EMV2H7#$]>!Q50_$V>WL-:S_9NHW-C9"\BEL6<12#>%9&#<JP)!ZG(/;%
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M^K75S-/J=OJ<DDB("9(@!MX  4[1QV%6]4\&6>JWFJ7,US.DE_';*K1X#0/
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MK^(+R\DGMA;(WEI&L:;PQ.Q>"Y*C+'\ .:["B@#,?1HW\3PZX97$L5G)9B/
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MDW0<;&8,206Y.,]".^:Z*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH R)-"=]>75/[8U15!!^Q+,OV<X7'W=N??KUJIXVTZ]UCPX=*LXV<7MQ#!
M<E6 *6YD7S3R?[@88]ZZ*B@!$18T5$4*JC  & !63IFA/INH3W;:QJEX)@0(
M+J96CCR<_* H(QTZ]*UZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex31articlesofincorporat008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQSA&4#.[<1@8SSQUH Z.BN93QSI2QWIOXKW39+2V-W)%>VY1VA'!=0,[N<#
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ML3;LWGHDB!O4#>,XQD<'- '=T50UC6+/0].>^OG98E94540N[NQ 554<EB2
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M]:1)XI)'C25&>,X=58$K]1VH Q/%VD7>K:;:MI_E&\L;V&]ACF8JDIC;)0D
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M65QE6!'J#2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN$WGS70@0YZ#/0?,3BM:[O3#XN\+:C$NP:Q#):7"9Z@1&:,GW4JX'^^:DOO
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MC (P,+CJ*@\77]G-!K^J0+I]O?6VHM''/=7COJ >-P/W: #RTP,@9(VY)ZT
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M '"W8\$XS0!Z_17C-S%:3SW.G:5.Y\-GQ#I\-O\ 9YCY89@?/2-@>%^[D*<
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M+-[I;5S LQ(&POC&<D#/3)QFFW/CC1K6]F@D:Z,-O,+>XO$MG:WAD.!M>0#
M.2 >PSR10!O+:VZ7#7"P1+,XPT@0!B/<]:E(R,&N.B\>01:QXCMM0MYX+72I
MHHHY!;N3*SA0%'JS,X"@=1@UNZ/K]IK37,<,5U!<6Q43074#1.FX94X/4$9Y
M&>E %ZWM+:U#"WMXH0QRWEH%R??%*MM MPUPL$8F88:0(-Q'N>M8FJ>,M*TF
M^N+25;R=[5!)=M:VKRK;*1D&0J...<=<<XQ64WBB[U#XBV>C:?-(FFBR2\>5
M+,R+<!B<8DSA4P/O#J3B@#H=<T.WUS1Y--D=H(Y)8Y2T8&<I(LGZE>?K6A#;
MPVZE8(8XE)+$(H4$^O%<WJGBJ6P\9VNA):2M'/837)F$+, RL@7D<;?F.3V.
MWUJEX0\?VNM:9H27RW,=]J-NN)FM'C@EF";G1'(P2,-^1P30!U\5I;0*ZQ6\
M4:R'+A$ #'W]:6:UM[B(130121C!".@(&.G!K!@\<:-<7T<"-=>3+.;:*\-L
MXMY)<D;%DQ@G((!Z$C )-3>*]=GT+2X&LX(YK^]NH[.T24D)YKG +8YV@ L<
M>E &PUM Z.CP1LCXW*4!#8Z9]>@I6MX6B>)H8S&_WU*C#?4=ZYRV@\7Z?J=F
M;F^L]7LIW*72I;"W>WX)#H=YW+D8*GGG(IT?CK19+U(5:Z\B2X^RI>FV<6SS
M9V[!)C&=W&>A/&: .A6WA2)(DAC6-,%%"@!?H.U."*'+A0&; )QR<5R\WQ#T
M&W?4=YO?)TUWCN[D6CF&)U<(5+XQNR0<>G-6[3QEI%RUTLK7%BUM;F[=;Z!H
M"8!UD&X<J._<<9 S0!NE$+ARJEP,!L<@4@AB"!!$@53N VC .<Y_.L"Q\:Z3
M?3B'9>VSO UQ +NU>'SXU&69-PYP"#CK@YQ5>W^(6B7=A'>01ZB\4[K':@64
MFZZ9E+?NACYP K9(X&.30!TOV:#S#)Y,?F,02VT9)'0Y]J>$4.SA0&;&2!R:
MXS5OB';V^E0W=A9W<DO]J0:?<V\MJXDA+NNX%>NXJV5[$D=>E7E\6V5FFIS7
MMX\HBU!;.&"*U82B1HT81!1DNWS$Y '!]B: .B>UMY)UG>")IE&%D* L!Z T
MY(HXSE(T7"A?E4#@=!]*YT^.M#BTRZOKF2YMA:31P7,,]NZRPM(0$W)C.#D8
M(R#5W1O$MCK=U=6D,=W;W=L%>2WN[=H7"-G:P##D'!_+F@#2DM+:: 0RV\+Q
M+R$9 5'X4]X8I559(D<(0RAE!P1T(IMU<P65I-=7,JQ00H9))'. J@9)/MBL
M*P\:Z3?W"PA;VV>6%KBW^UVKQ"XC49+1[AS@$''7!SB@#?\ )B"*@C3:IR!M
M& >N::UK;M<+<-!$9U&%D*#<!['K67X>\36'B>V>YTZ.[^S!59)IK9XDE# \
MH6 W8P0<52C\3Q+=:_?W<Z0:-I+"V+E<EY0 TAXY.-Z( .I#=>* .D5%4L54
M L<L0.I]Z9/;07*!+B&.50<@2*& /KS7(V?BR?6_%\FBV:7-BO\ 94EQB[M&
MCE23S%5&PW5<$_B,=JW/#.L-KFA0WDL:Q7*L\%S&O1)HV*.![;E./;% &E-;
M6]RJK/!%*%.5#H&P?49I^Q=X?:-X&-V.<>E<]%XWT::^2W1KKR9+C[+'>FV<
M6TDV<;!)C!.00#T)X!S4+_$#0X[J6(_;3%!=FRGN1:.889@^S:[XP,MC\QG&
M: -/0_#UIH5KY,0$K^=-*)G0;QYLC2%<^@+$5HM;0/.D[P1M,@PLA0%E'L>H
MKGM5\>:+H\UZMQ]L>*PXN[B"U>2*!L9"LP&-V"..V1G%/U'QMI6G331&.^N3
M;Q+-<FUM'E%NC#(+D#CCG'7'.* .A"(K,P506Y8@=?K445G:P "&VAC ;<-B
M <^O'>L:]\9:39RP1I]JO'FMUN\6=L\VR ])&VC@'G'<X.!Q4?\ PG.C26&G
MW5J;J\.H(TMM!:V[22NBG#/M X4'')QU% &^EM!&Q9(8U8L6RJ@')ZGZFB.V
M@BEDEC@C223[[J@!;ZGO5?2M5L]:TZ.^L93) Y(^92K*P)#*RGD,"""#T(KG
MK7QQI]O8:>+FXN+^[OC<FW6TLGW2^5+M8!!G&W(&2><$\4 =6(8@BH(T"J<J
M-HP#ZBH;2QM[$W!@0AKB9IY23DLYP,_D /PJ#1M9L]>TU;ZQ9S$6:-ED0HZ.
MI*LK*>0001BLJ3QUHT=V8B+TVXN?LC7HM7-NLV[9M,F,?>^7/3/&: -2'28[
M?7KG589&1KJ%(YXL?*[(3M?V(!(/J,>E.N]+CFTR[L[1A8FY1E:6! &4L,%A
M_M8[UBWGQ T.RN;N*7[:4LI_(NYTM)&BMVX^^X& .1_6M&3Q-I<-MK$\L[1I
MHY(O-R$%,('R!W!4C&.M %^VL;>STV+3[:,16T,0AC1>BJ!@ ?A530-!M/#V
MCV>GVX#FVMTM_/9 '=5&!DCZ5-?ZO9:7I$FJ7TIM[6- [LZG(SC VCG)) QU
MR<5SVH>/K.#0]8N8+2]34-/LFNQ9W=J\;NN#M?!'*9ZD=.^* .I^R6PF:;[/
M%YKX+/L&3CID^U2*B("%50"22 .I/6N%3Q](FO64$]G>/#=:0MXMM!9.\WF>
M858[1R%P._J/45M/XUT;[!IUU;/<7G]HJSVL%K;M)*ZK]X[<94+T.<8/'6@#
M<CL[:&(Q16\*1EMQ14 &?7'K4ACC9BS(I)7:21U'I]*YNX\>Z'!865T'NIOM
MDDD,,$-J[S&5/OQF,#<&&#D$=J?XM\32>'O"3ZS;VDLLA,02-HF)7>P'S*.1
M@'\\"@#=AM+:W55AMXHU7.T(@&,]<8I8+6WMM_D011;SEO+0+N/J<=:P?^$W
MTD:JVFE+T7$2+)<9M'VVRLF\&5L808]>X/I2Z;XUTK4[^UM(X[Z%KQ&DM)+F
MT>)+A5&XE"1S\O.#CCF@#=AM;>W9VA@BC:0Y<H@!8^IQUI9H(;F(Q3Q1RQGJ
MLBA@?P-<UIGQ T/5IK!;;[:(;\[+6YEM)$AE?!.P.1C=@'\01U%6++QII-_?
MPVL*W@2XE>&WNGM76"9USE5<C!^ZV.QP<9H WA%&-F(U^3[G'W>W'I3R 001
MD&N:A\=:-/>6\*"]\BYN/LT%Z;5Q;RRY(VJ^,')! /0D<&G2>.-&CU!K4FZ,
M:7(M'NQ;.;=9R=OEF3&,[B!Z G&<T ;T-M;V\1B@@CBC))*(@4'\!2Q6\,
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MC,>,AOE/Z5T=K.MU:0W"I)&LJ*X25"CJ",X93R#Z@T 2T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5S?C32IM6TVUCCTJ+4XXK@220^>8)E&U@'AD!&UP2.I&1D9KI** /-8=
M \4P6.GWCQ3WCZ?K!N[:QN[U9+A;8PM&4,I^4MN=F&2>.-U,N?#_ (GNI=2U
M/^R[=+J?6K+4(K5KE2/+B1%(9AP&^7MGGID<UZ:2 ,G@4T2(Q #J2PR,'J*
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M .)FL=?T75O$)TW28]2@UB19XI3<+'Y$GE+&5D#<E?D!!7)Y(Q3_  QX5O-
MUJQWLLMK:Z#!IYF#?>E1V)P.N,$5V=% '*ZWIFI/XRTW4[2T%Q;?8+FRG(E5
M#$9&C97P?O#Y",#GFL^S\,ZG#X;\"63PH)M(FA>\ <?(%MY$.#W^9ATKNJ*
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MR175>$=:DUW1FNI;S3KPK,T8GL"P1P,8)1B2C<\J2<>O-5_^$.Q9!5UW51J
MNC=_;_,4N7*[<;-NS9MXV[<=^O-);^%KC3(5^P:E<M=7&I)>W]S*55IP  RE
M54#!50  !V.>N0"UXIUJZTBUL8K"*&2^U"\2SMS/GRT9@S%FQR0%5C@8SP,B
MN;U;Q?X@\/QZK8746G7FJ6T5K<6LL<;Q131S3B$AE+,58'/(8CD'MBNNUW0[
M?7K%+>>6:!X9EG@N(& DAE7[K+D$9ZC!!!!(KD_$O@>>?PWJWE7=[JFL7[6J
M/<2LB.(HYE;:@4*J@#>W R3Z\4 .U3QEJOA.34(M=2SO6CTU[^V>SB:$,5=4
M,;!F;^*1,-GIGCBJMEX\U-;B2"=[._WV,]PLEM87$"V\L:;@C^83O4C.&!4\
M=.:WU\$6=P+YM8OKS5I;RU-DTESL4QPDYVJ(U4 DX);&<@>E+!X.;,G]H:]J
MNHC[+):1"=HU$:.,,<(HW/@#YFS0!BCQ1XB@\-:;J>I7N@6)U/RY(W>.1A C
M1[MH3>#,^<?=*XYZXK'NO%&N:_I%IY%Y:0SVOB6"R:=;6:-+A?D=&,;.&4?-
MRI)SC@BNUN_!\,MOH@M=1N[.YT:+RK6YC",VPH$8,K*5.0H[=>E5/^%?6@L+
MN!=6U(3W&H1ZE]K9HVD2X0*-PRFW!VC@C'.!@8% &5;>(KV+4;S2M*L["'4;
M[7I[99G1S&!' DCRNN[+-C  !4=.F#3KWQEK^F_;-,D@TZ?5[:_LK9955TAF
MCN6VJVW<2A!# C)Z9[UM2^![-UEDBOKR&];4&U&*[C*>9#*R!&P"NTJ5&"I!
MSD^V"/P/9E&>ZOKRZO9+ZWOIKN0H'D>%@8UP%"A!C& !U/.3F@#*N?%'B72Q
MX@L9[:SU'4-/AMKB![.WD56CE=E8M%N9B4V,V%/S =JT_!GB.77A?+)J>F:@
MMNR!9+.)X)!D'(DA<ED((X.>?08JWJ/A.TU&]U"\-W>6]Q>PP1&2WD"&+R79
MT93CKESG.0<8QUJ31O#BZ7J-WJ=SJ%SJ&H74:127$ZHN(TR54*BJ!RQ/3)S0
M!E7.L^(M2UC6;;0O[-AATAEB;[9$[M<RF,2%059?+4!E&<-SGBJ>D^+]:\3Z
MY8Q:3%86VGR:9:ZE.URCO(!([AHUPP&<)PW;'0YXU]2\'K>:C>WEGK&H::=0
M14O4M3'B;:-H;YU8HVWC<N. /3-7-+\,:?H^H_:[(/&!8PV"0Y!1(XBQ7'?/
MSG))["@"MXAUC4;?5M)T72?LR7FH^:_GW*,Z0QQ %CL4J6)+J ,CO6;)K7BG
M^T;#P^8],@U6=9YY+PH\D/D1LBAUCW [F,BC:7XP>3Q6YK?A^/69+.Y2[N+&
M_LG9K>ZM]I9-PPRD,"K*1C(([#TK,'@6WC6WN+?5M0AU:&668ZD"C22&3&\,
MI4H5.U?EV@#:,8H Q_\ A,O$$M[::+%!IJZL=4ETZXE=7,.%@\X2JN[/W<?*
M3UR,]ZHZUK?B.\L%LGNK*"_T_P 2VEE+-%#)Y<ZL8G0[?,R!\XW+N.<<$=:Z
MRQ\%6%C<V%T+F[FNK6\EO7GE92UQ-)$8V+X &-IX"X P*2_\%6=['J(6\NX)
MKV_AU$31E-T,T00*5!4C'[L<$'J: ,.Z\8Z_9GQ)J$D.G/I>B3M;>4J.)KB0
MQHRX;=A!ND7)P>"?3E^L:OK^FQOI>NMIUPFJ:?=^5)91/&898XBQ0AF;<I7.
M&XY'3FNA3PEIYT[6K&Y::ZAUB4RW7F$ [C&D9V[0,<(#[&JD?@F.28S:GK.H
MZG*EK):V[7)C'D)(-K$;$&7(XW-G^= "6&K1Z#\*[+5Y8S(EGHT4Y13@MMA!
MQ^/2J@UGQ3I][I4&J/I+?VQOAA,$$@^R3^6TBALO^]7"D$C8<_6NDCT2S'AM
M-!F4SV(M!9LLAY>,)LYQCDCTK+TWP<EGJ%C=WFKZAJ7]GJRV4=T8]L.5VEOE
M4%VVY&6)X)[G- &3\)]/>V\!VUVRV?VJ]W3/-% 4:0DGF4EB7;.>>."!CBN5
ML9/$$UEX7<W=G<7S>)+Y(7EB<*N!<JQ;YR6 Y( (X 7/>O5-"T>#P_HEKI5M
M)))#;)L1I2"Q&2>< #O619>"+2RN[:5;^]DBM=0EU"W@<IMC>42!U!"Y*YE8
M\G/3F@#!OO'NJ:-9WUG?K8R:I!JL6G1W,<,@A(DB$PD:,%GX7=E0>2!R*V?"
M'B>ZUF_U#3[LQW'V98Y(KV"TEMXY5;(*[)"2&4KS@D$$59OO!5A?2ZA.US=Q
M7%Y>17J31,H:WFCC6-63(QT7D'(.3VJ[HVAOI<]U=7.IWFHW=SM#RW)4!57.
M%5$ 51R>@R2>30!S8TRS\5_$+7K?7($O+328K:.TLYQNB!D0NTA0\,Q/R@GI
MM-/N!#X(MFT_P](DDVHZC%;VUE/)NAL6D4DG:/F"81FVYZ],9K9U?PLFH:JN
MK6.IWFE:D(O)>>UV$2Q@DA71U96P2<'&1D\U47P%IW]F36\EW?27TUTEX^IO
M(OVCSTX1P<;1@<!=NW&1CDT 8^L>,=?\.0ZM97<6GWFI6L%M=6LL4;Q131RS
MB(JR%F*L#GD,0<@]B*M_VEXR;Q##H'VC1%G^PF\FNQ:RLB_O"JJJ>8"<C'.>
MQ^E7'\"6MW;WW]HZE?7MY>^2LMW)Y:NJ12"1$154*J[LD\9.3S4&K>'=3U'X
M@QZE:WUYIT":48!=6_EMES+DH5<,#QSG'&.M %.P\8ZSKTUAI6GQ6-IJC)=-
M?33HTL47D2B%MBAE+;F.1EA@>M0MXR\17$UGI-K!IJ:NVJ3Z;<2R*[0@QP^:
M)% 8'!4@[2>O&>];?_"#65M;Z<-,OKW3[RP618[R-E>202-ND$@=2K[F^8Y'
M7D8J6Q\%:?83Z?<+<74MQ:74UXTTK*6N)I4*,S\8Z'@# &!VH YCQ+XYUC0O
M[1/]H:(9].A5VLDMIIY+@A S$LC?N 3G 8-@8).*IZ]J6HK>>.KN<V=WIT6B
MVTRV,\3E2&$I"DAQCHV[ &>.F.>HO_ %O?+K%LNL:E;Z?J[O+=6D)C"L[*%8
MABA< X!QG''H2*?J/@.TU%K[=J-]%%?Z<FGW4<9CQ(J!@K\J2&&YNG'/2@"O
M/KOB+4+O6CH8TV*UT=Q"4NXG=[J41K(P#*P$8 8 '#<]JJVOBO7_ !)J'E:"
M--M;=M)M=262]B>5LR[_ -V0K+_='S=L'@YXU]0\%QW=Y?3VFKZCIT>HJ%OH
M;8Q[9\+MW99248J "5(R ._-7].\-6&E:C+=V>^,/906*PY&Q(XM^S'&<_.>
MI["@!WA?6&\0>%M,U=XA"]Y;)*T8.0I(Y ]LUC^-/$FH:#<6"0-#9V4ZR&?4
M9[*6ZCA9=NU"L;*5W9/S$X&VKND^'9M#;1K.QO9CI>GV;V[QR,"96RNPD!1R
M &YR.O3GBSK&A2:E=VUY:ZM>Z;=P*T8DM]C*Z-C(9'5E/(!!QD4 <4VH:QK/
MBOPK=Z=<Z1]LN-)O/,N(RT]N%$D.60 J6Y &"1C)Y..;A\:ZE_8%M+<7.CZ?
M=_;[BQN;B<.\>Z)F7,4(8,Y; .-W'/6M_2/!FG:+=:?<6TURTEG#<1 R,I\P
MS2+)([8 ^8LO; Y/'2JK^!+9)X+JRU.]L[V"ZNKF.=!&Y'VAMTB;64@C(&.,
MC'6@#F8O$=SXC_X1][ORFFL_%)M#+#"\*R@6TC!]C_,N0XX)/2NG^&W_ "(E
MC_UUN?\ T?)2V7@2QLI(Y/MU_.Z:I_:I>9U):8Q&,YPH^4@YP,8/3 XJSI_A
MR;1O['M=.O9A86<EP]PDC#,PDW, 0%YPS9!R, =\\ #==NEA\6>%8#:P2M/<
M7"K*X.Z+%NYRF#C)Q@Y!X)KG=%\8>);G3O#6LZ@FE_8=9N$MFMH(I!)$65MK
MARY!Y7[NW@'J:[2^T>"_U72]1DDD673I))(E4C:Q>,H=W'HQZ8YK.M_!UA;:
M)HFE)/<F'1YXYX&)7<[(& #<8Q\QZ8H =XEUF^L;G2=,TM;?[?JEPT4<MRI:
M.)41G=RH(+'"X R,D]:R[G6O%%K=V&A2QZ8-4OIY1%>A','D1HK&0Q;MP;+!
M=N[&><XK?US08=;CM6-Q/:7=G-Y]M=6Y7?$^"I^\"""&(((((-9)\"VY5+C^
MUM0_MA+DW0U/*>;O*!"-NW9LV@#;MQQZ\T 9%UXRU^T=]),&G2:Q#JUO8--M
M=8)(YHRZR!=Q92,<KD]#SSPE[XP\0Z3;:S:3Q:;=ZEI]W8Q12)&\44J7#JO*
MEF*D9;G)'0X[5N0>"+*/RY9KR\N;P:@FHS74K+OFE1=J@@* %"\ *!C%2W_@
MZQU&[O[F6>Y5[V:TFD"E< V[[DQQT)'/Z8H P=1\::OX7_MR'6DL;V:RL8;R
MW>TB>%7\V1H@C*6<\.!R#T/2JT'Q%N[ WC:@UOJ4$6GS7GFV=C/;"-XP#Y3>
M83G<#PP(Z'(KJ]5\(Z;K-[?W-Z9G^VV*6,D8; "*[.K*<9#!FSG/85!!X/1V
MG_M?5]0U=);5[,1W3(J+$_WOEC506.!\QR?3% &-K-QXTB\)ZI<7,NE!)-*G
MF\RVCD1[1PF=O+_/D;@&&W! .".*S1XDN/#RQW5U:6EY?0^'()%FC5HVD9YM
MB1G+-A<LN3USD^U=+#X&A9#%J.L:EJ,2VDEE EPR#R8Y%VMRBC<VT ;FR?S-
M(G@'3Y+5H+^\O+\-IPTUFE**3$'+J?D489<@ _[([\T 4[SQ%XA\/77V;6#I
MMTUS87-S;26L+QB.6% Y1U9VW*0>&!!X/'-&D>)/$3:EX<_M5=-:UUZ!G2*V
MC=7MF$7F@%F8AP0"#PN#ZU?3P5'+++-JFL:AJ<YM)+.&2X\M?(CD&'*A$ +$
M 98Y/%7T\-6B2:"XEGSHJ%+?D?.#$8OFX]#GC'- %3Q!XF?P[J]L+I(O[,FL
MKF4R8.]985$FW.<8*!STSE:YZP\;ZIJNE65K=6%HFI/'?'5(-K%(DA4C ^;/
MS%XNIZ$UUGB?PO8>*]/@L]0:58X;A9U,3 '(!!4Y!X*LRGV)J&'P=IL&MZWJ
MR--]HU>)8IAN&V,!=I*#'!. 3G.2HH \^%UJ=U'(R2VL&G/X(6<6<<3[8PR-
MPI+D A@.2#\H Z\UT7AK5]?L)/"MAJ7]GR6>J61$26\;K);M'$'&YBQ#Y .<
M!>:U&\!V>VU6+4+Z)(=)_LB15*$3P;2HW97A@3G(QS[<5I#PW:"?0YO-FW:,
MC) ,C#@Q^6=W'IZ8YH QO%$FJ+XY\(165Y##;R37'F1O&S;\1,3G#@'Y<@<<
M'GGI7->%M7U_1?"^E7?_ !+WTB;6'LS!Y;^?B6[=/,W[MH(9ON[>@ZYKT#6-
M CU>]TR]%Y<6ESITQEBD@VG<&4JRL&!&""1Z^AJHG@ZPCT"TT<3W/D6MZMZC
MDKN+B?S@#QC&XXZ=/SH Y"Y^)E\);^]M1;/:6EV]NNGBRG>>X1'V,XE7Y%8X
M8A=IZ<D=NS\8>(O^$9\-RZE'$LLQDCAA1\[2\CA06P"<#.3CGCBJ<O@>$SW*
M0:QJ=KIMU<&YGL(7149RVYL/MWJK'DA6'4],UM:WHUKKVDS:=>>8(I"K!XFV
MO&ZD,K*>Q# $?2@#D=(\6:YJ=W?Z5:RV%[>"R-S:7@L)[>#>& ,4BNV>XPP;
MIGCCFM!\2[FZ\,:MXFCT^)-.L4CMDA=LRR7C,JL"5) C5G5>A)Y(XQGH/^$/
MEEAOOMGB+5KFXN[?[+]HW1QF*+.2$5$"ACW;!/H139/ &B,EY!$DMO97EI':
MS6D+!8SY>/+D'&1(H  (/89S@4 <]'X_U.WBU-9'L]0:'2[B^AN(+">WCCEC
M7/EN)"=P.>""#\IX'%7X=>\532Z1IS-I$>H:K')=K(()&CM8$5,J5W@R/ND
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MZ8K2T+0(M$-[*;J>\O+Z837-S.%#2,%"CA0%  4# % &O1110 4444 %%%%
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M)?L^H-<6:AY45C&QP4^7)93TW ]ZL:]/::?K.J:JES;:G;VMU#M6*^DM[^S
M6/:D*G*R(>HQC=N/)H ]FJMJ-_;Z5IEUJ%V^RVM8FFE8#.%4$DX^@KG?B%<2
MVWAA"L\MO:/>V\=]/$Q5H[9I%$AW#E1C@D= 37#>)K72HX?%.FZ)*)M(7PY-
M=7$45PTD45RI_=,#D[6*[B1WV@D4 >IZ?K$5]HPU22VN;*#8TA2[CV.JCG)
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M9\^3;Q-*^T9.U02<?@*\JU"UG32?'OB"SDN6U>SOYH+603/_ */%Y<6\HH.
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MEHY8%"@VXB0$?>X/ ^8D@YJ:32AK<_C*ZUC[0;NTL;>2)%G=%MYOLH9F4*0
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M:1I_CK1+?PK=B6VNK.=[^.&Y:9"@"^7(V2<,6. W4Y/7%>B4 %%%% !1110
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MYJ.WLK2SMS;VUK#! <_NXHPJ\]>!Q4]% %:UTZRL8GBM+.WMXW.72*)4#'W
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MX)Y]S5JB@!C11NZ.\:L\9)1B,E21CCTXJM)I.G2PR0R:?:O%*_F2(T*E7?\
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M[W*W+01&=5*K*4&X ]0#UQ4M% %:UT^RL=_V.TM[?S#N?R8PFX^IP.:LT44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "LNUUZSO9(5MUN)$FGE@258B
M4+1YW'=T"Y! )ZD<5+KLT]OX?U*:US]HCM97BQUWA"1^M<7IC_9D^&=O:2NM
MM);/N56($@^R%@6]>>>>] '<:9J5OJUBEW:LQC8LI5AAD92596'8@@@CVJW7
M*>%"4\3>,+>/_CU34HW3T#M;Q-(!^//U)KJZ "BBB@ HHHH K7NH6NG1127<
MPB26:.!"03ND=@JKQZD@5'8:K:ZE-?16S,SV-Q]FGRN,/L5\#UX=>:Y;XFVM
MK<Z-I+79*Q)K-EN;S6C"J9E#$D$8X/7MUKE+_2;=M(^(FLQ7-Y'=V%W))9O#
M=R(L3):PL& !P2> 2<Y % 'L-%>/ZO<:AJGB3Q!]MDM%2RMX&MFN-9FLC;1M
M$&,R*B,&.\M\Q_NX^O;RW^K1?"Q]0CE2YU==(,RRPH<22B+(958 \GG! ^E
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MU(D4^G3S6OVN1X8-UR%W[R3M9E)R-W8-C/- 'K=%>-:M)=W>K^)O,N+2*+3
MB64UQK<]LUI#Y*LLJ(B,'R23N)))&WMSNZ%;-JWC&YO-;OYG;3M+TZZQ'<21
M0"5EE+R%?EX^3HPZ$Y% 'HTCB.-G()"@D@#)_*HK.Z2]LH+J-)$2:-9%65"C
M@$9PRGD'V-17<Z2Z-/<6\JO&]NSQR1MD,"N001_.O-/#=B/$=_H%MJEU>S6Q
M\*6D[Q+=2())2Q&]BK D]>I_D* /3I=0M8-0MK&28+=7*N\,>#EPF-Q_#</S
MJS7CFC8NK_P+?WDTMQ>K9:C'$\UPP,KQ2((P>?F/K_>[YQ4'AJYU26+PUJS7
MMC%?WMY&MS.^L3RRW.XGS86M_*VJ0,X&0$*CGO0![55>_O(]/L9;N6.:1(AD
MK#&9'/T4<FO'IKFT?PM9ZM<ZS<Q^*)M9BAN8A?.&W?:PK0F+=@(J#@8Z 'OS
M:U*U;_A&?'&NF]OC?V^H7-O;L+N0+#'O3Y54';U)YQF@#U:#4+6YO;JSAF#W
M%H5$Z 'Y"PW*#]1S5FO*[C1O.\0^/CI,TL6LQ/;75J%N'RS+&DF-N>59EV].
MAQTXK=\):]#XAU"\\3/=>3I]SY-AIT4LFT.0N]R >"Q=BOK^[H ZK4M5M=*2
MV>[9E%Q<QVT>%)S(YPH_/O5VN*^)PMVT'3%N[EK6W.L6@DG2388U\SDAOX?K
MVZURVO7"Z-_PDEGHM_/_ &5;0Z=/(1<O(+:9KG#@.22 8P&89]^] 'KU5[^\
MCT^QENY8YI$B&2L,9D<_11R:\\\3ZNESXDUR"TU\6<47AX%KB.1G2W=ICACL
MY!P1R.0#FL&]O9=*T/Q+IZQRV5X-,2Y5K+57NK9@) OF*6^>-SGIW ]J /::
M*\MUG3AJ-W\0[R>\OQ+IJJ]D(KN2-;=Q9H^Y0K 9W8ZY_4YS[N[U'6M>O%U!
MK5XK?3+6:#[3K$MAY8>/<\R"-"&._(W'IM [T >Q45XY=-J&HV^F3W>I6FK3
M1Z+')-;?VC-8-R6_TJ)RH5BP SN QM'3-&IWG]KI!J<-S)>VRZ+!,;.ZU.2Q
MN[8$,?/1@/+=F[D]U'8XH ]CIDTJ6\$DTAPD:EV(] ,FN7UG43=?";4=2M9+
ME#)H<L\3RG;*N8"P)(Z-].]<LAL[*ZT Z)J<]XVHZ=</J&Z[:;S8Q!N$K DA
M2)-H!&/O$>P /2].O[?5=,M-1M6+6]U"DT1(P2K $<=N#5.S\0V-[?6UD@GC
MN;FV>Z2.:%D;RT=48D'H<L.*\\\-Z;'HNG_#B^M+B\$^H(D-UON7=94:T=PI
M0G: I5<8 QBLJRU+4X=+LM1M))9M2C\*ZE)$[$N^\7$>#SU(Q^E 'MM%>7_\
M2_2=2\./X>UJYE;4(9C>N;I[GS(1 S>>RDGYE<+@@#[VWVK(TF^O=$CB-OF[
MU&[TFYDL[VQU-[F*^D2+>'EAD&Y&R.".[%>] 'L]%>7:>;&QG\&7FB:K<7=]
MJ<JK>AKQYOM,1A9I'=2Q *L%.0!@G'M67X>FMXO"WA+5K'5[FYUVZU"&"8->
M/(TJ%R)8V0L1M5,GIQM![\@'K&EZK:ZQ:/<V;,T2320$LN/GC<HWZJ:NUXW!
MIL=CX0N?$5O<7B:C%XC<1NMRX14;4/+9-F=NTAFR,<DUK7EQ?1>(KKP0+BXW
M:AJ4=[#-O;<EDV9)E#=L/&R#T$BT >G45ROCZ]CM=$M8)#=EKR^BMDCM[D6_
MFL23L>7JB$*<D<]AUKSN2ZO+>Q\9Z;!="R6WDTHQQ66HR7(MGDGVOMD8 @D!
M<@#'ZT >W52EU6UAUFVTIV87=Q#)/&NW@HA4-S]76O-?$BW'A2^\06NA7-[#
M$VAI=,&N))C&_GE'E4N20P0DY']T&M#3+'1;#XHZ1'HU\\ZOH]R[H;MIP 9(
M=KY9C@MSGUVT =CJWB&ST>]L;*:.YFNKYF$,5M"9&PN-S''11N7)/K5ZQO$U
M"Q@NXDE1)D#JLT9C< ^JGD'V-<=X@TRUG^*7ANXD63S!8WCY69U&4,)7@''\
M1SZ]\X%<WX3M#XCN/#=KJEW>S6S>&EGDB6ZD02R>: &8JP).">I_D* /7:*\
M?L[]]0T3PWI5P;O4+HB^(BN-2-K#)'%.8P99 "[LHVX SW)Z"H-"EGUB#P_I
MLVH3FS;Q!?6Q^RWTC!H4AD=8Q+PS)Q@$\D4 >SU7N[R.S:W#QS/Y\PA7RXR^
MTD$Y;'W5XZGCI7ED\DFGRWNA?;KN#1$\2PVLKFY?=% ]LLGE^83N56D('7^+
M'>M&Z;3].U/3K#0]5O)84\06Z3P&=I(X-T$A,:N>H. Q7)P3T&: /2JI:;JM
MKJJ7+6C,PMKF2UDW+C$B'##\^]>/2ZF7?1M=LFEB^UZY%&EY=:P[7,Z-/M9#
M;JNQ4VY&W/  XS7H?@/_ (]M>_[#M[_Z,- '5U6LM0M=1CEDM)A*D4SP.0#P
MZ,58?@017E5I<FP\1VU_<7+:A%<ZRUNE_9ZE(LP+2,HAFMG&-BYP=O0*&%06
M']G:=X>FTZ W;SWGB:ZMOL\6HF$/MEE*I+(22BE5R<?,Q ZY- 'KE_J%KI=H
M;J]F$, 9$+D$_,S!5''JQ _&K->%W82XT'Q7I]U)&MI8:KIKQPV^HRSQ6Y>1
M!(!(VTD<G(Z YQR,UT]WK$&FVWQ$A;4_*6"WC-F'N#E5-F@4H2<\MG!'4^]
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M"312Q/%)$Q&0&1P&&1TR.:Y77OB$VG/XIMK6U_TC1K6*:-YH9/+D+9W;C@
M<8YYY(S@X .\HK#T[Q?H>JW$\%M>,)(8?M#">&2$&+IYBEU 9/\ :&11I7B[
M1-:NUM;*ZD,LD9EB$MO)$)D'5HRZ@..1RN>M &Y17/:SXIBTCQ/HFC/!*YU)
MI 9%BD8)M7C[JD<G&>>!R>.:CA\?^&9X;B:+46:*WP'D%O+M+%MH13M^9L\;
M5R?:@#I:*Y^/QOX?>POKU[U[>*Q*"Z%S;R0O#O.$+(ZA@"3P<8Z^E+:^-?#]
MU'>R+?-$+*(3SBY@D@*QG.' =064X/(R* -\C(P:R-%T&#1K&&S!2:.UDD-F
M7C&ZWC8G" ^P)4$8^7 ^L%MXRT*ZAO)?MCVXLHA/<+=V\ENR1G.'VR*I*G!Y
M IVG>+]%U.XG@AN98I883<.EW;2VY\H<&0>8JY7W'% %G0]'71K%XC+Y]Q/,
M]Q<S[=OFRN<DXR<#H ,G  %:=<C=_$70H](O[RSEFGEMK-[N*)[6:/[0B]T+
M)\RY(RRY !R>*FT_Q=;71CN;B[M[:T_LM;Z6.:&2*2/YB&<E@!LX('?C/0B@
M#J**P+/QIH-\MR8[N6,V]N;IUN+:6%C".LBJZ@LONN:72_&6@ZS?QV5C>.\T
ML9EAWV\D:S*,9,;,H5P,C[I- &]1573]0MM5L8[VS<O;RYV,R,A."0>& (Y!
MJU0!#=6EM?6SVUW;Q7$#\/%,@=6^H/!I@T^R6WFMUL[<0S_ZV,1+MDX"_,,8
M/  Y[ 59HH HWFBZ5J,D,E[IEG<O#_JFG@5S'_NDCC\*O444 4(-#TBV^T^1
MI=E%]J!%QY=NB^<#U#X'S?C5HVMNSQ.8(B\0*QL4&4!X('H#@5+10!GVN@Z/
M9-NM-)L;=O,\W,5LB'?@C=P.N">?<U++I6G3Z?\ 8)K"UDLO^?=X5,?7/W2,
M=:MT4 4X-*TZVB:*WL+6*-HQ$R1PJH*#.%( Z<GCW-,AT32;:QEL8-+LHK.7
MF2WCMT6-_JH&#5^B@#/GT+1[E[=Y]*L96ME"P&2W1C$!T"Y'R@>U6);*WE%P
M?*19+B/RY9 B[F7! !R#G&3@'(Y-6** *UE8V]AIMOI\"8MK>%841N?D4;0#
MZ\"G0V5I;LC06T,3)&(5*1A2J#HHQT4>G2IZ* *C:5IS+;JUA:E;9_,@!A7$
M3YSN7CY3GG(IL6C:7!J#ZA%IMG'>OG?<I HD;/7+8R:NT4 <7)X$GNM226]U
M6*XM$NEN<?856YDV/O2-Y\_,@8+_  @X4#-=8UA9M!-"UI 8IF+RH8QMD8]2
MP[GZU8HH S=1TMIUGN=.:ULM6DC$27[VJRLJY!(/()''3.,\U5L?"NGV6AZ7
MI7S20Z=(DR,P&7E4D[SQU+$L<8_+(.Y10!%<6MO=QB.Y@BFC!#!9$##([X-0
M6VDZ=9V3V5KI]K!:/G=!%"JHV>N5 P<U<HH HVNC:78Q&*STVSMXRI0K# J
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M^XEN++3;.VGE_P!9)# J,_U(&35ZB@"E:Z/IEC=2W5IIUI;W$W^MEB@5'?\
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M)[XI9=-L9[>>WELK:2&X;?-&\2E9&XY88P3P.OI5JB@"O9V-IIULMM8VL%K
MOW8H(PBCZ <5%<Z/IE[>17=UIUI/<P_ZJ:6!6=/HQ&1^%7:* *ESI>GWDWG7
M5A:SR^68M\L*LVP]5R1T/I4YMX6FCF,,9EC4JCE1N4'&0#V!P/R%244 4K71
MM+L;N6ZM--L[>YF_ULT4"H[_ %(&3^-68((;:!(+>)(HD&$CC4*JCT '2I**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-% &?HFJ?VSI$-_]G>W\PN/*=@Q&UBO4<$'&01V-:%(      .@%+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA79&S_,QP,X' ]SP*\LGFN-+UN?4[FZO+ZQBU=8%OK+57\RW'F*@MY+9_E8
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M<NG7.DV,UDK%UMWMT,:L222%Q@'))S[FJ^F^*]#U<S"TOU)AC\Z02HT1$?\
M?PX&5_VAQ[UE0>/-/U+Q/I&EZ3/'<17B3/*S1NC!44%63<!N4G/S#(XZT ='
M#I6GVR6J06%K$EIG[,J0J!#D$'9@?+D$CCUJM<>&]"N[]K^YT;3YKQUV-/);
M(SL,8P21D\<?2J>L>*K?1_$NBZ-+&S/J3.-X5CLP..@.<GCKQU-/A\8^'Y]4
M&G1:E&UPTIA7Y&V-(.J+)C86X/R@YH N3Z!HUS(LD^DV,KK ;<-);HQ$1_Y9
M\C[OMTI+_P /Z+JEQ#<:AI-C=S0\123VZ.R?0D<58L]0M+]KE;682&VF,$V
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MJ^'UC99+"*)P^UL.6W;NV!C"]^<G'2@#;:UMWNDNF@B-PB-&DI0;U4X) /4
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M>.6,Y5E/0@T ,.F6#6TML;&V,$LAEDB,2[7<MN+$8P3NYSUSS5JBB@ HHHH
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MO.;:8W@=92'4YSP2N1@$$BD\3^%]7U#4]>N[6WG*?;].O(A#(J/<+"N'"%N
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M&<9ZUR<VD:S_ ,(9>>"1HMRUU-=R;-1RGV<QO.9?.+;LA@#]W&=P].:]2HH
MYOPIIMSI]UXCDN;<Q?:]7DGB)Q^\C,<8#?FI_*LCQUH&K7NHV\^BQDG4H#I.
MHN& ,4#,&\WZJ/, _P"NE=W10!YUK6GZQ'KU[:6UIJD6G&TAAL5TD0QK*0K
MK/*WS*%) &"  3C)K'M_"&N7'AHV)L7BG;P>NG 2, !<!C\A.?ISTYKUVB@#
MS34[+6O%VHPA-'O=+A&B7UD9KLHNV:58P!A6)P-O7OS3/#NB7\FJ^'ENM/\
M$"-I@+2M?740@MV$93$6P$R Y('08Y//%>G44 <IXDMKVV\4:'K\%A-?V]G%
M<03PP;3(GFA,2*I(SC9@X.<-WK 30M7N[L:JVFRVRWGB6"_^RLR[X84A$9=\
M$@,Q7) )ZBO2J* .;\>65W?^$IXK&V>YN$N+:<0QD;G$<\;L!D@9VJ>]8_\
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ME5#.W.5'0Q[0/[N/I5[3? EY9R:#'<>('N;+0Y,V<'V54)3RVC =@?F(##!
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M\;*AHI'+R'9P!L!XR<'U%6YO'%]9?:]-N],@;7(KNWM(889SY,QF!*/N*Y4
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M_8EC<) H?)ZG..I[GO6K10!R^@>!M)T=S=3V=G<ZB+J>X6\, #KYDKN!GDY
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** *]_>1Z?IUS>RY\NWB>5\>B@D_RKB=,OIH8O",E^;B6]
MU<7%W*RW+*B,T!DVE>C*HPJCM@'K7;7UI'J&GW-E-GRKB)HGQZ,"#_.N3T/0
M[F^T_P -O?2-;WF@"6UFC,1Q,WE&'<#GH1AP>>N.* *7AC4;?7O[-LC'?Q+>
M>'%FW-?O(55GVXY RXZ^9UKH_!NJ7&K>&8);Q@UY!)+:7+8QNDB=HV;\2N?Q
MK-T?PLGA*.UOWO)+I=-T46!CCMSND"-OW  DY.,;>?K6EX-TJXTCPS;PWBA;
MV=Y+JY4'.V65VD9?P+8_"@#>HHHH **** .4\>ZCJVFZ;ICZ1Y7FRZK:0OYD
MQCW*TJC;D*W#=">P)Z]*YV+Q3K^CR>,;_P#LZ.^T_3=0,D[2WS*R1B"(LD*[
M"#MY;DJ#N]2:[3Q/H<NOZ5';6]V+2X@N8;J&9HO,4/&X<97(R.,=16=)X.>;
M0?$^G2:@"^O/([2K#@0EX4B.%W<_<SU'7'O0!FZQ\1DL]6OK*R32V&GQH\_V
M_4EMGE9D#A(E*G<=I')P,G'K71MXA@D\&OXDM(S+;FP-]&C':679O /7![=Z
MQ;OP5>IJ-[=:1JEK:_VA&BW(N; 3E75 GF1G<NT[0.#N&0#6MK=@\/@+4M/@
M\ZYD73)84R-TDK>40. .6)]!U- &79>,-3$VEG5M&AL[?5HF:T:.Z,CJXC,@
M24; %)4$Y!/(Q5+3_'FL7^E:5=#P_!'<:T4&FP&^)W#8SR/*=GR*H7(QN)R.
M :GT/PKJES;:)<:WJJSII]K_ *+;K:>4ZR/%L+2DL=S*K,. O4FK0\%R0>'O
M#UE9ZEY.HZ$J"VO&@W*^(S&P:/=RK*3P&!''/% %"\\5S/(FG:G8/;:E::M8
MPR):7C>6RS/\D@?:"R\-E"!G!!]:K7?Q5MK::[N0FF'3+2Z:VD#ZDJW;A6V-
M(D.WE0<X!8$@9QTJ/6=!NK74;"2XFFU+6=3UBRN)I+>S9(8H;=P<=6"  D_,
MV22<>VF/ EY;R7%K8ZO!;Z5<737+)]A#7$>Y][HDN[ 4DGJI(!(S0!9D\5:O
M<WFHMH^A1WUAIUQ]FG<W6R:5P 7\I-I!V[OXF7)! K$@\;:EHR^)[K5X[:2.
M+6EL;)#>;0':.+"$L@"( =Y;)ZMP< G:N/".II<ZE'I6O&PT_4Y_M%Q&MN3/
M&Y #F&4.-F[;W5L$DBH+SP%)=RZKC50D-W?1:E; VVY[>Y147));#H0@!4@=
M3S0!5B^)D,<.I17,-C<WUK'"\*:9?"XBN/-D\M%#[1M;>0"". 0>:L:7J&NS
M?$L6FKV\=JHT=I%CMKIIH7/G*-W*KAAR#Q^/-3/X)NM0L=0CU75HC-<+%Y!L
M;001VS1OO5U4LQ9MP!.3T&.*MZ5X=U6'Q.==U;6(;R;[$;-88+0PHJ[PV[EV
M.3CGGTZ8Y *OB7QI-HNOQ:1;6^G^<]M]I5]0OOLJS?,5\N([&#/QSG&,CUXF
MG\3:M<ZFNF:/HT,E[%9Q7=XMY=^4D'F9VQY17W.=K=.!CJ<U+XB\.:AK%PS6
M^HV8M98?)EL]0L1=19!/[Q!N7#<X.<@X''%4;3P1>:&;63P]K*V\L=A%83F\
MMO/698\['P'4AAN;N1@XQQ0 EKXYNM:_L^VT/2HY-0N()9YXKRX,26HCD\I@
MS*K%CO! P.Q/%$7B*Z;7 UQHM[%J"Z-+<M9"Z!!9)0NP+PI)/(<XX/04MMX%
MGT<:?<:'JRPZA;02P337=OYR7(DD\UBRJRD'>2PP>,D<U%=_#V2_MKA+O7KJ
M::XTR6PEG=,L6DE$A<<\*#\H3IMXS0!3?QU<W,M_H]RFF)=2:7<W44FF:E]H
M:$HH^63Y5*M\V01Z&NN\+2R3^$=%FFD:262P@9W<Y+$QJ223U-<XG@.\EO(;
MFZU.Q0165Q9);V.G>1$%E4 MC>3N^4=\8& !U.YI.GZEI=S8:>)UETJTTQ("
MQC"EIE(4,.2>5!R.@XY.3@ Q]=U\:#XVFO+N>;^S[7P_-=20JQPS+,G(7INQ
MP#[U5L/B9!]LCBU0:6B3VTMRAT_4ENFB$:;V20!1@[03D9&01]=O6_!]MK^I
MW-Q=SM]GN-+DTUX57!P[AMX;/48Z8JC#X1U (_\ :VHP7]M':2P"VM+);9KG
M>NTF1BQRV,@8VC)S0 VT\8:T;W05O] @M[36Y"L$D=Z7>$>4T@$B[ -Q"] 2
M.O/', \?W4&M:?:7UCIT$=]=BT2W74@]Y$22%9X@N .!D!CC(ZU@Z/;:KJNN
M>%K;[7JDUII3.\J76EO:-;KY#QJ))&XDDRP *<8W'WK7T_X;W=E;:39_VO9B
MUTN\BNH_)TX)+<;&S^^?>=Q()Y '/)STH V_ MS/=:)>/<323.NJWR!I'+$*
MMPX4<]@  !V K+OO']UINJV\5Y8Z=#;SWRV:P-J0-[AGV+)Y(7&WD'&[.#GV
MKI?#VB_V#83VOVCS_-O+BZW;-N/-E:3;C)Z;L9[XKDHOAK=Q64>GIK%JEK#?
M)>K(NGC[1,5F$H6:3?\ /SQD 'H>V" 3WGCS5+>'5M030H&TK2;YK2YE:\(E
M<*P!>--F#@,#@L.X%-\4^*-8GTGQ3'HFFI):Z9;RP3W9NS%*)?)W$Q*%.=@9
M3DLN3TZ5IW/@O[1X<U_2/M^W^U[N6Y\WRL^5O*G;C/.-O7(ZU!JO@S4+EM;@
MTO6TL;'6@6NXGM/-='*!&:-MXV[E49!!Z9&* -8ZS#HW@A-9OV=HK:P6>4CE
MFP@)Z]2?ZUSNF_$J%[^&WU,:6B7-O+<1G3]26Z:+RTWLDJA1M.T$Y&1P1]>H
MN]!MM0\*R:!=LSV\MI]E=U^4XV[=P]#WK&LO!]^9576-5MKJT2WDM_)M;$6Y
MF#KM+2MN;)QG[NT9.: &6_C#58].36=4T%;;19;22\$T-UYLL"*F\>:A4 %E
M'&TM@\'UJ2R\5ZJE[I*ZUHT-E:ZN2EK)#=F5XY-A=4E4HH!*J>5+#(Q[U%#X
M+U&:PATC5=?:ZT:"V>U2W@@,,DR-&8QYS[B'VJ>,*HS@]JFLO">IF]TI]9UN
M.^MM))>UCCM/*9WV% \K;VW$*Q^Z%&3GVH H:-X\U34+;P_J-YH4%KI>M2+!
M"Z7ADFCD968%DV ;3M(&&ST) Z5(GCN^;3XM?;1XAX;EN!"MQ]J)G"-)Y:S&
M/9C86(XW9P<X[5=M/!?V7P[X9TG[?N_L2XBF\WRL>=L5EQC/RYW>IZ533P'=
MK81:&VLH?#D5P)UM/LN)BHD\Q8C+NQL# ?PYP,9H @O/'^JV\6H7T?A^*73;
M#4SITK_;,32-Y@C#(FS&,LN<L.I],TFK>++V/3=>LM8TP6]UIZVDV+"_;$D<
MTNU<2;%92"IR,<_C6I-X+\W1-1TW[?C[;JHU+S/*^Y^^279C//W,9]\XHUOP
M7_;-UK,WV_R?[2@M(<>5N\OR)6DSU&<[L=L8[T -D\4ZO<7FHMH^A1WUAIMS
M]FG8W6R:5P 7\I-I!V[OXF7)! K2\5>)(/"^B_;YD61WF2"&-Y1$K2.<#<YX
M51R23T -9EQX1U-+G4H]*UXV&GZG.;BXC6W)GC<@!S%*'&S=CNK8))%:OB3P
M_'XATE+,SM;S0S1W%O/M#^7(ARI*GAAV(/4$T <-KWC^]N_"OB6SLWTU=4M-
M/-RMQIVI>='Y394LKA 1(I'W2!U!S5&UN[OPSXBU*\UB#;I^@Z9#-'#%K-Q/
MM:5I><.JB1G;@[^%PN,]NMG\%W^HZ1K-IJ6KVYEU&U^RH+2R\F&!><L$+DLQ
M)Y);L!Q5O4_!5OJUQKC75T_E:K906A1%PT1B+L'!SR<N#C'\/?- &59?$FW6
MZDAU7^RP/L4UZKZ9J(NPJQ#<Z/A5VM@Y'4'!YXJ6Z\2>*6T&XNSH%O;)/I\M
MS;3)>ES 0FX"4>7P2#D;=PR,'UJU;^#[VY,Z:YJEM<VTEG):&"RLA;!PXPSN
M=S$MC@8P!D\46WA35W@2SU/Q$;BR@M)+6*.WMS"9 R;-TQWD.0.@ 49YQ0!C
M0^.]3L-.T"QN8-+&H76F)=F:^U(PQS=@B.8_FD(PQ!  SU/6NV?5DM?#K:Q?
MPO:I%:FYGB+!VC 7<PR#@D<]#S7-?\(;K0TFRL6UO3[J."T%I+#>:7YL#JOW
M'$?F#:X7@G)!]!6WI_AFTLO!L7AF222XLULS:.SG#.A4J?IU/TH R(/%VLHV
MF/J.AVUK;ZN?+LF6]+LDI0NB3#R_EW!3RN[!XYJ'X7I?3^')M4U'+W=[<2LT
MAO9)M^V1P/E8 1@= %X( )]!:LO".I?:=(75];2^LM(<26D4=IY3NX0HK2MO
M(8JK'[H4$\^U;/AO1?\ A'M"@TSS_/\ *:1O,V;<[Y&?ID]-V/PH \X_X2#Q
M1)96$TJ))<_\);-:QQ0WK 2*!.OEL=@Q&I5<'!R%S@'BNBN?B#+I-EJ2:OI]
MO!J=E=PVBQQW?[B5IE#(WFLJ[5QDL2.-IZU9@\$3Q7B,VJH]K#K;ZO#%]FPR
MEQ+OC+;N1F7(.!C'0YX?JW@5-4N]5N_MYBGN[FVNK=O)#"WE@7:"03AP><CC
M@D>] $GACQBFNZI>:5,=/-Y;1).)-.O1<PR1L2.&P"&!&"".X/>B]\2:TWB3
M4-'T?1;>Z-C;Q7$DUQ>&(-OW80 (WS?(>O'KBKFA:)?Z?>7-YJ.H07$LR+&D
M5I:_9X8E&3D+N8EB3R2>PXK"DTKQ#/\ $'7[C2[]=.@ELK2/S9[(S)(?WN2A
MW+\Z\>H^;D=* )+7QW=ZQJ.FVVB:0D\=WI\>H2RW-SY7DQERC*0%;+ CZ'GI
MCE+?QU?R6-EKDNC11^';VX2&*X%T3.JN^R.5X]F I)' 8D @UIZ'X-MM!U&V
MGM;AF@M]+33EB=<EMKERY;/4DG(Q6=;^!+R.RL]%EUI9/#UG<)-%:BUQ,RH^
M](WEW8*@@=%!( &: (V\=ZG'::AJTFAPKHNGW\MG<3?:R9BJ2F,RHFS!4=2"
MP/7'09GO/&>I(NKW^GZ+%<Z1I$KQ7,KW6R:0QC,IB3800O/5AD@XK(TCPGK.
MK:?K&GWVH&VT:ZUF[EEM'LR)GC^T,P"2%@ CX!SM)P3@\\:][X+U"1=7L;#6
MUM=(U>5Y;J VN^5#(,2"*3< H;GJK8).* *]S\096UZ;3]-L[&<0K"ZQ7%^+
M>XNED56W0(R[6 #=V&2".*9K/Q)33]3U2WMH],>+2CMN!=ZDMO-,VT,RPQE3
MNP"!DD G@>M3Z[X"N-8@N-.&IVPTB=$C6"YL1/+:@*%/D2%ALR!GD-@\BGW7
M@>\CO=1?2-6@M(-1(><7%D)Y(WV!"\3EA@D*/O!AGGVH ;=^,+_55OD\.:;'
M>6]M91SS32W)A<^;'O18P%.6V$-R5'(&>XUO!UU-+\/="NYC+<SMI<$CDMN>
M1O*!/)/))]35*Y\(7\5[=S:-K0LDO[>."[$UMYS$HFP2(=R[7VX!R". <5IV
M?AY;;P3!X;:[D*QZ>+$W,8V-@1[-X&3@]Z .?T_Q_._B'3M,U*UTN$Z@LA6.
MUU(3SVQ1"Y$R;1CA2,@D C'/6K6E^*-?U:VL]1MO#T)TS4%8VLAO#YB#:3&\
MJ[,*C8'W2Q7<.#533? %U:W6AR7&I6/D:06"06FG"!9U:)HB9#O.6PV<C Z\
M'/%[1_">JZ6-.L?^$@9M&TULV]O' 8YG4 A(Y9-^&50>@49P,^X!SWAKQ5=C
M2/"U]K^]I9K.]N6N(KMBICC56+.FT MR<#^''!YXW;+QAJGF:/<:KHL-IIVL
M2+%:R1W9DEB9E+()4V #<!_"6P>#ZU!IOP]:VM=,L[[4TN[33X;NUC1;;RR\
M,RJNUCN/(P>0.<]!CFQ9>#M1632(-4UQ+S3M'D62UA2T\N1V52J&5]Q#;0?X
M57)Y- %/3?'FJ7EMI&IW&A00:3J5V+)'%X7F1RS*&*; -A9<?>SSG%=%XBUV
M318K**UM!=W]_<BVM8#)Y:EMK,2S8.%"JQ) )XZ5G6_@OR/#>BZ/]OW?V9?1
MW?F^5_K-DA?;C/&<XSDUI>(M"?6H;.2WN_L=_8W N;6?R_,"OM*D,N1N4JS
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M75P^R&%&DD;!.U0,D\>PKSKQUKVH6.H>)H['4)8C:^'H[B-4?_5RF9QNQV.
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MA"2LMQYH"1D=0Q/0\C@^HH BUGP_!?\ AW7=.LUBMIM6@E627;P9'CV;V]>
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MCP6(4!B/3<1DXZ]ZK>$O 6E>&K"P+V=I+J=M&5:[6/!+'@L >A(X)ZFNLHH
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M4");<&XE@\N,&39& ">N0HR.A&0:NKIFHV6M#6IM+O)[*U\175R\$<):0I)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<>%M$NH!#-I\;(+MKT<D$3L22X(.03D_G5/1] NHO%&I>(=4^QF\N(DM(!;
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M* *5SI&GW=S+<7%I'++-;&TD9QG="3DH1Z&G:?IEGI>FQ:?9PB.TB4JD9)8
M$YQR2>]6Z* ,33?"&@:1?+>6&F10SH&6,@L1$&ZA%)(0'_9 JU'H.EQ6-C9)
M91K;6,BRVT8SB)ES@CZ9-:-% &1#X6T2WO'NXM/C2=[K[86!./.PPWXS@'#M
MGUS61KO@Y;G1K[2=%@LK.WU:5CJ+R;B0K?>:->F\\^@R<UUU% &5=:#:7+:0
M HCCTN82P(HZ8C9 !Z##?I6K110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R7CV2[BL]+:
MVM/,1;]6ENA9M=M: *V)%B7DG.!G!QNSBNMHH \:_LG4=1DUSS[/4[R"[U?2
M91+=V'DF>)742-L"C"@*<Y&0 "W6MCQ?H5_>:YXA:RTZ66"6PTYW1(\+="*Y
MD:2,'HS>6,8]P.]>FT4 <+I$\>J_$PZK9Z5?06HT<P/=7%E);AW$JD)AU!R!
MGMZXSBNZHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM%A1A,$AEP>&&"#S5JP34M2UB+P^NO7]G;6&DV]SYL0B\ZX>4N,EBA&U0F,
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M#F2?S2N[);HH"X![]-+3;[7/%NI/:SZK-HQM-+M+ADL3$^^>8.6;<0P9%V8
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M0E&! 8'!''<'BGUQ?PQM'MO#=WOO+BXW:G>@><5^7%Q("1A1UZGW/&!Q7:4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=3O+'3Y;R)76*6[C()(!(5LX?&>HZU8&H'^UY;-HXUACMEG\[SUSRS @IU
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M@);D< MFNR^'UJ8UUJZCEN)+>ZO!(CR67V6-V"*&>./.<$CDD#)!//6NTHH
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MQ):W%G>Q_,!-'(ORGC/*N ?H35F[\,:FNA^%(+*:T-[H<D+L)BPCE"P-$P!
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MJMWXD%I<62VNM:=%;$RE@\4D>_!X!!4A^>_%:'B3PB?$>J"26=8[1]*N]/D
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MM[-IVB:>9T2..VTJW"A0,DEI-JLQ)(XP ,?C0!U=%%% !1110 4444 %%%%
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MM*MM&2(1;%^A&"V1D,<]!G(XH ],J"XO;6TC>2XN8840J':1PH4L<+G/3)(
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M!$0NX 8 Y))X.1SGH/&6JS6$.GV]MJ,UI-=3E-MI:_:+F50I)$2D%0>A+,,
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M!U.,C-/9T5E5F4,QPH)Y)Z\5Y\+#5;/Q_P"$WU'7&U/S8+L_/#''L?RTSLV
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M,Z!=:M=*72!?EC#!3(QX"@GU-/T[68KFTM3>/:VMW/TMENEDYZ@ C&[C!X%
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MK5?6-,CADF?4;18HW\MW:=0JM_=)SP?:K*W$#F,+-&QE7=& P.\>H]1R/SH
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M![9IDFO0+XEM-%1?,DN()YO,5P0AB9 5(]?W@_*@#6HJG%JNG3/,D6H6LCP
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M+1^,FDN8#;D PMYS1D\8*$=.HQ]:]>MK6&SA\FWC")N9\#NS$LQ^I))_&IJ
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MQ["Q8^';S7M-\N,0E(IB.)W52!\A^4$XP<&M&X_X1/2/B%KT.K:; (!IEK'
MBV9= I,NZ-0JD!FXP.IP<=#7J54;?2;:VUF]U6/?]IO(XHI<M\N(]VW [??-
M 'E^A01:+=:7+XWM6,/]A0P6CW4!F2%P[F2-N#B0J8ASR=N.<4[PWX?6\U?P
MO#JVEE[*.TU.2VM[R'<(8FN(_)5E8<$1G@'I^%>N44 >%>(IOM5EK/E6MI:7
MBZJ9391Z=++>$K.O[YIRV$4J-P(& , &MC7;:"+4/&EK':;;R;4]-N8]L!!>
M+?;;F# 8(WAL\]<FO7:* /']4CTZ/2/%VFZEI\DWB>\O+A['%LS32[C_ *,T
M3@?=4;.0?EVG.*OR^'X;R7X@3:GI\5U>&SA199(0Q+"S7.PD?WO3N!Z5ZC10
M!RT\/VOX7&&[CO9?-T@),EJ,SMF+#;0>K=>#WKSB0M)HOB2ULH[+4XCX?G3^
MT++3WM)$(QMAD3[C,<DC !&T\#->X44 >;ZKI5OH6MZ1-I.C9"Z%?I)#:)Y;
M3[5B*1EEYR3G!ZY)KG] *2>*_!TMK]@\J-9XY$T[3)(4M@;=\1R2NQ+-D=#@
MY&2*]HHH \N^'MM/%J/A<R0R($\,,C%E(PWG1\'W]JO>(GT6T^)\%YKUHKVB
MZ.4CFEMS+$CF4\'@@,1G'XCO7H=% 'B,=A?62^';F_9+#1D2^^R?;]/:YCM=
M\VZ%73<NP^5PI/3E>,UZ!\.K7[-X;GV2RR6\M[-+;[[/[*H0G_EG&68B,G<1
MG'!Z 8KKJ* /)[72TM6MV@L5AQXTD8E(=O[L"3:>!]T9X[<TW1+?R?&\>KM8
MW">&[N[G324?.RWNF #3%,959"'VD],G@;Z]:HH \,T"PF$.B6%U>+'KL&HI
M+/!#HK?:UD$A,CO.9 #&PSE^A5N >!5C4XM,C\+WNFZAISR>*?[9,[M]E9I&
MS=!EE#X_U?E$#.<8^7KQ7M=% ')_$NT%YX U*/[.)W C9%V;B#O7D#UQFL1_
M#J3^(_&\UEI\*ZA'901Z9*8@/)?R& \LX^7YL<CT%>CT4 >4Z6-(N;CP9;^'
M=/:WU.QE4W^VU:)[>$1,)5F8@<LQ7@YR>?>J6D>&+ ^%_A^9-(B,SZD3=,T'
MS,#',3O.,D9"<'C@"O8Z* .2\%6BV-]XJ@BMQ!;C66:*-4VJ 8(22HZ8W9Z=
M\UQ]Y;007WB"SCM/+O6\4V%R L!!: O;?,#C!7<'[]<UZ[10!X_J'AVTN/"W
MB*XDTQ7O)?% (E,69"GVN,<'&0NTMTXY/J:D\6:+/%>>+;;1['R+5[;2Y)HK
M>VRLD:RR^;A%QO.P#*@@D#'>O7** /./!,,4WC*YO;*_BNH!IXBF:QTDVEL6
MW@H&)<[I%&[@#@-R1P*;XNM7_P"$VNS:0;-2O?#MQ!83B+DW()P ^.&V]R1Q
M7I-% 'ENF?V/=ZGX.B\,Z>UO>V+G[>5M6B:"#R6#QS$@<ERG!R21GWK>\:1V
ML7B?PA?WMNKV\-]*DDIA+A"T#A,X!P-^W\<5VE% 'DGA[1X[W6/"Z7]AYT44
MFMOMFBRH8W0VD@C'0DC\Z9I^@6UGX9TBX@TQ(KM/%7^L6'#K&+MT'.,A=F!Z
M8KUZB@#PL:?<&&ZT^^O5BUU]6:411:*TMXS^?N25)C(H*;=IW< *".U>@_%+
MR#X'D^U1/-;_ &ZS\V)%+,Z?:8\@ <DD9&*[.J.K:3;:U9+:7>_REFBG&QL'
M=&ZNOX944 >6^(+>#6$\37/A:R9M..BI%-]FMS&DTZR[E"K@;F5 P.!_$![5
M:\0ZM;>(]8U2XTI9[BV7PEJ$?G"!U5I&:,[ 2!EL=O>O5J* /*M9T72=)TSP
MO)"(](DBMV(N)--6XM6=HT#"=>"';'#]>&&><5'I.H+IDWA+5=0T]=,TZ%=1
MMM\$,@A!=T,;A6!9%?:Q4'_"O6:* /&OM@^Q1336$,5O<^(KZ=+S5+65XK4$
M$HSQ KEF#$+N( /O5>PTX7L$UG/;>?:2>+;:4K]B-O')&85RPB.<(Q!^O?K7
MMM% 'D?B?1X8%\<10::JVJG3+A8XK?*Y#_O&50.NT<X[5V/C.&'5/A?K"6$
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M "BBB@ HHHH *RM=UV#0K>W:2">YN+J86]M;6X!DFD()P,D 8 )))  !K5K
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M#[FV;/MGGXSC.[;QTQGOCFNLMC?&YN_M:VP@$@^S&)F+%-HSOR, [L],\8H
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M^=MZ?>V\8Z9[]ZA\1> [G7+W6K@R6A%S+97%K',&9&:#=E91C[K!L<9/.>U
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M0Y4%G.YC]T#H/>H+_P (^)!HFH>'-/?2SIEQ>-=1W,\KB6-6F\UHR@0@G<2
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M;![^SBM+2WD'V+3?M?F2RQ^9\Y/1 "!@8)YYH ]-J.2>&*2*.26-))25C5F
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M._!S@E3M([$G':H="N]=T7PM;:M#JB&Q_MV2W-@;=<-')>M&Q+_>W98D8P.
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MZ5I%U#/86YA:&S6RC4.2!$&+ <]3DDY/)J]97,EQI\-S<P?9I'3>\9D5]G_
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M6I->\3+HU[IMA#9O>WNH.RQ1)*D8"J,LQ9B!CT]36R+F!KAK=9HS,HR8PPW
M>N.M '/P^"[*S>^NH+F^EU&ZLVLS=75W([A#R #G*X/<8/4]:UDTN)]!72;U
MC=PFU%M,TA.9EV[6)[\\_G5I;F!I3$LT9D +%0PR #C./KQ21W=M-"9HKB)X
MER"ZN"HQ[T 8%EX'TJROM/O?.U"XN-.)^R/<W;R>4I0H5 )Q@@^F>!SQ5N'P
MMI<&E:9IJ12"VTR9)[93(<JZYQD]^IK6CN()GD2*:-WC.'56!*GT/I21W,$T
MDD<4T;O&<.JL"5/N.U '.3> -#FN?,;[8L(NA>+:K=.($F#A]X3. 2W)'3D\
M<ULZSH]IKVE2Z=?"0P2%6)C<HRLK!E8,.00R@_A5J*Y@G>1(IHY&C.'5&!*G
MT/I2S3Q6\1EGE2*,=7=@H'XF@#*C\,:<EKJEN1,ZZH@2[:24LT@$0BSGUVJ.
M?7FJMYX*TJ[E25)+ZTD%NMK(]G=/$9HE&%5\'G&3@]1D\UT"RQMLVR(=XW+@
M_>'J/6D>XAB1WDFC1(_OLS !?KZ4 0VNG6=EID6FV]M&EE%$(4@ RH0#&W'<
M8K#L/ FCZ?J%A>1-?.VGEOL4<UV\B6ZLI4JBDX P<?@/2NA-Q (5F,T?E,,A
M]PP1C/7Z55U76;/1]#NM8N9,V=M"TS-'ABR@9^7U)[4 5-*\+:7HTUG+9Q2*
M]I:-9Q;I"<1LX<@^IRHYJI)X$T66\>5A=BWDN/M4EB+EQ;/+G=O,><?>YQT)
MYQ5N'Q-82ZU<:<S"/R;6&Y\YW4(PE9U !SU_=G\ZU9KB"VC\R>:.),XW.P49
M^IH P;OP1HU[?3W,HNA'<RK-<VB7#K;SR#&&>,'!/ SV.!G-+/X)T:X?43(M
MSB^G6Y=5N'41SKC$L>#\C\#D>E=$"",@Y%<G)XTGN);IM&\/:AJME:2-%-=0
MO$BLZG#B,.P,F""..,C )H LIX)T<6=W!-]JN7O'B>XN+BX9Y9#$P:,;CT (
MZ# Z^M6-5\+6.K:@M^T][:78B\AIK.Y:%GCR3M;'4 DD=QDX-6[#6].U'1K;
M5H;E%L[E \;RG9U['/0]L5<DGAB3?)+&BX+;F8 8]: ,FQ\/0Z9J-B]B[6]A
M9V+6B6BNQ0Y92&()QD!2,\D[CSZOUCPY9:S<6]U*]S;WEN&6*YM)FBD56QN7
M(ZJ<#@YZ5HB[MF>-%N(BTHW1@.,N/4>HI3=6XE6(SQ>8V0J;QDXZX'M0!A_\
M(7HRV6GVT*7$'V"X-S#+%<.)?,;.]F?.6W;FSG.<U./"VEC1DTGRI/LB77VL
M+YASYGG>=G/IOYQ^%:T5Q!.C/#-'(JD@LC @$=1Q38[NVFA,T5Q$\2G!=7!4
M?C0!@7G@31;V[N)91=K!=2B:ZLX[EUMYY./F>,'!S@9[''.:V++2K73[N_NK
M=&66^F$TY+9!8(J#'I\JBK,=Q!,\B131NT9PZJP)4^A]*Q]<\1G2KVSTZTTZ
MXU+4KM7DBMX71,(F-SLSD  ;E'J2>E $VH^';'4]4M=1F,Z7-O&\*M#,R!XW
MQN1@.&7(!P>XI$\,Z9'9Z-:")_)T?;]D!<G;MC,8SZ_*Q'-9L?CFSBTS4;K5
M+*ZTZXTZ6.*YM9=K,"^-A5E)5@<]0>QSC%=&]W;1F(/<1*9?]6&<#?\ 3UH
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MRN<L1MVG@=!6C;&RL/%MNMLEEJ-P^MLS6EQ:M#J=LSR,&D\Q3^\C )/S#!3
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MU% '+?#R![?P;:H9Y)H3)*T!>V:#$1=BH5&9B$ ^[DYVXK \*^)M*\&>'O\
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M5_C _B(R:N3R>$UU+Q$_B"WMI8KJ&$Z/N@W"2T\A=J6W'!#[^%YR0?2O6:*
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M!R.W6@"]%X^L+JZTRVL]-U.ZFU&RAOXUAA4^7!(<!G)8 8/7KUXS573_ !U
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MV6-9G5%*X&"% '//'-8FE^$=;\,2Z=J&GBSU&\6VF@O8996@5C),9MT;;6P
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M3(XD)$>S8S!MS J #UX.*KZ5XGOM3\?-I<ME>Z?;II?VAK6[CC#%_- #AE+
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MPGEV,'C.#@8.#@=?:KFI>(-?T_78_#LFISR3068NY[ZST5YVD+NRHGEIN"*
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MJO?>+-3M_!_BW4T:+[1I=]-!;$IP%79C([GYC0!W=,DECAC:25U1$!9F8X
MZDGTK@-6UKQ,]YXPEL-1M+:VT$+)#$]KYAF_T=92KG<,#)/(YY]JR-4OKYM4
M\5ZN9H9(?^$5ANA9S0!XSE9R$.3R,@D\<@X[4 >K)-%([(DJ,Z %E5@2,],_
M6B6:*"-I)I$C11EF=@ /J37'^%&W^-/$KX W6^GG"C '[INE<CXOCOA+\2':
M]$D2V5H%A,0'7)7G/;GZYH ]>FABN(S'-$DL9ZJZA@?P-* D48 "HBC@#@ 5
MP&I^)M<\(WM^NJW5OJ<:Z-/J48CM_)V21LJ[!@G*'>.3R,=ZATOQ+X@>^MX;
MN.\OK>ZMI3<-+HLMK':N(RRX9AAD."N#SR.>U 'HL<B31++$ZO&X#*RG(8'H
M0:=7FWAS5]>U:Z\/Z=8W5EIUE_8%GJ$ZQV8;)9BIC09 12![XP,5T'BW4=8M
M]2T'3-'NH+674KF2&2:6'S=BK$SY"Y&3\M '4T5Y;=>,?$3W6KI927,DFE2_
M98H8=%EG2\E1%+EY%R$W,2  ?E&"<U9U_P 6:_97SSS/+HUA]FAFMI)]->>!
MF9<NL[K\T6#\O08QGGI0!Z317"RZGXDU36O$,>F:K96UIID<+VX-N)?.9X1(
M0S9'R>XYYZ\<XX\?ZGKMS"E@;JPB73;:[<V^E27S-+,I8*=HPJ #ZMDX(Q0!
MZE2,ZHI9F"J!DDG&!7!6'B'Q'XDO-/TV/;H5U_9@OKPRVI=]YD:,(J.1M7*,
MW.3@J/>LZ=M;7QB;C4+VRDFB\-SO-#!%OAD(DP0-W."0"?3!7GK0!Z9$8FC#
MPE"C_.&3&&SSGCKFGUYS:>,[G1=(CDOHH/L\GAZ#4-/BACV R!0KP@#_ &GB
MP!T#8[5!<^*O$7]K3:.US/!<Z=:0&XEM-'DO!-<2)N;.SA$' QU.3SQ0!Z;1
M6-I6IZEJ/A&#49--:WU22U+FSF!3$N#\ISR 2._8UQ6F>,=82*\34-0V:@FF
M3W)L+W36MI(YD7/[H\K)&.<\D]#GK0!Z=17&S>*+RV'A*2388]1MI9KL!.3M
MMC)\OIR*K:;J_B7^P;'Q3>7UA+8W-H;R?3Q#Y9BC,1D01/DEG' .[@\D8Q0!
MW=%<+::KXEL]"M_$NHW]A<V4MB]Y<62P^48OW1D58FR2QXP=W49(QC%4/#WB
MSQ%=W^CR3QWEW#J'_'U%_8TUO':;D+*R2L,,H.%.>N<C'2@#TFBO./#_ (IU
MV77+6SUFY%K?7 E#Z9=V#0*6"DJ+>8960<<Y)R,GCI4.D>-=6MIR=>NC%=+:
M33SZ7<Z>UNV^--^+>7E9%&#U)..?:@#TVBN"M=:\1V,7AS5=2OK2ZMM9GBAE
MM(K?9]G,JED*/DEL$ '=U&3Q6?9ZYXTNO!T6OI.ES]JF$9M[2P#R6T2R,K2*
M-W[QB%'R]L]#CD ]-HKF?!>MR:S87?FZE%?26\_E[OLSVTR#:"%EB8#:V2>G
M!&*Y7Q9XTU;2FUNZL=3CE_LQCML[;3))XMJ@%A//@*C')X!^7CJ: /4**X"^
M\2:W!K/BB\%U FD^'X4G-J+?=)<YM_,*E\_* >X!Z^U1>'?$_B&YU?24NDO;
MRWOU/VH'1IK:.T.PLI21AADR-O/)R#[4 >B4QY8XV17D16D;:@9@"QQG ]3@
M'\JY#QIXEO=*U72-)L3-$]\LTLMQ!9/=O&D>WA8U'4EQR>  ?45A+J^I:I>^
M&/[4MIXY;;Q \4<\MH]L;F/[)*5?RWY!Y(/;*G% 'I]%>5Z1X[\0:FFGZM#!
M>SP7ERJMIZ:--Y<=NS[=PN,8+*N&)^Z<$ #K6[I>I>)=<B?6[34+""R74)($
ML)X<!H8Y3$Q:3)(D.UB,#'08[T =OFBO'].U[5] TN2U2\>XN=2\0WMN)DL&
MF:%4>1I'6-,ER=HP.B_05KQ^+_$(MFT\Q2K<3ZC;V5GJ5[ITEN&2169F,38R
MR;&'! .5Z4 >C"6-I6B61#(@!9 PRH.<$CWP?RI]</X7M]0MOB)XFCU*\CO)
M18V.R9(O++)NGQN4$C.<].V*B\5^(]1M-7O;2PU80M;6RR);6FF27DA<@G,Q
M VQKP,<@D9.: .]HKSW3]?\ $7B;4-,MK*^M=-CNM MM3E?[-YS++(S JH)
MV].N>GOFFZ/XHU[Q0-$L;:YMM/N9]/DO;RX6#S-Q27R@J*3@ G).<X&![T >
M@QRQS*6BD1P&*DJP."#@CZ@T^N/^&ZW">';U;MHVN1JU\)6B!"E_M#Y(!)P,
MUC-XD\33^'8/%$%]:):7.HQVXL6ML^7 UR(<[\Y+]SVY.!Q0!Z317"7OBS4X
M/!_BO4T:+[1IE_-;VY*<!5* 9'<_,:I^+?%>J:?>:S_9^JH&TZ'S([2UTR2Z
M&1'O/VB3&V//H",#![XH ]!>[MHRXDN(E,>W>&<#;N.%SZ9/3UJ.34K"&[^R
MR7MLES@'R6E4/@G .,YY) _&O,=0U9_MGB74_L]N[36NA.8IHQ(@WS/V/INR
M#V(!J QW%AK7B;49VL[R4^(K&U_?V:$@,;;!#=1M#<#L1NZT >OTV21(HVDD
M=41069F.  .I)KRZY\<^(+B?5;S38;R5;*]EMX-/AT>:9+A8GVMNG485F(;&
M.%XSGFK'B/4-=\0:#XSDLKRWM+#3H9[3[++;[FFQ &D+-G*GY\+CIC)STH ]
M*5@RAE(*D9!!X(I:HZ)_R =._P"O6+_T$5A:A?ZSJ?BZXT+2K^'3HK*SCN9I
MVMQ,\C2,X50"0 H"$D]3D#B@#JZ*\ULO$_B7Q#>Z/IUI=V>GSS0WHO)A;><N
M^WF6+,8+#AB3U/ /J*ZSQ-JUUI1T46Q3_2]4AM9=RYRC!LX]#P* -ZBN \1>
M+-8L+OQ#!8M;A[*?38K;S8\@>?(%?=@Y/7\*R?&-]KUOHGB[0;[5(KGR]$%]
M%<I;")@K-(CQD D8.S@]1GO0!Z?)=VT1<27$2% I8,X&T$X!/ID\"IN@R:\G
M\5W%PMOKUA<FWFDAL=*=KE8 DDA:Z88)'8;>!VR?6NH^*"W#> KS[-<>0PE@
MW'9NW RH,?F0?PQWH ZU98WD>-9$9X\;U# E<],CM3Z\P9/$$'B;QG<:?J]O
M ]G;VLLC/:!_M$BV^>1N^53CMSSUXY6;QSJNJ7\5O9O<V*)IMM=R/:Z5)?%Y
M9E+!3MX5 !]3DX(Q0!Z=16%I&N74_@N/6M4L);2Z2V>6XMF1D8,F<X#<@';D
M9[$5Q_A_QAXBOKC1;N6*\NH=2=/M-LNC3116J.N5=)R,,%.T$G@@DC% 'IM,
MEEC@C,DLB1H,99V  [=:\Q?QMJT>I6$\6IQWL%QJL=G+#;Z9)]E2-Y?+&VY8
M ,XR#D9!.1C%5]?OM=UCPKXEN[R_MQI]KJ;64-I';X8B.[0*[/GKCC&/>@#U
M9)8Y6=8Y$<QMM<*P.TXS@^AP1^=/KS+4/%MYI=UJMK96\<5Q<^(/L2S0633.
MJ"UCD9S&G,CX! _#/"T2^+O$T.E7L:1RF9+ZR@M+Z^TV2V$RSR!&#1MC)4]2
MN.&'2@#TVBL'4+^\\,>"[[4=0N!J5U86LL[R+$(1*5!(&T$X[#]:Q#?^)M+O
M=%BU#5;2Y76B]N?*M GV2;RFD5D^8[T&T@AN>ASVH [*WO;6[>5+:YAF>%MD
MJQR!BC>C8Z'ZU)%+'/&)(I$D0D@,C C@X//UKB_A/9-:^ +&5WB=[C=(62$(
M?O'[Q'WCG)R?6N=\-WVO:+X5TK44O[9M.EUEK0V)MN3'+>/&6\S.=P9LCC&.
M,=Z /5HY8Y=WER(^UBK;6!PPZ@^]/KS.37M:@M+Q].M3#;+KMW#=W&GV GEC
M1?NMY8^\2?O-@GVKK_".K-K.@1W4E_;7TBR/&TT$319VL0 T;<H^,97U]J -
MVBO-QXH\0_\ ",#QF;NU_LXW'_(+^S\^1YWE_P"LSGS,?-TQGC'>MOPS?:[J
M^MZO<7-_;KIME?SV45HEO\SA<8<OGC&<8 [4 =4)8S,T(D0RJ S(&&0#G!(]
M.#^5/KS^[M=8N_BCJZ:3J4-@1I%H7D>W$Q)\R?: "0 .N>_3&*S(_B!JNK1Z
M'!"9[*2YTE-0NIK/39+QBS,4"JHSM7*L23GL!ZT >IT5YO'XC\5ZM+X>TZ)H
M](N[Y;T7,UQ8-DB%D"2)&Y! 8-G!Z;O:NG\5ZK?:78:=!8/$M[J%[%9)/*FY
M8BP)9RN1G 5L#/4B@#9BCLTNIA"D"W! :78 '(.<%L<\X/7TJQ7D]YJ^K^$=
M=\6WEQ/%J-]]ETR&VD6W(SYDLR*712<D%CPN,X'0FM6Q\5:W;/J4=R\LMK%I
M[W,>HZGIDMA%#,I V/D<J<Y&.?E(YXH ]#IAFB$JQ&1/,92RIN&2!U('IR/S
MKS2S\3ZS<ZNNE_VG-<PWVFW,J7,VD/:>5)&%YCWXWK\YZ]..:R_#EKK$TO@&
M.TU2.&>3P[,QN'M@Y2,_9R%"YP6Z#)]^* /8J*Y_P=JM[JVB2MJ+1/=VMY<6
M<DL2;%D,4C(&VY.,@ XKH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,UK0K77(;=
M9Y+B":VE\ZWN+:39)$^",@^X)!!!!!K3I"P49) 'O0!S]IX,TNU>WFWW4US#
M>F_:XFEW22S&,QY<]QL. !@# HU#P9I>HSW=R[W45S<745YY\,NUHI8T$:LG
M&!\O!!R#DUO&6,;,R+\_W>?O?3UI6D1"H9U4L<*"<9/M0!S(\!:21?F::^GE
MU#[.;J6:X+-(87WH>G&#Q@8&.U7=6\,6FJZA%J NKVQOHXC#]ILIO+=HR<[&
MR"",\C(R#TQ6E'=M)J%Q:FVF1841Q.V-DF[=D+SG(V\Y ZCK4ZR(Z[E=67U!
MR* ,:P\*:5IDVFRVD<B'3H9H8<R%LB4JSEB>68E0<^YJO-X*TJ6(A'NK><7L
MM]'<P3;98I9,[]I_NG)&T@C%="KHQ8*RDJ<, >E()8V9E5U++]X \CZT 8-M
MX,TJVC@&;F6:*^&H-<2REI)IPI0,Y/4;3C P!@8JM)\/](DF4^?J"6J7:WL=
MDER1!','W[@ONV3C..3@"M/3O$%OJT&GW-A!<36M[YFV<* L>SCY@3D9(XX^
MN*U1(C.R*ZEEZ@'D4 <U>>!-)O+FZ=IKZ.UO)O/NK&*X*P3OQDLO7G R 0#W
MS5]_#.F2Q:S#+"TD6L-NNT9N#^[6/C'3Y5'X\UK>8F\)O7<1D+GG%.H PM*\
M+6FEZB-0:\O[Z[6$V\<M[/YABC)!*KP.I R3DG YHU'PI9ZAJ[:FMW?V=S+"
ML$YM)_+$T:DE0W';<V",'GK6WO7<%W#<>@SS3'N(8X993(NR($N0<[<<F@#&
MTCPAI6B/IS62S+_9\$UO;AI,A4E=78'UY48]JBE\%:7)"JQ27=O.EY->Q7,$
MVV6*24DR;3C&TY(VD$=/2K^G:Y#JL>GSVEO<-:7UI]J2X( 55.TA6YR&(;/3
ML:T3+&%9C(NU?O'/ ^M &9H/AZR\.V]U#9O</]JN&N9GN)3([R,%!))]=H-9
M6I?#[2-4DU#SKC4$MM0?S;FTBN2L+R8 W[?7Y0>N,@'%=5N7:&W#!Z'--$T1
M"$2(0_W?F'S?3UH RW\.6$@UL,)<:R,7?S_],A%\OI\H'XU1O/ ^E7KR%Y+R
M-9=-_LR9(YL++#A@-PQR1O;!]ZZ,NBLJLZAF^Z">3]*&D1/ONJY..3CF@"A8
M:+::=J%W>P!_.NTB27<V1B-2JX_ UG:IX+TS5KS4+F>2[3^T;=+>ZBCFPD@4
MY5L8^\.F?0UJ'5K0:Z-'WM]L-L;G;C@)NV]?7/;VJ]0!EWWA_3M2U WEY"97
M-G+9-&Q^1HI"I8$>^T5G6/@G3K*YBF>[U&\-O"\%JMW<F06Z,,$)[XXR<G'>
MM+5-;MM*FL(I0\CWEVEH@CP=CLK,"W/ PIJQ:7PN+/[1-!):?.Z;+@J#PQ4'
M@D8.,CV(H HZ3X8T[1I[>:T$N^WL(M.3>^?W49)7/OR>:MWFDVM]J.G7TP?S
MM/D>2#:V!ED*'([\,:N,Z(NYV55]2<"ER/44 <WJ/@?3-1N[R8W%_;1W^/MM
MM;7)CBN< +\P[$J "5(R!S1J'@?3+^XN76XOK2*[B6&[M[6<QQW"*NT!ACCY
M?ERI!QQ72%@ 22 !U.>E9NKZY:Z18P7<H>:*:YAME\K!^:20(#UZ L,T <PO
M@,77B37[B>>\L["\6WACCL[GRUFB2((48#H 01D8.">:V+WP;IUQ<1W%I/>Z
M9*ENMJ6T^;RM\*_=0C!'&3@]1G@TNK>*QI5M&S:5>RW,]\;&VME,:M.V"=P+
M, $(5CDD=.E:MC?-=VCSSVLUD4D="EP5SA3C=D$C!ZCVH QY?!.E"*Q6QDN]
M-DLH#;0S64Q1_*)R48G.X9&>><\YR:0>!=&B:S-M]JMA:VLEF%BF.)8GY8/G
M.X[B6SUSS71M(BQ^8SJ$QG<3Q^=4K_6+/39+!+ASNOK@6\&T9W.59OP&%/-
M&?<^#M'O+31+:>%W31GC>TR_(V !0WJ.%)'JHHU3PE9ZGJ,FH)=W]A=31"&>
M2QN/+\Y!G ;@\C)P1@C/6M6TO3<1322V\ML(I7C_ 'V!N"G&\8)^4]1GG'I5
MD,I4,&!!Z'/6@"E!H]A;:(FC16RKIZP?9Q!R1Y>,8]3Q618^!],M)8WFN+^_
M6"![:WCO+@R+#&X"LJC Z@ 9.3CO71HZR*&1@RGH0<BAI$1E5G4%CA03U^E
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M.TNS%F5-S)-;7K7_ )TLI9Y9F1D+.3U^5L8X P/2MY75RP5@2IP<'H:'D2,
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MLPP2,^G:@#*?P3I$D%Q"_P!H*W$5I%(?,Y*VS;H^W7/7UJ>?PGIEP;PN)O\
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MB7@DEO;B6\FMY[B:><N\CP/N0YQQR ,#C QQ5[4O"^F:M<7\UVDCM?6']GS
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M#*LTMY=3S74%W+<SS;I9'A8-&"<8"@CH !R?6MJVO?.%R9;>6V6"8Q[IL 2
M ?.N"?E.>^#P>*L@A@"""#T(H CN;:&\M9K6YB66"9#')&PR&4C!!^HK"TSP
M9I^F7UK=_:;^[:S1H[-+NX,BVRD8.P>N.,G)QQFGMXNTY?&:^&"LWVLP^9YN
MT>5NP6\O.<[]H+8QT[UMRS10H6D=5 !)R?09H JZ/I-MH>DV^F68<6]NI5-[
M9.,D\G\:HIX3TQ-%MM) F^RV]V+R/Y_F\P3><,GTW'IZ5/INNPZM%IUQ9V]Q
M):7]L;F.X*@*@^7"MSD,0V1QV-3ZKJMOI.CZAJ4N9(K&!YY4B(+852Q YZX'
M>@#)G\%:9(?,AFO;6Y%Y->)<V\VV1'E^^!P1M/'!!Z"M/1M%M-"LFMK3S6\R
M5II99G+O+(QRS,3U)JW#=136T$^X(LRJR!B >1G'UI\LL<$+S2L%CC4LS'H
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M< %<  =AR!GU)I^C>#M-T.6QDMI;N0V%O);6WGS;]D3E"4Z=!Y:X]*Z"B@#
M3PTMG):#3KJ>")-1EO[A?-/[TR!RRD#J-S X/3%;]%% !1110 4444 %%%%
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M^H\WS#Y/FYXV_?QNXSCVJ)[.PU":.UL8P_A>;Q1;+9I'D0N/L[><(^WEE\C
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M1Z$4M '*_#=G;X?:0'9F*1M&"QR=JNR@<^@ %=51THH **** "BBB@ HHHH
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M4EVE0Z_(=IZ@G'2M[X:RW%UI.KWMQY!-UK%S*KV[%HF&0N48@;ERI&['.,T
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MB#PHFJ6M[<6=_.FD3:C:7"6QBPT;*K(Z;CD?.I!!'<4 >A%T#A"RAV!(7/)
MZU#=V-I?QB.\M8+A%.X+-&' /K@UP.I3Z[!J5I;7]QITFH7&E7\\=U%:%3;@
M"'Y%^?)&2<G(SA>F*/"_B"]T+1O"L6L7,#Z9>:&)4G$11HY(XUDVL=QS^ZW'
M/<H3WQ0!Z*JJBA5 50,  8 %+7/Z5K-X/ ZZ[JT*K/\ 97O'AC&-J8+JG/\
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MX,3L",-WZ,O&.<UZ1K]WJVF^%KFYTZ!;[4X8AM18SAVR S! <G R=N<G&,T
M;%%>:)XYU"+0=7N(]4LKZXM&MMB2V4EK/%YDH1Q)"YZ8/RL#USZ<['BGQC=>
M'=4U!%ACF@M=&:^1#D,TOF[%!/9>1VH [%W2-"[LJJ.2S' %.KS;QM%XGMO
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MCJ6.!0KHY8*RL5.&P<X/H:\BU?Q+?:MX>\2Z7=S_ &J.T^P30W+6$EF[B2X
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MC=+=Q;#C+JK*,\<C#&K]9>OZ[!X?T]+J:"XN&EFCMX8+=07ED=MJJ,D#KW)
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M-TBVTJ;49;<R%K^Z-W-O.<.41...!A!^M/M=4M;S4+ZQ@<M/8LB3C:0%+*'
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MK0JA5"J  !@ =J /&?">CZ!K<O@>U:"UNK1/#TSSPH04:<&W#B0#@G))(/<
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M8H*.V<Y;S409_P!LUU/A_3+[1_!<=N3OU5H7GF8_Q7+Y=OPWL1] *LZUH/\
M;=Q9">]F2QMY5FELT5=EPRL&3<2,X# ' (SWK8H \9TL:&=.\)3:3*C^*Y[N
M!-2 ?-U(#_Q]"<?>V@;_ +W (7':NP^&FF6.GZ1JK6EK% 7U>]C8QJ!E4N)
M@^@' KLE@B25I5B19'X9PH!/U-/554850 3G@=Z /%+C3='+ZQIR1P17,GC"
MU6:*)MDODLT>WIR%)+X/N<5:\1V;: _C#3] B%E8BWTV::&#<J1H\LBS. O(
MRB_,5YP">M>OF&(N7,:;SC+;1DXZ4[:NXMM&XC!..30!YKX%BMX?&-PFEWFB
M_8SIX:>UT4.T&_>-CLW*A\;ACJ1R>E:>IWMKX=^)ZZIJ\R6VGW^EK:0W<QVQ
MQRI*S%&8\+N# C.,[37:100VZE88DC4G)"* ,^O%.DC2:,QRHKHW56&0?PH
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M:]K+P!]1_MB^@6=V)*1^:?D7T&><>I-=U2*JKG:H&3DX'>EH **** "BBB@
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M:[13:S+$(RKG^)/E!RN3UXK3T[P[/I7PY3PZDBS7,6G-;;QPK.4(XST&3^5
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MND3W:,SR;T?EAP%.TX/L2<=*WV1_$?A$QSQ/9/J5AMDC)RT)DCY';)&[VZ4
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MU*=5*X.[. /Q%5=:M-:M_&MEK>FZ:E_;Q:?-:S1^>L;Y:1&&W=P?N<Y(X]\
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M6"WN#&(V$TN-AD))3.1R<XQUZ4 =1/X^T2-=.-O]LO6U&%I[9+.U>5G12 W
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M\QG90P+-C@ $#GVJGKO_  D_]O\ A6&X;3?[134KE(+I8V\IX_LS_.T>[(8
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MYBY#Y (/ YQ3+?Q/XI-GX<UB;^RC8:W=01_9EA<26T<H++\^_#MC&?E&">]
M'H5%8'BW69]%TR&:"[L+1I;A8FGO=S*@())5%(,C<<*"/7M7(Q>/M:;3K^.
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MZ:=IMK#;V^IW5W<0M=SVLHA,4*JQE2)BK?,'0 $\'/)Q0!Z""#G!Z=:6N,\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW#.T-C\.*27P-;//<K#JVIVVG75P;F?3X9$6)Y"VYL-MWJ&/)"L <GUKJJ*
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M%U+L-U.MO"-I.Z1@2!QTX!_*@#,U7PCIFM7E[<7OG/\ ;+)+*1%? "JY=67
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M6TN[+5HM2U*_OKK5+;[)->2F-9$B&<*@5 JC))^[R3SFNEMIC<6L4S0R0F1
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MTFV:2;5=0>,(SQEMUO$BY9B3RV020 .E02:KJK^'XKN"[NFN6\'6<DLL;$N
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MGTR:[!;*U2Z>Z2VA6X<8:81@.P]SU-2I&D>[RT5=S%CM&,D]3]: /&-5T_3
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M>"0>1SQ@OL_&6MZHFF:9;06$.LW%Q>0W$LBN\$:VTFQV500QW$K@;AC)YXH
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M?F8 D@\'H,<U=.^(ES'>QIJ4EC>02VLT[FPMYD-LT:&0JQ?(<$!@&&WD=.:
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MSYFC5B "1TW$BO79((9?+\R)'\M@Z;E!VL.A'H>336M+9C,6MXB9P%E)0?O
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MX8QR.,Y';%8?AB#7]*TO1/#<F@(%T]A'/J$SQM T2 X>(!M^]N.JC&3GWU/
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MHRYPOS#GD-BJ,?AG7XM/UN<:3>,\FL6.H6\%Q>I-/-'$8MP+E\;_ )#P3@=
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M0_(%X\IEN&*P000/-+(0,G:B L<#J<8%5/\ A,]".CIJ@NW,#SFV5!;R&8S
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MSQF:);BUEA\Z,8R\9=1O'(Y&>HI^N>*M(\.S6\.HW$B37*NT,44$DKR!=N[
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MMC+C.?3U.<5:N/ L<\NI,NJ742W5\FI6^Q$W6MRH WJ2/F! P5;(P3ZUUU%
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M0I'J+W*01OL\Q/-< E<YR#P"2*L^.;J+5#XZM_MCS6]G8Z>P2.X8)'(9)-W
M..F,_09Z5Z<NAZ0EK+:KI=DMO,BI+$+= CJ.@88P0.P-)!H.CVMK):V^E6,-
MO)'Y3Q1VZ*CIS\I &"/F;CW/K0!Y^?#]CJ'BCQ;BZOA%::?:?9C!?2K@^7)A
MRP;+L,#!8GOZTS0IQXIO+.+Q)J5S'&GA^RNX(TNWMQ*\BMYTQ*,I8J0HZX&?
M>O2+;2]/LHVCM;&V@1D6-EBB5044853@= "0!VS4-WX?T6_MK>VO-(L+B"V
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MY3R% 69,D[2>XR3Q[FJ=IX>T73X+B"RT>PMH;D%9XX;9$64'@A@!\PY/7UH
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MJ@W+&,80'KMX''M0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKFO%6O7NDW6DV5DU
ME;OJ$SQF\O@QAAVH6P0&7+-T W#H: .EHK!\(ZY/K^BO=7,<(EBN9;<R6Y)A
MFV,5\R,GG:<>_?DUO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&1)H3OKRZI_;&J*H(/V)9E^SG"X^[MS[]>M8WB_3+BYUK1K^327UG2[59EN+
M!-A.]@NR78Y"OMPPP3D;LBNPHH YCP/IEYIFF7PN+0V,%Q>R3V=@7#&UA(4!
M/E)4<AFV@D#=BM#3-"?3=0GNVUC5+P3 @074RM''DY^4!01CIUZ5KT4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex31articlesofincorporat009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1L=W0X.21P:V-6L/"NGZKXFLM?AM;=8+2)=%CD^4I#Y7_+L/[_F[L[><X]J
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MD<<5%:0:797L]K9Q6L%XGC2+SHHE57$1),>0.=O+8[=<4 >R;AD#(R>@S1N
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M_:?M/\6,Y^_WQCM5:Q\.Z7+X7\+7[VBF\N]?>"XN 2))(C).IC+==A  V]*
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M7-0^P2Z2OVLV_P!JOTM\"'S/-RKG9U&W.W.[GITYH UJ*Y2W^(6CW,]N$@U
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MFE8@G]X(R/*7@ =>YS76V=G=P:OJ5U-=/);7!C\B$ON$6U<-@8&,GMSTSGG
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M:UXGOCKD^F7&FQ0:+(;<QSVS,;N5(U=SD./+7YL#[Q[G/2K\W@.RO+2^CO\
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M;@$9Y!!&"0000<T <-)\0;J+0[3R=0T^]NKO46LX[NVLYV\J-4+EI+<?.)
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MAE D1]NY'!!R#L7I@\=:K0>$=.M](T/3$DN#!HTL<ML2XW,45E&XXY&&/3%
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M8?!-A#>>>+N^9!J9U6.!G4I',0X;;\N=I\QB02>0,8H A^&W_(AV/_76Y_\
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M;QZ1%/:J)!+F%&*;=JMG&-QQ@< \"O1J "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,W4=Z ,[0_$<MI>VT9LK.WTV\UG4+.1XE8%9UD<QL26(^?8^>/O$8QTJI/\
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MF- 37[&.;PUH<NG1MHL$7VN>]B>4W5U*OFOC:R[02V2QW'+=.*IV'B#4M?\
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MQ.J*=B9VJ%15  W-VR<UMT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDN%M9#!'*V,(TH7:#\RCKQD9K4U35;+1;![Z_F\J!"JY"EBS,0%55 )8DD
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M,^M:7BVQU">[\/WVGV37AT_4?/FA21$8H8I(R06('!<'&:Z:B@#SZ7PQJK>
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MLINKA4;:[JP^53D'"D'..2,UJR^*O$<E]XCDL--L[FPT9F41#>;BY;R%D55
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M6X381OR3PV1P,\]*G;QW>S>']&OO-T?2WO4E\Z2^E+J)(VV%(XU*L^2"<YX
M[DUO:'X.L/#]W;364LQ6WT];!$<@Y4.7W$X^\2Q]O:J%OX!33GL)M+UBZM+J
MTAFM_-\J.3?'))YA&&! (;H1^.: ,*S\1S^)-0\(WLRI'*+O4;>40[@CF.*1
M=P#<@'&<'D9KH? MP\7PKT2YSO=-,C?YCG)"9YIVF>!+33'L&6_NYC9W5U=*
MTQ4L[3J0VX@#/WB:UM)T*'2/#%KH44LCP6]L+99&QN*A<9/;- '+:/XO\03+
MX8OM4M=-33]>4*J6^_S8&,+2J22<,"$/&!C(Y-%OXSUPZ/8>)KBTL%T&]GB0
M0*7^T112N$20MG:QRRDJ , ]3BMZ'PG:PV'ART%Q,4T(H82<9DVPM%\WX,3Q
MWJA;^ 8H$M;%M6O9-$M+A;BWTUE38K*VY%+[=S(K<A2>PR2!0 G@&?5K@>(&
MU.YBG":O/''L#97:<$?,3\O3 [<UA6VI^(M*N/&VI6$-C-86.I23R17!?S)@
ML$1=4(.$PHX)!R3T'6NUT70?[%O=4EBO9I;>_N3="WD5<0R-]_:0,D$XX.<8
MK'N_ ?VF?5@FNW\-CJ\QEOK1%CVN"JJ55BNY<A<$@\CTZT 8VI?$N0ZE>PZ9
M-IL,5G%$^V^64O=,\8DVKLX0 ,HR=W)Z<5UK^)[>+P0WBB2"58%L/MIA;AP-
MF[9]>U4KOP:3?7=QI&LWFDK?1I'=16R1L'VKL5EW*2C;0%R/0<9&:VY=(M+C
M0GT:X5YK-[<VSB5RS.A7:<L>22._6@#B-$^(-W=ZK8VMT^FW(OXW8+9)*&M7
M5"X5RW#@@$;AMYQQS4FD>,/$=S:^&=1O[73$LM=*Q)'#YGF0NT3.K$DX93L.
M1@$9')K;T[PI<VEQ;M=^(M2OH+2)HK>"38B@%=N9-@'F$#@%OKC/-20>$;6W
MTGP[IZW,QCT.2.2%CC,A2-HQN_!R>* .-\.:EJCV?AW^T3:WES<ZUJ$4$[F3
M,)47/)^;D94@ ]%..HS5;P_J6H)%X-O]7NQ-B?4Y&=-Q8HJ29W9)R<@X]L5V
M=AX(AL+JTD&I7,L-EJ$U_;0NJ8C,JR!DR!DC,K$9YZ4W3O EM826(>_N+FWL
M9[F2WAE1,*LRD,A( ) W,<GGF@# T3XEW.H7FD23?V?);ZI*L8M+99?/M0XR
MC.Q^5^P; &,\9Q5?5M<U[7]"T?6!%8Q:-=:U9^5&A<3I&+E0KLV=IW8Y4 8W
M=3BNJTSP;+IKV$ U_4I=,T]MUK9$JH4 $*KNH#.J@\ GL,YQ58_#] +:UCUN
M^32;6]2^M[ +'M1UD$FW=MW%,YP">,]>!0!)\1;C4K;0+-],N$@E;4[.-V;=
MR&G08^4C@DC([C([U5G\3>([A-:O-,MM-:ST:1H94GWB2ZDC0-)L(.(QS@9#
M9(YQ71^(M#3Q#I#6+W,MLPEBGCGB +1R1N'4X8$'E1P:QKKP.\QOXX->OK6U
MU/!U"")(\3/M".RDKF,L ,X_#!H T-2\46]CX(D\3)"\L/V-;J*+."^X JN>
MV20*QM6U[Q;X=T34-1U*STJ>.&T\])+8NJQR;@/+8,V6!!)##'3D#(KIKW0]
M/O\ P]+H<T.+"2W^S^6AQM3&!@]B.,'VK"F\#?VC;74&MZYJ&I++:-9QE@D?
ME(Q!+850&?*K\Q].G)R 2>(_%%SHVIW%K#!#(L>BW>I OG)>(H O!Z'<<UE0
M>)/%\VI:58FVT5'U>R>[@;]Z1;!-A97&?WA_>*.-O.?3F^? KW-Q<W.IZ]>W
MUS/ILVF%WCC0+%)MR0JJ!N&WJ>N?85KQ^';>/4](OA-*7TRTDM(UXPZOY>2?
M?]V/S- &)H/C*]U2ZT"VN+6WCDODOUN3&20LEM(L?R9_A))///2L]];N-8\5
MZ 946,6VO7]F!&3\ZQV\H!/O6M_P@J00Z>VGZM=6=Y8SW4L5PJ(^1<.7D1E8
M$$9(QW&T4ZQ\!6=D;0M?7=PUO>W%Z7E*[I7FC9'W$ ?WB>,<T 8=M\0KXZWI
MEO-<:).E[>?9)+2R=Y9;4G=M+2@E&((&1@=>.E5-&U+4_(L3JIMKV27Q9<VT
M+GS 82OVC)'S<@;<*IX"GUP:W[/X??9K?1[5]=OI;+1[B.:RMS'$H&S( <A0
M7X)&>.N>O-6H/!$,%VLG]I7+P1ZLVK0P,J8CD<2;UR!DJ3*3SR,"@"K8^,[N
M\M]$M_LT":I=7DUO?0\[8%@W><P[]0NW/_/1:Q-,^*4U_+I]Y_Q+WLKZZ6%;
M*))3<PQNVU9&;[A[$J , GDXKL;'PG86'BO4?$,;2&XO4"-$Q&R,X4.5'8ML
M3/\ NBJ5AX);3FM;:#7M171[2;SH-/4JH7!R$,@&]HP3]TGT!)'% &CX@UF?
M1'TN?RHVLI[U+6Z=LYB$F51AVQO* Y[-6!+XSU.ZOS9:7:VI>[U.6QL99RVS
M;#'F:5\'Y@&#* ,9QUKJM:TJ#7-%O-+N2RQ7,1C+)]Y#V8>X."/<5D/X+M$T
M/2;"TO+FUN-)8/:WJ;3('P0[,""&W[FW#'.>U '+>(_$7B%[.XTII+2VU2PU
M73EDF@\P1SQ32KL(&[*\@AE).0#SS5N;Q+?Z9?:I%8:?9-?3:];Z>[.[A'9[
M9&\P\G&.!@=AZ\UK2^!(KC3K]+C5;N34KVX@N9-0*H'5X6#1!4QM"KMZ8[G/
M6IQX+MVNFN9;V>29]3AU-VVJ-TD<2QXP!T(7/U- &3+XSUG3CJFFWMK8SZO!
M=6EK:M 7CAE-QPA8$DKMPQ/)SCBM31]8UT^+;C0=9BL&\NQ2[CN+0.H?<Y7!
M5B=N,'N?7V%?Q/X81X-8U&&VN[VYO'M7\JWE6.6$PM\LD188WKDM@\'&.]5/
M!^EZH_B[4==OFU-HGLHK2.34DCCD=@[,=L<8 5 "O49))- &E<ZUKDWCI]#T
MZ&P%G;VL%U<37&\OM=W5E4 XSA,@G@8YSGC!\,>(]4U+2]$TO0+/3K1_[*2^
MG-SYDD<:L[*D:#=N))5N23@#H<UVT.C0P^([O6A*YFN;6*V:,XVA8V=@1WR?
M,/Y"N)O/#DWAE](BTN/7-MKIYL_[0TX0RR2*&R(Y(G7'<E7'0D@T 4TUW7]>
MUKPA>6]O96VHRC589$D9VAB\N5$S@8+GY/4<GM4UYXA\0ZG)X>1)+2UN8?$$
MVGW8C\PQS-''(00-P.P@9VG/.WGBM?P9X.ETW2] N-0::.^T];P^2SA_^/B7
M>0[=V  &1QG-7;CP1#)%FWU*YMKA=6?5HYE5&*2,"I7# @KAB/6@#*L/'.H7
M7BK^S+A]+M6^V/;G3KGS(;KRPQ"RH[?))D -M4=#UXK=\5726MUX<5[9)O.U
M>.)2[,/+)BE.X8(R>,8.1STJK)X)-Q=P"ZUN^N-.M[T7T-G*$8I('WJ/,(W[
M0W(&>G&<<5M:MHT6KRZ;)+*Z&PO%NT"X^9@K+@^WSG\J ..L_&?B*6PT[6;B
MTTQ=+NM3&GM"A?S@&G,(D#9VCYL?+@\=^U=7XGU:;1=%:\@:RC82(AEOIA%#
M$I."S'OC^Z.2>*IQ^#;2/P]9:.+F<Q6E^M\K\;F99S-M/'3)Q]*N>(O#Z>(+
M6U3[5+:SV=TEW;S1JK;)%R!E6!!&&/% '%I\1]0&E:_)&FG:C<:8]GY,UNLD
M4,ZSR;,88D@C!Y!(Z>XK1N_$_B;2YM7L;JTTVZO;73AJ5O\ 91(JN@<AXR&)
M.[ ."#SD<5;?P!%<'5)+S6+VYGU/[*;B1U08-O(73:  %'.,?CUYK6OM/BL]
M8G\2>7=7,R6/V7[+ H8NH??\H.,MSZT 0Z=XC_MCQ%]DT\1RZ?'I\=W+<<YW
M2G,2CM]Q68_5:Q/$?CF6P\2S:+9W.FVC6MNDTLU^DCB1GSM10F,<+DL2>HX-
M7OAWX<;P[X<99H'@N+N=[AH9&#-"GW8HB1_<C5%],@U<U/PQ+<ZQ)JVF:O<Z
M7>3PK!<-%&DBRJI)4E7!PR[C@CUYS0!QO_";1C4X?%<UK+'&GAF>=[7=SO6X
M12H)']X8!QT.:NZ;\1IEOTBU*73[N&2UFN&;3HY0;<QIO*/OX8%0V&&.1TYK
M>?P+ILRB.ZGN[J(Z6^F2">7>TB,P8N6/.[(Z]J?9>%)TG5M4UZ_U2".W>WCM
MYMD:%6&&,@0#S&QQD^_&3F@#-BU7QC=Z*FH/;:7';7MD\Z>4S[[,E-R;R3^\
M]#M"X/J*P-*\3RZ)H^A:EJT,=W/%X6EO3.C.)&53#A#EB"6W#+$=1V&:ZRP\
M%&U:TBN=;O[RQL8FBM+638HC5E*?,R@%R%) S]>3S4-G\/;**SM[2^OKB_@@
MTR72E6547,#E."5 Y C !_&@!G_"0^(=)O\ 3H==M].:/4DE$)L]X,$J1F38
M^XG>"%8;AMY'3FJFB^+O$-PGA>^U.UTU;#7L(L=N7\V%C"TBL23A@0AXP,9'
M)K5M?!C"[M;C4];O=2^Q1/%9K,L:^5O787.U1O?;QD^IXR:LP>$K6#3?#ED+
MB8IH3HT+'&9-L31#=^#D\=Z #Q%K5]97^E:3I45NVH:D\@22YSY421KN=B%P
M6/(  (Z]1BN)\6ZKK.KZ9+H%XE@EU;:Q8VUWL#F&YBE=&0@;@0#R&4D].#S7
M?:[H":R]E<17<UE?V,ADMKJ$*2FX;64JP(92#R/I6:G@>V,#FYO[JYO9M0@U
M"XNW"AI'A*E%P  J *!@>_>@"SK>HOX6\-6<=C:0/<M);V%I ,I$)'8(OJ0@
MZ^N!BN&\07FJV.J^)YM<@L;LP^'XF5(#(D4R^=)U&[<ISD<-V!SS@>D:[HMO
MK^EM8W$DL7SI+%-"0'BD1@R.I.1D$ US]QX &H+JKZGK=[>7&I62V4DA2- B
M*Q8;%48'4^O4T 5[WQAJ]GJWB25K:Q&B^'P&G8[S//FW64*G.T'<V,GL?;FE
MI7Q'F;4+6/49-/N(;F"65A8)*&M2D9DVN7X<$*1N&WD#CFNL_P"$7L9&U\7!
M>:'6R/M,3<  0K%@8YY"Y^IJI8>$YX)X#J&O:AJ5M;PM!#;3;$0JPVDR; /,
M.WC)^N,\T 4+/5O&&H:1;ZD;32TM+^T:9%1G\RSRFZ,N2<2=@=H7!/<5E>%=
M?\17.A>&='M7LI=1N-(2_FO+L2.JQ855! ;+R,2<G('!/M70:=X*^Q/913:U
M?W6GZ>K)9VDFQ1&"I0;F4 OM4D#/ZGFJ]GX"?3K3318Z]>0WFG0-:071BB8F
MW.,1.NW# ;00>#GO0!0/C77KI]/TVRL=/35Y;^YT^Y,S.T*/"F_>N,,5*X..
MO.,]Z:_CC58/$K:7=OH]G+'<QP"UNQ)$]TI"[I(I6.P\EL+@GC!()K=T_P %
M66GW&F7*W5S+<6=Q/=22RE2UQ+,I5V?  '7@# & *AU/P2=5DNH+C6[YM*NK
MA;B:Q<(XW @X1V!9%)4< \<XQF@#1\4:W-HFG6[6D"3WMY=16=LDC%4\QS@%
MB.=H )..>,5Q7C/7_$-OX<\2Z+>M8I?1Z2U[%=VBNJO"24==I8E7!Q@Y(.:[
MW7M$@U_3A:32RP.DJ3P3PD!X94.5=<@C(/J,$9%8D_@6/4+35EU75KJ]O-2M
M/L3W+(B>5#R=J*HP.222<Y- #[RPG\/_  SOK;3EM+.XMK&9T^S(R1H<%B5&
M<@]3G/7FN7TJ7Q+)XET5+2:P:\D\-(\LUP)#&!YHQ\H;+,1@$Y'<^@KTJ^LH
MK_3;FPF+>5<0M"Y4X.U@0<>^#6-H?A0:/>6MW)J,]Y/;6 T]6D1%S&'W*2%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1%MRV'.!DY"]/7CCK5QO!-Q')8WMIK]W'JML9_,NYHUE$PF*LX*' 4 JNT#
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MI]V==RNJO[!T1A[CWH RSXD\27D^HQZ9IVG-_9*HEV)YG'G3F-9'CCP/E #
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M?1LY[5=?Q/>V-Q=6^D:;;O=W?B.33_\ 2)WV;OLX?S#UP/E&57C ..35ZX\
M/+;OIT.NW,&CF\%XEDL*':_FB4KOZ[-V3CJ,]<#%7T\&0)J"7GVN3<NL/JNW
M:,;FA,6SZ8.<T <UJ7Q*NK&]O[1I-"BN-+1%N8KBY=&N9M@=UAXX49P&;.3V
M%:\7BW5M>N9$\,V5F\<%G!=2-?.REVF0ND:A1P=N,L>F1Q5N]\)73:AJ-SI.
MO7.F1ZF0UW''$CDN%";XV/*,5 &>>@.,TMUX0N%OI;O2-<NM/DN;:.VNB46<
MRA 0KY;D2 $C=SGC(XH YY_%6LZ3XA\2ZCJ-NOV2TTVRE73_ #B7260R!4!&
M5R7X9AZ+UQ6I=>*=<T*<V^N65@9)[&XN;5[.1RHDA3>T;AAGIT8>AX%2S_#^
MTGDNHSJ%U]BN].BL;B%L,[^5N\N02'D."Q/?)I[>"[B^D>;6M<GU"9;.:SMF
M\A(A")5VNY"_><@ 9X'7 &: ,>Z\<:]8:/I5_J5KI-C#JG[R.YD>5X;5"@95
ME('WV)P.0O!Y]>Q\/:E-JVB6][<"U$DF[+6DXFB<!B R..H(&?49P>E4[GPY
M=?V?I4&G:S<64NGPB$'8)(YUVA2)(R<'[H(.<CGU-6?#?A^'PWI;6<4K3-)-
M)<2R%0FZ1VW,0J\*/0#I0!S*^-]7.CQ^)VT^S_X1U[@1A1*WVD1&3RQ+TV]<
M';Z=\T>!K6\G\5>*M4U!;=[A+]K194=RRH(XFV '@+R#ZYS5M? .($TLZQ<'
MP^ER+A=.\I,\/Y@C\SKY8;G'7'&<5OZ1HT>D3:I*DS2'4+UKQ@PQL)1%VCV^
M0?G0!YOXGU'753QXKS(\%K<6(MHTE8,N6B(49X ()W>Y]*Z&\\;:CX<EU2/Q
M%9V9-KIW]H1&QD8AAOV>6=PZ[BOS=.>@J]JG@A=2OM8E_M.6*WU7R&F@$2G;
M)$R%6#=>0F"/?-6]9\(6.NZA=7%[)(8[G3FT]XDXPI</O![,"!B@#%\.>/FU
M/Q#:Z3=3Z1<O>0O)&^F3M)Y+( 2CY'<$X8==IXJQXC5]:\;:3X;GFFCTQK.>
M^N8XI#&;DHR(J%E(.T;RQ //&:U-+T'4[74(KO4O$5WJ @B,44/EK"ASC+2!
M?OMQP3@#G YJ37_#JZS+9WEO>S:?J5BS-;7<*JQ4,,,K*PPRG R/8=* ,BXL
M-/\ A];:IKEG+<+IT=F7;2A(61I >'3<3L)R%...0>U))XFU[1[RWM]=L; ?
M;;>:2W:TE<^7+'&9#&^X<Y4'##T/%2CP)%?F_F\0ZE/JMU>6C67F&-85AA)R
M1&J]"2 2Q)/ ]*<G@VYN+F*XUC7)]1>VMY8+7,*1B/S%V,[;?OOMXSP.3QS0
M!E6WB_Q5/8Z!.=+TL2:\Z_98Q/)^YC,+2EI#CJ H.!],]ZGD\;:G!++HTEA:
MOX@&H1V,:I(PMW#Q&42DXW !%;*\G(QGG-&M>&;]$\$Z=I=S<1C2Y=C7J1AC
M&J6SH&93QAC@$?[7;K5MO B2V\DTNJW#:T]ZE\-2$:@K*B;% 3IL"97:<Y!/
M.>: *&I>-]8T6#4K2]TZTFU:S>S:(0RL(KB.XF\H$9&5((8$'/8U/J_B?7-%
M6TM]1G\-V-P\3.\]S=L(Y&W$+'&G#D[<$G&!G S5A_ HNTNYM1U6:ZU"[FM9
M)+GRE0*EO()$C1!T7.<\D_,35O4?"T]QXD;6[#5GL;B6U6UF_P!'27Y%9F!0
MM]QOF/J#QQQ0!S>G^*-8\0^(/!E[;>3;V5_9W4D]N9'(+(R*QXP#C^'/J<U)
MX=\37]]IVCZ5H%A:0W$MG)>2M=S2/'#&)610.K,S,#U/ !]A6KIW@1=*3P^+
M359U;1C.H9XU;SXI7#,C>AX W"FVO@1M+@TYM)UB:TOK*W>U,[0K(LT3/OVL
MA]&Y!!'?KF@"G'XWU>]GTS3K+3+1-3N+F[L[D33,8H)( "6! RRD'(& >0..
M370>%M:N]9L[T7]O##>6-Y)9S"!BT;,N#N7/."&'!JKIO@JVTV[TRZ6\GFGL
MY;F>620#=<2SXWLV, =. !TP*U-'T:/1WU)HYFD^W7KWC;AC:6"C:/;Y: .7
MNO&FLKINI^(+73K-]"TZ>6.17E87$R1,5DD7C:,$-A3U"]1FFZCXQUY)/$L^
MFZ?ITECH6)':>5P]PGD+,0H PI 8\GCIQUJY=> S<1WVGQZS<PZ'?SM/<V"Q
M*22[;I%63JJ,<DCD\G!&:T)/"<$EMXE@%RZKKJE9,*/W.8%A^7UX7- &W:W"
MW=G!<H"%FC60 ]0",U-4-G;BSLH+96+"&-8PQ[X&,U-0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M117)>-[B43:!8-=S6>GW^HB"\GAE,;;?+=E3>,%=SJJY!![9YH ZVBO(]9EN
MK*ZUC0M,U>_6PBU#2DCE%T[R6SS3;98Q(Q+8VA3@DXW>AKT"\6U\+^#;TK<7
MB6UE:RR><9#/,H +9!<DL1VSQT'2@#<K#TKQ=H^LR1I:32_OI7BMVE@>-;@J
M"6,98#<HP>1Q7G^E?:H?%_AVQD%[:P:M:7 G277)+B:Y3RMPD90<1G/1D;N0
M.E4O"VCV,<?PXF:6[4RM=.=U]-MW!"0 -^ ,@<#@\@@Y- 'M-%>*Z-?Z_=:=
MI>OR3)!J%QJ*QS3S:U(5<F7:UO\ 9=FT<94 <@@'/6NT\#63W%]K6KW5]?W%
MPNJWMK%'+=.8HXEF.%"9V\8X.,C..F* .DO]?TS3$OVNKI5-A;?:[E0"S1Q?
M-AL#UV-^5:".LD:NIRK $'VKR;QE96R:UX_G,DPF/AI'53</M.1.#\F<$84<
M8P#DC!)S<OX[SPEJ%D^D7=_<SW6AWLTD5S<O,LLT21M&P5B0IRQ&% &#C% '
MI]%>3>&)=5BU'PO>+<HHU$$W#RZW)=&_4Q%B1$4VHRG!RN  "M=3XL=KKQ3X
M<T:YNY[;3+S[0TWDS-"9I$5=D9=2" 0SM@$9VT =A17DOVZY_M/_ (1X:K>'
MP_\ \) ++[;]J;S-GV;S/(\[.['F_)G.[^'-7KW[+!K=AX;M=>U!]*FU1XKP
M&YDW0L+?>EL)R=V&/.-V?X<CI0!Z917G,5U;Z;XMT/3K#7;RYLDU.Z@F2>=V
M6-OLVX0[V_U@!Y&22"<=JR[J^N-8N;BVAU>\6VF\8BS+VURRGR?LH+1JP/"Y
M!Z=#R.>: /6J*\O>QN;/5_%UQ:WVJ3OH-G$VFVS7DK()/LQ.67=^\)('#9_6
MJWAF358=2\,W2W**NHHQN'EUN2[-\OE%BRQ%,(RM@Y7  R* /6:*\CT"*YM?
M#O@77?[5U.;4+^\B@NFGO)'26-TD^4H3MXVK@XSD9SDUH^'VMKG2].\1:GKU
M_;ZQ/J;0R(MR[(7\UD%KY.2H7&!]W(QNSWH ]+HKQ72+_7[K3M.U^29(-0GU
M)8Y9YM9D*L3-M:V^R[-HXRH Y! ;-=_X\NIH;/2+87<MG:7NIQ6UY<12&-DB
M(8X#CE=S!5R,'YJ .@U34[31M,N-1OY?*M;="\CX)P/H.2?856D\065OX=DU
MVZ%Q:V4432R>?;NDB*.N4(W#ITQ7E_C"UC@M/%>AVUY>7&EVMG:701[R1S;3
MM*RE-Y;<05 ;:Q(!YQ7:_$"VCM/A7KUM&9#''I\BJ9)&D;&WNS$DGW)H Z\'
M(!'0T5Y9K-S/X8N(W\,ZE=ZA)<Z)>74J3737(9HT4Q3@,2%)8D8& <XQQ5B*
MWM["^\*?V9K-_>G6M\5ZKW\DOVB$P,S3#+?(58+ADVXW8]* .WA\1:5<S:='
M!=K*=1$C6K(I*R"/[QSC''Z]JU*\5\,Z/:WMC\/K07-VL4J7SS^5=R!B0J@J
M&#;D' R%([^IKO\ P(\R6NM6+W$\\5CJT]M;F>0R.L8"L%+-DG&X@9).,4 =
M766GB"QD\0R:'%]HDO(4#S%(',<61E0SXV@D<@9KSF_N'E\+^)_$L^L7L&NZ
M??7,=M&EVZI"8W(AA\H'8P<!>JDMOSZ5T'A+3XH_'_BV[/VA9RUL61KF1E!>
M$,PVEB.#TXX' P.* .HO]?TS3$OVNKI5^P6PNKE0"S1Q'=AL#UV-^5:".LD:
MNIRK $'VKR7QE96R:S\0)S),)CX;C=5-P^TY$X/R;L$?*.V <D8).;NH1WGA
M+4+1](N[^YGN=#OII(KFY>=99XDC:-@K$A3EB,* ,'&* /3ZR];U^QT"""2\
M\]FN)?)@AMX&FDD?!;"JH)/"D_A7G7AB758=2\+W:W**-1!-P\NMR71OU,18
MD1%-J,IP<K@ 96NB\:Z;;WWBSP:9FN 3?RH?*N9(^!;RM_"PYR!SUQD="10!
MVP.0#R,^M9,?B?29;N.U2Y)FDO)+%5\MN9HU+LN<=@"<]*\X%U,/!2^*_P"U
MKW_A)#J(C,/VM]F_[1L^S>1G;C;QC;G^+-26S.GB*S>--\B^+-1*KZG[+)@4
M >M45Y+8SO%X7\+^(X-8O9]<U&]MH[F-[MV28R.!-%Y1.U0@+8P 5V?6J<FO
M:M8W5M;/J-UY?A.Y8ZHS2,3/#).J1%_[V("S\]QF@#UZ2]ABOX+)O,\Z='=,
M1L5PN,Y;&!]X8!//..E6*\IM]0U0G2;V:]NU.J:;JNHF(S-A%;RVA &>-J%0
M/0D^M2:5#=:6? FHP:AJ-S>:M;L+Q;B\DD2X)M&E'RL2JX91C '% 'J5%>/6
MEQ%_8_@S5U\07S:SJ>I6RWT9OG(E9B3)&8MVU0AXP ,8P>M=9\1KV_M[;1;2
MS8I#?:BL%PPNC;;EV.P3S0"4W,H&1SVXS0!VM%>4(=<LK#Q T%P4&B3VU]%8
MQ:E)=N@4$S0N[ $JR#(4DX)^E1ZQKFIW^ESZY87DW]G:MK4-A!BZ:!%M$#*6
M5\'R_,E!&\#."OM0!ZW4-W=P6%G/=W4JQ6\$;22R,<!% R2?H*\CU";6=-TK
MQ%8Q7K6*1MIYCAAU22[FM'>X56(D=00K+_"2>A[&K/BO35TU/%FCP7>H/8R>
M&GO3%/>RRD3*SC<&9B1D 9&<''(Q0!ZO'(LL:2(<HX#*?4&G5Y)JUM.LBBQN
MI]0LK328G-K#K<MM<6F=Y,ZDG;+GI\YXV8Z<5W^AS66HI8:M#?73RW.FQ,L,
M\V"8S\PD:,<!R3@L![4 ;E%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYOF)/+$]@. *Q-0\!SW5[KKVVL"VMM:'^DC[&KSKF,1D)*3PI Z%3C)P1F@
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MS;6T$5M<$Q7#7'$?S,H*X.=W!Z<9J>U\"/$YFN=7DN;A]8CU:20P!=SK&$V
M \+QQZ#CGK5C4_!4.I7FJW9OI89[Q[6:%T09MI;<DHPSPW)Y![9% %+5O&.J
M^&=.FEU[3;&*5IH8+2=+S;;2M)G[[, 4";222#QC'I6=_P +0$>G:N0FF:C>
M:?'!,O\ 9E[YL,R22"/&[&58'J#Z@]^->Z\%WNJ12S:IX@FFU 2PRVLT,(CB
MMFB)*E8BS D[F#$GD''&*=<^#K[4]-U"WU77GN);OR0OE6XBAA6-P_RQ[CRQ
M'+%CV]* *C^*/%B:M>Z1_8VE?;;:T6^W_;7\HQ,64)_J\[\H1TQCGVJK=?$Z
M%O[+BM7TFREO--BU%WU:^$$:+)]V-2 2S9!SV &>^*ZM]!5_$5[J_P!H(:YL
M$LC'MX4*SMNSG_IIT]JQ+?P+<:7'ILFCZP+:\M-.BTZ62:T$T<\<?W6*;AM8
M$M@@]\'- %6S\?WNN_V)'H6FVLDVIV]S(S3W1\N!H)%1OF53O4EC@CKP>,U4
MD\4Z[JFH>%C;P6]J[:K=65]!]H;8[PQR@@$+\R_*6&1U"_6NFL/"QL]2TJ^E
MU.XNYK&UGMV>< M,971BQ/;!3  &,'':J1\$/']EEM-5,-S;:M<:FDC0!Q^^
MWAHRN1VD(SGWQ0!;\:7DT6FV6G6\C12ZM?16/F(<,B-EI"#V.Q7 /8D&LC7/
M'S^'M/UE1I8EN]-NX[>&V23'G1-&) X..,()./6,UL^,M/N+O2[6\LXFFNM+
MO(K^.%!EI0A(=![E&<#WQ3+OPC9ZGXMMO$<DKX6U,+VI3"R$APKMGD$++(O3
M^+VH YWQ9XHO+NXABTB$21VFKZ?&DBSE!<22 N8R0.%"M'D\_>Z<5-JGBB]7
M3]8L-9TZ$7>GW%@3]BNW"2)-,H4AL!@00<CH<>AJ]I7P^@TOP[IFDKJ,LK66
MHQW[7#H-TQ0_*I&>/E"KG_9JUJW@N/5;O5;AKUHSJ'V+($>=GV>4R#OSNSCV
M]Z (?^$FUR]N]0ET?1K>[T_3[LVD@>Y*3SLI D,8V[0%)(^9AG:>E<_9^)M=
MT6V\2ZE]B@NM*LM:G65IKIA-L+J"(UVD84'H2,\CCOT4_@Z\%QJ$>GZ]-8Z;
MJ-P;FY@CA_>ASC?Y<NX% V.>"1DX(J2X\%QS^'=<TC[:ZKJMW)<M)Y>3'O8'
M&,\XV]: .IKS'6=4N=-^(>M:OJ,"W%EHVFP2VT,=U(&!D:51A,!2S, IST &
M,UWMFFI#6=2:YE#6#>5]D3:H*G;\_(Y()QUYSGM@G,U/P=::O>:U+=3R>5JE
ME#:,B#!C\MG8.K>N7ST_A[T 4)_%FLZ-<"WUW3+..2XLY[FU:TN6D7?$F]HG
MW*,''(8<'!XK7\+:GJVLZ1%J.IV5K:)=1I-;1PS-(PC9<_/E0 W/09K,;P;>
MZA,9];US[=+%:36MJ8[40K'YJ[6D8!CN?''8=>.:Z32[$:9I%E8"0R"U@2$.
M1C=M4#./PH XW_A.-833[S6YM'M4T6ROY;29A<L9F1)C$957;C ZE2<\'VS?
MN_&<MMX;\3ZJ+)&;1;F6!8_,.)=BH<DXXSN_2L70_!^JZCIE_9:EJ,UOI,^K
MW4\E@]J \B?:6=0)">(VP&/!)R<$ UH:OX NM1AURRM]?>TTS6)#// +57=9
M"J@[7)^Z=H)&,]<$9H DO?%VL1ZQX@AM-+M'L-$B\R>:6X97DS!YH"*%(SG@
MY(X(I+;QGJ5K_95SKVFVUI8:I"SPO!.TCPLL1EVR J!RBMR#P1CGK5S5/#SV
M^F^+[JW=[B?5K9BL*IRK+;^6%'KG'ZU0T/P?>7-EHLGB#4GO(;&TVP6;6PB*
M,\6QC(V3O8*S*.%ZDG)H ?9^,-7\O1M1U+2;:#2=8ECB@,5P7GA,HS$9%*A?
MFX!P>"1UJ+PYX[NM=U=+?[/IJ1F21)K47N+RT"YPTD3 9!QSMSC(ZC)JS9>"
M+J+^RK2]UR2[TK294EL[8VX1R4&(_,D!^<+VP%R0"<TD?@>YDU73KG4M9^W0
M:;.9[8O:J+DG# +)-DEE ;H ,X&<T 8UC\6K6[GLKCS-'^P7MTMM';QZ@&O8
MPS;%D>+&,$X)4'(!SS@BM'3?'5WJ7B5].CM]-41WCVLEI)>;+V-%)'G>6P 9
M3@'"DG!')Z5:TWP7>Z6+2QM]?E31;282PVJ6X67:#D1--GE >,;02!@FDN?
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MN*QIA3\V%)R>!D5R&B^/FTOPQX9TMKO38[Z;2DNYKG6+[R4VYV@ X)=B0WT
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MC;FWFE,TD1C&UW+;BQ'<[N<^M)9Z5;V6I:A?Q ^=?.C2G 'W$"CH.>!U.3^
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MQS75PVNJ>'OA7'9Z98W']J16?E6]LTPF>*1S@9<*H(3=DD #"UV0    P!T
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MMN]/F(!]S7;V%XU];F9K2XM2)'3R[A0K':Q&[@G@XR/8BK5% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ JCJFCZ=K=JMMJ5I'<Q*XD4./NL.C ]
M0>3R/6KU% &/;^%=!M$9+?2;6)6DCE8(F-SQMN1CZD'G/7-7)M)T^YFN99[.
M"5[F$6\Y= WF1@DA&SU'S-Q[FKE% &3I7AC1-$G,^FZ9;VTS(8S(B_,5R#@D
M\XX'Y5K444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^6K[@-@QQQP"1[U=O/A^MY<:G>_;5BU&?[+):720_-:RP)M#=?F!R<KQP2*
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M)VBRL4*.'2!ES\R#Y@>1D,:LZ=X9DT#69?$>H3V"6T6G/;/9Z=I[1QHN]7W
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MM01Y3#@RFZ?=NQGC'Z^U $2?$2[&DZ;>7.B0VLFKE3IT<^H*JNA3>SROMQ&
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MX&S_ !9P,XKI/#^DIH7A^QTN-M_V:%49SU=NK,?<MD_C7,/X%U%M-E\/+J\
M\.2W!F,7V8_:!&9/,,(?=MV[B1G;G!Q[T :FD>);_6/$&H64.C!-/L+E[66]
M>Y&3(JAAMCVY(^89.1C/>NEK(T+16T>35G,XE^WW[W@ 7&P,JC;UY^[U]ZUZ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M >I5GZKKFF:(D;ZE=I;K('92P/(1"[=!V4$_A7GEGJFM:OJ>CZ,^MW4<0O\
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MS"Y,>MZ<XM8Q).5N4(B0]&8YX'UJSIFKZ;K-L;G3+^VO(0VTO!*' /H<=#0
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M/E)S(> >HQS[5CVOPZ^R07=J-2DEMM6LI(-8\S):XG8']^G96^9ACIC;_=H
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M=&NI7L8+6==3L_-57B7:)(SG(R.J]\#D4 =78^(+/4O"Z:_:AVM7MC<!2,,
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M-Q]HNXY5.=T(E41IU=CG;CZ>O$-OXUO7U:+2[O1%MKRZMI9[6,7R2$L@!V2
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M%S)*TBNI^\K*&QW!SVH OWGC9X'T^SBTEQJEW;FY>UN[E+<6Z [3O<Y&2QP
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M_1?&EQ-IVA66EZ5>:E=7NF?;5:ZNU#! P4^8^.3DCD#J>G>MF+PO+'_PB?\
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MK>DKJ@TLZI9#4#TM3.OF^OW,Y_2@"EJO@_0M:O'NKZR+32((Y3'/)$)D'19
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M80Y<)DMG 9B>N>W2F:YXBN['6+31=*TU+_4KB%[C;+<>1''$A52Q;:Q)RP
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MS2S/))*Z,&0L[,6."HQDUN44 8VI^%='U>_%]>6KFY\OR6>.>2+S(\D['",
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M+@11;&7=:'*L>,$OCKW]ZQ_#T%]'>:9IVDK/<1Q6<\"_VAI36]QI/[HA09@
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M/OHO-MIUVNNXJ>N001R"" 01T(JEI/AJQTB\EO8Y+NYO)8Q$;B\N&F<1@Y"
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MVC)+$'G@5>T'6-8UTZ-HZ:D^GB>/4+JXN;:&(2.(KHQHB J5'WLD[23CW)H
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MD1P>=TV[/,.=N=N."<9K6\%VUS:>*O%\%U?-?2K<VW[]U578>0N-P4 9 P.
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M/A[4M6LKFVU(6"[I8K:X5B#G&"1G'XUJV>JZ=J,DT=E?VMR\)VRK#,KF,^C
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M, <'YNE<5/;(/!]_X>;3+AO%TFHR21R"T<LTIN"Z7 EQ@*$P=V> ,>U>Q44
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MT;;:L@N;A)2Q9$(!8JAP6 ]NU2:]9KJ\GB)[:REEL+R71/+7[.RAXQ-\WRD
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M7@&R>P\%V%NXNE \QD2ZA$4B(SL54H"=H (P,Y P#CI72T44 %%%% !1110
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M-O&Z*>^"Q8#W857U/P;K.OKJEYJ5Q80W]U!;VL$5NSM%%'',)22Q +,QS_"
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M[(4\]D3Y<[BJ@J"0./?!KI_">A/H&DR6\L6GPRS3O,T6GVRPPQYP H  +8
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M+(H92D98,_RD'@>PR>*I7?AGQ+Y_B2WL;O3%L=<F+%Y=_FVRM$D;$ ##DA>
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M\L:HTA4,PRJ #T' [4 :":E8O.L"WEN9FD>)4$@W,ZC+*!W('4=JLLP52S'
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M"Q.9)&+,>?4D\5G/X/T9[^XO#!-YD]U%>2(+A_+,T9!5PF< _*N<#G'-;M%
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M^8@ XR?E' X'%6J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUC$4D_S8&T-N .T@':!D?C4VE^$-8TE_"\L;V,KZ8UVETK2.H,<\@;<AV\L
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M$EC:(XE#EF"KM. 3GG(QG-10_$"QGL7DCTS4OMGV]M-2P9$$TDZH'8#YMH4
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M QM"@?**U?$GA35]4U'6;S3;Z*U>\TVWM(F\QU8-',[N"5&55E?;D'(R>.*
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M"P\9R:K(UI=7Z1OIGE1^4EM)/Y2[3MW[P"K9+8)R,8K1M_AU#8>*M&U&RO\
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MX!C+,CH5!' PIR,\'IGK6_X9T>XT6UU"*X>)VN=2N;M/+)("22%E!R!S@\T
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M&>W% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB,CE6#_>W#:,Y.#D\"IYO&6KQWMG>V^J37EM-JL=I)'%II6R$3S>7A9V 9F
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M$*R,\@_A4[P $QT)S4.D:YX@\8:BHLM432;5M&L[_8MNDKB6;S.,MU3Y.>_
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MQ)X0%]X;L?">FZ;"NDO*AN)WG(:!5D5V('+.[_,,YZDDUVB(L:*B*%51@ #
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M%S['J ,\5Z;10!X;9><++4;+PVNF:A=MH<\<5_I-L]K-#C;MCF0$KYC<[>C
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M>7;PQDVD;0*[[SN&XYW< L>#CBNB\9:1=ZYX6N["Q,7VIFBDC$K%5)217P2
M<9VXSCO6=#X?U.7_ (2N>X2WBFUJWC6*-)2XC<6XC8%MHX#9YQR.<#I0!:NO
M&5I'<K;Z?I^H:M+]F2[D%C&I\J)\["Q=EY;!PHRQQTK7LM6L]1T:'5;27S;2
M:'SD<#!*XST/0^QKSZ7X?WMK=Q7:Z7IVK-+IUM;2QW%W)!Y,L2;=RE5.Y",9
M& >..M=GI>EG1?!T6G,MNKP6K!Q;H5CW$$G:"20,D]: ,_2?'MAJQTR0:=J5
MK::IA;*[N8E6.5]I;9PQ93@'&0 <'!/&8;;XC:;<Z>U^FFZJ+5I!!;R&!?\
M2IBQ3RXQNR6R#UP.#SQ6%X0TW7==\*>"X[Z&R@TS3X[:\6>*9FDGV1_NUV;0
M%QD;CDYQQUXTXO!^J6_@S1+.&2U.J:1??;8U=SY4IWR90MC(RDAYP<'L: -+
M_A.["%)Q?V-_87%M+ EQ;W")NC29]B2DJQ4Q[N"5)Q@Y%+X@\4VUG//81SW4
M$]M)9F::&%)%7SI@BQ_,>K '/HIR.<547PO>Z]>ZS?>(8;>V&H:>NFQVMO*9
M?+C!9B[.57+%GXP.,#FJ-OX+UEO"#P:A<6T^N76IVU[>3!CL812QX .,\1Q#
MC'4F@#<B\9VT^I-;0:9J<MJEX;%KZ.)6A68':5(#;P >"VW;[XYJM#XPM[6.
M=&-]J=Y+JEQ9VUK% BR,8R=RKR%V*!]]B/?FL>\\&ZQ/XD:]M[/3[*Y-\L_]
ML6=U)"[P!PQ22 #;(Q7*DDX.<^U3Q^$M:T[4$UBS%I/=V^J7UPMM)*466"X(
MXW[3M<;5/0CJ* -23Q_ID-B)Y;/44N?MRZ>]CY(,\<[*652 V"",8()!R.>N
M%'CVP2SO)+FPU"VO+6XBM7L)8T\YI)<>6%PQ0AL]=V.#G%9:^$=8N]236+PV
MD=Y/K-O?3012,R10Q1-&JABHW-SDG '/M5C5_"NHW=]XBN([?3+R'46M"MK>
MY*2I$"'5C@["<_*P!P1TH Z/1]9_M9;@/I][83V[A)(;N, @D @AE+*PP>H)
MK,U+QM:6%Y?0QZ;J5[%IP'VZXM(E:.WRH;!RP+$*02$#$ U#X*\/W^AG43<*
M+6SG=#:Z<MX]RML "&(=P"-Q.=HX&/>JESHGB/3Y]?MM'AT^XM-9E:=9KF=H
MVM9'C5'RH4[U^4$8(]/>@!L'B#4-7^)<=A:RWL>CPZ?%=*T4<)BN/,+X=F)+
M["% &W!R#GCDV-:\4:C9>+Y='@LY?LXTB:[%PJH0LBD88Y;.T=,8SDCJ.1/X
M?\+3:%KBRK*DEE%HUIIT;$_.6A:3)(Z $,O?UINNZ'JESXHCU&R2VDMY=+GT
M^82RE&C+D,K@!3NY7!&1US0!6\*>.?[3LO#]OJ-CJ$5SJ5HIBO)H46*YE6/>
M^W!R.C$94 @<4:9XXB;2],2&WU36[VYM&NSY,$4<GE!]N]E+JHYX 4D\=*FM
M_#%]%:>"(F:#=H@476&/.+5XODXY^9AUQQ6!_P (+J46@Z)8W6D:5JOV*U:(
MYNGMIH92Y.^.95)VD'!''(SS0!Z##JEM-HRZJ?,BM3!YY\V,HR+C)W*>00.U
M8^F>,[6_599M-U&PM)+5KR*ZNHT\J2)0"6W(S;>"#AL'':K>B:9J5AX1MM-O
M;];K48[8QO<R R O@X)SRP' YY..>M<58_#[499)K=[2ST.SN+&XM;U-/O))
M(KMY$VAUA*A8PI);U[=.: .JTSQG:ZC>64$FG:C9)J"EK&>[B54N<+NP,,2I
MV@L P4D U5TOXB:?JO\ 9DL>F:K#9:FWEVEY/"BQO)M)V<,6!^4@$C!(X-9/
MAWP5>V6J:5)=:+H]JNG@F2[BN))GG<(5!16 $?4DY)]!ZU=L?"&HVWA+P?I;
MO;^?H]U!-<D.=I5%<':<<G+#KB@!NB>/I)]&DNM2TR\%U)J<]E:6L,:%YRKN
M J@.1E50[BQ !!YQBM"7Q]IMM833W5GJ$%Q!=Q6<UDT(:=)),;.%8A@V1@J3
MFN<N? >K3VRI+:V%Q]@UBYOK:.2Y=5NHIVD+(Q"YC8;Q@C<,CTJS:^![X0K*
MMAING.VK6=V8()7D*PPMD[I"/F;EL   9QGO0!N)XZT]+75);^SO]/FTWRC-
M;7$:F1A(<1[-C,&W'@8/7@XI3XXL[>VO)-2T[4M.EM5C?[/<1*SRB1MJ"/8S
M!B6^7&<@]<5GZ]X.U#5=6UJ]MY[>-IX[![,N21YUM*\F' 'W3E1D9ZGCBH]=
M\/\ B3Q=IES#J*:?9)&T$MI9K,TR/+')O)DD"J0K ;< <=>O% '0Z1XDBU._
MFTZ:PO=.OXHA-]FO%0,T9. ZE&92,\'G(/457U7Q=!IFISZ?#IFHZA/;0+<W
M(LT1O)C8L 2&92Q.UN%!/'2L_P *>&9].UNXU.;1M-TQ3;B"..WN'N)&);<Q
M+L  O"X4#MG/:J_C'PM?ZSJK7$.DZ=>9MQ';71NY+2YM),G)WHI+IR#CC!!X
M.: %E\:75IXPU2T6PU'4;./3[6ZA@M($W1!O,WLQ<J<D!/E))X.!UK5?QE;2
MP6,FEZ;J.JF]M1>1K:1J-L1Q@L9&50>?NYSP>*AT#P[J6FZM>W=]=I=M/IEG
M:&<D[Y)8A)O9ACC)<'KZUS<'@C7;:ST2TN8+74[2TTJ*T:T?4)8(HIU)W2$*
MI\P$8'(R,=.: -"^\9S7L^GW6D3O'976C:A=[)(E#"6(QA<Y!P5)8$=/K76>
M'KN:_P##6E7ER^^>>SAED; &YF0$G X')KA]*\!:O8Z7IEK*]EOM-,U*S8QL
M0I:>16C*C' P.?3WKJM"&HZ:VF:'-;1M;VVE1^9<H6.)EPFWD8P0"1SG@Y X
MH L:OX@_LR\ALX-+U#4;N6-I?*M$3Y4! )9G95')X&<GTKD=9\97NK3>&8M!
M358+;4Y9C-+!#!YP\H,&BQ*< AE.[CH.":T_%/A_5=4\0V]REO#J.F+:F+[#
M-?R6R)-NSYC!%.\%<#!Z8XZU3\-^"]3TB+PQ'<-9XTJYOI)O(8A2LQ<IL!'^
MV.#T]Z )=!\?27/AV"\U'3+PW]U?7%K:VL$:;Y]DD@PHWX 54PQ8@94^V;\_
MC_3;;3VN)[+44N4O4L)+'R5,Z3.NY%P&P0PQ@@D'(YZXYN3P%JTEA8QSVFGW
M1TK4;N>"%[IU6[AG=W.2%S&Z[AC[P^7WJ[9^"+Y([:866FV#C68+U[>WD=]L
M,:D8,C#YWY)Z #..U '6W&O6]CX:DUS4(+FS@BA,TL,R#S4 [$*2,_0UF2>-
MK>UT_4+O4=(U6P%E"MPZ3Q(3)&QP"C([*3GJ"P(]*V-<M+B_T.]M+06IGFB9
M$6[CWQ,3V=>ZGH?K7G\?P_U2?3M;LX(+;1+.]T\V\5A%?27,)GW!A+AE C'&
MW"CD$GM0!W6H>(]/TO4C97CO$5LI;]Y2/D2*,J&)/7/S#MZUS>L^.Y/^$9U6
M>UT[4],NQI<][83W<";9-B9R,,V",@[7 ..U0W_A?7_%.HW,VLQ6.GV\^BW.
MFA+:X:9E>1D._)51CY3Q[=>>)M1TOQCKOAZ]TF[33+.-],FM3Y4[2"YF9-JM
MR@,:#DXY//MR :FB>,(M2OK33[C3]0L[BYMC<6\EU$JK<JNW<5PQ((W X8*<
M'I5O6/$L6E:C;Z=%I][J%]/$\ZV]H$W"-2 6)=E'5@,9R?2H9]#NI/$GAW4%
M:+R=.M;B&8%CN+2",+MXY'R']*I>,O#UQK5U9R#1].U6VB1P8IYVMIHG)&'C
MF4$@8!!''8YXQ0!4N?&EROBG2H[2QU&ZL[[2I;A;&.W59O,$D8!;>5V8!8'+
M 9(ZG%:<?C6TN=+L+RPT[4KR6]:1([2*)1*C1DK('+,%7:1CEN3TS5'PUX6U
MC2]6TF\U*]2[:UTJ>TED,C.Y=YD=0"PRP55V[CR<#CFLI_!FNPVUC"5AO;..
M[OIKBP6^DMED\Z8O$Y95^;:"05/'/?% &Y)\0M.CT^VN?[/U-IY[V33Q9K"I
MF6X168H1NQ_#U!(Y'.,D.N/'=K 9RND:M-'9QI)?O%"A%GN4/M?Y\LP4@D(&
MQ6+H/@;5-,ETXRI81);:Y/J)CMW8JL4D#(%7(R2&;'/4#/M46K> KPZSK4]K
MI.EZBFJ2^='/>74D9M7*!6#(H(D7Y=PP0>2/>@#T:">*YMXYX'62*50Z.IR&
M4C((_"I*K:?:+8:9:V:! MO"D0"+M7"@#@<X''2K- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 445S?C'4M4L(M'ATB:"&XOM2CM&DGCWJJ,CDG&1DC:".?:@#I**\
M\N_%&MZ/?7>D7%S#=SV]]IJI=>2$+P7,NQE90<!AM;D=B.*F\6^+-5T>[\0Q
M6)@/V'3;2Y@$B9_>23.C9]L** .]IGFQ^=Y/F)YNW=LW#=MZ9QZ5Q?VCQ._B
M"+PW_;ENMQ'9F^N+Y;$98,Y1(U0L0 -K$DY/3IUK,2#Q'>_$&"/^T["SOQH0
M%S<6\!F1B+A@-BL1C/4YSCD#UH ]*HKS=/&.IWN@:%+)J4%C=7:3^>+6QDNI
MY6C?9F.)0<*2"2QZ9 [YJ"+Q?XEN_#=I<K'<!8]0N;2^N[73C+,BQL0C>1G*
MDX^;KC'3G@ ]/HKS&;QU?RVFAV=IJ"W$]Z;DSW]CILLSJD+  >1C*N=Z[MW"
MX/J*F;Q1XK?0E<6-\GDZ@T$]['I3^<UOLW+*EN^#DL0K=<8) ] #TBF1RQS*
M6BD1P&*DJP."#@CZ@UA^#]7;6M#,\FH6]^\<[Q&:*%H3P> \;<HX!&1^76N&
MT^^UW0/#FNZ_!?6QL+/6KQVL#;Y,L?VE@^7SD-R<8&.!G.: /6*,XZUP=[XK
MU2UDU;1LQ?VR-3AMK E/E:&?YD<COL59<^OEU:^)J73^$HA:W7V=O[1L@S;
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MBCC#+D9P?>N7FM9=/\2^%[V[\)6'A^W6^$7VW3Y4D>1Y$9$B<*J$(Q(R?FY
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M??YSO&^T=P"IQG&1G&:U+GP'I%U<W#/+>K9W4_VBXT]+@BWFDR"69?<@$@$
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M73);?4([VZU"^EOK4V<D]U<;I%A/\"X "\\],D]<UTRJ$15'0# I:* .8MO
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MN2P%>M:8VDQ"72=-6!%TTK&]O$N!!E=RC';@YX]:T H     Z"EH 0 *
M. !2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/,RQ*X+-O& "PXQSSTH ]&HK@M2\4:WX2E237)+2^AN-/N;I4MH3$8984#E
M2QW*1D9.#D>]31:SXETJ[T)]6GL+R#6'\DPV\!B-M*8FD4*Q8[U^0J20#T/M
M0!V]%>:Z'XXU3[8!KEU;P7 MIIKG2I["6VFC*+NQ"[$K,.#DYZ<^U)H'CC6[
M^ZT:>5)+F'4G43VL6C7,0M%=2583L-K@' )Z'.1Q0!Z717G?A_Q=K%UXBM;'
M6+JVLKF>219=,N;&6!E !*^3,25FZ#/J,D8QBN@\1:KJ46LZ1H>E2007.HB:
M1[F>,R"*.(+NPN1EB74#)P.3S0!T,LT<$32S2)'&HRSNP 'U)I4=9$5T8,C#
M*LIR"/45Y/XGN]7UJ&/0=0N+$SV'B"TMIW^R%XKE9 LD;%"_&,_,N2#CJ*Z;
MXBQ75OX&CBL+B*U,=W9QG;#\I7SXU  !&!D@X] 1WR #L@Z,S*K*67A@#R/K
M0'0NR!E+J 2N>1GI7E[2^([#6_'=_IU_8Q_8?(GD$UJS_:'6T0E>'&Q3CW//
MMS<F\2:F;G7+W2-*ADO!IVFSCRX#)+ME:3=D @R;%R548SSZT >C4UI$1U1G
M4,_"@GD_2N6\%^()=:%_'-JEK?&W= NRUDM9X\@Y$L3_ '>0<$<'GTKAO'.M
MV]YXJU&[BGE%WX;CB_LY$AD=9;G<LLP)52!E%2/D_P 34 >R4UG1"H9E4L<+
MDXR?05Q5QXBU;6M>T>S\.WEG;V=]IAU$W%Q;F4[0Z * &7KOP?3FL#0KF_M8
M;'[?+:WYG\6W,"M);D&(CS\NI+'!^7CT!(YZT >K4U'21 Z,K*>A4Y!KC?#N
MJ>)]=M-/U^.?3AIMY,2;!H65XX,D!A+N.9. 2-H!R1QUKDM!\5W>G:!X>T.S
ME:U,EI/=372Z=+>L%$[*JK''TR<Y8\#&.IH ]AIGG1>=Y/F)YN,[-PW8]<5B
M>$-8O=;T/[1J%J\%S'-)"Q:WD@$H4_+(J2?,H88.#TY':O,4B;$>N_V9&+#_
M (2+[1_PD>1]I,1GVX*?>V9_==<;>=M 'ME%5;5+U9[HW4T,D329MUCC*E$P
M.&.3DYR<\<$5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVT$=JYE9XSAU*XRI'.<X'!YQ3_\ A-='_LE;\-<EFN39BT$#?://'6+R^NX
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M:NT5N3C!=@,8.X=,^]+X,T.72AJ5U/IRV#WDRLL37LMU*450H,DCLP+=>%X
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MRK,ZK@>NU16%IGAS6/"MY87NGZ5:W8.EI8W%I;W)00NLC2!D:4DLF9&!R<\
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M@A=F(RY##&X <$]!G R:A^',S2>![&*261[BV:6WG27.Z%UD8&(Y)SL^Z#W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQF56#+PH)7YV(R<Y[TZ[\%:?=?;)!<W<-S<7ZZBEQ$ZA[>98UC!3*XQM7!#
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MQC# Y(R"/EK9OK#7_$^HV%Q=:*=,33K>Y)$ES'(9Y9(C&%383A/F)RV#TXH
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M,[F"X)P>OMT.B6^L77C>_P!;O](;3K673X;:%9)HWD++)(QW;"0/O\<GCWX
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M:@\=.5/!K+M[;7?"FJ:J-/T9M7TW4+IKV/R;B..6"5P-ZL)" 5)&00<C)&*
M)]#\8%[V31=>6*#68;S[&?(5C%,QB,J,N<[=R G!/52,FM"+QAHD]M=3Q7F]
M+;4!ILFV-B?M!95" 8YY8<CCOVKF+CPIKD^CZMK+Q6__  DEU?0:C;VR29CB
M,&T1Q;S@$E P+<#YSVJOHG@34]-\2Z/Y@1M+CMH;R];>,O?QHZ9QU(/F!L],
MH* .EA\?Z!/=10QRW122Y-F+@VD@A$^XKY9DV[0Q(QU[CUJ6Z\;:)9WTUM++
M<%+>407%TEM(UO!(<85Y0-JGD9YXR,XK!7POJH\!0Z7]F7[8NM"[9/,7_5_;
MO.W9SC[G..O;K6-=>"-30ZQIG]E7U]%J%[--'<#69(;3RY7W$2Q+(#D9(PJG
M=@<T =AJOBR.:YU'0]#\^77H$9% M'>**7RPZ!WX4 @\9(SS6SHYU,P7']J&
M/S/M,HAV*%_=;ODS@GG'_P"H=*S?#FD7.FZUXDN)X@L5Y>1R6[;@2Z+!&F3S
MD?,K=:Z*@#G(_'.ARWR6RS7'ER7'V6.[-M(+=YLXV"7&TG((ZX)XSFJ/A+Q'
M?^(M?UPRM)%8V=PUM#;/8O&> IW&1NK<M\F.!@UB0^'O$)\)V?@I]*5(+>YB
MW:K]H3RVACF$@94SO\PA0,$8R2<UUOA?3+O39=>:ZC""[U66YAPP.Z-E0 \=
M.5/!H CU/QOHVDW-U#.;QUL\?:YH+226*VR ?G=00.""?0'FDU+QSHNF7ES:
M2-=S36T:S3K:VDDPBC89#L5! 7'>N2\4^'?$^L_\)):/:7]U]K#KI[PZDMO:
M)&8P )$5@S/G/WE93QR!6_I>@ZC!>^(IIK<(+[3[6&'YU)9TB=6!P>,%A[4
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MWE6Z8!.TL22<!0HR222  .37"ZCI37?Q4CL;:6-].N1%JNH1*V2LMOE$R/\
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M;D>F!G!OO#.J3>%/'=C';J;G5KJ>2T7S%_>*T,:J2<\<J>M=W$"L2*>H4 T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'N=75U#LH(^7!&0>AYH LW'CKP[;Z;:7[7[-#=N\< C@D=W=?O)L"[@P_ND
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/NX^8 G/;CJ:AU?XAW=K?PQPC3+"&6SANK<ZH[QK=LX),:2#Y$(X&3GD],4
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M#.QL$9'O@G\ZFJKIYOC8QG4EMEN^?,%LS-'U.,%@#TQ^.:M4 %%%% !1110
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MJ* *NGV]Q:6,<%U>R7DRYW3R(JL^22,A0!P,#\*M444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7.:_K.IP:YI>AZ.MHMY>QS3M/=JSQQ1Q[0?E4J68EU &1W- '1T5A^&-;FUF
MUO8[N.)+[3[Q[.Y\DDQLZ@$,N>0"K*<'IR.<9K<H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex31articlesofincorporat010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex31articlesofincorporat010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*0D $D@ =2:JOJFGQ[?,O[5-ZAUW3*-RGH1STH MT4PS1#R\RH/-.(\L/G."
M>/7@$_A3Z "BBB@ HHHH ***;)(D,;22NJ(HRS,< ?C0 ZBD9E1&=V"JHR23
M@ 4*P90RD%2,@@\$4 +135D1I&174NF-R@\KGIFG4 %%%% !12$A5+,0 !DD
M]J1'61%=&#(PRK*<@CU% #J*AN+JWM%#7-Q%"I. 9'"@G\:6"Y@ND+V\\<R
MXW1N&'Z4 2T444 %%%% !1110 4444 %%%% !1110 45"UW;)=):O<1+<2 L
MD1<!V ZD#J:FH **** "BFB1#*8@Z^8 &*YY /0X_ TZ@ HJI%JFGS2".*^M
MI)#P%2923^&:MT %%%% !1110 44R*:*92T4B2!6*DHP."#@CZBGT %%,$T;
M2M$LB&10"R!AD ],BHI;^S@F\F:[@CE"&38\@#;1U;![>] %BBJ\6H64\8DA
MNX)$)"ADD!!)Z#(/>IDD24$QNK@$J2IS@CJ/K0 ZBBB@ HHHH **** "BF":
M-I6B61#(H!9 PR >F13Z "BBB@ HHIJ2)(6".K%#M;!SM/H?>@!U%%% !113
M9)$AC:21U1%&69C@ >YH =1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '+^/)W&B6FGHQ1=4O[>PE8'!$;O^\'XH&'XURFIV!N/
MB=K21>$M/UU8].LP$NGC00#,N-N]6ZX[8Z"NY\5:1+K.AO%:E5OH)8[JT9C@
M":-@Z@^Q(P?8FJ5YX0@U35&UK[?J^F7MS!''/':703A<D X!!(W-R#0!Q^G(
M8OA'K?EJUIJ&B75S<K;'D6,T3&98D()R@4@ CJK'@9Q7J-I<"[LH+E05$L:R
M 'MD9KE]1\(QP^$YO#ND1R^5J4^+ZYEF+R%'.9I&9CEF905'NP["NM1%C140
M!548 '84 +1110 4444 <7XF\4ZAH.IZA:((F\[3EETL,O6Y\T1%3ZC=+"?Q
M-<GXC\57_B'P#J4)6)1#H#3:D%7I<F3RP@] #%,<?2O2M7\.:=KE]I=Y>H[3
M:;/]HMRK8^;T/J,A3CU450_X0711I^O62QS+%K<K379#\Y;J%XX&<G'J30!A
MZKJVO:3/J&G:M<V&H1W&AW=ZBBTV+&\04%""QWH=_?GCWI^GZKK^NRRV6C75
MCIJ:=86KD/:^8)998]X7&X;(P,#CGD^E=/JGARPU>[-S=>;YALI['Y&P/+EV
M[^W7Y1@U0NO!&GSNKV]YJ-BYM4M)FM)]GVB)!A0_!Y )^88/)YH Y:,^(V\4
M>*[NRO["RGALK.:9?(,ZR2B%CM4DKA.#SC)R.G?M;/5KS4?!-OK-I:I)?7.G
M+=16^["M(T>X)GTR0*+'PMI>FB]6TB>*.\MXK9XU;Y5CC0HH7TX-68=$LHO#
MD>@E&DL$M!9[';EHPFS!([X[T <)I_C/55LM5^U:C&U];Z5-=_8KS39+2>*9
M%S\H.5DC]2"3TY.:W+[Q5=V#^&Y'"-#>V4]S=*%Y/EP"3Y?3G-6[3P1I\,OF
M7EW?ZD5MGM(A?3!Q%$X =5P!U  ).3QUIFG>!--L+VQNGO-1O7L8WAMEN[C>
ML<;+M* 8&1C')R>!DG% &5!<>*+WPS%JUY?:=)9:AI\DTUHL)C: /$601OD[
MR. <XSR1C&*I>$]0U[2K'P/#=WMI<6&JVJ0"W2W*-!MMC(A#[CN.$P<COQBN
M@MO .E6YA0W.H3VMLCI:6LUQNBM0RE#L&,Y"L0-Q. >*TH_#5A'%H<:^;MT4
M 6F6](C%\W'/RL?QH YCXD+&^K>$5FTDZM&=0ES9!8V\W_1Y.TA"\=>3VK)?
M[3X7N=8\86GA5="L+72C%]BW1*;N<N"C,D)*@+R,]?F->BW^CVNHZAIM[/O\
MW3IFF@VM@;F1D.?7AC4^H6%KJFGW%A>PK-:W$9CEC;HRD8(H X"T\6>(()Y(
MYENKV)[&>9IY=$GLTM9D3<HRXPR-R.><@<\T/K?C"#PQI.JSW"S1ZB$FN)+#
M3#,]C&T>X (&)?)P"V..>.F.BMO!-C$[/<W^IW[?9GM8C=W&_P B-QA@N .2
M /F.3QUJS=>%+*XT_2[6*YO+1]+0):7-O*%E0!-A!R"""!R""* .:M/%>J:N
MFBZ9IVJZ?+=7TET9=1CMGPD<.WCR7(*RG>@()P.3SQ45SXJ\1P3C1%FLCJ<6
MMQ:<]V8#Y;Q26[2J^S=PPXR,X)';/'0?\(+I:VD,<4]]%>0W#W2Z@DW^D&5Q
MAV+$8.X8!!&, <<"IK;P9I=M';?-<RS0W_\ :+7$LNZ2:?84W.<<C:V,# &!
MB@"+PQJ6IRZMKFCZK<0W<NFRQ".YCA\KS$DC#@,N2,@Y&1UXK-N-7\1:I=>(
M9])O+.TMM&F,$<,]N9#<R+&LC;VW#:OS!1CGJ?:NIM-)MK/5=0U&+?Y]^8S-
MELCY%VK@=N*RM2\%:?J5[>7 N]0M%OP%O8;6XV1W.!M^88)!V@ E2"0.: ,?
M0_$>N>*?$,9L[FVLM+2PL;^2)[?S))/.#$Q[MPV\+UP>U:?B_6[C2Y=/M[?4
MX+'[29-Q%I)=7#A0,"*) <\GECTX]>-:PT&PTS4;B]M(S&\\$-N4!^14B#!
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M)X])DU&TN!;^459'5&1U#$$?.I!X[CFNSTI=1L]+>37-0M[B;)E:2*'R4C3
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M:6&&0HY:3=E7.UB,# X!S6]/X&TVXNYG>[U#['-<B[ET\3_Z.\H8-N(QNQN
M;:&QGM27/@/2KJ>XW7%\MC=3_:+C3DGQ;RR9R25QG!(R0" 3U% %%-5\2:[=
MZS<:+>6%K;Z9<_9HK>Z@+?:&5$=S(X.4!WX&!QC)STJA)XCN+.'6S#<:;IK_
M -O?93-]F>5W7R(V)6-!F67M]!GMBN@U+P1INI7=Y,US?P0W^#?6MO/LBNL
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MC*G'M6@6 (!(R>@]:\:;1=.A\':EKZ6J#5XO$DC17G_+2/\ XF&S"MU"D$Y
MX.3ZU2UQ%DU/Q2=6O='MM56]<6;W44C7\<>!Y!MMK D=,!!RV<T >Y9 (&1D
M]*"RJ,L0.W)K@/#FBVE[\0O$.HZC EQJ%FUGY,KK_JF-LNYE'\)/?Z#TJM\1
M(+&3Q%I[WEYHRLMG($M=?B/V24%ADI)G"2C [$X/2@#TFD+!1DD #N:\KT#7
M]/L-:\/ZEJ1&CV4_A]X8?MMP2NY)E^42/@ME<,,\D$5F:))IEQ9>%W\1^4/#
MTAU-@+T;8/M/VD[!*&XSL\S:&[Y[T >KS:U;0:]:Z.ZR>?<6TMRKX&P+&R*<
MG.<_..WK6CUKR>PTGPYKGBSP_;6]G)<Z)'9:BUO%=C=&X$T(!4'.Z+).T'C
M!'05U?P[00>'KRTCR(+35+VW@3.1'&L[A5'L!P* .DO;PV=OYJV\URV]%\N
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M!T>I>)+#3)KZ"8R--96#:A+&B\^4-PX)XR2K<>U:%G=QWUG!<Q9"S1K(%;J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'/7WHVKD':,CH<=*YS3_ !I8:A?VMH;/4;4WD;2VDEU;%$N%4;CM.<@[><,
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MJ#VPM=0>*.Y6TENTMB88YC@;&/7JP!., GDT =)1110 4444 %%%% !1110
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MRH?$%YJ#?/SY4D4BJ?KEAQ7>44 >:Z_I%SI.K76N23VD+MKT%U8I<2E(Y_\
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MA:&2+< <D$%"&[<@CH<U3\*>#[_0-7TV:X>&5(-*F@FDC.!YTEP)2%!YVCD
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M Y[4 8.B>*O$TUAX4UC4I=->TUR5+=[6"W=6B+1NRN'+G/*<C'?&>,UI^/\
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MMU,Z[\8C)\M0I7J2<DXZ4EQ\0=0O+JPM(4?1Y7TZ.]N3-I<]XZ.Y91%LCP5
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MIA\9>#+K4DMUC%Y-'YLQ"J#Y+E!D]]X&/?% '5Z-J]MKNFK?V@D$+221@2
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M( )/0=:JZ9J5KK&EVVI64ADM;F,21.5*[E/0X/(KR/1(;$>-='LK>/14@O\
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MGA>_MK'4_$J3W$<-M-KYAM=[8WRM#&65?4E]_'KFNSH **** "BBB@ HHHH
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M&T#((W<YQC!]*I77C^V:?PZ=.MKBXM]3O);:4_9GWPE$?<I7J'#* 0>P8^]
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MOOB*(Y*E>"KAE&01P 3[U6\/?$*VN;:--56Y69]1FLOM*6CBW5Q.R1H7QC)
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MW9YF,9W?+GIGC.:AN/B!H=K<W,4GVTQVEQ]FNKA+21H;=\@8=P,#DC\P3C-
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M8;MN\(S<E0V.3V.*UK'0(]/\0:GJL-Y<;=1*/-:MM,8D550..-P.U0,9Q[4
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M0:YM'&X@-M89C<Y]\@>U 'HE%%% !1110 4444 %%%% !1110 4444 %%%%
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M5N&::XM1!;&\;[9:R0;H!UD7>HW+R.GJ/6@#8.FV)MGMC96Q@< /$8EVL ,
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MTK0O]>T[3+@6]W.4D-K+=@!&/[J+;O;@=MPXZG- %F;3K&XNH[J:SMY+B/\
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MB 3RV/RC<6R<$X'%>@T4 < T/BB_\-C1&\/16GDZ9-;33RS1N)7\DH@@VMD
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MJUM[0^1JD%I+;W7GJJ^9 P)B;!WJ6Q]X# ]:JR^%M3U*WU:1=%U.WF.C75I
M=4U8W,CRRKC8@\QE"<#+,0<XX%>HT4 <1K/A>^U230($3RH8--N[2XE##]RT
MD*HN!GGD'IZ52MM/\17EQX1L[K0#9Q:-(1=70N8F5L6\D0,0#;BI+ \@$9'!
MY(]$HH \ET3P5JEG;Z/HUUI6HRBPN8VDNY-88V92-]RND0DW;N!A2@ /?%:U
MSX/U2Z^'^HZ6(Q'?-J\U_%'YVSS5%T95&]?NEEQ@]02.F*]$HH \LG\&:CKD
M.JLNFW]C*^GFW@DU?5&NI'?S%DVX#NJQYC )Z\]*Z"T37-6\<:7JMYH$FFVE
MI8W$#M+<1.QD=HC@!&/R_(<'KUR!QGLZ* .*\9:/<WNK6=W#I%]<B.!T6[TJ
M^%M=0L2#@[G56C/H<X(Z5@MX7\21WFE:OJD6HZC<_P!F?8[I-,U 6TR,)&="
M2&17&&PW/5<@&O4Z* /.--\.:MX?ET76(-':>2%+Q+K3XKP2RIY\BN'$DK ,
MV4^;YA]XXS5J2#Q+'KFD^(I= 29XTO();&SFC62))6C:-F+L%9OW?S8/4\9Q
M7>T4 ><Z%X:UN'4]%O+^Q2%H=6U*\G59E<1K,'V8/?E@.!GUQ2W_ (>UN+^T
M+NWTXW+CQ-%J<4"3(K30K%&I(+$ '(;@D=*]%HH \NO_  =K$EPVHBTN7,&N
MW-X+:UO1!-+!+$$W)(& # CH2,C([T__ (12\DTN_N)/#ES*US?0R_9[C5F>
M]\N-"HD67S-JR G@!\;>":].HH Y?P59ZU9VU^NJ/>BV:<&RBU"9)KF./:,B
M1T)!^;..20.IKCO%/ASQ5K5IXCLGL=1N9KF60V+1:A'!9>3QL#(K!F? P0RD
M$]2!7K-% '%GPS?7K^-X95%LFM0I%;S%@3_QZB,D@'(PV:R?#WAK41JNA_;=
M'U*#^S<O+/>:PT\(<1E!Y""0YSD_>5<#(QFO2J* .2\8VNM7%]I36$5]-IR&
M7[9'IT\<-P20/+P[E?E^]D!@>E<SI/A;7]+$>I_V9))-::[-?)9/>B62:"6W
M$>1([<R*2?O$9P><8->IT4 <'=VWB2[U73O$C:'&IL;N4IIJRQBX>%X0A=GW
M>69 W(&[&WC.:IZWHOB#6[G3=<N-*EA^R74^-/L;T071@DC50QE5PID!7. P
M&TXSD5Z110!Y'?:;?:-;Z9?C1YEN[KQ)!*EK=7YGGE58'4%Y&9E#X!P <#"Y
M-:>K:!KNLVWB'5AI36]S>-8"VT^2>/S&2VF\PEF#% S98 ;CT&3S7HD]K;W)
MB,\$<IAD$L9=0VQP" PST/)Y]ZEH \LO_#.KKJFMW(T?5[I=7*W$26VK_9TB
M<Q*C13J) " 5^\H;(X["M.ST;6?"MY>I8:*-1M[ZQMH$\JX55MY(HO+VOYC!
MC'C!R-QZ\5Z!10!A>$-.NM*\#Z-IMY'Y=W;6,4,J;@=KJ@!&1P>:Y/0]!UWP
MU;^&-0_LI[V6TT<Z=>6<,T8DB)9'#(68(W*D'YAVQFO2:* /.])\+ZQ'K^EZ
MM=VB1&35[S4+B%95;[,LD'EHI/\ $>!G;GEC]:U?B:TB>!;EH8TEE6ZLRD;G
M"L?M,6 3Z&NOJ*YM;>\A,-U!'/$65BDBAER""#@^A (]Q0!Y[KGA_6_%[:S=
M/IK:6TFBRZ=;0W,T;/+([!RQ*%@%!0 <YY)P*74;#Q'XBU/[7+H$EA&FAWMF
M$FN8F9IY!'@?*Q&T[>#GL<@<9]&HH XBXT?5=/3PCJ5MIYO)=(M&MKFRCD17
MP\:*2A8A25*#C(R"<&G6^GZ[J'BC0]8O],@M(K=[TM$CJ7B1UC$?F$$AG.UL
ME<@<#W/:T4 >;7.A^);7[2;:WNOLL^NW%U.EC/$ES) T8"%&<@+\PY&0V*IP
M>$]66TUMKK0)[F*ZU*WNHH9=4+7018@A=)M_$JD9P6"X) .,5ZK10!Y5/X5\
M37VF12SC4Y8K'5$NK2SN;]5O3#Y11P9T;&[<Q*Y;H,$\UTW@W1I[+4-5U&XT
MZ\LS=>5'&+^_-U<.J!N7.]E498X )[YKKZ* .%FL]=T74/$D=EHC:G%K$OVB
M"=9XT6)S$L924.P.T;,@J&X/2IO!WA>]\/:O(+@+)!'H]A9)<!A\[Q>8'P.H
M'S+U]?:NTHH XKQKX?O;_6]&UBU@O;J.R2>&:WL;S[-/MDV$,C;E!P4P5+#(
M/M63_P (EJ=YX9N='&EO9IK6H&6\FN+W[3+;PJ%^=F9FS,=@ VY"\'/'/I=%
M 'G5KHFOZ7!X=F_LI+E_#TDUJ(;>2./[7;L@59D!(57P!E6(YW8/2M"&PU[4
MO$^AZO?:7!9PV]Q=N8E=3)%&\2JAD(8AG)!SMR ,#WKM:* /.+S0_$EM]O:T
MM[G[-<Z_)=S)931)<26YA508V<@+\XY&0V <=:HVOA'7#/?R-IUQ''/K6FWD
M:W5\+B7RHF7S"[EC\P"DXR1R N<5ZK10!YSXRT.[DO\ 7M4=[>WMFMM.,$MQ
M*%CDEAN'?8W< Y09(Q\WM69K-KJGC3Q3JFF2V"Z7-+X;EA19)TD8,TR%=Y0D
M!25('.<!CCM7JMQ;PW5O);W$,<T,BE7CD4,K ]00>"*J:7H>DZ)$\>E:;:6*
M2'+BVA6/<?? YH XS0-"OV\1Z??W6C:I;"QAD+2ZCK#7(\QEV[8E$C#:1G+,
M!VXS77Z5?-K_ (<@O'@>T-Y!GR]X8ID=F'!]016G10!YM::)X@F\/:!X5GT?
M[/'I=S;--J7GQF)XX'# QJ&W[FV@8*C&3S74>#-+NM(T*6VO(1%,U]=S8# Y
M5YW=3D>JD5T-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!7OKZWTVPN+Z[E$5O!&9)
M'/90,FLO4O%>GZ6]K!+%>37US%YL=C;6[2SA.Y95SM /&20,\50\>DG3M'@;
M_CWGUFRCG'8IYH(!]BP4?C5.UNK;2?BIK?\ :<\<#:C96K6$DS!0Z1[Q(BD]
MPS D?[0- &Q;^,=(N=(N=2629(K2417<<L+));,2 ?,1L%0 02>F.>E;]<Q#
MJ>A:^GB2&T@1X8X_(O;U$7RYR8SE0X/SE%.#GIG%3^!9[BY\ ^'YKHL9WT^
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M3X,B;BIP&^4>G/WNIS5VZU74/#5G9BTDE<Z_HMO;V*EB1'?*%C7 [ K(&/\
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M\60F,!BQ(WA1N7/(Y[UN>"]7?Q;J=[XDC:5+#R(;2UA+$+NVB29B/4,X3/\
MTS- ':45Y7XRN8K[6]?14>0Z9:Q^9+=ZN]I%:ED+AHDC4EV.1DGN  >*70;4
M^+-7TE-7N[V>%_"UG<R1I=21K),S/EVV$9/7_(& #U.BO(['Q#>>'O#7AOQ7
M?7-S=6S6<]A=AW+%V4LT#'U8F,IGJ=XKNM*M=3T?P(%D=[G6%M9)Y"Y+%KA@
M7(^FXX ] * .BK)7Q+I4CV"Q7'F?;KF6U@95.#)&'+CVQY;\^U>>6#6<.G>#
M=2TW5KFZU?5+B&.]#7CR&Y1T)GWH6P-G)X VE0.*S-'TC3[BR\+6"2S*'\1:
M@MP(KIPX"BYPN=V5RH .,$@GUS0![917CFKW%]I$6JZ+87$BZ9'XBM[9OM%]
M)&(H)+=9"AFPS(AD(&1TW8XS3+UM1M=(\06$.H0VL"W.FJD%AJ4URUH[W"JV
M)'1=H9<':"<8)XW4 >QS2I!!)-(<)&I9B/0#-<E!\2M!EMH+N2'5;:QGVE+V
MXTZ9(,-C:3)MP <CD\<UL_V9:Z/X8N;&S$H@C@E*B69Y6Y!)^9R2>3ZUP?AS
MPUXA\2?#31M,O=;L(=%N=/@#Q06+>>8MJG9YC2$ D<%MOX4 >IT5XSK,VHW>
MI^+)KBXM+:339C':SW&LS6K640C4QND21L&!))R<[CE<<5M6EI)JGB/7KW5-
M2N8YM/TZTFB>"64102M"Y>01C&[D9PP_#F@#TRBO%[#4+[0K:06H,^IW&BW,
MUI=V&IO=0WCH@82212#<KYQ@CNQ6MNQ^P:=J?@^;0-5N+NXU)B+T->/-]IA\
MEF:5PS$ JX7D8QNQ[4 >FT5Y!X?M7L_#?@/74O;]]2O;V&"YEENY'$L;I)E"
MI.W PN..V>N:]?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***JW&I6EI?6=E/-LN+PNMNA
M4_.57<PSC . 3SZ&@"U16/!XJT2YMC<PWZ21"]_L_<J,?](W!=F,9ZGKTQSG
M'-8=EXZ235= TV39=-J<,\AN;6VF$8V.$4 %3W)R2?EQDX#"@#M**XOPA\0]
M-U_3-)%Y.(M2ODQM2WE6%I0"2BR$;2P /R[B>*ZJXU*TM;^TL9IMES>;_(0J
M?GV#+#.,# YY]_2@"U16/;^*M$NK5+F"_22%[W[ K*C',^[;LQC/7OTQSG'-
M87A/XB:=KFGZ8M[.(M1O"4PEO*L)D!/R+(05W8'W=V: .UHKFX?%VGVVF+=:
MA?12O+>3VT*V=O*[2%'9=JQ@%V90OS$#&03TQ5"^^(.GV^IZ$;>=9=-U!+H.
MR6\CS"2+8 BQ@;MV6;*E<\=J .SHJCI.L6.N6"WVG3^= 69,E&1E93@JRL 5
M((Z$ UGIXRT*35%TY;M_.:<VRR&WD$+2C.8Q+MV%L@C ;.1CK0!O45E?\))I
M/]EG4OM8^QBY^RF38W^M\WRMN,9^_P 9Z=^G-5KKQGH-EJ3V$]ZRRQR+%*ZP
M2-%$[8VJ\@78A.1P2.HH WJ*XK3OB)IWVS4K75IQ!);:G)9JT=O*T:J&"IYD
M@!5"2>Y%:_C36KGP[X0U'5K-(GN+9 T:S E"2P'(!![^M &]17%7.M>*/#^I
M:0NLOH]Y::A>I98LX9(I49P<,-SL& QR...:UX_&>@RZF-/2]8RF8VZR>1)Y
M+2CCRQ+MV%L\8W9SQUH WJ*YQ_'GAM+F]@;43OLBZW)%O(5C96V%2VW&[<0
MN<G(P#D5-!XQT*:QOKLWK01V(4W2W4$D#Q!ONY1U#<]N.>U &[17/P^-= EL
M[ZY-Y)"EC&)KE+BVEADCC/1]CJ&*G'4#%3:5XLT;6K][*QNG:X6/S@DD$D6^
M/.-Z%U =<D<KD<B@#:HK*U?Q'IFAR017LTGGSAC%!!!)/(X'4A(U+8&1DXQ5
M*Z\<^&[.PLKV34@T%\'-L8H7D:7:0& 55)R,\C&1SZ&@#HJ*I7^KV.EZ8=1O
M9Q#:@+\[*<DL0% 7&222  !G-9D7C;0)+*_NFO)(([ *;I;FVEA>(,<*2CJ&
MP?7&.* .@HKG(O'7AV6*]E%[(BV4'VF;S;66,^3G'F*&4%D_VER*UWU2R34+
M6P,X-S=1O-"B@G<B[=S9' 'S+U]: +E%9&K^)])T.XBM[V>4W$B&18;>WDGD
MV#@L5C5B%]SQ7/ZSXV+ZWX<T[0KF%XM5#3&[:SEN$\L8 "[,#))())^3&6 R
M* .WHK-U?7M/T,0?;9)?,G8K#%! \TDA R<(@+$ =3CBH[+Q+H^H&P%K>K(;
M]96M@$8%_+(#@Y'RE2<$'!S0!-K>DPZYH]SIT[,BS*-LB?>C<$%7'NK $>XI
M]SI=IJ5C';:O:VE^% +B:!60MCDA6SBJ=SXKT6TM9KF6]^2&Z-DRI$[.TXZQ
MJ@!9C_N@UB:A\0M.@NM%DMI@]A=W4UM=;K>7SHG2(L$$>-X<MM&TJ2<].: -
M_4M"AN_#TVBV92PM9D\IA!&%"Q$_.J@8"DKD9[9S6E%%'!"D,2*D<:A451@*
M!P *I:/K>GZ]9M=:=,9(TD:*0/&T;QN.JLK ,I&1P1WKF+?5O%VL:UKL.ESZ
M)!:Z;>?946ZMI7=_W:/DLL@'\>.G:@#MZ*Y#1_'UC<^&=.U+4P8+J[>6);:U
MCDN&D:)RCF-44LR_+G.. 1FKUSXX\.VFG6E_)J(,%X66W\N&1VD9?O*%52VX
M="I&>OI0!T-%<]_PF_A_[:EK]LE#-(D/F&UE$2R-C:C2;=BL<CY20<G'6G77
MC7P_9:A)93WS+)%(L4T@@D:&)SC"O*%V(>1P2.M &U+;03O$\T,<C1-OC9U!
M*-C&1GH<$\U&=/LFBN(C9VYCN&+3H8EQ*3@$L,<G@=?2L;4?'7AW2KRZM+N^
M=9K1@MR$MI9!!E0P+LJD*I##YB<=>>#B6YUQM+NK^ZU22*/1U6 6DL<;-))(
MY8,H R7/W,;1W/7L :\UG;7#[YK>&1O+:+<Z G8V-R\]C@9'?%5[K1=*OO(^
MV:99W'V?_4^= K^7_NY''X4S2-=T_7(IGL)78P/Y<T<L+Q21M@'#(X##@@\B
MN<U_QI<Z3XLM;&&WADTN#R1JMPV=T!G8I#@YP/F&6R#P1TH Z_[+;AYG\B+=
M, )6V#,@ P WKQQS3HX8HH%@CC1(54(L:J H4#  'ICM7$>*?&]QH_BNVTFV
M&R*.T>\NG;3Y[@R*K* B%.%R&.7.0IQD=CG:;X[U:7PI-JUQ<Z=)='19]4BM
M!8SPE2BH0,LV'0%B"PQNR". 30!W=IH.CV!!L])L;<A_,!AMT3#8(W<#K@D9
M]S4[:?9-8?8&L[<V>W9]G,0\O;Z;<8Q6'%XJMK=K^74[ZUBM[6WM961(WWQM
M*#@'J&W$ *%R?7J*J:M\0]+M/#>L:E9+/-<Z;$'>TGM9H7!;.PLK(&"G!^;&
M.#S0!U%EI]EIEL+:PM+>T@!R(H(Q&H/T Q4-QHFDW=RMS<Z9933JX=99+=68
M,  ""1G. !GV%9MUXTT.Q6#[1/<"26'[1Y26<SR)'TWNBH61<@\L!T-.OO&6
MA:>(#+>/*)X!<I]EMY+C]R>DA\M6VI_M' H T;_2-,U7R_[1TZTO/*.8_M$"
MR;#[;@<58%M LXG$,8F">6) HW!<YVY],]J;#>6UQ8QWL,\;VLD8E28-\I0C
M(;/ICFLC3/&6A:Q>QVEG>.TLRL\!DMY(UG4=3&S*%D Z_*3QS0!HSZ/IEU9?
M8KC3K2:TW%_(D@5DW$DD[2,9R2?QJ5+"SCA@A2T@6*W.Z%%C 6(X(RHQQP2.
M/4UG:%XJT;Q*9?[(NGN4C56:002*A!ST9E )X.0#D=ZQ-9\:7.F^,[?3HK>%
M])A>"'4;AL[H99]PB .<8RJ[L]I%H ZB?2M.N;22TGT^UEMI',CPR0JR,Q.2
MQ4C!)/.:?%IUC L"PV=O&MNI2$)$H$:GJ%P. <#I6;J_BS1M#NC;7UQ*)5B\
MZ18;:6;RH\D;W**=B\'EL=#Z5'J'C30-,D"7%Z[#R5N'>"WDF2.)L[7=D4A%
M.#@L1TS0!?M=!T>Q;=::38VY\SS<Q6Z)\^"-W ZX)&?<TZ338H[5ETZ.VL[E
M86BMYA;@B('G&T8RN<';D9Q5#4_&.A:3.(+F\=I/*$["WMY)_+C/1W,:G8IY
MY.!3M0\7:)IHMO.O&E-S#Y\2VL$EPS1?\],1JQ"<_>/% $OAW1%T'2S;&<W-
MQ+-)<7-P4"F:5V+,V!TY. .P %6K_2=.U5474=/M;Q8SN07$*R!3ZC<#BLE/
M%>G&[NIVU6R.F1:?#>AP&W!'9QO+?=*G:  .<@YZBH+CQ[HZZ;J=Q;FY>YL;
M1KHVLUG-#(Z= 0K("5)P-P! [T ='):6TRQ++;Q.L+!X@R A&'0KZ$>HIIL;
M-EN%-I 1<_Z\&,?O>,?-_>XXY[5@0>.=)_L?3+RZ>=)[ZW\Y;:*SFDEP,;CY
M:J6"@_Q$8/'/-6KCQCH5O:V=P+Q[A+V,RVXM+>2X=T&-S;8U) &0"2.#QUH
MV#;0&6*4PQF2$%8WV#* XR >V<#\JKVVC:79WLM[:Z;9P74N?,GB@57?ZL!D
MU)I]_::I807UC.D]K.H>.1.C"N3\'_$33O$&EZ.+N<1:G?QCY4MY5A:7!+(D
MA&TL #\NXGB@#IQHFDK>O>C3+(7;L&:<6Z;V(Y!+8R2*=8:;;Z<;HVZD&ZN&
MN)2<<NV >@] !^'.3DUE#QOX?.HI9"\DWO<?95E^S2^0TV<>6)=NPMGC&[KQ
MUIY\9:$NJ_V<;MQ-]H^R[_L\GD^=T\OS=NS?GC&[.>.M &A<Z)I5[=?:KK3+
M*>XV%/-EMU9]IZC)&<>U3-86;R-(UI SLZR,QC!)=1A6SZ@#@]JBU35K'1;(
MWFH3^3#N5 =I9F9C@*JJ"6)/0 $UEIXW\/'3KR_DOFMX+)XX[H7-O)"\)<@)
MN1U# $D<XQ^1H U+_1],U0QG4-.M+LQ',9N(%DV'VR#BEOM)T[4XHXM0T^UN
MXXSE$N(5D"GU (.*R8O'/AZ6WO)C>R1+9A&G$]K+$R*[;5?:R@E2?X@,>];!
MU*T754TPS?Z8T)N!$%)_=A@I8G&!R0.>O/H: $GTO3[F2*2>QMI7A5DC:2%6
M**1@@$C@$<$>E9MSX=:\\0Z??3W:?V?IWSVMBD 4++M*;RV>0%8X7 QG/I3]
M6\6:/HET;6\GF,ZQ^<\=O:RSF./)&Y_+5MHX/)QT-,O/&.A645G(]XTHO(?M
M$ MH))V:+C]YA%)"\CDX% &Z0",'D51M-%TJP69;/3+*V$_^N$,"IYG^]@<_
MC61-\0/#$-E97AU/?#?"4VIB@DD,PC8*^U54DX)].F3T&:FE\::!!J+6,EZP
MD258'D^SR&&.0XPC2[=BMR."0>: -V.-(8DBB14C10JHHP% Z #L*A2PLXW1
MTM(%=':16$8!5F^\P]"<G)[YK)U'QEH.E7TMG=WC++#M,[)!(\<&[IYCJI6/
M/7YB..:9J?CCP]H]W/:WE\ZS6ZJ\ZQV\LGE(PR'8JI"KC^(\4 ;$NG6,\%Q!
M+96\D-PVZ>-XE*RG &6&.3P.OH*CAT?2[:$0P:;9Q1!E8(D"JH*\J< =1V]*
MH:?XOT+4[V2TM;[=*D)GR\3QH\0."Z.P"NH)'S*2.:33/&&AZQ=I;6=V[22(
M9(?,MY(EG0=6C9U D ]5)H V([:"))$C@C19&9W54 #,>I/J3WJ"PTC3-*$@
MT[3K2S$AS(+>%8]Y]3M S6/I_CWPWJMS:P6=^\ANP?L\AMI5CE(&XJKE0I8
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MK/&SF0ADX PY)&W&,D=*Z31].?2]-CM9+ZYOI069[BY?<[LQ)/L!SP!P!@4
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ML&O2H*@;_M,GF'/T/ K&USPXVC^3>V0U*2X.J3WHN[*)99+;S5PRF(@^8AP
M<<C@]J -[PQK>HZK<ZQ::I:6]O<Z;=+;GR'++(#&CAAD C._IVK)O/%NMM%K
M>I:9IUE+I>CS212K-*RS7!B&92F!M7'(&<Y([5-X TR_M(];OM0^U[]1O_/C
M-XJI,R"-$W,J\+DJ<+V&*??>")+AM4M[36[FSTO59&DO;1(D8EF $FQSRFX#
MGKU)&,T 96@B?6_BCJ6J3"WEMK:QM7LR7?=$DJR$;5^[DC[WX8K4\5>*;S1=
M16VBN-$LXS")$EU.ZPT[DD;$C7YN,#+>XP#S6QIOA^WTO6;[4('(%U!;P"''
MRQK"&"X/_ OTJA?>$YYO$5UJ]AJ\ME)>P1V]R! DC;4W8,;-]P_,>Q'?% &3
M9>-=8UY]$AT?3[*.74M+.H.UW*VV'#*I'RC+<MCMZ^U6-&\:W-])H?VZRAMX
MM1>ZM9'20D1W4#,-H)QE6$<A'?BKOA_P9!X?GTR6*\EF_L_3GT] Z@;D:17W
M'W&T"L+Q/X6=/"4'ABPBOKBYN]0>YAO8D 6T+3^8[NW\("NX'=NE '6>&M8E
MU[1%U1X%BAGDD-L%/+PAB$<^[ !OQ%<OX<^(%SJ]\%NAI<*!)7N+(3,EY9;0
M3\Z.!OZ8)4<>XKN;6TAL[&&RMT\N"&-8HU4XVJ!@ ?A7+0>!G>_T^75-9GU*
MWTXN;5)X4\T[E9,22_><!6/IG@G- &)H_P 4AJ%YI3R/I36VJ3K"EK;W!:ZM
M]_W&D&,'G 8#&W/?%;>C>(O$.MI::K:Z79OHMU<&-4$Q%PL08KYQSA<<9V#G
M!ZD\5+I?@^\TPV%J/$5\^DZ>P-M9A51BH!"I)(.710>G&<#.:2R\%RV,EO;0
MZY=KHUM<_:H;!452#N+A#(.3&&.=OT!)% $5MXRN)_"V@ZL;2(2:G?Q6CQAC
MA TC)D>_&:Q[[Q1JVH:'JE]>:98_V3;:E]BC5;B59I'2\2,/\N,+CG&>2OH:
MTX/A]) +"U_MZY;3-.OEO;2T\E!M8.7VL_5@,D#IU[X%:#^#('\-W>C?:Y!'
M<:@U\9-HR&-QY^W'ID8^E '*IJVII-K9U18KNWC\46MM BS2*8BQ@ Q@CY1N
M#;>A.[(P:=?_ !72VN-0N(WTK[%873V[6DEPPNYPC;7=!C YSA3U ZC-=%/X
M($U]?2_VG*+:[U&WU(V_E*=DT10G#=<,(U&.U(W@RYBENX+#Q!>V.EW=RUU-
M:PHH=79MSB.7[R*QR2.2,G!% &==>/+R/Q5/I:+I<'E7$<4=K>SM#/=QL%)D
MB8C81\QPO).T],UTOB;6WT+2XYH+<7-W<7$5I;0L^Q6ED8*NYL'"C.3QT%96
MM>")=;:[MKC7+EM)NYEFELY(ED9",9$<C<HIV],'&3C%;6OZ)#K^F?8Y9I8'
M25)X)XL;X948,CC.1P1T/49H XGQ9XC\0VF@^(M(NTLH=131Y;Z"ZM'<(T0R
MK@ \JZDC!R0<CIBM^*SN="^&L\5BEM;74-E)(OELY16P3D$_-GO]:CG\#OJ,
M&K-JVL2WE[J%@VGB=85C6"%LDA4'<DY)).<#IBNEGL8[C2Y+"1F\J2$PL1P<
M%<&@#S31[WQ--KGAP6[6<UY-X:\R1[B63RP/,CPY Y9SP#TZDY[&]-\36&G:
M.K+IUA?WWV@3/>SD00>1(8VP0 6+-]T<<9STKH=!\)-HUW874VI27DMGIQTY
M"T2IF/>K*3CN H'OUJM'X%%G%8R:;JLUKJ%G+<M'<^4KATGD,CQNAZC.,<@C
M:* +W@[Q,OBG2I[C;");:Y>UE:WDWQ.R@$,C$ E2&!YZ<CM7/Z'HEGXTDUC5
M=?$UTZ:E<6EM 9W1+:.)R@"JI&&."Q;KS78:+IDVEV317&HW.H3R2M+)/<'J
MS=E4<(H[*.!6-<>$KV#4KV[T'7Y]*2^D\VY@^SI,ADP 9$#?=8X&>H)YQ0!7
M^UZIH1TKPOIMRFJ:A,L\@N]08XB@C8#Y]O+L-ZIVS@DU2F\<:R/(TZ'3+/\
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MAR=V1UZ8XH MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %<WX_T^[U7P#K=A8PM/=3VK)%&N,LQ[<UTE%
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M(4TO3]5LLZH9;FVFDCGTXPF0L\L;-\R,02P"X(8XQCFO4** /.1X=U,?#PV
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MS!]<5V^F:HNI2ZA&L$L)LKIK9O,Q\Y"JVY<$\$,/?K5^D5%0$*H4$DG QR:
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MB@!  3U)) Z#C.AXP\/:IJ5WXM:SLVD%YH<$$!! \R59)6*C)ZX9>OK7HE%
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MFC0(,)G!7 (P>QQG/- $EWXFU[3(DM+[1K8ZG<WD=I9-%<G[/.65G+$E=RA
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M+'RA-Y[MM0(1G<2>@Q0!;HKF+KQYH2>']4U6SO8KG^SX#*\0RK=#M!!&0&/
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MZ;1N^KFNBU72;+6]/>QU&'SK:0@M'O9<X.>H(-6HHHX(DBB14C10J(HP% X
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M)$MXU93U!"@$5=HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N3\=ZCK&G0:+_ &0(
M=\^JP0R"68Q[@3PF0C?*<<GL.QKK*Q?$^A3:]86T=K>+9W5K=Q7<,KP^:H=#
MD!ER,@\]Q0!QEOXKUS18_%6HOIZ7NEZ?JTOG22WK"18]L>5B3:00H.<$J#G
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M]IXN/+*KM,D/SC8Q'/.[D UNWOANTO\ PBWAR:28VQM5MA+N_> * %;/]X$
M_6@#"O?&.N:/F+5= MTN9[2:YLH[:],@D>)-[0N3&-K;<D$ @X-2?\+#L!XA
M%@83]A.E?VC]MW\9V[_+QCKY?SYS5NR\-:G)K5EJ>O:O#?O81R1VL<%IY"Y<
M!6=\NVYBO'& ,GBL#_A4UM_PCZ:4=4E^74/M/G>5\Q@\OR?L_7[OE?)G\<4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&'&1C'-&C^/="U/PT-<FO;>TMC.\!\R4<,&( ]R0 V!ZT =1166/$>BG1CK
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MK%))NX*[8D0*!E5);CCM6W=>/[BS@E@FT-CK$-_#8O9)<@J6F&8W60J,J?<
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M(V>:;@-VS\N"WO2R^!"_A#0-)2\A-[HGEM!/-;^9%(RH4(>,GE6!/?(X.>*
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MQVXA%S,Q.WA3\J)DX7DY"DDXH G_ .$MU.8Z;9VN@?\ $VOK=[LVEQ=>6MO
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M,.N< ^YZ9JQI7@.XT^6TDFU.*9H-9DU0[+;RP=\)C*!0QV@%LCKP />@!_\
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M +U=HVE@K$89O?!K+\/>.Y[;PMX;L3Y%[JUSIBW<\NHWXMT"9V@ER&+,2#@
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M&.,CC@D]:NQ>$]>T[46O=)UJSB>73[:QE2XLVD7,08>8N''/S' /'K0!F_\
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M8V>G>JNA^$]1L-3L[F]O-,:*SC9$%EIPA>X8C;OD8LV,#/"XY/IQ0!U]%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%<IXYN;V*+0K>RU*33S>ZM%;2S1
M[=WELDA*C((R<#'OB@#JZ*\QU#5]5T74M0TB+5;FXM[74=**3S,&D1)YMLD3
M-CD87//.'Z]*E\9^(-4LK[Q1%87[0FTTNREA P1%*\\BL<>ZA?PH ])JO]NM
M?[1.G^<OVL1>?Y7?9G;N^F>*XK[#?MXLA\,/XBU;[+%I[7[3^:@GGD:39C<%
MX5<9P /O#/%9EII\^L^.;:'_ (2>YG$>AE9;ZPV1/.5N67DX(&".<8R1V'%
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M5F79*>KH0<H?]W'4U-_PBNA?V-_9']F0?8=_F^7@Y\S.=^[[V_/\6<^];%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYG)))!^Z1C% 'IM%>8:WKFKV.LW^H7.HZE!I,-Q']GO-/CAN;2&(!"RW$?\
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M:>75+BQM(])T_4'L[=$VR22^864EE)V$+C (/3D8H ]&HHHH **** "BBB@
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M>GM0!F6G@CP]9+*L5BS"2W:UQ+<2R[(F&&1-S'8I]%QT%:,FAZ;*;$R6B/\
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MOK">XL[:&\WS1VS3"W=A$%9@H)'<=.^>Q-<C/I>H*+/5HH+JRT3^W;J[C3[
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M2$=EYLJ_(^'>+&7VNP)&"1UQQ4O]FI=Z?KM^[ZU<6\UY9R"[@TQ8<21G/G)
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M#ZYKB[O31<3:EI4NF3NS>+;:ZD1K5MCV[&/YMV-K+PV>>.<UZTJJBA54*JC
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M;O #KRL@+$@'[P)]*Z;X;07<7A'S;TL9;J]NKD.T1C+J\SLK[#RNX$$#T(H
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M<PE!&\2E5EC6/"]#]S@<#!%:NAZ%<:5X'L]!:[VW,%D+;[3$/NMMQO7/H>:
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M@.] I(Q#G'((YZ=.]<MHNEZA<^(?#]K!KMY;'_A%T>2YCCB,K R*0@RA4 9
MSMSA1SDDT >KT5Y/#XOU_4;;0-.\V_,\\5W)=W.F6\)GE\B;R5VB3Y%S]YL
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M;")+1(XV61FMQ*YE+*21\^T;2O3-;4,;S?"*!$F>%CHB8DC"DC]R/[P(]NE
M'6(Z2QK)&ZNC ,K*<@@]"#3J\R\-OJU[#H'AV#7;NS@BT""_DN(XX3-(7.U4
M!9"H1 O]W)R,GJ3U7@_4[W5]#N5OIP]W:7EQ8M<Q(%$OEN5$@7H"0!D=,YH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT[:V9GTO4-+/FPEI26GCN4XV@$L"V1CCVKU*PU.VU)KM;9G)M+AK:4.A7#J
M3C/488'(X.:N5%#;0VWF>3&J>8YD? ^\QZD^] 'D^JZ='/-XDTJ33I&DN/$E
MC<,GV9MLELQMP3NQ@KD/D9XP<U/XST*\DU#Q3!HUBZ)<:38LZ6\/$P2XD\Q0
M!@,WE@C;U(('>O5J* /./",*W7C07]M>3W,<6GM#+)'I/V.'EU*HV2"SC!(
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MFWTMVCEW1CR[DVS$E06+C/0$[AP:]HHH \>AT;[;# _EW-[8W7B:VF82:?\
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M$LQ7@9SC/O7/K!XATVW77UL+N>^\,LFC6\7EDFXC"RH9 .X8R0-G_8->XT4
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M"8)5E P%5=G.1MV$<5V'ABP>V\9>*II;<*SR6N)O+VB0^0NX@XY^;K[UU]%
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MVNM3VLE\&C"PH9=B +D,P7*Y('&>^#72^*M'O]6BTN737MENM/OTNU6Y+!'
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M#;9!Y4B%?EY&=_7MUYZ$ K1^.;=6$-[IUU9W,=_%8W,3LC>0THS&Y8'!1C@
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MM7U?Q!:02*+AIU7? G\3*-B9 !W'KP.*N:]HNNR^*[#7=$?3BUO9S6KQWK.
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MBZ=;KJ @%V$ E%NQ*9]B0#CZU:H **** "BBB@ HHHH **** "BBB@ HHHH
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M"0I(P2,\'-<)I/B_Q/J-K8:Y%'JDB75VH:S-G"MHL#2;<+)_K-X7G)."1C%
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MEY3S)! M[+:^7NW+$W[OS Q /'W1D"@#TRBN;\%ZL^JZ3<>=J$UY/;W+PO\
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M7M3+]CU2PCB?>K ,T4D0".@SC')Y!S0!WE%%% !1110 4444 %%%% !1110
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MK/RXDDW)>1SJ=Q;NO3 4')&#GC.#6A!J-C=6SW-O>6\L"9W2QRJRKCKD@X%
M&9;^$=&MK6*!;>1_+O%OC)+,[R23KT=W)RQZ=3C  K(U[PD1!9)I.F07$,-S
M/<R(U[+;3K)*2Q>*9#E>2V5Z$'MBMK4_%.D:9X>O-;-W%<V=JA9S;2*Y)'\(
MYQGVS5Z75-/@CADFOK6-)^(F>90)/]TD\_A0!R6@?#ZUM]$,.I1^3='4)=0B
M-E=2!K5G&W:LO#-\HPQ/WB36H/ F@"QOK3[-/LOI(YKAS=2F1I(R"K[RVX,"
M <@]JW;F]M+)4:[NH8%=MJF60*&/H,]35/P_K,?B#18=2BA:%)'D0(QR1L=D
M_7;F@"I+X.T6>UNH);>5OM,\=R\AG?S!*B*BR*^=RL @Y!'?U-)#X,T6*TE@
M,$TQGN(KF::>X>2662)@R%G8Y(!48&<>W-:T.H65Q=26L-Y;R7$7^LB252Z?
M4 Y%9OASQ/8>(]*LKN*2**>Z@$XM&E4R*I]1U_&@"34?#.D:M/=S7UIYSW=L
MEK-EV&8T8NN,'@AF)!'.<<\4:1X;T_1KB:Y@-S-=3*L;W%W<O/(47)"AG)(4
M$DX'K5W^TK'[=]B^VVWVOKY'FKYG_?.<TX7]FUS]F%W 9\$^4)!NP.#QUXH
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M/+J=]I\EE'<7]W),RJ5.$#.257)R<?CFKNE^"M(T^/)BGEE-J;4&>ZDE$4;
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M Y^7.0.V1WI=>OO#TMG?7&AZ!'/;226<=U>-#(MF,2$@O&F/,\O@M@8PR@G
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M3H0'8&,^I QVK'\-:,Z:IX+>\TUD"1ZDT*W$/SPP^8K6ZMD9!52, \BO5Z*
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M:3 %Y'\1QUZ\5D>'K2WGU711971D>TM)EGM].T4VLD:&(@QS2-)PV[&!@DL
M>!DU['10!Y)X&\JU\1Z+:6*6VH01VLD33'3FM+O3T"@[)R#L<D@+R <\C/-;
M7C^*V77=+O);M;*:.WF2.:]L!=63@E"8V&04<X&",9 (YZ5Z#10!Y7X:TV+5
MM>\,2:CH,-O%!HEUY=LT3&*,B>-5*A^1N3+ 'D!L=JSHRNG:7HMG-96=O;Q:
MGJ8AO-0MI)H+0"9PBB)64$LI.TL<  XZU[+10!XWX:MYQ+IBB*38GB^:1?\
M1&MU\MK1R'$9^XI)R/KZUW?PYCDA\!:;'*C(X\W*L,$?O7[5U-% 'BGAJ'3)
M/#7A'3]+TYX?$4&H0SSG[*R21QAR9G=R/N,F0.<'< .G%:'3[CR)-/O;U8M>
M;5C*8HM%:2\,GG[EE68R %-N#NX 7(]J]THH Y;Q[')+HM@L:,Y&KV#$*,X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !534[$ZE826JWE
MU9E\?O[5PDBX(/!(/7&.G2K=% %33+$Z;I\=HUY=7A3/[^Z</(V23R0 .,XZ
M=!63_9UW_P +&_M/R3]B_LG[/YN1_K/.W;<=>G-=#10!YG!H>M?\(]8^"WTF
M98+:_1WU(R)Y+6T<_FJ1\V[>0%7;MX.3G%=YK&E-J]HD"ZE?V!5P_FV4@1SP
M1M)(/'.?P%:%% $-I;FTLX;<SS3F) GFS,"[X'5B ,DU-110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297312240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jul. 22, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WEST PHARMACEUTICAL SERVICES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-1210010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Herman O. West Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341-1147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">594-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, par value $0.25 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,541,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000105770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292501600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 702.1<span></span>
</td>
<td class="nump">$ 753.8<span></span>
</td>
<td class="nump">$ 1,397.5<span></span>
</td>
<td class="nump">$ 1,470.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">472.1<span></span>
</td>
<td class="nump">462.4<span></span>
</td>
<td class="nump">937.3<span></span>
</td>
<td class="nump">907.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">230.0<span></span>
</td>
<td class="nump">291.4<span></span>
</td>
<td class="nump">460.2<span></span>
</td>
<td class="nump">562.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">17.5<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">83.0<span></span>
</td>
<td class="nump">88.4<span></span>
</td>
<td class="nump">169.7<span></span>
</td>
<td class="nump">174.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other expense (income) (Note 14)</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">126.2<span></span>
</td>
<td class="nump">182.5<span></span>
</td>
<td class="nump">249.0<span></span>
</td>
<td class="nump">337.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense, net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(9.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating (income) expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">128.7<span></span>
</td>
<td class="nump">184.9<span></span>
</td>
<td class="nump">256.1<span></span>
</td>
<td class="nump">342.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">34.8<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="nump">58.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net income of affiliated companies</a></td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 111.3<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="nump">$ 226.6<span></span>
</td>
<td class="nump">$ 295.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="nump">$ 3.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.51<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
<td class="nump">$ 3.06<span></span>
</td>
<td class="nump">$ 3.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">73.7<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">75.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294206112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 111.3<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="nump">$ 226.6<span></span>
</td>
<td class="nump">$ 295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments, net of tax of $0.7, $1.3, $1.7 and $1.5, respectively</a></td>
<td class="num">(21.7)<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
<td class="num">(68.0)<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Defined benefit pension and other postretirement plan adjustments, net of tax of $(0.1), $(0.3), $(0.1), and $(0.5), respectively</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentAfterTaxParent', window );">Net loss on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, $0.0 and $0.0, respectively</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax', window );">Net loss on derivatives, net of tax of $0.3, $(1.0), $(0.4) and $(1.1), respectively</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(73.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 86.7<span></span>
</td>
<td class="nump">$ 140.0<span></span>
</td>
<td class="nump">$ 153.5<span></span>
</td>
<td class="nump">$ 294.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentAfterTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentAfterTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911296905696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent', window );">Defined benefit pension and other postretirement plan adjustments, tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentTaxParent', window );">Net loss on equity affiliate accumulated other comprehensive income, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Net loss on derivatives, tax</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="num">$ (1.0)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (1.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293151632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 446.2<span></span>
</td>
<td class="nump">$ 853.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">479.4<span></span>
</td>
<td class="nump">512.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">419.2<span></span>
</td>
<td class="nump">434.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">138.2<span></span>
</td>
<td class="nump">135.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,483.0<span></span>
</td>
<td class="nump">1,936.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">2,863.6<span></span>
</td>
<td class="nump">2,738.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="nump">1,369.9<span></span>
</td>
<td class="nump">1,324.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,493.7<span></span>
</td>
<td class="nump">1,413.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">110.3<span></span>
</td>
<td class="nump">99.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliated companies</a></td>
<td class="nump">198.2<span></span>
</td>
<td class="nump">210.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="nump">108.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">33.9<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,489.4<span></span>
</td>
<td class="nump">3,829.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_NotesPayableAndOtherDebtCurrent', window );">Notes payable and other current debt</a></td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">211.7<span></span>
</td>
<td class="nump">242.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_AccruedSalariesWagesAndBenefitsCurrent', window );">Accrued salaries, wages and benefits</a></td>
<td class="nump">82.9<span></span>
</td>
<td class="nump">105.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">169.0<span></span>
</td>
<td class="nump">155.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">633.7<span></span>
</td>
<td class="nump">671.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">72.9<span></span>
</td>
<td class="nump">72.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">29.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">84.6<span></span>
</td>
<td class="nump">84.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation benefits</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">18.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">63.1<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">912.6<span></span>
</td>
<td class="nump">948.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 3.0&#160;million shares authorized; 0 shares issued and outstanding</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: 75.3&#160;million and 75.3 million as of June 30,2024 and December 31, 2023, respectively; shares outstanding: 72.6&#160;million and 73.5 million as of June 30, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">120.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,720.9<span></span>
</td>
<td class="nump">3,523.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(216.9)<span></span>
</td>
<td class="num">(143.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost (2.7&#160;million and 1.8 million shares)</a></td>
<td class="num">(979.5)<span></span>
</td>
<td class="num">(637.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Equity</a></td>
<td class="nump">2,576.8<span></span>
</td>
<td class="nump">2,881.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 3,489.4<span></span>
</td>
<td class="nump">$ 3,829.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccruedSalariesWagesAndBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Salaries, Wages, and Benefits, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccruedSalariesWagesAndBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_NotesPayableAndOtherDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Payable and Other Debt, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_NotesPayableAndOtherDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911290666704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">72.6<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293709696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 226.6<span></span>
</td>
<td class="nump">$ 295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">72.7<span></span>
</td>
<td class="nump">64.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of plant</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items, net</a></td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Changes in assets and liabilities</a></td>
<td class="num">(20.5)<span></span>
</td>
<td class="num">(72.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">283.2<span></span>
</td>
<td class="nump">307.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(190.8)<span></span>
</td>
<td class="num">(157.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(191.8)<span></span>
</td>
<td class="num">(164.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings of long-term debt</a></td>
<td class="nump">35.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(36.1)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal repayments on finance leases</a></td>
<td class="num">(22.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividend payments</a></td>
<td class="num">(29.3)<span></span>
</td>
<td class="num">(28.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock-based compensation awards</a></td>
<td class="nump">19.9<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Employee stock purchase plan contributions</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Shares purchased under share repurchase programs</a></td>
<td class="num">(454.1)<span></span>
</td>
<td class="num">(233.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for employee tax withholdings</a></td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(489.3)<span></span>
</td>
<td class="num">(247.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash</a></td>
<td class="num">(9.8)<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(407.7)<span></span>
</td>
<td class="num">(98.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, including cash equivalents at beginning of period</a></td>
<td class="nump">853.9<span></span>
</td>
<td class="nump">894.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, including cash equivalents at end of period</a></td>
<td class="nump">$ 446.2<span></span>
</td>
<td class="nump">$ 796.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295175024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial reporting and U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and six months ended June&#160;30, 2024, should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as &#8220;West&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577024000015/wst-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The results of operations for any interim period are not necessarily indicative of results for the full year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291528432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New Accounting Standards<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendment enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures. The Company does not expect the adoption to have a material impact on the consolidated financial statements and disclosures.</span></div>In December 2023, the FASB issued guidance that seeks to enhance income tax disclosures to provide information to better assess how an entity's operations and related tax risks affect its tax rate and prospects for future cash flows. Within the income tax rate reconciliation, the amendment requires disclosure of additional categories and greater detail about individual reconciling items over a specified threshold. It also requires information pertaining to taxes paid to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions over a specified threshold. This guidance is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures, but we do not expect the adoption to have a material impact on the consolidated financial statements other than the expanded footnote disclosure.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org/250/tableOfContent<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295021056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. </span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company's reassessment of product categories, beginning in the second quarter of 2023 certain product types have been moved from High-Value Product Components to High-Value Product Delivery Devices. No adjustments were made to the product categorization prior to the second quarter of 2023. </span></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - decrease (increase)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. During the six months ended June&#160;30, 2024, $24.2&#160;million of revenue was recognized that was included in deferred income at the beginning of the year. </span></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year are not material as of June&#160;30, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911290051440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2024 and 2023, there were 0.3 million and 0.1 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were 0.3 million and 0.1 million antidilutive shares outstanding during the six months ended June&#160;30, 2024 and 2023, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2024, we purchased 509,336 shares of our common stock under the program at a cost of $187.1 million, or an average price of $367.48 per share. During the six months ended June&#160;30, 2024, we purchased 1,239,015 shares of our common stock under the program at a cost of $454.1 million, or an average price of $366.53 per share. </span></div>During the three months ended June&#160;30, 2023, we purchased 492,710 shares of our common stock under the program at a cost of $173.4 million, or an average price of $351.82 per share. During the six months ended June&#160;30, 2023, we purchased 676,070 shares of our common stock under the program at a cost of $233.5 million, or an average price of $345.33 per share.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294762368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory balances were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294477312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. Lease payments included in the measurement of the lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease - amortization of right-of-use (ROU) assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-427">Other noncurrent assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (current)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-429">Other current liabilities</span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (noncurrent)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-431">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average remaining lease term for operating leases was 8.6 years and 9.8 years, respectively. As of June&#160;30, 2024, the weighted average remaining lease term for finance leases was 7.6 years. As of December&#160;31, 2023, finance leases were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average discount rate for operating leases was 3.96% and 3.55%, respectively. As of June&#160;30, 2024, the weighted average discount rate for finance leases was 4.94%. As of December&#160;31, 2023, finance leases were not material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, finance leases were not material.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. Lease payments included in the measurement of the lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease - amortization of right-of-use (ROU) assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-427">Other noncurrent assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (current)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-429">Other current liabilities</span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (noncurrent)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-431">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average remaining lease term for operating leases was 8.6 years and 9.8 years, respectively. As of June&#160;30, 2024, the weighted average remaining lease term for finance leases was 7.6 years. As of December&#160;31, 2023, finance leases were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average discount rate for operating leases was 3.96% and 3.55%, respectively. As of June&#160;30, 2024, the weighted average discount rate for finance leases was 4.94%. As of December&#160;31, 2023, finance leases were not material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, finance leases were not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294593664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Affiliated Companies</a></td>
<td class="text">Affiliated Companies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024 and December&#160;31, 2023, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $191.0 million and $203.2 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $7.2 million and $6.8 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases from, and royalty payments made to, affiliates totaled $24.9 million and $53.5 million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $39.9 million and $84.1 million, respectively, for the same period in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the payable balance due to affiliates was $20.4 million and $25.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. ("Daikyo") that allows us to purchase and re-sell Daikyo products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to affiliates were $4.0 million and $7.2 million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $2.7 million and $6.0 million, respectively, for the same periods in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the receivable balance due from affiliates was $2.4 million and $1.6 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org/323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294763696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of June&#160;30, 2024.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:69.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (8.50%)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024, the borrowing capacity available under our $500.0&#160;million multi-currency revolving credit facility (the &#8220;Credit Facility&#8221;), including outstanding letters of credit of $2.4 million, was $497.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2024, we had $79.9 million in borrowings under the Term Loan, of which $79.9 million was classified as current. Please refer to Note 9, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8e08f59eae304691ab0e971847e56044_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At June&#160;30, 2024, we were in compliance with all of our debt covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295184816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of both June&#160;30, 2024 and December&#160;31, 2023, the total amount of these forward exchange contracts was Singapore Dollar (&#8220;SGD&#8221;) 601.5 million and $13.4 million. We have also entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany demand notes which were executed at various times throughout 2023 and 2024. As of June&#160;30, 2024, the total amount of these forward exchange contracts was Euro ("EUR") 290.2 million, SGD 98.1 million, $178.3 million, and EUR 23.5 million. As of December&#160;31, 2023, the total amount of these forward exchange contracts was EUR 278.6 million and SGD 94.0 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of June&#160;30, 2024, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SGD</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,750.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we entered into a cross-currency swap for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. As of June&#160;30, 2024, the notional amount of the cross-currency swap is &#165;8.7&#160;billion ($79.9&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded Secured Overnight Financing Rate ("SOFR") plus a margin, in return for paying floating interest rate payments based on Japanese Yen (&#8220;Yen&#8221;) Tokyo Overnight Average Rate ("TONAR") plus a margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we will periodically enter into forward exchange contracts to mitigate our exposure to fluctuating foreign exchange rates on assets and liabilities, other than the intercompany loans and demand notes referenced above, which are denominated in foreign currencies. The Company has elected not to designate these forward contracts in hedging relationships, and any change in the value of the contracts is recognized in income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From November 2017 through June 2024, we purchased several series of call options for a total of 1,079,145 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regard to a portion of our forecasted elastomer purchases. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2024, we had outstanding contracts to purchase 201,801 barrels of crude oil from June 2024 to December 2025, at a weighted-average strike price of $86.26 per barrel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 10, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8e08f59eae304691ab0e971847e56044_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the balance sheet location and fair values of our derivative instruments as of June&#160;30, 2024 and December&#160;31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in earnings the initial value of forward point components for hedges of intercompany loans on a straight-line basis over the life of the fair value hedge. The value of forward point components for hedges of intercompany demand notes is recognized currently in earnings using a market approach. The expense recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2024 was $1.7 million and $3.5 million, respectively. The income recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2023 was $0.2 million and $1.4 million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (&#8220;OCI&#8221;) and earnings, net of tax:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:26.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.227%"></td><td style="width:0.1%"></td></tr><tr style="height:44pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:26.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.227%"></td><td style="width:0.1%"></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our condensed consolidated statements of income for the three and six months ended June&#160;30, 2024 and June&#160;30, 2023. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.473%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency forwards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2024 and 2023, there was no material ineffectiveness related to our hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294476784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities as of June 30, 2024, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of the cross-currency swap, included within other current assets, is valued using a market approach. Please refer to Note 9, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8e08f59eae304691ab0e971847e56044_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of our derivatives. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform (the &#8220;SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration&#8221;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of short-term and long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At June&#160;30, 2024, the estimated fair value of short-term and long-term debt was $203.0 million compared to a carrying amount of $205.8 million. At December&#160;31, 2023, the estimated fair value of short-term and long-term debt was $204.4 million and the carrying amount was $206.8 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293171488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June 30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out from accumulated other comprehensive loss is presented in the following table: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.269%"></td><td style="width:0.1%"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This component is included in the computation of net periodic benefit cost.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291109008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.423%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.431%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,523.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.20 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,624.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.20 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(979.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,720.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.421%"><tr><td style="width:1.0%"></td><td style="width:32.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.768%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.932%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.768%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.19 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,113.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.19 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295044592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At June&#160;30, 2024, there were 1,339,458 shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted 85,263 stock options at a weighted average exercise price of $350.28 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $134.93 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 4.3%; expected life of 6.0 years based on prior experience; stock volatility of 32.0% based on historical data; and a dividend yield of 0.3%. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted 32,876 stock-settled performance share unit (&#8220;PSU&#8221;) awards at a weighted average grant-date fair value of $350.28 per share to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2024, we granted 7,019 stock-settled restricted share unit (&#8220;RSU&#8221;) awards at a weighted average grant-date fair value of $350.65 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. </span></div>Stock-based compensation expense was $4.3 million and $9.3 million for the three and six months ended June&#160;30, 2024, respectively. For the three and six months ended June&#160;30, 2023, stock-based compensation expense was $7.5 million and $16.0 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911392481168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Expense (Income)</a></td>
<td class="text">Other Expense (Income)<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Disposal of Plant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents changes in the fair value of the SmartDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contingent consideration. Please refer to Note 10, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8e08f59eae304691ab0e971847e56044_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan is expected to require restructuring and related charges of approximately $22&#160;million to $24&#160;million, with annualized savings in the range of $22&#160;million to $24&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance<br/>and benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Credits) Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/720/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 610<br> -Publisher FASB<br> -URI https://asc.fasb.org/610/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291110848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $21.9 million and $34.8 million for the three months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 17.0% and 18.8%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for three months ended June&#160;30, 2024 as compared to the same period in 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $38.3 million and $58.4 million for the six months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 15.0% and 17.0%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for six months ended June&#160;30, 2024, as compared to the same period in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to address the change in tax laws enacted pursuant to the Organization for Economic Cooperation and Development (OECD)&#8217;s 15% global minimum tax initiative (Pillar 2). The 2024 forecasted impact of Pillar 2 is not expected to be material to the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911395180576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to commitments and contingencies since December 31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911402578432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summarized financial information for our segments:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net and other nonoperating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During the three and six months ended June&#160;30, 2024, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June&#160;30, 2023, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1&#160;million </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2023 represents the net impact of an</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inventory write down of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.9&#160;million within cost of goods and services sold and a $0.8&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> benefit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within other expense (income) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for revised severance estimates in connection with its 2022 restructuring plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 14, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i8e08f59eae304691ab0e971847e56044_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Expense (Income)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion of certain unallocated items referenced above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295047376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 2, 2024, the Company entered into the Third Amendment to the Credit Facility Agreement, which amended the Existing Credit Facility Agreement. Among other changes to the existing credit agreement, the Third Amendment established an incremental term loan in the stated principal amount of $130.0&#160;million (the &#8220;New Term Loan&#8221;), which was fully drawn at closing and matures on July 2, 2027. The entire stated principal amount of the New Term Loan is due at maturity and there is no scheduled amortization prior to such date. Together with cash on hand, proceeds from the New Term Loan were used to repay an outstanding term loan under the Existing Credit Facility Agreement in the principal amount of $79.9&#160;million and to repay an aggregate principal amount of  $53.0&#160;million of the Company&#8217;s 3.82% Series B Senior Notes due July 5, 2024 issued under that certain Note Purchase Agreement dated as of July 5, 2012.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911392668160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial reporting and U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and six months ended June&#160;30, 2024, should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as &#8220;West&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577024000015/wst-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The results of operations for any interim period are not necessarily indicative of results for the full year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Standards Issued Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendment enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures. The Company does not expect the adoption to have a material impact on the consolidated financial statements and disclosures.</span></div>In December 2023, the FASB issued guidance that seeks to enhance income tax disclosures to provide information to better assess how an entity's operations and related tax risks affect its tax rate and prospects for future cash flows. Within the income tax rate reconciliation, the amendment requires disclosure of additional categories and greater detail about individual reconciling items over a specified threshold. It also requires information pertaining to taxes paid to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions over a specified threshold. This guidance is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures, but we do not expect the adoption to have a material impact on the consolidated financial statements other than the expanded footnote disclosure.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294611456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by market group:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Components</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High-Value Product Delivery Devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Packaging</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the approximate percentage of our net sales by geographic location: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 %</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 %</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 %</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Change in Contract with Customer, Asset and Liability</a></td>
<td class="text"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets and liabilities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in contract assets - increase (decrease) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, December&#160;31, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income, June&#160;30, 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred income - decrease (increase)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294767552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic to Diluted Net Income Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295184816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory balances were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293704032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease - amortization of right-of-use (ROU) assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule Of Assets And Liabilities, Lessee</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.831%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-427">Other noncurrent assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (current)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-429">Other current liabilities</span></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities (noncurrent)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-431">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Lessee, Finance Lease, Liability, Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of finance lease liabilities were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (remaining period as of)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed lease interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297189872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-term Debt Obligations, Net of Current Maturities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of June&#160;30, 2024.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:69.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, due December 31, 2024 (8.50%)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B notes, due July 5, 2024 (3.82%)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C notes, due July 5, 2027 (4.02%) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292555136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Foreign Currency Contracts</a></td>
<td class="text">As of June&#160;30, 2024, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sell</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EUR</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SGD</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,750.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SGD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged item (intercompany loan)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative designated as hedging instrument </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (&#8220;OCI&#8221;) and earnings, net of tax:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:26.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.227%"></td><td style="width:0.1%"></td></tr><tr style="height:44pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:26.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.227%"></td><td style="width:0.1%"></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow Hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Investment Hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our condensed consolidated statements of income for the three and six months ended June&#160;30, 2024 and June&#160;30, 2023. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.473%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income for the </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency forwards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CC<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297189872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity call options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911392632048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June 30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in equity affiliate investment AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit<br/>pension and other <br/>postretirement plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign <br/>currency <br/>translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out from accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out from accumulated other comprehensive loss is presented in the following table: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.269%"></td><td style="width:0.1%"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Location on Statement of Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Detail of components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Losses) gains on derivatives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward treasury locks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This component is included in the computation of net periodic benefit cost.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291249808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.423%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.431%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,523.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.20 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,624.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.20 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(979.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,720.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in shareholders&#8217; equity for the six months ended June&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.421%"><tr><td style="width:1.0%"></td><td style="width:32.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.768%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.932%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.768%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in Excess of Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,987.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.19 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,113.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Activity related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares purchased under share repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared ($0.19 per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911392586272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock', window );">Schedule of Other Expense (Income)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income) consists of:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange transaction losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance<br/>and benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Credits) Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Other Income And Expense, By Component</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295049744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Sales by Significant Product Group</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summarized financial information for our segments:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract-Manufactured Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business segment operating profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate general costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated Items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquisition-related intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of plant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Corporate and Unallocated</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net and other nonoperating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net income of affiliated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) During the three and six months ended June&#160;30, 2024, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June&#160;30, 2023, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#8217;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other charges of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1&#160;million </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2023 represents the net impact of an</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inventory write down of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.9&#160;million within cost of goods and services sold and a $0.8&#160;million</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> benefit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within other expense (income) </span>for revised severance estimates in connection with its 2022 restructuring plan.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291486368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue Recognition (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Biologics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Europe, Middle East, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember', window );">Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember', window );">Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk | High-Value Product Components</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember', window );">Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk | High-Value Product Delivery Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember', window );">Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk | Standard Packaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember', window );">Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_BiologicsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_GenericsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_PharmaCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_StandardPackagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_StandardPackagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_DeliveryDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_DeliveryDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297784640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Contracts and Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerAssetRollForward', window );"><strong>Contract With Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December&#160;31, 2023</a></td>
<td class="nump">$ 21.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, June&#160;30, 2024</a></td>
<td class="nump">22.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Change in contract assets - increase (decrease)</a></td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityRollForward', window );"><strong>Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December&#160;31, 2023</a></td>
<td class="num">(53.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, June&#160;30, 2024</a></td>
<td class="num">(52.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Change in deferred income - decrease (increase)</a></td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291818464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the deferred income balance</a></td>
<td class="nump">$ 24.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911290003888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Summary of Net Income Per Share (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 111.3<span></span>
</td>
<td class="nump">$ 115.3<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="nump">$ 140.0<span></span>
</td>
<td class="nump">$ 226.6<span></span>
</td>
<td class="nump">$ 295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of equity awards, based on the treasury stock method (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares assuming dilution (in shares)</a></td>
<td class="nump">73.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">75.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292749392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive options excluded from computation of diluted net income per share (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase program, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share purchased under share repurchase program (in shares)</a></td>
<td class="nump">509,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239,015<span></span>
</td>
<td class="nump">676,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock purchase program, cost of shares purchased</a></td>
<td class="nump">$ 187.1<span></span>
</td>
<td class="nump">$ 267.0<span></span>
</td>
<td class="nump">$ 173.4<span></span>
</td>
<td class="nump">$ 60.1<span></span>
</td>
<td class="nump">$ 454.1<span></span>
</td>
<td class="nump">$ 233.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Stock repurchase program, average price per share (in dollars per share)</a></td>
<td class="nump">$ 367.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 351.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 366.53<span></span>
</td>
<td class="nump">$ 345.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911401391280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 173.7<span></span>
</td>
<td class="nump">$ 172.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">81.1<span></span>
</td>
<td class="nump">87.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">164.4<span></span>
</td>
<td class="nump">175.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 419.2<span></span>
</td>
<td class="nump">$ 434.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294159792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 11.7<span></span>
</td>
<td class="nump">$ 10.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease - amortization of right-of-use (ROU) assets</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911395005280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Assets And Liabilities, Lessee (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">ROU assets, net</a></td>
<td class="nump">$ 31.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other noncurrent assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Lease liabilities (current)</a></td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Lease liabilities (noncurrent)</a></td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297286464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cash Flow and Supplemental Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 20.3<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new lease liabilities, Operating leases</a></td>
<td class="nump">29.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">34.1<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for new lease liabilities, Finance Leases</a></td>
<td class="nump">$ 24.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 24.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Amounts Included In The Measurement Of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294607504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Weighted Average (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term, operating lease</a></td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term, finance lease</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, operating lease</a></td>
<td class="nump">3.96%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, finance lease</a></td>
<td class="nump">4.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293709136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024 (remaining period as of)</a></td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">19.8<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">42.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Operating leases liabilities payments due</a></td>
<td class="nump">119.9<span></span>
</td>
<td class="nump">118.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed lease interest</a></td>
<td class="num">(15.0)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 104.9<span></span>
</td>
<td class="nump">$ 102.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293154960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Finance Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024 (remaining period as of)</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance leases liabilities payments due</a></td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed lease interest</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 3.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292669056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying amount, equity-method investments</a></td>
<td class="nump">$ 191.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying amount, investments not accounted for under the equity method</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Amount due to affiliates</a></td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">702.1<span></span>
</td>
<td class="nump">$ 753.8<span></span>
</td>
<td class="nump">1,397.5<span></span>
</td>
<td class="nump">$ 1,470.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Amount receivable from affiliates</a></td>
<td class="nump">138.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Amount due to affiliates</a></td>
<td class="nump">20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Amount receivable from affiliates</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=wst_DistributorshipAgreementMember', window );">Distributorship Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party transaction, purchases from related party</a></td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="nump">$ 39.9<span></span>
</td>
<td class="nump">$ 53.5<span></span>
</td>
<td class="nump">$ 84.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=wst_DistributorshipAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=wst_DistributorshipAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291300208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Long-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 05, 2012</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 205.9<span></span>
</td>
<td class="nump">$ 207.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Less: unamortized debt issuance costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">205.8<span></span>
</td>
<td class="nump">206.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 72.9<span></span>
</td>
<td class="nump">72.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (8.50%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 79.9<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">$ 79.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member', window );">Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.82%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member', window );">Series C notes, due July 5, 2027 (4.02%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297114480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 205.9<span></span>
</td>
<td class="nump">$ 207.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">132.9<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, current borrowing capacity</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit Facility, unused commitment level</a></td>
<td class="nump">497.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving Credit Facility, Due 2024 | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">79.9<span></span>
</td>
<td class="nump">$ 81.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 79.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911297358352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">80 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>SGD ($) </div>
<div>$ / bbl </div>
<div>bbl</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>SGD ($) </div>
<div>$ / bbl </div>
<div>bbl</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>EUR (&#8364;) </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>JPY (&#165;) </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>SGD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | EUR | Intercompany Demand Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 278.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | SGD | Intercompany Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | SGD | Intercompany Demand Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 98.1<span></span>
</td>
<td class="nump">98.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | USD | Intercompany Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | USD | Intercompany Demand Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsOneMember', window );">Forward Contracts, One | EUR | Intercompany Demand Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 290.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsTwoMember', window );">Forward Contracts, Two | EUR | Intercompany Demand Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract term</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Purchase | Designated as Hedging Instrument | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Purchase | Designated as Hedging Instrument | Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 5,750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Purchase | Designated as Hedging Instrument | SGD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 41.1<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Sell | Designated as Hedging Instrument | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Sell | Designated as Hedging Instrument | Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Sell | Designated as Hedging Instrument | SGD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">&#8364; 14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract | Net Investment Hedges: | Yen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 8,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract | Net Investment Hedges: | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember', window );">Options Held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume', window );">Derivative, nonmonetary notional amount, volume | bbl</a></td>
<td class="nump">201,801<span></span>
</td>
<td class="nump">1,079,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice', window );">Derivative, average price risk option strike price | $ / bbl</a></td>
<td class="nump">86.26<span></span>
</td>
<td class="nump">86.26<span></span>
</td>
<td class="nump">86.26<span></span>
</td>
<td class="nump">86.26<span></span>
</td>
<td class="nump">86.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average strike price on the group of price risk option contracts such as put options or call options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAveragePriceRiskOptionStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmountVolume">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal volume used to calculate payments on a derivative instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmountVolume</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:volumeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=wst_IntercompanyDemandNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=wst_IntercompanyDemandNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=wst_IntercompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=wst_IntercompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardContractsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294067056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Derivative gain (loss) recognized in income, fair value hedges</a></td>
<td class="num">$ (1.7)<span></span>
</td>
<td class="num">$ (0.9)<span></span>
</td>
<td class="num">$ (3.5)<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, forward point components, gain (loss), recognized in earnings</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(6.5)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges: | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember', window );">Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Derivative gain (loss) on hedged item, fair value hedges</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in unrealized gain (loss) on fair value hedging instruments</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Derivative gain (loss) on amount excluded from effectiveness testing, fair value hedges</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember', window );">Other expense (income) | Fair Value Hedges | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember', window );">Other expense (income) | Net Investment Hedges: | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Fair value and net investment hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net sales | Cash Flow Hedges: | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods and services sold | Cash Flow Hedges: | Foreign currency hedge contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges, amount of gain (loss) recognized in OCI</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -SubTopic 20<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480627/815-20-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292916944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details) - Not Designated as Hedging Instrument - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember', window );">Commodity call options | Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Currency forwards | Other expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CC<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_OtherExpenseIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911290880784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">$ 10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">44.2<span></span>
</td>
<td class="nump">34.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember', window );">Commodity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commodity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">33.8<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commodity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Commodity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Commodity call options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommodityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293647520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Other Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherFinancialInstrumentsAbstract', window );"><strong>Other Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 203.0<span></span>
</td>
<td class="nump">$ 204.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="nump">$ 205.8<span></span>
</td>
<td class="nump">$ 206.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911293046528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,680.6<span></span>
</td>
<td class="nump">$ 2,881.0<span></span>
</td>
<td class="nump">$ 2,776.2<span></span>
</td>
<td class="nump">$ 2,684.9<span></span>
</td>
<td class="nump">$ 2,881.0<span></span>
</td>
<td class="nump">$ 2,684.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74.5)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="num">(73.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">2,576.8<span></span>
</td>
<td class="nump">2,680.6<span></span>
</td>
<td class="nump">2,746.7<span></span>
</td>
<td class="nump">2,776.2<span></span>
</td>
<td class="nump">2,576.8<span></span>
</td>
<td class="nump">2,746.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(6.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(4.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociEquityMethodInvestmentParentMember', window );">Change in equity affiliate investment AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined benefit pension and other postretirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175.4)<span></span>
</td>
<td class="num">(136.0)<span></span>
</td>
<td class="num">(175.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.0)<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified out from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.0)<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(204.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(171.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204.0)<span></span>
</td>
<td class="num">(171.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(192.3)<span></span>
</td>
<td class="num">(143.8)<span></span>
</td>
<td class="num">(168.4)<span></span>
</td>
<td class="num">(183.0)<span></span>
</td>
<td class="num">(143.8)<span></span>
</td>
<td class="num">(183.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (216.9)<span></span>
</td>
<td class="num">$ (192.3)<span></span>
</td>
<td class="num">$ (183.5)<span></span>
</td>
<td class="num">$ (168.4)<span></span>
</td>
<td class="num">$ (216.9)<span></span>
</td>
<td class="num">$ (183.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociEquityMethodInvestmentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociEquityMethodInvestmentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911295365616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 702.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 753.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,397.5<span></span>
</td>
<td class="nump">$ 1,470.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="num">(472.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(462.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(937.3)<span></span>
</td>
<td class="num">(907.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other expense (income)</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(16.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">128.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256.1<span></span>
</td>
<td class="nump">342.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="num">(21.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38.3)<span></span>
</td>
<td class="num">(58.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total reclassifications for the period, net of tax</a></td>
<td class="nump">111.3<span></span>
</td>
<td class="nump">$ 115.3<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
<td class="nump">$ 140.0<span></span>
</td>
<td class="nump">226.6<span></span>
</td>
<td class="nump">295.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total reclassifications for the period, net of tax</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | (Losses) gains on derivatives:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total reclassifications for the period, net of tax</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | (Losses) gains on derivatives: | Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other expense (income)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | (Losses) gains on derivatives: | Forward treasury locks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Loss | Amortization of defined benefit pension and other postretirement plans:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gains</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total reclassifications for the period, net of tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan cost (credit), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292334896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's Equity - Change in Shareholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,680.6<span></span>
</td>
<td class="nump">$ 2,881.0<span></span>
</td>
<td class="nump">$ 2,776.2<span></span>
</td>
<td class="nump">$ 2,684.9<span></span>
</td>
<td class="nump">$ 2,881.0<span></span>
</td>
<td class="nump">$ 2,684.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">111.3<span></span>
</td>
<td class="nump">$ 115.3<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
<td class="nump">140.0<span></span>
</td>
<td class="nump">$ 226.6<span></span>
</td>
<td class="nump">$ 295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share purchased under share repurchase program (in shares)</a></td>
<td class="nump">509,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239,015<span></span>
</td>
<td class="nump">676,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (187.1)<span></span>
</td>
<td class="num">(267.0)<span></span>
</td>
<td class="num">$ (173.4)<span></span>
</td>
<td class="num">(60.1)<span></span>
</td>
<td class="num">$ (454.1)<span></span>
</td>
<td class="num">$ (233.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">(14.1)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="num">(73.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 2,576.8<span></span>
</td>
<td class="nump">$ 2,680.6<span></span>
</td>
<td class="nump">$ 2,746.7<span></span>
</td>
<td class="nump">$ 2,776.2<span></span>
</td>
<td class="nump">$ 2,576.8<span></span>
</td>
<td class="nump">$ 2,746.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares)</a></td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares)</a></td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital in Excess of Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">55.2<span></span>
</td>
<td class="nump">120.2<span></span>
</td>
<td class="nump">181.4<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
<td class="nump">120.2<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="num">(21.7)<span></span>
</td>
<td class="num">(65.0)<span></span>
</td>
<td class="num">(23.2)<span></span>
</td>
<td class="num">(50.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">55.2<span></span>
</td>
<td class="nump">158.2<span></span>
</td>
<td class="nump">181.4<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">158.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (825.2)<span></span>
</td>
<td class="num">$ (637.6)<span></span>
</td>
<td class="num">$ (369.2)<span></span>
</td>
<td class="num">$ (370.9)<span></span>
</td>
<td class="num">$ (637.6)<span></span>
</td>
<td class="num">$ (370.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 79.4<span></span>
</td>
<td class="nump">$ 41.2<span></span>
</td>
<td class="nump">$ 61.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Activity related to stock -based compensation (in shares)</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Share purchased under share repurchase program (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (187.1)<span></span>
</td>
<td class="num">$ (267.0)<span></span>
</td>
<td class="num">$ (173.4)<span></span>
</td>
<td class="num">$ (60.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (979.5)<span></span>
</td>
<td class="num">$ (825.2)<span></span>
</td>
<td class="num">$ (501.4)<span></span>
</td>
<td class="num">$ (369.2)<span></span>
</td>
<td class="num">$ (979.5)<span></span>
</td>
<td class="num">$ (501.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 3,624.1<span></span>
</td>
<td class="nump">$ 3,523.4<span></span>
</td>
<td class="nump">$ 3,113.6<span></span>
</td>
<td class="nump">$ 2,987.8<span></span>
</td>
<td class="nump">$ 3,523.4<span></span>
</td>
<td class="nump">$ 2,987.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">111.3<span></span>
</td>
<td class="nump">115.3<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
<td class="nump">140.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">(14.1)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">3,720.9<span></span>
</td>
<td class="nump">3,624.1<span></span>
</td>
<td class="nump">3,254.6<span></span>
</td>
<td class="nump">3,113.6<span></span>
</td>
<td class="nump">3,720.9<span></span>
</td>
<td class="nump">3,254.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(192.3)<span></span>
</td>
<td class="num">(143.8)<span></span>
</td>
<td class="num">(168.4)<span></span>
</td>
<td class="num">(183.0)<span></span>
</td>
<td class="num">(143.8)<span></span>
</td>
<td class="num">(183.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (216.9)<span></span>
</td>
<td class="num">$ (192.3)<span></span>
</td>
<td class="num">$ (183.5)<span></span>
</td>
<td class="num">$ (168.4)<span></span>
</td>
<td class="num">$ (216.9)<span></span>
</td>
<td class="num">$ (183.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291756720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the 2016 plan (in shares)</a></td>
<td class="nump">1,339,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,339,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options, granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock options, weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Stock options, weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Target award percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Target award percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291765936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Other Expense (Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of plant</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction losses</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and related charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other items</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Total other expense (income)</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292675232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of plant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation', window );">Restructuring plan, implementation period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember', window );">2022 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and related cost, expected cost</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOnFutureEarningsAmount', window );">Effect on future earnings, amount</a></td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringAndRelatedActivitiesPeriodOfImplementation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Activities, Period of Implementation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringAndRelatedActivitiesPeriodOfImplementation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291043120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Income) - Schedule of Restructuring Reserve (Details) - 2022 Restructuring Plan<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2023</a></td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringChargesCredits', window );">(Credits) Charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, June 30, 2024</a></td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2023</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringChargesCredits', window );">(Credits) Charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, June 30, 2024</a></td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember', window );">Other charges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wst_RestructuringChargesCredits', window );">(Credits) Charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, June 30, 2024</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RestructuringChargesCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring (Charges) Credits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RestructuringChargesCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_The2022RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911294192624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="nump">$ 34.8<span></span>
</td>
<td class="nump">$ 38.3<span></span>
</td>
<td class="nump">$ 58.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.80%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291251328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911291270048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Sales by Product Group (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 702.1<span></span>
</td>
<td class="nump">$ 753.8<span></span>
</td>
<td class="nump">$ 1,397.5<span></span>
</td>
<td class="nump">$ 1,470.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">559.7<span></span>
</td>
<td class="nump">618.0<span></span>
</td>
<td class="nump">1,119.2<span></span>
</td>
<td class="nump">1,201.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 142.4<span></span>
</td>
<td class="nump">$ 135.8<span></span>
</td>
<td class="nump">$ 278.3<span></span>
</td>
<td class="nump">$ 269.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911292589168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">$ 126.2<span></span>
</td>
<td class="nump">$ 182.5<span></span>
</td>
<td class="nump">$ 249.0<span></span>
</td>
<td class="nump">$ 337.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of plant</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest (income) expense, net and other nonoperating (income) expense, net</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes and equity in net income of affiliated companies</a></td>
<td class="nump">128.7<span></span>
</td>
<td class="nump">184.9<span></span>
</td>
<td class="nump">256.1<span></span>
</td>
<td class="nump">342.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">148.2<span></span>
</td>
<td class="nump">209.1<span></span>
</td>
<td class="nump">291.6<span></span>
</td>
<td class="nump">397.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Proprietary Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">131.0<span></span>
</td>
<td class="nump">194.2<span></span>
</td>
<td class="nump">257.3<span></span>
</td>
<td class="nump">364.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Contract-Manufactured Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">17.2<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="nump">32.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="num">(22.0)<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
<td class="num">(42.6)<span></span>
</td>
<td class="num">(59.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Corporate general costs</a></td>
<td class="num">(17.5)<span></span>
</td>
<td class="num">(16.6)<span></span>
</td>
<td class="num">(32.9)<span></span>
</td>
<td class="num">(31.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of plant</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and severance related charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Unallocated | 2022 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Benefit within other expense (income) for revised severance estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_A2022RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_A2022RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139911296419424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 02, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jul. 05, 2012</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,100,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan, due December 31, 2024 (8.50%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member', window );">Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.82%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Term Loan, Due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Term Loan, due December 31, 2024 (8.50%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">79,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Series B notes, due July 5, 2024 (3.82%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'9(QJB92OT#JGX?T*:5",A'NT2/;<"%U>&8I*5)=I3C&J)IX@P)O<![>G(F
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M-<&P5R4 OJ\H%2\-.4#UKXGQ?U!+ P04    " !:@?E8_<#LVHP#   Y"P
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MC?$83W%9XO\ VR" ^]P8WV^"@>$?QO(?4$L#!!0    ( %J!^5CIE[M8"P8
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MF./"R\8;X/]*:[>?^ 4.5^C%7U!+ P04    " !:@?E8%JPMD:("  "W!0
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M5H5H+$K?^I<CT92R]D?"6*$^SW6#FO0"_0#Z0*!-08P>I2IT#7ORF:P?%1-
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M'*IP5[+ABV28>-/P5\ 'XW%@Y^%,29PPB0#OI\;X;D(*EI^%K_\$4$L#!!0
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M%X*G70*K >$H@Q>#6+09I />;28\I2 XIY.?4"B>($<X>6!6!Q7+R /HCO@
MEUN9/T4EX"Z!]Z"WM\6G'$1^JBW[?*SI[,D?R9A[ZLTQ >0),>6$I"8;+0W!
M:7QG'QREA$\(!N]5(W0P4%T'AE4=&%)-(HL,68E#5N*BR89@G-,U1Q9M,>P=
MX.\N&[FQ3;CZAF\>)_[[Y\R#!N?!C;\P7P8^[/O/SI=-A-^5+Q2#"\U&WZ<A
M]2G/R94]RA)$*OXB87YFKI!\C^?)GN^/.CO^<\#1&D&*9^7) 3>5^VS<9^?)
MX\378?BAP.6CG6JZ\*<%/WW&H-&U.J/1Z^7FCN[Q7^#6C2+/;X%HR5*G\9>,
M6<U/!)N;A=MYI34-&<]7_>A)\]%3T*))J^72M)Q\W\J>4)%"MCU(C]7\H?\_
MQ?1T3O1PJOK_:(NKYH1SZ3RK\6RG[VMY\#MFO?[&0;/^L:9J\RW[T+.BILE?
M?6N:##OU"9OK2(N(]/Q[LKG^)=$HGAH*^MD6L>=?$%B>@Q?.-BG=?)STUKW?
MLKWPQM)$F3&_ET4O0L#5_N6E^F[]ZM>)?^.I6>[?&WO//Q)8D:L12%$>=UO"
M^'>Q_!>GI_S^TZUV3D_X,E42T4X+\'RD,7567VB#^H6XX_\"4$L#!!0    (
M %J!^5@D#M129@<  )H5   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;*U8:8_;.!+]*X2G,4B C@_9[?3T!?2QP68QV0DF<WQ8[ =:HMO<4*1"4NWN
M?[^OBI(L.W;GF/EBZR@67SV^*A9UL7;^8U@I%<5C:6RX'*QBK,Y&HY"O5"G#
MT%7*XLW2^5)&W/K[4:B\D@4/*LTH&X_GHU)J.[BZX&?O_=6%JZ/15KWW(M1E
M*?W3C3)N?3F8#-H'O^K[5:0'HZN+2MZK#RK^7KWWN!MU7@I=*ANTL\*KY>7@
M>G)V,R-[-OA#JW7H70N*9.'<1[IY6UP.Q@1(&95'\B#Q]Z!NE3'D"# ^-3X'
MW90TL'_=>G_#L2.6A0SJUID_=1%7EX/3@2C44M8F_NK6_U1-/"?D+W<F\*]8
M)]OI;"#R.D17-H.!H-0V_<O'AH?>@-/Q@0%9,R!CW&DB1GDGH[RZ\&XM/%G#
M&UUPJ#P:X+2E1?D0/=YJC(M7;Z3VX@]I:B7>*1EJK\!X#!>C".=D,LH;1S?)
M47; T5R\<S:N@OB'+52Q/7X$4!VRK$5VDSWK\%^U'8KI^%ADXVSVC+]I%^F4
M_4V_'.F=#KEQ%&P0_[E>A.@ACO_NBSFYG.UW20ES%BJ9J\L!,B(H_Z &5S_^
M,)F/SY\!/.L SY[S_BU+\UV.!#]_X.<ZD)0QKA RB+A2HO(Z5[B2$7E5FT(L
M%)(P5\BA0D0GD%A&2*15""@=SHM*:GX!,FU8*B^D,%HNM-'Q2;R I7K4,;E]
M*;1M)[&YKJ0A!Z4+4<CB0=J(<N#J )W[CW".TL/6W50;O_ #S\X7RING-+5,
MZ;Y0<:V4;7U4TD=-4U'@+LU>;L@0A8QJ*'[#TZ4SJ%3:WHOEAI^55E[Z?/4D
M<@,8>JE5HDG;JH9'Q$V&DJ>.*E]9_:F&21T26\U4?9?:XKFS2K@E/'FEA%$/
MRH0S\>,/IUDV/Q<_T[V8B#/QNY7%_U ,X.Q3[>B/>0P</]>U)L[ 9.D"(>D<
MM#)EH<\9@ ]W9L@PP]L4AT-,1#9(W9Z(A2 1@5N0SN7"J&?6Y5@HS9X*#<U$
M+ VALNT=$QV(@MS4A=J9BMP&76HC_7[\>Z*6=I>9;1Z^QF7KJPO5NMC,L\O8
ME->D1T4K QJ*;87V'*;&J\I!>! 3(8E/Y&;R^AS3KSEUZK(BR81=Z47R&@17
M%1LW+*=(^\#!*,D?>1O[ZJ(-C][5WI,_;%P:RKJ11EJD-6QOZ EI[U!U>''$
MI&AC".!+@7JLN!ZWLFS%TU)RS0#/Q)U"]GL@REV)WB&DI&C@'XG)>#C;_#$A
MV7GO"ILMME(K"+JR.3(.^PH5Z"!>8TAKUK^^]2Z$5]V L):5R$Z&KSN#K9M;
M5Y:NH.H!94 ::07$N&="UT=B-AMF&Z33Z?"T!_/GS1J<P:6E1::E MH W?D4
M-89MC>I?T9O]7/77%[//TT\[\BN(FLQZP6S='(GLI^$D136GOQF'2EC^BCCN
ML#.4"R3\=/)W""3;_'V30$Z&X\ZL?[U/()/3GH*V;@X*9-X3R+R_DK,^XFR&
MF;]'*/.#0IE_G5!FZ><;A)(!<9<DO6L$,^^+/^.;PT#:XN2[HEZ@D8TKB"1M
M*=;9-'WL%S*RYWI58*>D.B7;_5I6E7<R7W'+75 Y:\I[NY]O]K^=S: II;U2
MN!2N]K0A'&#A^ #F#C"0'HCBF-JE-;="X> HX^S]JZA\N;5>DA.LJZK4Y1Y3
M'[;-AR5LKE2'"4%<:^F++C[UF&/[OL?>@Y8FT1PJ[&3-[>Z^U&M\MB@CJ_SS
MM/DB5PTMGP6RN[!#\=Z@HA 4:A;1"_T;X8B?CJ$PKQ\DK^@;;5&2-#;PMQ9=
M>IV*SS%O[LO:-RU&P#F)#XG-2A>=@W!(#/G>%/]+0OB*B ^P?*@F]-JI!DX?
MR%Y5'8-.(V-J.LGY!X"(=PX\XUSR>G:>FE-GW/V3J&!)QWKQ@BRYPQF??S;@
M$#RVGYR_%&M)>8CIP>03R"=,?))H>4#XBR:25VL^)N/ECJR/.29-_4S#(I2J
M2._;4DT'!>JDO4*';:FWU$N1:Y_798BT@>$HH_/(LK[E3 CM<6.7>]KC%D;?
M-S7,JUXW%5J$F% ]4J53VZ)H'[Y(=GRF2=+" =@&KI V.*,+7H] B))^,7<:
MLT\1Q1<+/5#OUH"F&C:"JBT?A[CK+"OCGI0*3>.)B9$5D8\\W:>1T'*_7_U[
MA384O_#+_1GZI\+YRVCL^ZDE9IE+[QF3+%W=T,!\R;!B 'R!147N&O;".T2>
M)^MT]N1FFS7SJ$N2 SR#O0V%6'SPF,2/9U9)G[##NO8-=&(=++"'8H?_L(+:
MTI#M+"O4(N[C?GM#HLK46(8ZJ9'([$X?Y"I%M@'4TM\=+5E^;??4K,6.?KL#
MZ5!<Q]U=)'YW?)3+1]EXB@ZF:>Y8A]*GBB)W5Y$\POX$[6-CSWBVVD%@FOX-
MF&9H1%I,9+5'4ZWIO =GWX>84>][6:G\/7\5!/_D(WTZZYYV'QZOT_>VC7GZ
M:OE.^GN-##)JB:$X-YP,A$]? M--=!5_?5NX&%W)ERLED:!D@/=+!Q4U-S1!
M]SGVZO]02P,$%     @ 6H'Y6-X4=4HM!0  5PX  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&ULU5=;;]LV%/XK!VI0V$ @ZV([3IH8<-(.R]"N19-M
M#\,>:(FRB%*B2U)QNE^_<TA)EI=+MW7 ,,"0>3NW[WR'E_.=TI],R;F%^TK6
MYB(HK=V>328F*WG%3*BVO,:90NF*6>SJS<1L-6>Y$ZKD)(FB^:1BH@Z6YV[L
M@UZ>J\9*4?,/&DQ354Q_N>12[2Z"..@&/HI-:6E@LCS?L@V_X?:G[0>-O4FO
M)1<5KXU0-6A>7 2K^.QR2NO=@I\%WYE!&RB2M5*?J'.=7P01.<0ESRQI8/AW
MQZ^XE*0(W?C<Z@QZDR0X;'?:OW.Q8RQK9OB5DK^(W)87P2* G!>LD?:CVGW/
MVWAFI"]3TK@O[/S:]"2 K#%65:TP>E")VO^S^Q:'@< B>D(@:042Y[<WY+Q\
MS2Q;GFNU TVK41LU7*A.&IT3-27EQFJ<%2AGEZLL:ZI&,LMS>&]+KN%*59C>
MDG"_X_!6&7,^L6B)UD^R5NNEUYH\H74.[U1M2P-OZISGA_(3]+!W,^G<O$R>
M5?A#4X>01L>01,GT&7UI'W;J]*5/Z'OSN1'V"_RZ6ANKD1F_/1:C5S%]7 55
MRYG9LHQ?!(B7X?J.!\N7+^)Y].H9!Z>]@]/GM/_CO'R[5K@M.11*8KF*>@.6
MK24'%V%M#: 09"6K-]R J'T75:C:S:H"RVQO0CD3V8$)46.?PRA8O;^Z#L8P
MDFAS? PU;D H;MG],5K73K,1]U!Y(G$B$B ->$^#,Q@=D0^5D!(+W(SA-=?B
MCE&9&[AR3M(\][EF12&D0+]P#!=8W%DLD!,H5B!..:QYC2T+6.Y8S#7<*LLD
M7#+)ZHP?X[*,5VL,*(V= RD<P<L7BR1.7F$K":D_BJ,P'KM&.@\CWYJFX6+<
MXGT(A@^^PV3-,7".6UTFF3&B$!FCG<O :!ZFB%04)N/>XFB^(/VCDVDX&\.J
M4@TE8"]+\#<6"JVJK^;DT(TX7.RM1.%T;S,.IU\/8YA*&#GOO.=>5^]W2D#U
MX!YDEE!S@@1KW,+JNJ,DFK:P)O$\/!W_7]B:_M=L31 S3 -^XW!.^)U2-@C:
MDUG76J2$[;<1U:<[=E]L8[9@Y%+];U(T#6=#BI[N*9I@<'^3HB[HUN>8H' ^
M.^\?I:>K\X1*FK"<M?1<M&#& S"I,+OKCC-7/@;:7\: 0@!A.GKCJI;3?^+_
M0ZK=EIKS@S,9;I"M!P-OE7<(\'=CT0E'.?3ZVF/^FELF) T,2LA5J\-DWQK1
M*<+1Z@;OA(;4Y7NFG_5\S1JM>9U]076U.X.-8Z@K]RB<CWN^8E)P]_L1,V:8
MQ%IY1@$N78Q;<<SKM&M?*>-"V2B5&V!U#G1>BPRU&27SYU3&1 :7[7W+$XS?
MX\W8(+4\J<:D9<=T#A9OQZ;!E$N5?3(]-0>$C3O"76,:,9NV5^:KN"TP1\\H
M/!G3=D@D3=PY,"4?;G&NVP((M1BQ0L[B?^JP:MF]![.CK,?HB/#Q!X>VXO<V
M\P5=: ]VEVU[_R;,/">WB*7F5FA/D"U6"&9UE=F&:8&^^ZQWR<,]WWUG[KN
M$>O@Z^"@%</V P0B%]FBC2YQD7=P#3!-!AM/RY<>@\Z7^<"CT];2PX+L-O0M
MTE;E!YO%47N*.3B3%LZN3Z1C5&Q8HWV-4,$B0623[^N5)AO;8T[ZO2V1]<!G
M"'/XV$5R,KCL5UQOW).&#.+NZN_]_6C_:EKYQ\)^N7]RO6-Z0\F2O$!1)-HL
M .V?,;YCU=8]'=;*XD/$-4M\^7%-"W"^4,IV'3+0OR67?P!02P,$%     @
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M_@!N!#=*VM+ E<PQ?Q\?$K6.7[SE-XL/ OZL90^2Z 3B*!X<P$NZ?!./EWR
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MM<+>J_47W-1SYO!R)4SWA77OF\0>Y*VQJMX$$X.:RWYESYMWV F8A&\$Q)N
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M-6*JMR3!MF*WROY9MC)!#3;1R!)2_W\YN+(.Y)2O :WLEA:6 SR+16$AH&]
MCQ1>%,HY_<0/@5WA@AO.X,]3+NN0X*V2*9'M+&N[#V-LV1$I[Z'OMFB.'2HS
M? @D:>;>0H2AV]%])E^\N&^2H:*!7!F<0654[#'>TFS#7-@9CH87,3VGI[,Z
M=T9*4]'($34"1?;4O*X%1RZHAGOM%QU-85PWA?';FL)M0B[* "^R-;E^BF
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MNPEGB#H:@+_'4IKZA29H+GR'_P!02P,$%     @ 6H'Y6!4DA'=X P  A0D
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MD>!.E!_\8\L8V;P_.B9*HSQHZ>.S"@P=PX]$5%-  TC>1CC^VU0XR-(P&L(
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M17\/4#L#6M\H9?<3MT'_AV/^+U!+ P04    " !:@?E88!1HV"8&  !'$
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M5WQ<,3IG(@^0^Q><9[LO>0?5NS^F_P-02P,$%     @ 6H'Y6$=E93/K @
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M=@(^7TIIZHY-T'QBQ'\ 4$L#!!0    ( %J!^5B97U[_3@(  .4$   9
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;(54VX[3,!#]E5%8H5T)FC3M%E32
M2+V  *FH:K7P@'APDVECK6,'VVD7OIZQDX8B=<M+XAG/G#ES<W)4^M$4B!:>
M2B'-)"BLK<9A:+("2V9ZJD))-SNE2V9)U/O05!I9[IU*$<91- I+QF60)EZW
MTFFB:BNXQ)4&4Y<ET[]F*-1Q$O2#DV+-]X5UBC!-*K;'#=J':J5)"CN4G)<H
M#5<2-.XFP;0_G@V=O3?XRO%HSL[@,MDJ]>B$3_DDB!PA%)A9A\#H=\ Y"N&
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MH"<*6!;'D'Z[1Q$Y3!5#.0Y\Q=L=EP/:;)+"+5HC_IP^4='3*I80QRAAF"2
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MV""D@7B^(80?.])!=<4V^Q]02P,$%     @ 6H'Y6+0/SZ*) @  V 8  !D
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M$[1U._.N$S>% H9#1O> *;144P.=?<V6^<)$G9.98/(IECP1?D$RRQRT@!Z
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M>O#JQE$U),O+0WO.I+H"E(]K=4L#K@6J?\F8?&WH>T!S[XO_ E!+ P04
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M!&-$BP'B\Q4A_/6F(&B.\^;_ U!+ P04    " !:@?E8N1&19W $  !3&0
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M^P@L 8YN4$X%\+(HR*\AWU#P4@^\T<0=K@=ZZ%-3F5&TR!1:5]:FA\:^T:*
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M WU]R;EZ6)A]8?4_0/P'4$L#!!0    ( %J!^5CX!]SIS@L  ,2F   9
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ML.5982!_OTM3\?RE<'!ZZ^#JOU!+ P04    " !:@?E8XGF,]_\'  ")0
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M^J&<G#F4:!GO(I4=<RKN%N<:+]+3?(W[E_AL@5ONN_C,RTXMEO#9(<HK_0[
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M&B?AXG"'GT,@C0'>WPBACR=F@?H#:_$-4$L#!!0    ( %J!^5A(N"T1500
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M-I?2S/P:):$9<$4%1Q)6$^\]/IOBD74H++Y3V*F],;*I+(6XLI//R<0+;$3
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MR&7"<R)@/77>T;N8CDU T>/W!([R[)B8I2PX_VP:[U=3QS,S@A26RB"8_CC
M Z2I(>EY?*F@3CVF"3P_?J'_7"Q>+V;!)#SP](]DI;939^20%:S9/E5/_/@+
M5 L*#6_)4UF\DV/9=^ Y9+F7BF=5L)Y!EN3E)_M:)>(L@/9?"?"K /\R('PE
M(*@"@FM'Z%<!_6L#PBJ@6+I;KKU(7,04FTT$/Q)A>FN:.2BR7T3K?"6Y^:',
ME=#?)CI.S>;[A80O>\@5B0_Z79*;"!1+4OF&O"6?YA&Y^?[-Q%5Z*!/@+BOL
M0XGU7\$.R$>>JZTD<;Z"53/>U5.LY^F_S//>MP)_W:<]XOFWQ/?\?MM\_BT\
M[Y' >S4\NCX\: F/KYE\:,*I;TE&4(L6%+S@2M'(GQ]T#_)>02;_:IG>?8GK
MM^.,%]W)'5O"U-%F(T$<P)G]^!T=>#^U91H3%F'"8B180Y-^K4G?1I\]P8X]
M9\45Q-<DY?GFK0*1:=-:J#9)K+2NDI2P<0$SMX;#+!A0S[PF[N$\W=]VI&W]
M8J39-3(9UID,K9G\S:3M V?Y+5GM@42PA&P!@@2TO'S)S:@7>C^TN=*]E=PU
MJYBP"!,6(\$:\@QJ>0:XYC/ U 03%F'"8B180Y-AK<G0>LE$VF1(DDLE]L:"
M;HE43,%*G](>!%(1H9MMVEBQ7;4I892>N8O7\T:A=_ZB%XZ$.8,8"=;08%1K
M,+)J, >1@"3W).<*9.E=^L;_3,(7VPIZ([_=MJSDKC)@PB),6(P$:\@SKN49
MX]K6&%,33%B$"8N18 U-J'>J/KS_Q[CLW*[R5+1+ZPI&_H5;H0X;7S%L,Z]G
M51VUF]'EK_UO<O98%6EKTI8T;$VL%=PYL9BT")468]&:$ODGB7Q<0ZIX6,I@
MTB)46HQ%:RISJJZIM5"</8HD7R8[EA*6\7W>6KY5B$8E%52/.$W/>+"/UCG3
MJ!4S%JV9Z5/-3.U%L]VF.E=_]M$Z7R&8M B5%F/1FKJ=*G0:(GL7:F&.2HM0
M:3$6K:G,J3BGUCJS\]]0%2X\\['A>-QJ8ZBE-RHMQJ(UDWZJOJF]_&ZQL?]2
M#=I'ZWRQ8-(B5%J,16OJ=JK8Z0C9QE +=51:A$J+L6A-94[%.K76G=UM;/S-
MXU@8M#^-H9;BJ+08BU8FW3W;%<Q ;(KM6$F6YI&VW'BKS]9;ON^*C<Z+\P_T
M+BHW;D^8<A_Y(Q,;7;V3%-8:Z?6&^CXBRJW9LJ'XKMA[7'"E>%8<;H&M0)@.
M^OLUU_98-<P ]0;Y[!]02P,$%     @ 6H'Y6/'FJHMA P  QA4   T   !X
M;"]S='EL97,N>&ULW5C=;ILP%'X51->IE:82PD+"FD3:(E6:M$V5VHO=54XP
MB25CF'&ZI)=[E]WM*?8H>Y+Y8 (D]>G?Q=J,*,4^'^<[WSD^@)MAH=:<7BPH
M5<XJY:(8N0NE\G>>5\P6-"7%2993H9$DDRE1>BKG7I%+2N("G%+N=3N=T$L)
M$^YX*);I6:H*9Y8MA1JY@]KDF-/'>.3ZX5O7,723+*8C]^KH];=EIDY?.>9\
M\.;@H'/2N3H^W46.*NC8]:S$O6WBAN@^Q_!!BNZ2A%+W'T"-\F*D TNBAW6>
MAYA;9*U/RQ,FB'._8T_DSX]?Z+HUV#T+T/?MY+]_(F6J@5:=O*K[QL,D$TT3
M!JXQZ+@DI<XUX2-W0CB;2@9>"4D97QMS%PRSC&?24;K[M1 ?+,6-@7TS@QNC
MXDF9R&09VT0P?Z?5Y3O 9@8"&>>UP*YK#.-A3I2B4ISI27EQ:;P%.=7X<IUK
MA7-)UGZWYS8.Y4D'F68RIK(.X[L;TWC(:0)R))LOX*RRW -0J2S5@YB1>29(
MJ6'C40TT[8QR?@%/C:_)%O<J::UHV2RB'FI!U=#0F GPM]D,=YNV]R1>)V?7
MF?JPU.F(<@Z=0L\E3=BJG*^26@#&[N/L),_Y^CUG<Y%2D_R# XZ'9./G+#+)
M;G0T:)69-E#I.M=4*C9K6[Y+DE_2E=JTTRK!-7?W4/._K?.<"BH);XO6O?^2
MJ_QDQ4'_N2273Y5=P5:-U5;@I8OL[8/(<!]$[D5/#O9!9+0'(OO/]M1\C$C_
MY8L,7N9J>]5VK;4GW-H1UE8'=MXC]POL\'D3U)DN&5=,5+,%BV,J;FT,-;TB
M4_U/ZA:_OCZF"5ER=5F#([<9?Z8Q6Z91?=4Y%**ZJAE_@O3\L-[VZUA,Q'1%
MXTDUE?-I.73T0$>M#G#81<[*PXY@/@:S(X!A<3 %F(_QPN+\3_D,T'P,AFD;
M6)$!ZC- ?8R7#9F4'RR.W2?2ASW3* J",,0J.IE8%4RPNH4A?.ULF#;PP.)
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M*>N]<^L_CA^?96>;_BV?C?\17+P 4$L! A0#%     @ 6H'Y6 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !:@?E8+3V5C.\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !:@?E8F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %J!
M^5C2;X<PV@4  -<>   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !:@?E8/!&0?S(&  "Z&P  &
M        @($>#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ 6H'Y6)!(Q]]Z!   IA   !@              ("!AA0  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( %J!^5C]P.S:C ,  #D+   8
M              " @389  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !:@?E8O6$6':P'  !U(0  &               @('X'   >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 6H'Y6-JD=)8M P
M3PH  !@              ("!VB0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( %J!^5C:=JW"4P8  *T9   8              " @3TH
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !:@?E8-OR0
M0*$$  #;"@  &               @('&+@  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ 6H'Y6*_*I'6D P  ;0@  !@
M ("!G3,  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %J!
M^5CIE[M8"P8  /H/   9              " @7<W  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ 6H'Y6+YRE+R5!   3@L  !D
M         ("!N3T  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !:@?E8%JPMD:("  "W!0  &0              @(&%0@  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( %J!^5@@4*HJ@@8  "(>
M   9              " @5Y%  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ 6H'Y6&!T=H=/!     L  !D              ("!%TP
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !:@?E85N6\
MR9T$   /"@  &0              @(&=4   >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( %J!^5@UG*'T"PP  !PG   9
M  " @7%5  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M6H'Y6"0.U%)F!P  FA4  !D              ("!LV$  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !:@?E8WA1U2BT%  !7#@  &0
M            @(%0:0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( %J!^5C46*MIW 0  ((0   9              " @;1N  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 6H'Y6&W>_W^D!0
ME X  !D              ("!QW,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !:@?E8,#=E(A\%   ##   &0              @(&B
M>0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( %J!^5@Z
MR*!B^P,  "$*   9              " @?A^  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ 6H'Y6,@7^A]0 P  2@<  !D
M     ("!*H,  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %J!^5CL"N%+" ,  +,&   9              "
M@>V>  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 6H'Y
M6(&,OBJQ @  P 4  !D              ("!+*(  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !:@?E8H DK.P4%  #:#0  &0
M        @($4I0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( %J!^5@EGQ4I*0,  /0&   9              " @5"J  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 6H'Y6!)T:S9:!@  _!4
M !D              ("!L*T  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !:@?E8%22$=W@#  "%"0  &0              @(%!M
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( %J!^5CM0($4
M5P4  !$/   9              " @?"W  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ 6H'Y6, <:03M!   >A   !D
M ("!?KT  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !:
M@?E8(W:*98(#  !\"   &0              @(&BP@  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( %J!^5A@%&C8)@8  $<0   9
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M970T,2YX;6Q02P$"% ,4    " !:@?E8"^7VFS\$  !N$P  &0
M    @(%\W0  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M %J!^5BT#\^BB0(  -@&   9              " @?+A  !X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ 6H'Y6!**I=@_ P  : L  !D
M             ("!LN0  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " !:@?E87!!.PK\"  #?!P  &0              @($HZ   >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( %J!^5@"=Q&G8@,
M %X+   9              " @1[K  !X;"]W;W)K<VAE971S+W-H965T-#8N
M>&UL4$L! A0#%     @ 6H'Y6&>DK/F* @  ! @  !D              ("!
MM^X  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !:@?E8
M-[5]'28#   #"@  &0              @(%X\0  >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;%!+ 0(4 Q0    ( %J!^5BZ=L8PO0(  .8'   9
M      " @=7T  !X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%
M  @ 6H'Y6#=)"='9!   VAL  !D              ("!R?<  'AL+W=O<FMS
M:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !:@?E8N1&19W $  !3&0
M&0              @('9_   >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+
M 0(4 Q0    ( %J!^5B(H3<5C@,  !,0   9              " @8 ! 0!X
M;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 6H'Y6/@'W.G.
M"P  Q*8  !D              ("!104! 'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6Q02P$"% ,4    " !:@?E8+ZH^"NX(   ^2@  &0
M@(%*$0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( %J!
M^5BL6=G;I0,  %$1   9              " @6\: 0!X;"]W;W)K<VAE971S
M+W-H965T-34N>&UL4$L! A0#%     @ 6H'Y6.)B]ZG:!@  2#0  !D
M         ("!2QX! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
M    " !:@?E81L:$*UT"  #&!0  &0              @(%<)0$ >&PO=V]R
M:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( %J!^5B"[7^6N@@  (%0
M   9              " @? G 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL
M4$L! A0#%     @ 6H'Y6.)YC/?_!P  B4   !D              ("!X3 !
M 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " !:@?E8@JA?
MA2D*   ,3P  &0              @($7.0$ >&PO=V]R:W-H965T<R]S:&5E
M=#8P+GAM;%!+ 0(4 Q0    ( %J!^5AA-5\_[ 4  "DJ   9
M  " @7=# 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @
M6H'Y6$4KU6&\ P  ; T  !D              ("!FDD! 'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q02P$"% ,4    " !:@?E82+@M$54$  ">'0  &0
M            @(&-30$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4
M Q0    ( %J!^5AMI'3E30,  .L,   9              " @1E2 0!X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ 6H'Y6(&EQ,C! @
MM @  !D              ("!G54! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6Q02P$"% ,4    " !:@?E85*8/@20"  "H!   &0              @(&5
M6 $ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( %J!^5CR
M5+7FI@,  ,P0   9              " @?!: 0!X;"]W;W)K<VAE971S+W-H
M965T-C<N>&UL4$L! A0#%     @ 6H'Y6'&9.X&S!@  2"@  !D
M     ("!S5X! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
M" !:@?E8I?HQKFD$   L'P  &0              @(&W90$ >&PO=V]R:W-H
M965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( %J!^5CQYJJ+80,  ,85   -
M              "  5=J 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 6H'Y
M6)>*NQS     $P(   L              ( !XVT! %]R96QS+RYR96QS4$L!
M A0#%     @ 6H'Y6',*QB=P!0  -BT   \              ( !S&X! 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %J!^5B7=W+D+ (  /8H   :
M          "  6ET 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( %J!^5C62",N]P$  "LH   3              "  <UV 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !- $T $A4  /5X 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>331</ContextCount>
  <ElementCount>295</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - New Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NewAccountingStandards</Role>
      <ShortName>New Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Affiliated Companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompanies</Role>
      <ShortName>Affiliated Companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Other Expense (Income)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncome</Role>
      <ShortName>Other Expense (Income)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NewAccountingStandards</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Revenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Inventories</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Debt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/ShareholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Other Expense (Income) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeTables</Role>
      <ShortName>Other Expense (Income) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Revenue - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenueRecognitionDetails</Role>
      <ShortName>Revenue - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Revenue - Contracts and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails</Role>
      <ShortName>Revenue - Contracts and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Net Income Per Share - Summary of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share - Summary of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Net Income Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails</Role>
      <ShortName>Net Income Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/InventoriesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Leases - Assets And Liabilities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails</Role>
      <ShortName>Leases - Assets And Liabilities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails</Role>
      <ShortName>Leases - Lease Cash Flow and Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Leases - Lease Weighted Average (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails</Role>
      <ShortName>Leases - Lease Weighted Average (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Leases - Maturities of Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Affiliated Companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesDetails</Role>
      <ShortName>Affiliated Companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompanies</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Debt - Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtLongtermDebtDetails</Role>
      <ShortName>Debt - Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails</Role>
      <ShortName>Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Other Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Shareholder's Equity - Change in Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails</Role>
      <ShortName>Shareholder's Equity - Change in Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensation</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Other Expense (Income) - Schedule of Other Expense (Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Other Expense (Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Other Expense (Income) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails</Role>
      <ShortName>Other Expense (Income) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Other Expense (Income) - Schedule of Restructuring Reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails</Role>
      <ShortName>Other Expense (Income) - Schedule of Restructuring Reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseIncomeTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxes</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Segment Information - Sales by Product Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails</Role>
      <ShortName>Segment Information - Sales by Product Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Segment Information - Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails</Role>
      <ShortName>Segment Information - Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="wst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SubsequentEvents</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="wst-20240630.htm">wst-20240630.htm</File>
    <File>wst-20240630.xsd</File>
    <File>wst-20240630_cal.xml</File>
    <File>wst-20240630_def.xml</File>
    <File>wst-20240630_lab.xml</File>
    <File>wst-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1060">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "wst-20240630.htm": {
   "nsprefix": "wst",
   "nsuri": "http://www.westpharma.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "wst-20240630.htm"
     ]
    },
    "schema": {
     "local": [
      "wst-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "wst-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wst-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wst-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wst-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 285,
   "keyCustom": 10,
   "axisStandard": 27,
   "axisCustom": 0,
   "memberStandard": 54,
   "memberCustom": 24,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://fasb.org/us-gaap/2024": 3
   },
   "contextCount": 331,
   "entityCount": 1,
   "segmentCount": 80,
   "elementCount": 497,
   "unitCount": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1060,
    "http://xbrl.sec.gov/dei/2024": 29,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.westpharma.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
     "longName": "9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "longName": "9952152 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical",
     "longName": "9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "longName": "9952154 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
     "longName": "9952155 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "longName": "9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.westpharma.com/role/BasisofPresentation",
     "longName": "9952157 - Disclosure - Basis of Presentation",
     "shortName": "Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.westpharma.com/role/NewAccountingStandards",
     "longName": "9952158 - Disclosure - New Accounting Standards",
     "shortName": "New Accounting Standards",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.westpharma.com/role/Revenue",
     "longName": "9952159 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.westpharma.com/role/NetIncomePerShare",
     "longName": "9952160 - Disclosure - Net Income Per Share",
     "shortName": "Net Income Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.westpharma.com/role/Inventories",
     "longName": "9952161 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.westpharma.com/role/Leases",
     "longName": "9952162 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.westpharma.com/role/AffiliatedCompanies",
     "longName": "9952163 - Disclosure - Affiliated Companies",
     "shortName": "Affiliated Companies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.westpharma.com/role/Debt",
     "longName": "9952164 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstruments",
     "longName": "9952165 - Disclosure - Derivative Financial Instruments",
     "shortName": "Derivative Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.westpharma.com/role/FairValueMeasurements",
     "longName": "9952166 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss",
     "longName": "9952167 - Disclosure - Accumulated Other Comprehensive Loss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.westpharma.com/role/ShareholdersEquity",
     "longName": "9952168 - Disclosure - Shareholders' Equity",
     "shortName": "Shareholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.westpharma.com/role/StockBasedCompensation",
     "longName": "9952169 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.westpharma.com/role/OtherExpenseIncome",
     "longName": "9952170 - Disclosure - Other Expense (Income)",
     "shortName": "Other Expense (Income)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.westpharma.com/role/IncomeTaxes",
     "longName": "9952171 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.westpharma.com/role/CommitmentsandContingencies",
     "longName": "9952172 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.westpharma.com/role/SegmentInformation",
     "longName": "9952173 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.westpharma.com/role/SubsequentEvents",
     "longName": "9952174 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.westpharma.com/role/BasisofPresentationPolicies",
     "longName": "9954471 - Disclosure - Basis of Presentation (Policies)",
     "shortName": "Basis of Presentation (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.westpharma.com/role/RevenueTables",
     "longName": "9954472 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.westpharma.com/role/NetIncomePerShareTables",
     "longName": "9954473 - Disclosure - Net Income Per Share (Tables)",
     "shortName": "Net Income Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.westpharma.com/role/InventoriesTables",
     "longName": "9954474 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.westpharma.com/role/LeasesTables",
     "longName": "9954475 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.westpharma.com/role/DebtTables",
     "longName": "9954476 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables",
     "longName": "9954477 - Disclosure - Derivative Financial Instruments (Tables)",
     "shortName": "Derivative Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.westpharma.com/role/FairValueMeasurementsTables",
     "longName": "9954478 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables",
     "longName": "9954479 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.westpharma.com/role/ShareholdersEquityTables",
     "longName": "9954480 - Disclosure - Shareholders' Equity (Tables)",
     "shortName": "Shareholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeTables",
     "longName": "9954481 - Disclosure - Other Expense (Income) (Tables)",
     "shortName": "Other Expense (Income) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.westpharma.com/role/SegmentInformationTables",
     "longName": "9954482 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
     "longName": "9954483 - Disclosure - Revenue - Revenue Recognition (Details)",
     "shortName": "Revenue - Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-26",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-26",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails",
     "longName": "9954484 - Disclosure - Revenue - Contracts and Liabilities (Details)",
     "shortName": "Revenue - Contracts and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.westpharma.com/role/RevenueNarrativeDetails",
     "longName": "9954485 - Disclosure - Revenue - Narrative (Details)",
     "shortName": "Revenue - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails",
     "longName": "9954486 - Disclosure - Net Income Per Share - Summary of Net Income Per Share (Details)",
     "shortName": "Net Income Per Share - Summary of Net Income Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails",
     "longName": "9954487 - Disclosure - Net Income Per Share - Narrative (Details)",
     "shortName": "Net Income Per Share - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.westpharma.com/role/InventoriesDetails",
     "longName": "9954488 - Disclosure - Inventories (Details)",
     "shortName": "Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.westpharma.com/role/LeasesLeaseCostDetails",
     "longName": "9954489 - Disclosure - Leases - Lease Cost (Details)",
     "shortName": "Leases - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails",
     "longName": "9954490 - Disclosure - Leases - Assets And Liabilities, Lessee (Details)",
     "shortName": "Leases - Assets And Liabilities, Lessee (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails",
     "longName": "9954491 - Disclosure - Leases - Lease Cash Flow and Supplemental Information (Details)",
     "shortName": "Leases - Lease Cash Flow and Supplemental Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails",
     "longName": "9954492 - Disclosure - Leases - Lease Weighted Average (Details)",
     "shortName": "Leases - Lease Weighted Average (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "longName": "9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails",
     "longName": "9954494 - Disclosure - Leases - Maturities of Finance Lease Liabilities (Details)",
     "shortName": "Leases - Maturities of Finance Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
     "longName": "9954495 - Disclosure - Affiliated Companies (Details)",
     "shortName": "Affiliated Companies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.westpharma.com/role/DebtLongtermDebtDetails",
     "longName": "9954496 - Disclosure - Debt - Long-term Debt (Details)",
     "shortName": "Debt - Long-term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.westpharma.com/role/DebtNarrativeDetails",
     "longName": "9954497 - Disclosure - Debt - Narrative (Details)",
     "shortName": "Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-83",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails",
     "longName": "9954498 - Disclosure - Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)",
     "shortName": "Derivative Financial Instruments - Foreign Exchange Rate and Commodity Price Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-93",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-93",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "eur",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
     "longName": "9954499 - Disclosure - Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "shortName": "Derivative Financial Instruments - Effects of Derivative Instruments on OCI and Earnings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
     "longName": "9954500 - Disclosure - Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details)",
     "shortName": "Derivative Financial Instruments - Derivative Instruments Not Designated as Hedges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-164",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-164",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails",
     "longName": "9954501 - Disclosure - Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Assets and Liabilities Recorded at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails",
     "longName": "9954502 - Disclosure - Fair Value Measurements - Other Financial Instruments (Details)",
     "shortName": "Fair Value Measurements - Other Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
     "longName": "9954503 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "shortName": "Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-252",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
     "longName": "9954504 - Disclosure - Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "shortName": "Accumulated Other Comprehensive Loss - Other Comprehensive Loss Reclassifications (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-234",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails",
     "longName": "9954505 - Disclosure - Shareholder's Equity - Change in Shareholders' Equity (Details)",
     "shortName": "Shareholder's Equity - Change in Shareholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-252",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.westpharma.com/role/StockBasedCompensationDetails",
     "longName": "9954506 - Disclosure - Stock-Based Compensation (Details)",
     "shortName": "Stock-Based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails",
     "longName": "9954507 - Disclosure - Other Expense (Income) - Schedule of Other Expense (Income) (Details)",
     "shortName": "Other Expense (Income) - Schedule of Other Expense (Income) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
     "longName": "9954508 - Disclosure - Other Expense (Income) - Narrative (Details)",
     "shortName": "Other Expense (Income) - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-288",
      "name": "wst:RestructuringAndRelatedActivitiesPeriodOfImplementation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails",
     "longName": "9954509 - Disclosure - Other Expense (Income) - Schedule of Restructuring Reserve (Details)",
     "shortName": "Other Expense (Income) - Schedule of Restructuring Reserve (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-295",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-295",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.westpharma.com/role/IncomeTaxesDetails",
     "longName": "9954510 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.westpharma.com/role/SegmentInformationNarrativeDetails",
     "longName": "9954511 - Disclosure - Segment Information - Narrative (Details)",
     "shortName": "Segment Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
     "longName": "9954512 - Disclosure - Segment Information - Sales by Product Group (Details)",
     "shortName": "Segment Information - Sales by Product Group (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-302",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails",
     "longName": "9954513 - Disclosure - Segment Information - Segment Financial Information (Details)",
     "shortName": "Segment Information - Segment Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.westpharma.com/role/SubsequentEventsDetails",
     "longName": "9954514 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RepaymentsOfOtherLongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-328",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wst-20240630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "wst_A2022RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "A2022RestructuringPlanMember",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Restructuring Plan",
        "label": "2022 Restructuring Plan [Member]",
        "documentation": "2022 Restructuring Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r942"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r138"
     ]
    },
    "wst_AccruedSalariesWagesAndBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "AccruedSalariesWagesAndBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued salaries, wages and benefits",
        "label": "Accrued Salaries, Wages, and Benefits, Current",
        "documentation": "Accrued Salaries, Wages, and Benefits, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit pension and other postretirement plans",
        "verboseLabel": "Amortization of defined benefit pension and other postretirement plans:",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r10",
      "r20",
      "r94",
      "r1002",
      "r1003",
      "r1004"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r202",
      "r741"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "(Losses) gains on derivatives:",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r228",
      "r229",
      "r563",
      "r892",
      "r1002"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r95",
      "r211",
      "r737",
      "r779",
      "r782"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r10",
      "r20",
      "r577",
      "r580",
      "r649",
      "r775",
      "r776",
      "r1002",
      "r1003",
      "r1004",
      "r1012",
      "r1013",
      "r1014",
      "r1015"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r20",
      "r92",
      "r93",
      "r228",
      "r229",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r1002"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital in excess of par value",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r942",
      "r1131"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital in Excess of Par Value",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1061",
      "r1132"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated Entity",
        "label": "Affiliated Entity [Member]",
        "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r827",
      "r875",
      "r964",
      "r1053",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Currencies [Domain]",
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r529"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AmericasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AmericasMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Americas",
        "label": "Americas [Member]",
        "documentation": "Continents of North and South America."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of acquisition-related intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r380",
      "r381",
      "r908"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive options excluded from computation of diluted net income per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_AociEquityMethodInvestmentParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AociEquityMethodInvestmentParentMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in equity affiliate investment AOCI",
        "label": "AOCI, Equity Method Investment, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) (AOCI) from proportionate share of equity method investee's other comprehensive income (loss) (OCI), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r227",
      "r228",
      "r229",
      "r347",
      "r563"
     ]
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia Pacific",
        "label": "Asia Pacific [Member]",
        "documentation": "Region of Asia Pacific."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairments",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r33"
     ]
    },
    "wst_AssetRelatedChargesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "AssetRelatedChargesMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other charges",
        "label": "Asset-Related Charges [Member]",
        "documentation": "Asset-Related Charges [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r148",
      "r205",
      "r239",
      "r277",
      "r284",
      "r302",
      "r306",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r561",
      "r564",
      "r613",
      "r731",
      "r820",
      "r900",
      "r901",
      "r942",
      "r970",
      "r1046",
      "r1047",
      "r1089"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r214",
      "r239",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r561",
      "r564",
      "r613",
      "r942",
      "r1046",
      "r1047",
      "r1089"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r929"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "wst_BiologicsCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "BiologicsCustomersMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biologics",
        "label": "Biologics Customers [Member]",
        "documentation": "Biologics Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r1008"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r130",
      "r556",
      "r592",
      "r593",
      "r594"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r200",
      "r886"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, including cash equivalents at beginning of period",
        "periodEndLabel": "Cash, including cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r112",
      "r235"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net decrease in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r112"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedges:",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "wst_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:",
        "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]",
        "documentation": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in unrealized gain (loss) on fair value hedging instruments",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Derivative gain (loss) on hedged item, fair value hedges",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r279",
      "r449",
      "r450",
      "r451",
      "r453",
      "r456",
      "r461",
      "r463",
      "r785",
      "r786",
      "r787",
      "r788",
      "r914",
      "r977",
      "r1009"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 16)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r140",
      "r734",
      "r809"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r400",
      "r401",
      "r870",
      "r1035",
      "r1041"
     ]
    },
    "us-gaap_CommodityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommodityMember",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commodity",
        "label": "Commodity [Member]",
        "documentation": "Trading in a derivative instrument whose primary underlying risk is tied to commodity prices."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_CommodityOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommodityOptionMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commodity call options",
        "label": "Commodity Option [Member]",
        "documentation": "Option contract in which the underlying asset is a commodity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per share (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r961",
      "r962",
      "r963",
      "r965",
      "r966",
      "r967",
      "r968",
      "r1012",
      "r1013",
      "r1015",
      "r1061",
      "r1129",
      "r1132"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r810"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r82",
      "r810",
      "r826",
      "r1132",
      "r1133"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: 75.3\u00a0million and 75.3 million as of June 30,2024 and December 31, 2023, respectively; shares outstanding: 72.6\u00a0million and 73.5 million as of June 30, 2024 and December 31, 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r736",
      "r942"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r224",
      "r226",
      "r231",
      "r727",
      "r748",
      "r749"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r230",
      "r726",
      "r746"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26",
      "r67",
      "r68",
      "r313",
      "r869"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26",
      "r67",
      "r68",
      "r313",
      "r784",
      "r869"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26",
      "r67",
      "r68",
      "r313",
      "r869",
      "r982"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk, percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26",
      "r67",
      "r68",
      "r313"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26",
      "r67",
      "r68",
      "r313",
      "r869"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r155",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r241",
      "r277",
      "r286",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r900",
      "r901",
      "r996",
      "r997",
      "r1046",
      "r1047"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r155",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r241",
      "r277",
      "r286",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r900",
      "r901",
      "r996",
      "r997",
      "r1046",
      "r1047"
     ]
    },
    "wst_ContractManufacturedCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ContractManufacturedCustomersMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract-Manufactured Products",
        "label": "Contract-Manufactured Customers [Member]",
        "documentation": "Contract-Manufactured Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "wst_ContractManufacturedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ContractManufacturedProductsMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract-Manufactured Products",
        "label": "Contract Manufactured Products [Member]",
        "documentation": "Contract Manufactured Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Change in Contract with Customer, Asset and Liability",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Contract assets, December\u00a031, 2023",
        "periodEndLabel": "Contract assets, June\u00a030, 2024",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r467",
      "r478"
     ]
    },
    "wst_ContractWithCustomerAssetRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ContractWithCustomerAssetRollForward",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract With Customer, Asset [Roll Forward]",
        "label": "Contract With Customer, Asset [Roll Forward]",
        "documentation": "Contract With Customer, Asset [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Deferred income, December\u00a031, 2023",
        "negatedPeriodEndLabel": "Deferred income, June\u00a030, 2024",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466",
      "r478"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized that was included in the deferred income balance",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "wst_ContractWithCustomerLiabilityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ContractWithCustomerLiabilityRollForward",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract With Customer, Liability [Roll Forward]",
        "label": "Contract With Customer, Liability [Roll Forward]",
        "documentation": "Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate and Unallocated",
        "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r1020"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of goods and services sold",
        "negatedTerseLabel": "Cost of goods and services sold",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r690"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of goods and services sold",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r1044"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r1044",
      "r1045"
     ]
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CrossCurrencyInterestRateContractMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cross Currency Interest Rate Contract",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1060"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency [Axis]",
        "label": "Currency [Axis]",
        "documentation": "Information by currency."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_CurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrencySwapMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cross-currency swap",
        "label": "Currency Swap [Member]",
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r313"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r237",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r406",
      "r407",
      "r419",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r435",
      "r442",
      "r443",
      "r445",
      "r626"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DebtLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, gross",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r139",
      "r446"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r626",
      "r627",
      "r910",
      "r911",
      "r940"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated fair value",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r612",
      "r910",
      "r911",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1074"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r421"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r940",
      "r1010",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r40",
      "r43",
      "r69",
      "r127",
      "r128",
      "r241",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r940",
      "r1010",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred compensation benefits",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation assets",
        "label": "Deferred Compensation Plan Assets",
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r534"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r534",
      "r732"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial gains",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanOtherCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "documentation": "Amount of defined benefit plan cost (credit), classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "wst_DeliveryDevicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "DeliveryDevicesMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard Packaging",
        "label": "Delivery Devices [Member]",
        "documentation": "Delivery Devices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r34"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commodity call options",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r216",
      "r590",
      "r591",
      "r604",
      "r612",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r814",
      "r815",
      "r855",
      "r858",
      "r861",
      "r862",
      "r863",
      "r864",
      "r891",
      "r929",
      "r933",
      "r963",
      "r1065",
      "r1066",
      "r1067",
      "r1130"
     ]
    },
    "us-gaap_DerivativeAveragePriceRiskOptionStrikePrice": {
     "xbrltype": "perUnitItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAveragePriceRiskOptionStrikePrice",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, average price risk option strike price",
        "label": "Derivative, Average Price Risk Option Strike Price",
        "documentation": "The average strike price on the group of price risk option contracts such as put options or call options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract Type [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r800",
      "r802",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r855",
      "r857",
      "r861",
      "r863",
      "r961",
      "r963",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, forward point components, gain (loss), recognized in earnings",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r1058"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r58",
      "r61",
      "r134",
      "r800",
      "r802",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r855",
      "r857",
      "r861",
      "r863",
      "r891",
      "r961",
      "r963",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivative Financial Instruments",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r574",
      "r583"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r56",
      "r58"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r56",
      "r58",
      "r61",
      "r65",
      "r66",
      "r573"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r983"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmountVolume": {
     "xbrltype": "volumeItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNonmonetaryNotionalAmountVolume",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, nonmonetary notional amount, volume",
        "label": "Derivative, Nonmonetary Notional Amount, Volume",
        "documentation": "Nominal volume used to calculate payments on a derivative instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r49",
      "r50",
      "r51",
      "r55",
      "r57",
      "r58",
      "r63",
      "r64",
      "r66",
      "r583"
     ]
    },
    "us-gaap_DerivativeTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTermOfContract",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative contract term",
        "label": "Derivative, Term of Contract",
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r498",
      "r526",
      "r527",
      "r528",
      "r926"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wst_DistributorshipAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "DistributorshipAgreementMember",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributorship Agreement",
        "label": "Distributorship Agreement [Member]",
        "documentation": "Distributorship Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends declared",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EMEAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EMEAMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe, Middle East, Africa",
        "label": "EMEA [Member]",
        "documentation": "Regions of Europe, Middle East and Africa."
       }
      }
     },
     "auth_ref": [
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "EUR",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EUR",
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income per share:",
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r263",
      "r265",
      "r270",
      "r271",
      "r272",
      "r276",
      "r554",
      "r559",
      "r587",
      "r588",
      "r728",
      "r750",
      "r893"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r265",
      "r270",
      "r271",
      "r272",
      "r276",
      "r554",
      "r559",
      "r587",
      "r588",
      "r728",
      "r750",
      "r893"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Income Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r273",
      "r274",
      "r275"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rates on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_EffectOnFutureEarningsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOnFutureEarningsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect on future earnings, amount",
        "label": "Effect on Future Earnings, Amount",
        "documentation": "The quantified amount of the future effect on earnings."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r927"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance and benefits",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity:",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r194",
      "r227",
      "r228",
      "r229",
      "r242",
      "r243",
      "r244",
      "r248",
      "r255",
      "r257",
      "r259",
      "r278",
      "r355",
      "r358",
      "r383",
      "r464",
      "r542",
      "r543",
      "r549",
      "r550",
      "r551",
      "r555",
      "r558",
      "r559",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r586",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r628",
      "r630",
      "r649",
      "r746",
      "r775",
      "r776",
      "r777",
      "r791",
      "r842"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount, equity-method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r294",
      "r306",
      "r348",
      "r999",
      "r1029"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]",
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompanies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated Companies",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r351",
      "r354",
      "r978"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount, investments not accounted for under the equity method",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "documentation": "Amount of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r604",
      "r929"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r604",
      "r929"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r589",
      "r591",
      "r592",
      "r593",
      "r594",
      "r603",
      "r604",
      "r606",
      "r660",
      "r661",
      "r662",
      "r910",
      "r911",
      "r922",
      "r923",
      "r924",
      "r929",
      "r933"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r605"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602",
      "r603",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r724",
      "r929",
      "r934"
     ]
    },
    "us-gaap_FairValueHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueHedgingMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hedges",
        "label": "Fair Value Hedging [Member]",
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r486",
      "r491",
      "r591",
      "r604",
      "r660",
      "r922",
      "r923",
      "r924",
      "r929"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r486",
      "r491",
      "r591",
      "r592",
      "r604",
      "r661",
      "r910",
      "r911",
      "r922",
      "r923",
      "r924",
      "r929"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r591",
      "r592",
      "r593",
      "r594",
      "r604",
      "r662",
      "r910",
      "r911",
      "r922",
      "r923",
      "r924",
      "r929",
      "r933"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r605"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r589",
      "r591",
      "r592",
      "r593",
      "r594",
      "r603",
      "r604",
      "r606",
      "r660",
      "r661",
      "r662",
      "r910",
      "r911",
      "r922",
      "r923",
      "r924",
      "r929",
      "r933"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r632",
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities (current)",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lessee, Finance Lease, Liability, Maturity",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities (noncurrent)",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance leases liabilities payments due",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 (remaining period as of)",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "wst_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, To Be Paid, After Year Four",
        "documentation": "Finance Lease, Liability, To Be Paid, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: imputed lease interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Principal repayments on finance leases",
        "terseLabel": "Financing cash flows from finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r635",
      "r642"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ROU assets, net",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease - amortization of right-of-use (ROU) assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r638",
      "r941"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.westpharma.com/role/LeasesAssetsAndLiabilitiesLesseeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate, finance lease",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r941"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term, finance lease",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r941"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r444",
      "r461",
      "r583",
      "r611",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r747",
      "r906",
      "r929",
      "r931",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r943",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1062",
      "r1065",
      "r1066",
      "r1067",
      "r1074",
      "r1077"
     ]
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency contracts",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591"
     ]
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency contracts",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign exchange transaction losses",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r615",
      "r616",
      "r617",
      "r839"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency hedge contracts",
        "verboseLabel": "Foreign currency contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r922",
      "r928",
      "r929"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Exchange Forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r818",
      "r823",
      "r833",
      "r837",
      "r859",
      "r860",
      "r861",
      "r963"
     ]
    },
    "us-gaap_ForwardContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForwardContractsMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency forwards",
        "label": "Forward Contracts [Member]",
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "wst_ForwardContractsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ForwardContractsOneMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward Contracts, One",
        "label": "Forward Contracts, One [Member]",
        "documentation": "Forward Contracts, One"
       }
      }
     },
     "auth_ref": []
    },
    "wst_ForwardContractsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ForwardContractsTwoMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward Contracts, Two",
        "label": "Forward Contracts, Two [Member]",
        "documentation": "Forward Contracts, Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "parentTag": "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Derivative gain (loss) on amount excluded from effectiveness testing, fair value hedges",
        "label": "Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net",
        "documentation": "Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r569"
     ]
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on derivative instruments, net, pretax",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Derivative gain (loss) recognized in income, fair value hedges",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal of plant",
        "negatedTerseLabel": "Loss on disposal of plant",
        "terseLabel": "Loss on disposal of plant",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Corporate general costs",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r829"
     ]
    },
    "wst_GenericsCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "GenericsCustomersMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Generics",
        "label": "Generics Customers [Member]",
        "documentation": "Generics Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Concentration Risk",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r869"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r369",
      "r725",
      "r901",
      "r907",
      "r930",
      "r942",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r101",
      "r147",
      "r239",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r613",
      "r895",
      "r900",
      "r1017",
      "r1019",
      "r1021",
      "r1022",
      "r1023",
      "r1046"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r573"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "wst_HighValueComponentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "HighValueComponentsMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "High-Value Product Components",
        "label": "High-Value Components [Member]",
        "documentation": "High-Value Components [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes and equity in net income of affiliated companies",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r143",
      "r147",
      "r729",
      "r744",
      "r895",
      "r900",
      "r1017",
      "r1019",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes and equity in net income of affiliated companies",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r751",
      "r895",
      "r1017",
      "r1019",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Equity in net income of affiliated companies",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r98",
      "r142",
      "r277",
      "r291",
      "r306",
      "r348",
      "r743"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r391",
      "r394",
      "r596",
      "r600",
      "r605",
      "r772",
      "r774",
      "r830",
      "r883",
      "r932",
      "r1100"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r394",
      "r596",
      "r600",
      "r605",
      "r772",
      "r774",
      "r830",
      "r883",
      "r932",
      "r1100"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r532",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r544",
      "r546",
      "r547",
      "r548",
      "r790",
      "r927"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax expense",
        "negatedTerseLabel": "Tax expense",
        "terseLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r258",
      "r259",
      "r277",
      "r292",
      "r306",
      "r535",
      "r536",
      "r545",
      "r752",
      "r927"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in contract assets - increase (decrease)",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in deferred income - decrease (increase)",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r689",
      "r1008"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Changes in assets and liabilities",
        "label": "Increase (Decrease) in Operating Capital",
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of equity awards, based on the treasury stock method (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r272",
      "r497"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r1033",
      "r1034"
     ]
    },
    "wst_IntercompanyDemandNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "IntercompanyDemandNotesMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intercompany Demand Notes",
        "label": "Intercompany Demand Notes [Member]",
        "documentation": "Intercompany Demand Notes"
       }
      }
     },
     "auth_ref": []
    },
    "wst_IntercompanyLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "IntercompanyLoansMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intercompany Loans",
        "label": "Intercompany Loans [Member]",
        "documentation": "Intercompany Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, net",
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r1005"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Disclosure [Abstract]",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r888"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.westpharma.com/role/InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.westpharma.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "totalLabel": "Total inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r887",
      "r942"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r890"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r889"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory write-down",
        "label": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest income",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r107"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in affiliated companies",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "currency_JPY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "JPY",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yen",
        "label": "Japan, Yen"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r941"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease, Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating leases liabilities payments due",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 (remaining period as of)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed lease interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r72",
      "r73",
      "r74",
      "r77",
      "r78",
      "r79",
      "r80",
      "r239",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r562",
      "r564",
      "r565",
      "r613",
      "r808",
      "r894",
      "r970",
      "r1046",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r141",
      "r739",
      "r942",
      "r1011",
      "r1030",
      "r1078"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r199",
      "r239",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r562",
      "r564",
      "r565",
      "r613",
      "r942",
      "r1046",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r591",
      "r1063"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term line of credit",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r139",
      "r1098"
     ]
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, current borrowing capacity",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r76"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r1010",
      "r1044"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit Facility, unused commitment level",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r76",
      "r407"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r76",
      "r407",
      "r1010",
      "r1044"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase",
        "label": "Long [Member]",
        "documentation": "Indicates an ownership position in, or purchase of, a security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DebtLongtermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.westpharma.com/role/DebtLongtermDebtDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total debt",
        "terseLabel": "Carrying amount",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r139",
      "r432",
      "r447",
      "r910",
      "r911",
      "r940",
      "r1098"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/DebtLongtermDebtDetails_1": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r206"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.westpharma.com/role/DebtLongtermDebtDetails_1": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.westpharma.com/role/DebtLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r1036",
      "r1037",
      "r1038"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r37",
      "r1036",
      "r1037",
      "r1038"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r917",
      "r953",
      "r958",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r192",
      "r193",
      "r402",
      "r403",
      "r404",
      "r405",
      "r493",
      "r530",
      "r594",
      "r688",
      "r771",
      "r773",
      "r783",
      "r801",
      "r802",
      "r848",
      "r850",
      "r852",
      "r853",
      "r865",
      "r881",
      "r882",
      "r905",
      "r914",
      "r925",
      "r933",
      "r934",
      "r938",
      "r939",
      "r954",
      "r1048",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r192",
      "r193",
      "r402",
      "r403",
      "r404",
      "r405",
      "r493",
      "r530",
      "r594",
      "r688",
      "r771",
      "r773",
      "r783",
      "r801",
      "r802",
      "r848",
      "r850",
      "r852",
      "r853",
      "r865",
      "r881",
      "r882",
      "r905",
      "r914",
      "r925",
      "r933",
      "r934",
      "r938",
      "r954",
      "r1048",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r917",
      "r953",
      "r958",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Total reclassifications for the period, net of tax",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r114",
      "r144",
      "r197",
      "r222",
      "r225",
      "r229",
      "r239",
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r269",
      "r353",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r554",
      "r559",
      "r588",
      "r613",
      "r745",
      "r828",
      "r840",
      "r841",
      "r969",
      "r1046"
     ]
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Investment Hedges:",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "wst_NetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "NetSalesMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "label": "Net Sales [Member]",
        "documentation": "Net sales member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandards"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "New Accounting Standards",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r195",
      "r245",
      "r246",
      "r249",
      "r250",
      "r260",
      "r261",
      "r314",
      "r356",
      "r357",
      "r552",
      "r553",
      "r555",
      "r559",
      "r581",
      "r585",
      "r648",
      "r650",
      "r651",
      "r691",
      "r692",
      "r693",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standards Issued Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest (income) expense, net and other nonoperating (income) expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "wst_NotesPayableAndOtherDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "NotesPayableAndOtherDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable and other current debt",
        "label": "Notes Payable and Other Debt, Current",
        "documentation": "Notes Payable and Other Debt, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r896",
      "r904",
      "r1018"
     ]
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income before reclassifications",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r20"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentAfterTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OciEquityMethodInvestmentAfterTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on equity affiliate accumulated other comprehensive income, net of tax of $0.0, $0.0, $0.0 and $0.0, respectively",
        "label": "OCI, Equity Method Investment, after Tax, Parent",
        "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r560",
      "r563"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OciEquityMethodInvestmentTaxParent",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on equity affiliate accumulated other comprehensive income, tax",
        "label": "OCI, Equity Method Investment, Tax, Parent",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r560",
      "r563"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating profit",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r895",
      "r1017",
      "r1019",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r941"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r642"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate, operating lease",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r941"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term, operating lease",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r941"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r900",
      "r901"
     ]
    },
    "us-gaap_OptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Held",
        "label": "Options Held [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r816",
      "r821",
      "r831",
      "r835",
      "r855",
      "r856",
      "r857",
      "r961",
      "r962"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "verboseLabel": "Amount receivable from affiliates",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r942"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Defined benefit pension and other postretirement plan adjustments, net of tax of $(0.1), $(0.3), $(0.1), and $(0.5), respectively",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r10",
      "r94",
      "r95",
      "r131"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Defined benefit pension and other postretirement plan adjustments, tax",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent",
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r131"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments, net of tax of $0.7, $1.3, $1.7 and $1.5, respectively",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r131"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments, tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent",
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r131"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges, amount of gain (loss) recognized in OCI",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r219",
      "r566",
      "r567",
      "r575"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash flow hedges, amount of (gain) loss reclassified from accumulated OCI into income",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on derivatives, tax",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax",
        "documentation": "Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r221"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on derivatives, net of tax of $0.3, $(1.0), $(0.4) and $(1.1), respectively",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax",
        "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r568",
      "r746"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value and net investment hedges, amount of gain (loss) recognized in OCI",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Fair value and net investment hedges, amount of (gain) loss reclassified from accumulated OCI into income",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income, net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive (loss) income, net of tax",
        "verboseLabel": "Other comprehensive (loss) income, net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r10",
      "r131",
      "r223",
      "r226",
      "r255"
     ]
    },
    "us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation liabilities",
        "label": "Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent",
        "documentation": "Amount of the liabilities, classified as other, for deferred compensation arrangements payable after one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "wst_OtherExpenseIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "OtherExpenseIncomeMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsNotDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense (income)",
        "label": "Other Expense (Income) [Member]",
        "documentation": "Other Expense (Income)"
       }
      }
     },
     "auth_ref": []
    },
    "wst_OtherFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "OtherFinancialInstrumentsAbstract",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Financial Instruments [Abstract]",
        "label": "Other Financial Instruments [Abstract]",
        "documentation": "-- None. No documentation exists for this element. --"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income and Expenses [Abstract]",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Expense (Income)",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r1055"
     ]
    },
    "wst_OtherIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "OtherIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense (income) (Note 14)",
        "terseLabel": "Other expense (income)",
        "negatedTotalLabel": "Total other expense (income)",
        "label": "Other Income (Expense)",
        "documentation": "The total amount of other income and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "verboseLabel": "Amount due to affiliates",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r942"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-cash items, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other nonoperating (income) expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOperatingIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other items",
        "label": "Other Operating Income (Expense), Net",
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r979",
      "r1006"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares purchased under share repurchase programs",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r1007"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividend payments",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares repurchased for employee tax withholdings",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension and other postretirement benefits",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r481",
      "r482",
      "r484",
      "r924"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Share Unit (PSUs)",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "wst_PharmaCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "PharmaCustomersMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma",
        "label": "Pharma Customers [Member]",
        "documentation": "Pharma Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PositionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PositionAxis",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Position [Axis]",
        "label": "Position [Axis]",
        "documentation": "Information by position taken for a security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PositionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PositionDomain",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Position [Domain]",
        "label": "Position [Domain]",
        "documentation": "Indicates position taken for a security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r810"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r449"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r810",
      "r826",
      "r1132",
      "r1133"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, 3.0\u00a0million shares authorized; 0 shares issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r735",
      "r942"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r785"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee stock purchase plan contributions",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r13"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from stock-based compensation awards",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r13"
     ]
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductConcentrationRiskMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Concentration Risk",
        "label": "Product Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r191",
      "r309",
      "r690",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r884",
      "r915",
      "r952",
      "r954",
      "r955",
      "r959",
      "r960",
      "r998",
      "r1042",
      "r1043",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r191",
      "r309",
      "r690",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r884",
      "r915",
      "r952",
      "r954",
      "r955",
      "r959",
      "r960",
      "r998",
      "r1042",
      "r1043",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r201",
      "r742"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, plant and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r647",
      "r730",
      "r742",
      "r942"
     ]
    },
    "wst_ProprietaryProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ProprietaryProductsMember",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proprietary Products",
        "label": "Proprietary Products [Member]",
        "documentation": "Proprietary Products"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r192",
      "r193",
      "r402",
      "r403",
      "r404",
      "r405",
      "r485",
      "r493",
      "r521",
      "r522",
      "r523",
      "r530",
      "r594",
      "r663",
      "r672",
      "r688",
      "r771",
      "r773",
      "r783",
      "r801",
      "r802",
      "r848",
      "r850",
      "r852",
      "r853",
      "r865",
      "r881",
      "r882",
      "r905",
      "r914",
      "r925",
      "r933",
      "r934",
      "r938",
      "r939",
      "r954",
      "r963",
      "r1039",
      "r1048",
      "r1066",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r161",
      "r163",
      "r192",
      "r193",
      "r402",
      "r403",
      "r404",
      "r405",
      "r485",
      "r493",
      "r521",
      "r522",
      "r523",
      "r530",
      "r594",
      "r663",
      "r672",
      "r688",
      "r771",
      "r773",
      "r783",
      "r801",
      "r802",
      "r848",
      "r850",
      "r852",
      "r853",
      "r865",
      "r881",
      "r882",
      "r905",
      "r914",
      "r925",
      "r933",
      "r934",
      "r938",
      "r939",
      "r954",
      "r963",
      "r1039",
      "r1048",
      "r1066",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Line Items]",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts reclassified out from accumulated other comprehensive (loss) income",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r20"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reclassification out of Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r492",
      "r652",
      "r653",
      "r733",
      "r740",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r825",
      "r827",
      "r847"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r653",
      "r1088"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transaction, purchases from related party",
        "label": "Related Party Transaction, Purchases from Related Party",
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r492",
      "r652",
      "r653",
      "r733",
      "r740",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r825",
      "r827",
      "r847",
      "r1088"
     ]
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfOtherLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments of long-term debt",
        "terseLabel": "Repayments of long-term debt",
        "label": "Repayments of Other Long-Term Debt",
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r883",
      "r900",
      "r1097"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "wst_RestructuringAndRelatedActivitiesPeriodOfImplementation": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "RestructuringAndRelatedActivitiesPeriodOfImplementation",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring plan, implementation period",
        "label": "Restructuring and Related Activities, Period of Implementation",
        "documentation": "Restructuring and Related Activities, Period of Implementation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and related cost, expected cost",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r395",
      "r397",
      "r399"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails": {
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restructuring and related charges",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r395",
      "r397",
      "r399"
     ]
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Restructuring and severance related charges",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r396",
      "r397",
      "r1040"
     ]
    },
    "wst_RestructuringChargesCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "RestructuringChargesCredits",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Credits) Charges",
        "label": "Restructuring (Charges) Credits",
        "documentation": "Restructuring (Charges) Credits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r397",
      "r398"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Axis]",
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Domain]",
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, December 31, 2023",
        "periodEndLabel": "Balance, June 30, 2024",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r398"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r129",
      "r738",
      "r778",
      "r782",
      "r789",
      "r811",
      "r942"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r242",
      "r243",
      "r244",
      "r248",
      "r255",
      "r257",
      "r259",
      "r355",
      "r358",
      "r383",
      "r542",
      "r543",
      "r549",
      "r550",
      "r551",
      "r555",
      "r558",
      "r559",
      "r576",
      "r578",
      "r579",
      "r582",
      "r586",
      "r628",
      "r630",
      "r775",
      "r777",
      "r791",
      "r1132"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r277",
      "r285",
      "r286",
      "r300",
      "r306",
      "r309",
      "r311",
      "r313",
      "r476",
      "r477",
      "r690"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer Benchmark",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r980"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerProductAndServiceBenchmarkMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer, Product and Service Benchmark",
        "label": "Revenue from Contract with Customer, Product and Service Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer for specified product or service, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r480"
     ]
    },
    "wst_RevolvingCreditFacilityDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "RevolvingCreditFacilityDue2024Member",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility, Due 2024",
        "label": "Revolving Credit Facility, Due 2024 [Member]",
        "documentation": "Revolving Credit Facility, Due 2024"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.westpharma.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities, Finance Leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r941"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities, Operating leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r941"
     ]
    },
    "currency_SGD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "SGD",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SGD",
        "label": "Singapore, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Loss",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r1079",
      "r1080"
     ]
    },
    "wst_ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Assets And Liabilities, Lessee",
        "label": "Schedule Of Assets And Liabilities, Lessee [Table Text Block]",
        "documentation": "Schedule Of Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Obligations, Net of Current Maturities",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and Earnings",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r58",
      "r573"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Foreign Currency Contracts",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r49",
      "r50",
      "r51",
      "r55",
      "r57",
      "r58",
      "r63",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Basic to Diluted Net Income Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Sales by Significant Product Group",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r349",
      "r350",
      "r352",
      "r353",
      "r613"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Table]",
        "label": "Equity Method Investment [Table]",
        "documentation": "Disclosure of information about equity method investment. Includes, but is not limited to, name of investee or group of investees, percentage ownership, difference between investment and value of underlying equity in net assets."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r239",
      "r349",
      "r350",
      "r352",
      "r353",
      "r613"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1063",
      "r1064"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r88",
      "r89",
      "r90"
     ]
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivatives Not Designated as Hedging Instruments",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r983"
     ]
    },
    "wst_ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Expense (Income)",
        "label": "Schedule Of Other Income And Expense, By Component [Table Text Block]",
        "documentation": "Schedule Of Other Income And Expense, By Component"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399"
     ]
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Reserve",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r122"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r496",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r125",
      "r127",
      "r128",
      "r129",
      "r208",
      "r209",
      "r210",
      "r279",
      "r449",
      "r450",
      "r451",
      "r453",
      "r456",
      "r461",
      "r463",
      "r785",
      "r786",
      "r787",
      "r788",
      "r914",
      "r977",
      "r1009"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stockholders Equity",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of each class",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r277",
      "r281",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r313",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r395",
      "r399",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r897",
      "r900",
      "r901",
      "r907",
      "r957",
      "r1099",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r164",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r311",
      "r312",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r794",
      "r797",
      "r799",
      "r849",
      "r851",
      "r854",
      "r866",
      "r868",
      "r871",
      "r872",
      "r873",
      "r874",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r885",
      "r916",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r956",
      "r963",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r277",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r296",
      "r298",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r896",
      "r898",
      "r899",
      "r900",
      "r902",
      "r903",
      "r904"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "wst_SeniorBNotesDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "SeniorBNotesDue2024Member",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B notes, due July 5, 2024 (3.82%)",
        "label": "Senior B Notes Due 2024 [Member]",
        "documentation": "Senior B Notes Due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "wst_SeniorCNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "SeniorCNotesDue2027Member",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C notes, due July 5, 2027 (4.02%)",
        "label": "Senior C Notes Due 2027 [Member]",
        "documentation": "Senior C Notes Due 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit within other expense (income) for revised severance estimates",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "negatedTerseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target award percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Actual Payout, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r496",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for issuance under the 2016 plan (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShortMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortMember",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sell",
        "label": "Short [Member]",
        "documentation": "Indicates the sale of a borrowed security or written option."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r941"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/BasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basis of Presentation",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r236"
     ]
    },
    "wst_StandardPackagingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "StandardPackagingMember",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "High-Value Product Delivery Devices",
        "label": "Standard Packaging [Member]",
        "documentation": "Standard Packaging [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r196",
      "r277",
      "r281",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r313",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r385",
      "r395",
      "r399",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r897",
      "r900",
      "r901",
      "r907",
      "r957",
      "r1099",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r82",
      "r85",
      "r86",
      "r194",
      "r227",
      "r228",
      "r229",
      "r242",
      "r243",
      "r244",
      "r248",
      "r255",
      "r257",
      "r259",
      "r278",
      "r355",
      "r358",
      "r383",
      "r464",
      "r542",
      "r543",
      "r549",
      "r550",
      "r551",
      "r555",
      "r558",
      "r559",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r586",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r628",
      "r630",
      "r649",
      "r746",
      "r775",
      "r776",
      "r777",
      "r791",
      "r842"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r164",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r311",
      "r312",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r794",
      "r797",
      "r799",
      "r849",
      "r851",
      "r854",
      "r866",
      "r868",
      "r871",
      "r872",
      "r873",
      "r874",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r885",
      "r916",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r956",
      "r963",
      "r1051",
      "r1099",
      "r1101",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Activity related to stock -based compensation (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r81",
      "r82",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Activity related to stock-based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r81",
      "r82",
      "r129"
     ]
    },
    "srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, shares authorized (in shares)",
        "label": "Share Repurchase Program, Authorized, Number of Shares",
        "documentation": "Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85",
      "r86",
      "r118",
      "r812",
      "r826",
      "r843",
      "r844",
      "r942",
      "r970",
      "r1011",
      "r1030",
      "r1078",
      "r1132"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r238",
      "r448",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r584",
      "r845",
      "r846",
      "r867"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r655"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r655"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r655"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r655"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r655"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r654",
      "r656"
     ]
    },
    "wst_TermLoanDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "TermLoanDue2024Member",
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails",
      "http://www.westpharma.com/role/DebtNarrativeDetails",
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan, due December 31, 2024 (8.50%)",
        "verboseLabel": "Term Loan Due 2024",
        "label": "Term Loan Due 2024 [Member]",
        "documentation": "Term Loan Due 2024"
       }
      }
     },
     "auth_ref": []
    },
    "wst_TermLoanDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "TermLoanDue2027Member",
     "presentation": [
      "http://www.westpharma.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan, Due 2027",
        "label": "Term Loan, Due 2027 [Member]",
        "documentation": "Term Loan, Due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "wst_The2022RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.westpharma.com/20240630",
     "localname": "The2022RestructuringPlanMember",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeNarrativeDetails",
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Restructuring Plan",
        "label": "The 2022 Restructuring Plan [Member]",
        "documentation": "The 2022 Restructuring Plan"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.westpharma.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r444",
      "r461",
      "r583",
      "r611",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r747",
      "r929",
      "r931",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r943",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1062",
      "r1065",
      "r1066",
      "r1067",
      "r1074",
      "r1077"
     ]
    },
    "us-gaap_TreasuryLockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryLockMember",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward treasury locks",
        "label": "Treasury Lock [Member]",
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, average price per share (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, at cost (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock, at cost (2.7\u00a0million and 1.8 million shares)",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r85"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share purchased under share repurchase program (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r82",
      "r129"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock purchase program, cost of shares purchased",
        "negatedTerseLabel": "Shares purchased under share repurchase program",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r44",
      "r129"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseIncomeScheduleofRestructuringReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r397",
      "r398"
     ]
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "USD",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateandCommodityPriceRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD",
        "label": "United States of America, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/DebtLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/DebtLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: unamortized debt issuance costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.westpharma.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r941"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares assuming dilution (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r272"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.westpharma.com/role/NetIncomePerShareSummaryofNetIncomePerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Weighted average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r272"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/220/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "83",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480647/815-10-15-83"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-1A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/250/tableOfContent"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/323/tableOfContent"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(dd)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481725/323-10-35-18"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "610",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/610/tableOfContent"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/720/tableOfContent"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479424/830-30-S99-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000105770-24-000066-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000105770-24-000066-xbrl.zip
M4$L#!!0    ( %J!^5@O-(#-YP8  +<A   /    97@S,3%Q,C(P,C0N:'1M
M[5I=;]LX%GW?7\%-,=,4D-/8B:>-DPG0C\RL!YBO;H#NVX(2KRPBDJB2E%WO
MKY]S22FV8W>;MIC"$TP>'$NZ)"]Y#\^YE]9%X:OR\J(@J2[_<?'/P4"\-EE;
M4>U%9DEZ4J)UNIZ)MXK<C1@,.JM7IEE:/2N\&!V/3L5;8V_T7,;G7ON2+OM^
M+I[&ZXNG89"+U*CEY872<Z'5]P=Z//YN.*)\G,K1L],S-9+967ZFTM&8Z.SD
M>3K\[_  36$>VSB_+.G[@TK7@X)X_,FS4>//%UKY8C(\/O[F(-A=7N2F]AC,
MHG'\&OO8ZLG3>S^0I9[5DS"?@]BT?YR9TMC)H^/P=\Y/!KFL=+F</+[6%3GQ
M"RW$&U/)^G'B9.T&CJS.HZ'3_R/X!/?"Y:+S%_V4NJ;>_^&(G;[ZS[^F+Z?7
MXF1X--ST^'8V7]>E\[ PBC)CI=>FGK2U(LM6!Y>OKMY<3W^8OGIQ/?WUEP]X
MNV/MO\),3G<N[C015U9GXN<C\:,EJA.1D?4Z7PI?2/_MH_'S\RU/;Y$F[0Q@
M\Z:9G&&P1BJ%[3 H*?>3D^]P)ZR3QN+4?C(8/F_^? 3MGN3PJ)_#UQ]]<UF&
MQT=C7H:I*.2<A*6YI@6(Q!?:B7>MM!Y 6N)^8ZP7IA8_&%N)X?'@=V%R\9:<
M%[\5TE8RH];K3);BWV3G.B.7B&F='2%@9P\@8*.]"]A+Z1 F!*1:BIO:+$I2
M,TIBW+IH*0,7:@-UP A2UT+62]'6WK:$&4 O@G0@C%)4N+(:T<MEAEM6F$I[
MX4VTVS*H"0%VTB[9I)(WA''7^G2XI^ ,ABR#[F ,-LBTA<[ K$9S$4A*+ J=
M%<*U_+%JOR!+72<\@4J[$H+$VK;0OL $74-9<)#[;>":49CF',V42)?KR_!
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MN'0A?_")EQ3ZS^Y]B:?I/8W_ 5!+ P04    " !:@?E8IO,Q/:(J  ">K0
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M2'EA6V#KC"@P&RW9 K*VY@\XL ((V?U&>.\^P%J[II@S?C'>PV#MQLX+."1
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M4SO99>+$I]Q/ODS&NDQ'2G!V.X@V,]#N69U )?5/E%PKO7^ZX9AJQR JX.Y
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MK^DV>JH29="__)MKG' 8_ISNH9"9T)0WM%Q@=,#OQ.5CMG1<U%4?01F5AEE
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MGQT /9ZPO9\<;(OSJ(VM+M85"KNM6DZL<$*C.G7[5D'?0ZVBNE9<4,L4S!6
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MPK*>4V!O(". 4T)T[K_ %R&0'R^BLO Z_==/+45N?G8ECYIT,K(M*EG,3KI
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MF1::\^W4?"$"-#R!9H>1MC=HVN@NJ'&C:<[!1W;OC:@3&F32!\/2[#']*'W
M$XXEN?91^,KBFV@N#!]^"\7AU?4N&7EO&%$WPKY>A4V*R"LI)$;63+)],2*7
M.K7#S7:!$0XQLF:"[8L1I=1IB$3&0F)DS>+:%R.^F[W-"4C.*C?M?D+1 +:>
M17[:,5UC<S+[HG!KNVZ$'-1 #I2&R/\0V$KB0HN'K3I@JZ6<36&DP%8JKK9X
MV&J4.DJM+?)K!;:2>.3B8:N)P=)F/OHJG(-O[@8;36&'U\ ]=R%9-([56'"L
M[[#_0JH%>Z [V[)#]$=@'N,425?JX^C%F.JOX,S=88 E8RX6#B0-0?'I]R@X
MUW>81HFXWF#N](3984*D,[--DC&7^<$3NJ\X\5+EP];P(X!GEIGU(57[XP7H
MB&F)OK%]1R-J11I*=#QG+=XJ$B-RA8V=YDL<;*BE3EU@HW#8V&GDQ,$&^JVC
MRA8%./(-CIU&4AQPU$N==H3[YN38. ?GC)\X92U9JXOLJ<!?(W*G]H[A(7&7
M=P+OPMK+/?*&QAO5RW]1QXZ0B :>RM!29.4S)Q%OD19Q2GMK%X[6\-(L=:H1
MOH/X&E3 A$-MLROREI:V:0EMDS<8I6FD)=8V;4ZTS5FE8?E,D084Q)H&[B[)
M(V_4;]9*_YP:W@P^QV!;^+4]E,AP:)@&\2B2: SC-@ZK7SSG:/5.#UH8I X[
M)QO6%,@11+%MR_W"F.=?]X2L^V98M@-\"]V874M??4J/L?4;]4:VOMA,143!
MFU7,#&OEHXN+R+#@)S"9)69ES#A+'!<1F"TX9G=Z'+/$K%+J*/7&V9R6)#";
MDB,T2\RJI8Y:4T2&'"_ NIE;[\+GFH[5#1(3[%>_4(M&]CELUD!SR]S4$ D?
MQ\G-W#@@P<Y+M<,UI0 )AR")95?& 4D#0-(2I>^%!$DL0RX.2)JE3CV%]D-\
M^4JY-JMZ)_*!YE "TLT4W&\7TL+<P?6:!9$"E&^T)/(PQD=+6V03%A$MB7Q[
ML='2JI8Z+1Y2R 1:3IM>N!]:9):-NAXJRVO&83XBV'=T4YG&KNF>[1G%B>?/
MM^RG:(0"F+85A;?P" =93FV/SD689LL&7DB0D*"$AODN"<*66_7TSBL0$L05
MD(0$';Y9V25!&'!2&JD=XR DB"L@"0DZ? .W2X+J>(1F3M:@8"\7#B(D61WD
M(UV_0(S[ER:JPE1T>SHPZ=I,]WVZ&%UN1G<.V30+OX(TH2!_(^+0RXWQG4,C
MI">\/Q?^O&A-+,@ER'4D<IU5U<\7XAK:(5[IHMG245/D&\+;S.4'ZO1QN=KJ
M_%3>6\T]XE@P>3>\FX%D;CU7Y]9S@S4)3*M7- >A,0'\H@._E@KPF]A L9I6
MNKL O@#^T8$OIP+\%O:0K*953R> +X!_=.#74P%^&X'?/MC3+M(ZDC/]VC"G
M'M4/\,5N<6054:Z3$Z!X4I]L@Q- ;%WNVU6VQ3E"?& '2_@/L0FA.CNA2K9Y
MVBQ4,ML^'2%L+82*!V@)H3K>QFRS4"EL:R:$2@B5$*J$F[[-0J6R;5\^S#^1
M'R)&Q]WHSB$_Y'?V!]4E J,BS]3/$'$E>^JY'K'8/-((R.<UH"[R#P2Y!+DX
M(9?(;IG/NICUKQO-97]52E@&%ZYM77]INYN.!]2Y'S*SV;U?+'"K<9-Y@G6[
M5NHTU=2.Y>4@8"C0DZ $[%#TU $]M<-K+ 5Z^$3/CO*G0]'38+I'H*>@Z-E1
M^G,H>II,]QS<7DM$_%.+^,>"_ZJKS9_&>T_%H<[AW(O.?D9?P)8U"8H0GA93
MO0>?%9 R,W/0_%#@-GUS,P%NVX#;>FH]%05N!6X/,'3CXQ8&Q:R5@_?9 K@"
MN(?;V$F *S.-N]ZU,W_ W6&BZX8[,<D,)TDWX_P<KQ*$.X1PGSP"*(9_=>.E
M\S/[X<O,P,%+ OD)OPP?M01KC>(!(*?71PKJHSZE$M'\KLDSD#[)LCUXNF>C
M(M*Q 392PF*=-%B#Y:%A$4LSB DCA0]8!\;*QFD&[VHJ,)B)[1JH6BX=:A+/
M>*&?7PW=&X6*<>FN0'U4%[>0 8P =-K&6WBAI[I*BN6?.%K4ND:+5EO#>IL2
MJE9KC;9,!E7:;LJM6I/6&]5:[?\4I13>-)KGDTQ P9<'#B4_RF0($[PDYBN9
MN8C#)3J,#:N\3/3W]-I(E>%P'ZJT0Z*P!UX:'K! VTDF7ZG#PF;[9^-<PD)"
M';P*!DGX'9PT<G!9_FDW!YNESA.J!>Q.CH<!H93\_(ETHM"QC2LI8;49B=6K
M^[OKWEV_=RW!;_W[VYOK[A/\T7^"?[[U[I[ZTOU7^.K;PV/O-[CNYE\]Z>8.
M_NY)'[[?=;]?W\#5']=$/QNY^YVZGO0 !L^8:'3*# 2I3YT70Z/NA71C:15V
MBF9_.G -W2#.<H?X;$?^P; D>*R)9T1%49,M+PO-R"PH&)M))BZ]#'_Y'"Y-
MAL7>P&[Z/";.,^B#0)W6)VO&$X.Z__5"4U2JOK8(+(+@S<'7%?CJT_KGM69%
M5IN17U4K<N3GFQXERQ5%;2=ZU.;/&]5D=XA!I3&HFKKU4>=P5,6.1)GV0;/U
M+1RNYOL$2R.5OL%U(U?JP8JI,_OW'U.+2FKU8J^,H3B1N,(1LF^\Q23C.:1V
M'IYOEJ0E(.?04*I*[>BDV#<OKUAT5K-,<2P6*05DLX#L.=A8>YPWD<I!QMP1
M(G'+D7/L5'S8>1-R-:T#)W)R+K@0(2%"Z1XX(5?3.G%"B) 0(8XF?KH3)^1J
M6D=."!$2(L31Q$]WY(1<3>O,B5.(T#GX^.Z]$74D3$%PZ(A:KO%"I0\F,.]C
ML+N[8,<]VT/)(V^BD#M_QQR<:ZFO(%<6E=&Q==U2UDSPB#)>SR*8?M.6+ CS
MU7;@3TO2IHY#+6TF>0X\S62I*!+1_Y@&I]XN*T7\YV\I^D*81KY:5LC^BAJ,
M[2H8VM-B9-WYP)[(VX/ML,\\SS$&4Y:*\&0_$+C'BUJ/&Z5.U%F]%\FFM&-O
M>MHI-;%KY;JG*.&4=NP53CNE%DYIG4LLJR;1K':8;Z>=59NU%XU@E$/="=4P
M2]&<O4O:.H\V!HF.\5[3)RZ,'WX[A+G^:[N6'LEJL/+OAXGY+5?!]H^"L3A'
M/M\ 7-/^O (03Z:/6AH$ /,-P+6UFE< *J5.HQ51J"8 R!T ,[*JC@([M=1)
MH3R2KV8..=]I7M,A?*9+ VK!;YXT06#@)A,L>IOYY":VZSG4,QQ6YB--3+)]
M"WJ8S1@/L<&HO_B#?H AN<G16,,MY[H#^.-%PCGLN>E,90YUG$.$(9%T#GON
M,E.90V,C']BV,M$\]M2 J<RCB?-8WT9^3&T?&:& <K*(9:03#EZP6LC2]:,5
MXYM)6QH <5R.7W2$I:>Q#T98&Q&V?I2;0%B^$9;>>GHHPI0J(FR]F8Y 6+X1
MEIZE<S#"T)W% \)$[#!,B,?$"0D 1/^<&MY,(L.A81K$8UT>IN.IR9HXV!$I
M%^NY%JF'%36CQT;UC7HC6[^Q7N@B;K,18@HJL77/0<KAP;V&IJ8RM%T+QEY#
MJT4/+?UPW5ZCJV\BG B['27LMHE)76PDLI53FW;HPEN<:^3$CI?MCYRF0$X1
MD1,[T+4_<@YVO0CD\(B<-4LB?>2T.=$Y(L#T?CNBPR->6->W3#(7L1;@>CZ$
MWIMF3G6JXX6V!5B"BQQ*7-@B^_\N]L48#(A FEJ-CKX<'$!*F#:0^KS8ACXB
M.^#@J%+6$U,V^,+2B#1E/3>LJXP.HXGPTRG3&),R%M>S)>YBRD4T@['J+Z+F
M3SAR\XVW4VO_V'C#$KE*2^"M8'@[]:(<&V\-S Z+R)\0>,LUWDYM*,7&6Q./
M%3\D!S:G82ONRWL/.2OTL%X .1>U-$S7_6+ :@N,A=I!UFE.FE$(,)[0KMT3
MC%C0%]7;08#Q7,&8AM&['QAK578*GP"C &.:%O&>8)0WY*ASA<5SZ'=S%9%V
ME>HY6SC\LVV,E3Z!^%8_*0;/(O1-J&NB%(I2ZK0:ISEC-A'#,G+\")$5(GOR
MEJL)118#A;6HS$LALT)FA<R>IL=K0IFMH4=#/<T)K4)FA<R>I\SN*'-(*+.L
MQ6R43SR/,BM.N16GW+ZC9^U=+ME^I]S6Q2FW/ XN+Z?<MBOU0XZY_=*][=Y=
M]:3^;[W>4_^41]JN#_R89]KFXOS89K6BR+5T#B!5*JV:PMNIJ#BH@TY%Y<+#
M'0.YU?=G&E](]$VC$^PO!5H>T$PE6&/)6MPAV9Q/>09;W%G/3^E$FRCFR7<Q
MFW[GC!+75*/C ?!;E>?4*-#Y='')T.WW86DYY.S;?8\HY(\6!_3'CQ-X/G=:
MYCIP&G?>?IM*3R*N2SWW6$>!\#=OKL^6R 6Y4EIN?(>@PHHJ^:;!%7%';'>@
MX2_8#.:%F/[^;/]2V(P=HG'GGO@4+1Y\FG$GE\2IV=CAU 1H="T=_^DM -+U
MKHCCH)?L7\2<TBCW)I9KU!H1)?K9M/,]P3ES0@KXFEP2*6@>20J:I4ZKKD9T
M<,QU4^O\+'%=38/I>*[DP&X3^#8P_5*2O6I(.*S(RF!%"$GZ.*?H'?4"JSM*
M!%JP$#3;$67U^\6Y.(@N"[#$5IQ)P=(N=>J@6-)*/N*D]BX_^A(;Z5B>O1(F
MR'E3O0Q49$C%&8 ] N7U*JA$N5TDVUB ([9*W 4.&<"AU@[/F18FXWZL#FJ1
M5]R(PES<6Q<R<G89%3>O^W6EU)'5UN$:41B)/$)DAT:,!Q',2U?K$1UG<FT:
M\JT+GVR/F&GHPKS5=6:QKUX5@*'MC(GW2\EX\RZMZ;BLVRP5"V^/D@[, +^H
MM:(ZENQG-W"1XGUNY<19[- /@ET=8==6&X>[=T3E<$K8>'#L"8QG=L'.XO-8
M@ ]C>Q-,4#[$D#UK*=JAO$.BXXDI7M?2>R'!?W5LUTTL5HU21[EH-=2TJP.X
M+=@1.$Q'FZ>,PR;BL*E&G07,(0[/PB2_I:Y[N7)0CTXG#K"0I>@S;4_&V/7C
M+_:!\.(>$N@*:7R]1&+XW:3!Z<?=)4IO%+W$4M="HTIMM+D)&PL'\8EC9MG@
MKLUPIQ3.]\RW0M]JKQ^<K'#6QM*^1CN+S"03GD:5.6#::MK-;H3)GG<4[FNR
M[X-"F:%05B..'>$0A6=AL-\#=V&AMIXE$QM02XPF97M8GL(?A[O4BRX]N\*+
M(75OD;B/^)+[X7>7,K=FE(1@I%&..I9'F-8%0,NN2&-2M*BE3IN?1)VSL(<7
M9[FYDF$M#B?6);\WQ[ZI:6<2:X^1FA90]\;JAK1UE_L#@##8&OL4K)%_V(;E
M_0LNGSK4C9(0##RV1>9&0=$4(Y<M531A4R0YO>:#PD"-@8=?;5M_-4Q36*%[
M:]60A%&0;H""K#:%P5E,8.Q0D-N T41@M YOVBB,RR3&I4>L9P.['?E;;U$-
M=J@]&1+43R2ZHYY_!A?09!OX,<:E'![@$E8CCYC9:37NAYE-Y_8(V_!H7+^F
M0^HXL/?VCZ# X]=$9=@!ZC*DI]\>]HF\S24@ O#-:JFC\E,\+BS'4RK)9$B1
M8=]<STO</NPC"0.EFX%US*O.PM;U"]E@RJ*6+?U:MKLY6:/$42EUZE5N+!5A
MW694S;8=)"KZ.E,+U MS-G8]6S=2#QZWB(@_6B3N_<3]D0^9%>TE3=-IUL"P
MOZBU4NB*DY-J/2%<0KCV+$U,+%QU%*Z6TD[-LWZ*'+AP$ $M@=:EDS=P79IG
MQ/DQ:;6'/='HSL*>N;WI?KFYO7FZZ?6E[MVUU/OG]YNG?Z?10#L?9GOV#<-S
M3Z^S<(6$3<%-@PP,T_ ,>K3.X/G@.C^MP?-!K[-K!'C'#C^;D!D[&0AKDNR5
MOE@Z':R%S0_VZ/-'!M$@>?L^^-7U+AE4'GRD="V=^;^N 1Z;>SDU,2=*32'\
MST]D2V"_N-C?L$W=$_N8]J764NO3Q$G:5WY6MGE+\&!Q$_&P@UN!!P*P!?0M
MC'7(J=7&BH@85S")V01\-TS: ).:PDVO^.+E,>1]6P)0<J84.$],5EUR(;V2
M9W@^;E &U*)#0U33[FG&!Z3M!Y3]'>D*)LV7@*J;I;95+75:A3+F!6)B&;_[
M(P;;%%3KW$#F[&S@FZ5L7F$'IV$'HR#,4S7I-NQC X*&J'PH)E!V6\+Q@:(R
MH*35 923_+#\Z,CW?5N68D?"PDRI7\MM0-/9%C&HP9Y0]&LI*%H2]6N)@Q9L
M2-[,2R%$\0S+U<-S#E699V(TQ*DZN%V0<@OZ,:[6:'/3/D,8ER<O/(B'$XQ!
MU>O<-.TYBUR]U;-T4K(FS[JQY@Z]&4\46J5.0TVA:VM.$O$%N-)1MO' U09P
M->7#SRP3A^.DE3!M6\]ECSKCR 2V),;&60O'+LT+5'X"(F,FS-8:R':UU&FF
MUP:&"^6;DC%[UOC:I7QCXTMF^$KKS$B^]&\>C6#13^;(_626[)+H5B%M=M0N
M-QXRX4\]I>+< RXJ:]3&"US.PDA]H)8;GN7E5UU,;-=SJ&<X%'OM'I;I=";.
MLEUGO_@T#G.V'U8(#&("[PX36?!@#G=94+9:'!BN:HO6+\4$U:ZC7(X%JCH#
M5<%2 ?A6PB+\?\+P_W;T-TJ=5NUP] N+E4? [)<!L!TP3088T5@[BXT]'M("
MRZ!_&JTP5%/;X5\MT761"&,2US6&!M6W"T2+=4X^6""$4<HC@&+N^0\"$+;>
M;@D#]/2I5.8\8"4,T&,D4VV#O5*M8G+ X9MY87GRB)2$Z53;D2*7.G5QEDL&
M"56WZ>28GG6X-7XB513TE5*G+2NI&0<BB%\05,7/H(I"%9Z\6DM!HYXP=!\.
M(J!8(U$/SY3Z$<::YZ'-#D\SN+-8Q&!7-C:"TVXQWH<B!(.GE@9R(7W _D*2
MW/B87O.^I O#FVM<6H;Y2\ESIO2]#"^-OFO!#G-I[ M)KOG,S*[KX!X3;Z8Q
M\?I\XAPI".[N/PLQ[_TY-;Q9*CU'L^J_G'F'9=UX"9\=/**,UU\JU:7".,/2
M02@ORVTF6]FD;SBA+]SU;.W'A;11\;@CPLY!3A9D#A_?QZ?WV2.Z4V]D.S!(
M/6&W=*7:V*(8H\>W*[,BW?$U2QTUHJ!M@UD(_#1Q"O[()3)_[^>D7-ACEO=3
MS_5@$0=DSF=27<RDE9C2>R!AQQC:IQC#C>M.D=-KKY>KIP#;YM?+I4X,).W^
M((27P=[DYVDMZ#Y7\J"PA(]VG]RL%:;^BYAH?RVKC:'Q1O7R7]2Q(S2&K& '
MYQ;\^YD3;YSPVYXT">LP]*B\H>?4]G%>S"S<@N%*[]M8$^)(+\AKZ6_;L/1
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M>0BH_V7VW:7ZDIQTYPR($A7LD]924SO!@8L.,.?6)2V31.T#,%<O==1J\_!
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M]Z%*.R0*>^ E'@YB:#O)Y L?:"3;81E5ERS?'*^"01)^!R>-'-2G/^WF("C
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MYU[4]O.M!A45:SN^*+E2F)_A8%U]C![*.?%#"/"FZIU- EX5P%M/VU,AP"O
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M 60H86=!TDK2>E;COU]:52ZMDC=D!#N:6/F===OI-<1W/AO;H?+%&G&\V%K
MQ*3"3PI4"EAV7Y32CJPYS EF9#U;ML/K406Z();4%H)^Z&?@R?P& [R?"$+&
M=(P<X8_Q<.ZBT;00CF-FA?_3LE_#&W<QNQY[O' >GYXF-EIKV,5>OSOD)L:S
MF"V<T+X6XC=Z4WSV[#G/G QB?2?Q^KY#*OV_/_4UK?-A:^WYI^J']U>*[49(
M)$"L$.'P^.\."\%?Y%7 T5/AMV*4S$"X6:=D&C'T_:@>5\711@Y9VS_BWJ,I
MJYL<L]$:&@-S#^A'9:"9"FJ.9556189_B,IX03C+HD@P<L_LM>Z.PIPE5HWM
MKM1:L :1NE86!X(H@#:ESB3?SE[K94T I7+D6$%@3VS&6_5&?D);^2ZP]'TV
MP4EY"H>T&%PM16('KQR&;9*#U<^(O")_=/FA5[I]+'KV[6>.%Z0(*'G;<I05
M(V] L9Q#A 62%4?/&RV ET3\..3X&3Y<Z"I+\S=EXR<$K B\D0 ?YKAZ&S)3
M"TC6[PL?CY-#E P^T>6Z(+0L_!YR)"_T:'A>R1)(,."J#5$[? 12CD#8T&R%
M\+_" O1=[0#HM(+_$&BU0#?.1P(S!&Y"-%OV"E[W>.,VAVU<W09.4="K#KD=
M%E#1\6"XVL'W>@B2!<N$>&>6_[::Q96"1<TK-?:"J3%N8*.JP\&!2\T9$\:#
MD_7F3# [O'>W9N?(@?!6Q*%S;)YOP_G <IP8K9I3;3F*7(!;.>&!^DEXH#.Q
MUA[LH$$I[*!87:SIB%MW_+\@>VCO<,$XRLP^@"'-3 (,:68:P%"6;I(-/B1&
MD3(V[9QH08C1#$;90W?\<1' ]T&P)@T@J',/S*G !7VV?-N#7WT[^ D2%BQ
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M9:2J)[/EXU$ACTY4%G^^W6&1OC'K-*!63:J1@/:3)R$F2DB#RL2);];X)@%
M)X]O^DUMUT5\HW8SRHO+\,V 6@HVEV\RBFE+\$VW4R5]T_A0_MX^%'FY_D)Z
MO70SZA7R<WWNG..N]$*$"@0'B*?6>"HCW;V,)M6:V@N(^$;M)D[6Y/'-C@,U
MXILF\,WQ#HZZ1I7XAB! R\!V9M6Z9*7WP\.^ <?X]FB; ;<9[L=HRL8+A]U/
M>&77BNN";U[X:9D6?AM@/1<PQ!HS_ECF==]/OMBNY8YLR_G.?.Y=N2-VZXY7
M'T<%-+]YH@",%S(\P+@^8@/A%0^#0##@[#F,$%[#SEEP("6QWO7"K>3Z*'_>
M$Z4%C4V9U]2V:G:EY%P/VCV]6/+]\3/F:4SU'9/>:1NF?L$Y_.F='VYGX ;P
MDR-T0I1WZ(:\5_Y@(^_)A<>,,;'[ZT8%4_/3^F512I&7YIRX[!)Y]>+K3=+)
MDK_>1 H+UH,HL<N)+M?2947A%2)ZQ#*<\Z9>74 E3OJ"4P%%87I==!G.<;A(
M!B/5DFJGX*54XEX"[NN=-YMY8SM\4V! CN+-T;)1'1 E5N^/.N=-K$X/.F<%
M N.@]3<6IL6E>Y1Q31G73<FX+BAXB93K4PJ>F9[*(T_PZBY[%RUX#9:ZO!W:
MCR)U?:J')7-WH>8N;R/VHPC> "LL.LTW=TW=VTKH[5*GZ=[%74LGGO]B^>/$
M+CXE;ZKIZ5&]C(*(8^B-7N> O*GCJ(&<V7,UY()B=J27J&\XH1V!EQ>*5Q K
M'%,A9.3\'X4!>.)VEQ1"A11"(DW_E I!K[Q"J*<'E.[P42^_ IL4:NQQP8T]
M"NK0O&!P1]&A.XH3#MV<U[1G!TDU2;5DJ4X4%)U2JCF85A)D@*2:I)JDNL2N
M-Y&O<0)9[AT!=Y($F@2ZH0)=T$R?,Q&DQ[''Y&5@U52J2]V_HRQW56B;491[
MMC+6+P=WF\)<WBN\UV?*BX6UK,H,&-"W+4>!U_#:5^!3EP6!PEOIP:-"CW>"
M$D6N[:W.9,7*F+$!'3)P=F,TC-B?CLR)Q&=.9A!1IJB=&T''R&@6JL3^8MG^
M/[ #V2<[&#E>L/!9D*R0[O6%;@$B@BH(H\_P:9MUT_@TA3].^9U9^+"9Z!>W
MQ;3I3%JZK'PYF;67?P=M,'H3/U,F-DB4?J=WHHNFFT*$L_:G^[+J(&=C0[4)
M7,$+OE'XYD R%$$K5%Z\A3-6'AF(S(B!^'"9"9CC@,S!Y0$+%9#8N67S+T(?
MAH2-[RS%L:U'V\'4[W=P)7NU0_'8]TK4I@[^<D?V'*03'C!#%%!K_&RYH?7$
MO$4 LNO_A(?'%8G+5ZV>"\^!)W,5[KR)5T>V[9&%+XRY\3/F%FII>!4O4!=O
MGZT66L$B]NW.=.L=]FSF6_YH^J;$76&C>GK;G2_@B3!OO% L>LA&4]?^SP(N
M602"6M&KUA]INZAY7-X;46@ZASTS)[@IP.#K'2\WZN1[V#14&(1K=,]NND;L
ML]E8OA_>7*M],!/G83S$I])Z2P_]]$/8I(UJM+LQ==*[<?Z&*Z.HYQMP:WBC
M_-VUQO]>!&BS_K/P\!\N3 $7 F[7(F8/N,38N,SHF BY"=8%QTY8.N*D4W*2
M=EY.^BJ4EF@2"BK>W6(HKO4M4%?>(P(Q<_".W4KX2F$V?]+8!@,1@AY&[G/C
MO[A6#5#?C9S%F&V]"A\;V#!+RT_GTQ3N1D\O^905O^=Y9/RLY501]D2\9[=D
MD!Q(E@/]W!IUC<%C2XX,X;.) \S+&=YG<P]\!_ 'D+_"-PZN:'X IGKAWL]B
M)BK:,K<.13=?,3TNKQ&X28W +[@1^.X]E):ZA]);!P.(+?=\M]Q.W+KCWU9F
M(MH'CN_=/]AHX<-6Y>FC%=C!#B PLU-I(+  ;"6883=<67%A2=<-HX^KC/$5
MT(%K6Q58! N_$T10'I$*]<+V,CIM4^M5K\ES)=MA-W]0^U'>&I2QGWX45B.
MG/1I?;0<A&L$-546N4'M5IX$Z; 5W!2A.=T9-FUF#4IQD*"JKFOZ_);85[@G
MR(GHTF30EG0J;07D".VF&.$T(MQAA#M+V^XSSGO?SE3LF6[RL)*,NM4*4ZF
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M&T#):15DJ$P/_C@LI1%+-9>ELMS<4W9[-W6]:AF2Q&TG=1-/RVUU*T:/&\_
M0-ENYKS$JR[A1$,RA%/>/7>]-<YA$$Y%^YWKF&;5) 1,XJ#2.$ZRVIWKA C0
M;/XZ$,RIL(XR24<UEX<.0W22IJ,J=[9W";'9<[?E;-H1#36;/=B/+MQJ5A^T
MAFJOO#FJ1*]9"4$BDEJ2VC/L70K+K=&1>AA <DMR2W);?$]87&Y5*;L_$EL2
M6Q+;@[?AQ<56DY+P5 FQY5OR7T(+7@C_CNWG83RM;XL9+,YH^"O_4,P)VT4O
MY\<_7WYY0A;0LIH&*I;/%-L=.8LQ7/!BAU/;53P\Q53<Y9GD\EIWS*]_QG4?
M*Y@2]Z18RLSR?S*X:#[W/6LT51ZM +Z%5_QGX87P6_3]'$@$DX+G PF0#YY9
M]%5;>9@R98+-T_FCL96ZM_ Q?K/CQ.AJQYB7 X:1[IC%%?RKO##'P7]WW>5X
M[M-UR/S9>JH8OV&B_&WA,D7O7"E:1S-@(,$6/5P<FS=CNPD"\WJQ_/%R?NQU
M-,738<6W0B;(',R],/XS5&!,BL_FGH\)A\H8/DXC&5XU2D)E9](J(DMB(ML+
MVU:^.PRF D,!AE)"3_D&TU$&5TK,Z#NX>S(IQ]W\B3=V"!(YRN3W?56TOUH5
M'ITR]5$-_\GNLTY_TATPB^D=HS=0K<<.&YAJWS!9M]<QC']U^RC4,8Z7\L5V
M+7=D6X[RU0U"?\&3#'[]Q1IF+,M1E<X5<K<R6?B<U\9@)!9!@'HGDNWQ<OS!
M+O$?I0*/EA+]'#R^0ZYVE.,M]</;53R<]8&DZI$K$"#'0D4 (H0/_P&#"#]Y
M 3O*@O7:W1PK]F'N!3;G2#XX6)</:$:O=7[WME$$+2 D"@RY:7PX)Z,I(1M-
M77C9TYLRAY%CT%]YAV3%B+[6^4#4+4/=78S/B:M^>*^\6&C387(@HV\@ULCM
M\)B5A(%@/48R$KT+OMPRD5=<6D Z?1;))U@]AK9ST^PIH%-F8#65B<_^LX!!
MP2OMB3*R_=%B%H2@!F'J8WL4<A-YQZTJ=SG"%*F&UWF/0/'('_+1L(W0@QPK
M?$Y\A/!"]HI>$]M4-_&'[\1U[_$E0FF!0G<#[FVYW 'EDA[@B+ABQG>+>])T
MS3@K7QV)M.U/1)Y5I*J$17E#DK'9W/'>& OXX9;Y 5X,^C;$<2C 8XP[XT%,
M^W2]FJK"VLJF;XN.L."4!1]QMBL<,W+$;:8&[)@4DA=['$[CG<S:7=$6H+.Z
MQ7H$8B_"W;>L.?HCF#_S3[\AXQ*E]K=(M_9SZL>CF5M/[/K19];/:VL"@[VQ
MG!?K+<!]R-J<0-"NUPFX/7?)'MF@R@Z9],'E]\?,UO !MX4H@7@TO>U_K2_Q
MEJ!$&^5>KW^M9ZR9)*XT4[F2)Z[N\B13=[&5VN+^DRF/8#,9>,/A--HPC2S?
MYUK0FGF+2/%R#6T%4Z[R^"]@1L /=;AFYOO;T4A<#;: P3>XK-Q*O=HS-$#P
M9-#7*Z4-Y@8TMW#DX#.76;[0EG#UPD]5EM4D(=HBL U\EN,MJQ1,P0:+:6UZ
MM6/V&*99I,TM/^X$HBN#A;#1:&*4P(9Y6+"3A$<)ZJ^(%ANET3)'&HWR;[#"
MCJ+%%FK+JD]M<$[\T?2MK=R&?)\NXDRKS7IX\"31S?ESD6!:9@^ QW E9,MH
M6EH,#12#UM%30/ 4()^#XT!GP?+%AL+:9GR<F\R1_P:$>0"ZX S2AFO@<+OM
M_L[A\M7Y!.(U>V1^M$(J7R']I"N4B<*?>X4P?;9CI)PJ+E<(QYNBE*0/.FMQ
M>CC2WK[%*>W8X:NR;68/V.1T*B_=Z/'PE:K>"!Z,8M(;(=WM /DVN;'$PV=3
M<-3!6_W*O7I\Z /<\M'Q1C]7A#=;T58*-C>W8?09/I#!(LW1/_6!MX:W(]C(
M+$1T0-CDC5<HOWE!H"3BSOG-2Z'9_1A-V7CAL/O)VK#XJ%+FC2/C7E#*Y/O;
MT]SA!D4D22&4=AKG:+=IG'B.X[V@Y/(3 #!M+.!. Y?JS8TFJF//C3=[UMJ2
M1J&JC26--IKO6K?W=U];[Y5W#E#R_16X$EQUA]:KB*7ADP/[%?:_;C@-%.;B
M5BUIY&Y2N$$,>;EWXH<D0#S'F@?L)O[E0UR48KN<!/RF#V#)GV"7$6VX4J(5
MW($67Z_V'^V.V(-$&8S1FZ.OV_#5+\G/-;,-^BGUJTY;3?U\UZ/43KL[Z!=Z
MU.[/>YUB=^P<5+=M:L7F=X)!]=O:H.C+CSVH07O0-2LV)K/=-_=S5$;*;ITR
M<]_]&559Y!$$[W,@&>Z9G8BV5&I^J\.3W;5GR;EE@#'6BP0B-HK+C#O@\$VQ
M)A/;L7&+NQ8D1)-TJ13ZQ"8\COW(7/@MY,X4AF1C=U[8<O&Q!]L$%MH^#_'B
M,<2>!GD-)UM<YLD)LSR(YG^%/CS7286QO!3J/'BAY90#,ZUAI<='R\&PS]5R
MUZ_$&_X#4X N/6_MLM+2!AG9I#]"V&U./0<H$WSFUJQ [9<A#ZFNZ!I5.WF4
M9.RB9"PC]3--QA*RU.U@EK9.<D1RU" Y>E=,D+1M00I@!O#;81(E\/#4A$@E
M-N4D321-#90F7:HT(12@WDLY2B5Q(G&Z!'$RI(J3#N)DZ"FGR=42IV*1>?[X
M+D_,K3+'WZ<<)8JCP_A$\9%A@0DF,D4Y-",>>BL%MU9.;=1>?+HYQ>=^9'_D
MU/]CF_C?6'@_>;!>;\/0MQ\7_)#UP?MN[0"O[1JM82]E1Y5?P(HN7 W0D"Z<
M"1/Y64=GPFYKF-;+F)BP04Q8C >SL.$/9+W<4=ONZ3J7$F^>G3<+*LC^R16D
M"5:Z7VI;25S8,"X\.0_V6T/3:'<KSH.2CKMKLDF[G2V+259U#-XB5":^-\O,
M#-W8SE&C&@G[LFTA^P++<.N-; $L&GZ'L7KCHH*'4( I,1!J^- $SLHHAI'
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MG27/)35WMA$KQAFC*1LO''8_2?((%X<4UM!35DU/LL:>=4]G+CU#WQUU\1_
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M$EJ1P8'2THV4CB++P<5\(@!*]@.3&'PJ J%D$]<"/^<LO^3PF*GYTNR<O+O
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M;O]Y???/F^O?Y1IKL:I!$V[@NZ[_C/9,SL7CH!LT$A:\GSJ!<!$$[0%83M=
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M>)[(;715L+@";@6!:YIMO:V0JY!;.>0V]+ITP%5I#D</TU?WJS0'&6.DCC]
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M#S>W7^_+S?8XV/L=V/EDN3&PD[0?[&V!Z6/B,]I=<9#82:'&G8#Q! T[V)T
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M]?+SY=>K:^W^;]?7#]KEW=WEU]^NOUQ_?9"LR\\2:*[=.PP&%[,[_EP1KR!
M%(@EEFP',#W0809,34NPI3[5/&!A-X#K?3_I/;<*.(B2U7N&7+>Z)RMP_!A?
M$,8!C5JX<D/:6X+ANE)"Y.+9$LUX=_-P<W7Y6;N\NKK]_O7AYNMOVK?;SS=7
M-]?WU&_J^O[AYLOE@VQ]II:ZZ@+&3\\>&?,0<XER21IGXXF:#3P2&1N(@6\^
MK):.,/BNP\@94Q?GOA/:KB^JS7VS@DB[N:EI-Q$;:YW$F*PHU[]>_YYG^/T#
M</KR[F.%>)PL(AX\U,I827)M!; ?L/K^!,6S7WJ5@AV&]A5$6S-KVAKOUW;6
M6C91&6W)_8]N<V.RT<&2E,]YX;Q/.)HW*H^!NTH(]M7E=VP:>'GW+Q3J![(=
MM+OKWT"X4= _W=[]#A\O/M_>_ET(/K_FOA(G,>C2%%H9S5[NC+#<:>B$?.V'
M_W[R@[%FU"_^D3B$T"LWIL.V9X#1A>O[/X2FB%@NY +]6*D/(2L)3%[PSON0
M^T,&?(VP0K#!)XGKH,#74$,WEEA&\(:DFVY(WD;+#?W$PEXUKM29E5C*(=I2
M8)^0!UPL:),8+"&;[)%GYKKX7Y! =\5S=>T^MD?Y%R5C6>XZ";(IY/8=["F-
M%I@F/E1N/FG<G>:2AQ38@NGJN.KZV0NPDBZG!ZW7%MAA8]38>&H*ROT)YCWQ
MP]"A^B/P%!@@:(3!=!7%'J<:&GI##(" -2#$>5K\*,.LO\?#G!I]-MXGW_%I
MSG\KG%_S7Z,;T^O/?XM>JX7'"O;/?X^8=+R8)5^3.<H=931BH&WH@.18 595
MQ%[+W+GH_1OL8#H61H<:<!M6L6%J)J,'OD:2$8=AXNL2/,H=)!(24^\N? ^4
M'*-9.XL>/#>(T*\W)%IKP\!_QG<"2OJQ'6E]H(SK3Y#B-8!F\ /L^,051>_(
M.]%T[1(>NR!LB5,OK=B=&PV"A",+/^7>)FX&&1".>HJ9 '/.F5!_;/0>^C;@
M*VUBS4EPD3LOR(V$.]K0-O#%>2<-/FEQG49<I 1(6W_2P&(ZNR4?8?9,&!A.
M#)_ZY#"XT'K$,\997N2:VEZ0WEDAJU50RY^6"^2,5EWFE5W4)JMD'![)R2Z\
MQ;65:AM@X%TD+Q8LF=7@P(NA%1 X9@;"9;,(H(+K$V;]@+>"CK-"X;-P CK#
MII,*C*;R86<9COS8[<-;P(SZ#_>GUS1GP/W@[I3VOKG1H"[&$P4+@8RP1JAY
M/SS_V=,")_S!L0>C"'!QHY/:9'F QV-$!WD_$H#9]/(GW TGE\& N;\>!&6&
M%3@K>/V_F2V./;))(!_)>X/+ )ZTXQ4L/;L!S6K3@5U,ZQ,_!R%ML$I=5P+<
ML\V D0YD3CACW.Q98AU#$O&#$B(W12+P<\)9;@"I^LY@ )JEF /..I*]6[33
M4G\X+Y>+A<_0'2Q";"\P*/I=JYE$2CL>+J/O+HSN)#K2(0"M?>TC!A;,TL9H
MZBVD!5\">.U^X2::.>>E&O_$9'[->\6) W$"SU)9Q.T)+B=DYP@K-4B/HQ.G
M'J[#V0J?M&$(Q1J@X3F13P*9._ C6PB?#8)-):G#2!@XX@4@;\C%H;!PPB28
MS[;2T+S8<V!-\=UXS&HB8E.HT %LFCER%$H.AI)Y/I.GCUO,O$#6- E,R X(
M9EMXX(8@L4A=6!Q!&3N\/PD5D:2EEC[1Q;A#";PP[2,A[&':E(7Q9,(W._#+
M6#']4$RG0)(@GJ3;TF<PPK@.2+2"8 6@P?'R>H&D'8/'\,Y'-O6%BJ<S(]]-
M-XO  $0,/AG53@TTA#?$BJ(8_66[M*U+O,HUS<,D#0Q#<T+8' -F0!, T-@8
M]^2PB%.(+6U=\2)K#/8IQ1&KF( T)J"G8@+..R9@4^5X)(#&'FQW1GX M_33
M:#\1(Q8(G]F"R4%[Q=0C$DY!-XPS&R*W2^C#=NF)P5H%'T1N5Q*,QB/<\K%3
M0,_ >L[\@37M!YOF,E70<H)]6;+:#1R/!](E2Y5:F ZU,-'YD@/Z9XCQQ,,8
M]#7E:4W0:L5L$XI.& -(R/D&BPWAB-(V1-NPU)X@@P06+C^8^-P%$.=^S>%)
ML?-0['P>L5P8*9J"%&E*?NA5C$FE67"(QS]RSQ =59)[5!B9_2 >IK?S>%:,
MUR$#@V.),YMC91"[.00Y_^':A?Q.?L@*\9$E(,$NY8F%E">'3@N$( -8QID3
MCOM+N9/9<FO99@G_P&0*\M_3^,%B\L&^T9Z<G%[*DZ*6YE@@E6H%DR%-5B F
MB6T]0YIB@9C3=4HD7D;#,9<W?TIC=.<7J '&U><B^E,0@FD=8C\I!!]F2($!
M#MPE0< D98>"K\,H=;GP$Z\$20)#](* (LD+1&%A(4XA!)N#JP @ N_^?\Q#
MH9R -0-#90@=W. QA9V#86?&)4+[G['SLY:HG91)L&/I)S[0@*)IA.?=\?OY
MK1SWV6!XV 5WGR(3R7W'CVH2?42YSJCFZ!V3P&$1.L*3@RP?/;%XUJ,8?RC&
M)]D@W*>"CC-TXGFI;D>Y98,!AE]Y:0@6YHB,F 4Z!O:P >WU%8<.Q:$^P\-:
M)@YLHI$3]"\F5A!-N2/%(=L'O9KPG4?^#3K_2+-HZ$0$GNJR"Y']E-U'094B
MWBZ+81 ^4F$IY%.Y NV_8='P&)HS_'5\J0& N Y9$A\MY\?45V@XY"+O^MP^
MHZTEL-'W/$:1&ZA.W>E%^(,OFVP\<?TI4^OF8=DQ8U_Q;22O(+' A]D\/#RN
MRMHA9_JV)H[)41@I]Y59@3W*1:)0/E5>,''U9A18@MN&]&TDQX2/,/FV+[*[
M@&8N3_/7'@$"8@'(DO448@Z)F-R&D:QG;K3#VNL2]5-KF1]9)1@)@?%X&UI(
MD9\4)0B<<&ZY1OC-P"/OD>+/)"<XEFZ"_5W@HA9!#SN+QQ<\5&/&AZ6P<$@L
MD+(0*^XP$#OOF0BN9=XJ?NXI]ESHNU!.Q$,S;"[BP'^DA&;.#)%5[8)X>>*T
M"[=)_XY!0OL.%TWX+DUM[OOI^;ABV"$E+#F;PZ!)Y@WY[O/[_4?D!O\-[6H_
MS4NG(CW.@H[$1UW'@5_3[G_[R)V!'RUTWVM_#WP/3-]_,5BZKV"RXT<'9O^-
MA7#MKX'U'[2-/>V.X7*>>$ON_1@&\G<?-+NG_0[[)_Q%P>" ,)CXD?!M67W8
MO\(6!O:US.;QTD/7?X1?8%/K1B,;MTPN&SI)I2<*C12' #RV* NVQ?4T\9W.
M>%$J$CSGA*"R8 FBDH,#/P!4PE.G-5!.$44/6JZ;.H(*0NDL(N)BS8T1%2=(
MXNKZ+(2-YB/KKX^@*PC-))N5,H>$ISE"9R4.+@E IQA'3 _D0<=I*+JH\I ?
M.Z_Q1,_%)Z05)J*4%/ LK'' 2T8PBI47@\-GX2,S+/&(3WSF3,BGCFD.VB .
M2*=D@=]B,"'+F?-B8#ROB106/#,=;D&2F\AQ,RZ7)[GEX\73S+B0QXV*&VF^
M?\3P(T:Y"G>>;+4EBU%[_=-F$YICNJ%ZG&HN&*UT.$OF$J\F(XK41-8/2D;+
MDE(),)29 7./)[PJUDI<4MH#,0S>:PED)Z97[CRY-A>EC$?0>-NS$Y:M#0@X
M_NNK]:?Y1KW^ZNB)33</UU^TALYS]?B___']\NO#S</EP\T_KRE5%;[XG/S]
M\>;^ZO/M_?<[3&/]]?;[@_;E\N[OUP_:W<W]WZL PH)4UH6$>1'QQ'Y.>$(4
ME=^A? R2<7&6E@]&R.?USZ6TKA!W5=YD,YXUZ\M#F<K(6R.5-Q4 )='@3JPH
M"JG4YE%3:O/J_&4&LB1M]O;KP]WM9U[QX-O=[=7U1UPYJK!.?,SR844D*\_6
MR?[@.P>;]:FH%9C*H">YCYA'PP)0IQKS^ K"(RVR!2/O4@:K=<9<Q,6"VW4A
MGOJGWE_:RB8U:"_MJ);&UA8:A36TM@,4N#[C.Q]T0^)'7NF&Q]UY?7$YZ^?K
M1*-S4YP0AYB293L#)ZL$<G]]E6:"!7&2XH>S Q.ZB'*B-F*-7H&9>UGMO]I&
M)-TW'>^9G12!SY,4%8O1:_ :E]:8BAD0'3%M;!SS"B9)S%F,L3NBI F^*TN3
MFS]^NX)MU0!>!"\EE\8M'LW"2%Z+]-6KZUN1N?J&UU&BZS^E.:4+UW]*KZ=3
M_^2X0"33D04LTEV3V"->6H4\D;#WY>%#/NZ*_.?$DPW*V0GG4O=2^F;YX9+M
MD(LUSW4:A84LS4'R*@^V;RG8)-$ZEUXN?HQ7C.(LG0%O&,.W3\0KD;')@^&$
MYPO3=L7$U\#R^I;#[=-MZBO@WA4 J2><VOYL<8!EPOK:RIHB@.S=@5;0C(9U
M8;1>LS>;"]Z;6I;UB;5$TE@64D6\SB7?-Q;J//3YI)4*=.W7)(.5+LXH6YN?
M/M\0P-Q$B7V>3<I'4E3+9$.BX(*1$K02<G.5;8%NT.+'H\E$9"21D5Q]-,'^
MM:71EE4N\BFG74PS25A!B.7R^;. J9D6(DG*+W>DX2J!6?-4M#5=_%WG!^/9
M2PLWU,J]^U >B/;Q/1#?+N\>8+L\8[/>/OSM^DZ[^?KI]N[+)19>.=#T>\>?
M/NT6C)G9?[[^[?(S-Y>OL;Q,)>SEK[YW*#^98<K"ILL9/J'+2_MT>?5P>U<)
M%G'7E[6D2J2H>[,'+[9R:VWHUC+VXM8R6LJM)>/@3M&M9<XHP.]?[ZY_N[E_
MN+Z[_JC=7WZ^OM=N/VG7__A^\_ O]!%\QR*8HM[E]_MK_%&L:E71E[D2)=05
M#X\@G\,9#P1MOD3_'7X\)1K0%+:S&EM]5KIV(J^_Q<LRI4E!PA60!O'VTS?S
M- TJ@U6P)ZL_7AC=U]:;UXTW2_Q*!<50UG!'T";1R)C:CYT)76L2LG?)A_>P
MFDQ<:_K.\8C6=--[$2,AU'AKLM"=D 2,_YSI)[W.=93H(BO>+'[6X:>W!=]W
M]4:O7?A373=*?M\TNZ7N4(,ZU4$UZ\V5CUK3[;A*38V_D1-FOBGIBDGEV]"6
MFSLWS*2:_0/U1?)B;'5$<>*\:6&6)?[:>'.NM+F<Z:\XL9Q^KL[?&=-E+6;0
MPXO[*@P;3^):+,_S,2RI+PKI^$%:'_V<:7F)9Q<_>1IW'VV*0.,YB!E=R4,W
MMJ;:%/O^Y7N-9I;.>IINVY]>&#X8[HG-EV$7"F* =*E4Y_I+D&%7,[0++3$_
M-P!<J8;DZ?WFOFA:V+9<OM[>9K-9ZQE;=I+?&%TR]IC?@8W2"4CI[O,;3EYN
M[#:Z3;W>/$'H*FVD6'HR+*W7:VWX!]XB&UM+&U4#^K]*F4Y?P/(DP\G8P7":
MFW=I7!?0K2KH-3JU=L<LB=QBG!Q,[9PO>QJMCMXN:P$H[BCA4>QY]<$PS5IW
MJY5Y3RS:UJE1I?473\ZD\5Q4$*3-=JW3,K:S'"MF]E>0.PVSK;>VW($K[BC9
M.6?N&/5.K;7+QEAM?S<\[#KFGE=X+T0L20/8U/=CC$PA#\9)>7I:]5ZMT6AO
M9TON@TY'VB8<#0+22=OFQQ#[)(W<4M%H=_1F]^R$0NE(I2,5' YG QX9$F0[
MOJ5PV;(Y%3-EM1IMB4J.Y8)N7O[UL^7&VGJ#NN#<>-HG]AC$6*D3LUIXM;A?
M?2OH\R3B@(E:5%3/$:.W1(1;P))(HR2J2 0<I64#,2@I=U4\P5#Q7PQ=0/$1
MB_OS2H,BE EK/.<"QWG[UJ5OZ_N,5];B/9\]K%WC\(P$ZIRZ9C@S(>H^S_'W
M)\Q+RM[XU/IW$CA/\"QW>N&QH1_QH/,H "Y826=3'.1"M!M/S<]>UR]H/D"5
M#/+/XFUH>15M:GF*S58=)GHA)+6WLGQF,5+L?N#PP1PH&:V[F(RV,FM!93W-
M93V9>\EZ,IL'RWI*KH,9VA?8M@[0]H[7S)@N)YHD64>YE*B9\;.?(^?1B=[+
M-^*#]S\KQ\?#)U&U9Y*HKO_OWVY^O7E(,Z(JD4O3U1M&8R\9%-T>[-@ZIY=!
ML<#_^FJQO>;RJ7VEU;-$C'>UI_V1*HQ2+Y(R,=@E)P]&^;$\$KJQ?U[RZ>P_
M/W>C.1US[=EU@&*I83\;!E7*<5GH#[(&:/HH @FYC0/MDI=^(D/UCE$UT;YV
M*6[!Y><FO8G*R:1%7C0>/H^E1W@!$BN*+!M[16+R/59<PKHW7-0!&WK!\G5:
M\#<5_&6#_RB*)N&[MV^?GY]U&*<^])_>7L+6#. ;OF7]H16\A3VC]=:HMSJ=
M^EL<+_]H-O!SN_M65$8+A&0\3EWK.?3MR*RO$:%?Z<J\O-S"3@ZWB[C=IE(2
MKW,-":G0$XR9!=1("<0GDQTSJ5AQY8\!!=/_%6:5GY)J4$G;P]DZ0?=L$C':
MHXHX$7@UKP^7#J;-OW]SZO+95,O3"<GG1:]W07^UR</W$X71??6!Q )]+.3>
MP7+GSH J%Y)\S/A^-A.^YJ+H&;U>-Y6_OR?RA '1($KP8^\,1$DM==*)TFI+
M+S7H6C6M4].ZM%;UD@(;R@;<EV TE&#()AB'MP%32;DA";KY9R)7B0V85=C%
M*CA^/!PI8W C9!]86IO:00[FVMC39SUR%\] \$3UHJ$7N#.QZQV7NGP*?\:8
MBBO.&R^,@IBZF(A6WJ)H%)T7TQ(T\MV^Z CK^M[P G ]AFL?L3%06F<7?OR=
MB79U3L2[U3M]!X_3PEQI5'_L1"!E^DGZX8RZVNE48Q5R?OZ?OF__=</5J(F?
M6ZVWSV%T@<96';[CZ\\#MESF1ASU@*)%"'MR4J].5_MDV;SO57I)C8[*^VG9
M9W>JF:D)!WND87Z%H?7KT0\"[)G^O[!D^@1[OE(;T"<&UB!8?$GQ:I=1)RR-
M]W^.$BL0!O2KY?W JV , >"JIGW5+_4:+^G/-*L_!J$')< ;X5E#G,>*)7$0
M^&-:8FGMZU[\2)8RFDN7S^7D-V(-0XFZ?**..S'C#Q,1R.7S*O5#8)#*(^_4
MN*Q1PK<X"&/+HP*+][P?6E(BT4RD[-X*'K')^<7M3Y=-DZ+R9AT4PNDC7OD>
MI$2\N2'B%UM]*,2OSH73C?^M("\AY,W]*'FCJWW7[_4K/0&_9C1:=;*,+OO^
M!$V? @G1>O6V$@X0#E,)AY3"L9_U0 G'+HX 0[_Y>G\H\3A*WB4U(\5&RS96
MQK3)992%A%N3";."I'4;M9RQ^#D%[JEIAZ@],MN*0T;NH?_[Z]UG+;*&HGW1
M^)'U^[/-X7C0(;\P>=^INHT,_?[J;Z>$EIL<\QZLG[[GCZ>P&$?,HWYB]_:(
MC2WMHV#KR7+UZO+S&7'URG)MT5Y;^^QX/]!S?OH\_GSYZQGQ^+/UR-PSXNZW
MN^LSXNZWU+M\5B+\\?K3&3'Y(YWR[<[BV4S5W8J1'Y/_&Q7P.HFYYH&1!"I0
MLU,-<]KXMLT)M7^D_4[O%ON=)NF069_F)$ ")$G+OR'!%&P-BPSW<KG&+Q\G
M8.XC3N 8N8_:[WB*AQV?8%L^B //"4=)Y,K]]55-BR>BIS4+L?\L0&!"":]T
MFNBD\0 +3:><$'?[-BN*!!!;?G%N61@%(%EKVF+B_6_M$Z<8-EO%C2V=;2X.
M_<4S:XOR"Q=[:1PKW;8QY\S9,MVVHYH,RCBX@R?/OCR.BS)G5['G_N:WKY</
MWW.[ 8F56-XO2Z%<H.L='I.2MCU?TR*]QJ.YOHVL8&S9+*:5#FX*GAQ8 &H8
MY*)K(VS]AU$?Y-?K<^M!!$+R>@PAL)0W1\?5X)&-+'>0.*&)NN(""E>)/;B)
MGF?%T<@/8,8%FE=">O]^??^@??O;Y=V7RZOK[P\W5Y>?8:6]^^?-U?4]D.KK
MU;)9O'@]E#LVI% ?+WJS#6$/].,+UV59(>:_3M]I;\.WVJ_8,3WH:_^M:[\Z
M6/,CDF+H,$!9!W;// >V%/_$UFSH1G#Z%.RVY*3IE/&%):+=*8^C,%NBN>KQ
M#4AI;,7F<EOQ[:/?G\)_,*7LP_\'4$L#!!0    ( %J!^5BT*_:IA X  .ZG
M   0    =W-T+3(P,C0P-C,P+GAS9.U=;7/:N!;^WE^ARY?MG5F7MR1M,DWO
MD(1LF<D+$]+MWD\[PI9!4V.QDIR$?W\EV0:#;,LB9,M=TP\IV#K/D<YSCBP=
M2>;S?UYF 7A"E&$2GC?:'UH-@$*7>#B<G#>^/5X[GQK_^?+NW>=_.<X?%P\W
MX(JXT0R%'%Q2!#GRP#/F4\"G"'PG] =^@F 80.X3.G.<+TKLDLP7%$^F''1:
MG:.T6'J7GG7:ON>=HA/''?O'SA'L(F?<]7WG>-SM?O1.3TX]#_XZ.?/=SKA]
M\O'8\;I=WSE"+>1\\C^U'??T",&3X_9)%WY4H"_LC+E3-(- -"UD9R_LO#'E
M?'[6;#X_/W]X[GX@=-+LM%KMYA^W-R-5M)&4#7#X8ZWTRY@&:?EN4]X>0X;2
MXL^,KV,CQN=32&?P@TMF3=G>UDFWE1:78+@$'H>,P]!=PGN<.GPQ1RQ?1MQN
MRMM23\=I=9UN6Y-LFT5;3JOM=(0HY)SB<<31M6#O"ODP"D3SHO"O" ;8Q\@3
MKA$@2?Y:@<QM#ND$\3LX0VP.753)-E_> 2 YP[,YH1R$FK /V5A5FE&NQ!H@
MYO>&N) KMY4EF2BJVJ>5;Z* ,_G-D=\^O#"OT:RN-6+.!,*YE>:L3*P]N6)3
M@XRSMD]/3YLOTOOR:Y#K3:J\(S\Z[8[P#0NU16Y97;?XYJ1RNZC#*O+LZI#*
MO;(.N?%2Y LF2?6=O;8:RXBWKD8B:54-!<20^V%"GIIN1*EX2"RJQ$2NS/*;
M33RLP7D(VVA/B\L/.3IA&!*NY.65Y-I\CD.?Q!?$)>E)9ZD[/2 _[=.U1T9.
MS*K_SB!U*0D, =Z<4S)'E&/$LH\;!3"ER#]OB(>.D_:>?\XI^B JDI;0\-=#
M0MX6"A 3?;AJ[LVJ/2F$](KS!A,T!"BVT!XWWT.^;?.%" [Q/Z'Q 1S;-EZ(
MH.#_O=TN#&S;+43<*-C&Y:7XH[@/L'?>N"1BI#R$$U$[>?W;PZ!LB*,TKT12
MW!1YY8A?6NI?&SBKX;4#E"20HI^;FP(;4!%#WGWX17W>#.]$."E2(KAAH\IR
MZP&5*Y9<3&U99N'[NZO^W:A_)3Z,[F\&5[W'_M7H4?R][=\]CNZO!W>7][?]
M;W>];U<#<<N""%OD$KY.3X\[[6/)UT@8&J6$I1I 5@58Z0#WUR#6 MXO]?S[
MP.Z* V&;X4/_JR@S^+W_=E27JC'RWMF&]S65!R_8FIXA% -'/D4<B[;\32ZQ
MKM/H']VW\ _P?JT6M?>7B]Y-[^ZR/_K:[S^.=M5'%( :&3^JQG@"#V+\0_2;
M#+_+6*^BP<CS\6MY/D1Q20_<&WV]OKG_OK-H-H ;V3[9JA\7BH#25-/XOH ,
M,^(/,XVHSF.>L)&GCW+>A)D;$!91)+XH%$!\D,6I$05WZ+GGNB0*.0XGPH-#
M#U*/56>A0-Y(Q*=-(@006"&!)52-N'A 3RB,+!(&J8#1VJ>;UDXD:V3<.\0'
MH; <&B(Z$G:T,+,N:C+X24MW;PYB$"!0@(*ID?4'H? W3BA&%GU+5LAH\?:F
MQ3/2-3+T#8+,QL9)>:-Y.YOFC05K9-F>[^, RWT,EV0VAZ&5*^<)&VW>W;3Y
M"@4L86K$P!4:\^HF5Z6--C[:M+$4JY5-*7X2=7A"USB$H8MA, @9IVIEP<+!
M#3A&'HYU'E) L$0$&<@:<70-,?T=!A&Z%7VNL(XE-?GB1D9.-AF1.$ !@2Q2
MC8@0\Y-H)FLAQ/D44=D)4S1%(1-N>D.8S0/!"&4D2)O+9C"! @5KJ$#"UH@M
M-<:>DL!#E/7_BC!?5*<G1];(AS:ES8+\ F*8.MF?$_?'A1@EJC&/\$'+!$^!
MO)$';;*K@!R%!+)0->)"=0?]%]ET%$]#J_.0(VOBX*,V_XW[HP0%O(]QZI3K
MC%O\"%_L9L K(:/-<V; *M^@Q&MD:1'B,\S5V 2&HN]0"44D!I VEB\#,3*A
M398S:$# @36\&E$S0A-IA$$H-_W;/@YT62,1V@PZ 0$9E#J9/QHS]%<D&M!_
MLIM#:))&TVL3ZQ4$B#%J9/B<M:HA";!=EU0&4D['T9'^<,A=^ +O4\0Z/9J3
MQ9!'. YL^%@7,S*@/102>? ^1JB3Q;45%5O;%P$86=">"'D+,W6D)+-<8DN&
M+FJD07LZ9##J:/UX-<76\&M21IMK*=98O([FEDE^6V-G9(RFUG*G4KB>ABY;
M%K"GH *:D1PM;VI::J@C<;F+!K9\E8$8:=+2J07K#W5DQ[AZ8,M454 C:UKR
MM<JB1!TIU%<8;#DK1#"1]$G+SN:M5-21%#W5;4M*(8*1%&V&GI\RKR,M>NK/
M.E:*$(RT:-/VG!1B'3E)LA?+_UPRB;&O$(<XL,^C%",9.=(F]6EJ9?4I PO>
M)\ UI$LN/%#HJD6-&PS'.,#R*/6VG!G@C,1I:8 5<4MHM6"2 :\S?7>04C51
MV98P#<!(D98U6%&T!*LE)5H*<A3-9I NB*_=L69K"VPCD5I.(C?S*==IE"JY
M-)"?&SUP35\1B&8H(Y-: J. R7K'9R:C;$U2CJR1%2U?L9;2KB$!<7I9_;TD
MC%N34"!O)$)+021Y[N0#D& U)J3'&.*LMS9@NT'BHGU?5A701-FIEI!84A:#
M@][Z&/!7$"NH,8UQ7$ VO0[(LQ@BCZ+Y/'[CHDR*+Z>FKXJZRNA&@K7DQF9,
M"E5 ZE*C_:RV]7EVO>G^CN2[49'7>T(43K:-US(H(Y$%Y\"61*:X( &N,66W
MD$=4=5?$OY\C.10+)^K6:V;>6V ;2=7R)TM25WKD?&"I*2&[[K-R>R[^;+\E
MTP+]P/7?QG6\5HS>(*(-R$:.M;1: <>)G@/#6S'\NE@V8A]8?A.6<TYB6T=L
M"8:1-2V?FG>HNY;,R#U2-R2<<"3?&#^V3Q@4 1@YR=^N)0)*@#D2+=F_=2"%
M;]'W%4,<B'D=,=MGH7.EC73D[)Q3=-0[T5R^*_&:4#$E#OLO[A2&$_0@.GIU
MH&PV(Q[FBR'%+GK [,<6%.Y2K9%[+;UMW#7I@*02(*T%D-5(#L E%0&J)D!6
MY> \&HM]WT<N%Z/%5;',71+>7PZ$-?N0AF*B9C^.>0OE1D?2TO,5'"FIBAS-
M9DIGRY 0B/HHWTIK=/ GC=)<)N^(>"0S$:=R# K95^1-MA@3[UJQP8^.6]J:
M004_*G >41&PJ@F #,1UJ:4'Y6[:CI=AUG?YR"U5U!/,\:6(M=?L0IG14[3%
MAZ*=Y,OEILTM1ZEV 'E6^. >B>745M7\N-^%0QCAC2Z@+5L4NT"\[;;@($@-
M"3<>#9 72*C&!'YIX7B+BGVVY8TJ8'0:_?U[5<XRJ+<])/61 Q:34+)QY^!:
M.<SF7Q6]<0 9PSZ.?\AKBP3>CA4;74G+U59TI<);6E5JZ4#Z$9A+-='$H7['
MVDFV 3<Z@I;^S6#]PM*C-Z(/B2?,."PXFU-'LG/?!V9/:RF,D4 M)5GT=K%:
M<J0??Y(_FNM% 2*^?L^:N^W@C9QJ><V"HU>"[$2=6B$O.)]UH%W88?O4= 4L
M(Z%:LK*0T'JGKLOBZ0')>8\K5Y+#B?B"Z$[(K*; R+"61:P4LFLJ0:*SELQG
MWBRXQ>YX3=;$5UO+UF5?3EA+!O0CJ=OWF16PC QI6;*\@ZYU[S!U0X]@@-AX
M,:3$$QW+;Y1$\QW05X)J)++2B65Q5:H 8[D"IY0 I>7 :FS_^$HFY[C]COJM
MT(TL5WFU9>9J-I]9[_WTFZ^RM.>S ,!(F?F5F/]T0CXW7]@9G,^Q\$%Y)?X>
MAB2NN[HDKJ#X\(>BZYGQ/^7ID"'$WC6AO9G\A3 F1@]!Y"%O$#Y.LTL%]_[F
MALK>F*ESY T DT_G#3$&1 T0PADZ;^P&.\1!(%\!D6++WQ7'9W-$,?%D\\\;
M7D15&QN "=8YYI'\IOK<\T9<'',T:P"NBL=7!+P8J [$=0D2_]YXGH%ZKBO4
M>J)+A_*XX7<X0?) U@4*!5&<7494_I)DU@0^#-C2!E7%S:W$(>-0%HUOC05B
MZ(KK+D4>YE9MGY%0Q )=F%LO8DK8:1QQ0MD4SWL3BE2!6S0;(UI$O$EJYY1Z
MG#KR$SOSR SBL *MG5:GLS9G&0I[EC>K7&8/&I6W\7GQ2"Z0C,*>SQ']+X+T
MFD2TT%]M(/;49]-9Z;U??'Q2O53F$;WPBX"X/PJML0W4&_H!3[68C;#FIJ+:
M#T@MB/1<,;]0E1^J"MW[@UEZ'C"N4H$EML9[H^X[%;)Q!Y7'B"?'H@5)/N-B
ML5Q3M'8*6\"W<XVVG6\\D>!)\'BIPO :NBK*KR(D.KBC\CZPFNQ;-K1J9_B;
M>,12[(I'+.."(,K*&U98?!_:(D90SY!ZRQ?WW(>HO#4E GOPG+K )""3ZMP4
ME]\'<E(C?\=\FE90/2X>2! D1!0.D2O)_N0A<*:;2_JXPKXQKZA-[?_.<8*8
M@FPQ"#1)[4%XC5"(";VX(QRQ2IUZB< ^!-@@%,-.5QW@6MP0&!IZB\+B^]"6
MS8[Y\9G8]>09@3UPM2$E<S&OE0&7Y#H-Y)0([$%SXA%]_EEPRXG4-E![.J&*
M'TCQ@/]R"ND$&4@N$=B'&"S<\VI*:%40_,F/ZCO$U>)#.3^;I?:!E*]X,E6;
MAE=;/,L;42*P#^V)GZF7F6?JQRH/X5R!?6B/OMV@O#G%Y?>@GT^?IK<PC'PH
M1W&BHZHV%ZDDN@^$/2(ZD\.?2B/ @L+[T(XK%. G1!=7Z F[IIZMH/ ^M&/=
MQ(;.H*#P'H3.VL0G>;C'N2!6+7FX*;.OT\.\0*\VQJTBN0\>J;8_:]MU>Y3*
M_=&RY,5B560(%_)23TY&>J)-,!!72,2'8JXEL[V3XJ3 SO6\81C,8S7;97V6
MX_LM,S_Y\C]Y2)F=3E^A&0P]-42I/@?/$=J#?FRHMAY4?.@7%-Z+(!;S04_X
MR1"Z/^!$,&H89185WX>V*!\1X2[KT0OC\T/R/1BF17:CW$^?6*O=&,R=BE#X
M\NY_4$L#!!0    ( %J!^5CHH\X\A20  %IA 0 4    =W-T+3(P,C0P-C,P
M7V-A;"YX;6S=?5ES6SFRYGO_"D_-ZV0;^]+1W3=47KHUX;(<MJOKSA,CL=F<
MIDC?<R@O\^LG04JR=E$D#G5THRIDBZ1Y/B _Y(9$XJ__\?UX]NQK[OKI8OZW
M7_B?V2_/\CPNTG3^Z6^__/[Q-;A?_N/O?_K37_\'P'_^^O[-LY>+>'*<Y\MG
M+[J,RYR>?9LN/S];?L[/_EAT_YY^Q6?O9K@LB^X8X.^K?_9B\>5'-_WT>?E,
M,*'./G;V;O<7P4M*/AN(H6A0*#,$60KH(*5-WOB4\']]^DN)(G!C-20I"ZC,
M,KCB.$2O,AK-C42[^M+9=/[OO]0? ?O\C(8W[U>__NV7S\OEE[\\?_[MV[<_
M?P_=[,^+[M-SP9A\?O;I7TX__OW:Y[_)U:>Y]_[YZMWSC_;3FSY(7\N?_^=O
M;S[$S_D883KOESB/]0']]"_]ZL4WBXC+U:S?B^O9K9^HO\'9QZ"^!%R Y'_^
MWJ=?_OZG9\_6T]$M9OE]+L_JG[^_/[R,./?++Y^Q.\8_Q\7Q\_J1YR^.WKY\
M]?;#JY?TEP]';PY?'GQ\]?+#1_KYVZNW'S\<O3Y\^^+HMU>_OSWX_>4AO47C
M6CUG^>-+_MLO_?3XRRR?O?:YR^5OOWSKEU#ESXQD%=S_?/ CGO\<3L19/)FM
M9N\-_7[ZH(I\X)'E[\L\3WD]M6=H9HMXZ4.S*MA%=_8O9QCR;/7JY*2'3XA?
M)D=?<D?HYY\.::D=YS>+OI_HDJW!)&@9& 0558+@5802T>G$M>-67Y[2.M*>
MAKIB1,$^K&AQ^HSG=;*?Y]FR/WME-?VKJ;\#QGJ6MQ_9/SKZDG?=HDR7$YDX
M#4D$",(P4(YI0($";!)*1;0L6MMX1!<>?WDD%QAST,5GBR[ECM3=+\^^Y:J:
M3C7?&@MV\1J5+J^ZTT\\[T^.CU??"=-E/C[[]Z5;'+>5]W+19I;74B3TNXKY
M?>XS?<WG@WEZF;_FV>)+M0FOOG_)\SY/$E<\F*! 9'2DT36#H$A?V\*U8BX4
M);"QX.\$M D5Q$\JP)/B0CM1-&/'ASRCMS[](\]IJ#,"=I".I_-IOZP#_YK/
ML*$,9/@3(TMO$V'+#GPFBX[.)D2OG/>A,4TV0[8)7^13Y<L PMF9..0<3([(
MA^S68SS#(%WRPH4,*3$#BC0=.%,"Q**B=RY*)=(]7L;-W[R)@-43LPT-YK"9
M GB;EQ=&4[2/2G@-V4A)$#A!2-Z22BJ2G'G#I6V]SB\!V'4T/[_I-4GOQ6).
MTCHA@9U*;C'O?\T4\.3UYS[B]]S_-ITONNGRQ^%\F3OR0FF97?Z65_]U0F__
MEI>?%_3.5_I(U=HD>5^0)D2 8RZ#*H7^)A4#$KSA*@02HF\\5WL<WIA\LNTY
M>E6CCI4?S9;S.?!3I?(KV8[J>MKLBU 4KR<G*"27$<%'\C6RS98%RR/R,@A9
MKT$9E8?7FEF[37QC%MQ'T*(2TQ2/$!87"5H.X!DF$-(+SD-T9F %MH/JD4]<
M];2023.Z7(Q18R&_)88$KF2*49,@/S(1"I-=L;Y8D9W85R9@FV#W:YZ?Y#/E
MWF%<_C%=?GYQTB]I\KM7W^/LI.9+#_H^T_^)UNO$!".%2A+H3YIR8Q)@MAHT
M"]YE53"6UB/> N:8[/&V?+D>#P\KK68+Y,6B7QZ5?RP6J2?S_R%W7Z<Q]Q\6
MLS0)II Y]Q'(M(>J$CSXY!"TD"JX2*H^MV;/[6A&95M;L:31Y ]D7(?U(3-&
M9IT.("@"I.C2:' .'<@L$CF1F>62_[O$&&UR\U@4\T$(8/1'];=HQH1FP$U)
MW&8BC&T]8_?FYA]76X^5KU?7^:[2;+C UZ,^]>3?+N:+,V@3;I46RM$ 4^*D
MR (%=5P@F%BR=MI;W]P]N@/.J/3]4^%9*_$VY-O9P-:#IYAC(I,RA3L+R21!
M0+@&U,:#%<)Z[9.TS#7GV3488XK$G@Z]=I-F,UJM,LP7V7TEV\R%YLYI2($5
M4"@8>-02DD\QV9*L3\T-Y9V(QI3I?RID:RCC*[S[Z_.K8GA#OP]8IO+BZ+=W
M[U_]DSYS^*]7>ZA9N?-Y>RI@V7S,K:I9*E]>+(Z_=/DS,63Z-?_D*"FJHT)4
M?K?H5JMNN>RFX62)898_+MYA1V2=!!]]YHIH9*($Q8L"7P(#QJV7O,@HBQE"
M:6P/N8D6O>'QKVGU3S_-7YQT])3XXV.'\Q[C"L4\K7X[55[I_YZL5_HF\VMU
M=LJS!)+L!:B@$LVTB< H9"XZJY!Q7_,[R #'%!?M<RW<J+='R:JV[L<-0WR9
MRW2>T^G^R+L9C>EAH_'.6_+1'61IR9F2(0)F7\B98@J=SYDHOJ<ULNM81A6_
MC7$][)4L[:@?IS<[>P>%?,.*> VN1.-C<A1C6EJ-2DM!X+0!G4W@REJMD;=F
M\F;0QA3X/2HO!Y#DX!JV3LS+W$V_GE:)U5V4G.H'%_-U6-IE[&EMK?]<#>7G
MJJI)]KK1(G)*2GD%UAE:.11& "I=("=F;#*ZB,+VZ.KM/* QA9=C5+7[9TW#
M[;EKHSF;Q0EG+F&BZ#<:<GM4Y@R<XAR"29K>2.B$:KX_=RN<MM5Z05B:3U\5
M#B<:8+*D?[2 0J$]=R;YC')_U7J/Z\VWXL#5Y;+]C.]%SV^B+=#XP#V!UJP.
M7^D((0H-Y!%I@EUT^^+MID'[O7[QDR36/J7Z&+F]7P_>'+Q]\>K#/U^]^OBA
M>2;OEF\?,&^WR7@:9>EJO4M-##,RZ@H5&!<=*$^QBR\F@<'@>) 4P8?6R:#U
MDW=56.MO62<QB*B)<#K!0!JF:1@B@&.*(C*'3*DD9-:MRPPO 1B3E=I"LE?U
MQO:3V\P@O>OJ?L/R1XW'ZSY'#9&^G$;D$^&EX*(X,!H-Z26&X&VQ$(3(Q0H1
MM6E]HNPN/&,R)0VDWVSJVWDG9UM/;VI8\+Y.XU'YG0*$.MA)T<HXJPRP$ E2
M+>7PND3@47")+IJH4VO?XRY 8TIL-*!#N\D?H)JA/YP?E#*=37&9^P\GH9^F
M*7;3W!.Z15R]2@S^WXOI?/DO^OA)EVDR.$M)>PD%+7G9,9"#S;0!Z70PEEN6
M;1RL[F$+P&/**C3@T_Z$UZYX?;%(WZ:SV40I1*FE!R-HM$KX FA" &&]]T4;
M+TMKZIP]>Q,6Z*?#@JVFM&7Y'<X_32G660^%+-MY)?@Y,AF"$T@&KE3G1T6>
MP#F*QJ40!2E 3R*VMBN;X-J$".;I$*&Y*)J1Y&4NF3S@=%Z <PYPDH.7**T!
M%V0&I0E98*$ N<7.YL@\<ZUW56Y'LPDA[-,A1*-I;YL:.\6PF,?3H$BF8IC+
M&601I+:LDN"C4Y!X,0%MMIX-4D5Q%<@FPG=/1_B[3W8SN5\.@HWSW*%QH"VR
M.B@%3K@ "FD\V=33(*V+9>_(,&RQ?X%][0E2_ZCQW%><K794EB^PZWZ0JOT7
MSD[RA$(X6DI> ^=<@'*\0#"10T[!,(/%V-@ZL-X(V/CR*]OPXMJIH^8R:4?^
M&!<G!.9]CIF D74F_7LV9D^A/X_%@?"BMFB+%/-)'D 76IK,%0RR>;;M#CSC
M2[^T($<S"32-NN?TD1_5%/,2HZ0IJKU@\JF2]XR\>(F*>9F\R*WMW\7GCR_'
MTD+F6\_P$,[.V8"*D<+XY(E<TH(RLI#Q30J0Y!.B#5KC($4:#TZP[S<'TD+>
M.\YV,ZF_F6*8SJ;+:3['D;3,(6ERM2FT L54!B=9=>*T4XJG+%/K;GW74>S2
M0.KM8IG[=_BC:DXRLJNI?IG#N0KEP44RK1$,SQ)4J<>P)*M-,ZRSCF56\I4&
MBS=VD[KG,6-R7':4\L7.4BTGM[G/<HKKW%9:J>E_7PN9"OE/D1:H$19B$!H3
M$M#0.HUS,Y(Q^2F-N-!PZIMTC2,<W4E.'W"VRB/_@9]6*>33VM[SH?JDI$LY
M@G"><"4LX'RL!^949"DQAKC)VM_L:6-R51JJ@ &FNJ4FJ-@NG)P[-Z_*V(Q)
M@O:U]TWF$GS2""&BUP&-#6Z T.5F,&/R:=KK@P8"&&C_^&RL/\Y=N!"2R5J2
M>4+RM-&1N^4U Z.2S5IG'IHWJ;H;T9CV>AHSHZ$HV@8]-XP3F5%2UF1C_:$D
ML=8[GR$H&Y+'2&9LD%- ]SG"C[OGTYH0#29_B$"H]@%:+N*_/R]F-+W]^HC&
MQ# 12BH16&$"ZM@@6!205-3"&<:<;+T!?!^FAF.>4+2J!4\1:(Y).S/N(!BC
MH/A2I$?& V^=U;GP^)$&2[LSX2KGMYWREJ<9CJ?GARK6O0<^Y7FL@(0LA2M!
M*XTQ4L$B\'H!AP%NN467O'2^]4[''7!&&C2UYT0KD;1KVW[#^#QZ(U0 4[*I
MR:D 7I$'AZ4>4_#&9=MZV_L^?3>:>*H](W84P)!$X%)G;XF!H:R\>'+@T6 B
M'68,<@PH1.M30>T-W[ONM-)@]=7KS;:J<9U,#K2LU4C&TMS:($&*&+/)%+^&
MUO;]!AAC,H0[2O]Z<?%ND][4!"[F%U#HX+10EM/:4K2VA!+@:L%[QN"##=QY
MU;I9T54,8S)VC>6^TW2W2PRE-*UCQ]D[G*;#^0O\,EWB;&(L\[J0@2VV5C&7
M6M!NO*/8@\7 L?9%;KW'=0N4,5FWQA1H,?D-KRQ:8FW[\ J[.3E:_4&,)\=U
MJG.J#2'B=#DQO/9RB)Z<\EQ(+7$/]#T69&1%<EZ[7+4FQ?VHQI0T;,R/QB)I
MF4T^P[')@<H)<QF=X!I*2KI>P840A$N0A<^,LYB#;VU('@AQ3/G%UDIF0&$U
M8]3'VM[@I/NQ&OO:,IYZ0IKB!9<5&&[KOJG0@%(GX*%>V^.2\+%U@'4;E@>F
M'(?M&]28)$WF?XBDXT09SU&: #R+ZA6Q!%YX ]&2,^R(DP1L7PFX)G4D,C%$
MXRR@B[2^K%$T(.U!*QVYUX&E.&#"=-Q5& ^2]ATYQ&WFNAU[%_-/'W-W7,L_
M+I1LZUJDYE'59OFK8ST9G H"LK.9H7+6N]8-(6Y&,J:8JIGL=Y_SX4[)7!AD
M+6,T*I8HA00=ZI63PE656F^V,5H)1%1)MDXGWP-I3"%6*T:TE$*[,_S5ZUJU
ME5RY8N\6_;++RVF7:Y;[AK9[%S'_9'7V01;!'#GY6.O?7:B'/S3HK+WF4=<+
MP%NGY%H 'U.DUHIF^Y?HT#4@%V I;S&JPD!@X#7"-. <RQ!3PJ1329X/VT?@
M!E!CBM1:D:BM))H;LAHQ$LU/N_J<U:?,L.^G99K3!9@^EQ210I"2E:WWLF8(
MMA[/"11&"&YY$JU]G >#'&GE2!-C-XRD!BLKNH"G6.%"4@(*JUT,=*@^&Q,0
MC/#:1X::M=X_NQW-F,X/-],Q;>9^/^V,%(U2!%)W7M?CK=$QP'HCC.+(M3;)
M.-:Z_G#S=D8-Q[JZK6V2@@\Z>3+W2H9U']O@E(&@G,G<:%]4ZQS7W8C&E!UH
MQI.-FSH]7"A#)-9?YB]=KBU?:(KH[[-\VH_^X+BV)_Q_J]=O'4+M(9)5X!%T
MJ><,/*? -QH/7"(SPJ:DXH 9]YVPCZH]^V#L>Q1)/_IM,P<?_OGZS=$?[3M3
MWO.4?=TL<\_X&G6JK,>>L?],G/@ZI6_[]<?O?<USG$<1!W$Y_;KV&!A&RWQ"
M$#'6:BM7VZ22:4]%H3,E2]:\/FUS=&W[,G.=G6%H0"=!7HRMA?*&8FB78[(N
MIE"PM<H;;5_F@1AR=YOFAPB@88SZ4WE.2BXR.,P@$Y(:#LZ!MZ9VPU')%RM-
MM*V/)UQ\_I@2ZWMBP-;3W[" Z:P;_NM%=]%D3@19Y6"U)*$A\1'K/<76*M#&
M:(,^<]F^D^]M8,:48=\3-=H(IEW-+AGS_"OVEY,DDUCUDBBR5@U;<I\4UCM$
M/ C!44B#2B3=F"0W(QE3<GQ/#&D@DG8-+7$ZKU;L:/X!9_FH7'*X?WK;3@<,
M7!5(065R^64!5))L' 6),M9+CF3K--5FR!Z8%A\V:MH3?P:06=M>:8?'7W#:
M51 OB.J?:+C(G;3*(]A259^N&SU6,=!>53A1JN;E3#<C&5,6?%\&:7>1-+\F
M.-*X+]\>RRF$%T9)X(S5?6DI 36+8+E*"IDJR;:N=[H5S /SX/\ME$H;R31L
M,7;Y!J@+ SZK%F?,1QE\ 1^"K/I-@HNN-AR/@BF?I6]^H=W]J![8A?._!74:
MRZK=P1X:^Y66BN]SO^RF<9G3:<O%RR]<^.2[W$WK'7Q7AW;:D/C5]_@9YY_R
M>USF5Z7D6/>JF<H.#6#,K!80!W#>(G"/F"-J:YH7NNUWA WR5AO3T>JB)'G
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M$!8(#.V:61B(.:N:UV%M"LAL:>VT/XSH/!C14.H=3I9Z@OZ^.$$OA"[%1!'
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M9\48G]/E=<9<O_MB,L')I*)]6^Z^+?.2#9+JD'[A%YR2 !GS3EN(0M/.;W6
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M,I6PH#5G/G,>??-B^>?87WXO!NPG]0[VYAI#>$[3"R:*2JAK1P"=: L4<C[
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M[\F[WWOTK&[],:&>^_-'KW%3'5TCMW[Z5:SO='G<H^CZX2Q")!#"$@&4YA3
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M*NFA0,^5[<@5#I,[=]T:FEJHZQ7_L"LW_B#4A^)9'Y,\@QS"B (.0Z:S*Q'
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M:II"<*1DT_A6US.46JB;]/3?-^)1+,MFI_'VNQYY)!8X9(1+)$'"9:0GA&:
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MY<1K!YC-[-JTX-D9-)V_UF#7<Z-W?S]JAA2$?PJV/ 4[IB9I..Z.B2<CYL#
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MO*EZ/0PHO6RKAT.1SW9Z.'*+JSNCVUOJ5-TV$U^/&\ZY(#Q)&! Y4JLSQRE
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M5>[$S?[Q+]G/V=7>_QM/WO[5,O)5-^C9B],@I1>])4]_G%[W@=[VW:<KT+(
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M(J>SKY:KKWK--TT1JO,G74'2C$FLM)$29J6F$.=(04YD 5&FLESRLM*,1]1
MGB0X317DMLCES;Q+>'4UD>W6=I>)7.[Q>?SBP$'M)Q7MYRLOTULDAM^>"OK%
MIJ.:L$CPK&2IYJB?I#/MP/1SXAY,1C][0^QV\WD>]^;1^IJ]#J"36;MV!!<1
M3%:NZ-=N-0W$)1:0<X5@@21#I*H01T$AW&7LC!RO'>2\5X]-'FR_2VX@1(L;
M?W;A"_+=S4ZE]M"-[;@:C]CDIE!4LOWN1<Q,O/5-H;C#77"2IUX,7M,^]7JI
MCM#:XMADE<HRS@F45#KT?U>0D>4(2DD-47EN& UJ5 RD/_9F=A\!Y[@UGL?
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M.9&NN2 C!<0Z8U#@DD$J,E-P:3+[YR68U1?P-K*[B853=HL&^,-QV<R2#CW
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MKMPAW17HI #[8KBQYZT@XW<JIU/VR W+"1C](?J6TRG<MWTY(<5+P"1_V]@
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M22R9#NJW.J P^N[(T6O'VX4OZL]UX;]N1TL8OC3WPHUP=G52DH2KZ_/G3[Z
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MCM=]?-B_^+N$)"_IO.><6O5A'K;1NF//]>EU2>\:]!S:'X#E$>PQ"6Y,V\(
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M@N,"HKR!]JLTY#S#4&M%1)'EN>?8G1]*JI&]TOY@@#T!@940[$0$O :=D'L
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MQA#6>4XXY+BP<0U5$G*JM US$"DJ(26E89VCT_(_>GG/2OX3K%K6KL"?'3N
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MM_9=;AP,V%=GP[-<&H6XUE"4#G%#XAQ2I"A4@@K&:,:TROU*!\((CUY2X%@
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M=>S3Z_W!)L_X:8==-QR%HNWX*-/3R%.K*-#B3VEDU/DO04(GP^CQH3DQ8$^
M&@[1>T)NCL4MN5;*?CWU[:K>\,7_F7]]MU)Z1AE7K,(:(I=YPS:ZACQ'UFL@
M)B7-$"^1%VCU,)F1_4)W>MQ1=F7TCC:PQ(&C'@IF<E11PRX@G?AA-A\K>03"
MR9!@%^"<''WLQ&@G0Z(=8IX,7GWI!+?/VL4+TDTL6]Y=+]5GW723O7,##1M_
M,,-V92]T44&M,PUQX29,LPS#' N*-#?*9$%EIP&T)US>G_'2))$Z;D##3K>D
MA=:L!:C9;\D?27EA3N"YKAS%L^JY8,R;MZ#)I[Z=I_Q*0^"\57)Z)IS_(\*7
M_]^T= ,0G_)"?)EO[+>-<I5G.2\A9E) G!MD]P99"4M$*3(T%UQ1WT7_Y<-'
M]A$-#><@-)?WH&G!]5_>#Q1Q?E&_1+PP*]Y*EA=OQ$^@)YQF"3\E1M3"??"P
MR9;K4V+L+](GKXGL GE99_[VZ8M]4H-KD#&I*V:MIRH+[(K";=RLC'0#JC 3
M@FI,O:#_/&B-;%9'FAT<Y3@\Z0&-^:VJB?009G^1*@AO^3@O7*IVCP%*T[9Z
MG!?YH,W#XY98@]XBY#:'63-%L[S*E(2\E-9VBSR#0E;N)U8A20DC&0NSXN<$
M1C?=!G.Y;C&7O_(U^-8<P?Y+]G-1@J]Z#6J'H?]OP%+Y.0,/\\7"?>!U.]:
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MO7GWWKPWO7DOQ\U+V/^?VI%MYW_PZ)GW_*=&G>[VSUR3&#7O<P0[+H:!QO6
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M'(:B ^^XC;3V?OU<.2>Y,>\WOEID^_V]>[M;M]WUKO.+OV0A2HV@JBB@M2:
MU 8#0:P$T!BA2%5:)6P:7^UUX0EAI\B(D_BR]-%M\X>;5]QFY'$3>XP=@638
M C0S.K=1U6[71:]%,:AQ5[2*W+71J9TN^5EJP^W/3% ;(/B'<-.& W*)EC;B
M"3<PTAX<Y;]U%O:Y'09)I35A0!)D :FD 5Q3YU @P;4I";<VJ@SVLJB)ET#=
M1NCA(/:5F  S E:8I\@#09QGZ*P_2HO9B\W,K#IJ6DYZU/."YN<X'37X+%'I
M^!WIC2&7'76IY\Y?KWQU7T>CN- (U[RT)<":EYZ^2@()"0*RU*P26 J,16R/
MR NR)A[&!Y*[;A>'LHMG/@.@*%ED+&L,NM!#IRR Q)XZ'6-Q)#9O+\4KMF5L
MJWA)TNP=%J^8?*[9XK5;$ODIVG#(7\WVTUIW;/2ME'TKM'OSQ_:%4_\?"UUQ
M[@^F !/*S=;6:" DX0YI658UY,Q64:=2X:(G'O;/K6TI ?O8J%A%3]L1*(8-
M^6FPB?, ?<"W4Z(XT*+U!W]9+U?;XO^[O_O]4;'7K/C=ZU:TRF7,6H]')!=7
M1KC@>0DTH@$Y8=6(?\*-),E=XI!S8>/DG>X"MW+9''%Y^N/!7[?F<[,@E'(N
M$ 720.IV#="ZI0;6P&!""4%EB6C4H5M6[29V57N6W;L^^ZX=C <*%X/&GB-@
MIW-[U:'6+6M-4_SN%2]:S5,ID[.\TS"O^,/>5)SC_"$O*9U .2>8N<F2L^CV
M8XB1<\)ZD00YJY#$S"7C=##'E"\[7N4ARO3JT?R[$9O[;^L%)YPQR0U01G!
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M:6,?+Q2*PDI1 TIC%""FQ%UEN,8(UT93)FS0I!LK>&)/T:L1YR2"00MS$U-
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M(*#;:2A*W5Z#&D1M% G#J+2I#RW.MQHI?F__H=4@,F%Z'+O 54<N1"*7&K>
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M@_2CF,G;,HQ)^C%'+^$-&$)NF394ZY/'[]V;, M34JUI60&I_!:IK@7@W$!
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M?<F+'+[7-^ZG?_VGX3?N?U(TYE__Z;\!4$L#!!0    ( %J!^5A$280[88@
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M)J9J@X2[=NT$<7>P.U]0?SD*Y9J)J*W5/@7PKLHC,@3GY'JP@8I2D*Q4ZR.
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M_UQ__4'F)TH(QFG]@4?RR91*#J*EY2.L9,JCM<XW-TZ-:._!.VH3XH^AS Y
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M\_!U2H[21&?FD&L#7#+:.ZVBO=/2OV*6HB2?D&36NJAE.RGC9MX;0J6%J#M
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M7\T7FT,+)X7E@(%)2*DPBK!L@, UA7%:%B\\%NV:CV!_B)B1AYKV!K@V2NL
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MN#?<1]K1&RFI/S_R/:[;,W^<?PS?_S%=?:Z=+$F,Q.\#I< Q<'=1]Z%2J8D
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MYNP@:NK9)%TP_#%\/[((_^:WFQ7A/T!0LR+\R^=O.3=A2061LP(7F:5X/U(
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M7F*$F!A"UHR+XHP,H7G'J =H.3FA?N>Y6^N$D:-#YD$)ET#5C3L8GT"+G)Q
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M1T^KT;(L$@15Z\>2J5F$G$#97 IR%75[;W6H;J\WMUMG*W(#_S'-N"'=C48
M+TFHBUDXN[JKO_SMQ[O%/-,ZJ0GF#[1(IFES.JFC8+D:9G)/:P\EG6J=M@Z
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MWUB[44PY[9,RD&(ML#.U.[,/$826W"L3 N[7&^01GW+;N\?M3SQ(Y'&RB/N
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MQ<5TGC^LPF(U/+!X=J&6] /MTA1H2/(.HHH*LN/22&%\\*T;>9T,K.91_OC
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M4]IC 0RJ9A%L/6"6!DR66*Q#D9I/W[Q'Q+B.;$. G";>#O!Q0WB4SEN=.4F
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M4DP4 8Q4)):L;9U$(2&2;95.HQ"V]33,S?>/>RP^!%:.EFX'S2<V:;\ZV*(
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M4%]^_(;?\6J5--:6#LXB ^YC !5D 5<HGO<Y6N]LR3JU#@\.DZP3/%X6-KO
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MWA.@FU[<2X+@8='XR1[I $ZG&^Y.[5FN/%Z_A]NIB4G[1,$+A^Q3+8[W F)
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MW[G/EGK<5JD^+JTN[/OGC/;?;^KBWKAK^>)[F%Y5\[^=+_Y&_^WU)!A,"HL
M+J("960EGR5CE!"<D0EI,VD]&WXH73J_@VB,R59+HB5 GO-">?]MQ4Z_4GKY
M;K9N%9GPY#1WE!PS- BUF!5\X0*\525E'[,NK>G[VFK0^:5(IXOB?# \AZ6P
M\X1^4OW_Q.GG+]>87WS'1?B,;_[$19HN\8_%-.$DEF 93QF<C)1R(B*%H$Q
M-EHP+532LCD[P>74&SGFZGP1C02CY[#"SK',Z@]?AVM\&Z:+55?/Q'@4-GB*
MF5D=>!(E96=!2=J I#'>!&5+\V*/RZHX;@=_[RMM1#@]Y]5VJ_&+Y?+FZ]I6
M'Z;+?[Y=(&Z'#GT@RTQR4$P(3"!7#"_>) A\U?PK''?<&!FZ65^'*C4N*<%S
M75&#0*:7-11_;9!XB$'J?*2T[LC[RB=&JDS6X"#K+!R56&4;+!XRCR*HI.K(
MVB$6SR#:C$N2T,.J&1\DO2R75OO'UA+_,;^B'W-5.SWJ#N(2N<JR %+*%1FK
M 2\R TE;1\X,R5$7KS<[7ZUQZ1YZ6$ =P>:ONI*VW2<K@Z!BJQFK( K90IDZ
M T);"U&Q+%.4L;A!Z#6'5&I<#HN_XBHZ&3+/>0VM^PK?S9;7BYO5C<VJ.?[3
MES![^J+3%2/UJNU="+*+0K*+*@C6FQA]LCKHUH7YE])M7+*.Y[JBA@30O]'"
M^O65C&*E1!X*>,DI/@Y.0Y E0$9>A*;_)]_-#41KY4<F)_DW69MM,3CBXOW7
M\OITH[U(US=U_M./^<TUV255I'W&2:+HF;8M ]&:N*ZW)M_1-N9LL49I;LR#
MXL%'';X#B#4RF\I("V-L_W9P+KVX6OT[F)^VPV8^^82QP*TQ&G2RE7TK9G!6
ME=J42JC$Y'EJ7:1PF&0C<[B,O*,/X+U^B1)6A\Y&I371UK94<%X>_]GI! JG
M?:<1L4(#)1L1+JR^MO[,BUG>?/:N.5VG9**ODW]<95QFTD(MW8;*ZN$(4CGY
MUH0*^R4Z=R?\6YC.*G/;^]G'4*M/_UC,O^'B^D?MEUK-HOU6%^\DAI@32Q9T
MO52FY4IZ9Q% 6.-]-BZJPVK C]#[,,G&K4ULB):'F]P CNF'(/+M?$'1\NS5
M#8DP2S\^T<&Q)(.1U[9JO\1"_\ZG\.?$\$3G08F@^8KO)CCPMA)X"4I_D]?&
MZ]:%M$>(-VX9X(#X&\I%_8#PY<V2PI%EY5R-T]G*9Z_FL^LIQ3"S:_K=<DK.
M>U23]>I+_>V[V8NO\YO9=64X>?(_^6T:XNI-@4]BY(K7VBO.#"U149_FHLU@
M<Q1>*8MDI<8 OI!JXY;O#0C^'J'10]JT7.+UNZ_?PG11%29]%Y\KZYVF2+Y8
M"5&[6LEN-00K*)87/&11DO6V^5SM)R49M\AM0#PV,'P'\%DUSM^DZ]7("#+1
M3X109+9ZT*Q^/TG.1.$H76-6<E"IJN5H:8@2#2/1,39_<#Q0M'%KO@8$V!"N
MZ8*\>66S]]]66^_L\]IX&\O]CM>3[)T+SB>(66I06GH(*DH02D@LFFG2=8A\
M;J=$X]9'#8BPAHX8/X2L5Z@_V6I[XY2S%YIE#TE*!(5"@W<%(5GA0C:H\\/9
M"4_><C_^R>,6_0R B@8&/!L%\^MP==F;N]_#HL+_>]-KND<_=+ [N?WB7^8"
MSC-1F)(2C.2I3N2S]<K84O#CI?5:T(G4NK5\V NXN\;O/6?P9NZXSYX+2:%>
M"(Q.WT"AGJ/U!=8KGIVQR97FS6"'B]?U5=PQN-G-*MK61;V%Y/5J<<5SDQ%1
MQ*(!:U<R'<,<0I012 5MD!G!L?6\O2<%Z85'M+';]\7>)_F@1R!MB-:<0_0\
M25"VKC9>NWH9"Q"*XX:[^OK7>K_>(<JX8&K@Y%_!Y@2+CUQE\ND+DO?$(TTV
MQ#DV&V94#, RNEJ)S2%ZK ^X/C"FI8P\'A!.[_]*9[ XQ8GS02S: ]O<:I&@
M9I;)7#?30HM$< ?!5!8FG8IE5@>'\9 MY+F1$PYSZIQNVQX L<&Q0R<(K;1O
M!D-KI"2*YG1FD+4(7LK"HS[H&?YYT0\>Y:P=](/'6&YL%KI[]'G9QJ2CBU!T
M5=Z1WE%I#[S.=@TLE"P.*IU_?O2#1[EL)_W@,?8;V_'WZ/.\SRK7,\OJ>F9Y
MFR!JC5!"P4SX]^:P01S/CW[P9,>?;+_>$HEZUJU.OB4NON-OM]6#/#/C0RVB
MEI$L(R4#"I@T*"PI.JZ"+*W[: Z1JQ<*P0OFJRT\U 'J#JRVHJA;:NL,"$L[
MJ<)ZU2T*AZ)"3-:X8'3KB=S/H0RN/2).*X8[QCU]/"+M6*DOTO7T^_1ZBLMU
M;\G[\JZ^#7S=.G52K)/6*0&:UWD'SG+P.4>0V8D44"*/A_13G/CY<3.DP=!V
M*8=TL-_M.2&V#;WU]WSB4]3)T_$0,IE0!63@D0?0B1LF Z>CHG7A[Z&RC7O:
M#K[G#>*B#J#WIA02_OWL[0VIAF_"8D;Z+=<U<Y,LN)?>&O"^7HC*(,%S+H%)
M5DK)6IKFD\OVR3-N0=G@$&OFBN?9/G//OAO##M- L^]+%VBA.5C1R[SAAY3J
M/"8Z(;6QH*S3X&6D6"U*0W_"8\+6;74=O>&7'#E2TB5XI6=WM%Y]9<HHPBLM
MM=-)E,;*_U7>\(_!S5EO^$>XJ(,#=<\QL;HVUB8:3-*#89YR?<T8!,,5F)!H
M#R]%>=8Z:?V%2,_H7?\8*!Q^3W*T7SJ 61VD]L!DF\?*F(P1UEK@.M"Z]")#
MU*&^6'K%DZ$$J/F\NIW"='L1<KS+YT/8OP,@O:%@:OX#\2-6IHQ9VEYWVU+(
M#%9",C+7Z<\9G,<ZS1%]](Y[QEOWUNX095P0-7+TPUB_@=5'+A=9=<%L]^AU
M"\QVMI8,V:20( <50;%$ZRIZ#]$&VKA#_7WY1?B^]P/C7GBU!40[2W:PESQ=
M5F6D0Z6"H<A0UT!1.W#T*\6-SCH,6*0?9(#J2?6+?522M(IS3O)!CT#:K#!5
MLHV:(;C$*XE(5G1BUQ8[GV+23M29C_^^]8M'.?G ^L5C+-YW_2*/5@7G<]V8
M:2\UJ"$(88%IU$%)Z0/3!YQ*S[%^\2@G'EZ_>(Q%>]M4=EW@FB@-KP3#UAA5
MJ;,<G;A)0$J2.19+,JHU,^%?K)9AF!S]- _UAKJ-,A_F5U=OYXO*P34QF<+#
M:!(HD9&24.2T?1>*^$P(OHXQ9FE0P#T6J:,]K D&]H'L3(=TBJ\)K3K)DE/@
M2YUFZ'3MKQ(*L@S<%9XQRT'[/#9R=(2D<QU] (B.LOK)R/FVJGCX>!T6UVWK
M73:9YRL29'J]G$BAL_".EAC:^GXI$X1Z,8$AFN)RE!F/KFFY_XF.ZE8:H:.E
M33O86C9<D4LRR3VM)B'[++468'GMAZE7J-Z26DIYJW@JVIK6=0&[9.FH[*3Q
M%M/$^N/7U>W=,85G6EJ=H)A26=09+8AH"R!W @,%BX9=(OCIJ+#D$N?4,58_
M\YQZ,\M#UI.L7Z<_A3]Q>7JIR!,_I%$5R*_$:U3@<?N9U]-ENIHO;Q9X^TJO
M"I<Q6 '.LE6/H0:'UD.VFIG$7*:CJ/$*VR/.N9O([8_>5".\Q!F6*6G)M&,B
M1) $Z9H/4-(9HH2,)D@71/;-.Q!VB#)NR-L*"0^WD19V[R"@65?83;_CK3YU
M/LZ:&/"&-L@-(=)\MIQ$$8(,18%6MG;DZ@S1,@2N*R6@QQ2;TT0>+MVXD?-0
M(!O(._U60W[$SS7">S<K<_KG]><UH"0ZX(<V.MV.%;_1:;?Y[ ?\-E]4\K);
M[&4K8@Z&0%&[3%21"#[J ED4YV(2*'/K);M+EG,WJM]OZ@5[O6ZM/[C>JVZ^
MM)PHX0PO-@!MO!3SZT3!6_:<\%^P^)(<#ZRQEKNE&;ETK 42'NY"C4S_G':=
MVL6UC#_^6,PSI0I_6\QOOK7<?_;\^,%VHD-5&GI/JC17)FL'60I%&3H3$'12
M((/PP7+4F3>O+QYH3_J :3Y+TZOIRL#ORRU[)!F98L':$/B6ENAVM7R:5YKE
M^=4TK^X15F]##+G47"'4X[L^&!8(+!JPTGI:6L'*YM8X7^I.][ACD/7X5N"B
MKNP@\O]('EO/PMEPB6]U6Q5.<"DTS\5#0!% >2<@>CHODO>6\<*+4:UKLO<*
M-/:[R671\; WH)FK>L#=6O9;'BF3A=<6#+=D%A4S!.X1(JUC7XI2QC4?./JS
M "-O9>T<^Q R)UMYY)*EVCF_F%)@LMB&*MO*3^O1Q<P\.!(:%"NQ7OIRL%RC
MT&2KHLTO(K&]'^CB5#O%8?/6UAL9 O5^HQ[H?P^SFQ+J33WF!]JXS"*:S(%5
M]F5E#&DC(@(E',B9RCKD<  6?OVED2MDFX"BL3W[.4-N0\#;\WGVN5;#O)TO
M]I_0]P_HWVZ+:)(I@GF.(%F,H&0=@!J1-F!C6':%.T+0P+E)(U7&KB08-U[J
M !X=K)(/^!UG-U@5VVX!_SF]_O+J9GD]_UI[L=/53:X)U'))H4<U_)^3)#5*
M7@MV9*7T<C*#MZLW#.]\MD%3DM4\'SU:S"Z.ZG'A]2A_'=;7S^KR;OU/WDYG
M@=P2KG[ZHZ:7>+_^S'"7>4>J./2E7BV_D3$$8,(1E(0KX%1F%$2(RO(B9%*M
M&1.&NM2[J^Q^^(6?C/SRQW8MKPXKIRVGT$P PZI^2!YB,@HB3RX:ZYS4K?GH
M3Q"SKUWS).SL9DT8QEDC$XW>G1.DQNJ06%T,.!\X0YN!=J="!P6=$;'RZIC@
M@\J4RBE^T+/>+QA'G_YZ+]P( SE\WM3ZW>%GDTI*SYDV*H)7R8#"&"!(%T$&
M6V(E_$^']?0<C: Q;]U:^70O1$XP< >IPFW NDW)MJ3,"G,):$'$Z$&5VCK)
MA0%GLXH)D5G6^F#;(4I/D#G%QP^GS34P> >X>35?T/9+:<SOMS'I5A&II$BT
MU6:9$FVZ5D# **"(FKE;*SAK_;"Y4YCQV+('P4X;HW> GOW/'X8A:1,=9&93
M+?*N'6T2P2B!03+/'+8F23C_"?("9 G#!C[M?=,#T.[=H[,<<_$N@,Z9S,)B
MJ=TBJ7*U"63)1^E;\_@\FS?'HQR[]\WQ&"MW^^:HBE;6TEZ:G*IQ84&2GW95
M)C7IASIJ<4C+W[-X<SS*80>].1YCO?[?'(W/TE5.QV1J+ZO'#%YD!V0<B5KS
MHCT[  O/Z\WQ5% TMF<'9\C3!#.,9>N%4"!7]M&6524R6))?R2R#;QZDG,[D
M= $VC,L$)^?[HD= ;9:<9\FY4 ?J:>%KPT@"5T@75H1+%,4;R@6'AE0/@4H#
M)Q_(Z'2,Q<>F&-S'/F2"YCG;NH5:TB,F!&?10,'HDB\V/"*G?YIE\-FQ.1WE
MP/D UNQ@.]FS\_[TQ!RE<CQ9*$%C+2FD\)XAG>XLQNR##L8._4[WE%SC=IM?
M/+5N[:D.T'=[G[GN5*P5#Q/)N3.V!*#0SM>Y'[2 7!WF*H-3(G">?.M&ZR?$
MZ"+%:NCK71?))QK^=.S,K\-5FYWK"YGR95A6TK2OM9EZ/;'(2\.SK\.F<^*@
M%)?@BS&@4XQ*F!#;#WE_6I(N\K'A$-3 _/UPJOP-9[0>KE[,\HO\=3J;UAJ#
MVGZ[Z=*?!,=I90@./E3ZD! #.(H>('N5LY#1%]GZ /R%2"-G;D.CJZ5#^H'9
MBZ_57/]W4][ZCAPV^SREN&#%6[V<<&9=C*4 CR: 2II!K!/7BG0Z,26PV-8W
MS/LE&CG &AID#=UQ+L;:[&*'C9/4QB9OF "R$)FL%NP'I1PH9F5V)J,KK=]8
M&T[[U,\6;@.XIX,0_BF:OHEFRG/.% 2N*D\RI<->* ,8DO0I^\(?-MHT)O]=
MRW$0H,RS!=39IN_G9/Q]/IO?3TFV)ST7(AO&&,C:F:TD;<!!<3KNG78R5FUL
MZ^::G<(<A"?[;/'4Q@G]@.HNM]TV.#SD/WJ)9$+\B5WNS9\4:)(CI[.P^+&R
M*!DEU5>I^=75RBRT<]*RH^ @*[24W12L\RDQ"PC!4*S DJ[$D3;EUL3  ZIS
M$+#=LP5V+T#HX-;DW>P[F7J^^/&?B^DUOI[_:S8ITB8I2&1,WE+>+BAE5[86
M;V2O?<E:R=8O1X^E. B!_ADC\"RS=Q#GW0[86HTHX!.&1B>AZHM:/1*P6D-S
M#S(%)8(,@9*FYF\"]T0X[(J6/5O,G&/QCAOO;N(2_\\-_; W=4F<03>[ZR>U
M:I\[1-!6'7(/OG7;Y91"]%G*##P[#<I1,A@=PU4;?V*HD^:M'T-VR7+V!G+_
MYVZ&G&BG61URDK&6'M>I.H$["3HEP27]FA[.$FJM7P\];BV\_VCW.-?</9PY
M#W2@_VQ5S>%+,K2+)K#%TDY8&5)#$;ABO/$85?1B:-1L1.D*."?X^!>@.<7@
M?>+F=H!74$R2^.AL!A4+@Y ID:5E15IATCDTIQ'<)4Q?V#G)U;^&SPEV[P]
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M&H/Z_Q3SC>S_CSB;SA<O?Y]?X_*^$IIYRY7$6DE<:F,X Z^U :SZL,"]%^D
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MZX;8L)JY9OCWZ<T?U%]B6.)__R__#U!+ 0(4 Q0    ( %J!^5@O-(#-YP8
M +<A   /              "  0    !E>#,Q,7$R,C R-"YH=&U02P$"% ,4
M    " !:@?E854P+^.(&  "N(0  #P              @ $4!P  97@S,3)Q
M,C(P,C0N:'1M4$L! A0#%     @ 6H'Y6*;S,3VB*@  GJT  !P
M     ( !(PX  &5X,S%A<G1I8VQE<V]F:6YC;W)P;W)A="YH=&U02P$"% ,4
M    " !:@?E8Y[M3=ZL#  !/#0  #P              @ '_.   97@S,C%Q
M,C(P,C0N:'1M4$L! A0#%     @ 6H'Y6!JA7$NC P  2@T   \
M     ( !USP  &5X,S(R<3(R,#(T+FAT;5!+ 0(4 Q0    ( %J!^5BUKJ5H
M+CD! $HG%P 0              "  :=   !W<W0M,C R-# V,S N:'1M4$L!
M A0#%     @ 6H'Y6+0K]JF$#@  [J<  !               ( ! WH! '=S
M="TR,#(T,#8S,"YX<V102P$"% ,4    " !:@?E8Z*/./(4D  !:80$ %
M            @ &UB $ =W-T+3(P,C0P-C,P7V-A;"YX;6Q02P$"% ,4
M" !:@?E8:MJ<@N9%   *% , %               @ %LK0$ =W-T+3(P,C0P
M-C,P7V1E9BYX;6Q02P$"% ,4    " !:@?E8H"78Z7OA  "$=P@ %
M        @ &$\P$ =W-T+3(P,C0P-C,P7VQA8BYX;6Q02P$"% ,4    " !:
M@?E81$F$.V&(   < @8 %               @ $QU0( =W-T+3(P,C0P-C,P
>7W!R92YX;6Q02P4&      L "P#" @  Q%T#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>wst-20240630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:currency="http://xbrl.sec.gov/currency/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:wst="http://www.westpharma.com/20240630"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wst-20240630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2024-07-22</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wst:DistributorshipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardContractsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardContractsTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wst:IntercompanyDemandNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:OtherExpenseIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommodityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociEquityMethodInvestmentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:The2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2022RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-02</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-07-05</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sgd">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="bbl">
        <measure>utr:bbl</measure>
    </unit>
    <unit id="usdPerBbl">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>wst:bbl</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>wst:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0000105770</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-427">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-429">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-431">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-8036</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">23-1210010</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">530 Herman O. West Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Exton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">19341-1147</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">594-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">WST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">72541593</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">702100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">753800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-32" unitRef="usd">1397500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-33" unitRef="usd">1470400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">472100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">462400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-36" unitRef="usd">937300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-37" unitRef="usd">907700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">230000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">291400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-40" unitRef="usd">460200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-41" unitRef="usd">562700000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">17500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">16500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-44" unitRef="usd">35100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-45" unitRef="usd">33600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">83000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">88400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-48" unitRef="usd">169700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-49" unitRef="usd">174400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <wst:OtherIncomeExpense contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">-3300000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">-4000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-1" decimals="-5" id="f-52" unitRef="usd">-6400000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-5" decimals="-5" id="f-53" unitRef="usd">-16900000</wst:OtherIncomeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">126200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">182500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-56" unitRef="usd">249000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-57" unitRef="usd">337800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">1500000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">2700000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-5" id="f-60" unitRef="usd">3100000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-5" id="f-61" unitRef="usd">4900000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InvestmentIncomeNet contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">4000000.0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">5000000.0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-1" decimals="-5" id="f-64" unitRef="usd">10200000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-5" decimals="-5" id="f-65" unitRef="usd">9800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-68" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-69" unitRef="usd">100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-3" decimals="-5" id="f-70" unitRef="usd">128700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-4" decimals="-5" id="f-71" unitRef="usd">184900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-5" id="f-72" unitRef="usd">256100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-5" id="f-73" unitRef="usd">342800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-3" decimals="-5" id="f-74" unitRef="usd">21900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">34800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-76" unitRef="usd">38300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-77" unitRef="usd">58400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-3" decimals="-5" id="f-78" unitRef="usd">4500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-4" decimals="-5" id="f-79" unitRef="usd">5000000.0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-5" id="f-80" unitRef="usd">8800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-5" id="f-81" unitRef="usd">10700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-82" unitRef="usd">111300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-83" unitRef="usd">155100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-84" unitRef="usd">226600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-85" unitRef="usd">295100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-3"
      decimals="2"
      id="f-86"
      unitRef="usdPerShare">1.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-4"
      decimals="2"
      id="f-87"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-88"
      unitRef="usdPerShare">3.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-89"
      unitRef="usdPerShare">3.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-3"
      decimals="2"
      id="f-90"
      unitRef="usdPerShare">1.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-4"
      decimals="2"
      id="f-91"
      unitRef="usdPerShare">2.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-92"
      unitRef="usdPerShare">3.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-93"
      unitRef="usdPerShare">3.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-3" decimals="-5" id="f-94" unitRef="shares">73000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-4" decimals="-5" id="f-95" unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-96" unitRef="shares">73300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-97" unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-3" decimals="-5" id="f-98" unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-4" decimals="-5" id="f-99" unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-100" unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-101" unitRef="shares">75500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-102" unitRef="usd">111300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-103" unitRef="usd">155100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-104" unitRef="usd">226600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-105" unitRef="usd">295100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-106" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-107" unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-108" unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-109" unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-110" unitRef="usd">-21700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-111" unitRef="usd">-11300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-112" unitRef="usd">-68000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-113" unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-114" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-115" unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-116" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-117" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-118" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-119" unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-120" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-121" unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OciEquityMethodInvestmentTaxParent contextRef="c-3" decimals="-5" id="f-122" unitRef="usd">0.0</us-gaap:OciEquityMethodInvestmentTaxParent>
    <us-gaap:OciEquityMethodInvestmentTaxParent contextRef="c-4" decimals="-5" id="f-123" unitRef="usd">0.0</us-gaap:OciEquityMethodInvestmentTaxParent>
    <us-gaap:OciEquityMethodInvestmentTaxParent contextRef="c-1" decimals="-5" id="f-124" unitRef="usd">0.0</us-gaap:OciEquityMethodInvestmentTaxParent>
    <us-gaap:OciEquityMethodInvestmentTaxParent contextRef="c-5" decimals="-5" id="f-125" unitRef="usd">0.0</us-gaap:OciEquityMethodInvestmentTaxParent>
    <us-gaap:OciEquityMethodInvestmentAfterTaxParent contextRef="c-3" decimals="-5" id="f-126" unitRef="usd">-100000</us-gaap:OciEquityMethodInvestmentAfterTaxParent>
    <us-gaap:OciEquityMethodInvestmentAfterTaxParent contextRef="c-4" decimals="-5" id="f-127" unitRef="usd">-100000</us-gaap:OciEquityMethodInvestmentAfterTaxParent>
    <us-gaap:OciEquityMethodInvestmentAfterTaxParent contextRef="c-1" decimals="-5" id="f-128" unitRef="usd">-200000</us-gaap:OciEquityMethodInvestmentAfterTaxParent>
    <us-gaap:OciEquityMethodInvestmentAfterTaxParent contextRef="c-5" decimals="-5" id="f-129" unitRef="usd">-100000</us-gaap:OciEquityMethodInvestmentAfterTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax contextRef="c-3" decimals="-5" id="f-130" unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax contextRef="c-4" decimals="-5" id="f-131" unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax contextRef="c-1" decimals="-5" id="f-132" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax contextRef="c-5" decimals="-5" id="f-133" unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax contextRef="c-3" decimals="-5" id="f-134" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax contextRef="c-4" decimals="-5" id="f-135" unitRef="usd">-2800000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax contextRef="c-1" decimals="-5" id="f-136" unitRef="usd">-4500000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax contextRef="c-5" decimals="-5" id="f-137" unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-138" unitRef="usd">-24600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-139" unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-140" unitRef="usd">-73100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-141" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-3" decimals="-5" id="f-142" unitRef="usd">86700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-4" decimals="-5" id="f-143" unitRef="usd">140000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-144" unitRef="usd">153500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-145" unitRef="usd">294600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-146" unitRef="usd">446200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-147" unitRef="usd">853900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-5" id="f-148" unitRef="usd">479400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-5" id="f-149" unitRef="usd">512000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-5" id="f-150" unitRef="usd">419200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-5" id="f-151" unitRef="usd">434700000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="c-6" decimals="-5" id="f-152" unitRef="usd">138200000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-7" decimals="-5" id="f-153" unitRef="usd">135800000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-5" id="f-154" unitRef="usd">1483000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-7" decimals="-5" id="f-155" unitRef="usd">1936400000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-6" decimals="-5" id="f-156" unitRef="usd">2863600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-7" decimals="-5" id="f-157" unitRef="usd">2738000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-6" decimals="-5" id="f-158" unitRef="usd">1369900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-159" unitRef="usd">1324700000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-5" id="f-160" unitRef="usd">1493700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-5" id="f-161" unitRef="usd">1413300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-162" unitRef="usd">110300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-163" unitRef="usd">99200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-6" decimals="-5" id="f-164" unitRef="usd">198200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-7" decimals="-5" id="f-165" unitRef="usd">210000000.0</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill contextRef="c-6" decimals="-5" id="f-166" unitRef="usd">107300000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-7" decimals="-5" id="f-167" unitRef="usd">108500000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-5" id="f-168" unitRef="usd">12900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-7" decimals="-5" id="f-169" unitRef="usd">15100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-6" decimals="-5" id="f-170" unitRef="usd">33900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-7" decimals="-5" id="f-171" unitRef="usd">25700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-5" id="f-172" unitRef="usd">50100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-7" decimals="-5" id="f-173" unitRef="usd">21300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-6" decimals="-5" id="f-174" unitRef="usd">3489400000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-5" id="f-175" unitRef="usd">3829500000</us-gaap:Assets>
    <wst:NotesPayableAndOtherDebtCurrent contextRef="c-6" decimals="-5" id="f-176" unitRef="usd">132900000</wst:NotesPayableAndOtherDebtCurrent>
    <wst:NotesPayableAndOtherDebtCurrent contextRef="c-7" decimals="-5" id="f-177" unitRef="usd">134000000.0</wst:NotesPayableAndOtherDebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-6" decimals="-5" id="f-178" unitRef="usd">211700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-7" decimals="-5" id="f-179" unitRef="usd">242400000</us-gaap:AccountsPayableCurrent>
    <wst:AccruedSalariesWagesAndBenefitsCurrent contextRef="c-6" decimals="-5" id="f-180" unitRef="usd">82900000</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <wst:AccruedSalariesWagesAndBenefitsCurrent contextRef="c-7" decimals="-5" id="f-181" unitRef="usd">105900000</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-6" decimals="-5" id="f-182" unitRef="usd">16900000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-7" decimals="-5" id="f-183" unitRef="usd">16600000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-184" unitRef="usd">20300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-185" unitRef="usd">17700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-186" unitRef="usd">169000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-187" unitRef="usd">155200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-188" unitRef="usd">633700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-189" unitRef="usd">671800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-6" decimals="-5" id="f-190" unitRef="usd">72900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-7" decimals="-5" id="f-191" unitRef="usd">72800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-6" decimals="-5" id="f-192" unitRef="usd">13700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-7" decimals="-5" id="f-193" unitRef="usd">12700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-194" unitRef="usd">29100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-7" decimals="-5" id="f-195" unitRef="usd">29600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-196" unitRef="usd">84600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-197" unitRef="usd">84500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c-6" decimals="-5" id="f-198" unitRef="usd">15500000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c-7" decimals="-5" id="f-199" unitRef="usd">18600000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-200" unitRef="usd">63100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-7" decimals="-5" id="f-201" unitRef="usd">58500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-6" decimals="-5" id="f-202" unitRef="usd">912600000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-7" decimals="-5" id="f-203" unitRef="usd">948500000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-204" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-7" id="f-205" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-7" decimals="-5" id="f-206" unitRef="shares">3000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="-5" id="f-207" unitRef="shares">3000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="-5" id="f-208" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-7" decimals="-5" id="f-209" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-7" decimals="-5" id="f-210" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="-5" id="f-211" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-6" decimals="-5" id="f-212" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-7" decimals="-5" id="f-213" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-214"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-215"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="-5" id="f-216" unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="-5" id="f-217" unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="-5" id="f-218" unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="-5" id="f-219" unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="-5" id="f-220" unitRef="shares">72600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="-5" id="f-221" unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-5" id="f-222" unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-7" decimals="-5" id="f-223" unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-6" decimals="-5" id="f-224" unitRef="usd">33500000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-7" decimals="-5" id="f-225" unitRef="usd">120200000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-5" id="f-226" unitRef="usd">3720900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-5" id="f-227" unitRef="usd">3523400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-228" unitRef="usd">-216900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-5" id="f-229" unitRef="usd">-143800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares contextRef="c-6" decimals="-5" id="f-230" unitRef="shares">2700000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-7" decimals="-5" id="f-231" unitRef="shares">1800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-6" decimals="-5" id="f-232" unitRef="usd">979500000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-7" decimals="-5" id="f-233" unitRef="usd">637600000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-5" id="f-234" unitRef="usd">2576800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-235" unitRef="usd">2881000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-5" id="f-236" unitRef="usd">3489400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-7" decimals="-5" id="f-237" unitRef="usd">3829500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-238" unitRef="usd">226600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-239" unitRef="usd">295100000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-240" unitRef="usd">72700000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-241" unitRef="usd">64300000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-1" decimals="-5" id="f-242" unitRef="usd">1800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-5" decimals="-5" id="f-243" unitRef="usd">1400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-244" unitRef="usd">9300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-5" id="f-245" unitRef="usd">16000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-5" id="f-246" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-5" decimals="-5" id="f-247" unitRef="usd">-11600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-248" unitRef="usd">900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-5" decimals="-5" id="f-249" unitRef="usd">3400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-250" unitRef="usd">7600000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-5" decimals="-5" id="f-251" unitRef="usd">12400000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c-1" decimals="-5" id="f-252" unitRef="usd">20500000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c-5" decimals="-5" id="f-253" unitRef="usd">72100000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-254" unitRef="usd">283200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-5" id="f-255" unitRef="usd">307300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-256" unitRef="usd">190800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-5" id="f-257" unitRef="usd">157500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-258" unitRef="usd">1000000.0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-5" decimals="-5" id="f-259" unitRef="usd">6700000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-260" unitRef="usd">-191800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-5" id="f-261" unitRef="usd">-164200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-5" id="f-262" unitRef="usd">35000000.0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-5" decimals="-5" id="f-263" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">36100000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-5" decimals="-5" id="f-265" unitRef="usd">1100000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-5" id="f-266" unitRef="usd">22900000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-5" decimals="-5" id="f-267" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-5" id="f-268" unitRef="usd">29300000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-5" decimals="-5" id="f-269" unitRef="usd">28200000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">19900000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-5" id="f-271" unitRef="usd">24000000.0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">3700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-5" decimals="-5" id="f-273" unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-274" unitRef="usd">454100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-5" decimals="-5" id="f-275" unitRef="usd">233500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">5500000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="-5" id="f-277" unitRef="usd">12500000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-278" unitRef="usd">-489300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-5" id="f-279" unitRef="usd">-247800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-280" unitRef="usd">-9800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-5" id="f-281" unitRef="usd">6700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-282" unitRef="usd">-407700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-5" id="f-283" unitRef="usd">-98000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-284" unitRef="usd">853900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-5" id="f-285" unitRef="usd">894300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-286" unitRef="usd">446200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-5" id="f-287" unitRef="usd">796300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-288">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial reporting and U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and six months ended June&#160;30, 2024, should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as &#x201c;West&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d; or &#x201c;our&#x201d;) appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the &#x201c;&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577024000015/wst-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2023 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The results of operations for any interim period are not necessarily indicative of results for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-289">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The condensed consolidated financial statements included in this report are unaudited and have been prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial reporting and U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) regulations. The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. In the opinion of management, these financial statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the financial position, results of operations, cash flows and the change in equity for the periods presented. The condensed consolidated financial statements for the three and six months ended June&#160;30, 2024, should be read in conjunction with the consolidated financial statements and notes thereto of West Pharmaceutical Services, Inc. and its majority-owned subsidiaries (which may be referred to as &#x201c;West&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d; or &#x201c;our&#x201d;) appearing in our Annual Report on Form 10-K for the year ended December&#160;31, 2023 (the &#x201c;&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577024000015/wst-20231231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2023 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The results of operations for any interim period are not necessarily indicative of results for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c-1" id="f-290">New Accounting Standards&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Standards Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendment enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures. The Company does not expect the adoption to have a material impact on the consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;In December 2023, the FASB issued guidance that seeks to enhance income tax disclosures to provide information to better assess how an entity's operations and related tax risks affect its tax rate and prospects for future cash flows. Within the income tax rate reconciliation, the amendment requires disclosure of additional categories and greater detail about individual reconciling items over a specified threshold. It also requires information pertaining to taxes paid to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions over a specified threshold. This guidance is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures, but we do not expect the adoption to have a material impact on the consolidated financial statements other than the expanded footnote disclosure.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-291">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Standards Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board ("FASB") issued guidance that seeks to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendment enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures. The Company does not expect the adoption to have a material impact on the consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;In December 2023, the FASB issued guidance that seeks to enhance income tax disclosures to provide information to better assess how an entity's operations and related tax risks affect its tax rate and prospects for future cash flows. Within the income tax rate reconciliation, the amendment requires disclosure of additional categories and greater detail about individual reconciling items over a specified threshold. It also requires information pertaining to taxes paid to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions over a specified threshold. This guidance is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on our financial statements and disclosures, but we do not expect the adoption to have a material impact on the consolidated financial statements other than the expanded footnote disclosure.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-292">Revenue&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the Company's reassessment of product categories, beginning in the second quarter of 2023 certain product types have been moved from High-Value Product Components to High-Value Product Delivery Devices. No adjustments were made to the product categorization prior to the second quarter of 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, June&#160;30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, June&#160;30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - decrease (increase)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets are included within other current assets and deferred income is included within other current liabilities and other long-term liabilities. During the six months ended June&#160;30, 2024, $24.2&#160;million of revenue was recognized that was included in deferred income at the beginning of the year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year are not material as of June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-293">&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High-Value Product Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100 %&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-10" decimals="2" id="f-294" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-11" decimals="2" id="f-295" unitRef="number">0.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-12" decimals="2" id="f-296" unitRef="number">0.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-13" decimals="2" id="f-297" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-14" decimals="2" id="f-298" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-15" decimals="2" id="f-299" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-16" decimals="2" id="f-300" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-17" decimals="2" id="f-301" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-18" decimals="2" id="f-302" unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-19" decimals="2" id="f-303" unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-20" decimals="2" id="f-304" unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-21" decimals="2" id="f-305" unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-22" decimals="2" id="f-306" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-23" decimals="2" id="f-307" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-24" decimals="2" id="f-308" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-25" decimals="2" id="f-309" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-26" decimals="2" id="f-310" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-27" decimals="2" id="f-311" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-28" decimals="2" id="f-312" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-29" decimals="2" id="f-313" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-30" decimals="2" id="f-314" unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-31" decimals="2" id="f-315" unitRef="number">0.49</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-32" decimals="2" id="f-316" unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-33" decimals="2" id="f-317" unitRef="number">0.50</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-34" decimals="2" id="f-318" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-35" decimals="2" id="f-319" unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-36" decimals="2" id="f-320" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-37" decimals="2" id="f-321" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-38" decimals="2" id="f-322" unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-39" decimals="2" id="f-323" unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-40" decimals="2" id="f-324" unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-41" decimals="2" id="f-325" unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-42" decimals="2" id="f-326" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-43" decimals="2" id="f-327" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-44" decimals="2" id="f-328" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-45" decimals="2" id="f-329" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-46" decimals="2" id="f-330" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-47" decimals="2" id="f-331" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-48" decimals="2" id="f-332" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-49" decimals="2" id="f-333" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-50" decimals="2" id="f-334" unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-51" decimals="2" id="f-335" unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-52" decimals="2" id="f-336" unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-53" decimals="2" id="f-337" unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-54" decimals="2" id="f-338" unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-55" decimals="2" id="f-339" unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-56" decimals="2" id="f-340" unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-57" decimals="2" id="f-341" unitRef="number">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-58" decimals="2" id="f-342" unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-59" decimals="2" id="f-343" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-60" decimals="2" id="f-344" unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-61" decimals="2" id="f-345" unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-62" decimals="2" id="f-346" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-63" decimals="2" id="f-347" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-64" decimals="2" id="f-348" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-65" decimals="2" id="f-349" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-350">&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets and liabilities:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets, June&#160;30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in contract assets - increase (decrease) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income, June&#160;30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred income - decrease (increase)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-7" decimals="-5" id="f-351" unitRef="usd">21500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-6" decimals="-5" id="f-352" unitRef="usd">22600000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-1" decimals="-5" id="f-353" unitRef="usd">1100000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:ContractWithCustomerLiability contextRef="c-7" decimals="-5" id="f-354" unitRef="usd">53900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-6" decimals="-5" id="f-355" unitRef="usd">52200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-5" id="f-356" unitRef="usd">-1700000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-357" unitRef="usd">24200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-358">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2024 and 2023, there were 0.3 million and 0.1 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. There were 0.3 million and 0.1 million antidilutive shares outstanding during the six months ended June&#160;30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Board of Directors approved a share repurchase program under which we may repurchase up to $1.0&#160;billion in shares of common stock. The share repurchase program does not have an expiration date under which we may repurchase common stock on the open market or in privately-negotiated transactions. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2024, we purchased 509,336 shares of our common stock under the program at a cost of $187.1 million, or an average price of $367.48 per share. During the six months ended June&#160;30, 2024, we purchased 1,239,015 shares of our common stock under the program at a cost of $454.1 million, or an average price of $366.53 per share. &lt;/span&gt;&lt;/div&gt;During the three months ended June&#160;30, 2023, we purchased 492,710 shares of our common stock under the program at a cost of $173.4 million, or an average price of $351.82 per share. During the six months ended June&#160;30, 2023, we purchased 676,070 shares of our common stock under the program at a cost of $233.5 million, or an average price of $345.33 per share.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-359">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-360" unitRef="usd">111300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-361" unitRef="usd">155100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-362" unitRef="usd">226600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-363" unitRef="usd">295100000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-3" decimals="-5" id="f-364" unitRef="shares">73000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-4" decimals="-5" id="f-365" unitRef="shares">74300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-366" unitRef="shares">73300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-367" unitRef="shares">74400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-3" decimals="-5" id="f-368" unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-4" decimals="-5" id="f-369" unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-5" id="f-370" unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-5" decimals="-5" id="f-371" unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-3" decimals="-5" id="f-372" unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-4" decimals="-5" id="f-373" unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-374" unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-375" unitRef="shares">75500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-3" decimals="-5" id="f-376" unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-4" decimals="-5" id="f-377" unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-378" unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="-5" id="f-379" unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c-66"
      decimals="INF"
      id="f-380"
      unitRef="shares">1000000000</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-3" decimals="INF" id="f-381" unitRef="shares">509336</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-3" decimals="-5" id="f-382" unitRef="usd">187100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-3"
      decimals="2"
      id="f-383"
      unitRef="usdPerShare">367.48</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="INF" id="f-384" unitRef="shares">1239015</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-5" id="f-385" unitRef="usd">454100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-1"
      decimals="2"
      id="f-386"
      unitRef="usdPerShare">366.53</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-4" decimals="INF" id="f-387" unitRef="shares">492710</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-4" decimals="-5" id="f-388" unitRef="usd">173400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-4"
      decimals="2"
      id="f-389"
      unitRef="usdPerShare">351.82</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-5" decimals="INF" id="f-390" unitRef="shares">676070</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-391" unitRef="usd">233500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-5"
      decimals="2"
      id="f-392"
      unitRef="usdPerShare">345.33</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-393">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory balances were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-394">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory balances were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-6" decimals="-5" id="f-395" unitRef="usd">173700000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-7" decimals="-5" id="f-396" unitRef="usd">172300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-6" decimals="-5" id="f-397" unitRef="usd">81100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-7" decimals="-5" id="f-398" unitRef="usd">87300000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-6" decimals="-5" id="f-399" unitRef="usd">164400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-7" decimals="-5" id="f-400" unitRef="usd">175100000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-5" id="f-401" unitRef="usd">419200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-5" id="f-402" unitRef="usd">434700000</us-gaap:InventoryNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-404">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. Lease payments included in the measurement of the lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease - amortization of right-of-use (ROU) assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.831%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-427"&gt;Other noncurrent assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-429"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (noncurrent)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-431"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average remaining lease term for operating leases was 8.6 years and 9.8 years, respectively. As of June&#160;30, 2024, the weighted average remaining lease term for finance leases was 7.6 years. As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average discount rate for operating leases was 3.96% and 3.55%, respectively. As of June&#160;30, 2024, the weighted average discount rate for finance leases was 4.94%. As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of finance lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-403">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. Lease payments included in the measurement of the lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease - amortization of right-of-use (ROU) assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.831%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-427"&gt;Other noncurrent assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-429"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (noncurrent)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-431"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average remaining lease term for operating leases was 8.6 years and 9.8 years, respectively. As of June&#160;30, 2024, the weighted average remaining lease term for finance leases was 7.6 years. As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2024 and December&#160;31, 2023, the weighted average discount rate for operating leases was 3.96% and 3.55%, respectively. As of June&#160;30, 2024, the weighted average discount rate for finance leases was 4.94%. As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of finance lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, finance leases were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-405">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease - amortization of right-of-use (ROU) assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-3" decimals="-5" id="f-406" unitRef="usd">6100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-4" decimals="-5" id="f-407" unitRef="usd">4800000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-408" unitRef="usd">11700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-5" id="f-409" unitRef="usd">10700000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-3" decimals="-5" id="f-410" unitRef="usd">300000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-4" decimals="-5" id="f-411" unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-5" id="f-412" unitRef="usd">300000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-5" decimals="-5" id="f-413" unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShortTermLeaseCost contextRef="c-3" decimals="-5" id="f-414" unitRef="usd">600000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-4" decimals="-5" id="f-415" unitRef="usd">1200000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-5" id="f-416" unitRef="usd">1100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-5" decimals="-5" id="f-417" unitRef="usd">2500000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-3" decimals="-5" id="f-418" unitRef="usd">1900000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-4" decimals="-5" id="f-419" unitRef="usd">1300000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-5" id="f-420" unitRef="usd">3800000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-5" decimals="-5" id="f-421" unitRef="usd">3000000.0</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost contextRef="c-3" decimals="-5" id="f-422" unitRef="usd">8900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-4" decimals="-5" id="f-423" unitRef="usd">7300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-5" id="f-424" unitRef="usd">16900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-5" id="f-425" unitRef="usd">16200000</us-gaap:LeaseCost>
    <wst:ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-426">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the finance lease amounts in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.562%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.831%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-427"&gt;Other noncurrent assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-429"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities (noncurrent)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-431"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfAssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-428" unitRef="usd">31000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-430" unitRef="usd">900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-432" unitRef="usd">2400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeasePayments contextRef="c-3" decimals="-5" id="f-433" unitRef="usd">15000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-4" decimals="-5" id="f-434" unitRef="usd">5000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-435" unitRef="usd">20300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-5" id="f-436" unitRef="usd">9900000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-3" decimals="-5" id="f-437" unitRef="usd">22900000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-4" decimals="-5" id="f-438" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-5" id="f-439" unitRef="usd">22900000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-5" decimals="-5" id="f-440" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-3" decimals="-5" id="f-441" unitRef="usd">29900000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-442" unitRef="usd">2900000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-443" unitRef="usd">34100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-444" unitRef="usd">3500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-3" decimals="-5" id="f-445" unitRef="usd">24300000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-4" decimals="-5" id="f-446" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-5" id="f-447" unitRef="usd">24300000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-5" decimals="-5" id="f-448" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-449">P8Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-450">P9Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-451">P7Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="4" id="f-452" unitRef="number">0.0396</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="4" id="f-453" unitRef="number">0.0355</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="4" id="f-454" unitRef="number">0.0494</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-455">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-6" decimals="-5" id="f-456" unitRef="usd">12100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-7" decimals="-5" id="f-457" unitRef="usd">20900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-5" id="f-458" unitRef="usd">22700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-7" decimals="-5" id="f-459" unitRef="usd">18700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-5" id="f-460" unitRef="usd">19800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-7" decimals="-5" id="f-461" unitRef="usd">15700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-5" id="f-462" unitRef="usd">15300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-7" decimals="-5" id="f-463" unitRef="usd">11200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-5" id="f-464" unitRef="usd">13800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-7" decimals="-5" id="f-465" unitRef="usd">9500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-6" decimals="-5" id="f-466" unitRef="usd">36200000</wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-7" decimals="-5" id="f-467" unitRef="usd">42100000</wst:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-5" id="f-468" unitRef="usd">119900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-7" decimals="-5" id="f-469" unitRef="usd">118100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-5" id="f-470" unitRef="usd">15000000.0</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-7" decimals="-5" id="f-471" unitRef="usd">15900000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-6" decimals="-5" id="f-472" unitRef="usd">104900000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-473" unitRef="usd">102200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-474">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of finance lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 (remaining period as of)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-6" decimals="-5" id="f-475" unitRef="usd">400000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-5" id="f-476" unitRef="usd">900000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-5" id="f-477" unitRef="usd">900000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-5" id="f-478" unitRef="usd">800000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-5" id="f-479" unitRef="usd">500000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <wst:FinanceLeaseLiabilityToBePaidAfterYearFour contextRef="c-6" decimals="-5" id="f-480" unitRef="usd">100000</wst:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-5" id="f-481" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-5" id="f-482" unitRef="usd">300000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability contextRef="c-6" decimals="-5" id="f-483" unitRef="usd">3300000</us-gaap:FinanceLeaseLiability>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="c-1" id="f-484">Affiliated Companies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2024 and December&#160;31, 2023, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $191.0 million and $203.2 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $7.2 million and $6.8 million, respectively. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our purchases from, and royalty payments made to, affiliates totaled $24.9 million and $53.5 million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $39.9 million and $84.1 million, respectively, for the same period in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the payable balance due to affiliates was $20.4 million and $25.9 million, respectively. The majority of these transactions related to a distributorship agreement with Daikyo Seiko, Ltd. ("Daikyo") that allows us to purchase and re-sell Daikyo products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales to affiliates were $4.0 million and $7.2 million, respectively, for the three and six months ended June&#160;30, 2024, as compared to $2.7 million and $6.0 million, respectively, for the same periods in 2023. As of June&#160;30, 2024 and December&#160;31, 2023, the receivable balance due from affiliates was $2.4 million and $1.6 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestments contextRef="c-6" decimals="-5" id="f-485" unitRef="usd">191000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-7" decimals="-5" id="f-486" unitRef="usd">203200000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-6" decimals="-5" id="f-487" unitRef="usd">7200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-7" decimals="-5" id="f-488" unitRef="usd">6800000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-67" decimals="-5" id="f-489" unitRef="usd">24900000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-68" decimals="-5" id="f-490" unitRef="usd">53500000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-69" decimals="-5" id="f-491" unitRef="usd">39900000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-70" decimals="-5" id="f-492" unitRef="usd">84100000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-71" decimals="-5" id="f-493" unitRef="usd">20400000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-72" decimals="-5" id="f-494" unitRef="usd">25900000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-73" decimals="-5" id="f-495" unitRef="usd">4000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-74" decimals="-5" id="f-496" unitRef="usd">7200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-75" decimals="-5" id="f-497" unitRef="usd">2700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-76" decimals="-5" id="f-498" unitRef="usd">6000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherAssetsCurrent contextRef="c-71" decimals="-5" id="f-499" unitRef="usd">2400000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-72" decimals="-5" id="f-500" unitRef="usd">1600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-501">Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.982%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.607%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (8.50%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2024, the borrowing capacity available under our $500.0&#160;million multi-currency revolving credit facility (the &#x201c;Credit Facility&#x201d;), including outstanding letters of credit of $2.4 million, was $497.6 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2024, we had $79.9 million in borrowings under the Term Loan, of which $79.9 million was classified as current. Please refer to Note 9, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8e08f59eae304691ab0e971847e56044_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for a discussion of the foreign currency hedge associated with the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At June&#160;30, 2024, we were in compliance with all of our debt covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-502">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities. The interest rates shown in parentheses are as of June&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.982%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.607%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, due December 31, 2024 (8.50%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C notes, due July 5, 2027 (4.02%) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-77"
      decimals="INF"
      id="f-503"
      unitRef="number">0.0850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-77" decimals="-5" id="f-504" unitRef="usd">79900000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-78" decimals="-5" id="f-505" unitRef="usd">81000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-79"
      decimals="INF"
      id="f-506"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-79" decimals="-5" id="f-507" unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-80" decimals="-5" id="f-508" unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-81"
      decimals="INF"
      id="f-509"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-81" decimals="-5" id="f-510" unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-82" decimals="-5" id="f-511" unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-6" decimals="-5" id="f-512" unitRef="usd">205900000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-7" decimals="-5" id="f-513" unitRef="usd">207000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-6" decimals="-5" id="f-514" unitRef="usd">100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-7" decimals="-5" id="f-515" unitRef="usd">200000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-5" id="f-516" unitRef="usd">205800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-7" decimals="-5" id="f-517" unitRef="usd">206800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-6" decimals="-5" id="f-518" unitRef="usd">132900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-7" decimals="-5" id="f-519" unitRef="usd">134000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-6" decimals="-5" id="f-520" unitRef="usd">72900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-7" decimals="-5" id="f-521" unitRef="usd">72800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="c-83" decimals="-5" id="f-522" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-84" decimals="-5" id="f-523" unitRef="usd">2400000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-83" decimals="-5" id="f-524" unitRef="usd">497600000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-77" decimals="-5" id="f-525" unitRef="usd">79900000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-77" decimals="-5" id="f-526" unitRef="usd">79900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-527">Derivative Financial Instruments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our condensed consolidated balance sheet at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of both June&#160;30, 2024 and December&#160;31, 2023, the total amount of these forward exchange contracts was Singapore Dollar (&#x201c;SGD&#x201d;) 601.5 million and $13.4 million. We have also entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany demand notes which were executed at various times throughout 2023 and 2024. As of June&#160;30, 2024, the total amount of these forward exchange contracts was Euro ("EUR") 290.2 million, SGD 98.1 million, $178.3 million, and EUR 23.5 million. As of December&#160;31, 2023, the total amount of these forward exchange contracts was EUR 278.6 million and SGD 94.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of June&#160;30, 2024, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, we entered into a cross-currency swap for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. As of June&#160;30, 2024, the notional amount of the cross-currency swap is &#xa5;8.7&#160;billion ($79.9&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on USD compounded Secured Overnight Financing Rate ("SOFR") plus a margin, in return for paying floating interest rate payments based on Japanese Yen (&#x201c;Yen&#x201d;) Tokyo Overnight Average Rate ("TONAR") plus a margin.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, we will periodically enter into forward exchange contracts to mitigate our exposure to fluctuating foreign exchange rates on assets and liabilities, other than the intercompany loans and demand notes referenced above, which are denominated in foreign currencies. The Company has elected not to designate these forward contracts in hedging relationships, and any change in the value of the contracts is recognized in income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commodity Price Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From November 2017 through June 2024, we purchased several series of call options for a total of 1,079,145 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regard to a portion of our forecasted elastomer purchases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2024, we had outstanding contracts to purchase 201,801 barrels of crude oil from June 2024 to December 2025, at a weighted-average strike price of $86.26 per barrel.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effects of Derivative Instruments on Financial Position and Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 10, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8e08f59eae304691ab0e971847e56044_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the balance sheet location and fair values of our derivative instruments as of June&#160;30, 2024 and December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.585%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize in earnings the initial value of forward point components for hedges of intercompany loans on a straight-line basis over the life of the fair value hedge. The value of forward point components for hedges of intercompany demand notes is recognized currently in earnings using a market approach. The expense recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2024 was $1.7 million and $3.5 million, respectively. The income recognized in earnings, pre-tax, for forward point components for the three and six months ended June&#160;30, 2023 was $0.2 million and $1.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (&#x201c;OCI&#x201d;) and earnings, net of tax:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:44pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:42pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our condensed consolidated statements of income for the three and six months ended June&#160;30, 2024 and June&#160;30, 2023. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our condensed consolidated statements of income:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended June&#160;30, 2024 and 2023, there was no material ineffectiveness related to our hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-85" decimals="-5" id="f-528" unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-86" decimals="-5" id="f-529" unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-87" decimals="-5" id="f-530" unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-88" decimals="-5" id="f-531" unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-89" decimals="-5" id="f-532" unitRef="eur">290200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-90" decimals="-5" id="f-533" unitRef="sgd">98100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-91" decimals="-5" id="f-534" unitRef="usd">178300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-92" decimals="-5" id="f-535" unitRef="eur">23500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-93" decimals="-5" id="f-536" unitRef="eur">278600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-94" decimals="-5" id="f-537" unitRef="sgd">94000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeTermOfContract contextRef="c-95" id="f-538">P18M</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock contextRef="c-1" id="f-539">As of June&#160;30, 2024, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-96" decimals="-5" id="f-540" unitRef="eur">30500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-97" decimals="-5" id="f-541" unitRef="usd">33400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-97" decimals="-5" id="f-542" unitRef="eur">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-97" decimals="-5" id="f-543" unitRef="sgd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-98" decimals="-5" id="f-544" unitRef="jpy">5750000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-99" decimals="-5" id="f-545" unitRef="usd">27600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-99" decimals="-5" id="f-546" unitRef="eur">11200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-99" decimals="-5" id="f-547" unitRef="sgd">1400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-100" decimals="-5" id="f-548" unitRef="sgd">41100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-101" decimals="-5" id="f-549" unitRef="usd">14900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-101" decimals="-5" id="f-550" unitRef="eur">14600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-101" decimals="-5" id="f-551" unitRef="sgd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-102" decimals="-6" id="f-552" unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-103" decimals="-8" id="f-553" unitRef="jpy">8700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-104" decimals="-5" id="f-554" unitRef="usd">79900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNonmonetaryNotionalAmountVolume contextRef="c-105" decimals="0" id="f-555" unitRef="bbl">1079145</us-gaap:DerivativeNonmonetaryNotionalAmountVolume>
    <us-gaap:DerivativeNonmonetaryNotionalAmountVolume contextRef="c-106" decimals="0" id="f-556" unitRef="bbl">201801</us-gaap:DerivativeNonmonetaryNotionalAmountVolume>
    <us-gaap:DerivativeAveragePriceRiskOptionStrikePrice
      contextRef="c-107"
      decimals="2"
      id="f-557"
      unitRef="usdPerBbl">86.26</us-gaap:DerivativeAveragePriceRiskOptionStrikePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-558">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges on the condensed consolidated statements of income:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.585%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged item (intercompany loan)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative designated as hedging instrument &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on other comprehensive income (&#x201c;OCI&#x201d;) and earnings, net of tax:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:44pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.803%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:42pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in OCI for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to the above table which summarizes the effects of derivative instruments designated as fair value hedges within the other expense (income) line in our condensed consolidated statements of income for the three and six months ended June&#160;30, 2024 and June&#160;30, 2023. The following table summarizes the effects of derivative instruments designated as cash flow and net investment hedges by line item in our condensed consolidated statements of income:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-108" decimals="-5" id="f-559" unitRef="usd">-2900000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-109" decimals="-5" id="f-560" unitRef="usd">-7400000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-110" decimals="-5" id="f-561" unitRef="usd">-10400000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-111" decimals="-5" id="f-562" unitRef="usd">-9900000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-108" decimals="-5" id="f-563" unitRef="usd">2900000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-109" decimals="-5" id="f-564" unitRef="usd">8200000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-110" decimals="-5" id="f-565" unitRef="usd">10400000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-111" decimals="-5" id="f-566" unitRef="usd">10700000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="c-108" decimals="-5" id="f-567" unitRef="usd">1700000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="c-109" decimals="-5" id="f-568" unitRef="usd">100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="c-110" decimals="-5" id="f-569" unitRef="usd">3500000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="c-111" decimals="-5" id="f-570" unitRef="usd">-1100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="c-3" decimals="-5" id="f-571" unitRef="usd">1700000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="c-4" decimals="-5" id="f-572" unitRef="usd">900000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="c-1" decimals="-5" id="f-573" unitRef="usd">3500000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="c-5" decimals="-5" id="f-574" unitRef="usd">-300000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings contextRef="c-112" decimals="-5" id="f-575" unitRef="usd">-1700000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings contextRef="c-113" decimals="-5" id="f-576" unitRef="usd">-3500000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings contextRef="c-114" decimals="-5" id="f-577" unitRef="usd">200000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings contextRef="c-115" decimals="-5" id="f-578" unitRef="usd">1400000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-116" decimals="-5" id="f-579" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-117" decimals="-5" id="f-580" unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-116" decimals="-5" id="f-581" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-117" decimals="-5" id="f-582" unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-112" decimals="-5" id="f-583" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-114" decimals="-5" id="f-584" unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-112" decimals="-5" id="f-585" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-114" decimals="-5" id="f-586" unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-118" decimals="-5" id="f-587" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-119" decimals="-5" id="f-588" unitRef="usd">-800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-118" decimals="-5" id="f-589" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-119" decimals="-5" id="f-590" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-120" decimals="-5" id="f-591" unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-121" decimals="-5" id="f-592" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-120" decimals="-5" id="f-593" unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-121" decimals="-5" id="f-594" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-122" decimals="-5" id="f-595" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-123" decimals="-5" id="f-596" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-122" decimals="-5" id="f-597" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-123" decimals="-5" id="f-598" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-124" decimals="-5" id="f-599" unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-125" decimals="-5" id="f-600" unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-124" decimals="-5" id="f-601" unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-125" decimals="-5" id="f-602" unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-126" decimals="-5" id="f-603" unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-127" decimals="-5" id="f-604" unitRef="usd">5500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-126" decimals="-5" id="f-605" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-127" decimals="-5" id="f-606" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-128" decimals="-5" id="f-607" unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-129" decimals="-5" id="f-608" unitRef="usd">5500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-128" decimals="-5" id="f-609" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-129" decimals="-5" id="f-610" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-130" decimals="-5" id="f-611" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-131" decimals="-5" id="f-612" unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-130" decimals="-5" id="f-613" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-131" decimals="-5" id="f-614" unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-113" decimals="-5" id="f-615" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-115" decimals="-5" id="f-616" unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-113" decimals="-5" id="f-617" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-115" decimals="-5" id="f-618" unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-132" decimals="-5" id="f-619" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-133" decimals="-5" id="f-620" unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-132" decimals="-5" id="f-621" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-133" decimals="-5" id="f-622" unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-134" decimals="-5" id="f-623" unitRef="usd">-6600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-135" decimals="-5" id="f-624" unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-134" decimals="-5" id="f-625" unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-135" decimals="-5" id="f-626" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-136" decimals="-5" id="f-627" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-137" decimals="-5" id="f-628" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-136" decimals="-5" id="f-629" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-137" decimals="-5" id="f-630" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-138" decimals="-5" id="f-631" unitRef="usd">-6500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-139" decimals="-5" id="f-632" unitRef="usd">-4500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-138" decimals="-5" id="f-633" unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax contextRef="c-139" decimals="-5" id="f-634" unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-140" decimals="-5" id="f-635" unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-141" decimals="-5" id="f-636" unitRef="usd">7200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-140" decimals="-5" id="f-637" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-141" decimals="-5" id="f-638" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-142" decimals="-5" id="f-639" unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-143" decimals="-5" id="f-640" unitRef="usd">7200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-142" decimals="-5" id="f-641" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-143" decimals="-5" id="f-642" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-144" decimals="-5" id="f-643" unitRef="usd">-100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-145" decimals="-5" id="f-644" unitRef="usd">400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-146" decimals="-5" id="f-645" unitRef="usd">-200000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-147" decimals="-5" id="f-646" unitRef="usd">1100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-148" decimals="-5" id="f-647" unitRef="usd">1400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-149" decimals="-5" id="f-648" unitRef="usd">400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-150" decimals="-5" id="f-649" unitRef="usd">2600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-151" decimals="-5" id="f-650" unitRef="usd">400000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-152" decimals="-5" id="f-651" unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-153" decimals="-5" id="f-652" unitRef="usd">100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-154" decimals="-5" id="f-653" unitRef="usd">100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-155" decimals="-5" id="f-654" unitRef="usd">100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c-1" id="f-655">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of derivative instruments not designated as hedges on the condensed consolidated statements of income:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized in Income for the &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-156" decimals="-5" id="f-656" unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-157" decimals="-5" id="f-657" unitRef="usd">-400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-158" decimals="-5" id="f-658" unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-159" decimals="-5" id="f-659" unitRef="usd">-1000000.0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-160" decimals="-5" id="f-660" unitRef="usd">100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-161" decimals="-5" id="f-661" unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-162" decimals="-5" id="f-662" unitRef="usd">500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-163" decimals="-5" id="f-663" unitRef="usd">-200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-164" decimals="-5" id="f-664" unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-165" decimals="-5" id="f-665" unitRef="usd">-600000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-166" decimals="-5" id="f-666" unitRef="usd">400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-167" decimals="-5" id="f-667" unitRef="usd">-1200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-668">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities as of June 30, 2024, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of the cross-currency swap, included within other current assets, is valued using a market approach. Please refer to Note 9, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8e08f59eae304691ab0e971847e56044_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Financial Instruments&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of our derivatives. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of the contingent consideration liability, within current and long-term liabilities, related to the SmartDose&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; technology platform (the &#x201c;SmartDose&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contingent consideration&#x201d;) was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this obligation are recorded as income or expense within other expense (income) in our condensed consolidated statements of income. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#x2019; investment selections and is included within other long-term liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of short-term and long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At June&#160;30, 2024, the estimated fair value of short-term and long-term debt was $203.0 million compared to a carrying amount of $205.8 million. At December&#160;31, 2023, the estimated fair value of short-term and long-term debt was $204.4 million and the carrying amount was $206.8 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-669">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-670">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-6" decimals="-5" id="f-671" unitRef="usd">10400000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-168" decimals="-5" id="f-672" unitRef="usd">10400000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-169" decimals="-5" id="f-673" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-170" decimals="-5" id="f-674" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-6" decimals="-5" id="f-675" unitRef="usd">7400000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-168" decimals="-5" id="f-676" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-169" decimals="-5" id="f-677" unitRef="usd">7400000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-170" decimals="-5" id="f-678" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets contextRef="c-171" decimals="-5" id="f-679" unitRef="usd">25700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-172" decimals="-5" id="f-680" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-173" decimals="-5" id="f-681" unitRef="usd">25700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-174" decimals="-5" id="f-682" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-175" decimals="-5" id="f-683" unitRef="usd">700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-176" decimals="-5" id="f-684" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-177" decimals="-5" id="f-685" unitRef="usd">700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-178" id="f-686" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-6" decimals="-5" id="f-687" unitRef="usd">44200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-168" decimals="-5" id="f-688" unitRef="usd">10400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-169" decimals="-5" id="f-689" unitRef="usd">33800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-170" decimals="-5" id="f-690" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-6" decimals="-5" id="f-691" unitRef="usd">3800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-168" decimals="-5" id="f-692" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-169" decimals="-5" id="f-693" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-170" decimals="-5" id="f-694" unitRef="usd">3800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-6" decimals="-5" id="f-695" unitRef="usd">10600000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-168" decimals="-5" id="f-696" unitRef="usd">10600000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-169" decimals="-5" id="f-697" unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-170" decimals="-5" id="f-698" unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-6" decimals="-5" id="f-699" unitRef="usd">14700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-168" decimals="-5" id="f-700" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-169" decimals="-5" id="f-701" unitRef="usd">14700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-170" decimals="-5" id="f-702" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-6" decimals="-5" id="f-703" unitRef="usd">29100000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-168" decimals="-5" id="f-704" unitRef="usd">10600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-169" decimals="-5" id="f-705" unitRef="usd">14700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-170" decimals="-5" id="f-706" unitRef="usd">3800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-7" decimals="-5" id="f-707" unitRef="usd">10200000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-179" decimals="-5" id="f-708" unitRef="usd">10200000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-180" decimals="-5" id="f-709" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-181" decimals="-5" id="f-710" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-7" decimals="-5" id="f-711" unitRef="usd">5000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-179" decimals="-5" id="f-712" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-180" decimals="-5" id="f-713" unitRef="usd">5000000.0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="c-181" decimals="-5" id="f-714" unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:DerivativeAssets contextRef="c-182" decimals="-5" id="f-715" unitRef="usd">18400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-183" decimals="-5" id="f-716" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-184" decimals="-5" id="f-717" unitRef="usd">18400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-185" decimals="-5" id="f-718" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-186" decimals="-5" id="f-719" unitRef="usd">600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-187" decimals="-5" id="f-720" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-188" decimals="-5" id="f-721" unitRef="usd">600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-189" decimals="-5" id="f-722" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-7" decimals="-5" id="f-723" unitRef="usd">34200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-179" decimals="-5" id="f-724" unitRef="usd">10200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-180" decimals="-5" id="f-725" unitRef="usd">24000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-181" decimals="-5" id="f-726" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-7" decimals="-5" id="f-727" unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-179" decimals="-5" id="f-728" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-180" decimals="-5" id="f-729" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-181" decimals="-5" id="f-730" unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-7" decimals="-5" id="f-731" unitRef="usd">10400000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-179" decimals="-5" id="f-732" unitRef="usd">10400000</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-180" decimals="-5" id="f-733" unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent contextRef="c-181" decimals="-5" id="f-734" unitRef="usd">0</us-gaap:OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-7" decimals="-5" id="f-735" unitRef="usd">2200000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-179" decimals="-5" id="f-736" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-180" decimals="-5" id="f-737" unitRef="usd">2200000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="c-181" decimals="-5" id="f-738" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-7" decimals="-5" id="f-739" unitRef="usd">16200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-179" decimals="-5" id="f-740" unitRef="usd">10400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-180" decimals="-5" id="f-741" unitRef="usd">2200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-181" decimals="-5" id="f-742" unitRef="usd">3600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue contextRef="c-6" decimals="-5" id="f-743" unitRef="usd">203000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-5" id="f-744" unitRef="usd">205800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue contextRef="c-7" decimals="-5" id="f-745" unitRef="usd">204400000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt contextRef="c-7" decimals="-5" id="f-746" unitRef="usd">206800000</us-gaap:LongTermDebt>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-747">Accumulated Other Comprehensive Loss &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit&lt;br/&gt;pension and other &lt;br/&gt;postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign &lt;br/&gt;currency &lt;br/&gt;translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out from accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit&lt;br/&gt;pension and other &lt;br/&gt;postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign &lt;br/&gt;currency &lt;br/&gt;translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out from accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out from accumulated other comprehensive loss is presented in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.269%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:35pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) This component is included in the computation of net periodic benefit cost.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-748">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit&lt;br/&gt;pension and other &lt;br/&gt;postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign &lt;br/&gt;currency &lt;br/&gt;translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out from accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the components of accumulated other comprehensive income ("AOCI") (loss), net of tax, for the six months ended June 30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in equity affiliate investment AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit&lt;br/&gt;pension and other &lt;br/&gt;postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign &lt;br/&gt;currency &lt;br/&gt;translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out from accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-190" decimals="-5" id="f-749" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-191" decimals="-5" id="f-750" unitRef="usd">2300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-192" decimals="-5" id="f-751" unitRef="usd">-10100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-193" decimals="-5" id="f-752" unitRef="usd">-136000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-194" decimals="-5" id="f-753" unitRef="usd">-143800000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-195" decimals="-5" id="f-754" unitRef="usd">-6300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-196" decimals="-5" id="f-755" unitRef="usd">-200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-197" decimals="-5" id="f-756" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-198" decimals="-5" id="f-757" unitRef="usd">-68000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-1" decimals="-5" id="f-758" unitRef="usd">-74500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-195" decimals="-5" id="f-759" unitRef="usd">-1800000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-196" decimals="-5" id="f-760" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-197" decimals="-5" id="f-761" unitRef="usd">400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-198" decimals="-5" id="f-762" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-1" decimals="-5" id="f-763" unitRef="usd">-1400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-195" decimals="-5" id="f-764" unitRef="usd">-4500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-196" decimals="-5" id="f-765" unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-197" decimals="-5" id="f-766" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-198" decimals="-5" id="f-767" unitRef="usd">-68000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-768" unitRef="usd">-73100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-199" decimals="-5" id="f-769" unitRef="usd">-4500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-200" decimals="-5" id="f-770" unitRef="usd">2100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-201" decimals="-5" id="f-771" unitRef="usd">-10500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-202" decimals="-5" id="f-772" unitRef="usd">-204000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-203" decimals="-5" id="f-773" unitRef="usd">-216900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-204" decimals="-5" id="f-774" unitRef="usd">200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-205" decimals="-5" id="f-775" unitRef="usd">1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-206" decimals="-5" id="f-776" unitRef="usd">-9400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-207" decimals="-5" id="f-777" unitRef="usd">-175400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-208" decimals="-5" id="f-778" unitRef="usd">-183000000.0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-209" decimals="-5" id="f-779" unitRef="usd">-6500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-210" decimals="-5" id="f-780" unitRef="usd">-100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-211" decimals="-5" id="f-781" unitRef="usd">-500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-212" decimals="-5" id="f-782" unitRef="usd">4000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-783" unitRef="usd">-3100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-209" decimals="-5" id="f-784" unitRef="usd">-3500000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-210" decimals="-5" id="f-785" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-211" decimals="-5" id="f-786" unitRef="usd">900000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-212" decimals="-5" id="f-787" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-788" unitRef="usd">-2600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-209" decimals="-5" id="f-789" unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-210" decimals="-5" id="f-790" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-211" decimals="-5" id="f-791" unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-212" decimals="-5" id="f-792" unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-793" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-213" decimals="-5" id="f-794" unitRef="usd">-2800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-214" decimals="-5" id="f-795" unitRef="usd">1500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-215" decimals="-5" id="f-796" unitRef="usd">-10800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-216" decimals="-5" id="f-797" unitRef="usd">-171400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-217" decimals="-5" id="f-798" unitRef="usd">-183500000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="c-1" id="f-799">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the reclassifications out from accumulated other comprehensive loss is presented in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.269%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:35pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Losses) gains on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) This component is included in the computation of net periodic benefit cost.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-218" decimals="-5" id="f-800" unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-219" decimals="-5" id="f-801" unitRef="usd">-600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-220" decimals="-5" id="f-802" unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-221" decimals="-5" id="f-803" unitRef="usd">-1300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-218" decimals="-5" id="f-804" unitRef="usd">1800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-219" decimals="-5" id="f-805" unitRef="usd">600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-220" decimals="-5" id="f-806" unitRef="usd">3400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-221" decimals="-5" id="f-807" unitRef="usd">600000</us-gaap:CostOfGoodsAndServicesSold>
    <wst:OtherIncomeExpense contextRef="c-218" decimals="-5" id="f-808" unitRef="usd">1000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-219" decimals="-5" id="f-809" unitRef="usd">-2800000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-220" decimals="-5" id="f-810" unitRef="usd">1000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-221" decimals="-5" id="f-811" unitRef="usd">-2800000</wst:OtherIncomeExpense>
    <us-gaap:InterestExpenseNonoperating contextRef="c-222" decimals="-5" id="f-812" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-223" decimals="-5" id="f-813" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-224" decimals="-5" id="f-814" unitRef="usd">100000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-225" decimals="-5" id="f-815" unitRef="usd">100000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-226" decimals="-5" id="f-816" unitRef="usd">-700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-227" decimals="-5" id="f-817" unitRef="usd">-4000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-228" decimals="-5" id="f-818" unitRef="usd">-2300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-229" decimals="-5" id="f-819" unitRef="usd">-4800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-226" decimals="-5" id="f-820" unitRef="usd">-100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-227" decimals="-5" id="f-821" unitRef="usd">-1200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-228" decimals="-5" id="f-822" unitRef="usd">-500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-229" decimals="-5" id="f-823" unitRef="usd">-1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-226" decimals="-5" id="f-824" unitRef="usd">-600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-227" decimals="-5" id="f-825" unitRef="usd">-2800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-228" decimals="-5" id="f-826" unitRef="usd">-1800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-229" decimals="-5" id="f-827" unitRef="usd">-3500000</us-gaap:NetIncomeLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-230" decimals="-5" id="f-828" unitRef="usd">200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-231" decimals="-5" id="f-829" unitRef="usd">400000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-232" decimals="-5" id="f-830" unitRef="usd">500000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-233" decimals="-5" id="f-831" unitRef="usd">800000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanOtherCosts contextRef="c-230" decimals="-5" id="f-832" unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts contextRef="c-231" decimals="-5" id="f-833" unitRef="usd">-400000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts contextRef="c-232" decimals="-5" id="f-834" unitRef="usd">0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts contextRef="c-233" decimals="-5" id="f-835" unitRef="usd">-400000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-230" decimals="-5" id="f-836" unitRef="usd">200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-231" decimals="-5" id="f-837" unitRef="usd">800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-232" decimals="-5" id="f-838" unitRef="usd">500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-233" decimals="-5" id="f-839" unitRef="usd">1200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-230" decimals="-5" id="f-840" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-231" decimals="-5" id="f-841" unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-232" decimals="-5" id="f-842" unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-233" decimals="-5" id="f-843" unitRef="usd">300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-230" decimals="-5" id="f-844" unitRef="usd">200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-231" decimals="-5" id="f-845" unitRef="usd">600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-232" decimals="-5" id="f-846" unitRef="usd">400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-233" decimals="-5" id="f-847" unitRef="usd">900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-234" decimals="-5" id="f-848" unitRef="usd">-400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-235" decimals="-5" id="f-849" unitRef="usd">-2200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-236" decimals="-5" id="f-850" unitRef="usd">-1400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-237" decimals="-5" id="f-851" unitRef="usd">-2600000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-852">Shareholders&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Equity&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in shareholders&#x2019; equity for the six months ended June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.728%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.886%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.423%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.728%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in Excess of Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of Treasury Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,523.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.20 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,624.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.20 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(979.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,720.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,576.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in shareholders&#x2019; equity for the six months ended June&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in Excess of Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of Treasury Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.19 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.19 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c-1" id="f-853">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in shareholders&#x2019; equity for the six months ended June&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.728%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.886%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.423%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.728%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.474%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in Excess of Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of Treasury Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,523.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.20 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,624.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.20 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(979.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,720.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,576.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in shareholders&#x2019; equity for the six months ended June&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.768%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.541%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in Excess of Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of Treasury Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,987.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.19 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Activity related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares purchased under share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends declared ($0.19 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesIssued
      contextRef="c-238"
      decimals="-5"
      id="f-854"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-238" decimals="-5" id="f-855" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-239" decimals="-5" id="f-856" unitRef="usd">120200000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-240"
      decimals="-5"
      id="f-857"
      unitRef="shares">1800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-240" decimals="-5" id="f-858" unitRef="usd">-637600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-241" decimals="-5" id="f-859" unitRef="usd">3523400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-194" decimals="-5" id="f-860" unitRef="usd">-143800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-861" unitRef="usd">2881000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-242" decimals="-5" id="f-862" unitRef="usd">115300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-243" decimals="-5" id="f-863" unitRef="usd">115300000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-244" decimals="-5" id="f-864" unitRef="usd">-65000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-245"
      decimals="-5"
      id="f-865"
      unitRef="shares">-200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-245" decimals="-5" id="f-866" unitRef="usd">79400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-243" decimals="-5" id="f-867" unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-245"
      decimals="-5"
      id="f-868"
      unitRef="shares">700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-245" decimals="-5" id="f-869" unitRef="usd">267000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-243" decimals="-5" id="f-870" unitRef="usd">267000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-243"
      decimals="INF"
      id="f-871"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-242" decimals="-5" id="f-872" unitRef="usd">14600000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-243" decimals="-5" id="f-873" unitRef="usd">14600000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-246" decimals="-5" id="f-874" unitRef="usd">-48500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-243" decimals="-5" id="f-875" unitRef="usd">-48500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="c-247"
      decimals="-5"
      id="f-876"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-247" decimals="-5" id="f-877" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-248" decimals="-5" id="f-878" unitRef="usd">55200000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-249"
      decimals="-5"
      id="f-879"
      unitRef="shares">2300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-249" decimals="-5" id="f-880" unitRef="usd">-825200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-250" decimals="-5" id="f-881" unitRef="usd">3624100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-251" decimals="-5" id="f-882" unitRef="usd">-192300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-252" decimals="-5" id="f-883" unitRef="usd">2680600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-253" decimals="-5" id="f-884" unitRef="usd">111300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-885" unitRef="usd">111300000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-254" decimals="-5" id="f-886" unitRef="usd">-21700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-255"
      decimals="-5"
      id="f-887"
      unitRef="shares">-100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-255" decimals="-5" id="f-888" unitRef="usd">32800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-3" decimals="-5" id="f-889" unitRef="usd">11100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-255"
      decimals="-5"
      id="f-890"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-255" decimals="-5" id="f-891" unitRef="usd">187100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-3" decimals="-5" id="f-892" unitRef="usd">187100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-3"
      decimals="INF"
      id="f-893"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-253" decimals="-5" id="f-894" unitRef="usd">14500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-3" decimals="-5" id="f-895" unitRef="usd">14500000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-256" decimals="-5" id="f-896" unitRef="usd">-24600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-3" decimals="-5" id="f-897" unitRef="usd">-24600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="c-257"
      decimals="-5"
      id="f-898"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-257" decimals="-5" id="f-899" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-258" decimals="-5" id="f-900" unitRef="usd">33500000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-259"
      decimals="-5"
      id="f-901"
      unitRef="shares">2700000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-259" decimals="-5" id="f-902" unitRef="usd">-979500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-260" decimals="-5" id="f-903" unitRef="usd">3720900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-203" decimals="-5" id="f-904" unitRef="usd">-216900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-5" id="f-905" unitRef="usd">2576800000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="c-261"
      decimals="-5"
      id="f-906"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-261" decimals="-5" id="f-907" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-262" decimals="-5" id="f-908" unitRef="usd">232200000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-263"
      decimals="-5"
      id="f-909"
      unitRef="shares">1200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-263" decimals="-5" id="f-910" unitRef="usd">-370900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-264" decimals="-5" id="f-911" unitRef="usd">2987800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-208" decimals="-5" id="f-912" unitRef="usd">-183000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-5" id="f-913" unitRef="usd">2684900000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-265" decimals="-5" id="f-914" unitRef="usd">140000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-266" decimals="-5" id="f-915" unitRef="usd">140000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-267" decimals="-5" id="f-916" unitRef="usd">-50800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-268"
      decimals="-5"
      id="f-917"
      unitRef="shares">-300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-268" decimals="-5" id="f-918" unitRef="usd">61800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-266" decimals="-5" id="f-919" unitRef="usd">11000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-268"
      decimals="-5"
      id="f-920"
      unitRef="shares">200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-268" decimals="-5" id="f-921" unitRef="usd">60100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-266" decimals="-5" id="f-922" unitRef="usd">60100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-266"
      decimals="INF"
      id="f-923"
      unitRef="usdPerShare">0.19</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-265" decimals="-5" id="f-924" unitRef="usd">14200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-266" decimals="-5" id="f-925" unitRef="usd">14200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-269" decimals="-5" id="f-926" unitRef="usd">14600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-266" decimals="-5" id="f-927" unitRef="usd">14600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="c-270"
      decimals="-5"
      id="f-928"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-270" decimals="-5" id="f-929" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-271" decimals="-5" id="f-930" unitRef="usd">181400000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-272"
      decimals="-5"
      id="f-931"
      unitRef="shares">1100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-272" decimals="-5" id="f-932" unitRef="usd">-369200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-273" decimals="-5" id="f-933" unitRef="usd">3113600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-274" decimals="-5" id="f-934" unitRef="usd">-168400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-275" decimals="-5" id="f-935" unitRef="usd">2776200000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-276" decimals="-5" id="f-936" unitRef="usd">155100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-937" unitRef="usd">155100000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-277" decimals="-5" id="f-938" unitRef="usd">-23200000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-278"
      decimals="-5"
      id="f-939"
      unitRef="shares">-200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-278" decimals="-5" id="f-940" unitRef="usd">41200000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-4" decimals="-5" id="f-941" unitRef="usd">18000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-278"
      decimals="-5"
      id="f-942"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-278" decimals="-5" id="f-943" unitRef="usd">173400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-4" decimals="-5" id="f-944" unitRef="usd">173400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-4"
      decimals="INF"
      id="f-945"
      unitRef="usdPerShare">0.19</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash contextRef="c-276" decimals="-5" id="f-946" unitRef="usd">14100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-4" decimals="-5" id="f-947" unitRef="usd">14100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-279" decimals="-5" id="f-948" unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-949" unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="c-280"
      decimals="-5"
      id="f-950"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-280" decimals="-5" id="f-951" unitRef="usd">18800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-281" decimals="-5" id="f-952" unitRef="usd">158200000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-282"
      decimals="-5"
      id="f-953"
      unitRef="shares">1400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-282" decimals="-5" id="f-954" unitRef="usd">-501400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-283" decimals="-5" id="f-955" unitRef="usd">3254600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-217" decimals="-5" id="f-956" unitRef="usd">-183500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-957" unitRef="usd">2746700000</us-gaap:StockholdersEquity>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-958">Stock-Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#x201c;2016 Plan&#x201d;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At June&#160;30, 2024, there were 1,339,458 shares remaining in the 2016 Plan for future grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2024, we granted 85,263 stock options at a weighted average exercise price of $350.28 per share based on the grant-date fair value of our stock to employees under the 2016 Plan. The weighted average grant date fair value of options granted was $134.93 per share as determined by the Black-Scholes option valuation model using the following weighted average assumptions: a risk-free interest rate of 4.3%; expected life of 6.0 years based on prior experience; stock volatility of 32.0% based on historical data; and a dividend yield of 0.3%. Stock option expense is recognized over the vesting period, net of forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2024, we granted 32,876 stock-settled performance share unit (&#x201c;PSU&#x201d;) awards at a weighted average grant-date fair value of $350.28 per share to eligible employees. These awards are earned based on the Company&#x2019;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock. Shares earned under PSU awards may vary from 0% to 200% of an employee&#x2019;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2024, we granted 7,019 stock-settled restricted share unit (&#x201c;RSU&#x201d;) awards at a weighted average grant-date fair value of $350.65 per share to eligible employees. These awards are earned over a specified performance period. The fair value of stock-settled RSU awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period, net of forfeitures. &lt;/span&gt;&lt;/div&gt;Stock-based compensation expense was $4.3 million and $9.3 million for the three and six months ended June&#160;30, 2024, respectively. For the three and six months ended June&#160;30, 2023, stock-based compensation expense was $7.5 million and $16.0 million, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-6" decimals="INF" id="f-959" unitRef="shares">1339458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c-1" decimals="INF" id="f-960" unitRef="shares">85263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-961"
      unitRef="usdPerShare">350.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-962"
      unitRef="usdPerShare">134.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-1" decimals="3" id="f-963" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-1" id="f-964">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-1" decimals="3" id="f-965" unitRef="number">0.320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="3" id="f-966" unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-284"
      decimals="INF"
      id="f-967"
      unitRef="shares">32876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-284"
      decimals="2"
      id="f-968"
      unitRef="usdPerShare">350.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage contextRef="c-285" decimals="2" id="f-969" unitRef="number">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage contextRef="c-286" decimals="2" id="f-970" unitRef="number">2</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-287"
      decimals="INF"
      id="f-971"
      unitRef="shares">7019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-287"
      decimals="2"
      id="f-972"
      unitRef="usdPerShare">350.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-3" decimals="-5" id="f-973" unitRef="usd">4300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-974" unitRef="usd">9300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-4" decimals="-5" id="f-975" unitRef="usd">7500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-976" unitRef="usd">16000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="c-1" id="f-977">Other Expense (Income)&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposal of plant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss on Disposal of Plant&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#x2019;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration represents changes in the fair value of the SmartDose&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contingent consideration. Please refer to Note 10, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8e08f59eae304691ab0e971847e56044_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Measurements&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring and Related Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes are expected to be implemented over a period of up to twenty-four months from the date of approval. The plan is expected to require restructuring and related charges of approximately $22&#160;million to $24&#160;million, with annualized savings in the range of $22&#160;million to $24&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;br/&gt;and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Credits) Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock contextRef="c-1" id="f-978">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense (income) consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposal of plant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange transaction losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfOtherIncomeAndExpenseByComponentTableTextBlock>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-3" decimals="-5" id="f-979" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-4" decimals="-5" id="f-980" unitRef="usd">-2200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-5" id="f-981" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-5" decimals="-5" id="f-982" unitRef="usd">-11600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-3" decimals="-5" id="f-983" unitRef="usd">-2000000.0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-4" decimals="-5" id="f-984" unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-5" id="f-985" unitRef="usd">-3200000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-5" id="f-986" unitRef="usd">-1200000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-3" decimals="-5" id="f-987" unitRef="usd">1000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-4" decimals="-5" id="f-988" unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-989" unitRef="usd">2000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-990" unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AssetImpairmentCharges contextRef="c-3" decimals="-5" id="f-991" unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-4" decimals="-5" id="f-992" unitRef="usd">1500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-993" unitRef="usd">900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-5" decimals="-5" id="f-994" unitRef="usd">3400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringAndRelatedCostIncurredCost contextRef="c-3" decimals="-5" id="f-995" unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost contextRef="c-4" decimals="-5" id="f-996" unitRef="usd">-800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost contextRef="c-1" decimals="-5" id="f-997" unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost contextRef="c-5" decimals="-5" id="f-998" unitRef="usd">-800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c-3" decimals="-5" id="f-999" unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c-4" decimals="-5" id="f-1000" unitRef="usd">-300000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c-1" decimals="-5" id="f-1001" unitRef="usd">-300000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="c-5" decimals="-5" id="f-1002" unitRef="usd">-700000</us-gaap:OtherOperatingIncomeExpenseNet>
    <wst:OtherIncomeExpense contextRef="c-3" decimals="-5" id="f-1003" unitRef="usd">-3300000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-4" decimals="-5" id="f-1004" unitRef="usd">-4000000.0</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-1" decimals="-5" id="f-1005" unitRef="usd">-6400000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense contextRef="c-5" decimals="-5" id="f-1006" unitRef="usd">-16900000</wst:OtherIncomeExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-4" decimals="-5" id="f-1007" unitRef="usd">-2200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-5" decimals="-5" id="f-1008" unitRef="usd">-11600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <wst:RestructuringAndRelatedActivitiesPeriodOfImplementation contextRef="c-288" id="f-1009">P24M</wst:RestructuringAndRelatedActivitiesPeriodOfImplementation>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-289" decimals="-6" id="f-1010" unitRef="usd">22000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-290" decimals="-6" id="f-1011" unitRef="usd">24000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:EffectOnFutureEarningsAmount contextRef="c-291" decimals="-6" id="f-1012" unitRef="usd">22000000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:EffectOnFutureEarningsAmount contextRef="c-292" decimals="-6" id="f-1013" unitRef="usd">24000000</us-gaap:EffectOnFutureEarningsAmount>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-1014">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance&lt;br/&gt;and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Credits) Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-293" decimals="-5" id="f-1015" unitRef="usd">3000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-294" decimals="-5" id="f-1016" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-295" decimals="-5" id="f-1017" unitRef="usd">3000000.0</us-gaap:RestructuringReserve>
    <wst:RestructuringChargesCredits contextRef="c-296" decimals="-5" id="f-1018" unitRef="usd">0</wst:RestructuringChargesCredits>
    <wst:RestructuringChargesCredits contextRef="c-297" decimals="-5" id="f-1019" unitRef="usd">0</wst:RestructuringChargesCredits>
    <wst:RestructuringChargesCredits contextRef="c-298" decimals="-5" id="f-1020" unitRef="usd">0</wst:RestructuringChargesCredits>
    <us-gaap:PaymentsForRestructuring contextRef="c-296" decimals="-5" id="f-1021" unitRef="usd">300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-297" decimals="-5" id="f-1022" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-298" decimals="-5" id="f-1023" unitRef="usd">300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-299" decimals="-5" id="f-1024" unitRef="usd">2700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-300" decimals="-5" id="f-1025" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-301" decimals="-5" id="f-1026" unitRef="usd">2700000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1027">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was $21.9 million and $34.8 million for the three months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 17.0% and 18.8%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for three months ended June&#160;30, 2024 as compared to the same period in 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was $38.3 million and $58.4 million for the six months ended June&#160;30, 2024 and 2023, respectively, and the effective tax rate was 15.0% and 17.0%, respectively. The decrease in the effective tax rate is primarily due to a shift in the forecasted geographic earnings mix, offset by a decrease in the tax benefit related to stock-based compensation for six months ended June&#160;30, 2024, as compared to the same period in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company continues to address the change in tax laws enacted pursuant to the Organization for Economic Cooperation and Development (OECD)&#x2019;s 15% global minimum tax initiative (Pillar 2). The 2024 forecasted impact of Pillar 2 is not expected to be material to the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-3" decimals="-5" id="f-1028" unitRef="usd">21900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-1029" unitRef="usd">34800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-3" decimals="3" id="f-1030" unitRef="number">0.170</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-4" decimals="3" id="f-1031" unitRef="number">0.188</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1032" unitRef="usd">38300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-1033" unitRef="usd">58400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1034" unitRef="number">0.150</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-1035" unitRef="number">0.170</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1036">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we are involved in product liability matters and other legal proceedings and claims generally incidental to our normal business activities. We accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. While the outcome of current proceedings cannot be accurately predicted, we believe their ultimate resolution should not have a material adverse effect on our business, financial condition, results of operations or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes to commitments and contingencies since December 31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1037">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Chief Operating Decision Maker ("CODM") evaluates the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that the CODM considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The segment operating profit metric is what the CODM uses in evaluating our results of operations and the financial measure that provides a valuable insight into our overall performance and financial position.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquisition-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposal of plant &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest (income) expense, net and other nonoperating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) During the three and six months ended June&#160;30, 2024, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June&#160;30, 2023, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#x2019;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other charges of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.1&#160;million &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for both the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended June&#160;30, 2023 represents the net impact of an&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; inventory write down of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.9&#160;million within cost of goods and services sold and a $0.8&#160;million&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; benefit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within other expense (income) &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for revised severance estimates in connection with its 2022 restructuring plan. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 14, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i8e08f59eae304691ab0e971847e56044_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Expense (Income)&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion of certain unallocated items referenced above.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1038"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="c-1" id="f-1039">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.242%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-302" decimals="-5" id="f-1040" unitRef="usd">559700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-303" decimals="-5" id="f-1041" unitRef="usd">618000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-304" decimals="-5" id="f-1042" unitRef="usd">1119200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-305" decimals="-5" id="f-1043" unitRef="usd">1201100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-306" decimals="-5" id="f-1044" unitRef="usd">142400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-307" decimals="-5" id="f-1045" unitRef="usd">135800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-308" decimals="-5" id="f-1046" unitRef="usd">278300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-309" decimals="-5" id="f-1047" unitRef="usd">269300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-3" decimals="-5" id="f-1048" unitRef="usd">702100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-5" id="f-1049" unitRef="usd">753800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1050" unitRef="usd">1397500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1051" unitRef="usd">1470400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1052">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.932%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate general costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated Items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquisition-related intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposal of plant &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Corporate and Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest (income) expense, net and other nonoperating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net income of affiliated companies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) During the three and six months ended June&#160;30, 2024, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June&#160;30, 2023, the Company recorded $0.2&#160;million and $0.4&#160;million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) During the three and six months ended June&#160;30, 2023, the Company recorded expense of $2.2&#160;million and $11.6&#160;million, respectively, within other expense (income), as a result of the sale of one of the Company&#x2019;s manufacturing facilities within the Proprietary Products segment. The transaction closed during the second quarter of 2023.  &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4) &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other charges of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.1&#160;million &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for both the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended June&#160;30, 2023 represents the net impact of an&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; inventory write down of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.9&#160;million within cost of goods and services sold and a $0.8&#160;million&lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; benefit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within other expense (income) &lt;/span&gt;for revised severance estimates in connection with its 2022 restructuring plan.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingIncomeLoss contextRef="c-310" decimals="-5" id="f-1053" unitRef="usd">131000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-311" decimals="-5" id="f-1054" unitRef="usd">194200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-312" decimals="-5" id="f-1055" unitRef="usd">257300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-313" decimals="-5" id="f-1056" unitRef="usd">364900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-314" decimals="-5" id="f-1057" unitRef="usd">17200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-315" decimals="-5" id="f-1058" unitRef="usd">14900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-316" decimals="-5" id="f-1059" unitRef="usd">34300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-317" decimals="-5" id="f-1060" unitRef="usd">32300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-318" decimals="-5" id="f-1061" unitRef="usd">148200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-319" decimals="-5" id="f-1062" unitRef="usd">209100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-320" decimals="-5" id="f-1063" unitRef="usd">291600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-321" decimals="-5" id="f-1064" unitRef="usd">397200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-322" decimals="-5" id="f-1065" unitRef="usd">4300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-323" decimals="-5" id="f-1066" unitRef="usd">7500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-324" decimals="-5" id="f-1067" unitRef="usd">9300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-325" decimals="-5" id="f-1068" unitRef="usd">16000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-322" decimals="-5" id="f-1069" unitRef="usd">17500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-323" decimals="-5" id="f-1070" unitRef="usd">16600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-324" decimals="-5" id="f-1071" unitRef="usd">32900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-325" decimals="-5" id="f-1072" unitRef="usd">31300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-322" decimals="-5" id="f-1073" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-323" decimals="-5" id="f-1074" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-324" decimals="-5" id="f-1075" unitRef="usd">400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-325" decimals="-5" id="f-1076" unitRef="usd">400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-322" decimals="-5" id="f-1077" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-323" decimals="-5" id="f-1078" unitRef="usd">-2200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-324" decimals="-5" id="f-1079" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-325" decimals="-5" id="f-1080" unitRef="usd">-11600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:RestructuringCharges contextRef="c-322" decimals="-5" id="f-1081" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-323" decimals="-5" id="f-1082" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-324" decimals="-5" id="f-1083" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-325" decimals="-5" id="f-1084" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingIncomeLoss contextRef="c-322" decimals="-5" id="f-1085" unitRef="usd">-22000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-323" decimals="-5" id="f-1086" unitRef="usd">-26600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-324" decimals="-5" id="f-1087" unitRef="usd">-42600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-325" decimals="-5" id="f-1088" unitRef="usd">-59400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-3" decimals="-5" id="f-1089" unitRef="usd">126200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-4" decimals="-5" id="f-1090" unitRef="usd">182500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-1091" unitRef="usd">249000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-1092" unitRef="usd">337800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-3" decimals="-5" id="f-1093" unitRef="usd">2500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-4" decimals="-5" id="f-1094" unitRef="usd">2400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-1095" unitRef="usd">7100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-1096" unitRef="usd">5000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-1097" unitRef="usd">128700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-1098" unitRef="usd">184900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1099" unitRef="usd">256100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-1100" unitRef="usd">342800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-322" decimals="-5" id="f-1101" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-324" decimals="-5" id="f-1102" unitRef="usd">400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-323" decimals="-5" id="f-1103" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-325" decimals="-5" id="f-1104" unitRef="usd">400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-323" decimals="-5" id="f-1105" unitRef="usd">-2200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-325" decimals="-5" id="f-1106" unitRef="usd">-11600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:RestructuringCharges contextRef="c-325" decimals="-5" id="f-1107" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-323" decimals="-5" id="f-1108" unitRef="usd">100000</us-gaap:RestructuringCharges>
    <us-gaap:InventoryWriteDown contextRef="c-326" decimals="-5" id="f-1109" unitRef="usd">900000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-327" decimals="-5" id="f-1110" unitRef="usd">900000</us-gaap:InventoryWriteDown>
    <us-gaap:SeveranceCosts1 contextRef="c-326" decimals="-5" id="f-1111" unitRef="usd">800000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-327" decimals="-5" id="f-1112" unitRef="usd">800000</us-gaap:SeveranceCosts1>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1113">Subsequent Events&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 2, 2024, the Company entered into the Third Amendment to the Credit Facility Agreement, which amended the Existing Credit Facility Agreement. Among other changes to the existing credit agreement, the Third Amendment established an incremental term loan in the stated principal amount of $130.0&#160;million (the &#x201c;New Term Loan&#x201d;), which was fully drawn at closing and matures on July 2, 2027. The entire stated principal amount of the New Term Loan is due at maturity and there is no scheduled amortization prior to such date. Together with cash on hand, proceeds from the New Term Loan were used to repay an outstanding term loan under the Existing Credit Facility Agreement in the principal amount of $79.9&#160;million and to repay an aggregate principal amount of  $53.0&#160;million of the Company&#x2019;s 3.82% Series B Senior Notes due July 5, 2024 issued under that certain Note Purchase Agreement dated as of July 5, 2012.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-328" decimals="INF" id="f-1114" unitRef="usd">130000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-329" decimals="-5" id="f-1115" unitRef="usd">79900000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-330" decimals="-5" id="f-1116" unitRef="usd">53000000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-331"
      decimals="INF"
      id="f-1117"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
